# EDGAR Filing Document

**Accession Number:** 0000817132
**File Stem:** 0001193125-26-177573
**Filing Date:** 2026-4
**Character Count:** 1194323
**Document Hash:** bc5b55e7aa4930572205754c1346b6b1
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-26-177573.hdr.sgml**: 20260424

**ACCESSION NUMBER**: 0001193125-26-177573

**CONFORMED SUBMISSION TYPE**: N-VPFS

**PUBLIC DOCUMENT COUNT**: 5

**CONFORMED PERIOD OF REPORT**: 20251231

**FILED AS OF DATE**: 20260424

**DATE AS OF CHANGE**: 20260424

**EFFECTIVENESS DATE**: 20260424

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** RIVERSOURCE OF NEW YORK ACCOUNT 8
- **CENTRAL INDEX KEY:** 0000817132

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** MN
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** N-VPFS
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-05213
- **FILM NUMBER:** 26895292

**BUSINESS ADDRESS:**
- **STREET 1:** 50605 AMERIPRISE FINANCIAL CENTER
- **STREET 2:** H27/5229
- **CITY:** MINNEAPOLIS
- **STATE:** MN
- **ZIP:** 55474
- **BUSINESS PHONE:** 6126784177

**MAIL ADDRESS:**
- **STREET 1:** 50605 AMERIPRISE FINANCIAL CENTER
- **STREET 2:** H27/5229
- **CITY:** MINNEAPOLIS
- **STATE:** MN
- **ZIP:** 55474

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** IDS LIFE OF NEW YORK ACCOUNT 8
- **DATE OF NAME CHANGE:** 19920703

## Series and Classes Contracts Data

### RIVERSOURCE OF NEW YORK ACCOUNT 8 (Series ID: S000003512)

| Class ID   | Class Name                                                                                        | Ticker Symbol   |
|:---|:---|:---|
| C000009719 | RiverSource Succession Select Variable Life Insurance                                             |  |
| C000009720 | RiverSource Variable Universal Life Insurance                                                     |  |
| C000009721 | RiverSource Variable Second-To-Die Life Insurance                                                 |  |
| C000009722 | RiverSource Variable Universal Life III                                                           |  |
| C000009723 | RiverSource Variable Universal Life IV/ RiverSource Variable Universal Life IV - Estate Series    |  |
| C000119303 | RiverSource Variable Universal Life 5 NY/RiverSource Variable Universal Life 5 NY - Estate Series |  |

![](g104622img13a032471.gif)

![](g104622img591c1a112.gif)

**2025 Annual Report**

**RiverSource of New York Account 8**

This wrapper contains financial statements provided for owners of:

• *RiverSource Succession Select*<sup>®</sup> Variable Life Insurance

• *RiverSource*<sup>®</sup> Variable Second-To-Die Life Insurance

• *RiverSource*<sup>®</sup> Variable Universal Life Insurance

• *RiverSource*<sup>®</sup> Variable Universal Life Insurance III

• *RiverSource*<sup>®</sup> Variable Universal Life IV

• *RiverSource*<sup>®</sup> Variable Universal Life IV – Estate Series

• *RiverSource*<sup>®</sup> Variable Universal Life 5

• *RiverSource*<sup>®</sup> Variable Universal Life 5 – Estate Series

This Annual Report contains financial information for all the subaccounts of RiverSource of New York Account 8. Not all subaccounts of RiverSource of New York Account 8 apply to your specific contract.

![](g104622imgdc1f7ead3.jpg)

Issued by: RiverSource Life Insurance Co. of New York

ANN9126_12_E01_(05/26)

------

**This page left blank intentionally**

------

**REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM**

**TO THE BOARD OF DIRECTORS OF RIVERSOURCE LIFE INSURANCE CO. OF NEW YORK AND**

**THE POLICY OWNERS OF RIVERSOURCE OF NEW YORK ACCOUNT 8**

***Opinions on the Financial Statements***

We have audited the accompanying statements of assets and liabilities of each of the divisions of RiverSource of New York Account 8, as indicated in Note 1, as of December 31, 2025, and the related statements of operations and of changes in net assets for each of the periods indicated in Note 1, including the related notes (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the financial position of each of the divisions of RiverSource of New York Account 8 as of December 31, 2025, and the results of each of their operations and the changes in each of their net assets of the periods indicated in Note 1 in conformity with accounting principles generally accepted in the United States of America.

***Basis for Opinions***

These financial statements are the responsibility of the RiverSource Life Insurance Co. of New York management. Our responsibility is to express an opinion on the financial statements of each of the divisions of the RiverSource of New York Account 8 based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to each of the divisions of the RiverSource of New York Account 8 in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits of these financial statements in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud.

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. Our procedures included confirmation of investments owned as of December 31, 2025, by correspondence with the investee mutual funds and the transfer agents of the investee mutual funds. We believe that our audits provide a reasonable basis for our opinions.

/s/ PricewaterhouseCoopers LLP

Minneapolis, Minnesota

April 24, 2026

We have served as the auditor of one or more of the divisions of RiverSource of New York Account 8 since 2010.

**RiverSource of New York Account 8** ■ 3

------

**Statement of Assets and Liabilities**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **December 31, 2025** | **AB VPS Dyn** <br> **Asset Alloc,** <br>**Cl B**<br>| **AB VPS Intl** <br> **Val,** <br>**Cl B**<br>| **AB VPS Lg** <br> **Cap Gro,** <br>**Cl A**<br>| **AB VPS Lg** <br> **Cap Gro,** <br>**Cl B**<br>| **AB VPS** <br> **Relative Val,** <br>**Cl B**<br>|
| **Assets** |  |  |  |  |  |
| Investments, at fair value | $599 | $3582272 | $1391228 | $3777009 | $2745728 |
| Dividends receivable | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Accounts receivable from RiverSource Life of NY for contract purchase payments | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 102 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 139 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 173 |
| Receivable for share redemptions | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1662 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1165 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1007 |
| Total assets | 599 | 3584036 | 1391367 | 3778174 | 2746908 |
| **Liabilities** |  |  |  |  |  |
| Payable to RiverSource Life of NY for: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Mortality and expense risk fee | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1357 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1165 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1007 |
| &nbsp;&nbsp;&nbsp; Contract terminations | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 305 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Payable for investments purchased | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 102 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 139 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 173 |
| Total liabilities | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1764 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 139 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1165 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1180 |
| Net assets applicable to Variable Life contracts in accumulation period | &nbsp;&nbsp;&nbsp;&nbsp; 1 | 3582272 | 1391228 | 3777009 | 2745728 |
| Net assets applicable to seed money | 598 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total net assets | $599 | $3582272 | $1391228 | $3777009 | $2745728 |
| Investment shares | &nbsp;&nbsp;&nbsp; 55 | &nbsp;&nbsp;&nbsp;&nbsp; 172059 | &nbsp;&nbsp;&nbsp;&nbsp; 15032 | &nbsp;&nbsp;&nbsp;&nbsp; 46355 | &nbsp;&nbsp;&nbsp;&nbsp; 89003 |
| Investments, at cost | $602 | $2673486 | $1248026 | $3141782 | $2622628 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **December 31, 2025 (continued)** | **Allspg VT** <br> **Index Asset** <br> **Alloc,** <br>**Cl 2**<br>| **Allspg VT Opp,** <br>**Cl 1**<br>| **Allspg VT Opp,** <br>**Cl 2**<br>| **Allspg VT Sm** <br> **Cap Gro,** <br>**Cl 1**<br>| **Allspg VT Sm** <br> **Cap Gro,** <br>**Cl 2**<br>|
| **Assets** |  |  |  |  |  |
| Investments, at fair value | $651933 | $27949 | $1340405 | $533563 | $1544460 |
| Dividends receivable | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Accounts receivable from RiverSource Life of NY for contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 49 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 29 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Receivable for share redemptions | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 210 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 402 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 406 |
| Total assets | 652143 | 27949 | 1340856 | 533592 | 1544866 |
| **Liabilities** |  |  |  |  |  |
| Payable to RiverSource Life of NY for: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Mortality and expense risk fee | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 210 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 402 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 395 |
| &nbsp;&nbsp;&nbsp; Contract terminations | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 11 |
| Payable for investments purchased | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 49 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 29 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total liabilities | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 210 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 451 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 29 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 406 |
| Net assets applicable to Variable Life contracts in accumulation period | 651800 | 27949 | 1340239 | 533563 | 1544460 |
| Net assets applicable to seed money | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 133 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 166 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total net assets | $651933 | $27949 | $1340405 | $533563 | $1544460 |
| Investment shares | &nbsp;&nbsp;&nbsp; 32597 | &nbsp;&nbsp;&nbsp; 1089 | &nbsp;&nbsp;&nbsp;&nbsp; 52156 | &nbsp;&nbsp;&nbsp; 51552 | &nbsp;&nbsp;&nbsp;&nbsp; 160881 |
| Investments, at cost | $635149 | $27972 | $1322344 | $500213 | $1545212 |

---

See accompanying notes to financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**4 ■ RiverSource of New York Account 8**

------

**Statement of Assets and Liabilities**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **December 31, 2025 (continued)** | **ALPS Alerian** <br> **Engy Infr,** <br> **Class I**<br>| **ALPS Alerian** <br> **Engy Infr,** <br> **Class III**<br>| **BlackRock** <br> **Global Alloc,** <br>**Cl I**<br>| **BlackRock** <br> **Global Alloc,** <br>**Cl III**<br>| **Calvert VP SRI** <br> **Bal,** <br>**Cl I**<br>|
| **Assets** |  |  |  |  |  |
| Investments, at fair value | $102515 | $517634 | $378192 | $618492 | $3010144 |
| Dividends receivable | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Accounts receivable from RiverSource Life of NY for contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 857 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 17 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Receivable for share redemptions | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 249 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 254 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1472 |
| Total assets | 103372 | 517883 | 378192 | 618763 | 3011616 |
| **Liabilities** |  |  |  |  |  |
| Payable to RiverSource Life of NY for: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Mortality and expense risk fee | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 249 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 254 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1351 |
| &nbsp;&nbsp;&nbsp; Contract terminations | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 121 |
| Payable for investments purchased | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 857 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 17 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total liabilities | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 857 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 249 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 271 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1472 |
| Net assets applicable to Variable Life contracts in accumulation period | 102515 | 517395 | 378192 | 618348 | 3010022 |
| Net assets applicable to seed money | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 239 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 144 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 122 |
| Total net assets | $102515 | $517634 | $378192 | $618492 | $3010144 |
| Investment shares | &nbsp;&nbsp;&nbsp;&nbsp; 8143 | &nbsp;&nbsp;&nbsp; 41180 | &nbsp;&nbsp;&nbsp; 21439 | &nbsp;&nbsp;&nbsp; 46364 | 1056191 |
| Investments, at cost | $102654 | $424425 | $371401 | $636986 | $2619045 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **December 31, 2025 (continued)** | **Col VP Acorn** | **Col VP Acorn** <br> **Intl**<br>| **Col VP Bal,** <br>**Cl 1**<br>| **Col VP Bal,** <br>**Cl 3**<br>| **Col VP** <br> **Commodity** <br> **Strategy,** <br>**Cl 1**<br>|
| **Assets** |  |  |  |  |  |
| Investments, at fair value | $5847052 | $4081173 | $3650762 | $20072505 | $103549 |
| Dividends receivable | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Accounts receivable from RiverSource Life of NY for contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1733 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3508 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1673 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 162 |
| Receivable for share redemptions | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2661 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1774 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 14115 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total assets | 5851446 | 4086455 | 3652435 | 20086620 | 103711 |
| **Liabilities** |  |  |  |  |  |
| Payable to RiverSource Life of NY for: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Mortality and expense risk fee | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2588 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1774 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 13509 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| &nbsp;&nbsp;&nbsp; Contract terminations | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 73 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 606 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Payable for investments purchased | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1733 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3508 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1673 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 162 |
| Total liabilities | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 4394 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5282 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1673 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 14115 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 162 |
| Net assets applicable to Variable Life contracts in accumulation period | 5847052 | 4081173 | 3650762 | 20072505 | 103549 |
| Net assets applicable to seed money | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total net assets | $5847052 | $4081173 | $3650762 | $20072505 | $103549 |
| Investment shares | &nbsp;&nbsp;&nbsp;&nbsp; 367739 | &nbsp;&nbsp;&nbsp;&nbsp; 199666 | &nbsp;&nbsp;&nbsp;&nbsp; 65485 | &nbsp;&nbsp;&nbsp;&nbsp; 364888 | &nbsp;&nbsp;&nbsp; 25256 |
| Investments, at cost | $6835728 | $4746495 | $2892861 | $8266497 | $109098 |

---

See accompanying notes to financial statements.

**RiverSource of New York Account 8** ■ 5

------

**Statement of Assets and Liabilities**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **December 31, 2025 (continued)** | **Col VP** <br> **Commodity** <br> **Strategy,** <br>**Cl 2**<br>| **Col VP** <br> **Contrarian** <br> **Core,** <br>**Cl 1**<br>| **Col VP** <br> **Contrarian** <br> **Core,** <br>**Cl 2**<br>| **Col VP** <br> **Corporate** <br> **Bond,** <br>**Cl 1**<br>| **Col VP** <br> **Corporate** <br> **Bond,** <br>**Cl 2**<br>|
| **Assets** |  |  |  |  |  |
| Investments, at fair value | $44101 | $631008 | $469827 | $14038 | $102075 |
| Dividends receivable | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Accounts receivable from RiverSource Life of NY for contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 1139 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Receivable for share redemptions | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total assets | 44101 | 632147 | 469827 | 14038 | 102075 |
| **Liabilities** |  |  |  |  |  |
| Payable to RiverSource Life of NY for: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Mortality and expense risk fee | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| &nbsp;&nbsp;&nbsp; Contract terminations | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Payable for investments purchased | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 1139 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total liabilities | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 1139 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net assets applicable to Variable Life contracts in accumulation period | 44101 | 631008 | 469827 | 14038 | 102075 |
| Net assets applicable to seed money | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total net assets | $44101 | $631008 | $469827 | $14038 | $102075 |
| Investment shares | 11025 | &nbsp;&nbsp;&nbsp;&nbsp; 9932 | &nbsp;&nbsp;&nbsp;&nbsp; 7649 | &nbsp;&nbsp;&nbsp; 1788 | &nbsp;&nbsp;&nbsp; 13291 |
| Investments, at cost | $50490 | $427025 | $286393 | $13621 | $110385 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **December 31, 2025 (continued)** | **Col VP** <br> **Corporate** <br> **Bond,** <br>**Cl 3**<br>| **Col VP** <br> **Disciplined** <br> **Core,** <br>**Cl 1**<br>| **Col VP** <br> **Disciplined** <br> **Core,** <br>**Cl 2**<br>| **Col VP** <br> **Disciplined** <br> **Core,** <br>**Cl 3**<br>| **Col VP Divd** <br> **Opp,** <br>**Cl 1**<br>|
| **Assets** |  |  |  |  |  |
| Investments, at fair value | $1202237 | $415891 | $548251 | $34146435 | $801503 |
| Dividends receivable | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Accounts receivable from RiverSource Life of NY for contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 50 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 26 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 29 |
| Receivable for share redemptions | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 557 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 25329 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total assets | 1202844 | 415891 | 548251 | 34171790 | 801532 |
| **Liabilities** |  |  |  |  |  |
| Payable to RiverSource Life of NY for: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Mortality and expense risk fee | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 531 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 25295 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| &nbsp;&nbsp;&nbsp; Contract terminations | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 26 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 34 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Payable for investments purchased | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 50 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 26 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 29 |
| Total liabilities | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 607 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 25355 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 29 |
| Net assets applicable to Variable Life contracts in accumulation period | 1202237 | 415891 | 548251 | 34146435 | 801503 |
| Net assets applicable to seed money | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total net assets | $1202237 | $415891 | $548251 | $34146435 | $801503 |
| Investment shares | &nbsp;&nbsp;&nbsp;&nbsp; 154728 | &nbsp;&nbsp;&nbsp;&nbsp; 3212 | &nbsp;&nbsp;&nbsp;&nbsp; 4402 | &nbsp;&nbsp;&nbsp;&nbsp; 269081 | &nbsp;&nbsp;&nbsp; 15278 |
| Investments, at cost | $1329130 | $308765 | $234616 | $7423614 | $673453 |

---

See accompanying notes to financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**6 ■ RiverSource of New York Account 8**

------

**Statement of Assets and Liabilities**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **December 31, 2025 (continued)** | **Col VP Divd** <br> **Opp,** <br>**Cl 2**<br>| **Col VP Divd** <br> **Opp,** <br>**Cl 3**<br>| **Col VP Emer** <br> **Mkts,** <br>**Cl 1**<br>| **Col VP Emer** <br> **Mkts,** <br>**Cl 2**<br>| **Col VP Emer** <br> **Mkts,** <br>**Cl 3**<br>|
| **Assets** |  |  |  |  |  |
| Investments, at fair value | $403004 | $13971040 | $393637 | $482118 | $2358589 |
| Dividends receivable | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Accounts receivable from RiverSource Life of NY for contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2270 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 235 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 116 |
| Receivable for share redemptions | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 6586 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1132 |
| Total assets | 403004 | 13979896 | 393872 | 482118 | 2359837 |
| **Liabilities** |  |  |  |  |  |
| Payable to RiverSource Life of NY for: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Mortality and expense risk fee | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 6586 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1117 |
| &nbsp;&nbsp;&nbsp; Contract terminations | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 15 |
| Payable for investments purchased | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2270 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 235 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 116 |
| Total liabilities | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 8856 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 235 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1248 |
| Net assets applicable to Variable Life contracts in accumulation period | 403004 | 13971040 | 393637 | 482118 | 2358589 |
| Net assets applicable to seed money | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total net assets | $403004 | $13971040 | $393637 | $482118 | $2358589 |
| Investment shares | &nbsp;&nbsp;&nbsp;&nbsp; 7993 | &nbsp;&nbsp;&nbsp;&nbsp; 271704 | &nbsp;&nbsp;&nbsp; 29310 | &nbsp;&nbsp;&nbsp; 36719 | &nbsp;&nbsp;&nbsp;&nbsp; 177338 |
| Investments, at cost | $281917 | $7043563 | $364200 | $500759 | $2376951 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **December 31, 2025 (continued)** | **Col VP Emerg** <br> **Mkts Bond,** <br>**Cl 1**<br>| **Col VP Emerg** <br> **Mkts Bond,** <br>**Cl 2**<br>| **Col VP Govt** <br> **Money Mkt,** <br>**Cl 1**<br>| **Col VP Govt** <br> **Money Mkt,** <br>**Cl 2**<br>| **Col VP Govt** <br> **Money Mkt,** <br>**Cl 3**<br>|
| **Assets** |  |  |  |  |  |
| Investments, at fair value | $54133 | $19266 | $697636 | $527679 | $3667213 |
| Dividends receivable | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 65 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 46 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 329 |
| Accounts receivable from RiverSource Life of NY for contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 664 |
| Receivable for share redemptions | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1733 |
| Total assets | 54133 | 19266 | 697701 | 527725 | 3669939 |
| **Liabilities** |  |  |  |  |  |
| Payable to RiverSource Life of NY for: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Mortality and expense risk fee | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1725 |
| &nbsp;&nbsp;&nbsp; Contract terminations | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 8 |
| Payable for investments purchased | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 664 |
| Total liabilities | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2397 |
| Net assets applicable to Variable Life contracts in accumulation period | 54133 | 19266 | 697701 | 527725 | 3667542 |
| Net assets applicable to seed money | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total net assets | $54133 | $19266 | $697701 | $527725 | $3667542 |
| Investment shares | &nbsp;&nbsp;&nbsp; 6376 | &nbsp;&nbsp;&nbsp; 2269 | 697637 | 527680 | 3667213 |
| Investments, at cost | $50769 | $20347 | $697637 | $527679 | $3667211 |

---

See accompanying notes to financial statements.

**RiverSource of New York Account 8** ■ 7

------

**Statement of Assets and Liabilities**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **December 31, 2025 (continued)** | **Col VP Hi** <br> **Yield Bond,** <br>**Cl 1**<br>| **Col VP Hi** <br> **Yield Bond,** <br>**Cl 2**<br>| **Col VP Hi** <br> **Yield Bond,** <br>**Cl 3**<br>| **Col VP Inc** <br> **Opp,** <br>**Cl 1**<br>| **Col VP Inc** <br> **Opp,** <br>**Cl 2**<br>|
| **Assets** |  |  |  |  |  |
| Investments, at fair value | $412384 | $401647 | $2783964 | $30445 | $88701 |
| Dividends receivable | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Accounts receivable from RiverSource Life of NY for contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 365 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 19 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Receivable for share redemptions | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1375 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total assets | 412749 | 401647 | 2785358 | 30445 | 88701 |
| **Liabilities** |  |  |  |  |  |
| Payable to RiverSource Life of NY for: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Mortality and expense risk fee | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1295 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| &nbsp;&nbsp;&nbsp; Contract terminations | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 80 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Payable for investments purchased | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 365 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 19 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total liabilities | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 365 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1394 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net assets applicable to Variable Life contracts in accumulation period | 412384 | 401647 | 2783964 | 30445 | 88701 |
| Net assets applicable to seed money | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total net assets | $412384 | $401647 | $2783964 | $30445 | $88701 |
| Investment shares | &nbsp;&nbsp;&nbsp; 65458 | &nbsp;&nbsp;&nbsp; 64677 | &nbsp;&nbsp;&nbsp;&nbsp; 444013 | &nbsp;&nbsp;&nbsp; 4497 | 13219 |
| Investments, at cost | $403423 | $411235 | $2857309 | $30567 | $85707 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **December 31, 2025 (continued)** | **Col VP Inc** <br> **Opp,** <br>**Cl 3**<br>| **Col VP Inter** <br> **Bond,** <br>**Cl 1**<br>| **Col VP Inter** <br> **Bond,** <br>**Cl 2**<br>| **Col VP Inter** <br> **Bond,** <br>**Cl 3**<br>| **Col VP Lg Cap** <br> **Gro,** <br>**Cl 1**<br>|
| **Assets** |  |  |  |  |  |
| Investments, at fair value | $1252829 | $270767 | $104129 | $5886117 | $4313303 |
| Dividends receivable | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Accounts receivable from RiverSource Life of NY for contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 15 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 806 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3831 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2067 |
| Receivable for share redemptions | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 659 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 210 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3008 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total assets | 1253503 | 271573 | 104339 | 5892956 | 4315370 |
| **Liabilities** |  |  |  |  |  |
| Payable to RiverSource Life of NY for: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Mortality and expense risk fee | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 578 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3008 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| &nbsp;&nbsp;&nbsp; Contract terminations | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 81 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 210 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Payable for investments purchased | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 15 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 806 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3831 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2067 |
| Total liabilities | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 674 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 806 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 210 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 6839 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2067 |
| Net assets applicable to Variable Life contracts in accumulation period | 1252829 | 270767 | 104129 | 5886117 | 4313303 |
| Net assets applicable to seed money | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total net assets | $1252829 | $270767 | $104129 | $5886117 | $4313303 |
| Investment shares | &nbsp;&nbsp;&nbsp;&nbsp; 183430 | &nbsp;&nbsp;&nbsp; 31485 | &nbsp;&nbsp;&nbsp; 12165 | &nbsp;&nbsp;&nbsp;&nbsp; 682844 | &nbsp;&nbsp;&nbsp;&nbsp; 75858 |
| Investments, at cost | $1291842 | $275551 | $107651 | $6613309 | $2900252 |

---

See accompanying notes to financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**8 ■ RiverSource of New York Account 8**

------

**Statement of Assets and Liabilities**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **December 31, 2025 (continued)** | **Col VP Lg Cap** <br> **Gro,** <br>**Cl 2**<br>| **Col VP Lg Cap** <br> **Gro,** <br>**Cl 3**<br>| **Col VP Lg Cap** <br> **Index,** <br>**Cl 1**<br>| **Col VP Lg Cap** <br> **Index,** <br>**Cl 3**<br>| **Col VP Limited** <br> **Duration Cr,** <br>**Cl 1**<br>|
| **Assets** |  |  |  |  |  |
| Investments, at fair value | $729328 | $4158682 | $12653642 | $18706072 | $104600 |
| Dividends receivable | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Accounts receivable from RiverSource Life of NY for contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5011 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 137 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 437 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 19 |
| Receivable for share redemptions | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2011 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 8106 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total assets | 729328 | 4165704 | 12653779 | 18714615 | 104619 |
| **Liabilities** |  |  |  |  |  |
| Payable to RiverSource Life of NY for: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Mortality and expense risk fee | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2011 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 7530 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| &nbsp;&nbsp;&nbsp; Contract terminations | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 576 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Payable for investments purchased | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5011 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 137 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 437 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 19 |
| Total liabilities | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 7022 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 137 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 8543 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 19 |
| Net assets applicable to Variable Life contracts in accumulation period | 729328 | 4158682 | 12653642 | 18706072 | 104600 |
| Net assets applicable to seed money | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total net assets | $729328 | $4158682 | $12653642 | $18706072 | $104600 |
| Investment shares | &nbsp;&nbsp;&nbsp; 13341 | &nbsp;&nbsp;&nbsp;&nbsp; 74515 | &nbsp;&nbsp;&nbsp;&nbsp; 213780 | &nbsp;&nbsp;&nbsp;&nbsp; 321631 | &nbsp;&nbsp;&nbsp; 10999 |
| Investments, at cost | $352964 | $1616277 | $8875987 | $8602134 | $105837 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **December 31, 2025 (continued)** | **Col VP Limited** <br> **Duration Cr,** <br>**Cl 2**<br>| **Col VP Long** <br> **Govt/Cr Bond,** <br>**Cl 1**<br>| **Col VP Long** <br> **Govt/Cr Bond,** <br>**Cl 2**<br>| **Col VP** <br> **Overseas** <br> **Core,** <br>**Cl 1**<br>| **Col VP** <br> **Overseas** <br> **Core,** <br>**Cl 2**<br>|
| **Assets** |  |  |  |  |  |
| Investments, at fair value | $924866 | $36481 | $526 | $987280 | $249608 |
| Dividends receivable | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Accounts receivable from RiverSource Life of NY for contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 430 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Receivable for share redemptions | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 506 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 177 |
| Total assets | 925372 | 36481 | 526 | 987710 | 249785 |
| **Liabilities** |  |  |  |  |  |
| Payable to RiverSource Life of NY for: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Mortality and expense risk fee | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 397 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| &nbsp;&nbsp;&nbsp; Contract terminations | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 109 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 177 |
| Payable for investments purchased | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 430 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total liabilities | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 506 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 430 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 177 |
| Net assets applicable to Variable Life contracts in accumulation period | 924771 | 36481 | 526 | 987280 | 249608 |
| Net assets applicable to seed money | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 95 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total net assets | $924866 | $36481 | $526 | $987280 | $249608 |
| Investment shares | &nbsp;&nbsp;&nbsp; 97766 | &nbsp;&nbsp;&nbsp; 5138 | &nbsp;&nbsp;&nbsp; 74 | &nbsp;&nbsp;&nbsp; 55186 | &nbsp;&nbsp;&nbsp; 14102 |
| Investments, at cost | $922639 | $38969 | $703 | $773565 | $188256 |

---

See accompanying notes to financial statements.

**RiverSource of New York Account 8** ■ 9

------

**Statement of Assets and Liabilities**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **December 31, 2025 (continued)** | **Col VP** <br> **Overseas** <br> **Core,** <br>**Cl 3**<br>| **Col VP Sel Gbl** <br> **Tech,** <br>**Cl 1**<br>| **Col VP Sel Gbl** <br> **Tech,** <br>**Cl 2**<br>| **Col VP Select** <br> **Lg Cap Val,** <br>**Cl 1**<br>| **Col VP Select** <br> **Lg Cap Val,** <br>**Cl 2**<br>|
| **Assets** |  |  |  |  |  |
| Investments, at fair value | $6205392 | $577656 | $207022 | $1380916 | $259221 |
| Dividends receivable | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Accounts receivable from RiverSource Life of NY for contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1166 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Receivable for share redemptions | &nbsp;&nbsp;&nbsp;&nbsp; 12557 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 4443 |
| Total assets | 6217949 | 577656 | 207022 | 1382082 | 263664 |
| **Liabilities** |  |  |  |  |  |
| Payable to RiverSource Life of NY for: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Mortality and expense risk fee | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 4574 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| &nbsp;&nbsp;&nbsp; Contract terminations | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 7983 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 4443 |
| Payable for investments purchased | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1166 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total liabilities | &nbsp;&nbsp;&nbsp;&nbsp; 12557 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1166 | &nbsp;&nbsp;&nbsp;&nbsp; 4443 |
| Net assets applicable to Variable Life contracts in accumulation period | 6205392 | 577656 | 207022 | 1380916 | 259221 |
| Net assets applicable to seed money | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total net assets | $6205392 | $577656 | $207022 | $1380916 | $259221 |
| Investment shares | &nbsp;&nbsp;&nbsp;&nbsp; 348226 | &nbsp;&nbsp;&nbsp; 13803 | &nbsp;&nbsp;&nbsp;&nbsp; 6094 | &nbsp;&nbsp;&nbsp;&nbsp; 24642 | &nbsp;&nbsp;&nbsp;&nbsp; 4806 |
| Investments, at cost | $4141028 | $412266 | $153053 | $996656 | $157269 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **December 31, 2025 (continued)** | **Col VP Select** <br> **Lg Cap Val,** <br>**Cl 3**<br>| **Col VP Select** <br> **Mid Cap Gro,** <br>**Cl 1**<br>| **Col VP Select** <br> **Mid Cap Gro,** <br>**Cl 2**<br>| **Col VP Select** <br> **Mid Cap Gro,** <br>**Cl 3**<br>| **Col VP Select** <br> **Mid Cap Val,** <br>**Cl 1**<br>|
| **Assets** |  |  |  |  |  |
| Investments, at fair value | $944723 | $697593 | $144413 | $1347673 | $626668 |
| Dividends receivable | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Accounts receivable from RiverSource Life of NY for contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 33 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Receivable for share redemptions | &nbsp;&nbsp;&nbsp;&nbsp; 1578 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 614 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total assets | 946334 | 697593 | 144413 | 1348287 | 626668 |
| **Liabilities** |  |  |  |  |  |
| Payable to RiverSource Life of NY for: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Mortality and expense risk fee | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 384 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 580 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| &nbsp;&nbsp;&nbsp; Contract terminations | &nbsp;&nbsp;&nbsp;&nbsp; 1194 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 34 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Payable for investments purchased | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 33 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total liabilities | &nbsp;&nbsp;&nbsp;&nbsp; 1611 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 614 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net assets applicable to Variable Life contracts in accumulation period | 944723 | 697593 | 144413 | 1347673 | 626668 |
| Net assets applicable to seed money | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total net assets | $944723 | $697593 | $144413 | $1347673 | $626668 |
| Investment shares | &nbsp;&nbsp;&nbsp; 17199 | &nbsp;&nbsp;&nbsp; 10790 | &nbsp;&nbsp;&nbsp;&nbsp; 2321 | &nbsp;&nbsp;&nbsp;&nbsp; 21257 | &nbsp;&nbsp;&nbsp; 13238 |
| Investments, at cost | $563378 | $473514 | $83107 | $858237 | $482630 |

---

See accompanying notes to financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**10 ■ RiverSource of New York Account 8**

------

**Statement of Assets and Liabilities**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **December 31, 2025 (continued)** | **Col VP Select** <br> **Mid Cap Val,** <br>**Cl 2**<br>| **Col VP Select** <br> **Mid Cap Val,** <br>**Cl 3**<br>| **Col VP Select** <br> **Sm Cap Val,** <br>**Cl 1**<br>| **Col VP Select** <br> **Sm Cap Val,** <br>**Cl 2**<br>| **Col VP Select** <br> **Sm Cap Val,** <br>**Cl 3**<br>|
| **Assets** |  |  |  |  |  |
| Investments, at fair value | $204449 | $1070683 | $246822 | $195519 | $1106997 |
| Dividends receivable | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Accounts receivable from RiverSource Life of NY for contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp; 1305 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 3316 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 74 |
| Receivable for share redemptions | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 371 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 570 |
| Total assets | 205754 | 1071056 | 246822 | 198835 | 1107641 |
| **Liabilities** |  |  |  |  |  |
| Payable to RiverSource Life of NY for: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Mortality and expense risk fee | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 371 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 513 |
| &nbsp;&nbsp;&nbsp; Contract terminations | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 57 |
| Payable for investments purchased | &nbsp;&nbsp;&nbsp;&nbsp; 1305 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 3316 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 74 |
| Total liabilities | &nbsp;&nbsp;&nbsp;&nbsp; 1305 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 373 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 3316 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 644 |
| Net assets applicable to Variable Life contracts in accumulation period | 204449 | 1070683 | 246822 | 195519 | 1106997 |
| Net assets applicable to seed money | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total net assets | $204449 | $1070683 | $246822 | $195519 | $1106997 |
| Investment shares | &nbsp;&nbsp;&nbsp;&nbsp; 4480 | &nbsp;&nbsp;&nbsp;&nbsp; 23040 | &nbsp;&nbsp;&nbsp;&nbsp; 5888 | &nbsp;&nbsp;&nbsp;&nbsp; 4848 | &nbsp;&nbsp;&nbsp;&nbsp; 26908 |
| Investments, at cost | $121805 | $672474 | $206842 | $134252 | $678148 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **December 31, 2025 (continued)** | **Col VP** <br> **Strategic Inc,** <br>**Cl 1**<br>| **Col VP** <br> **Strategic Inc,** <br>**Cl 2**<br>| **Col VP US** <br> **Govt Mtge,** <br>**Cl 1**<br>| **Col VP US** <br> **Govt Mtge,** <br>**Cl 2**<br>| **Col VP US** <br> **Govt Mtge,** <br>**Cl 3**<br>|
| **Assets** |  |  |  |  |  |
| Investments, at fair value | $267354 | $271905 | $26937 | $15518 | $1237089 |
| Dividends receivable | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Accounts receivable from RiverSource Life of NY for contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 843 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 210 |
| Receivable for share redemptions | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 630 |
| Total assets | 268197 | 271905 | 26937 | 15518 | 1237929 |
| **Liabilities** |  |  |  |  |  |
| Payable to RiverSource Life of NY for: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Mortality and expense risk fee | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 614 |
| &nbsp;&nbsp;&nbsp; Contract terminations | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 16 |
| Payable for investments purchased | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 843 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 210 |
| Total liabilities | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 843 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 840 |
| Net assets applicable to Variable Life contracts in accumulation period | 267354 | 271905 | 26937 | 15518 | 1237089 |
| Net assets applicable to seed money | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total net assets | $267354 | $271905 | $26937 | $15518 | $1237089 |
| Investment shares | &nbsp;&nbsp;&nbsp; 70542 | &nbsp;&nbsp;&nbsp; 72702 | &nbsp;&nbsp;&nbsp; 2878 | &nbsp;&nbsp;&nbsp; 1663 | &nbsp;&nbsp;&nbsp;&nbsp; 132168 |
| Investments, at cost | $266377 | $269338 | $26473 | $15585 | $1293074 |

---

See accompanying notes to financial statements.

**RiverSource of New York Account 8** ■ 11

------

**Statement of Assets and Liabilities**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **December 31, 2025 (continued)** | **CS Commodity** <br> **Return,** <br>**Cl 1**<br>| **CTIVP AC Div** <br> **Bond,** <br>**Cl 1**<br>| **CTIVP AC Div** <br> **Bond,** <br>**Cl 2**<br>| **CTIVP BR Gl** <br> **Infl Prot Sec,** <br>**Cl 1**<br>| **CTIVP BR Gl** <br> **Infl Prot Sec,** <br>**Cl 2**<br>|
| **Assets** |  |  |  |  |  |
| Investments, at fair value | $423099 | $48595 | $26806 | $49330 | $21613 |
| Dividends receivable | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Accounts receivable from RiverSource Life of NY for contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 19 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Receivable for share redemptions | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 206 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total assets | 423324 | 48595 | 26806 | 49330 | 21613 |
| **Liabilities** |  |  |  |  |  |
| Payable to RiverSource Life of NY for: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Mortality and expense risk fee | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 187 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| &nbsp;&nbsp;&nbsp; Contract terminations | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 19 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Payable for investments purchased | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 19 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total liabilities | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 225 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net assets applicable to Variable Life contracts in accumulation period | 423099 | 48595 | 26806 | 49330 | 21613 |
| Net assets applicable to seed money | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total net assets | $423099 | $48595 | $26806 | $49330 | $21613 |
| Investment shares | &nbsp;&nbsp;&nbsp; 21261 | &nbsp;&nbsp;&nbsp; 5220 | &nbsp;&nbsp;&nbsp; 2892 | 11237 | &nbsp;&nbsp;&nbsp; 5074 |
| Investments, at cost | $481688 | $50128 | $29571 | $56301 | $25469 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **December 31, 2025 (continued)** | **CTIVP BR Gl** <br> **Infl Prot Sec,** <br>**Cl 3**<br>| **CTIVP** <br> **CenterSquare** <br> **Real Est,** <br>**Cl 1**<br>| **CTIVP** <br> **CenterSquare** <br> **Real Est,** <br>**Cl 2**<br>| **CTIVP Prin Lg** <br> **Cap Gro,** <br>**Cl 1**<br>| **CTIVP Prin Lg** <br> **Cap Gro,** <br>**Cl 2**<br>|
| **Assets** |  |  |  |  |  |
| Investments, at fair value | $488190 | $89931 | $200111 | $224405 | $120568 |
| Dividends receivable | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Accounts receivable from RiverSource Life of NY for contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 26 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Receivable for share redemptions | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 222 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total assets | 488438 | 89931 | 200111 | 224405 | 120568 |
| **Liabilities** |  |  |  |  |  |
| Payable to RiverSource Life of NY for: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Mortality and expense risk fee | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 207 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| &nbsp;&nbsp;&nbsp; Contract terminations | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 15 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Payable for investments purchased | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 26 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total liabilities | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 248 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net assets applicable to Variable Life contracts in accumulation period | 488190 | 89931 | 200111 | 224405 | 120568 |
| Net assets applicable to seed money | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total net assets | $488190 | $89931 | $200111 | $224405 | $120568 |
| Investment shares | 112228 | 14030 | &nbsp;&nbsp;&nbsp; 31563 | &nbsp;&nbsp;&nbsp;&nbsp; 2753 | &nbsp;&nbsp;&nbsp;&nbsp; 1537 |
| Investments, at cost | $587050 | $97929 | $241229 | $159170 | $64980 |

---

See accompanying notes to financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**12 ■ RiverSource of New York Account 8**

------

**Statement of Assets and Liabilities**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **December 31, 2025 (continued)** | **CTIVP T Rowe** <br> **Price LgCap** <br> **Val,** <br>**Cl 1**<br>| **CTIVP T Rowe** <br> **Price LgCap** <br> **Val,** <br>**Cl 2**<br>| **CTIVP TCW** <br> **Core Plus** <br> **Bond,** <br>**Cl 1**<br>| **CTIVP TCW** <br> **Core Plus** <br> **Bond,** <br>**Cl 2**<br>| **CTIVP Vty** <br> **Sycamore Estb** <br> **Val,** <br>**Cl 1**<br>|
| **Assets** |  |  |  |  |  |
| Investments, at fair value | $357572 | $178984 | $92301 | $44777 | $908098 |
| Dividends receivable | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Accounts receivable from RiverSource Life of NY for contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 648 |
| Receivable for share redemptions | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total assets | 357572 | 178984 | 92301 | 44777 | 908746 |
| **Liabilities** |  |  |  |  |  |
| Payable to RiverSource Life of NY for: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Mortality and expense risk fee | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| &nbsp;&nbsp;&nbsp; Contract terminations | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Payable for investments purchased | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 648 |
| Total liabilities | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 648 |
| Net assets applicable to Variable Life contracts in accumulation period | 357572 | 178984 | 92301 | 44777 | 908098 |
| Net assets applicable to seed money | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total net assets | $357572 | $178984 | $92301 | $44777 | $908098 |
| Investment shares | &nbsp;&nbsp;&nbsp;&nbsp; 8099 | &nbsp;&nbsp;&nbsp;&nbsp; 4215 | &nbsp;&nbsp;&nbsp; 9914 | &nbsp;&nbsp;&nbsp; 4836 | &nbsp;&nbsp;&nbsp; 17490 |
| Investments, at cost | $288777 | $115810 | $98924 | $47314 | $787755 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **December 31, 2025 (continued)** | **CTIVP Vty** <br> **Sycamore Estb** <br> **Val,** <br>**Cl 2**<br>| **CTIVP Vty** <br> **Sycamore Estb** <br> **Val,** <br>**Cl 3**<br>| **CTIVP** <br> **Wellington Lg** <br> **Cap Val,** <br>**Cl 1**<br>| **CTIVP** <br> **Wellington Lg** <br> **Cap Val,** <br>**Cl 2**<br>| **CTIVP** <br> **Westfield Mid** <br> **Cap Gro,** <br>**Cl 1**<br>|
| **Assets** |  |  |  |  |  |
| Investments, at fair value | $481542 | $1372971 | $872765 | $358325 | $160019 |
| Dividends receivable | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Accounts receivable from RiverSource Life of NY for contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 135 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 139 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Receivable for share redemptions | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 639 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total assets | 481542 | 1373745 | 872904 | 358325 | 160019 |
| **Liabilities** |  |  |  |  |  |
| Payable to RiverSource Life of NY for: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Mortality and expense risk fee | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 626 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| &nbsp;&nbsp;&nbsp; Contract terminations | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 13 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Payable for investments purchased | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 135 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 139 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total liabilities | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 774 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 139 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net assets applicable to Variable Life contracts in accumulation period | 481542 | 1372971 | 872765 | 358325 | 160019 |
| Net assets applicable to seed money | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total net assets | $481542 | $1372971 | $872765 | $358325 | $160019 |
| Investment shares | &nbsp;&nbsp;&nbsp;&nbsp; 9640 | &nbsp;&nbsp;&nbsp;&nbsp; 26947 | &nbsp;&nbsp;&nbsp; 16953 | &nbsp;&nbsp;&nbsp;&nbsp; 7235 | &nbsp;&nbsp;&nbsp;&nbsp; 2759 |
| Investments, at cost | $322179 | $978907 | $713878 | $217198 | $125228 |

---

See accompanying notes to financial statements.

**RiverSource of New York Account 8** ■ 13

------

**Statement of Assets and Liabilities**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **December 31, 2025 (continued)** | **CTIVP** <br> **Westfield Mid** <br> **Cap Gro,** <br>**Cl 2**<br>| **CTIVP** <br> **Westfield Sel** <br> **Lg Cp Gr,** <br>**Cl 1**<br>| **CTIVP** <br> **Westfield Sel** <br> **Lg Cp Gr,** <br>**Cl 2**<br>| **CVT EAFE Intl** <br> **Index,** <br>**Cl F**<br>| **CVT EAFE Intl** <br> **Index,** <br>**Cl I**<br>|
| **Assets** |  |  |  |  |  |
| Investments, at fair value | $66635 | $269817 | $79179 | $18599 | $484247 |
| Dividends receivable | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Accounts receivable from RiverSource Life of NY for contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 347 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Receivable for share redemptions | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total assets | 66635 | 270164 | 79179 | 18599 | 484247 |
| **Liabilities** |  |  |  |  |  |
| Payable to RiverSource Life of NY for: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Mortality and expense risk fee | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| &nbsp;&nbsp;&nbsp; Contract terminations | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Payable for investments purchased | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 347 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total liabilities | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 347 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net assets applicable to Variable Life contracts in accumulation period | 66635 | 269817 | 79179 | 18599 | 484247 |
| Net assets applicable to seed money | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total net assets | $66635 | $269817 | $79179 | $18599 | $484247 |
| Investment shares | &nbsp;&nbsp;&nbsp; 1196 | &nbsp;&nbsp;&nbsp;&nbsp; 3896 | &nbsp;&nbsp;&nbsp; 1190 | &nbsp;&nbsp;&nbsp;&nbsp; 154 | &nbsp;&nbsp;&nbsp;&nbsp; 3953 |
| Investments, at cost | $42494 | $174715 | $56219 | $14582 | $423840 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **December 31, 2025 (continued)** | **CVT Nasdaq** <br> **100 Index,** <br>**Cl F**<br>| **CVT Nasdaq** <br> **100 Index,** <br>**Cl I**<br>| **CVT Russ 2000** <br> **Sm Cap Ind,** <br>**Cl F**<br>| **CVT Russ 2000** <br> **Sm Cap Ind,** <br>**Cl I**<br>| **DWS Alt Asset** <br> **Alloc VIP,** <br>**Cl A**<br>|
| **Assets** |  |  |  |  |  |
| Investments, at fair value | $99508 | $695300 | $20209 | $263802 | $256748 |
| Dividends receivable | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Accounts receivable from RiverSource Life of NY for contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 651 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 419 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 41 |
| Receivable for share redemptions | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total assets | 99508 | 695951 | 20209 | 264221 | 256789 |
| **Liabilities** |  |  |  |  |  |
| Payable to RiverSource Life of NY for: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Mortality and expense risk fee | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| &nbsp;&nbsp;&nbsp; Contract terminations | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Payable for investments purchased | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 651 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 419 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 41 |
| Total liabilities | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 651 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 419 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 41 |
| Net assets applicable to Variable Life contracts in accumulation period | 99508 | 695300 | 20209 | 263802 | 256748 |
| Net assets applicable to seed money | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total net assets | $99508 | $695300 | $20209 | $263802 | $256748 |
| Investment shares | &nbsp;&nbsp;&nbsp;&nbsp; 519 | &nbsp;&nbsp;&nbsp;&nbsp; 3512 | &nbsp;&nbsp;&nbsp;&nbsp; 227 | &nbsp;&nbsp;&nbsp;&nbsp; 2911 | &nbsp;&nbsp;&nbsp; 18727 |
| Investments, at cost | $78201 | $569695 | $18126 | $250614 | $245793 |

---

See accompanying notes to financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**14 ■ RiverSource of New York Account 8**

------

**Statement of Assets and Liabilities**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **December 31, 2025 (continued)** | **DWS Alt Asset** <br> **Alloc VIP,** <br>**Cl B**<br>| **EV VT** <br> **Floating-Rate** <br> **Inc, Init Cl**<br>| **EV VT** <br> **Floating-Rate** <br> **Inc, Inst Cl**<br>| **Fid VIP** <br> **Contrafund,** <br> **Init Cl**<br>| **Fid VIP** <br> **Contrafund,** <br>**Serv Cl 2**<br>|
| **Assets** |  |  |  |  |  |
| Investments, at fair value | $397697 | $1282291 | $6649 | $3175185 | $9873592 |
| Dividends receivable | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 6860 | &nbsp;&nbsp;&nbsp;&nbsp; 38 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Accounts receivable from RiverSource Life of NY for contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 27 | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 17405 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Receivable for share redemptions | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 69 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 624 | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 6353 |
| Total assets | 397766 | 1289802 | 6687 | 3192590 | 9879945 |
| **Liabilities** |  |  |  |  |  |
| Payable to RiverSource Life of NY for: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Mortality and expense risk fee | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 69 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 571 | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 4101 |
| &nbsp;&nbsp;&nbsp; Contract terminations | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 53 | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2252 |
| Payable for investments purchased | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 6887 | &nbsp;&nbsp;&nbsp;&nbsp; 38 | &nbsp;&nbsp;&nbsp;&nbsp; 17405 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total liabilities | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 69 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 7511 | &nbsp;&nbsp;&nbsp;&nbsp; 38 | &nbsp;&nbsp;&nbsp;&nbsp; 17405 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 6353 |
| Net assets applicable to Variable Life contracts in accumulation period | 397593 | 1282291 | 4391 | 3175185 | 9873592 |
| Net assets applicable to seed money | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 104 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | 2258 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total net assets | $397697 | $1282291 | $6649 | $3175185 | $9873592 |
| Investment shares | &nbsp;&nbsp;&nbsp; 29029 | &nbsp;&nbsp;&nbsp;&nbsp; 153201 | &nbsp;&nbsp;&nbsp;&nbsp; 794 | &nbsp;&nbsp;&nbsp;&nbsp; 53017 | &nbsp;&nbsp;&nbsp;&nbsp; 173647 |
| Investments, at cost | $379121 | $1353522 | $6862 | $2965959 | $8066510 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **December 31, 2025 (continued)** | **Fid VIP Emer** <br> **Mkts, Init Cl**<br>| **Fid VIP** <br> **Energy, Init Cl**<br>| **Fid VIP Gro &** <br> **Inc,** <br>**Serv Cl**<br>| **Fid VIP Gro &** <br> **Inc,** <br>**Serv Cl 2**<br>| **Fid VIP Gro** <br> **Opp, Init Cl**<br>|
| **Assets** |  |  |  |  |  |
| Investments, at fair value | $57967 | $2860 | $5968902 | $3026476 | $95427 |
| Dividends receivable | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Accounts receivable from RiverSource Life of NY for contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 15 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Receivable for share redemptions | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 4425 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 890 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total assets | 57967 | 2860 | 5973327 | 3027381 | 95427 |
| **Liabilities** |  |  |  |  |  |
| Payable to RiverSource Life of NY for: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Mortality and expense risk fee | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3436 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 890 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| &nbsp;&nbsp;&nbsp; Contract terminations | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 989 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Payable for investments purchased | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 15 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total liabilities | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 4425 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 905 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net assets applicable to Variable Life contracts in accumulation period | 57967 | 2740 | 5968902 | 3026275 | 95427 |
| Net assets applicable to seed money | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 120 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 201 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total net assets | $57967 | $2860 | $5968902 | $3026476 | $95427 |
| Investment shares | &nbsp;&nbsp;&nbsp; 3662 | &nbsp;&nbsp;&nbsp;&nbsp; 105 | &nbsp;&nbsp;&nbsp;&nbsp; 181757 | &nbsp;&nbsp;&nbsp;&nbsp; 94607 | &nbsp;&nbsp;&nbsp;&nbsp; 957 |
| Investments, at cost | $44759 | $2777 | $3867295 | $2513230 | $79026 |

---

See accompanying notes to financial statements.

**RiverSource of New York Account 8** ■ 15

------

**Statement of Assets and Liabilities**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **December 31, 2025 (continued)** | **Fid VIP Invest** <br> **Gr, Init Cl**<br>| **Fid VIP Mid** <br> **Cap, Init Cl**<br>| **Fid VIP Mid** <br> **Cap,** <br>**Serv Cl**<br>| **Fid VIP Mid** <br> **Cap,** <br>**Serv Cl 2**<br>| **Fid VIP** <br> **Overseas,** <br>**Serv Cl**<br>|
| **Assets** |  |  |  |  |  |
| Investments, at fair value | $54591 | $1434670 | $6494276 | $6357968 | $1855538 |
| Dividends receivable | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Accounts receivable from RiverSource Life of NY for contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 114 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 67 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 17 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Receivable for share redemptions | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 4119 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1834 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3527 |
| Total assets | 54591 | 1434784 | 6498462 | 6359819 | 1859065 |
| **Liabilities** |  |  |  |  |  |
| Payable to RiverSource Life of NY for: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Mortality and expense risk fee | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3973 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1834 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1153 |
| &nbsp;&nbsp;&nbsp; Contract terminations | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 146 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2374 |
| Payable for investments purchased | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 114 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 67 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 17 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total liabilities | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 114 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 4186 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1851 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3527 |
| Net assets applicable to Variable Life contracts in accumulation period | 54591 | 1434670 | 6494276 | 6357764 | 1855538 |
| Net assets applicable to seed money | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 204 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total net assets | $54591 | $1434670 | $6494276 | $6357968 | $1855538 |
| Investment shares | &nbsp;&nbsp;&nbsp; 4806 | &nbsp;&nbsp;&nbsp;&nbsp; 38248 | &nbsp;&nbsp;&nbsp;&nbsp; 176523 | &nbsp;&nbsp;&nbsp;&nbsp; 180778 | &nbsp;&nbsp;&nbsp;&nbsp; 67919 |
| Investments, at cost | $54695 | $1416796 | $6045689 | $6335476 | $1501644 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **December 31, 2025 (continued)** | **Fid VIP** <br> **Overseas,** <br>**Serv Cl 2**<br>| **Fid VIP** <br> **Strategic Inc,** <br> **Init Cl**<br>| **Fid VIP** <br> **Strategic Inc,** <br>**Serv Cl 2**<br>| **Frank Global** <br> **Real Est,** <br>**Cl 2**<br>| **Frank Inc,** <br>**Cl 1**<br>|
| **Assets** |  |  |  |  |  |
| Investments, at fair value | $1389477 | $566176 | $67153 | $1845233 | $123519 |
| Dividends receivable | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Accounts receivable from RiverSource Life of NY for contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 25 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 828 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1063 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 29 |
| Receivable for share redemptions | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 424 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 810 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total assets | 1389926 | 567004 | 67153 | 1847106 | 123548 |
| **Liabilities** |  |  |  |  |  |
| Payable to RiverSource Life of NY for: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Mortality and expense risk fee | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 424 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 773 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| &nbsp;&nbsp;&nbsp; Contract terminations | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 37 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Payable for investments purchased | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 25 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 828 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1063 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 29 |
| Total liabilities | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 449 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 828 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1873 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 29 |
| Net assets applicable to Variable Life contracts in accumulation period | 1389312 | 566176 | 67153 | 1845233 | 123519 |
| Net assets applicable to seed money | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 165 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total net assets | $1389477 | $566176 | $67153 | $1845233 | $123519 |
| Investment shares | &nbsp;&nbsp;&nbsp;&nbsp; 51234 | &nbsp;&nbsp;&nbsp; 50416 | &nbsp;&nbsp;&nbsp; 6066 | &nbsp;&nbsp;&nbsp;&nbsp; 141289 | &nbsp;&nbsp;&nbsp;&nbsp; 7710 |
| Investments, at cost | $1272764 | $549597 | $66242 | $1974678 | $118793 |

---

See accompanying notes to financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**16 ■ RiverSource of New York Account 8**

------

**Statement of Assets and Liabilities**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **December 31, 2025 (continued)** | **Frank Inc,** <br>**Cl 2**<br>| **Frank Mutual** <br> **Shares,** <br>**Cl 1**<br>| **Frank Mutual** <br> **Shares,** <br>**Cl 2**<br>| **Frank Sm Cap** <br> **Val,** <br>**Cl 1**<br>| **Frank Sm Cap** <br> **Val,** <br>**Cl 2**<br>|
| **Assets** |  |  |  |  |  |
| Investments, at fair value | $509757 | $38143 | $1957689 | $372990 | $3062522 |
| Dividends receivable | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Accounts receivable from RiverSource Life of NY for contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1207 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 389 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 102 |
| Receivable for share redemptions | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 241 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 701 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1242 |
| Total assets | 509998 | 38143 | 1959597 | 373379 | 3063866 |
| **Liabilities** |  |  |  |  |  |
| Payable to RiverSource Life of NY for: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Mortality and expense risk fee | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 241 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 701 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1242 |
| &nbsp;&nbsp;&nbsp; Contract terminations | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Payable for investments purchased | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1207 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 389 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 102 |
| Total liabilities | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 241 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1908 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 389 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1344 |
| Net assets applicable to Variable Life contracts in accumulation period | 509757 | 38143 | 1957689 | 372990 | 3062522 |
| Net assets applicable to seed money | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total net assets | $509757 | $38143 | $1957689 | $372990 | $3062522 |
| Investment shares | &nbsp;&nbsp;&nbsp; 33625 | &nbsp;&nbsp;&nbsp; 2298 | &nbsp;&nbsp;&nbsp;&nbsp; 121596 | &nbsp;&nbsp;&nbsp; 24966 | &nbsp;&nbsp;&nbsp;&nbsp; 220802 |
| Investments, at cost | $492909 | $36846 | $2068293 | $358742 | $3170762 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **December 31, 2025 (continued)** | **GS VIT Mid** <br> **Cap Val, Inst**<br>| **GS VIT Sm Cap** <br> **Eq Insights,** <br> **Inst**<br>| **GS VIT U.S. Eq** <br> **Insights, Inst**<br>| **Invesco VI Am** <br> **Fran, Ser I**<br>| **Invesco VI Am** <br> **Fran, Ser II**<br>|
| **Assets** |  |  |  |  |  |
| Investments, at fair value | $6523219 | $436745 | $3309189 | $785636 | $1264210 |
| Dividends receivable | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Accounts receivable from RiverSource Life of NY for contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3345 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 33 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Receivable for share redemptions | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2799 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 248 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1475 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 481 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 436 |
| Total assets | 6529363 | 436993 | 3310697 | 786117 | 1264646 |
| **Liabilities** |  |  |  |  |  |
| Payable to RiverSource Life of NY for: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Mortality and expense risk fee | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2799 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 226 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1387 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 481 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 436 |
| &nbsp;&nbsp;&nbsp; Contract terminations | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 22 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 88 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Payable for investments purchased | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3345 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 33 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total liabilities | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 6144 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 248 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1508 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 481 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 436 |
| Net assets applicable to Variable Life contracts in accumulation period | 6523219 | 436745 | 3309189 | 785636 | 1263844 |
| Net assets applicable to seed money | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 366 |
| Total net assets | $6523219 | $436745 | $3309189 | $785636 | $1264210 |
| Investment shares | &nbsp;&nbsp;&nbsp;&nbsp; 400443 | &nbsp;&nbsp;&nbsp; 30584 | &nbsp;&nbsp;&nbsp;&nbsp; 151867 | &nbsp;&nbsp;&nbsp;&nbsp; 9699 | &nbsp;&nbsp;&nbsp;&nbsp; 17571 |
| Investments, at cost | $6602982 | $394965 | $2982236 | $576062 | $1105024 |

---

See accompanying notes to financial statements.

**RiverSource of New York Account 8** ■ 17

------

**Statement of Assets and Liabilities**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **December 31, 2025 (continued)** | **Invesco VI Bal** <br> **Risk Alloc, Ser** <br> **I**<br>| **Invesco VI Bal** <br> **Risk Alloc, Ser** <br> **II**<br>| **Invesco VI** <br> **Comstock, Ser** <br> **II**<br>| **Invesco VI** <br> **Core Eq, Ser I**<br>| **Invesco VI Dis** <br> **Mid Cap** <br> **Gro, Ser I**<br>|
| **Assets** |  |  |  |  |  |
| Investments, at fair value | $46039 | $318803 | $622451 | $12479703 | $1009742 |
| Dividends receivable | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Accounts receivable from RiverSource Life of NY for contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 101 |
| Receivable for share redemptions | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 110 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 332 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 10247 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 474 |
| Total assets | 46039 | 318913 | 622785 | 12489950 | 1010317 |
| **Liabilities** |  |  |  |  |  |
| Payable to RiverSource Life of NY for: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Mortality and expense risk fee | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 110 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 332 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 9806 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 474 |
| &nbsp;&nbsp;&nbsp; Contract terminations | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 441 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Payable for investments purchased | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 101 |
| Total liabilities | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 110 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 334 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 10247 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 575 |
| Net assets applicable to Variable Life contracts in accumulation period | 46039 | 318691 | 622451 | 12479703 | 1009742 |
| Net assets applicable to seed money | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 112 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total net assets | $46039 | $318803 | $622451 | $12479703 | $1009742 |
| Investment shares | &nbsp;&nbsp;&nbsp; 5341 | &nbsp;&nbsp;&nbsp; 37953 | &nbsp;&nbsp;&nbsp; 29237 | &nbsp;&nbsp;&nbsp;&nbsp; 346370 | &nbsp;&nbsp;&nbsp;&nbsp; 13426 |
| Investments, at cost | $49174 | $351552 | $561975 | $10165721 | $999497 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **December 31, 2025 (continued)** | **Invesco VI Div** <br> **Divd, Ser I**<br>| **Invesco VI** <br> **EQV Intl** <br> **Eq, Ser II**<br>| **Invesco VI Gbl** <br> **Strat Inc, Ser I**<br>| **Invesco VI Gbl** <br> **Strat Inc, Ser** <br> **II**<br>| **Invesco VI** <br> **Global, Ser I**<br>|
| **Assets** |  |  |  |  |  |
| Investments, at fair value | $1077103 | $1008624 | $58525 | $1668523 | $780281 |
| Dividends receivable | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Accounts receivable from RiverSource Life of NY for contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 19 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 4 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 972 |
| Receivable for share redemptions | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 515 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 463 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3331 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total assets | 1077618 | 1009106 | 58525 | 1671858 | 781253 |
| **Liabilities** |  |  |  |  |  |
| Payable to RiverSource Life of NY for: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Mortality and expense risk fee | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 485 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 463 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 707 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| &nbsp;&nbsp;&nbsp; Contract terminations | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 30 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2624 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Payable for investments purchased | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 19 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 4 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 972 |
| Total liabilities | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 515 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 482 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3335 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 972 |
| Net assets applicable to Variable Life contracts in accumulation period | 1077103 | 1008624 | 58525 | 1668523 | 780281 |
| Net assets applicable to seed money | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total net assets | $1077103 | $1008624 | $58525 | $1668523 | $780281 |
| Investment shares | &nbsp;&nbsp;&nbsp;&nbsp; 39570 | &nbsp;&nbsp;&nbsp;&nbsp; 28500 | 12806 | &nbsp;&nbsp;&nbsp;&nbsp; 353501 | &nbsp;&nbsp;&nbsp; 20561 |
| Investments, at cost | $991071 | $967058 | $55309 | $1723559 | $785870 |

---

See accompanying notes to financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**18 ■ RiverSource of New York Account 8**

------

**Statement of Assets and Liabilities**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **December 31, 2025 (continued)** | **Invesco VI** <br> **Global, Ser II**<br>| **Invesco VI** <br> **Mn St Sm** <br> **Cap, Ser I**<br>| **Invesco VI** <br> **Mn St Sm** <br> **Cap, Ser II**<br>| **Invesco VI** <br> **Tech, Ser I**<br>| **Invesco VI** <br> **Tech, Ser II**<br>|
| **Assets** |  |  |  |  |  |
| Investments, at fair value | $1901368 | $653384 | $2143675 | $2083951 | $9978 |
| Dividends receivable | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — |
| Accounts receivable from RiverSource Life of NY for contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 409 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 62 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 13 | &nbsp;&nbsp;&nbsp;&nbsp; — |
| Receivable for share redemptions | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 624 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1560 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 842 | &nbsp;&nbsp;&nbsp;&nbsp; — |
| Total assets | 1901992 | 653793 | 2145297 | 2084806 | 9978 |
| **Liabilities** |  |  |  |  |  |
| Payable to RiverSource Life of NY for: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Mortality and expense risk fee | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 624 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 631 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 746 | &nbsp;&nbsp;&nbsp;&nbsp; — |
| &nbsp;&nbsp;&nbsp; Contract terminations | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 929 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 96 | &nbsp;&nbsp;&nbsp;&nbsp; — |
| Payable for investments purchased | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 409 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 62 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 13 | &nbsp;&nbsp;&nbsp;&nbsp; — |
| Total liabilities | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 624 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 409 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1622 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 855 | &nbsp;&nbsp;&nbsp;&nbsp; — |
| Net assets applicable to Variable Life contracts in accumulation period | 1901073 | 653384 | 2143675 | 2083951 | 9978 |
| Net assets applicable to seed money | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 295 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — |
| Total net assets | $1901368 | $653384 | $2143675 | $2083951 | $9978 |
| Investment shares | &nbsp;&nbsp;&nbsp;&nbsp; 52379 | &nbsp;&nbsp;&nbsp; 22894 | &nbsp;&nbsp;&nbsp;&nbsp; 77361 | &nbsp;&nbsp;&nbsp;&nbsp; 81119 | &nbsp;&nbsp;&nbsp;&nbsp; 469 |
| Investments, at cost | $1990226 | $637570 | $1952189 | $1748430 | $7283 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **December 31, 2025 (continued)** | **Janus Hend** <br> **VIT Gbl Tech** <br> **Innov, Srv**<br>| **Janus** <br> **Henderson VIT** <br> **Bal, Inst**<br>| **Janus** <br> **Henderson VIT** <br> **Bal, Serv**<br>| **Janus** <br> **Henderson VIT** <br> **Enter, Serv**<br>| **Janus** <br> **Henderson VIT** <br> **Flex Bd, Inst**<br>|
| **Assets** |  |  |  |  |  |
| Investments, at fair value | $3196496 | $1353692 | $59526 | $949496 | $568043 |
| Dividends receivable | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Accounts receivable from RiverSource Life of NY for contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 370 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 28 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 131 |
| Receivable for share redemptions | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1494 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 450 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total assets | 3198360 | 1353692 | 59526 | 949974 | 568174 |
| **Liabilities** |  |  |  |  |  |
| Payable to RiverSource Life of NY for: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Mortality and expense risk fee | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1494 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 450 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| &nbsp;&nbsp;&nbsp; Contract terminations | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Payable for investments purchased | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 370 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 28 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 131 |
| Total liabilities | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1864 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 478 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 131 |
| Net assets applicable to Variable Life contracts in accumulation period | 3196496 | 1353692 | 59526 | 949496 | 568043 |
| Net assets applicable to seed money | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total net assets | $3196496 | $1353692 | $59526 | $949496 | $568043 |
| Investment shares | &nbsp;&nbsp;&nbsp;&nbsp; 133521 | &nbsp;&nbsp;&nbsp;&nbsp; 24234 | &nbsp;&nbsp;&nbsp; 1001 | &nbsp;&nbsp;&nbsp; 12945 | &nbsp;&nbsp;&nbsp; 57205 |
| Investments, at cost | $1896093 | $1120226 | $44100 | $780595 | $572654 |

---

See accompanying notes to financial statements.

**RiverSource of New York Account 8** ■ 19

------

**Statement of Assets and Liabilities**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **December 31, 2025 (continued)** | **Janus** <br> **Henderson VIT** <br> **Flex Bd, Serv**<br>| **Janus** <br> **Henderson VIT** <br> **Overseas,** <br> **Serv**<br>| **Janus** <br> **Henderson VIT** <br> **Res, Inst**<br>| **Janus** <br> **Henderson VIT** <br> **Res, Serv**<br>| **Lazard Ret** <br> **Global Dyn** <br> **MA, Inv**<br>|
| **Assets** |  |  |  |  |  |
| Investments, at fair value | $56919 | $2213371 | $102385 | $892248 | $24208 |
| Dividends receivable | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Accounts receivable from RiverSource Life of NY for contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 25 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Receivable for share redemptions | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1426 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 422 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total assets | 56919 | 2214797 | 102385 | 892695 | 24208 |
| **Liabilities** |  |  |  |  |  |
| Payable to RiverSource Life of NY for: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Mortality and expense risk fee | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1109 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 422 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| &nbsp;&nbsp;&nbsp; Contract terminations | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 317 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Payable for investments purchased | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 25 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total liabilities | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1426 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 447 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net assets applicable to Variable Life contracts in accumulation period | 56919 | 2213371 | 102385 | 892248 | 24208 |
| Net assets applicable to seed money | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total net assets | $56919 | $2213371 | $102385 | $892248 | $24208 |
| Investment shares | &nbsp;&nbsp;&nbsp; 5109 | &nbsp;&nbsp;&nbsp;&nbsp; 41746 | &nbsp;&nbsp;&nbsp;&nbsp; 1578 | &nbsp;&nbsp;&nbsp; 14570 | &nbsp;&nbsp;&nbsp; 1662 |
| Investments, at cost | $58073 | $1520884 | $65961 | $598466 | $21091 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **December 31, 2025 (continued)** | **Lazard Ret** <br> **Global Dyn** <br> **MA, Serv**<br>| **Lord Abt Bond** <br> **Debenture,** <br>**Cl VC**<br>| **LVIP AC Intl,** <br>**Serv Cl**<br>| **LVIP AC Intl,** <br> **Std** <br>**Cl II**<br>| **LVIP AC Mid** <br> **Cap Val, Std** <br>**Cl II**<br>|
| **Assets** |  |  |  |  |  |
| Investments, at fair value | $20881 | $25987 | $759820 | $664294 | $49079 |
| Dividends receivable | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Accounts receivable from RiverSource Life of NY for contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 24 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Receivable for share redemptions | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 9 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 240 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 407 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total assets | 20890 | 25987 | 760084 | 664701 | 49079 |
| **Liabilities** |  |  |  |  |  |
| Payable to RiverSource Life of NY for: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Mortality and expense risk fee | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 9 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 240 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 382 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| &nbsp;&nbsp;&nbsp; Contract terminations | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 25 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Payable for investments purchased | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 24 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total liabilities | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 9 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 264 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 407 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net assets applicable to Variable Life contracts in accumulation period | 20481 | 25987 | 759724 | 664294 | 49079 |
| Net assets applicable to seed money | &nbsp;&nbsp;&nbsp;&nbsp; 400 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 96 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total net assets | $20881 | $25987 | $759820 | $664294 | $49079 |
| Investment shares | &nbsp;&nbsp;&nbsp; 1441 | &nbsp;&nbsp;&nbsp; 2449 | &nbsp;&nbsp;&nbsp; 62122 | &nbsp;&nbsp;&nbsp; 54250 | &nbsp;&nbsp;&nbsp; 2537 |
| Investments, at cost | $18789 | $26873 | $691263 | $536193 | $51395 |

---

See accompanying notes to financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**20 ■ RiverSource of New York Account 8**

------

**Statement of Assets and Liabilities**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **December 31, 2025 (continued)** | **LVIP AC Val,** <br>**Serv Cl**<br>| **LVIP AC Val,** <br> **Std** <br>**Cl II**<br>| **MFS Gbl Real** <br> **Est, Init Cl**<br>| **MFS Intl Gro,** <br> **Init Cl**<br>| **MFS Mass Inv** <br> **Gro Stock,** <br>**Serv Cl**<br>|
| **Assets** |  |  |  |  |  |
| Investments, at fair value | $2644989 | $4183696 | $126 | $236435 | $2871756 |
| Dividends receivable | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Accounts receivable from RiverSource Life of NY for contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 34 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 8 |
| Receivable for share redemptions | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 794 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2904 | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1392 |
| Total assets | 2645817 | 4186600 | 126 | 236435 | 2873156 |
| **Liabilities** |  |  |  |  |  |
| Payable to RiverSource Life of NY for: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Mortality and expense risk fee | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 794 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2516 | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1368 |
| &nbsp;&nbsp;&nbsp; Contract terminations | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 388 | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 24 |
| Payable for investments purchased | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 34 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 8 |
| Total liabilities | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 828 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2904 | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1400 |
| Net assets applicable to Variable Life contracts in accumulation period | 2644884 | 4183696 | &nbsp;&nbsp;&nbsp; 49 | 236435 | 2871756 |
| Net assets applicable to seed money | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 105 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; 77 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total net assets | $2644989 | $4183696 | $126 | $236435 | $2871756 |
| Investment shares | &nbsp;&nbsp;&nbsp;&nbsp; 204451 | &nbsp;&nbsp;&nbsp;&nbsp; 323841 | &nbsp;&nbsp;&nbsp; 10 | &nbsp;&nbsp;&nbsp; 13179 | &nbsp;&nbsp;&nbsp;&nbsp; 131310 |
| Investments, at cost | $2372731 | $3216396 | $126 | $221450 | $2739726 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **December 31, 2025 (continued)** | **MFS New Dis,** <br>**Serv Cl**<br>| **MFS Utilities,** <br> **Init Cl**<br>| **MFS Utilities,** <br>**Serv Cl**<br>| **MS VIF Dis,** <br>**Cl I**<br>| **MS VIF Dis,** <br>**Cl II**<br>|
| **Assets** |  |  |  |  |  |
| Investments, at fair value | $2131136 | $148621 | $1226312 | $687860 | $1438091 |
| Dividends receivable | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Accounts receivable from RiverSource Life of NY for contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 84 | &nbsp;&nbsp;&nbsp;&nbsp; 1664 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 10 |
| Receivable for share redemptions | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2152 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 543 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 612 |
| Total assets | 2133288 | 148621 | 1226939 | 689524 | 1438713 |
| **Liabilities** |  |  |  |  |  |
| Payable to RiverSource Life of NY for: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Mortality and expense risk fee | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 911 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 446 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 596 |
| &nbsp;&nbsp;&nbsp; Contract terminations | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1241 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 97 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 16 |
| Payable for investments purchased | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 84 | &nbsp;&nbsp;&nbsp;&nbsp; 1664 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 10 |
| Total liabilities | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2152 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 627 | &nbsp;&nbsp;&nbsp;&nbsp; 1664 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 622 |
| Net assets applicable to Variable Life contracts in accumulation period | 2131136 | 148621 | 1226312 | 687860 | 1438091 |
| Net assets applicable to seed money | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total net assets | $2131136 | $148621 | $1226312 | $687860 | $1438091 |
| Investment shares | &nbsp;&nbsp;&nbsp;&nbsp; 176127 | &nbsp;&nbsp;&nbsp;&nbsp; 3939 | &nbsp;&nbsp;&nbsp;&nbsp; 33306 | &nbsp;&nbsp;&nbsp; 94227 | &nbsp;&nbsp;&nbsp;&nbsp; 223653 |
| Investments, at cost | $2459066 | $137701 | $1070409 | $528021 | $1640805 |

---

See accompanying notes to financial statements.

**RiverSource of New York Account 8** ■ 21

------

**Statement of Assets and Liabilities**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **December 31, 2025 (continued)** | **NB AMT** <br> **Quality Eq,** <br>**Cl I**<br>| **NB AMT** <br> **Quality Eq,** <br>**Cl S**<br>| **Nom VIP Asset** <br> **Strategy,** <br>**Serv Cl**<br>| **Nom VIP Asset** <br> **Strategy, Std** <br> **Cl**<br>| **Nom VIP Intl** <br> **Core Eq, Std Cl**<br>|
| **Assets** |  |  |  |  |  |
| Investments, at fair value | $60402 | $88173 | $51758 | $274 | $94 |
| Dividends receivable | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; — |  |
| Accounts receivable from RiverSource Life of NY for contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; — |  |
| Receivable for share redemptions | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5 | &nbsp;&nbsp;&nbsp; — |  |
| Total assets | 60402 | 88173 | 51763 | 274 | &nbsp;&nbsp; 94 |
| **Liabilities** |  |  |  |  |  |
| Payable to RiverSource Life of NY for: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Mortality and expense risk fee | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5 | &nbsp;&nbsp;&nbsp; — |  |
| &nbsp;&nbsp;&nbsp; Contract terminations | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; — |  |
| Payable for investments purchased | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; — |  |
| Total liabilities | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5 | &nbsp;&nbsp;&nbsp; — |  |
| Net assets applicable to Variable Life contracts in accumulation period | 60402 | 88173 | 51488 | 175 |  |
| Net assets applicable to seed money | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 270 | &nbsp;&nbsp;&nbsp; 99 | &nbsp;&nbsp; 94 |
| Total net assets | $60402 | $88173 | $51758 | $274 | $94 |
| Investment shares | &nbsp;&nbsp;&nbsp; 1413 | &nbsp;&nbsp;&nbsp; 2059 | &nbsp;&nbsp;&nbsp; 5176 | &nbsp;&nbsp;&nbsp; 27 | &nbsp;&nbsp;&nbsp; 5 |
| Investments, at cost | $47671 | $69872 | $48277 | $258 | $81 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **December 31, 2025 (continued)** | **PIMCO VIT All** <br> **Asset, Advisor** <br> **Cl**<br>| **PIMCO VIT All** <br> **Asset, Inst Cl**<br>| **PIMCO VIT Glb** <br> **Man As Alloc,** <br> **Adv Cl**<br>| **PIMCO VIT Tot** <br> **Return,** <br> **Advisor Cl**<br>| **PIMCO VIT Tot** <br> **Return, Inst Cl**<br>|
| **Assets** |  |  |  |  |  |
| Investments, at fair value | $621982 | $21010 | $6725 | $871868 | $332149 |
| Dividends receivable | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 3010 | &nbsp;&nbsp;&nbsp;&nbsp; 1201 |
| Accounts receivable from RiverSource Life of NY for contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 18 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Receivable for share redemptions | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 280 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 627 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total assets | 622280 | 21010 | 6725 | 875505 | 333350 |
| **Liabilities** |  |  |  |  |  |
| Payable to RiverSource Life of NY for: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Mortality and expense risk fee | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 280 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 446 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| &nbsp;&nbsp;&nbsp; Contract terminations | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 182 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Payable for investments purchased | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 18 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 3009 | &nbsp;&nbsp;&nbsp;&nbsp; 1201 |
| Total liabilities | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 298 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 3637 | &nbsp;&nbsp;&nbsp;&nbsp; 1201 |
| Net assets applicable to Variable Life contracts in accumulation period | 621982 | 21010 | 6725 | 869390 | 332149 |
| Net assets applicable to seed money | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 2478 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total net assets | $621982 | $21010 | $6725 | $871868 | $332149 |
| Investment shares | &nbsp;&nbsp;&nbsp; 63728 | &nbsp;&nbsp;&nbsp; 2153 | &nbsp;&nbsp;&nbsp;&nbsp; 573 | &nbsp;&nbsp;&nbsp; 92261 | &nbsp;&nbsp;&nbsp; 35148 |
| Investments, at cost | $641446 | $20405 | $6450 | $885934 | $329100 |

---

See accompanying notes to financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**22 ■ RiverSource of New York Account 8**

------

**Statement of Assets and Liabilities**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **December 31, 2025 (continued)** | **Put VT Global** <br> **Hlth Care,** <br>**Cl IA**<br>| **Put VT Global** <br> **Hlth Care,** <br>**Cl IB**<br>| **Put VT Hi** <br> **Yield,** <br>**Cl IB**<br>| **Put VT Intl Eq,** <br>**Cl IB**<br>| **Put VT Intl Val,** <br>**Cl IA**<br>|
| **Assets** |  |  |  |  |  |
| Investments, at fair value | $93995 | $1438540 | $273624 | $222030 | $90127 |
| Dividends receivable | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Accounts receivable from RiverSource Life of NY for contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 10 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Receivable for share redemptions | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 668 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 227 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 82 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total assets | 93995 | 1439218 | 273851 | 222112 | 90127 |
| **Liabilities** |  |  |  |  |  |
| Payable to RiverSource Life of NY for: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Mortality and expense risk fee | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 628 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 172 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 82 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| &nbsp;&nbsp;&nbsp; Contract terminations | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 40 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 55 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Payable for investments purchased | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 10 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total liabilities | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 678 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 227 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 82 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net assets applicable to Variable Life contracts in accumulation period | 93995 | 1438540 | 273624 | 222030 | 90127 |
| Net assets applicable to seed money | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total net assets | $93995 | $1438540 | $273624 | $222030 | $90127 |
| Investment shares | &nbsp;&nbsp;&nbsp; 5254 | &nbsp;&nbsp;&nbsp;&nbsp; 85576 | &nbsp;&nbsp;&nbsp; 47670 | &nbsp;&nbsp;&nbsp; 11208 | &nbsp;&nbsp;&nbsp; 5591 |
| Investments, at cost | $88644 | $1342679 | $288069 | $172792 | $75545 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **December 31, 2025 (continued)** | **Put VT Lg Cap** <br> **Val,** <br>**Cl IA**<br>| **Put VT Sus** <br> **Leaders,** <br>**Cl IA**<br>| **Put VT Sus** <br> **Leaders,** <br>**Cl IB**<br>| **Royce Micro-**<br> **Cap, Invest Cl**<br>| **Temp Global** <br> **Bond,** <br>**Cl 1**<br>|
| **Assets** |  |  |  |  |  |
| Investments, at fair value | $227394 | $14183494 | $217429 | $2072883 | $38233 |
| Dividends receivable | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Accounts receivable from RiverSource Life of NY for contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 856 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Receivable for share redemptions | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 11861 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 69 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1277 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total assets | 227394 | 14195355 | 217498 | 2075016 | 38233 |
| **Liabilities** |  |  |  |  |  |
| Payable to RiverSource Life of NY for: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Mortality and expense risk fee | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 11283 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 69 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1261 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| &nbsp;&nbsp;&nbsp; Contract terminations | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 578 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 16 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Payable for investments purchased | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 856 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total liabilities | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 11861 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 69 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2133 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net assets applicable to Variable Life contracts in accumulation period | 227394 | 14183494 | 217171 | 2072883 | 38233 |
| Net assets applicable to seed money | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 258 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total net assets | $227394 | $14183494 | $217429 | $2072883 | $38233 |
| Investment shares | &nbsp;&nbsp;&nbsp;&nbsp; 6259 | &nbsp;&nbsp;&nbsp;&nbsp; 291003 | &nbsp;&nbsp;&nbsp;&nbsp; 4696 | &nbsp;&nbsp;&nbsp;&nbsp; 217969 | &nbsp;&nbsp;&nbsp; 2731 |
| Investments, at cost | $189391 | $9644922 | $188936 | $2117170 | $37779 |

---

See accompanying notes to financial statements.

**RiverSource of New York Account 8** ■ 23

------

**Statement of Assets and Liabilities**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **December 31, 2025 (continued)** | **Temp Global** <br> **Bond,** <br>**Cl 2**<br>| **Third Ave VST** <br> **Third Ave** <br> **Value**<br>| **VanEck VIP** <br> **Global Gold,** <br>**Cl S**<br>| **VP Aggr,** <br>**Cl 1**<br>| **VP Aggr,** <br>**Cl 2**<br>|
| **Assets** |  |  |  |  |  |
| Investments, at fair value | $157410 | $2754059 | $498517 | $5327202 | $31188294 |
| Dividends receivable | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Accounts receivable from RiverSource Life of NY for contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1877 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1029 |
| Receivable for share redemptions | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 49 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 7484 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 192 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5975 |
| Total assets | 157459 | 2761543 | 498709 | 5329079 | 31195298 |
| **Liabilities** |  |  |  |  |  |
| Payable to RiverSource Life of NY for: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Mortality and expense risk fee | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 49 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1597 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 192 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5975 |
| &nbsp;&nbsp;&nbsp; Contract terminations | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5887 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Payable for investments purchased | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1877 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1029 |
| Total liabilities | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 49 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 7484 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 192 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1877 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 7004 |
| Net assets applicable to Variable Life contracts in accumulation period | 157342 | 2754059 | 498517 | 5327202 | 31188294 |
| Net assets applicable to seed money | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 68 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total net assets | $157410 | $2754059 | $498517 | $5327202 | $31188294 |
| Investment shares | &nbsp;&nbsp;&nbsp; 11952 | &nbsp;&nbsp;&nbsp;&nbsp; 109986 | &nbsp;&nbsp;&nbsp; 20481 | &nbsp;&nbsp;&nbsp;&nbsp; 140190 | &nbsp;&nbsp;&nbsp;&nbsp; 833243 |
| Investments, at cost | $165795 | $1975845 | $212036 | $4269547 | $18850938 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **December 31, 2025 (continued)** | **VP Aggr,** <br>**Cl 4**<br>| **VP Conserv,** <br>**Cl 1**<br>| **VP Conserv,** <br>**Cl 2**<br>| **VP Conserv,** <br>**Cl 4**<br>| **VP Man Vol** <br> **Conserv Gro,** <br>**Cl 1**<br>|
| **Assets** |  |  |  |  |  |
| Investments, at fair value | $28239661 | $26 | $628602 | $583374 | $67944 |
| Dividends receivable | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Accounts receivable from RiverSource Life of NY for contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 235 |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Receivable for share redemptions | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 11584 |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 274 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 246 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total assets | 28251480 | &nbsp;&nbsp; 26 | 628876 | 583620 | 67944 |
| **Liabilities** |  |  |  |  |  |
| Payable to RiverSource Life of NY for: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Mortality and expense risk fee | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 11584 |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 255 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 246 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| &nbsp;&nbsp;&nbsp; Contract terminations | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 19 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Payable for investments purchased | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 235 |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total liabilities | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 11819 |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 274 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 246 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net assets applicable to Variable Life contracts in accumulation period | 28239661 |  | 628486 | 583278 | 67944 |
| Net assets applicable to seed money | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp; 26 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 116 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 96 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total net assets | $28239661 | $26 | $628602 | $583374 | $67944 |
| Investment shares | &nbsp;&nbsp;&nbsp;&nbsp; 753259 | &nbsp;&nbsp;&nbsp; 1 | &nbsp;&nbsp;&nbsp; 35514 | &nbsp;&nbsp;&nbsp; 32959 | &nbsp;&nbsp;&nbsp; 3994 |
| Investments, at cost | $16239658 | $20 | $554631 | $486774 | $61295 |

---

See accompanying notes to financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**24 ■ RiverSource of New York Account 8**

------

**Statement of Assets and Liabilities**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **December 31, 2025 (continued)** | **VP Man Vol** <br> **Conserv Gro,** <br>**Cl 2**<br>| **VP Man Vol** <br> **Conserv,** <br>**Cl 1**<br>| **VP Man Vol** <br> **Conserv,** <br>**Cl 2**<br>| **VP Man Vol** <br> **Gro,** <br>**Cl 1**<br>| **VP Man Vol** <br> **Gro,** <br>**Cl 2**<br>|
| **Assets** |  |  |  |  |  |
| Investments, at fair value | $378455 | $3969 | $383602 | $2405149 | $2880397 |
| Dividends receivable | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Accounts receivable from RiverSource Life of NY for contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Receivable for share redemptions | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 87 | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 434 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 771 |
| Total assets | 378542 | 3969 | 384036 | 2405149 | 2881168 |
| **Liabilities** |  |  |  |  |  |
| Payable to RiverSource Life of NY for: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Mortality and expense risk fee | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 87 | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 174 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 771 |
| &nbsp;&nbsp;&nbsp; Contract terminations | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 260 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Payable for investments purchased | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total liabilities | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 87 | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 434 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 771 |
| Net assets applicable to Variable Life contracts in accumulation period | 378425 | 3944 | 383519 | 2405149 | 2880360 |
| Net assets applicable to seed money | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 30 | &nbsp;&nbsp;&nbsp;&nbsp; 25 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 83 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 37 |
| Total net assets | $378455 | $3969 | $383602 | $2405149 | $2880397 |
| Investment shares | &nbsp;&nbsp;&nbsp; 22621 | &nbsp;&nbsp;&nbsp;&nbsp; 269 | &nbsp;&nbsp;&nbsp; 26419 | &nbsp;&nbsp;&nbsp;&nbsp; 107229 | &nbsp;&nbsp;&nbsp;&nbsp; 130335 |
| Investments, at cost | $330989 | $3564 | $368505 | $1938231 | $1885981 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **December 31, 2025 (continued)** | **VP Man Vol** <br> **Mod Gro,** <br>**Cl 1**<br>| **VP Man Vol** <br> **Mod Gro,** <br>**Cl 2**<br>| **VP Mod Aggr,** <br>**Cl 1**<br>| **VP Mod Aggr,** <br>**Cl 2**<br>| **VP Mod Aggr,** <br>**Cl 4**<br>|
| **Assets** |  |  |  |  |  |
| Investments, at fair value | $1371617 | $2391814 | $17841740 | $47982947 | $63499168 |
| Dividends receivable | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Accounts receivable from RiverSource Life of NY for contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3592 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 19094 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Receivable for share redemptions | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 635 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 109229 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 26865 |
| Total assets | 1371617 | 2392449 | 17845332 | 48111270 | 63526033 |
| **Liabilities** |  |  |  |  |  |
| Payable to RiverSource Life of NY for: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Mortality and expense risk fee | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 635 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 15126 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 25851 |
| &nbsp;&nbsp;&nbsp; Contract terminations | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 94103 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1014 |
| Payable for investments purchased | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3592 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 19094 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total liabilities | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 635 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3592 | &nbsp;&nbsp;&nbsp;&nbsp; 128323 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 26865 |
| Net assets applicable to Variable Life contracts in accumulation period | 1371617 | 2391780 | 17841740 | 47982947 | 63499168 |
| Net assets applicable to seed money | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 34 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total net assets | $1371617 | $2391814 | $17841740 | $47982947 | $63499168 |
| Investment shares | &nbsp;&nbsp;&nbsp;&nbsp; 63915 | &nbsp;&nbsp;&nbsp;&nbsp; 113195 | &nbsp;&nbsp;&nbsp;&nbsp; 557032 | &nbsp;&nbsp;&nbsp; 1521819 | &nbsp;&nbsp;&nbsp; 2011377 |
| Investments, at cost | $1166414 | $1822044 | $14259045 | $30648741 | $37253696 |

---

See accompanying notes to financial statements.

**RiverSource of New York Account 8** ■ 25

------

**Statement of Assets and Liabilities**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **December 31, 2025 (continued)** | **VP Mod** <br> **Conserv,** <br>**Cl 1**<br>| **VP Mod** <br> **Conserv,** <br>**Cl 2**<br>| **VP Mod** <br> **Conserv,** <br>**Cl 4**<br>| **VP Mod,** <br>**Cl 1**<br>| **VP Mod,** <br>**Cl 2**<br>|
| **Assets** |  |  |  |  |  |
| Investments, at fair value | $857 | $2605804 | $2951280 | $7000185 | $29451534 |
| Dividends receivable | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Accounts receivable from RiverSource Life of NY for contract purchase payments | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 170 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1766 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 176 |
| Receivable for share redemptions | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 924 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1136 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 12338 |
| Total assets | 857 | 2606898 | 2952416 | 7001951 | 29464048 |
| **Liabilities** |  |  |  |  |  |
| Payable to RiverSource Life of NY for: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Mortality and expense risk fee | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 924 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1136 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 11992 |
| &nbsp;&nbsp;&nbsp; Contract terminations | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 346 |
| Payable for investments purchased | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 170 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1766 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 176 |
| Total liabilities | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1094 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1136 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1766 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 12514 |
| Net assets applicable to Variable Life contracts in accumulation period | 857 | 2605701 | 2951280 | 7000185 | 29451534 |
| Net assets applicable to seed money | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 103 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total net assets | $857 | $2605804 | $2951280 | $7000185 | $29451534 |
| Investment shares | &nbsp;&nbsp;&nbsp; 39 | &nbsp;&nbsp;&nbsp;&nbsp; 120695 | &nbsp;&nbsp;&nbsp;&nbsp; 136444 | &nbsp;&nbsp;&nbsp;&nbsp; 259651 | &nbsp;&nbsp;&nbsp; 1109704 |
| Investments, at cost | $664 | $2127403 | $2246442 | $5864230 | $20292349 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **December 31, 2025 (continued)** | **VP Mod,** <br>**Cl 4**<br>| **VP Ptnrs Core** <br> **Bond,** <br>**Cl 1**<br>| **VP Ptnrs Core** <br> **Bond,** <br>**Cl 2**<br>| **VP Ptnrs Core** <br> **Eq,** <br>**Cl 1**<br>| **VP Ptnrs Core** <br> **Eq,** <br>**Cl 2**<br>|
| **Assets** |  |  |  |  |  |
| Investments, at fair value | $35843400 | $38118 | $25383 | $8063 | $43880 |
| Dividends receivable | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Accounts receivable from RiverSource Life of NY for contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 290 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Receivable for share redemptions | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 15500 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total assets | 35859190 | 38118 | 25383 | 8063 | 43880 |
| **Liabilities** |  |  |  |  |  |
| Payable to RiverSource Life of NY for: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Mortality and expense risk fee | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 15071 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| &nbsp;&nbsp;&nbsp; Contract terminations | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 429 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Payable for investments purchased | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 290 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total liabilities | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 15790 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net assets applicable to Variable Life contracts in accumulation period | 35843400 | 38118 | 25383 | 8063 | 43880 |
| Net assets applicable to seed money | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total net assets | $35843400 | $38118 | $25383 | $8063 | $43880 |
| Investment shares | &nbsp;&nbsp;&nbsp; 1349018 | &nbsp;&nbsp;&nbsp; 3906 | &nbsp;&nbsp;&nbsp; 2617 | &nbsp;&nbsp;&nbsp;&nbsp; 155 | &nbsp;&nbsp;&nbsp;&nbsp; 874 |
| Investments, at cost | $22977217 | $38286 | $25506 | $7060 | $29090 |

---

See accompanying notes to financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**26 ■ RiverSource of New York Account 8**

------

**Statement of Assets and Liabilities**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **December 31, 2025 (continued)** | **VP Ptnrs Core** <br> **Eq,** <br>**Cl 3**<br>| **VP Ptnrs Intl** <br> **Core Eq,** <br>**Cl 1**<br>| **VP Ptnrs Intl** <br> **Core Eq,** <br>**Cl 2**<br>| **VP Ptnrs Intl** <br> **Gro,** <br>**Cl 1**<br>| **VP Ptnrs Intl** <br> **Gro,** <br>**Cl 2**<br>|
| **Assets** |  |  |  |  |  |
| Investments, at fair value | $511016 | $431661 | $73163 | $267497 | $231802 |
| Dividends receivable | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Accounts receivable from RiverSource Life of NY for contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 108 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 82 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Receivable for share redemptions | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 230 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total assets | 511354 | 431743 | 73163 | 267497 | 231802 |
| **Liabilities** |  |  |  |  |  |
| Payable to RiverSource Life of NY for: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Mortality and expense risk fee | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 230 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| &nbsp;&nbsp;&nbsp; Contract terminations | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Payable for investments purchased | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 108 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 82 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total liabilities | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 338 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 82 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net assets applicable to Variable Life contracts in accumulation period | 510784 | 431661 | 73163 | 267497 | 231802 |
| Net assets applicable to seed money | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 232 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total net assets | $511016 | $431661 | $73163 | $267497 | $231802 |
| Investment shares | &nbsp;&nbsp;&nbsp;&nbsp; 9993 | &nbsp;&nbsp;&nbsp; 34313 | &nbsp;&nbsp;&nbsp; 5886 | &nbsp;&nbsp;&nbsp; 20451 | &nbsp;&nbsp;&nbsp; 17941 |
| Investments, at cost | $252207 | $385469 | $60450 | $232326 | $210091 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **December 31, 2025 (continued)** | **VP Ptnrs Intl** <br> **Val,** <br>**Cl 1**<br>| **VP Ptnrs Intl** <br> **Val,** <br>**Cl 2**<br>| **VP Ptnrs Sm** <br> **Cap Gro,** <br>**Cl 1**<br>| **VP Ptnrs Sm** <br> **Cap Gro,** <br>**Cl 2**<br>| **VP Ptnrs Sm** <br> **Cap Val,** <br>**Cl 1**<br>|
| **Assets** |  |  |  |  |  |
| Investments, at fair value | $75223 | $83192 | $73546 | $24838 | $4388 |
| Dividends receivable | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — |
| Accounts receivable from RiverSource Life of NY for contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — |
| Receivable for share redemptions | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — |
| Total assets | 75223 | 83192 | 73546 | 24838 | 4388 |
| **Liabilities** |  |  |  |  |  |
| Payable to RiverSource Life of NY for: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Mortality and expense risk fee | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — |
| &nbsp;&nbsp;&nbsp; Contract terminations | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — |
| Payable for investments purchased | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — |
| Total liabilities | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — |
| Net assets applicable to Variable Life contracts in accumulation period | 75223 | 83192 | 73546 | 24838 | 4388 |
| Net assets applicable to seed money | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — |
| Total net assets | $75223 | $83192 | $73546 | $24838 | $4388 |
| Investment shares | &nbsp;&nbsp;&nbsp; 5630 | &nbsp;&nbsp;&nbsp; 6264 | &nbsp;&nbsp;&nbsp; 1968 | &nbsp;&nbsp;&nbsp;&nbsp; 691 | &nbsp;&nbsp;&nbsp;&nbsp; 104 |
| Investments, at cost | $55407 | $61002 | $58928 | $18897 | $3871 |

---

See accompanying notes to financial statements.

**RiverSource of New York Account 8** ■ 27

------

**Statement of Assets and Liabilities**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **December 31, 2025 (continued)** | **VP Ptnrs Sm** <br> **Cap Val,** <br>**Cl 2**<br>| **VP Ptnrs Sm** <br> **Cap Val,** <br>**Cl 3**<br>| **VP US Flex** <br> **Conserv Gro,** <br>**Cl 1**<br>| **VP US Flex** <br> **Gro,** <br>**Cl 1**<br>| **VP US Flex** <br> **Mod Gro,** <br>**Cl 1**<br>|
| **Assets** |  |  |  |  |  |
| Investments, at fair value | $7200 | $689516 | $10418 | $313712 | $131359 |
| Dividends receivable | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Accounts receivable from RiverSource Life of NY for contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 7 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 672 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Receivable for share redemptions | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 256 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total assets | 7200 | 689779 | 10418 | 314384 | 131359 |
| **Liabilities** |  |  |  |  |  |
| Payable to RiverSource Life of NY for: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Mortality and expense risk fee | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 256 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| &nbsp;&nbsp;&nbsp; Contract terminations | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Payable for investments purchased | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 7 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 672 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total liabilities | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 263 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 672 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net assets applicable to Variable Life contracts in accumulation period | 7200 | 689516 | 10418 | 313712 | 131359 |
| Net assets applicable to seed money | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Total net assets | $7200 | $689516 | $10418 | $313712 | $131359 |
| Investment shares | &nbsp;&nbsp;&nbsp;&nbsp; 177 | &nbsp;&nbsp;&nbsp; 16675 | &nbsp;&nbsp;&nbsp;&nbsp; 645 | &nbsp;&nbsp;&nbsp; 14564 | &nbsp;&nbsp;&nbsp;&nbsp; 7013 |
| Investments, at cost | $5136 | $532266 | $8802 | $246593 | $118026 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | |
|:---|:---|:---|
| **December 31, 2025 (continued)** | **WA Var Global** <br> **Hi Yd Bond,** <br>**Cl I**<br>| **WA Var Global** <br> **Hi Yd Bond,** <br>**Cl II**<br>|
| **Assets** |  |  |
| Investments, at fair value | $30293 | $7541 |
| Dividends receivable | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — |
| Accounts receivable from RiverSource Life of NY for contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp; 461 | &nbsp;&nbsp;&nbsp;&nbsp; — |
| Receivable for share redemptions | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — |
| Total assets | 30754 | 7541 |
| **Liabilities** |  |  |
| Payable to RiverSource Life of NY for: |  |  |
| &nbsp;&nbsp;&nbsp; Mortality and expense risk fee | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — |
| &nbsp;&nbsp;&nbsp; Contract terminations | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — |
| Payable for investments purchased | &nbsp;&nbsp;&nbsp;&nbsp; 461 | &nbsp;&nbsp;&nbsp;&nbsp; — |
| Total liabilities | &nbsp;&nbsp;&nbsp;&nbsp; 461 | &nbsp;&nbsp;&nbsp;&nbsp; — |
| Net assets applicable to Variable Life contracts in accumulation period | 30293 | 7541 |
| Net assets applicable to seed money | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — |
| Total net assets | $30293 | $7541 |
| Investment shares | &nbsp;&nbsp;&nbsp; 4886 | 1162 |
| Investments, at cost | $31119 | $8126 |

---

See accompanying notes to financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**28 ■ RiverSource of New York Account 8**

------

**Statement of Operations**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025** | **AB VPS Dyn** <br> **Asset Alloc,** <br>**Cl B**<br>| **AB VPS Intl** <br> **Val,** <br>**Cl B**<br>| **AB VPS Lg** <br> **Cap Gro,** <br>**Cl A**<br>| **AB VPS Lg** <br> **Cap Gro,** <br>**Cl B**<br>| **AB VPS** <br> **Relative Val,** <br>**Cl B**<br>|
| **Investment income** |  |  |  |  |  |
| Dividend income | $9 | $74053 | $— | $— | $23502 |
| Reimbursement of income from trade error |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Variable account expenses | &nbsp;&nbsp;&nbsp; 1 | &nbsp;&nbsp;&nbsp;&nbsp; 13695 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; 12123 | &nbsp;&nbsp;&nbsp; 11042 |
| Investment income (loss) — net | &nbsp;&nbsp;&nbsp; 8 | &nbsp;&nbsp;&nbsp;&nbsp; 60358 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | (12123) | &nbsp;&nbsp;&nbsp; 12460 |
| **Realized and unrealized gain (loss) on investments — net** |  |  |  |  |  |
| Realized gain (loss) on sales of investments: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Proceeds from sales | &nbsp;&nbsp;&nbsp; 2 | &nbsp;&nbsp;&nbsp;&nbsp; 892373 | &nbsp;&nbsp;&nbsp; 70211 | 691844 | 456420 |
| &nbsp;&nbsp;&nbsp; Cost of investments sold | &nbsp;&nbsp;&nbsp; 2 | &nbsp;&nbsp;&nbsp;&nbsp; 707078 | &nbsp;&nbsp;&nbsp; 62522 | 572039 | 428914 |
| Net realized gain (loss) on sales of investments |  | &nbsp;&nbsp;&nbsp;&nbsp; 185295 | &nbsp;&nbsp;&nbsp;&nbsp; 7689 | 119805 | &nbsp;&nbsp;&nbsp; 27506 |
| Distributions from capital gains |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | 107630 | 351576 | 219459 |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp; 61 | &nbsp;&nbsp;&nbsp;&nbsp; 790758 | &nbsp;&nbsp;&nbsp; 38288 | (36111) | (12702) |
| Net gain (loss) on investments | &nbsp;&nbsp; 61 | &nbsp;&nbsp;&nbsp;&nbsp; 976053 | 153607 | 435270 | 234263 |
| Net increase (decrease) in net assets resulting from operations | $69 | $1036411 | $153607 | $423147 | $246723 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **Allspg VT** <br> **Index Asset** <br> **Alloc,** <br>**Cl 2**<br>| **Allspg VT Opp,** <br>**Cl 1**<br>| **Allspg VT Opp,** <br>**Cl 2**<br>| **Allspg VT Sm** <br> **Cap Gro,** <br>**Cl 1**<br>| **Allspg VT Sm** <br> **Cap Gro,** <br>**Cl 2**<br>|
| **Investment income** |  |  |  |  |  |
| Dividend income | $7668 | $75 | $701 | $— | $— |
| Reimbursement of income from trade error | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Variable account expenses | &nbsp;&nbsp;&nbsp; 2210 | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 4541 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 4181 |
| Investment income (loss) — net | &nbsp;&nbsp;&nbsp; 5458 | &nbsp;&nbsp;&nbsp;&nbsp; 75 | &nbsp;&nbsp;&nbsp; (3840) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; (4181) |
| **Realized and unrealized gain (loss) on investments — net** |  |  |  |  |  |
| Realized gain (loss) on sales of investments: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Proceeds from sales | 44490 | 2578 | 266571 | 14617 | 305601 |
| &nbsp;&nbsp;&nbsp; Cost of investments sold | 44389 | 2533 | 264575 | 14069 | 325122 |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp; 101 | &nbsp;&nbsp;&nbsp;&nbsp; 45 | &nbsp;&nbsp;&nbsp;&nbsp; 1996 | &nbsp;&nbsp;&nbsp;&nbsp; 548 | (19521) |
| Distributions from capital gains | 52145 | 2585 | 141165 | 24176 | &nbsp;&nbsp;&nbsp; 85817 |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp; 7285 | &nbsp;&nbsp; (933) | (56294) | 18007 | &nbsp;&nbsp;&nbsp; 60606 |
| Net gain (loss) on investments | 59531 | 1697 | &nbsp;&nbsp;&nbsp; 86867 | 42731 | 126902 |
| Net increase (decrease) in net assets resulting from operations | $64989 | $1772 | $83027 | $42731 | $122721 |

---

See accompanying notes to financial statements.

**RiverSource of New York Account 8** ■ 29

------

**Statement of Operations**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **ALPS Alerian** <br> **Engy Infr,** <br> **Class I**<br>| **ALPS Alerian** <br> **Engy Infr,** <br> **Class III**<br>| **BlackRock** <br> **Global Alloc,** <br>**Cl I**<br>| **BlackRock** <br> **Global Alloc,** <br>**Cl III**<br>| **Calvert VP SRI** <br> **Bal,** <br>**Cl I**<br>|
| **Investment income** |  |  |  |  |  |
| Dividend income | $4893 | $25208 | $12303 | $24370 | $46819 |
| Reimbursement of income from trade error | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Variable account expenses | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 2943 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; 2644 | &nbsp;&nbsp;&nbsp; 13511 |
| Investment income (loss) — net | &nbsp;&nbsp;&nbsp;&nbsp; 4893 | &nbsp;&nbsp;&nbsp; 22265 | 12303 | 21726 | &nbsp;&nbsp;&nbsp; 33308 |
| **Realized and unrealized gain (loss) on investments — net** |  |  |  |  |  |
| Realized gain (loss) on sales of investments: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Proceeds from sales | &nbsp;&nbsp;&nbsp; 39411 | &nbsp;&nbsp;&nbsp; 88922 | 53781 | 88713 | 130792 |
| &nbsp;&nbsp;&nbsp; Cost of investments sold | &nbsp;&nbsp;&nbsp; 32960 | &nbsp;&nbsp;&nbsp; 73905 | 50640 | 94452 | 113936 |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp; 6451 | &nbsp;&nbsp;&nbsp; 15017 | &nbsp;&nbsp;&nbsp; 3141 | (5739) | &nbsp;&nbsp;&nbsp; 16856 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp; 11591 | &nbsp;&nbsp;&nbsp; 64343 | 28293 | 59409 | 153580 |
| Net change in unrealized appreciation (depreciation) of investments | (18088) | (80480) | 17354 | 24051 | &nbsp;&nbsp;&nbsp; 86265 |
| Net gain (loss) on investments | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (46) | &nbsp;&nbsp;&nbsp; (1120) | 48788 | 77721 | 256701 |
| Net increase (decrease) in net assets resulting from operations | $4847 | $21145 | $61091 | $99447 | $290009 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **Col VP Acorn** | **Col VP Acorn** <br> **Intl**<br>| **Col VP Bal,** <br>**Cl 1**<br>| **Col VP Bal,** <br>**Cl 3**<br>| **Col VP** <br> **Commodity** <br> **Strategy,** <br>**Cl 1**<br>|
| **Investment income** |  |  |  |  |  |
| Dividend income | $— | $50935 | $— | $— | $7000 |
| Reimbursement of income from trade error | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Variable account expenses | &nbsp;&nbsp;&nbsp;&nbsp; 27898 | &nbsp;&nbsp;&nbsp;&nbsp; 19818 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 144618 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Investment income (loss) — net | &nbsp;&nbsp;&nbsp;&nbsp; (27898) | &nbsp;&nbsp;&nbsp;&nbsp; 31117 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp; (144618) | &nbsp;&nbsp;&nbsp; 7000 |
| **Realized and unrealized gain (loss) on investments — net** |  |  |  |  |  |
| Realized gain (loss) on sales of investments: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Proceeds from sales | 1094905 | &nbsp;&nbsp;&nbsp; 707198 | 426918 | 1565430 | &nbsp;&nbsp;&nbsp; 5594 |
| &nbsp;&nbsp;&nbsp; Cost of investments sold | 1394603 | &nbsp;&nbsp;&nbsp; 845428 | 381467 | &nbsp;&nbsp;&nbsp;&nbsp; 646492 | &nbsp;&nbsp;&nbsp; 6348 |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp; (299698) | (138230) | &nbsp;&nbsp;&nbsp; 45451 | &nbsp;&nbsp;&nbsp;&nbsp; 918938 | &nbsp;&nbsp;&nbsp;&nbsp; (754) |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 19526 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp;&nbsp; 555721 | &nbsp;&nbsp;&nbsp; 536360 | 371163 | 1613230 | &nbsp;&nbsp;&nbsp; 6130 |
| Net gain (loss) on investments | &nbsp;&nbsp;&nbsp;&nbsp; 256023 | &nbsp;&nbsp;&nbsp; 417656 | 416614 | 2532168 | &nbsp;&nbsp;&nbsp; 5376 |
| Net increase (decrease) in net assets resulting from operations | $228125 | $448773 | $416614 | $2387550 | $12376 |

---

See accompanying notes to financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**30 ■ RiverSource of New York Account 8**

------

**Statement of Operations**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **Col VP** <br> **Commodity** <br> **Strategy,** <br>**Cl 2**<br>| **Col VP** <br> **Contrarian** <br> **Core,** <br>**Cl 1**<br>| **Col VP** <br> **Contrarian** <br> **Core,** <br>**Cl 2**<br>| **Col VP** <br> **Corporate** <br> **Bond,** <br>**Cl 1**<br>| **Col VP** <br> **Corporate** <br> **Bond,** <br>**Cl 2**<br>|
| **Investment income** |  |  |  |  |  |
| Dividend income | $3502 | $— | $— | $599 | $6420 |
| Reimbursement of income from trade error | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — |
| Variable account expenses | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — |
| Investment income (loss) — net | 3502 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 599 | 6420 |
| **Realized and unrealized gain (loss) on investments — net** |  |  |  |  |  |
| Realized gain (loss) on sales of investments: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Proceeds from sales | 6169 | 40275 | &nbsp;&nbsp;&nbsp; 3240 | 2093 | 6841 |
| &nbsp;&nbsp;&nbsp; Cost of investments sold | 7101 | 28788 | &nbsp;&nbsp;&nbsp; 2047 | 2088 | 7580 |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp; (932) | 11487 | &nbsp;&nbsp;&nbsp; 1193 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5 | &nbsp;&nbsp; (739) |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | 3580 | 80282 | 65602 | &nbsp;&nbsp;&nbsp;&nbsp; 340 | 1420 |
| Net gain (loss) on investments | 2648 | 91769 | 66795 | &nbsp;&nbsp;&nbsp;&nbsp; 345 | &nbsp;&nbsp;&nbsp;&nbsp; 681 |
| Net increase (decrease) in net assets resulting from operations | $6150 | $91769 | $66795 | $944 | $7101 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **Col VP** <br> **Corporate** <br> **Bond,** <br>**Cl 3**<br>| **Col VP** <br> **Disciplined** <br> **Core,** <br>**Cl 1**<br>| **Col VP** <br> **Disciplined** <br> **Core,** <br>**Cl 2**<br>| **Col VP** <br> **Disciplined** <br> **Core,** <br>**Cl 3**<br>| **Col VP Divd** <br> **Opp,** <br>**Cl 1**<br>|
| **Investment income** |  |  |  |  |  |
| Dividend income | $77750 | $— | $— | $— | $— |
| Reimbursement of income from trade error | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Variable account expenses | &nbsp;&nbsp;&nbsp;&nbsp; 5897 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 265316 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Investment income (loss) — net | &nbsp;&nbsp;&nbsp; 71853 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp; (265316) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| **Realized and unrealized gain (loss) on investments — net** |  |  |  |  |  |
| Realized gain (loss) on sales of investments: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Proceeds from sales | 383951 | 11862 | 77276 | 3647662 | &nbsp;&nbsp;&nbsp; 25928 |
| &nbsp;&nbsp;&nbsp; Cost of investments sold | 435749 | &nbsp;&nbsp;&nbsp; 9275 | 36592 | &nbsp;&nbsp;&nbsp;&nbsp; 913130 | &nbsp;&nbsp;&nbsp; 23145 |
| Net realized gain (loss) on sales of investments | (51798) | &nbsp;&nbsp;&nbsp; 2587 | 40684 | 2734532 | &nbsp;&nbsp;&nbsp;&nbsp; 2783 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp; 61386 | 45750 | 28462 | 1673504 | 100552 |
| Net gain (loss) on investments | &nbsp;&nbsp;&nbsp;&nbsp; 9588 | 48337 | 69146 | 4408036 | 103335 |
| Net increase (decrease) in net assets resulting from operations | $81441 | $48337 | $69146 | $4142720 | $103335 |

---

See accompanying notes to financial statements.

**RiverSource of New York Account 8** ■ 31

------

**Statement of Operations**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **Col VP Divd** <br> **Opp,** <br>**Cl 2**<br>| **Col VP Divd** <br> **Opp,** <br>**Cl 3**<br>| **Col VP Emer** <br> **Mkts,** <br>**Cl 1**<br>| **Col VP Emer** <br> **Mkts,** <br>**Cl 2**<br>| **Col VP Emer** <br> **Mkts,** <br>**Cl 3**<br>|
| **Investment income** |  |  |  |  |  |
| Dividend income | $— | $— | $839 | $265 | $3486 |
| Reimbursement of income from trade error | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Variable account expenses | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 71195 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; 11135 |
| Investment income (loss) — net | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (71195) | &nbsp;&nbsp;&nbsp;&nbsp; 839 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 265 | &nbsp;&nbsp;&nbsp; (7649) |
| **Realized and unrealized gain (loss) on investments — net** |  |  |  |  |  |
| Realized gain (loss) on sales of investments: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Proceeds from sales | &nbsp;&nbsp;&nbsp; 8373 | 2728127 | 12362 | &nbsp;&nbsp;&nbsp; 35602 | 322913 |
| &nbsp;&nbsp;&nbsp; Cost of investments sold | &nbsp;&nbsp;&nbsp; 6224 | 1335347 | 12860 | &nbsp;&nbsp;&nbsp; 40825 | 382462 |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp; 2149 | 1392780 | &nbsp;&nbsp;&nbsp;&nbsp; (498) | &nbsp;&nbsp;&nbsp; (5223) | (59549) |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | 50217 | &nbsp;&nbsp;&nbsp;&nbsp; 545711 | 87484 | 121485 | 624796 |
| Net gain (loss) on investments | 52366 | 1938491 | 86986 | 116262 | 565247 |
| Net increase (decrease) in net assets resulting from operations | $52366 | $1867296 | $87825 | $116527 | $557598 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **Col VP Emerg** <br> **Mkts Bond,** <br>**Cl 1**<br>| **Col VP Emerg** <br> **Mkts Bond,** <br>**Cl 2**<br>| **Col VP Govt** <br> **Money Mkt,** <br>**Cl 1**<br>| **Col VP Govt** <br> **Money Mkt,** <br>**Cl 2**<br>| **Col VP Govt** <br> **Money Mkt,** <br>**Cl 3**<br>|
| **Investment income** |  |  |  |  |  |
| Dividend income | $2575 | $922 | $20858 | $18394 | $141733 |
| Reimbursement of income from trade error | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Variable account expenses | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; 19550 |
| Investment income (loss) — net | 2575 | &nbsp;&nbsp;&nbsp;&nbsp; 922 | &nbsp;&nbsp;&nbsp; 20858 | 18394 | 122183 |
| **Realized and unrealized gain (loss) on investments — net** |  |  |  |  |  |
| Realized gain (loss) on sales of investments: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Proceeds from sales | 4247 | &nbsp;&nbsp;&nbsp;&nbsp; 343 | 142808 | 64534 | 873994 |
| &nbsp;&nbsp;&nbsp; Cost of investments sold | 4060 | &nbsp;&nbsp;&nbsp;&nbsp; 380 | 142808 | 64534 | 873993 |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp; 187 | &nbsp;&nbsp;&nbsp;&nbsp; (37) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | 2981 | 1260 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (1) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (1) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net gain (loss) on investments | 3168 | 1223 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (1) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (1) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1 |
| Net increase (decrease) in net assets resulting from operations | $5743 | $2145 | $20857 | $18393 | $122184 |

---

See accompanying notes to financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**32 ■ RiverSource of New York Account 8**

------

**Statement of Operations**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **Col VP Hi** <br> **Yield Bond,** <br>**Cl 1**<br>| **Col VP Hi** <br> **Yield Bond,** <br>**Cl 2**<br>| **Col VP Hi** <br> **Yield Bond,** <br>**Cl 3**<br>| **Col VP Inc** <br> **Opp,** <br>**Cl 1**<br>| **Col VP Inc** <br> **Opp,** <br>**Cl 2**<br>|
| **Investment income** |  |  |  |  |  |
| Dividend income | $19282 | $23204 | $163468 | $537 | $1612 |
| Reimbursement of income from trade error | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Variable account expenses | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; 14088 | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Investment income (loss) — net | 19282 | 23204 | 149380 | &nbsp;&nbsp;&nbsp;&nbsp; 537 | &nbsp;&nbsp;&nbsp; 1612 |
| **Realized and unrealized gain (loss) on investments — net** |  |  |  |  |  |
| Realized gain (loss) on sales of investments: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Proceeds from sales | 47365 | 27313 | 523776 | 4425 | 16374 |
| &nbsp;&nbsp;&nbsp; Cost of investments sold | 46576 | 28120 | 546953 | 4529 | 16304 |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp; 789 | &nbsp;&nbsp;&nbsp;&nbsp; (807) | (23177) | &nbsp;&nbsp; (104) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 70 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp; 7164 | &nbsp;&nbsp;&nbsp; 9555 | &nbsp;&nbsp;&nbsp; 81493 | 1997 | &nbsp;&nbsp;&nbsp; 5653 |
| Net gain (loss) on investments | &nbsp;&nbsp;&nbsp; 7953 | &nbsp;&nbsp;&nbsp; 8748 | &nbsp;&nbsp;&nbsp; 58316 | 1893 | &nbsp;&nbsp;&nbsp; 5723 |
| Net increase (decrease) in net assets resulting from operations | $27235 | $31952 | $207696 | $2430 | $7335 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **Col VP Inc** <br> **Opp,** <br>**Cl 3**<br>| **Col VP Inter** <br> **Bond,** <br>**Cl 1**<br>| **Col VP Inter** <br> **Bond,** <br>**Cl 2**<br>| **Col VP Inter** <br> **Bond,** <br>**Cl 3**<br>| **Col VP Lg Cap** <br> **Gro,** <br>**Cl 1**<br>|
| **Investment income** |  |  |  |  |  |
| Dividend income | $22984 | $10593 | $5540 | $306097 | $— |
| Reimbursement of income from trade error | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Variable account expenses | &nbsp;&nbsp;&nbsp;&nbsp; 6294 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 33082 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Investment income (loss) — net | &nbsp;&nbsp;&nbsp; 16690 | 10593 | &nbsp;&nbsp;&nbsp; 5540 | &nbsp;&nbsp;&nbsp;&nbsp; 273015 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| **Realized and unrealized gain (loss) on investments — net** |  |  |  |  |  |
| Realized gain (loss) on sales of investments: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Proceeds from sales | 191337 | 76786 | 22966 | 1179613 | 146042 |
| &nbsp;&nbsp;&nbsp; Cost of investments sold | 209907 | 80123 | 23920 | 1358140 | 116351 |
| Net realized gain (loss) on sales of investments | (18570) | (3337) | &nbsp;&nbsp;&nbsp;&nbsp; (954) | &nbsp;&nbsp; (178527) | &nbsp;&nbsp;&nbsp; 29691 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp; 96647 | &nbsp;&nbsp;&nbsp; 7456 | &nbsp;&nbsp;&nbsp; 3374 | &nbsp;&nbsp;&nbsp;&nbsp; 369609 | 548288 |
| Net gain (loss) on investments | &nbsp;&nbsp;&nbsp; 78077 | &nbsp;&nbsp;&nbsp; 4119 | &nbsp;&nbsp;&nbsp; 2420 | &nbsp;&nbsp;&nbsp;&nbsp; 191082 | 577979 |
| Net increase (decrease) in net assets resulting from operations | $94767 | $14712 | $7960 | $464097 | $577979 |

---

See accompanying notes to financial statements.

**RiverSource of New York Account 8** ■ 33

------

**Statement of Operations**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **Col VP Lg Cap** <br> **Gro,** <br>**Cl 2**<br>| **Col VP Lg Cap** <br> **Gro,** <br>**Cl 3**<br>| **Col VP Lg Cap** <br> **Index,** <br>**Cl 1**<br>| **Col VP Lg Cap** <br> **Index,** <br>**Cl 3**<br>| **Col VP Limited** <br> **Duration Cr,** <br>**Cl 1**<br>|
| **Investment income** |  |  |  |  |  |
| Dividend income | $— | $— | $— | $— | $6076 |
| Reimbursement of income from trade error | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Variable account expenses | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; 20826 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 78606 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Investment income (loss) — net | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | (20826) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (78606) | &nbsp;&nbsp;&nbsp; 6076 |
| **Realized and unrealized gain (loss) on investments — net** |  |  |  |  |  |
| Realized gain (loss) on sales of investments: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Proceeds from sales | 42667 | 524950 | &nbsp;&nbsp;&nbsp;&nbsp; 189642 | 2768901 | &nbsp;&nbsp;&nbsp; 5566 |
| &nbsp;&nbsp;&nbsp; Cost of investments sold | 24005 | 233658 | &nbsp;&nbsp;&nbsp;&nbsp; 137467 | 1505169 | &nbsp;&nbsp;&nbsp; 5509 |
| Net realized gain (loss) on sales of investments | 18662 | 291292 | &nbsp;&nbsp;&nbsp;&nbsp; 52175 | 1263732 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 57 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | 78056 | 287518 | 1648823 | 1558802 | (1700) |
| Net gain (loss) on investments | 96718 | 578810 | 1700998 | 2822534 | (1643) |
| Net increase (decrease) in net assets resulting from operations | $96718 | $557984 | $1700998 | $2743928 | $4433 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **Col VP Limited** <br> **Duration Cr,** <br>**Cl 2**<br>| **Col VP Long** <br> **Govt/Cr Bond,** <br>**Cl 1**<br>| **Col VP Long** <br> **Govt/Cr Bond,** <br>**Cl 2**<br>| **Col VP** <br> **Overseas** <br> **Core,** <br>**Cl 1**<br>| **Col VP** <br> **Overseas** <br> **Core,** <br>**Cl 2**<br>|
| **Investment income** |  |  |  |  |  |
| Dividend income | $56018 | $3303 | $70 | $12543 | $3665 |
| Reimbursement of income from trade error | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Variable account expenses | &nbsp;&nbsp;&nbsp;&nbsp; 4496 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Investment income (loss) — net | &nbsp;&nbsp;&nbsp; 51522 | &nbsp;&nbsp;&nbsp; 3303 | &nbsp;&nbsp;&nbsp;&nbsp; 70 | &nbsp;&nbsp;&nbsp; 12543 | &nbsp;&nbsp;&nbsp; 3665 |
| **Realized and unrealized gain (loss) on investments — net** |  |  |  |  |  |
| Realized gain (loss) on sales of investments: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Proceeds from sales | 130869 | 12246 | &nbsp;&nbsp;&nbsp; 469 | &nbsp;&nbsp;&nbsp; 26685 | 36264 |
| &nbsp;&nbsp;&nbsp; Cost of investments sold | 130119 | 13542 | &nbsp;&nbsp;&nbsp; 625 | &nbsp;&nbsp;&nbsp; 24166 | 32610 |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 750 | (1296) | (156) | &nbsp;&nbsp;&nbsp;&nbsp; 2519 | &nbsp;&nbsp;&nbsp; 3654 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp; (3481) | &nbsp;&nbsp;&nbsp;&nbsp; (337) | &nbsp;&nbsp;&nbsp; 143 | 216546 | 61416 |
| Net gain (loss) on investments | &nbsp;&nbsp;&nbsp; (2731) | (1633) | &nbsp;&nbsp;&nbsp; (13) | 219065 | 65070 |
| Net increase (decrease) in net assets resulting from operations | $48791 | $1670 | $57 | $231608 | $68735 |

---

See accompanying notes to financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**34 ■ RiverSource of New York Account 8**

------

**Statement of Operations**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **Col VP** <br> **Overseas** <br> **Core,** <br>**Cl 3**<br>| **Col VP Sel Gbl** <br> **Tech,** <br>**Cl 1**<br>| **Col VP Sel Gbl** <br> **Tech,** <br>**Cl 2**<br>| **Col VP Select** <br> **Lg Cap Val,** <br>**Cl 1**<br>| **Col VP Select** <br> **Lg Cap Val,** <br>**Cl 2**<br>|
| **Investment income** |  |  |  |  |  |
| Dividend income | $97962 | $— | $— | $— | $— |
| Reimbursement of income from trade error | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Variable account expenses | &nbsp;&nbsp;&nbsp;&nbsp; 45663 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Investment income (loss) — net | &nbsp;&nbsp;&nbsp;&nbsp; 52299 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| **Realized and unrealized gain (loss) on investments — net** |  |  |  |  |  |
| Realized gain (loss) on sales of investments: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Proceeds from sales | &nbsp;&nbsp;&nbsp;&nbsp; 723660 | &nbsp;&nbsp;&nbsp; 66016 | &nbsp;&nbsp;&nbsp;&nbsp; 469 | 140360 | 15824 |
| &nbsp;&nbsp;&nbsp; Cost of investments sold | &nbsp;&nbsp;&nbsp;&nbsp; 551100 | &nbsp;&nbsp;&nbsp; 54641 | &nbsp;&nbsp;&nbsp;&nbsp; 389 | 119628 | 11027 |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp; 172560 | &nbsp;&nbsp;&nbsp; 11375 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 80 | &nbsp;&nbsp;&nbsp; 20732 | &nbsp;&nbsp;&nbsp; 4797 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; 43289 | 16586 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | 1480929 | &nbsp;&nbsp;&nbsp; 91265 | 35803 | 272192 | 52636 |
| Net gain (loss) on investments | 1653489 | 145929 | 52469 | 292924 | 57433 |
| Net increase (decrease) in net assets resulting from operations | $1705788 | $145929 | $52469 | $292924 | $57433 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **Col VP Select** <br> **Lg Cap Val,** <br>**Cl 3**<br>| **Col VP Select** <br> **Mid Cap Gro,** <br>**Cl 1**<br>| **Col VP Select** <br> **Mid Cap Gro,** <br>**Cl 2**<br>| **Col VP Select** <br> **Mid Cap Gro,** <br>**Cl 3**<br>| **Col VP Select** <br> **Mid Cap Val,** <br>**Cl 1**<br>|
| **Investment income** |  |  |  |  |  |
| Dividend income | $— | $— | $— | $— | $— |
| Reimbursement of income from trade error | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Variable account expenses | &nbsp;&nbsp;&nbsp;&nbsp; 3922 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 6293 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Investment income (loss) — net | &nbsp;&nbsp;&nbsp; (3922) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; (6293) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| **Realized and unrealized gain (loss) on investments — net** |  |  |  |  |  |
| Realized gain (loss) on sales of investments: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Proceeds from sales | 287380 | &nbsp;&nbsp;&nbsp; 9102 | 26329 | 325525 | &nbsp;&nbsp;&nbsp; 9728 |
| &nbsp;&nbsp;&nbsp; Cost of investments sold | 187979 | &nbsp;&nbsp;&nbsp; 6380 | 14656 | 190406 | &nbsp;&nbsp;&nbsp; 7934 |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp; 99401 | &nbsp;&nbsp;&nbsp; 2722 | 11673 | 135119 | &nbsp;&nbsp;&nbsp; 1794 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | 113140 | 84765 | 11042 | &nbsp;&nbsp;&nbsp; 45290 | 72895 |
| Net gain (loss) on investments | 212541 | 87487 | 22715 | 180409 | 74689 |
| Net increase (decrease) in net assets resulting from operations | $208619 | $87487 | $22715 | $174116 | $74689 |

---

See accompanying notes to financial statements.

**RiverSource of New York Account 8** ■ 35

------

**Statement of Operations**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **Col VP Select** <br> **Mid Cap Val,** <br>**Cl 2**<br>| **Col VP Select** <br> **Mid Cap Val,** <br>**Cl 3**<br>| **Col VP Select** <br> **Sm Cap Val,** <br>**Cl 1**<br>| **Col VP Select** <br> **Sm Cap Val,** <br>**Cl 2**<br>| **Col VP Select** <br> **Sm Cap Val,** <br>**Cl 3**<br>|
| **Investment income** |  |  |  |  |  |
| Dividend income | $— | $— | $— | $— | $— |
| Reimbursement of income from trade error | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Variable account expenses | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 4047 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 5742 |
| Investment income (loss) — net | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; (4047) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; (5742) |
| **Realized and unrealized gain (loss) on investments — net** |  |  |  |  |  |
| Realized gain (loss) on sales of investments: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Proceeds from sales | 10119 | 260270 | 10745 | &nbsp;&nbsp;&nbsp; 4029 | 338922 |
| &nbsp;&nbsp;&nbsp; Cost of investments sold | &nbsp;&nbsp;&nbsp; 6306 | 153263 | &nbsp;&nbsp;&nbsp; 9248 | &nbsp;&nbsp;&nbsp; 2920 | 208143 |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp; 3813 | 107007 | &nbsp;&nbsp;&nbsp; 1497 | &nbsp;&nbsp;&nbsp; 1109 | 130779 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | 21491 | &nbsp;&nbsp;&nbsp; 31429 | 14277 | 11046 | (68239) |
| Net gain (loss) on investments | 25304 | 138436 | 15774 | 12155 | &nbsp;&nbsp;&nbsp; 62540 |
| Net increase (decrease) in net assets resulting from operations | $25304 | $134389 | $15774 | $12155 | $56798 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **Col VP** <br> **Strategic Inc,** <br>**Cl 1**<br>| **Col VP** <br> **Strategic Inc,** <br>**Cl 2**<br>| **Col VP US** <br> **Govt Mtge,** <br>**Cl 1**<br>| **Col VP US** <br> **Govt Mtge,** <br>**Cl 2**<br>| **Col VP US** <br> **Govt Mtge,** <br>**Cl 3**<br>|
| **Investment income** |  |  |  |  |  |
| Dividend income | $10960 | $13313 | $585 | $305 | $25614 |
| Reimbursement of income from trade error | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Variable account expenses | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 6772 |
| Investment income (loss) — net | 10960 | &nbsp;&nbsp;&nbsp; 13313 | &nbsp;&nbsp;&nbsp;&nbsp; 585 | &nbsp;&nbsp;&nbsp;&nbsp; 305 | &nbsp;&nbsp;&nbsp; 18842 |
| **Realized and unrealized gain (loss) on investments — net** |  |  |  |  |  |
| Realized gain (loss) on sales of investments: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Proceeds from sales | 22740 | 150868 | 1871 | 5734 | 317159 |
| &nbsp;&nbsp;&nbsp; Cost of investments sold | 22960 | 149483 | 1900 | 5935 | 344801 |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp; (220) | &nbsp;&nbsp;&nbsp;&nbsp; 1385 | &nbsp;&nbsp;&nbsp;&nbsp; (29) | &nbsp;&nbsp; (201) | (27642) |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp; 5128 | &nbsp;&nbsp;&nbsp;&nbsp; 6478 | 1604 | 1330 | 106656 |
| Net gain (loss) on investments | &nbsp;&nbsp;&nbsp; 4908 | &nbsp;&nbsp;&nbsp;&nbsp; 7863 | 1575 | 1129 | &nbsp;&nbsp;&nbsp; 79014 |
| Net increase (decrease) in net assets resulting from operations | $15868 | $21176 | $2160 | $1434 | $97856 |

---

See accompanying notes to financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**36 ■ RiverSource of New York Account 8**

------

**Statement of Operations**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **CS Commodity** <br> **Return,** <br>**Cl 1**<br>| **CTIVP AC Div** <br> **Bond,** <br>**Cl 1**<br>| **CTIVP AC Div** <br> **Bond,** <br>**Cl 2**<br>| **CTIVP BR Gl** <br> **Infl Prot Sec,** <br>**Cl 1**<br>| **CTIVP BR Gl** <br> **Infl Prot Sec,** <br>**Cl 2**<br>|
| **Investment income** |  |  |  |  |  |
| Dividend income | $16080 | $1459 | $773 | $1883 | $707 |
| Reimbursement of income from trade error | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; — |
| Variable account expenses | &nbsp;&nbsp;&nbsp; 1963 | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; — |
| Investment income (loss) — net | 14117 | 1459 | &nbsp;&nbsp;&nbsp;&nbsp; 773 | &nbsp;&nbsp;&nbsp; 1883 | 707 |
| **Realized and unrealized gain (loss) on investments — net** |  |  |  |  |  |
| Realized gain (loss) on sales of investments: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Proceeds from sales | 53292 | 5422 | 1121 | 12280 | 129 |
| &nbsp;&nbsp;&nbsp; Cost of investments sold | 61611 | 5735 | 1261 | 14271 | 154 |
| Net realized gain (loss) on sales of investments | (8319) | &nbsp;&nbsp; (313) | &nbsp;&nbsp; (140) | (1991) | (25) |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | 48528 | 1899 | 1175 | &nbsp;&nbsp;&nbsp; 2165 | &nbsp;&nbsp;&nbsp; 68 |
| Net gain (loss) on investments | 40209 | 1586 | 1035 | &nbsp;&nbsp;&nbsp;&nbsp; 174 | &nbsp;&nbsp;&nbsp; 43 |
| Net increase (decrease) in net assets resulting from operations | $54326 | $3045 | $1808 | $2057 | $750 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **CTIVP BR Gl** <br> **Infl Prot Sec,** <br>**Cl 3**<br>| **CTIVP** <br> **CenterSquare** <br> **Real Est,** <br>**Cl 1**<br>| **CTIVP** <br> **CenterSquare** <br> **Real Est,** <br>**Cl 2**<br>| **CTIVP Prin Lg** <br> **Cap Gro,** <br>**Cl 1**<br>| **CTIVP Prin Lg** <br> **Cap Gro,** <br>**Cl 2**<br>|
| **Investment income** |  |  |  |  |  |
| Dividend income | $17513 | $2445 | $5365 | $— | $— |
| Reimbursement of income from trade error | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Variable account expenses | &nbsp;&nbsp;&nbsp;&nbsp; 2397 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Investment income (loss) — net | &nbsp;&nbsp;&nbsp; 15116 | &nbsp;&nbsp;&nbsp; 2445 | &nbsp;&nbsp;&nbsp; 5365 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| **Realized and unrealized gain (loss) on investments — net** |  |  |  |  |  |
| Realized gain (loss) on sales of investments: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Proceeds from sales | 113436 | &nbsp;&nbsp;&nbsp; 3751 | 21649 | &nbsp;&nbsp;&nbsp; 6609 | 13477 |
| &nbsp;&nbsp;&nbsp; Cost of investments sold | 144360 | &nbsp;&nbsp;&nbsp; 4012 | 25677 | &nbsp;&nbsp;&nbsp; 5064 | &nbsp;&nbsp;&nbsp; 8394 |
| Net realized gain (loss) on sales of investments | (30924) | &nbsp;&nbsp;&nbsp;&nbsp; (261) | (4028) | &nbsp;&nbsp;&nbsp; 1545 | &nbsp;&nbsp;&nbsp; 5083 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; 4446 | 10651 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp; 32565 | (4734) | (7746) | 24164 | &nbsp;&nbsp;&nbsp; 8434 |
| Net gain (loss) on investments | &nbsp;&nbsp;&nbsp;&nbsp; 1641 | &nbsp;&nbsp;&nbsp;&nbsp; (549) | (1123) | 25709 | 13517 |
| Net increase (decrease) in net assets resulting from operations | $16757 | $1896 | $4242 | $25709 | $13517 |

---

See accompanying notes to financial statements.

**RiverSource of New York Account 8** ■ 37

------

**Statement of Operations**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **CTIVP T Rowe** <br> **Price LgCap** <br> **Val,** <br>**Cl 1**<br>| **CTIVP T Rowe** <br> **Price LgCap** <br> **Val,** <br>**Cl 2**<br>| **CTIVP TCW** <br> **Core Plus** <br> **Bond,** <br>**Cl 1**<br>| **CTIVP TCW** <br> **Core Plus** <br> **Bond,** <br>**Cl 2**<br>| **CTIVP Vty** <br> **Sycamore Estb** <br> **Val,** <br>**Cl 1**<br>|
| **Investment income** |  |  |  |  |  |
| Dividend income | $— | $— | $4102 | $1975 | $— |
| Reimbursement of income from trade error | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Variable account expenses | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Investment income (loss) — net | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | 4102 | 1975 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| **Realized and unrealized gain (loss) on investments — net** |  |  |  |  |  |
| Realized gain (loss) on sales of investments: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Proceeds from sales | 31173 | &nbsp;&nbsp;&nbsp; 4169 | 3788 | &nbsp;&nbsp;&nbsp;&nbsp; 995 | 63126 |
| &nbsp;&nbsp;&nbsp; Cost of investments sold | 26119 | &nbsp;&nbsp;&nbsp; 2820 | 4099 | 1060 | 53855 |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp; 5054 | &nbsp;&nbsp;&nbsp; 1349 | &nbsp;&nbsp; (311) | &nbsp;&nbsp;&nbsp;&nbsp; (65) | &nbsp;&nbsp;&nbsp; 9271 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | 31402 | 17676 | 2478 | 1111 | 11051 |
| Net gain (loss) on investments | 36456 | 19025 | 2167 | 1046 | 20322 |
| Net increase (decrease) in net assets resulting from operations | $36456 | $19025 | $6269 | $3021 | $20322 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **CTIVP Vty** <br> **Sycamore Estb** <br> **Val,** <br>**Cl 2**<br>| **CTIVP Vty** <br> **Sycamore Estb** <br> **Val,** <br>**Cl 3**<br>| **CTIVP** <br> **Wellington Lg** <br> **Cap Val,** <br>**Cl 1**<br>| **CTIVP** <br> **Wellington Lg** <br> **Cap Val,** <br>**Cl 2**<br>| **CTIVP** <br> **Westfield Mid** <br> **Cap Gro,** <br>**Cl 1**<br>|
| **Investment income** |  |  |  |  |  |
| Dividend income | $— | $— | $— | $— | $— |
| Reimbursement of income from trade error | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Variable account expenses | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 6453 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Investment income (loss) — net | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; (6453) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| **Realized and unrealized gain (loss) on investments — net** |  |  |  |  |  |
| Realized gain (loss) on sales of investments: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Proceeds from sales | 157670 | 239971 | &nbsp;&nbsp;&nbsp; 37937 | 33134 | 28415 |
| &nbsp;&nbsp;&nbsp; Cost of investments sold | 103995 | 163162 | &nbsp;&nbsp;&nbsp; 33049 | 21671 | 21408 |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp; 53675 | &nbsp;&nbsp;&nbsp; 76809 | &nbsp;&nbsp;&nbsp;&nbsp; 4888 | 11463 | &nbsp;&nbsp;&nbsp; 7007 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | (44498) | (41005) | 120892 | 47818 | &nbsp;&nbsp;&nbsp; 9279 |
| Net gain (loss) on investments | &nbsp;&nbsp;&nbsp;&nbsp; 9177 | &nbsp;&nbsp;&nbsp; 35804 | 125780 | 59281 | 16286 |
| Net increase (decrease) in net assets resulting from operations | $9177 | $29351 | $125780 | $59281 | $16286 |

---

See accompanying notes to financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**38 ■ RiverSource of New York Account 8**

------

**Statement of Operations**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **CTIVP** <br> **Westfield Mid** <br> **Cap Gro,** <br>**Cl 2**<br>| **CTIVP** <br> **Westfield Sel** <br> **Lg Cp Gr,** <br>**Cl 1**<br>| **CTIVP** <br> **Westfield Sel** <br> **Lg Cp Gr,** <br>**Cl 2**<br>| **CVT EAFE Intl** <br> **Index,** <br>**Cl F**<br>| **CVT EAFE Intl** <br> **Index,** <br>**Cl I**<br>|
| **Investment income** |  |  |  |  |  |
| Dividend income | $— | $— | $— | $440 | $7400 |
| Reimbursement of income from trade error | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Variable account expenses | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Investment income (loss) — net | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 440 | &nbsp;&nbsp;&nbsp; 7400 |
| **Realized and unrealized gain (loss) on investments — net** |  |  |  |  |  |
| Realized gain (loss) on sales of investments: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Proceeds from sales | 30729 | &nbsp;&nbsp;&nbsp; 5840 | &nbsp;&nbsp;&nbsp; 4631 | 4402 | 50255 |
| &nbsp;&nbsp;&nbsp; Cost of investments sold | 22452 | &nbsp;&nbsp;&nbsp; 4144 | &nbsp;&nbsp;&nbsp; 3778 | 4008 | 44311 |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp; 8277 | &nbsp;&nbsp;&nbsp; 1696 | &nbsp;&nbsp;&nbsp;&nbsp; 853 | &nbsp;&nbsp;&nbsp;&nbsp; 394 | &nbsp;&nbsp;&nbsp; 5944 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | (3787) | 38118 | 10991 | 3906 | 56684 |
| Net gain (loss) on investments | &nbsp;&nbsp;&nbsp; 4490 | 39814 | 11844 | 4300 | 62628 |
| Net increase (decrease) in net assets resulting from operations | $4490 | $39814 | $11844 | $4740 | $70028 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **CVT Nasdaq** <br> **100 Index,** <br>**Cl F**<br>| **CVT Nasdaq** <br> **100 Index,** <br>**Cl I**<br>| **CVT Russ 2000** <br> **Sm Cap Ind,** <br>**Cl F**<br>| **CVT Russ 2000** <br> **Sm Cap Ind,** <br>**Cl I**<br>| **DWS Alt Asset** <br> **Alloc VIP,** <br>**Cl A**<br>|
| **Investment income** |  |  |  |  |  |
| Dividend income | $263 | $1556 | $291 | $1978 | $6833 |
| Reimbursement of income from trade error | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Variable account expenses | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Investment income (loss) — net | &nbsp;&nbsp;&nbsp;&nbsp; 263 | &nbsp;&nbsp;&nbsp;&nbsp; 1556 | &nbsp;&nbsp;&nbsp;&nbsp; 291 | &nbsp;&nbsp;&nbsp; 1978 | &nbsp;&nbsp;&nbsp; 6833 |
| **Realized and unrealized gain (loss) on investments — net** |  |  |  |  |  |
| Realized gain (loss) on sales of investments: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Proceeds from sales | 14870 | &nbsp;&nbsp;&nbsp; 22815 | 1258 | 12372 | 12729 |
| &nbsp;&nbsp;&nbsp; Cost of investments sold | 12692 | &nbsp;&nbsp;&nbsp; 19709 | 1181 | 11692 | 12421 |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp; 2178 | &nbsp;&nbsp;&nbsp;&nbsp; 3106 | &nbsp;&nbsp;&nbsp;&nbsp; 77 | &nbsp;&nbsp;&nbsp;&nbsp; 680 | &nbsp;&nbsp;&nbsp;&nbsp; 308 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp; 1542 | &nbsp;&nbsp;&nbsp;&nbsp; 9131 | &nbsp;&nbsp;&nbsp;&nbsp; 947 | &nbsp;&nbsp;&nbsp; 6435 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | 12249 | &nbsp;&nbsp;&nbsp; 87968 | &nbsp;&nbsp;&nbsp;&nbsp; 844 | &nbsp;&nbsp;&nbsp; 7090 | 10582 |
| Net gain (loss) on investments | 15969 | 100205 | 1868 | 14205 | 10890 |
| Net increase (decrease) in net assets resulting from operations | $16232 | $101761 | $2159 | $16183 | $17723 |

---

See accompanying notes to financial statements.

**RiverSource of New York Account 8** ■ 39

------

**Statement of Operations**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **DWS Alt Asset** <br> **Alloc VIP,** <br>**Cl B**<br>| **EV VT** <br> **Floating-Rate** <br> **Inc, Init Cl**<br>| **EV VT** <br> **Floating-Rate** <br> **Inc, Inst Cl**<sup>(1)</sup> <br>| **Fid VIP** <br> **Contrafund,** <br> **Init Cl**<br>| **Fid VIP** <br> **Contrafund,** <br>**Serv Cl 2**<br>|
| **Investment income** |  |  |  |  |  |
| Dividend income | $12520 | $91568 | $449 | $4099 | $— |
| Reimbursement of income from trade error | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 12 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Variable account expenses | &nbsp;&nbsp;&nbsp;&nbsp; 575 | &nbsp;&nbsp;&nbsp;&nbsp; 7079 | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 40688 |
| Investment income (loss) — net | 11945 | &nbsp;&nbsp;&nbsp; 84489 | &nbsp;&nbsp;&nbsp; 461 | &nbsp;&nbsp;&nbsp;&nbsp; 4099 | &nbsp;&nbsp;&nbsp;&nbsp; (40688) |
| **Realized and unrealized gain (loss) on investments — net** |  |  |  |  |  |
| Realized gain (loss) on sales of investments: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Proceeds from sales | 37681 | 357053 | &nbsp;&nbsp;&nbsp; 131 | &nbsp;&nbsp;&nbsp; 79202 | 1080865 |
| &nbsp;&nbsp;&nbsp; Cost of investments sold | 36863 | 377495 | &nbsp;&nbsp;&nbsp; 134 | &nbsp;&nbsp;&nbsp; 69659 | &nbsp;&nbsp;&nbsp;&nbsp; 865581 |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp; 818 | (20442) | &nbsp;&nbsp;&nbsp;&nbsp; (3) | &nbsp;&nbsp;&nbsp;&nbsp; 9543 | &nbsp;&nbsp;&nbsp;&nbsp; 215284 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | 448457 | 1515934 |
| Net change in unrealized appreciation (depreciation) of investments | 21580 | (18428) | (207) | &nbsp;&nbsp;&nbsp; 56370 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 6134 |
| Net gain (loss) on investments | 22398 | (38870) | (210) | 514370 | 1737352 |
| Net increase (decrease) in net assets resulting from operations | $34343 | $45619 | $251 | $518469 | $1696664 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **Fid VIP Emer** <br> **Mkts, Init Cl**<br>| **Fid VIP** <br> **Energy, Init Cl**<br>| **Fid VIP Gro &** <br> **Inc,** <br>**Serv Cl**<br>| **Fid VIP Gro &** <br> **Inc,** <br>**Serv Cl 2**<br>| **Fid VIP Gro** <br> **Opp, Init Cl**<br>|
| **Investment income** |  |  |  |  |  |
| Dividend income | $953 | $53 | $81561 | $37871 | $— |
| Reimbursement of income from trade error | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Variable account expenses | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 35481 | &nbsp;&nbsp;&nbsp;&nbsp; 9162 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Investment income (loss) — net | &nbsp;&nbsp;&nbsp;&nbsp; 953 | &nbsp;&nbsp;&nbsp;&nbsp; 53 | &nbsp;&nbsp;&nbsp;&nbsp; 46080 | &nbsp;&nbsp;&nbsp; 28709 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| **Realized and unrealized gain (loss) on investments — net** |  |  |  |  |  |
| Realized gain (loss) on sales of investments: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Proceeds from sales | 34599 | &nbsp;&nbsp;&nbsp;&nbsp; 998 | &nbsp;&nbsp;&nbsp;&nbsp; 543674 | 784185 | 28950 |
| &nbsp;&nbsp;&nbsp; Cost of investments sold | 33423 | 1028 | &nbsp;&nbsp;&nbsp;&nbsp; 341074 | 585880 | 29171 |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp; 1176 | &nbsp;&nbsp;&nbsp;&nbsp; (30) | &nbsp;&nbsp;&nbsp;&nbsp; 202600 | 198305 | &nbsp;&nbsp;&nbsp;&nbsp; (221) |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp; 367 | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 527382 | 271539 | &nbsp;&nbsp;&nbsp; 1340 |
| Net change in unrealized appreciation (depreciation) of investments | 13212 | &nbsp;&nbsp;&nbsp;&nbsp; 169 | &nbsp;&nbsp;&nbsp;&nbsp; 260018 | &nbsp;&nbsp;&nbsp; 23816 | 14725 |
| Net gain (loss) on investments | 14755 | &nbsp;&nbsp;&nbsp;&nbsp; 139 | &nbsp;&nbsp;&nbsp;&nbsp; 990000 | 493660 | 15844 |
| Net increase (decrease) in net assets resulting from operations | $15708 | $192 | $1036080 | $522369 | $15844 |

---

See accompanying notes to financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**40 ■ RiverSource of New York Account 8**

------

**Statement of Operations**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **Fid VIP Invest** <br> **Gr, Init Cl**<br>| **Fid VIP Mid** <br> **Cap, Init Cl**<br>| **Fid VIP Mid** <br> **Cap,** <br>**Serv Cl**<br>| **Fid VIP Mid** <br> **Cap,** <br>**Serv Cl 2**<br>| **Fid VIP** <br> **Overseas,** <br>**Serv Cl**<br>|
| **Investment income** |  |  |  |  |  |
| Dividend income | $1593 | $5421 | $22692 | $14840 | $27769 |
| Reimbursement of income from trade error | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Variable account expenses | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; 42039 | &nbsp;&nbsp;&nbsp;&nbsp; 19434 | &nbsp;&nbsp;&nbsp; 12334 |
| Investment income (loss) — net | 1593 | &nbsp;&nbsp;&nbsp;&nbsp; 5421 | (19347) | &nbsp;&nbsp;&nbsp;&nbsp; (4594) | &nbsp;&nbsp;&nbsp; 15435 |
| **Realized and unrealized gain (loss) on investments — net** |  |  |  |  |  |
| Realized gain (loss) on sales of investments: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Proceeds from sales | 4627 | 149688 | 605435 | 1330567 | 123929 |
| &nbsp;&nbsp;&nbsp; Cost of investments sold | 4612 | 168063 | 561393 | 1352859 | &nbsp;&nbsp;&nbsp; 94872 |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp; 15 | (18375) | &nbsp;&nbsp;&nbsp; 44042 | &nbsp;&nbsp;&nbsp;&nbsp; (22292) | &nbsp;&nbsp;&nbsp; 29057 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp; — | 123826 | 707850 | &nbsp;&nbsp;&nbsp;&nbsp; 703456 | 161537 |
| Net change in unrealized appreciation (depreciation) of investments | 1325 | &nbsp;&nbsp;&nbsp; 37342 | (67996) | &nbsp;&nbsp;&nbsp;&nbsp; (30392) | &nbsp;&nbsp;&nbsp; 98772 |
| Net gain (loss) on investments | 1340 | 142793 | 683896 | &nbsp;&nbsp;&nbsp;&nbsp; 650772 | 289366 |
| Net increase (decrease) in net assets resulting from operations | $2933 | $148214 | $664549 | $646178 | $304801 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **Fid VIP** <br> **Overseas,** <br>**Serv Cl 2**<br>| **Fid VIP** <br> **Strategic Inc,** <br> **Init Cl**<br>| **Fid VIP** <br> **Strategic Inc,** <br>**Serv Cl 2**<br>| **Frank Global** <br> **Real Est,** <br>**Cl 2**<br>| **Frank Inc,** <br>**Cl 1**<br>|
| **Investment income** |  |  |  |  |  |
| Dividend income | $18713 | $25599 | $2077 | $25653 | $3603 |
| Reimbursement of income from trade error | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — |
| Variable account expenses | &nbsp;&nbsp;&nbsp;&nbsp; 4679 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 8768 | &nbsp;&nbsp;&nbsp;&nbsp; — |
| Investment income (loss) — net | &nbsp;&nbsp;&nbsp; 14034 | &nbsp;&nbsp;&nbsp; 25599 | 2077 | &nbsp;&nbsp;&nbsp; 16885 | 3603 |
| **Realized and unrealized gain (loss) on investments — net** |  |  |  |  |  |
| Realized gain (loss) on sales of investments: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Proceeds from sales | 349294 | 261046 | 7841 | 402848 | 7331 |
| &nbsp;&nbsp;&nbsp; Cost of investments sold | 286117 | 257625 | 7767 | 443520 | 7216 |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp; 63177 | &nbsp;&nbsp;&nbsp;&nbsp; 3421 | &nbsp;&nbsp;&nbsp;&nbsp; 74 | (40672) | &nbsp;&nbsp;&nbsp;&nbsp; 115 |
| Distributions from capital gains | 121771 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 721 |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp; 36156 | &nbsp;&nbsp;&nbsp; 23516 | 1828 | 155428 | 4783 |
| Net gain (loss) on investments | 221104 | &nbsp;&nbsp;&nbsp; 26937 | 1902 | 114756 | 5619 |
| Net increase (decrease) in net assets resulting from operations | $235138 | $52536 | $3979 | $131641 | $9222 |

---

See accompanying notes to financial statements.

**RiverSource of New York Account 8** ■ 41

------

**Statement of Operations**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **Frank Inc,** <br>**Cl 2**<br>| **Frank Mutual** <br> **Shares,** <br>**Cl 1**<br>| **Frank Mutual** <br> **Shares,** <br>**Cl 2**<br>| **Frank Sm Cap** <br> **Val,** <br>**Cl 1**<br>| **Frank Sm Cap** <br> **Val,** <br>**Cl 2**<br>|
| **Investment income** |  |  |  |  |  |
| Dividend income | $24252 | $815 | $37707 | $3492 | $31635 |
| Reimbursement of income from trade error | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Variable account expenses | &nbsp;&nbsp;&nbsp; 2566 | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 7597 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; 13341 |
| Investment income (loss) — net | 21686 | &nbsp;&nbsp;&nbsp;&nbsp; 815 | &nbsp;&nbsp;&nbsp; 30110 | &nbsp;&nbsp;&nbsp; 3492 | &nbsp;&nbsp;&nbsp; 18294 |
| **Realized and unrealized gain (loss) on investments — net** |  |  |  |  |  |
| Realized gain (loss) on sales of investments: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Proceeds from sales | 93461 | 1711 | 494455 | &nbsp;&nbsp;&nbsp; 8559 | 611889 |
| &nbsp;&nbsp;&nbsp; Cost of investments sold | 94276 | 1592 | 528908 | &nbsp;&nbsp;&nbsp; 8260 | 669930 |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp; (815) | &nbsp;&nbsp;&nbsp;&nbsp; 119 | (34453) | &nbsp;&nbsp;&nbsp;&nbsp; 299 | (58041) |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp; 5098 | 3536 | 185784 | 21971 | 246722 |
| Net change in unrealized appreciation (depreciation) of investments | 28193 | &nbsp;&nbsp; (714) | &nbsp;&nbsp;&nbsp; 12079 | (1051) | &nbsp;&nbsp;&nbsp; (1084) |
| Net gain (loss) on investments | 32476 | 2941 | 163410 | 21219 | 187597 |
| Net increase (decrease) in net assets resulting from operations | $54162 | $3756 | $193520 | $24711 | $205891 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **GS VIT Mid** <br> **Cap Val, Inst**<br>| **GS VIT Sm Cap** <br> **Eq Insights,** <br> **Inst**<br>| **GS VIT U.S. Eq** <br> **Insights, Inst**<br>| **Invesco VI Am** <br> **Fran, Ser I**<br>| **Invesco VI Am** <br> **Fran, Ser II**<br>|
| **Investment income** |  |  |  |  |  |
| Dividend income | $75192 | $2974 | $21739 | $— | $— |
| Reimbursement of income from trade error | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Variable account expenses | &nbsp;&nbsp;&nbsp;&nbsp; 30750 | &nbsp;&nbsp;&nbsp; 2344 | &nbsp;&nbsp;&nbsp;&nbsp; 14831 | &nbsp;&nbsp;&nbsp;&nbsp; 5190 | &nbsp;&nbsp;&nbsp;&nbsp; 4648 |
| Investment income (loss) — net | &nbsp;&nbsp;&nbsp;&nbsp; 44442 | &nbsp;&nbsp;&nbsp;&nbsp; 630 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 6908 | &nbsp;&nbsp;&nbsp; (5190) | &nbsp;&nbsp;&nbsp; (4648) |
| **Realized and unrealized gain (loss) on investments — net** |  |  |  |  |  |
| Realized gain (loss) on sales of investments: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Proceeds from sales | 1267478 | 96688 | &nbsp;&nbsp;&nbsp; 934572 | 120602 | 210567 |
| &nbsp;&nbsp;&nbsp; Cost of investments sold | 1221828 | 92689 | &nbsp;&nbsp;&nbsp; 783055 | &nbsp;&nbsp;&nbsp; 86671 | 177980 |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp; 45650 | &nbsp;&nbsp;&nbsp; 3999 | &nbsp;&nbsp;&nbsp; 151517 | &nbsp;&nbsp;&nbsp; 33931 | &nbsp;&nbsp;&nbsp; 32587 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp; 681715 | 33849 | &nbsp;&nbsp;&nbsp; 411506 | &nbsp;&nbsp;&nbsp; 73992 | 126809 |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp; (239111) | 17456 | (120072) | (23239) | (31960) |
| Net gain (loss) on investments | &nbsp;&nbsp;&nbsp;&nbsp; 488254 | 55304 | &nbsp;&nbsp;&nbsp; 442951 | &nbsp;&nbsp;&nbsp; 84684 | 127436 |
| Net increase (decrease) in net assets resulting from operations | $532696 | $55934 | $449859 | $79494 | $122788 |

---

See accompanying notes to financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**42 ■ RiverSource of New York Account 8**

------

**Statement of Operations**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **Invesco VI Bal** <br> **Risk Alloc, Ser** <br> **I**<br>| **Invesco VI Bal** <br> **Risk Alloc, Ser** <br> **II**<br>| **Invesco VI** <br> **Comstock, Ser** <br> **II**<br>| **Invesco VI** <br> **Core Eq, Ser I**<br>| **Invesco VI Dis** <br> **Mid Cap** <br> **Gro, Ser I**<br>|
| **Investment income** |  |  |  |  |  |
| Dividend income | $2985 | $20944 | $8464 | $79441 | $— |
| Reimbursement of income from trade error | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Variable account expenses | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; 1142 | &nbsp;&nbsp;&nbsp; 3414 | &nbsp;&nbsp;&nbsp;&nbsp; 104640 | &nbsp;&nbsp;&nbsp;&nbsp; 5166 |
| Investment income (loss) — net | 2985 | 19802 | &nbsp;&nbsp;&nbsp; 5050 | &nbsp;&nbsp;&nbsp;&nbsp; (25199) | &nbsp;&nbsp;&nbsp; (5166) |
| **Realized and unrealized gain (loss) on investments — net** |  |  |  |  |  |
| Realized gain (loss) on sales of investments: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Proceeds from sales | 4327 | &nbsp;&nbsp;&nbsp; 8965 | 88918 | 1453105 | 192677 |
| &nbsp;&nbsp;&nbsp; Cost of investments sold | 4789 | 10212 | 83093 | 1195720 | 182828 |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp; (462) | (1247) | &nbsp;&nbsp;&nbsp; 5825 | &nbsp;&nbsp;&nbsp;&nbsp; 257385 | &nbsp;&nbsp;&nbsp;&nbsp; 9849 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | 62727 | &nbsp;&nbsp;&nbsp;&nbsp; 914520 | &nbsp;&nbsp;&nbsp; 82408 |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp;&nbsp; 872 | &nbsp;&nbsp;&nbsp; 5319 | 14869 | &nbsp;&nbsp;&nbsp;&nbsp; 591269 | (45023) |
| Net gain (loss) on investments | &nbsp;&nbsp;&nbsp;&nbsp; 410 | &nbsp;&nbsp;&nbsp; 4072 | 83421 | 1763174 | &nbsp;&nbsp;&nbsp; 47234 |
| Net increase (decrease) in net assets resulting from operations | $3395 | $23874 | $88471 | $1737975 | $42068 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **Invesco VI Div** <br> **Divd, Ser I**<br>| **Invesco VI** <br> **EQV Intl** <br> **Eq, Ser II**<br>| **Invesco VI Gbl** <br> **Strat Inc, Ser I**<br>| **Invesco VI Gbl** <br> **Strat Inc, Ser** <br> **II**<br>| **Invesco VI** <br> **Global, Ser I**<br>|
| **Investment income** |  |  |  |  |  |
| Dividend income | $16529 | $11449 | $3210 | $85733 | $— |
| Reimbursement of income from trade error | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Variable account expenses | &nbsp;&nbsp;&nbsp;&nbsp; 5121 | &nbsp;&nbsp;&nbsp;&nbsp; 5399 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 7519 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Investment income (loss) — net | &nbsp;&nbsp;&nbsp; 11408 | &nbsp;&nbsp;&nbsp;&nbsp; 6050 | &nbsp;&nbsp;&nbsp; 3210 | &nbsp;&nbsp;&nbsp; 78214 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| **Realized and unrealized gain (loss) on investments — net** |  |  |  |  |  |
| Realized gain (loss) on sales of investments: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Proceeds from sales | 232257 | 290487 | 12383 | 230010 | &nbsp;&nbsp;&nbsp; 14843 |
| &nbsp;&nbsp;&nbsp; Cost of investments sold | 214898 | 272358 | 11569 | 245644 | &nbsp;&nbsp;&nbsp; 13858 |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp; 17359 | &nbsp;&nbsp;&nbsp; 18129 | &nbsp;&nbsp;&nbsp;&nbsp; 814 | (15634) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 985 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp; 79032 | &nbsp;&nbsp;&nbsp; 62473 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | 135195 |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp; 37647 | &nbsp;&nbsp;&nbsp; 68014 | &nbsp;&nbsp;&nbsp; 2219 | 117179 | (38338) |
| Net gain (loss) on investments | 134038 | 148616 | &nbsp;&nbsp;&nbsp; 3033 | 101545 | &nbsp;&nbsp;&nbsp; 97842 |
| Net increase (decrease) in net assets resulting from operations | $145446 | $154666 | $6243 | $179759 | $97842 |

---

See accompanying notes to financial statements.

**RiverSource of New York Account 8** ■ 43

------

**Statement of Operations**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **Invesco VI** <br> **Global, Ser II**<br>| **Invesco VI** <br> **Mn St Sm** <br> **Cap, Ser I**<br>| **Invesco VI** <br> **Mn St Sm** <br> **Cap, Ser II**<br>| **Invesco VI** <br> **Tech, Ser I**<br>| **Invesco VI** <br> **Tech, Ser II**<br>|
| **Investment income** |  |  |  |  |  |
| Dividend income | $— | $2698 | $4781 | $— | $— |
| Reimbursement of income from trade error | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — |
| Variable account expenses | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 6596 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 6513 | &nbsp;&nbsp;&nbsp;&nbsp; 7900 | &nbsp;&nbsp;&nbsp;&nbsp; — |
| Investment income (loss) — net | &nbsp;&nbsp;&nbsp;&nbsp; (6596) | &nbsp;&nbsp;&nbsp; 2698 | &nbsp;&nbsp;&nbsp; (1732) | &nbsp;&nbsp;&nbsp; (7900) | &nbsp;&nbsp;&nbsp;&nbsp; — |
| **Realized and unrealized gain (loss) on investments — net** |  |  |  |  |  |
| Realized gain (loss) on sales of investments: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Proceeds from sales | &nbsp;&nbsp;&nbsp; 344341 | 55220 | 221047 | 340140 | &nbsp;&nbsp;&nbsp;&nbsp; 301 |
| &nbsp;&nbsp;&nbsp; Cost of investments sold | &nbsp;&nbsp;&nbsp; 331179 | 56234 | 193085 | 294642 | &nbsp;&nbsp;&nbsp;&nbsp; 215 |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp; 13162 | (1014) | &nbsp;&nbsp;&nbsp; 27962 | &nbsp;&nbsp;&nbsp; 45498 | &nbsp;&nbsp;&nbsp;&nbsp; 86 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp; 345924 | 60557 | 212569 | 223546 | 1234 |
| Net change in unrealized appreciation (depreciation) of investments | (105227) | (7979) | (73334) | 109869 | &nbsp;&nbsp;&nbsp;&nbsp; 360 |
| Net gain (loss) on investments | &nbsp;&nbsp;&nbsp; 253859 | 51564 | 167197 | 378913 | 1680 |
| Net increase (decrease) in net assets resulting from operations | $247263 | $54262 | $165465 | $371013 | $1680 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **Janus Hend** <br> **VIT Gbl Tech** <br> **Innov, Srv**<br>| **Janus** <br> **Henderson VIT** <br> **Bal, Inst**<br>| **Janus** <br> **Henderson VIT** <br> **Bal, Serv**<br>| **Janus** <br> **Henderson VIT** <br> **Enter, Serv**<br>| **Janus** <br> **Henderson VIT** <br> **Flex Bd, Inst**<br>|
| **Investment income** |  |  |  |  |  |
| Dividend income | $— | $22720 | $947 | $440 | $27380 |
| Reimbursement of income from trade error | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Variable account expenses | &nbsp;&nbsp;&nbsp; 15125 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 4854 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Investment income (loss) — net | (15125) | &nbsp;&nbsp;&nbsp; 22720 | &nbsp;&nbsp;&nbsp;&nbsp; 947 | &nbsp;&nbsp;&nbsp; (4414) | 27380 |
| **Realized and unrealized gain (loss) on investments — net** |  |  |  |  |  |
| Realized gain (loss) on sales of investments: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Proceeds from sales | 380453 | &nbsp;&nbsp;&nbsp; 21421 | &nbsp;&nbsp;&nbsp;&nbsp; 675 | &nbsp;&nbsp;&nbsp; 34889 | 47603 |
| &nbsp;&nbsp;&nbsp; Cost of investments sold | 251258 | &nbsp;&nbsp;&nbsp; 17791 | &nbsp;&nbsp;&nbsp;&nbsp; 523 | &nbsp;&nbsp;&nbsp; 29323 | 48123 |
| Net realized gain (loss) on sales of investments | 129195 | &nbsp;&nbsp;&nbsp;&nbsp; 3630 | &nbsp;&nbsp;&nbsp;&nbsp; 152 | &nbsp;&nbsp;&nbsp;&nbsp; 5566 | &nbsp;&nbsp;&nbsp;&nbsp; (520) |
| Distributions from capital gains | 265641 | &nbsp;&nbsp;&nbsp; 35265 | 1672 | &nbsp;&nbsp;&nbsp; 78476 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | 250275 | &nbsp;&nbsp;&nbsp; 95148 | 4839 | (18166) | &nbsp;&nbsp;&nbsp; 7669 |
| Net gain (loss) on investments | 645111 | 134043 | 6663 | &nbsp;&nbsp;&nbsp; 65876 | &nbsp;&nbsp;&nbsp; 7149 |
| Net increase (decrease) in net assets resulting from operations | $629986 | $156763 | $7610 | $61462 | $34529 |

---

See accompanying notes to financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**44 ■ RiverSource of New York Account 8**

------

**Statement of Operations**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **Janus** <br> **Henderson VIT** <br> **Flex Bd, Serv**<br>| **Janus** <br> **Henderson VIT** <br> **Overseas,** <br> **Serv**<br>| **Janus** <br> **Henderson VIT** <br> **Res, Inst**<br>| **Janus** <br> **Henderson VIT** <br> **Res, Serv**<br>| **Lazard Ret** <br> **Global Dyn** <br> **MA, Inv**<br>|
| **Investment income** |  |  |  |  |  |
| Dividend income | $2495 | $26690 | $— | $— | $274 |
| Reimbursement of income from trade error | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — |
| Variable account expenses | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; 11259 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 4383 | &nbsp;&nbsp;&nbsp;&nbsp; — |
| Investment income (loss) — net | 2495 | &nbsp;&nbsp;&nbsp; 15431 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; (4383) | &nbsp;&nbsp;&nbsp;&nbsp; 274 |
| **Realized and unrealized gain (loss) on investments — net** |  |  |  |  |  |
| Realized gain (loss) on sales of investments: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Proceeds from sales | &nbsp;&nbsp;&nbsp;&nbsp; 401 | 206922 | &nbsp;&nbsp;&nbsp;&nbsp; 168 | 116052 | 2246 |
| &nbsp;&nbsp;&nbsp; Cost of investments sold | &nbsp;&nbsp;&nbsp;&nbsp; 411 | 156181 | &nbsp;&nbsp;&nbsp;&nbsp; 110 | &nbsp;&nbsp;&nbsp; 83012 | 2053 |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp; (10) | &nbsp;&nbsp;&nbsp; 50741 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 58 | &nbsp;&nbsp;&nbsp; 33040 | &nbsp;&nbsp;&nbsp;&nbsp; 193 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; 6173 | &nbsp;&nbsp;&nbsp; 65748 | &nbsp;&nbsp;&nbsp;&nbsp; 607 |
| Net change in unrealized appreciation (depreciation) of investments | 1189 | 421123 | &nbsp;&nbsp;&nbsp; 8575 | &nbsp;&nbsp;&nbsp; 39956 | 2101 |
| Net gain (loss) on investments | 1179 | 471864 | 14806 | 138744 | 2901 |
| Net increase (decrease) in net assets resulting from operations | $3674 | $487295 | $14806 | $134361 | $3175 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **Lazard Ret** <br> **Global Dyn** <br> **MA, Serv**<br>| **Lord Abt Bond** <br> **Debenture,** <br>**Cl VC**<br>| **LVIP AC Intl,** <br>**Serv Cl**<br>| **LVIP AC Intl,** <br> **Std** <br>**Cl II**<br>| **LVIP AC Mid** <br> **Cap Val, Std** <br>**Cl II**<br>|
| **Investment income** |  |  |  |  |  |
| Dividend income | $180 | $1510 | $8028 | $7809 | $873 |
| Reimbursement of income from trade error | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Variable account expenses | &nbsp;&nbsp;&nbsp;&nbsp; 90 | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 2614 | &nbsp;&nbsp;&nbsp; 4098 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Investment income (loss) — net | &nbsp;&nbsp;&nbsp;&nbsp; 90 | 1510 | &nbsp;&nbsp;&nbsp;&nbsp; 5414 | &nbsp;&nbsp;&nbsp; 3711 | &nbsp;&nbsp;&nbsp;&nbsp; 873 |
| **Realized and unrealized gain (loss) on investments — net** |  |  |  |  |  |
| Realized gain (loss) on sales of investments: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Proceeds from sales | 1669 | 2358 | 163871 | 37178 | &nbsp;&nbsp;&nbsp; 4515 |
| &nbsp;&nbsp;&nbsp; Cost of investments sold | 1597 | 2401 | 155677 | 30985 | &nbsp;&nbsp;&nbsp; 4524 |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp; 72 | &nbsp;&nbsp;&nbsp;&nbsp; (43) | &nbsp;&nbsp;&nbsp;&nbsp; 8194 | &nbsp;&nbsp;&nbsp; 6193 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (9) |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp; 455 | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; 3815 |
| Net change in unrealized appreciation (depreciation) of investments | 1712 | &nbsp;&nbsp;&nbsp;&nbsp; 228 | &nbsp;&nbsp;&nbsp; 87740 | 79417 | (1900) |
| Net gain (loss) on investments | 2239 | &nbsp;&nbsp;&nbsp;&nbsp; 185 | &nbsp;&nbsp;&nbsp; 95934 | 85610 | &nbsp;&nbsp;&nbsp; 1906 |
| Net increase (decrease) in net assets resulting from operations | $2329 | $1695 | $101348 | $89321 | $2779 |

---

See accompanying notes to financial statements.

**RiverSource of New York Account 8** ■ 45

------

**Statement of Operations**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **LVIP AC Val,** <br>**Serv Cl**<br>| **LVIP AC Val,** <br> **Std** <br>**Cl II**<br>| **MFS Gbl Real** <br> **Est, Init Cl**<br>| **MFS Intl Gro,** <br> **Init Cl**<br>| **MFS Mass Inv** <br> **Gro Stock,** <br>**Serv Cl**<br>|
| **Investment income** |  |  |  |  |  |
| Dividend income | $37082 | $64805 | $2 | $1773 | $523 |
| Reimbursement of income from trade error | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Variable account expenses | &nbsp;&nbsp;&nbsp;&nbsp; 8503 | &nbsp;&nbsp;&nbsp; 26983 |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 16509 |
| Investment income (loss) — net | &nbsp;&nbsp;&nbsp; 28579 | &nbsp;&nbsp;&nbsp; 37822 | &nbsp;&nbsp;&nbsp; 2 | &nbsp;&nbsp;&nbsp; 1773 | &nbsp;&nbsp;&nbsp;&nbsp; (15986) |
| **Realized and unrealized gain (loss) on investments — net** |  |  |  |  |  |
| Realized gain (loss) on sales of investments: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Proceeds from sales | 739748 | 405621 | &nbsp;&nbsp; 23 | 83763 | 1099767 |
| &nbsp;&nbsp;&nbsp; Cost of investments sold | 647452 | 298666 | &nbsp;&nbsp; 23 | 80607 | &nbsp;&nbsp;&nbsp;&nbsp; 997182 |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp; 92296 | 106955 |  | &nbsp;&nbsp;&nbsp; 3156 | &nbsp;&nbsp;&nbsp;&nbsp; 102585 |
| Distributions from capital gains | 190564 | 309726 |  | 10547 | &nbsp;&nbsp;&nbsp;&nbsp; 452917 |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp; 41933 | 119770 | &nbsp;&nbsp;&nbsp; 2 | 15475 | &nbsp;&nbsp; (279561) |
| Net gain (loss) on investments | 324793 | 536451 | &nbsp;&nbsp;&nbsp; 2 | 29178 | &nbsp;&nbsp;&nbsp;&nbsp; 275941 |
| Net increase (decrease) in net assets resulting from operations | $353372 | $574273 | $4 | $30951 | $259955 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **MFS New Dis,** <br>**Serv Cl**<br>| **MFS Utilities,** <br> **Init Cl**<br>| **MFS Utilities,** <br>**Serv Cl**<br>| **MS VIF Dis,** <br>**Cl I**<br>| **MS VIF Dis,** <br>**Cl II**<br>|
| **Investment income** |  |  |  |  |  |
| Dividend income | $— | $3960 | $32213 | $2676 | $5396 |
| Reimbursement of income from trade error | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Variable account expenses | &nbsp;&nbsp;&nbsp;&nbsp; 9603 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 4862 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 6320 |
| Investment income (loss) — net | &nbsp;&nbsp;&nbsp; (9603) | &nbsp;&nbsp;&nbsp; 3960 | &nbsp;&nbsp;&nbsp; 27351 | &nbsp;&nbsp;&nbsp; 2676 | &nbsp;&nbsp;&nbsp;&nbsp; (924) |
| **Realized and unrealized gain (loss) on investments — net** |  |  |  |  |  |
| Realized gain (loss) on sales of investments: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Proceeds from sales | 263050 | &nbsp;&nbsp;&nbsp; 4713 | 222753 | 19073 | 145169 |
| &nbsp;&nbsp;&nbsp; Cost of investments sold | 337500 | &nbsp;&nbsp;&nbsp; 4501 | 202339 | 14357 | 163913 |
| Net realized gain (loss) on sales of investments | (74450) | &nbsp;&nbsp;&nbsp;&nbsp; 212 | &nbsp;&nbsp;&nbsp; 20414 | &nbsp;&nbsp;&nbsp; 4716 | (18744) |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; 1811 | &nbsp;&nbsp;&nbsp; 16065 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | 313375 | 12234 | &nbsp;&nbsp;&nbsp; 94486 | 55339 | 149991 |
| Net gain (loss) on investments | 238925 | 14257 | 130965 | 60055 | 131247 |
| Net increase (decrease) in net assets resulting from operations | $229322 | $18217 | $158316 | $62731 | $130323 |

---

See accompanying notes to financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**46 ■ RiverSource of New York Account 8**

------

**Statement of Operations**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **NB AMT** <br> **Quality Eq,** <br>**Cl I**<br>| **NB AMT** <br> **Quality Eq,** <br>**Cl S**<br>| **Nom VIP Asset** <br> **Strategy,** <br>**Serv Cl**<br>| **Nom VIP Asset** <br> **Strategy, Std** <br> **Cl**<br>| **Nom VIP Intl** <br> **Core Eq, Std Cl**<br>|
| **Investment income** |  |  |  |  |  |
| Dividend income | $— | $— | $629 | $4 | $1 |
| Reimbursement of income from trade error | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |  |  |
| Variable account expenses | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 60 |  |  |
| Investment income (loss) — net | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 569 | &nbsp;&nbsp;&nbsp; 4 | &nbsp;&nbsp;&nbsp; 1 |
| **Realized and unrealized gain (loss) on investments — net** |  |  |  |  |  |
| Realized gain (loss) on sales of investments: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Proceeds from sales | 2138 | &nbsp;&nbsp;&nbsp;&nbsp; 532 | 13642 |  |  |
| &nbsp;&nbsp;&nbsp; Cost of investments sold | 1667 | &nbsp;&nbsp;&nbsp;&nbsp; 429 | 13857 |  |  |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp; 471 | &nbsp;&nbsp;&nbsp;&nbsp; 103 | &nbsp;&nbsp;&nbsp;&nbsp; (215) |  |  |
| Distributions from capital gains | 3393 | &nbsp;&nbsp;&nbsp; 4959 | &nbsp;&nbsp;&nbsp; 3276 | &nbsp;&nbsp; 16 | &nbsp;&nbsp;&nbsp; 4 |
| Net change in unrealized appreciation (depreciation) of investments | 3246 | &nbsp;&nbsp;&nbsp; 5635 | &nbsp;&nbsp;&nbsp; 3541 | &nbsp;&nbsp; 13 | &nbsp;&nbsp; 14 |
| Net gain (loss) on investments | 7110 | 10697 | &nbsp;&nbsp;&nbsp; 6602 | &nbsp;&nbsp; 29 | &nbsp;&nbsp; 18 |
| Net increase (decrease) in net assets resulting from operations | $7110 | $10697 | $7171 | $33 | $19 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **PIMCO VIT All** <br> **Asset, Advisor** <br> **Cl**<br>| **PIMCO VIT All** <br> **Asset, Inst Cl**<br>| **PIMCO VIT Glb** <br> **Man As Alloc,** <br> **Adv Cl**<br>| **PIMCO VIT Tot** <br> **Return,** <br> **Advisor Cl**<br>| **PIMCO VIT Tot** <br> **Return, Inst Cl**<br>|
| **Investment income** |  |  |  |  |  |
| Dividend income | $27045 | $822 | $266 | $29366 | $10975 |
| Reimbursement of income from trade error | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Variable account expenses | &nbsp;&nbsp;&nbsp;&nbsp; 3126 | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; 4213 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Investment income (loss) — net | &nbsp;&nbsp;&nbsp; 23919 | &nbsp;&nbsp;&nbsp;&nbsp; 822 | &nbsp;&nbsp;&nbsp;&nbsp; 266 | 25153 | 10975 |
| **Realized and unrealized gain (loss) on investments — net** |  |  |  |  |  |
| Realized gain (loss) on sales of investments: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Proceeds from sales | 139596 | 3862 | &nbsp;&nbsp;&nbsp;&nbsp; 326 | 46227 | 10513 |
| &nbsp;&nbsp;&nbsp; Cost of investments sold | 149127 | 3901 | &nbsp;&nbsp;&nbsp;&nbsp; 343 | 49030 | 10692 |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp; (9531) | &nbsp;&nbsp;&nbsp;&nbsp; (39) | &nbsp;&nbsp;&nbsp;&nbsp; (17) | (2803) | &nbsp;&nbsp;&nbsp;&nbsp; (179) |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp; 62136 | 1497 | &nbsp;&nbsp;&nbsp;&nbsp; 980 | 39336 | 12458 |
| Net gain (loss) on investments | &nbsp;&nbsp;&nbsp; 52605 | 1458 | &nbsp;&nbsp;&nbsp;&nbsp; 963 | 36533 | 12279 |
| Net increase (decrease) in net assets resulting from operations | $76524 | $2280 | $1229 | $61686 | $23254 |

---

See accompanying notes to financial statements.

**RiverSource of New York Account 8** ■ 47

------

**Statement of Operations**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **Put VT Global** <br> **Hlth Care,** <br>**Cl IA**<br>| **Put VT Global** <br> **Hlth Care,** <br>**Cl IB**<br>| **Put VT Hi** <br> **Yield,** <br>**Cl IB**<br>| **Put VT Intl Eq,** <br>**Cl IB**<br>| **Put VT Intl Val,** <br>**Cl IA**<br>|
| **Investment income** |  |  |  |  |  |
| Dividend income | $— | $— | $15925 | $21 | $38 |
| Reimbursement of income from trade error | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Variable account expenses | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 6577 | &nbsp;&nbsp;&nbsp; 1829 | &nbsp;&nbsp;&nbsp;&nbsp; 844 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Investment income (loss) — net | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; (6577) | 14096 | &nbsp;&nbsp;&nbsp;&nbsp; (823) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 38 |
| **Realized and unrealized gain (loss) on investments — net** |  |  |  |  |  |
| Realized gain (loss) on sales of investments: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Proceeds from sales | &nbsp;&nbsp;&nbsp; 1634 | 322822 | 16894 | 61735 | 67436 |
| &nbsp;&nbsp;&nbsp; Cost of investments sold | &nbsp;&nbsp;&nbsp; 1692 | 345343 | 18331 | 53200 | 64809 |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp; (58) | (22521) | (1437) | &nbsp;&nbsp;&nbsp; 8535 | &nbsp;&nbsp;&nbsp; 2627 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp; 4660 | &nbsp;&nbsp;&nbsp; 97266 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | 11789 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 24 |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp; 6548 | 105498 | &nbsp;&nbsp;&nbsp; 7362 | 41632 | 14585 |
| Net gain (loss) on investments | 11150 | 180243 | &nbsp;&nbsp;&nbsp; 5925 | 61956 | 17236 |
| Net increase (decrease) in net assets resulting from operations | $11150 | $173666 | $20021 | $61133 | $17274 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **Put VT Lg Cap** <br> **Val,** <br>**Cl IA**<br>| **Put VT Sus** <br> **Leaders,** <br>**Cl IA**<br>| **Put VT Sus** <br> **Leaders,** <br>**Cl IB**<br>| **Royce Micro-**<br> **Cap, Invest Cl**<br>| **Temp Global** <br> **Bond,** <br>**Cl 1**<br>|
| **Investment income** |  |  |  |  |  |
| Dividend income | $925 | $123032 | $1312 | $— | $— |
| Reimbursement of income from trade error | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — |
| Variable account expenses | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 120777 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 748 | &nbsp;&nbsp;&nbsp; 12665 | &nbsp;&nbsp;&nbsp;&nbsp; — |
| Investment income (loss) — net | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 925 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2255 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 564 | (12665) | &nbsp;&nbsp;&nbsp;&nbsp; — |
| **Realized and unrealized gain (loss) on investments — net** |  |  |  |  |  |
| Realized gain (loss) on sales of investments: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Proceeds from sales | 109316 | 1782952 | &nbsp;&nbsp;&nbsp; 60320 | 207891 | &nbsp;&nbsp;&nbsp;&nbsp; 664 |
| &nbsp;&nbsp;&nbsp; Cost of investments sold | 112528 | 1276491 | &nbsp;&nbsp;&nbsp; 50994 | 206712 | &nbsp;&nbsp;&nbsp;&nbsp; 672 |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp; (3212) | &nbsp;&nbsp;&nbsp;&nbsp; 506461 | &nbsp;&nbsp;&nbsp;&nbsp; 9326 | &nbsp;&nbsp;&nbsp;&nbsp; 1179 | &nbsp;&nbsp;&nbsp;&nbsp; (8) |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp; 3865 | 1579985 | &nbsp;&nbsp;&nbsp; 23079 | 308901 | &nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp; 37107 | &nbsp;&nbsp; (747557) | (12746) | (53290) | 4791 |
| Net gain (loss) on investments | &nbsp;&nbsp;&nbsp; 37760 | 1338889 | &nbsp;&nbsp;&nbsp; 19659 | 256790 | 4783 |
| Net increase (decrease) in net assets resulting from operations | $38685 | $1341144 | $20223 | $244125 | $4783 |

---

See accompanying notes to financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**48 ■ RiverSource of New York Account 8**

------

**Statement of Operations**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **Temp Global** <br> **Bond,** <br>**Cl 2**<br>| **Third Ave VST** <br> **Third Ave** <br> **Value**<br>| **VanEck VIP** <br> **Global Gold,** <br>**Cl S**<br>| **VP Aggr,** <br>**Cl 1**<br>| **VP Aggr,** <br>**Cl 2**<br>|
| **Investment income** |  |  |  |  |  |
| Dividend income | $— | $55769 | $4547 | $— | $— |
| Reimbursement of income from trade error | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Variable account expenses | &nbsp;&nbsp;&nbsp;&nbsp; 459 | &nbsp;&nbsp;&nbsp; 15550 | &nbsp;&nbsp;&nbsp;&nbsp; 1421 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 64454 |
| Investment income (loss) — net | &nbsp;&nbsp;&nbsp;&nbsp; (459) | &nbsp;&nbsp;&nbsp; 40219 | &nbsp;&nbsp;&nbsp;&nbsp; 3126 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (64454) |
| **Realized and unrealized gain (loss) on investments — net** |  |  |  |  |  |
| Realized gain (loss) on sales of investments: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Proceeds from sales | 56429 | 245443 | 108613 | 361896 | 2715266 |
| &nbsp;&nbsp;&nbsp; Cost of investments sold | 66036 | 194272 | &nbsp;&nbsp;&nbsp; 75083 | 296622 | 1764568 |
| Net realized gain (loss) on sales of investments | (9607) | &nbsp;&nbsp;&nbsp; 51171 | &nbsp;&nbsp;&nbsp; 33530 | &nbsp;&nbsp;&nbsp; 65274 | &nbsp;&nbsp;&nbsp;&nbsp; 950698 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | 181041 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | 28443 | 448792 | 276549 | 720784 | 3765517 |
| Net gain (loss) on investments | 18836 | 681004 | 310079 | 786058 | 4716215 |
| Net increase (decrease) in net assets resulting from operations | $18377 | $721223 | $313205 | $786058 | $4651761 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **VP Aggr,** <br>**Cl 4**<br>| **VP Conserv,** <br>**Cl 1**<br>| **VP Conserv,** <br>**Cl 2**<br>| **VP Conserv,** <br>**Cl 4**<br>| **VP Man Vol** <br> **Conserv Gro,** <br>**Cl 1**<br>|
| **Investment income** |  |  |  |  |  |
| Dividend income | $— | $— | $— | $— | $— |
| Reimbursement of income from trade error | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — |
| Variable account expenses | &nbsp;&nbsp;&nbsp;&nbsp; 123359 |  | &nbsp;&nbsp;&nbsp;&nbsp; 2785 | &nbsp;&nbsp;&nbsp;&nbsp; 2703 | &nbsp;&nbsp;&nbsp;&nbsp; — |
| Investment income (loss) — net | &nbsp;&nbsp; (123359) |  | &nbsp;&nbsp;&nbsp; (2785) | &nbsp;&nbsp;&nbsp; (2703) | &nbsp;&nbsp;&nbsp;&nbsp; — |
| **Realized and unrealized gain (loss) on investments — net** |  |  |  |  |  |
| Realized gain (loss) on sales of investments: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Proceeds from sales | 4561264 |  | 408746 | 101453 | 1885 |
| &nbsp;&nbsp;&nbsp; Cost of investments sold | 2673924 |  | 372788 | &nbsp;&nbsp;&nbsp; 85907 | 1798 |
| Net realized gain (loss) on sales of investments | 1887340 |  | &nbsp;&nbsp;&nbsp; 35958 | &nbsp;&nbsp;&nbsp; 15546 | &nbsp;&nbsp;&nbsp;&nbsp; 87 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | 2440166 | &nbsp;&nbsp;&nbsp; 3 | &nbsp;&nbsp;&nbsp; 54368 | &nbsp;&nbsp;&nbsp; 39997 | 6706 |
| Net gain (loss) on investments | 4327506 | &nbsp;&nbsp;&nbsp; 3 | &nbsp;&nbsp;&nbsp; 90326 | &nbsp;&nbsp;&nbsp; 55543 | 6793 |
| Net increase (decrease) in net assets resulting from operations | $4204147 | $3 | $87541 | $52840 | $6793 |

---

See accompanying notes to financial statements.

**RiverSource of New York Account 8** ■ 49

------

**Statement of Operations**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **VP Man Vol** <br> **Conserv Gro,** <br>**Cl 2**<br>| **VP Man Vol** <br> **Conserv,** <br>**Cl 1**<br>| **VP Man Vol** <br> **Conserv,** <br>**Cl 2**<br>| **VP Man Vol** <br> **Gro,** <br>**Cl 1**<br>| **VP Man Vol** <br> **Gro,** <br>**Cl 2**<br>|
| **Investment income** |  |  |  |  |  |
| Dividend income | $— | $— | $— | $— | $— |
| Reimbursement of income from trade error | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Variable account expenses | &nbsp;&nbsp;&nbsp;&nbsp; 933 | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; 1031 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 7965 |
| Investment income (loss) — net | &nbsp;&nbsp;&nbsp;&nbsp; (933) | &nbsp;&nbsp;&nbsp; — | (1031) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; (7965) |
| **Realized and unrealized gain (loss) on investments — net** |  |  |  |  |  |
| Realized gain (loss) on sales of investments: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Proceeds from sales | 28242 | &nbsp;&nbsp;&nbsp; — | 22613 | 101068 | 368018 |
| &nbsp;&nbsp;&nbsp; Cost of investments sold | 26063 | &nbsp;&nbsp;&nbsp; — | 21835 | &nbsp;&nbsp;&nbsp; 91293 | 289249 |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp; 2179 | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 778 | &nbsp;&nbsp;&nbsp;&nbsp; 9775 | &nbsp;&nbsp;&nbsp; 78769 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | 35896 | 301 | 12588 | 289340 | 301805 |
| Net gain (loss) on investments | 38075 | 301 | 13366 | 299115 | 380574 |
| Net increase (decrease) in net assets resulting from operations | $37142 | $301 | $12335 | $299115 | $372609 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **VP Man Vol** <br> **Mod Gro,** <br>**Cl 1**<br>| **VP Man Vol** <br> **Mod Gro,** <br>**Cl 2**<br>| **VP Mod Aggr,** <br>**Cl 1**<br>| **VP Mod Aggr,** <br>**Cl 2**<br>| **VP Mod Aggr,** <br>**Cl 4**<br>|
| **Investment income** |  |  |  |  |  |
| Dividend income | $— | $— | $— | $— | $— |
| Reimbursement of income from trade error | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Variable account expenses | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 6889 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 162297 | &nbsp;&nbsp;&nbsp;&nbsp; 277846 |
| Investment income (loss) — net | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; (6889) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp; (162297) | &nbsp;&nbsp; (277846) |
| **Realized and unrealized gain (loss) on investments — net** |  |  |  |  |  |
| Realized gain (loss) on sales of investments: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Proceeds from sales | &nbsp;&nbsp;&nbsp; 39020 | 385716 | &nbsp;&nbsp;&nbsp;&nbsp; 913203 | 5181255 | 9620244 |
| &nbsp;&nbsp;&nbsp; Cost of investments sold | &nbsp;&nbsp;&nbsp; 35529 | 299954 | &nbsp;&nbsp;&nbsp;&nbsp; 741462 | 3538719 | 5691873 |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp; 3491 | &nbsp;&nbsp;&nbsp; 85762 | &nbsp;&nbsp;&nbsp;&nbsp; 171741 | 1642536 | 3928371 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | 154362 | 174022 | 2077575 | 5012459 | 4856012 |
| Net gain (loss) on investments | 157853 | 259784 | 2249316 | 6654995 | 8784383 |
| Net increase (decrease) in net assets resulting from operations | $157853 | $252895 | $2249316 | $6492698 | $8506537 |

---

See accompanying notes to financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**50 ■ RiverSource of New York Account 8**

------

**Statement of Operations**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **VP Mod** <br> **Conserv,** <br>**Cl 1**<br>| **VP Mod** <br> **Conserv,** <br>**Cl 2**<br>| **VP Mod** <br> **Conserv,** <br>**Cl 4**<br>| **VP Mod,** <br>**Cl 1**<br>| **VP Mod,** <br>**Cl 2**<br>|
| **Investment income** |  |  |  |  |  |
| Dividend income | $— | $— | $— | $— | $— |
| Reimbursement of income from trade error | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Variable account expenses | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; 10048 | &nbsp;&nbsp;&nbsp; 11949 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 126042 |
| Investment income (loss) — net | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | (10048) | (11949) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp; (126042) |
| **Realized and unrealized gain (loss) on investments — net** |  |  |  |  |  |
| Realized gain (loss) on sales of investments: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Proceeds from sales | 362966 | 315725 | 717743 | 838930 | 3234096 |
| &nbsp;&nbsp;&nbsp; Cost of investments sold | 307602 | 261209 | 570235 | 741265 | 2286396 |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp; 55364 | &nbsp;&nbsp;&nbsp; 54516 | 147508 | &nbsp;&nbsp;&nbsp; 97665 | &nbsp;&nbsp;&nbsp;&nbsp; 947700 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | (45335) | 197889 | 167268 | 699351 | 2672204 |
| Net gain (loss) on investments | &nbsp;&nbsp;&nbsp; 10029 | 252405 | 314776 | 797016 | 3619904 |
| Net increase (decrease) in net assets resulting from operations | $10029 | $242357 | $302827 | $797016 | $3493862 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **VP Mod,** <br>**Cl 4**<br>| **VP Ptnrs Core** <br> **Bond,** <br>**Cl 1**<br>| **VP Ptnrs Core** <br> **Bond,** <br>**Cl 2**<br>| **VP Ptnrs Core** <br> **Eq,** <br>**Cl 1**<br>| **VP Ptnrs Core** <br> **Eq,** <br>**Cl 2**<br>|
| **Investment income** |  |  |  |  |  |
| Dividend income | $— | $1570 | $1272 | $— | $— |
| Reimbursement of income from trade error | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — |
| Variable account expenses | &nbsp;&nbsp;&nbsp;&nbsp; 165205 | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — |
| Investment income (loss) — net | &nbsp;&nbsp; (165205) | 1570 | 1272 | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — |
| **Realized and unrealized gain (loss) on investments — net** |  |  |  |  |  |
| Realized gain (loss) on sales of investments: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Proceeds from sales | 6456306 | 2683 | 5325 | 2927 | 1394 |
| &nbsp;&nbsp;&nbsp; Cost of investments sold | 4392155 | 2709 | 5295 | 2481 | 1019 |
| Net realized gain (loss) on sales of investments | 2064151 | &nbsp;&nbsp;&nbsp;&nbsp; (26) | &nbsp;&nbsp;&nbsp;&nbsp; 30 | &nbsp;&nbsp;&nbsp;&nbsp; 446 | &nbsp;&nbsp;&nbsp;&nbsp; 375 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | 2429611 | &nbsp;&nbsp;&nbsp;&nbsp; 653 | &nbsp;&nbsp;&nbsp;&nbsp; 198 | &nbsp;&nbsp;&nbsp;&nbsp; 185 | 4752 |
| Net gain (loss) on investments | 4493762 | &nbsp;&nbsp;&nbsp;&nbsp; 627 | &nbsp;&nbsp;&nbsp;&nbsp; 228 | &nbsp;&nbsp;&nbsp;&nbsp; 631 | 5127 |
| Net increase (decrease) in net assets resulting from operations | $4328557 | $2197 | $1500 | $631 | $5127 |

---

See accompanying notes to financial statements.

**RiverSource of New York Account 8** ■ 51

------

**Statement of Operations**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **VP Ptnrs Core** <br> **Eq,** <br>**Cl 3**<br>| **VP Ptnrs Intl** <br> **Core Eq,** <br>**Cl 1**<br>| **VP Ptnrs Intl** <br> **Core Eq,** <br>**Cl 2**<br>| **VP Ptnrs Intl** <br> **Gro,** <br>**Cl 1**<br>| **VP Ptnrs Intl** <br> **Gro,** <br>**Cl 2**<br>|
| **Investment income** |  |  |  |  |  |
| Dividend income | $— | $4686 | $853 | $1129 | $1082 |
| Reimbursement of income from trade error | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Variable account expenses | &nbsp;&nbsp;&nbsp;&nbsp; 2532 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Investment income (loss) — net | &nbsp;&nbsp;&nbsp; (2532) | &nbsp;&nbsp;&nbsp; 4686 | &nbsp;&nbsp;&nbsp;&nbsp; 853 | &nbsp;&nbsp;&nbsp; 1129 | &nbsp;&nbsp;&nbsp; 1082 |
| **Realized and unrealized gain (loss) on investments — net** |  |  |  |  |  |
| Realized gain (loss) on sales of investments: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Proceeds from sales | 101032 | 20663 | &nbsp;&nbsp;&nbsp; 1937 | &nbsp;&nbsp;&nbsp; 5444 | 18178 |
| &nbsp;&nbsp;&nbsp; Cost of investments sold | &nbsp;&nbsp;&nbsp; 48436 | 19445 | &nbsp;&nbsp;&nbsp; 1704 | &nbsp;&nbsp;&nbsp; 4890 | 17053 |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp; 52596 | &nbsp;&nbsp;&nbsp; 1218 | &nbsp;&nbsp;&nbsp;&nbsp; 233 | &nbsp;&nbsp;&nbsp;&nbsp; 554 | &nbsp;&nbsp;&nbsp; 1125 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | 14839 | &nbsp;&nbsp;&nbsp; 2898 | &nbsp;&nbsp;&nbsp; 1278 | &nbsp;&nbsp;&nbsp; 1822 |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp; 11937 | 52665 | 10544 | 24470 | 30622 |
| Net gain (loss) on investments | &nbsp;&nbsp;&nbsp; 64533 | 68722 | 13675 | 26302 | 33569 |
| Net increase (decrease) in net assets resulting from operations | $62001 | $73408 | $14528 | $27431 | $34651 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **VP Ptnrs Intl** <br> **Val,** <br>**Cl 1**<br>| **VP Ptnrs Intl** <br> **Val,** <br>**Cl 2**<br>| **VP Ptnrs Sm** <br> **Cap Gro,** <br>**Cl 1**<br>| **VP Ptnrs Sm** <br> **Cap Gro,** <br>**Cl 2**<br>| **VP Ptnrs Sm** <br> **Cap Val,** <br>**Cl 1**<br>|
| **Investment income** |  |  |  |  |  |
| Dividend income | $1651 | $2090 | $— | $— | $— |
| Reimbursement of income from trade error | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — |
| Variable account expenses | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — |
| Investment income (loss) — net | &nbsp;&nbsp;&nbsp; 1651 | &nbsp;&nbsp;&nbsp; 2090 | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — |
| **Realized and unrealized gain (loss) on investments — net** |  |  |  |  |  |
| Realized gain (loss) on sales of investments: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Proceeds from sales | &nbsp;&nbsp;&nbsp; 2530 | &nbsp;&nbsp;&nbsp; 9925 | 4379 | 20981 | 4616 |
| &nbsp;&nbsp;&nbsp; Cost of investments sold | &nbsp;&nbsp;&nbsp; 2095 | &nbsp;&nbsp;&nbsp; 7987 | 3729 | 18353 | 4314 |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp; 435 | &nbsp;&nbsp;&nbsp; 1938 | &nbsp;&nbsp;&nbsp;&nbsp; 650 | &nbsp;&nbsp;&nbsp; 2628 | &nbsp;&nbsp;&nbsp;&nbsp; 302 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp; 154 | &nbsp;&nbsp;&nbsp;&nbsp; 199 | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | 16161 | 18725 | 4839 | (2610) | &nbsp;&nbsp;&nbsp;&nbsp; (82) |
| Net gain (loss) on investments | 16750 | 20862 | 5489 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 18 | &nbsp;&nbsp;&nbsp;&nbsp; 220 |
| Net increase (decrease) in net assets resulting from operations | $18401 | $22952 | $5489 | $18 | $220 |

---

See accompanying notes to financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**52 ■ RiverSource of New York Account 8**

------

**Statement of Operations**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **VP Ptnrs Sm** <br> **Cap Val,** <br>**Cl 2**<br>| **VP Ptnrs Sm** <br> **Cap Val,** <br>**Cl 3**<br>| **VP US Flex** <br> **Conserv Gro,** <br>**Cl 1**<br>| **VP US Flex** <br> **Gro,** <br>**Cl 1**<br>| **VP US Flex** <br> **Mod Gro,** <br>**Cl 1**<br>|
| **Investment income** |  |  |  |  |  |
| Dividend income | $— | $— | $— | $— | $— |
| Reimbursement of income from trade error | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Variable account expenses | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 2697 | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Investment income (loss) — net | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; (2697) | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| **Realized and unrealized gain (loss) on investments — net** |  |  |  |  |  |
| Realized gain (loss) on sales of investments: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Proceeds from sales | 314 | 145174 | 724 | &nbsp;&nbsp;&nbsp; 9165 | &nbsp;&nbsp;&nbsp; 2988 |
| &nbsp;&nbsp;&nbsp; Cost of investments sold | 234 | 103375 | 634 | &nbsp;&nbsp;&nbsp; 7611 | &nbsp;&nbsp;&nbsp; 2850 |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp; 80 | &nbsp;&nbsp;&nbsp; 41799 | &nbsp;&nbsp;&nbsp; 90 | &nbsp;&nbsp;&nbsp; 1554 | &nbsp;&nbsp;&nbsp;&nbsp; 138 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | 408 | &nbsp;&nbsp;&nbsp;&nbsp; 6115 | 732 | 29399 | 12322 |
| Net gain (loss) on investments | 488 | &nbsp;&nbsp;&nbsp; 47914 | 822 | 30953 | 12460 |
| Net increase (decrease) in net assets resulting from operations | $488 | $45217 | $822 | $30953 | $12460 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | |
|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **WA Var Global** <br> **Hi Yd Bond,** <br>**Cl I**<br>| **WA Var Global** <br> **Hi Yd Bond,** <br>**Cl II**<br>|
| **Investment income** |  |  |
| Dividend income | $1892 | $463 |
| Reimbursement of income from trade error | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — |
| Variable account expenses | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — |
| Investment income (loss) — net | 1892 | &nbsp;&nbsp;&nbsp;&nbsp; 463 |
| **Realized and unrealized gain (loss) on investments — net** |  |  |
| Realized gain (loss) on sales of investments: |  |  |
| &nbsp;&nbsp;&nbsp; Proceeds from sales | 1211 | 1652 |
| &nbsp;&nbsp;&nbsp; Cost of investments sold | 1223 | 1812 |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp; (12) | &nbsp;&nbsp; (160) |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp;&nbsp; 676 | &nbsp;&nbsp;&nbsp;&nbsp; 399 |
| Net gain (loss) on investments | &nbsp;&nbsp;&nbsp;&nbsp; 664 | &nbsp;&nbsp;&nbsp;&nbsp; 239 |
| Net increase (decrease) in net assets resulting from operations | $2556 | $702 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

<sup>(1)</sup> See Note 9 in the Notes to Financial Statements.

See accompanying notes to financial statements.

**RiverSource of New York Account 8** ■ 53

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025** | **AB VPS Dyn** <br> **Asset Alloc,** <br>**Cl B**<br>| **AB VPS Intl** <br> **Val,** <br>**Cl B**<br>| **AB VPS Lg** <br> **Cap Gro,** <br>**Cl A**<br>| **AB VPS Lg** <br> **Cap Gro,** <br>**Cl B**<br>| **AB VPS** <br> **Relative Val,** <br>**Cl B**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $8 | $60358 | $— | $(12123) | $12460 |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 185295 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 7689 | &nbsp;&nbsp;&nbsp;&nbsp; 119805 | &nbsp;&nbsp;&nbsp;&nbsp; 27506 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 107630 | &nbsp;&nbsp;&nbsp;&nbsp; 351576 | &nbsp;&nbsp;&nbsp;&nbsp; 219459 |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp; 61 | &nbsp;&nbsp;&nbsp;&nbsp; 790758 | &nbsp;&nbsp;&nbsp;&nbsp; 38288 | &nbsp;&nbsp;&nbsp;&nbsp; (36111) | &nbsp;&nbsp;&nbsp;&nbsp; (12702) |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp; 69 | 1036411 | &nbsp;&nbsp;&nbsp;&nbsp; 153607 | &nbsp;&nbsp;&nbsp;&nbsp; 423147 | &nbsp;&nbsp;&nbsp;&nbsp; 246723 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 98904 | &nbsp;&nbsp;&nbsp;&nbsp; 214157 | &nbsp;&nbsp;&nbsp;&nbsp; 116004 | &nbsp;&nbsp;&nbsp;&nbsp; 40287 |
| Net transfers<sup>(1)</sup> <br>| &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 113268 | &nbsp;&nbsp;&nbsp;&nbsp; 86825 | &nbsp;&nbsp;&nbsp;&nbsp; 48524 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 9387 |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (16396) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (495) | &nbsp;&nbsp;&nbsp;&nbsp; (30579) | &nbsp;&nbsp;&nbsp;&nbsp; (11002) |
| Policy charges | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (85036) | &nbsp;&nbsp;&nbsp;&nbsp; (74757) | &nbsp;&nbsp;&nbsp;&nbsp; (61330) | &nbsp;&nbsp;&nbsp;&nbsp; (53742) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (81932) | &nbsp;&nbsp;&nbsp;&nbsp; (3150) | &nbsp;&nbsp; (119556) | &nbsp;&nbsp; (102266) |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (38047) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (9239) | &nbsp;&nbsp;&nbsp;&nbsp; 222580 | &nbsp;&nbsp;&nbsp;&nbsp; (46937) | &nbsp;&nbsp; (117336) |
| Increase (decrease) in net assets | &nbsp;&nbsp;&nbsp; 69 | 1027172 | &nbsp;&nbsp;&nbsp;&nbsp; 376187 | &nbsp;&nbsp;&nbsp;&nbsp; 376210 | &nbsp;&nbsp;&nbsp;&nbsp; 129387 |
| Net assets at beginning of year | 530 | 2555100 | 1015041 | 3400799 | 2616341 |
| Net assets at end of year | $599 | $3582272 | $1391228 | $3777009 | $2745728 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | &nbsp;&nbsp;&nbsp; — | 1392469 | &nbsp;&nbsp;&nbsp;&nbsp; 404413 | &nbsp;&nbsp;&nbsp;&nbsp; 457167 | &nbsp;&nbsp;&nbsp;&nbsp; 685025 |
| Units purchased | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 431189 | &nbsp;&nbsp;&nbsp;&nbsp; 115246 | &nbsp;&nbsp;&nbsp;&nbsp; 99213 | &nbsp;&nbsp;&nbsp;&nbsp; 121826 |
| Units redeemed | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp; (305118) | &nbsp;&nbsp;&nbsp;&nbsp; (29728) | &nbsp;&nbsp;&nbsp;&nbsp; (62680) | &nbsp;&nbsp;&nbsp;&nbsp; (87560) |
| Units outstanding at end of year | &nbsp;&nbsp;&nbsp; — | 1518540 | &nbsp;&nbsp;&nbsp;&nbsp; 489931 | &nbsp;&nbsp;&nbsp;&nbsp; 493700 | &nbsp;&nbsp;&nbsp;&nbsp; 719291 |

---

See accompanying notes to financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**54 ■ RiverSource of New York Account 8**

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **Allspg VT** <br> **Index Asset** <br> **Alloc,** <br>**Cl 2**<br>| **Allspg VT Opp,** <br>**Cl 1**<br>| **Allspg VT Opp,** <br>**Cl 2**<br>| **Allspg VT Sm** <br> **Cap Gro,** <br>**Cl 1**<br>| **Allspg VT Sm** <br> **Cap Gro,** <br>**Cl 2**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $5458 | $75 | $(3840) | $— | $(4181) |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 101 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 45 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1996 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 548 | &nbsp;&nbsp;&nbsp;&nbsp; (19521) |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp; 52145 | &nbsp;&nbsp;&nbsp; 2585 | &nbsp;&nbsp;&nbsp;&nbsp; 141165 | &nbsp;&nbsp;&nbsp; 24176 | &nbsp;&nbsp;&nbsp;&nbsp; 85817 |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp;&nbsp; 7285 | &nbsp;&nbsp;&nbsp;&nbsp; (933) | &nbsp;&nbsp;&nbsp;&nbsp; (56294) | &nbsp;&nbsp;&nbsp; 18007 | &nbsp;&nbsp;&nbsp;&nbsp; 60606 |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp; 64989 | &nbsp;&nbsp;&nbsp; 1772 | &nbsp;&nbsp;&nbsp;&nbsp; 83027 | &nbsp;&nbsp;&nbsp; 42731 | &nbsp;&nbsp;&nbsp;&nbsp; 122721 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp; 17732 | &nbsp;&nbsp;&nbsp; 4944 | &nbsp;&nbsp;&nbsp;&nbsp; 28412 | 110795 | &nbsp;&nbsp;&nbsp;&nbsp; 62186 |
| Net transfers<sup>(1)</sup> <br>| &nbsp;&nbsp;&nbsp; (4060) | &nbsp;&nbsp;&nbsp;&nbsp; (178) | &nbsp;&nbsp;&nbsp;&nbsp; (26023) | &nbsp;&nbsp;&nbsp; 19657 | &nbsp;&nbsp;&nbsp;&nbsp; (27947) |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp;&nbsp; 2029 | (1015) | &nbsp;&nbsp;&nbsp;&nbsp; (18636) | &nbsp;&nbsp;&nbsp;&nbsp; (508) | &nbsp;&nbsp;&nbsp;&nbsp; (3500) |
| Policy charges | (15480) | (1645) | &nbsp;&nbsp;&nbsp;&nbsp; (27378) | (30261) | &nbsp;&nbsp;&nbsp;&nbsp; (31171) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | &nbsp;&nbsp;&nbsp; (7045) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (41158) | &nbsp;&nbsp;&nbsp; (1340) | &nbsp;&nbsp;&nbsp;&nbsp; (25780) |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | &nbsp;&nbsp;&nbsp; (6824) | &nbsp;&nbsp;&nbsp; 2106 | &nbsp;&nbsp;&nbsp;&nbsp; (84783) | &nbsp;&nbsp;&nbsp; 98343 | &nbsp;&nbsp;&nbsp;&nbsp; (26212) |
| Increase (decrease) in net assets | &nbsp;&nbsp;&nbsp; 58165 | &nbsp;&nbsp;&nbsp; 3878 | &nbsp;&nbsp;&nbsp;&nbsp; (1756) | 141074 | &nbsp;&nbsp;&nbsp;&nbsp; 96509 |
| Net assets at beginning of year | 593768 | 24071 | 1342161 | 392489 | 1447951 |
| Net assets at end of year | $651933 | $27949 | $1340405 | $533563 | $1544460 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | 243112 | 11774 | &nbsp;&nbsp;&nbsp;&nbsp; 262672 | 265123 | &nbsp;&nbsp;&nbsp;&nbsp; 451556 |
| Units purchased | &nbsp;&nbsp;&nbsp; 14428 | &nbsp;&nbsp;&nbsp; 2385 | &nbsp;&nbsp;&nbsp;&nbsp; 49811 | &nbsp;&nbsp;&nbsp; 85161 | &nbsp;&nbsp;&nbsp;&nbsp; 70567 |
| Units redeemed | (16523) | (1383) | &nbsp;&nbsp;&nbsp;&nbsp; (38857) | (21289) | &nbsp;&nbsp;&nbsp;&nbsp; (43106) |
| Units outstanding at end of year | 241017 | 12776 | &nbsp;&nbsp;&nbsp;&nbsp; 273626 | 328995 | &nbsp;&nbsp;&nbsp;&nbsp; 479017 |

---

See accompanying notes to financial statements.

**RiverSource of New York Account 8** ■ 55

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **ALPS Alerian** <br> **Engy Infr,** <br> **Class I**<br>| **ALPS Alerian** <br> **Engy Infr,** <br> **Class III**<br>| **BlackRock** <br> **Global Alloc,** <br>**Cl I**<br>| **BlackRock** <br> **Global Alloc,** <br>**Cl III**<br>| **Calvert VP SRI** <br> **Bal,** <br>**Cl I**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $4893 | $22265 | $12303 | $21726 | $33308 |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp; 6451 | &nbsp;&nbsp;&nbsp; 15017 | &nbsp;&nbsp;&nbsp;&nbsp; 3141 | &nbsp;&nbsp;&nbsp; (5739) | &nbsp;&nbsp;&nbsp;&nbsp; 16856 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp; 11591 | &nbsp;&nbsp;&nbsp; 64343 | &nbsp;&nbsp;&nbsp; 28293 | &nbsp;&nbsp;&nbsp; 59409 | &nbsp;&nbsp;&nbsp;&nbsp; 153580 |
| Net change in unrealized appreciation (depreciation) of investments | (18088) | (80480) | &nbsp;&nbsp;&nbsp; 17354 | &nbsp;&nbsp;&nbsp; 24051 | &nbsp;&nbsp;&nbsp;&nbsp; 86265 |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp;&nbsp; 4847 | &nbsp;&nbsp;&nbsp; 21145 | &nbsp;&nbsp;&nbsp; 61091 | &nbsp;&nbsp;&nbsp; 99447 | &nbsp;&nbsp;&nbsp;&nbsp; 290009 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp; 15849 | &nbsp;&nbsp;&nbsp;&nbsp; 8806 | &nbsp;&nbsp;&nbsp; 73221 | &nbsp;&nbsp;&nbsp; 18270 | &nbsp;&nbsp;&nbsp;&nbsp; 133182 |
| Net transfers<sup>(1)</sup> <br>| &nbsp;&nbsp;&nbsp; (3300) | (33551) | &nbsp;&nbsp;&nbsp; 20133 | (48675) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 12 |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; (6448) | (38276) | &nbsp;&nbsp;&nbsp; (6547) | &nbsp;&nbsp;&nbsp;&nbsp; 131982 |
| Policy charges | &nbsp;&nbsp;&nbsp; (3473) | &nbsp;&nbsp;&nbsp; (7733) | (27328) | &nbsp;&nbsp;&nbsp; (7983) | &nbsp;&nbsp; (120992) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | &nbsp;&nbsp;&nbsp;&nbsp; (441) | &nbsp;&nbsp;&nbsp; (7298) | &nbsp;&nbsp;&nbsp; (2450) | &nbsp;&nbsp;&nbsp; (1851) | &nbsp;&nbsp;&nbsp;&nbsp; (5151) |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | &nbsp;&nbsp;&nbsp;&nbsp; 8635 | (46224) | &nbsp;&nbsp;&nbsp; 25300 | (46786) | &nbsp;&nbsp;&nbsp;&nbsp; 139033 |
| Increase (decrease) in net assets | &nbsp;&nbsp;&nbsp; 13482 | (25079) | &nbsp;&nbsp;&nbsp; 86391 | &nbsp;&nbsp;&nbsp; 52661 | &nbsp;&nbsp;&nbsp;&nbsp; 429042 |
| Net assets at beginning of year | &nbsp;&nbsp;&nbsp; 89033 | 542713 | 291801 | 565831 | 2581102 |
| Net assets at end of year | $102515 | $517634 | $378192 | $618492 | $3010144 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | &nbsp;&nbsp;&nbsp; 44434 | 344212 | 197043 | 350296 | &nbsp;&nbsp;&nbsp;&nbsp; 687351 |
| Units purchased | &nbsp;&nbsp;&nbsp;&nbsp; 7597 | &nbsp;&nbsp;&nbsp;&nbsp; 6539 | &nbsp;&nbsp;&nbsp; 57840 | &nbsp;&nbsp;&nbsp; 10030 | &nbsp;&nbsp;&nbsp;&nbsp; 77369 |
| Units redeemed | &nbsp;&nbsp;&nbsp; (3345) | (36761) | (41705) | (39439) | &nbsp;&nbsp;&nbsp;&nbsp; (35320) |
| Units outstanding at end of year | &nbsp;&nbsp;&nbsp; 48686 | 313990 | 213178 | 320887 | &nbsp;&nbsp;&nbsp;&nbsp; 729400 |

---

See accompanying notes to financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**56 ■ RiverSource of New York Account 8**

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **Col VP Acorn** | **Col VP Acorn** <br> **Intl**<br>| **Col VP Bal,** <br>**Cl 1**<br>| **Col VP Bal,** <br>**Cl 3**<br>| **Col VP** <br> **Commodity** <br> **Strategy,** <br>**Cl 1**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $(27898) | $31117 | $— | $(144618) | $7000 |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp; (299698) | &nbsp;&nbsp; (138230) | &nbsp;&nbsp;&nbsp;&nbsp; 45451 | &nbsp;&nbsp;&nbsp;&nbsp; 918938 | &nbsp;&nbsp;&nbsp;&nbsp; (754) |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 19526 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp;&nbsp; 555721 | &nbsp;&nbsp;&nbsp;&nbsp; 536360 | &nbsp;&nbsp;&nbsp;&nbsp; 371163 | &nbsp;&nbsp;&nbsp; 1613230 | &nbsp;&nbsp;&nbsp;&nbsp; 6130 |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp;&nbsp; 228125 | &nbsp;&nbsp;&nbsp;&nbsp; 448773 | &nbsp;&nbsp;&nbsp;&nbsp; 416614 | &nbsp;&nbsp;&nbsp; 2387550 | &nbsp;&nbsp;&nbsp; 12376 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp; 121514 | &nbsp;&nbsp;&nbsp;&nbsp; 133030 | &nbsp;&nbsp;&nbsp;&nbsp; 568961 | &nbsp;&nbsp;&nbsp;&nbsp; 523647 | &nbsp;&nbsp;&nbsp; 19502 |
| Net transfers<sup>(1)</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp; (46182) | &nbsp;&nbsp;&nbsp;&nbsp; (52390) | &nbsp;&nbsp;&nbsp;&nbsp; 414772 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 44828 | &nbsp;&nbsp;&nbsp; 10755 |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp;&nbsp; (9694) | &nbsp;&nbsp;&nbsp;&nbsp; 40048 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (649) | &nbsp;&nbsp;&nbsp;&nbsp; (13443) | &nbsp;&nbsp;&nbsp; (3744) |
| Policy charges | &nbsp;&nbsp; (123206) | &nbsp;&nbsp; (100892) | &nbsp;&nbsp; (135057) | &nbsp;&nbsp;&nbsp;&nbsp; (854204) | &nbsp;&nbsp;&nbsp; (4621) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | &nbsp;&nbsp; (180097) | &nbsp;&nbsp;&nbsp;&nbsp; (93864) | &nbsp;&nbsp; (168717) | &nbsp;&nbsp;&nbsp;&nbsp; (722353) | &nbsp;&nbsp;&nbsp;&nbsp; (278) |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (13094) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | &nbsp;&nbsp; (237665) | &nbsp;&nbsp;&nbsp;&nbsp; (87162) | &nbsp;&nbsp;&nbsp;&nbsp; 679310 | (1021525) | &nbsp;&nbsp;&nbsp; 21614 |
| Increase (decrease) in net assets | &nbsp;&nbsp;&nbsp;&nbsp; (9540) | &nbsp;&nbsp;&nbsp;&nbsp; 361611 | 1095924 | &nbsp;&nbsp;&nbsp; 1366025 | &nbsp;&nbsp;&nbsp; 33990 |
| Net assets at beginning of year | 5856592 | 3719562 | 2554838 | 18706480 | &nbsp;&nbsp;&nbsp; 69559 |
| Net assets at end of year | $5847052 | $4081173 | $3650762 | $20072505 | $103549 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | 1307007 | 1564404 | 1426886 | &nbsp;&nbsp;&nbsp; 5376587 | &nbsp;&nbsp;&nbsp; 44276 |
| Units purchased | &nbsp;&nbsp;&nbsp;&nbsp; 327626 | &nbsp;&nbsp;&nbsp;&nbsp; 272923 | &nbsp;&nbsp;&nbsp;&nbsp; 532872 | &nbsp;&nbsp;&nbsp;&nbsp; 204399 | &nbsp;&nbsp;&nbsp; 17929 |
| Units redeemed | &nbsp;&nbsp; (184836) | &nbsp;&nbsp; (174287) | &nbsp;&nbsp; (172056) | &nbsp;&nbsp;&nbsp;&nbsp; (476233) | &nbsp;&nbsp;&nbsp; (5130) |
| Units outstanding at end of year | 1449797 | 1663040 | 1787702 | &nbsp;&nbsp;&nbsp; 5104753 | &nbsp;&nbsp;&nbsp; 57075 |

---

See accompanying notes to financial statements.

**RiverSource of New York Account 8** ■ 57

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **Col VP** <br> **Commodity** <br> **Strategy,** <br>**Cl 2**<br>| **Col VP** <br> **Contrarian** <br> **Core,** <br>**Cl 1**<br>| **Col VP** <br> **Contrarian** <br> **Core,** <br>**Cl 2**<br>| **Col VP** <br> **Corporate** <br> **Bond,** <br>**Cl 1**<br>| **Col VP** <br> **Corporate** <br> **Bond,** <br>**Cl 2**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $3502 | $— | $— | $599 | $6420 |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp; (932) | &nbsp;&nbsp;&nbsp; 11487 | &nbsp;&nbsp;&nbsp;&nbsp; 1193 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5 | &nbsp;&nbsp;&nbsp;&nbsp; (739) |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp; 3580 | &nbsp;&nbsp;&nbsp; 80282 | &nbsp;&nbsp;&nbsp; 65602 | &nbsp;&nbsp;&nbsp;&nbsp; 340 | &nbsp;&nbsp;&nbsp;&nbsp; 1420 |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp; 6150 | &nbsp;&nbsp;&nbsp; 91769 | &nbsp;&nbsp;&nbsp; 66795 | &nbsp;&nbsp;&nbsp;&nbsp; 944 | &nbsp;&nbsp;&nbsp;&nbsp; 7101 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp; 2568 | 120395 | &nbsp;&nbsp;&nbsp; 15082 | &nbsp;&nbsp;&nbsp; 6321 | &nbsp;&nbsp;&nbsp;&nbsp; 6234 |
| Net transfers<sup>(1)</sup> <br>| (4354) | &nbsp;&nbsp;&nbsp; (1971) | &nbsp;&nbsp;&nbsp; 42909 | &nbsp;&nbsp;&nbsp; 2481 | &nbsp;&nbsp;&nbsp;&nbsp; 2786 |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp;&nbsp; 896 | &nbsp;&nbsp;&nbsp;&nbsp; 7117 | &nbsp;&nbsp;&nbsp; 14843 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (54) |
| Policy charges | (1065) | (41632) | &nbsp;&nbsp;&nbsp; (3872) | (2312) | &nbsp;&nbsp;&nbsp; (3212) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | &nbsp;&nbsp;&nbsp;&nbsp; (943) | &nbsp;&nbsp;&nbsp; (1504) | &nbsp;&nbsp;&nbsp; (1633) | &nbsp;&nbsp;&nbsp;&nbsp; (80) | &nbsp;&nbsp;&nbsp; (4681) |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | (2898) | &nbsp;&nbsp;&nbsp; 82405 | &nbsp;&nbsp;&nbsp; 67329 | &nbsp;&nbsp;&nbsp; 6410 | &nbsp;&nbsp;&nbsp;&nbsp; 1073 |
| Increase (decrease) in net assets | &nbsp;&nbsp;&nbsp; 3252 | 174174 | 134124 | &nbsp;&nbsp;&nbsp; 7354 | &nbsp;&nbsp;&nbsp;&nbsp; 8174 |
| Net assets at beginning of year | 40849 | 456834 | 335703 | &nbsp;&nbsp;&nbsp; 6684 | &nbsp;&nbsp;&nbsp; 93901 |
| Net assets at end of year | $44101 | $631008 | $469827 | $14038 | $102075 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | 42468 | 190262 | &nbsp;&nbsp;&nbsp; 83512 | &nbsp;&nbsp;&nbsp; 6375 | &nbsp;&nbsp;&nbsp; 95276 |
| Units purchased | &nbsp;&nbsp;&nbsp; 3380 | &nbsp;&nbsp;&nbsp; 50915 | &nbsp;&nbsp;&nbsp; 17352 | &nbsp;&nbsp;&nbsp; 8317 | &nbsp;&nbsp;&nbsp;&nbsp; 8726 |
| Units redeemed | (6086) | (17798) | &nbsp;&nbsp;&nbsp; (1265) | (2139) | &nbsp;&nbsp;&nbsp; (7700) |
| Units outstanding at end of year | 39762 | 223379 | &nbsp;&nbsp;&nbsp; 99599 | 12553 | &nbsp;&nbsp;&nbsp; 96302 |

---

See accompanying notes to financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**58 ■ RiverSource of New York Account 8**

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **Col VP** <br> **Corporate** <br> **Bond,** <br>**Cl 3**<br>| **Col VP** <br> **Disciplined** <br> **Core,** <br>**Cl 1**<br>| **Col VP** <br> **Disciplined** <br> **Core,** <br>**Cl 2**<br>| **Col VP** <br> **Disciplined** <br> **Core,** <br>**Cl 3**<br>| **Col VP Divd** <br> **Opp,** <br>**Cl 1**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $71853 | $— | $— | $(265316) | $— |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp; (51798) | &nbsp;&nbsp;&nbsp;&nbsp; 2587 | &nbsp;&nbsp;&nbsp; 40684 | &nbsp;&nbsp;&nbsp; 2734532 | &nbsp;&nbsp;&nbsp;&nbsp; 2783 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp;&nbsp; 61386 | &nbsp;&nbsp;&nbsp; 45750 | &nbsp;&nbsp;&nbsp; 28462 | &nbsp;&nbsp;&nbsp; 1673504 | 100552 |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp;&nbsp; 81441 | &nbsp;&nbsp;&nbsp; 48337 | &nbsp;&nbsp;&nbsp; 69146 | &nbsp;&nbsp;&nbsp; 4142720 | 103335 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp; 35557 | &nbsp;&nbsp;&nbsp; 49718 | &nbsp;&nbsp;&nbsp; 16400 | &nbsp;&nbsp;&nbsp;&nbsp; 716155 | 154004 |
| Net transfers<sup>(1)</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp; (15597) | &nbsp;&nbsp;&nbsp; 45619 | (33520) | &nbsp;&nbsp;&nbsp;&nbsp; (395204) | &nbsp;&nbsp;&nbsp; 64788 |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp;&nbsp; (10171) | &nbsp;&nbsp;&nbsp; (1118) | (27268) | &nbsp;&nbsp;&nbsp;&nbsp; (14447) | (12848) |
| Policy charges | &nbsp;&nbsp;&nbsp;&nbsp; (42702) | (22665) | (17669) | (1270475) | (35398) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | &nbsp;&nbsp;&nbsp;&nbsp; (44171) | &nbsp;&nbsp;&nbsp; (2626) | &nbsp;&nbsp;&nbsp;&nbsp; (719) | (1825841) | &nbsp;&nbsp;&nbsp;&nbsp; (549) |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | &nbsp;&nbsp;&nbsp;&nbsp; (77084) | &nbsp;&nbsp;&nbsp; 68928 | (62776) | (2789812) | 169997 |
| Increase (decrease) in net assets | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 4357 | 117265 | &nbsp;&nbsp;&nbsp;&nbsp; 6370 | &nbsp;&nbsp;&nbsp; 1352908 | 273332 |
| Net assets at beginning of year | 1197880 | 298626 | 541881 | 32793527 | 528171 |
| Net assets at end of year | $1202237 | $415891 | $548251 | $34146435 | $801503 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | &nbsp;&nbsp;&nbsp;&nbsp; 940952 | 138550 | 117867 | &nbsp;&nbsp;&nbsp; 8049457 | 309273 |
| Units purchased | &nbsp;&nbsp;&nbsp;&nbsp; 157603 | &nbsp;&nbsp;&nbsp; 41594 | &nbsp;&nbsp;&nbsp;&nbsp; 3426 | &nbsp;&nbsp;&nbsp;&nbsp; 285486 | 122571 |
| Units redeemed | &nbsp;&nbsp; (209034) | (11823) | (17007) | &nbsp;&nbsp;&nbsp;&nbsp; (924180) | (26665) |
| Units outstanding at end of year | &nbsp;&nbsp;&nbsp;&nbsp; 889521 | 168321 | 104286 | &nbsp;&nbsp;&nbsp; 7410763 | 405179 |

---

See accompanying notes to financial statements.

**RiverSource of New York Account 8** ■ 59

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **Col VP Divd** <br> **Opp,** <br>**Cl 2**<br>| **Col VP Divd** <br> **Opp,** <br>**Cl 3**<br>| **Col VP Emer** <br> **Mkts,** <br>**Cl 1**<br>| **Col VP Emer** <br> **Mkts,** <br>**Cl 2**<br>| **Col VP Emer** <br> **Mkts,** <br>**Cl 3**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $— | $(71195) | $839 | $265 | $(7649) |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp; 2149 | &nbsp;&nbsp;&nbsp; 1392780 | &nbsp;&nbsp;&nbsp;&nbsp; (498) | &nbsp;&nbsp;&nbsp; (5223) | &nbsp;&nbsp;&nbsp;&nbsp; (59549) |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp; 50217 | &nbsp;&nbsp;&nbsp;&nbsp; 545711 | &nbsp;&nbsp;&nbsp; 87484 | 121485 | &nbsp;&nbsp;&nbsp;&nbsp; 624796 |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp; 52366 | &nbsp;&nbsp;&nbsp; 1867296 | &nbsp;&nbsp;&nbsp; 87825 | 116527 | &nbsp;&nbsp;&nbsp;&nbsp; 557598 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp; 9558 | &nbsp;&nbsp;&nbsp;&nbsp; 281637 | &nbsp;&nbsp;&nbsp; 50381 | &nbsp;&nbsp;&nbsp; 27562 | &nbsp;&nbsp;&nbsp;&nbsp; 72237 |
| Net transfers<sup>(1)</sup> <br>| &nbsp;&nbsp;&nbsp; 23675 | &nbsp;&nbsp;&nbsp;&nbsp; (129585) | &nbsp;&nbsp;&nbsp; 16139 | &nbsp;&nbsp;&nbsp; (6395) | &nbsp;&nbsp;&nbsp;&nbsp; (50260) |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (88291) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | (18323) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 9161 |
| Policy charges | &nbsp;&nbsp;&nbsp; (4948) | &nbsp;&nbsp;&nbsp;&nbsp; (352719) | (12690) | (13883) | &nbsp;&nbsp;&nbsp;&nbsp; (54798) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | &nbsp;&nbsp;&nbsp;&nbsp; (308) | &nbsp;&nbsp;&nbsp;&nbsp; (419479) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (32) | &nbsp;&nbsp;&nbsp; (1430) | &nbsp;&nbsp;&nbsp;&nbsp; (30332) |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (41893) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | &nbsp;&nbsp;&nbsp; 27977 | &nbsp;&nbsp;&nbsp;&nbsp; (750330) | &nbsp;&nbsp;&nbsp; 53798 | (12469) | &nbsp;&nbsp;&nbsp;&nbsp; (53992) |
| Increase (decrease) in net assets | &nbsp;&nbsp;&nbsp; 80343 | &nbsp;&nbsp;&nbsp; 1116966 | 141623 | 104058 | &nbsp;&nbsp;&nbsp;&nbsp; 503606 |
| Net assets at beginning of year | 322661 | 12854074 | 252014 | 378060 | 1854983 |
| Net assets at end of year | $403004 | $13971040 | $393637 | $482118 | $2358589 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | 105682 | &nbsp;&nbsp;&nbsp; 3114323 | 222132 | 269789 | &nbsp;&nbsp;&nbsp;&nbsp; 726270 |
| Units purchased | &nbsp;&nbsp;&nbsp; 10156 | &nbsp;&nbsp;&nbsp;&nbsp; 678139 | &nbsp;&nbsp;&nbsp; 52281 | &nbsp;&nbsp;&nbsp; 17497 | &nbsp;&nbsp;&nbsp;&nbsp; 123487 |
| Units redeemed | &nbsp;&nbsp;&nbsp; (1617) | &nbsp;&nbsp;&nbsp;&nbsp; (476321) | &nbsp;&nbsp;&nbsp; (9910) | (24388) | &nbsp;&nbsp;&nbsp;&nbsp; (90725) |
| Units outstanding at end of year | 114221 | &nbsp;&nbsp;&nbsp; 3316141 | 264503 | 262898 | &nbsp;&nbsp;&nbsp;&nbsp; 759032 |

---

See accompanying notes to financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**60 ■ RiverSource of New York Account 8**

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **Col VP Emerg** <br> **Mkts Bond,** <br>**Cl 1**<br>| **Col VP Emerg** <br> **Mkts Bond,** <br>**Cl 2**<br>| **Col VP Govt** <br> **Money Mkt,** <br>**Cl 1**<br>| **Col VP Govt** <br> **Money Mkt,** <br>**Cl 2**<br>| **Col VP Govt** <br> **Money Mkt,** <br>**Cl 3**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $2575 | $922 | $20858 | $18394 | $122183 |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp; 187 | &nbsp;&nbsp;&nbsp;&nbsp; (37) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp; 2981 | &nbsp;&nbsp;&nbsp; 1260 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (1) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (1) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp; 5743 | &nbsp;&nbsp;&nbsp; 2145 | &nbsp;&nbsp;&nbsp; 20857 | &nbsp;&nbsp;&nbsp; 18393 | &nbsp;&nbsp;&nbsp;&nbsp; 122184 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | 10985 | &nbsp;&nbsp;&nbsp;&nbsp; 689 | 129161 | &nbsp;&nbsp;&nbsp; 91711 | &nbsp;&nbsp;&nbsp;&nbsp; 220478 |
| Net transfers<sup>(1)</sup> <br>| &nbsp;&nbsp;&nbsp; 2244 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; 77284 | (39968) | &nbsp;&nbsp;&nbsp;&nbsp; (17995) |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp;&nbsp; (830) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | (13286) | &nbsp;&nbsp;&nbsp;&nbsp; 128534 |
| Policy charges | (2034) | &nbsp;&nbsp;&nbsp;&nbsp; (415) | (26336) | (20140) | &nbsp;&nbsp; (271128) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; (3615) | &nbsp;&nbsp; (207128) |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | 10365 | &nbsp;&nbsp;&nbsp;&nbsp; 274 | 180109 | &nbsp;&nbsp;&nbsp; 14702 | &nbsp;&nbsp; (147239) |
| Increase (decrease) in net assets | 16108 | &nbsp;&nbsp;&nbsp; 2419 | 200966 | &nbsp;&nbsp;&nbsp; 33095 | &nbsp;&nbsp;&nbsp;&nbsp; (25055) |
| Net assets at beginning of year | 38025 | 16847 | 496735 | 494630 | 3692597 |
| Net assets at end of year | $54133 | $19266 | $697701 | $527725 | $3667542 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | 34578 | 12713 | 438092 | 432457 | 3376528 |
| Units purchased | 11566 | &nbsp;&nbsp;&nbsp;&nbsp; 494 | 176466 | &nbsp;&nbsp;&nbsp; 78283 | &nbsp;&nbsp;&nbsp;&nbsp; 570998 |
| Units redeemed | (2498) | &nbsp;&nbsp;&nbsp;&nbsp; (301) | (22750) | (65872) | &nbsp;&nbsp; (711758) |
| Units outstanding at end of year | 43646 | 12906 | 591808 | 444868 | 3235768 |

---

See accompanying notes to financial statements.

**RiverSource of New York Account 8** ■ 61

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **Col VP Hi** <br> **Yield Bond,** <br>**Cl 1**<br>| **Col VP Hi** <br> **Yield Bond,** <br>**Cl 2**<br>| **Col VP Hi** <br> **Yield Bond,** <br>**Cl 3**<br>| **Col VP Inc** <br> **Opp,** <br>**Cl 1**<br>| **Col VP Inc** <br> **Opp,** <br>**Cl 2**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $19282 | $23204 | $149380 | $537 | $1612 |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 789 | &nbsp;&nbsp;&nbsp;&nbsp; (807) | &nbsp;&nbsp;&nbsp;&nbsp; (23177) | &nbsp;&nbsp;&nbsp;&nbsp; (104) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 70 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp;&nbsp; 7164 | &nbsp;&nbsp;&nbsp;&nbsp; 9555 | &nbsp;&nbsp;&nbsp;&nbsp; 81493 | &nbsp;&nbsp;&nbsp; 1997 | &nbsp;&nbsp;&nbsp; 5653 |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp; 27235 | &nbsp;&nbsp;&nbsp; 31952 | &nbsp;&nbsp;&nbsp;&nbsp; 207696 | &nbsp;&nbsp;&nbsp; 2430 | &nbsp;&nbsp;&nbsp; 7335 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | 154529 | &nbsp;&nbsp;&nbsp; 22083 | &nbsp;&nbsp;&nbsp;&nbsp; 51130 | &nbsp;&nbsp;&nbsp; 5399 | &nbsp;&nbsp;&nbsp; 3574 |
| Net transfers<sup>(1)</sup> <br>| &nbsp;&nbsp;&nbsp; 26734 | &nbsp;&nbsp;&nbsp; 10038 | &nbsp;&nbsp;&nbsp;&nbsp; 86398 | (3484) | (3784) |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (70) | (18052) | &nbsp;&nbsp;&nbsp;&nbsp; (4414) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Policy charges | (21085) | (12714) | &nbsp;&nbsp;&nbsp;&nbsp; (72934) | (1257) | (2756) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | &nbsp;&nbsp;&nbsp;&nbsp; (361) | &nbsp;&nbsp;&nbsp;&nbsp; (141) | &nbsp;&nbsp;&nbsp;&nbsp; (67784) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | (5039) |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | 159747 | &nbsp;&nbsp;&nbsp;&nbsp; 1214 | &nbsp;&nbsp;&nbsp;&nbsp; (7604) | &nbsp;&nbsp;&nbsp;&nbsp; 658 | (8005) |
| Increase (decrease) in net assets | 186982 | &nbsp;&nbsp;&nbsp; 33166 | &nbsp;&nbsp;&nbsp;&nbsp; 200092 | &nbsp;&nbsp;&nbsp; 3088 | &nbsp;&nbsp;&nbsp;&nbsp; (670) |
| Net assets at beginning of year | 225402 | 368481 | 2583872 | 27357 | 89371 |
| Net assets at end of year | $412384 | $401647 | $2783964 | $30445 | $88701 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | 170489 | 210790 | &nbsp;&nbsp;&nbsp;&nbsp; 996371 | 21205 | 53149 |
| Units purchased | 131749 | &nbsp;&nbsp;&nbsp; 17766 | &nbsp;&nbsp;&nbsp;&nbsp; 238052 | &nbsp;&nbsp;&nbsp; 3992 | &nbsp;&nbsp;&nbsp; 2056 |
| Units redeemed | (15576) | (16783) | &nbsp;&nbsp; (137038) | (3503) | (6555) |
| Units outstanding at end of year | 286662 | 211773 | 1097385 | 21694 | 48650 |

---

See accompanying notes to financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**62 ■ RiverSource of New York Account 8**

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **Col VP Inc** <br> **Opp,** <br>**Cl 3**<br>| **Col VP Inter** <br> **Bond,** <br>**Cl 1**<br>| **Col VP Inter** <br> **Bond,** <br>**Cl 2**<br>| **Col VP Inter** <br> **Bond,** <br>**Cl 3**<br>| **Col VP Lg Cap** <br> **Gro,** <br>**Cl 1**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $16690 | $10593 | $5540 | $273015 | $— |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp; (18570) | &nbsp;&nbsp;&nbsp; (3337) | &nbsp;&nbsp;&nbsp;&nbsp; (954) | &nbsp;&nbsp; (178527) | &nbsp;&nbsp;&nbsp;&nbsp; 29691 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp;&nbsp; 96647 | &nbsp;&nbsp;&nbsp;&nbsp; 7456 | &nbsp;&nbsp;&nbsp;&nbsp; 3374 | &nbsp;&nbsp;&nbsp;&nbsp; 369609 | &nbsp;&nbsp;&nbsp;&nbsp; 548288 |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp;&nbsp; 94767 | &nbsp;&nbsp;&nbsp; 14712 | &nbsp;&nbsp;&nbsp;&nbsp; 7960 | &nbsp;&nbsp;&nbsp;&nbsp; 464097 | &nbsp;&nbsp;&nbsp;&nbsp; 577979 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp; 26083 | 151836 | &nbsp;&nbsp;&nbsp; 17536 | &nbsp;&nbsp;&nbsp;&nbsp; 174871 | &nbsp;&nbsp;&nbsp;&nbsp; 809136 |
| Net transfers<sup>(1)</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp; (37587) | &nbsp;&nbsp;&nbsp;&nbsp; 6512 | &nbsp;&nbsp;&nbsp; 18569 | &nbsp;&nbsp;&nbsp;&nbsp; (47408) | &nbsp;&nbsp;&nbsp;&nbsp; 213792 |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp;&nbsp; (3936) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; (1034) | &nbsp;&nbsp;&nbsp;&nbsp; (12587) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 7514 |
| Policy charges | &nbsp;&nbsp;&nbsp;&nbsp; (28725) | (17994) | &nbsp;&nbsp;&nbsp; (4292) | &nbsp;&nbsp; (232276) | &nbsp;&nbsp; (143096) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | &nbsp;&nbsp;&nbsp;&nbsp; (53427) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (696) | &nbsp;&nbsp; (227973) | &nbsp;&nbsp;&nbsp;&nbsp; (1287) |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | &nbsp;&nbsp;&nbsp;&nbsp; (97592) | 140354 | &nbsp;&nbsp;&nbsp; 30083 | &nbsp;&nbsp; (345373) | &nbsp;&nbsp;&nbsp;&nbsp; 886059 |
| Increase (decrease) in net assets | &nbsp;&nbsp;&nbsp;&nbsp; (2825) | 155066 | &nbsp;&nbsp;&nbsp; 38043 | &nbsp;&nbsp;&nbsp;&nbsp; 118724 | 1464038 |
| Net assets at beginning of year | 1255654 | 115701 | &nbsp;&nbsp;&nbsp; 66086 | 5767393 | 2849265 |
| Net assets at end of year | $1252829 | $270767 | $104129 | $5886117 | $4313303 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | &nbsp;&nbsp;&nbsp;&nbsp; 622475 | 106717 | &nbsp;&nbsp;&nbsp; 54495 | 3644272 | 1064402 |
| Units purchased | &nbsp;&nbsp;&nbsp;&nbsp; 16930 | 137988 | &nbsp;&nbsp;&nbsp; 29126 | &nbsp;&nbsp;&nbsp;&nbsp; 457738 | &nbsp;&nbsp;&nbsp;&nbsp; 374927 |
| Units redeemed | &nbsp;&nbsp;&nbsp;&nbsp; (55016) | (15715) | &nbsp;&nbsp;&nbsp; (4730) | &nbsp;&nbsp; (576053) | &nbsp;&nbsp;&nbsp;&nbsp; (51877) |
| Units outstanding at end of year | &nbsp;&nbsp;&nbsp;&nbsp; 584389 | 228990 | &nbsp;&nbsp;&nbsp; 78891 | 3525957 | 1387452 |

---

See accompanying notes to financial statements.

**RiverSource of New York Account 8** ■ 63

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **Col VP Lg Cap** <br> **Gro,** <br>**Cl 2**<br>| **Col VP Lg Cap** <br> **Gro,** <br>**Cl 3**<br>| **Col VP Lg Cap** <br> **Index,** <br>**Cl 1**<br>| **Col VP Lg Cap** <br> **Index,** <br>**Cl 3**<br>| **Col VP Limited** <br> **Duration Cr,** <br>**Cl 1**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $— | $(20826) | $— | $(78606) | $6076 |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp; 18662 | &nbsp;&nbsp;&nbsp;&nbsp; 291292 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 52175 | &nbsp;&nbsp;&nbsp; 1263732 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 57 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp; 78056 | &nbsp;&nbsp;&nbsp;&nbsp; 287518 | &nbsp;&nbsp;&nbsp; 1648823 | &nbsp;&nbsp;&nbsp; 1558802 | &nbsp;&nbsp;&nbsp; (1700) |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp; 96718 | &nbsp;&nbsp;&nbsp;&nbsp; 557984 | &nbsp;&nbsp;&nbsp; 1700998 | &nbsp;&nbsp;&nbsp; 2743928 | &nbsp;&nbsp;&nbsp;&nbsp; 4433 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp; 34716 | &nbsp;&nbsp;&nbsp;&nbsp; 74049 | &nbsp;&nbsp;&nbsp; 1802485 | &nbsp;&nbsp;&nbsp;&nbsp; 377649 | &nbsp;&nbsp;&nbsp; 19406 |
| Net transfers<sup>(1)</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp; 6965 | &nbsp;&nbsp;&nbsp;&nbsp; (81819) | &nbsp;&nbsp;&nbsp; 1316885 | &nbsp;&nbsp;&nbsp;&nbsp; 292260 | &nbsp;&nbsp;&nbsp; 45265 |
| Transfers for policy loans | (21892) | &nbsp;&nbsp;&nbsp;&nbsp; 46932 | &nbsp;&nbsp;&nbsp;&nbsp; (25645) | &nbsp;&nbsp;&nbsp;&nbsp; (145670) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Policy charges | &nbsp;&nbsp;&nbsp; (9310) | &nbsp;&nbsp;&nbsp;&nbsp; (90585) | &nbsp;&nbsp;&nbsp;&nbsp; (637285) | &nbsp;&nbsp;&nbsp;&nbsp; (332753) | &nbsp;&nbsp;&nbsp; (8773) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | (17982) | &nbsp;&nbsp;&nbsp;&nbsp; (93640) | &nbsp;&nbsp;&nbsp;&nbsp; (15607) | &nbsp;&nbsp;&nbsp;&nbsp; (670302) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | &nbsp;&nbsp;&nbsp; (7503) | &nbsp;&nbsp; (145063) | &nbsp;&nbsp;&nbsp; 2440833 | &nbsp;&nbsp;&nbsp;&nbsp; (478816) | &nbsp;&nbsp;&nbsp; 55898 |
| Increase (decrease) in net assets | &nbsp;&nbsp;&nbsp; 89215 | &nbsp;&nbsp;&nbsp;&nbsp; 412921 | &nbsp;&nbsp;&nbsp; 4141831 | &nbsp;&nbsp;&nbsp; 2265112 | &nbsp;&nbsp;&nbsp; 60331 |
| Net assets at beginning of year | 640113 | 3745761 | &nbsp;&nbsp;&nbsp; 8511811 | 16440960 | &nbsp;&nbsp;&nbsp; 44269 |
| Net assets at end of year | $729328 | $4158682 | $12653642 | $18706072 | $104600 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | 108794 | &nbsp;&nbsp;&nbsp;&nbsp; 692592 | &nbsp;&nbsp;&nbsp; 3730062 | &nbsp;&nbsp;&nbsp; 2986091 | &nbsp;&nbsp;&nbsp; 37692 |
| Units purchased | &nbsp;&nbsp;&nbsp;&nbsp; 6793 | &nbsp;&nbsp;&nbsp;&nbsp; 82089 | &nbsp;&nbsp;&nbsp; 1266194 | &nbsp;&nbsp;&nbsp;&nbsp; 534824 | &nbsp;&nbsp;&nbsp; 53291 |
| Units redeemed | &nbsp;&nbsp;&nbsp; (8590) | &nbsp;&nbsp;&nbsp;&nbsp; (63796) | &nbsp;&nbsp;&nbsp;&nbsp; (280246) | &nbsp;&nbsp;&nbsp;&nbsp; (333439) | &nbsp;&nbsp;&nbsp; (7240) |
| Units outstanding at end of year | 106997 | &nbsp;&nbsp;&nbsp;&nbsp; 710885 | &nbsp;&nbsp;&nbsp; 4716010 | &nbsp;&nbsp;&nbsp; 3187476 | &nbsp;&nbsp;&nbsp; 83743 |

---

See accompanying notes to financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**64 ■ RiverSource of New York Account 8**

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **Col VP Limited** <br> **Duration Cr,** <br>**Cl 2**<br>| **Col VP Long** <br> **Govt/Cr Bond,** <br>**Cl 1**<br>| **Col VP Long** <br> **Govt/Cr Bond,** <br>**Cl 2**<br>| **Col VP** <br> **Overseas** <br> **Core,** <br>**Cl 1**<br>| **Col VP** <br> **Overseas** <br> **Core,** <br>**Cl 2**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $51522 | $3303 | $70 | $12543 | $3665 |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 750 | (1296) | (156) | &nbsp;&nbsp;&nbsp;&nbsp; 2519 | &nbsp;&nbsp;&nbsp;&nbsp; 3654 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp; (3481) | &nbsp;&nbsp;&nbsp;&nbsp; (337) | &nbsp;&nbsp;&nbsp; 143 | 216546 | &nbsp;&nbsp;&nbsp; 61416 |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp; 48791 | &nbsp;&nbsp;&nbsp; 1670 | &nbsp;&nbsp;&nbsp;&nbsp; 57 | 231608 | &nbsp;&nbsp;&nbsp; 68735 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp; 5136 | 10321 | &nbsp;&nbsp;&nbsp; 259 | 154775 | &nbsp;&nbsp;&nbsp;&nbsp; 7040 |
| Net transfers<sup>(1)</sup> <br>| &nbsp;&nbsp;&nbsp; 42766 | 15542 | &nbsp;&nbsp;&nbsp;&nbsp; — | 118179 | (18915) |
| Transfers for policy loans | (26903) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (120) |
| Policy charges | (18212) | (1468) | &nbsp;&nbsp;&nbsp; (31) | (43414) | &nbsp;&nbsp;&nbsp; (3525) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | &nbsp;&nbsp;&nbsp; (9675) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | (476) | &nbsp;&nbsp;&nbsp; (1580) | &nbsp;&nbsp;&nbsp;&nbsp; (110) |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | &nbsp;&nbsp;&nbsp; (6888) | 24395 | (248) | 227960 | (15630) |
| Increase (decrease) in net assets | &nbsp;&nbsp;&nbsp; 41903 | 26065 | (191) | 459568 | &nbsp;&nbsp;&nbsp; 53105 |
| Net assets at beginning of year | 882963 | 10416 | &nbsp;&nbsp;&nbsp; 717 | 527712 | 196503 |
| Net assets at end of year | $924866 | $36481 | $526 | $987280 | $249608 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | 795296 | 10579 | &nbsp;&nbsp;&nbsp; 638 | 384087 | 107729 |
| Units purchased | &nbsp;&nbsp;&nbsp; 82715 | 25730 | &nbsp;&nbsp;&nbsp; 224 | 162538 | &nbsp;&nbsp;&nbsp;&nbsp; 3438 |
| Units redeemed | (93833) | (1434) | (421) | (26913) | (11904) |
| Units outstanding at end of year | 784178 | 34875 | &nbsp;&nbsp;&nbsp; 441 | 519712 | &nbsp;&nbsp;&nbsp; 99263 |

---

See accompanying notes to financial statements.

**RiverSource of New York Account 8** ■ 65

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **Col VP** <br> **Overseas** <br> **Core,** <br>**Cl 3**<br>| **Col VP Sel Gbl** <br> **Tech,** <br>**Cl 1**<br>| **Col VP Sel Gbl** <br> **Tech,** <br>**Cl 2**<br>| **Col VP Select** <br> **Lg Cap Val,** <br>**Cl 1**<br>| **Col VP Select** <br> **Lg Cap Val,** <br>**Cl 2**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $52299 | $— | $— | $— | $— |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp; 172560 | &nbsp;&nbsp;&nbsp; 11375 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 80 | &nbsp;&nbsp;&nbsp;&nbsp; 20732 | &nbsp;&nbsp;&nbsp;&nbsp; 4797 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; 43289 | &nbsp;&nbsp;&nbsp; 16586 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | 1480929 | &nbsp;&nbsp;&nbsp; 91265 | &nbsp;&nbsp;&nbsp; 35803 | &nbsp;&nbsp;&nbsp;&nbsp; 272192 | &nbsp;&nbsp;&nbsp; 52636 |
| Net increase (decrease) in net assets resulting from operations | 1705788 | 145929 | &nbsp;&nbsp;&nbsp; 52469 | &nbsp;&nbsp;&nbsp;&nbsp; 292924 | &nbsp;&nbsp;&nbsp; 57433 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp; 181719 | 111444 | &nbsp;&nbsp;&nbsp;&nbsp; 3650 | &nbsp;&nbsp;&nbsp;&nbsp; 280033 | &nbsp;&nbsp;&nbsp; 12228 |
| Net transfers<sup>(1)</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp; 201042 | &nbsp;&nbsp;&nbsp; 27603 | &nbsp;&nbsp;&nbsp; 48918 | &nbsp;&nbsp;&nbsp;&nbsp; (1241) | &nbsp;&nbsp;&nbsp; (7050) |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5749 | (37239) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 20 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (903) | &nbsp;&nbsp;&nbsp; (2074) |
| Policy charges | &nbsp;&nbsp; (220801) | (37903) | &nbsp;&nbsp;&nbsp;&nbsp; (583) | &nbsp;&nbsp;&nbsp;&nbsp; (88728) | &nbsp;&nbsp;&nbsp; (5561) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | &nbsp;&nbsp; (291903) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (39) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (509) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | &nbsp;&nbsp; (124194) | &nbsp;&nbsp;&nbsp; 63866 | &nbsp;&nbsp;&nbsp; 52005 | &nbsp;&nbsp;&nbsp;&nbsp; 188652 | &nbsp;&nbsp;&nbsp; (2457) |
| Increase (decrease) in net assets | 1581594 | 209795 | 104474 | &nbsp;&nbsp;&nbsp;&nbsp; 481576 | &nbsp;&nbsp;&nbsp; 54976 |
| Net assets at beginning of year | 4623798 | 367861 | 102548 | &nbsp;&nbsp;&nbsp;&nbsp; 899340 | 204245 |
| Net assets at end of year | $6205392 | $577656 | $207022 | $1380916 | $259221 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | 3143782 | 231373 | &nbsp;&nbsp;&nbsp; 64936 | &nbsp;&nbsp;&nbsp;&nbsp; 506999 | &nbsp;&nbsp;&nbsp; 55434 |
| Units purchased | &nbsp;&nbsp;&nbsp;&nbsp; 243622 | &nbsp;&nbsp;&nbsp; 82030 | &nbsp;&nbsp;&nbsp; 32959 | &nbsp;&nbsp;&nbsp;&nbsp; 147663 | &nbsp;&nbsp;&nbsp;&nbsp; 3170 |
| Units redeemed | &nbsp;&nbsp; (313047) | (43734) | &nbsp;&nbsp;&nbsp;&nbsp; (335) | &nbsp;&nbsp;&nbsp;&nbsp; (47738) | &nbsp;&nbsp;&nbsp; (3627) |
| Units outstanding at end of year | 3074357 | 269669 | &nbsp;&nbsp;&nbsp; 97560 | &nbsp;&nbsp;&nbsp;&nbsp; 606924 | &nbsp;&nbsp;&nbsp; 54977 |

---

See accompanying notes to financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**66 ■ RiverSource of New York Account 8**

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **Col VP Select** <br> **Lg Cap Val,** <br>**Cl 3**<br>| **Col VP Select** <br> **Mid Cap Gro,** <br>**Cl 1**<br>| **Col VP Select** <br> **Mid Cap Gro,** <br>**Cl 2**<br>| **Col VP Select** <br> **Mid Cap Gro,** <br>**Cl 3**<br>| **Col VP Select** <br> **Mid Cap Val,** <br>**Cl 1**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $(3922) | $— | $— | $(6293) | $— |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp; 99401 | &nbsp;&nbsp;&nbsp;&nbsp; 2722 | &nbsp;&nbsp;&nbsp; 11673 | &nbsp;&nbsp;&nbsp;&nbsp; 135119 | &nbsp;&nbsp;&nbsp;&nbsp; 1794 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | 113140 | &nbsp;&nbsp;&nbsp; 84765 | &nbsp;&nbsp;&nbsp; 11042 | &nbsp;&nbsp;&nbsp;&nbsp; 45290 | &nbsp;&nbsp;&nbsp; 72895 |
| Net increase (decrease) in net assets resulting from operations | 208619 | &nbsp;&nbsp;&nbsp; 87487 | &nbsp;&nbsp;&nbsp; 22715 | &nbsp;&nbsp;&nbsp;&nbsp; 174116 | &nbsp;&nbsp;&nbsp; 74689 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp; 9282 | &nbsp;&nbsp;&nbsp; 78964 | &nbsp;&nbsp;&nbsp;&nbsp; 8606 | &nbsp;&nbsp;&nbsp;&nbsp; 21410 | 102278 |
| Net transfers<sup>(1)</sup> <br>| (41996) | &nbsp;&nbsp;&nbsp; 26754 | &nbsp;&nbsp;&nbsp; (6945) | &nbsp;&nbsp;&nbsp;&nbsp; 103658 | &nbsp;&nbsp;&nbsp; 17042 |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp; 47863 | &nbsp;&nbsp;&nbsp;&nbsp; (448) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 12291 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Policy charges | (18364) | (18996) | &nbsp;&nbsp;&nbsp; (1898) | &nbsp;&nbsp;&nbsp;&nbsp; (22153) | (32196) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | (34827) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (330) | &nbsp;&nbsp; (141872) | &nbsp;&nbsp;&nbsp;&nbsp; (249) |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | (38042) | &nbsp;&nbsp;&nbsp; 86274 | &nbsp;&nbsp;&nbsp;&nbsp; (567) | &nbsp;&nbsp;&nbsp;&nbsp; (26666) | &nbsp;&nbsp;&nbsp; 86875 |
| Increase (decrease) in net assets | 170577 | 173761 | &nbsp;&nbsp;&nbsp; 22148 | &nbsp;&nbsp;&nbsp;&nbsp; 147450 | 161564 |
| Net assets at beginning of year | 774146 | 523832 | 122265 | 1200223 | 465104 |
| Net assets at end of year | $944723 | $697593 | $144413 | $1347673 | $626668 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | 186370 | 266259 | &nbsp;&nbsp;&nbsp; 31170 | &nbsp;&nbsp;&nbsp;&nbsp; 295741 | 258911 |
| Units purchased | &nbsp;&nbsp;&nbsp; 85981 | &nbsp;&nbsp;&nbsp; 50827 | &nbsp;&nbsp;&nbsp;&nbsp; 2027 | &nbsp;&nbsp;&nbsp;&nbsp; 49007 | &nbsp;&nbsp;&nbsp; 64006 |
| Units redeemed | (36327) | &nbsp;&nbsp;&nbsp; (9125) | &nbsp;&nbsp;&nbsp; (1144) | &nbsp;&nbsp;&nbsp;&nbsp; (33986) | (17398) |
| Units outstanding at end of year | 236024 | 307961 | &nbsp;&nbsp;&nbsp; 32053 | &nbsp;&nbsp;&nbsp;&nbsp; 310762 | 305519 |

---

See accompanying notes to financial statements.

**RiverSource of New York Account 8** ■ 67

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **Col VP Select** <br> **Mid Cap Val,** <br>**Cl 2**<br>| **Col VP Select** <br> **Mid Cap Val,** <br>**Cl 3**<br>| **Col VP Select** <br> **Sm Cap Val,** <br>**Cl 1**<br>| **Col VP Select** <br> **Sm Cap Val,** <br>**Cl 2**<br>| **Col VP Select** <br> **Sm Cap Val,** <br>**Cl 3**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $— | $(4047) | $— | $— | $(5742) |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp; 3813 | &nbsp;&nbsp;&nbsp;&nbsp; 107007 | &nbsp;&nbsp;&nbsp;&nbsp; 1497 | &nbsp;&nbsp;&nbsp;&nbsp; 1109 | &nbsp;&nbsp;&nbsp;&nbsp; 130779 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp; 21491 | &nbsp;&nbsp;&nbsp;&nbsp; 31429 | &nbsp;&nbsp;&nbsp; 14277 | &nbsp;&nbsp;&nbsp; 11046 | &nbsp;&nbsp;&nbsp;&nbsp; (68239) |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp; 25304 | &nbsp;&nbsp;&nbsp;&nbsp; 134389 | &nbsp;&nbsp;&nbsp; 15774 | &nbsp;&nbsp;&nbsp; 12155 | &nbsp;&nbsp;&nbsp;&nbsp; 56798 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp; 5688 | &nbsp;&nbsp;&nbsp;&nbsp; 25933 | &nbsp;&nbsp;&nbsp; 68518 | &nbsp;&nbsp;&nbsp;&nbsp; 6751 | &nbsp;&nbsp;&nbsp;&nbsp; 26007 |
| Net transfers<sup>(1)</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp; 5515 | &nbsp;&nbsp;&nbsp;&nbsp; (28267) | &nbsp;&nbsp;&nbsp; 10684 | &nbsp;&nbsp;&nbsp; 11546 | &nbsp;&nbsp; (129295) |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp; (4145) | &nbsp;&nbsp;&nbsp;&nbsp; (19687) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 127 |
| Policy charges | &nbsp;&nbsp;&nbsp; (4243) | &nbsp;&nbsp;&nbsp;&nbsp; (23245) | (14138) | &nbsp;&nbsp;&nbsp; (4761) | &nbsp;&nbsp;&nbsp;&nbsp; (33422) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | &nbsp;&nbsp;&nbsp; (2186) | &nbsp;&nbsp;&nbsp;&nbsp; (7183) | &nbsp;&nbsp;&nbsp;&nbsp; (385) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (30527) |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 629 | &nbsp;&nbsp;&nbsp;&nbsp; (52449) | &nbsp;&nbsp;&nbsp; 64679 | &nbsp;&nbsp;&nbsp; 13536 | &nbsp;&nbsp; (167110) |
| Increase (decrease) in net assets | &nbsp;&nbsp;&nbsp; 25933 | &nbsp;&nbsp;&nbsp;&nbsp; 81940 | &nbsp;&nbsp;&nbsp; 80453 | &nbsp;&nbsp;&nbsp; 25691 | &nbsp;&nbsp; (110312) |
| Net assets at beginning of year | 178516 | &nbsp;&nbsp;&nbsp;&nbsp; 988743 | 166369 | 169828 | 1217309 |
| Net assets at end of year | $204449 | $1070683 | $246822 | $195519 | $1106997 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | &nbsp;&nbsp;&nbsp; 51264 | &nbsp;&nbsp;&nbsp;&nbsp; 285745 | 104737 | &nbsp;&nbsp;&nbsp; 53584 | &nbsp;&nbsp;&nbsp;&nbsp; 275450 |
| Units purchased | &nbsp;&nbsp;&nbsp;&nbsp; 3125 | &nbsp;&nbsp;&nbsp;&nbsp; 97591 | &nbsp;&nbsp;&nbsp; 50281 | &nbsp;&nbsp;&nbsp;&nbsp; 5973 | &nbsp;&nbsp;&nbsp;&nbsp; 65009 |
| Units redeemed | &nbsp;&nbsp;&nbsp; (2831) | &nbsp;&nbsp;&nbsp;&nbsp; (49830) | &nbsp;&nbsp;&nbsp; (9233) | &nbsp;&nbsp;&nbsp; (1523) | &nbsp;&nbsp;&nbsp;&nbsp; (56301) |
| Units outstanding at end of year | &nbsp;&nbsp;&nbsp; 51558 | &nbsp;&nbsp;&nbsp;&nbsp; 333506 | 145785 | &nbsp;&nbsp;&nbsp; 58034 | &nbsp;&nbsp;&nbsp;&nbsp; 284158 |

---

See accompanying notes to financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**68 ■ RiverSource of New York Account 8**

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **Col VP** <br> **Strategic Inc,** <br>**Cl 1**<br>| **Col VP** <br> **Strategic Inc,** <br>**Cl 2**<br>| **Col VP US** <br> **Govt Mtge,** <br>**Cl 1**<br>| **Col VP US** <br> **Govt Mtge,** <br>**Cl 2**<br>| **Col VP US** <br> **Govt Mtge,** <br>**Cl 3**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $10960 | $13313 | $585 | $305 | $18842 |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp; (220) | &nbsp;&nbsp;&nbsp;&nbsp; 1385 | &nbsp;&nbsp;&nbsp;&nbsp; (29) | &nbsp;&nbsp;&nbsp;&nbsp; (201) | &nbsp;&nbsp;&nbsp;&nbsp; (27642) |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp;&nbsp; 5128 | &nbsp;&nbsp;&nbsp;&nbsp; 6478 | &nbsp;&nbsp;&nbsp; 1604 | &nbsp;&nbsp;&nbsp; 1330 | &nbsp;&nbsp;&nbsp;&nbsp; 106656 |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp; 15868 | &nbsp;&nbsp;&nbsp; 21176 | &nbsp;&nbsp;&nbsp; 2160 | &nbsp;&nbsp;&nbsp; 1434 | &nbsp;&nbsp;&nbsp;&nbsp; 97856 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp; 44078 | &nbsp;&nbsp;&nbsp; 37060 | &nbsp;&nbsp;&nbsp; 4418 | &nbsp;&nbsp;&nbsp;&nbsp; 306 | &nbsp;&nbsp;&nbsp;&nbsp; 53282 |
| Net transfers<sup>(1)</sup> <br>| &nbsp;&nbsp;&nbsp; 19658 | &nbsp;&nbsp;&nbsp; 16473 | &nbsp;&nbsp;&nbsp;&nbsp; 501 | (4189) | &nbsp;&nbsp;&nbsp;&nbsp; (22024) |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp;&nbsp; (253) | &nbsp;&nbsp;&nbsp; (6037) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (7083) |
| Policy charges | (15848) | (80760) | (2096) | &nbsp;&nbsp;&nbsp;&nbsp; (955) | &nbsp;&nbsp;&nbsp;&nbsp; (60268) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (8693) |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | &nbsp;&nbsp;&nbsp; 47635 | (33264) | &nbsp;&nbsp;&nbsp; 2823 | (4838) | &nbsp;&nbsp;&nbsp;&nbsp; (44786) |
| Increase (decrease) in net assets | &nbsp;&nbsp;&nbsp; 63503 | (12088) | &nbsp;&nbsp;&nbsp; 4983 | (3404) | &nbsp;&nbsp;&nbsp;&nbsp; 53070 |
| Net assets at beginning of year | 203851 | 283993 | 21954 | 18922 | 1184019 |
| Net assets at end of year | $267354 | $271905 | $26937 | $15518 | $1237089 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | 171794 | 199307 | 21645 | 16665 | &nbsp;&nbsp;&nbsp;&nbsp; 974870 |
| Units purchased | &nbsp;&nbsp;&nbsp; 51196 | &nbsp;&nbsp;&nbsp; 37576 | &nbsp;&nbsp;&nbsp; 4652 | &nbsp;&nbsp;&nbsp;&nbsp; 259 | &nbsp;&nbsp;&nbsp;&nbsp; 169431 |
| Units redeemed | (13049) | (58815) | (1975) | (4366) | &nbsp;&nbsp; (197669) |
| Units outstanding at end of year | 209941 | 178068 | 24322 | 12558 | &nbsp;&nbsp;&nbsp;&nbsp; 946632 |

---

See accompanying notes to financial statements.

**RiverSource of New York Account 8** ■ 69

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **CS Commodity** <br> **Return,** <br>**Cl 1**<br>| **CTIVP AC Div** <br> **Bond,** <br>**Cl 1**<br>| **CTIVP AC Div** <br> **Bond,** <br>**Cl 2**<br>| **CTIVP BR Gl** <br> **Infl Prot Sec,** <br>**Cl 1**<br>| **CTIVP BR Gl** <br> **Infl Prot Sec,** <br>**Cl 2**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $14117 | $1459 | $773 | $1883 | $707 |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp; (8319) | &nbsp;&nbsp;&nbsp;&nbsp; (313) | &nbsp;&nbsp;&nbsp;&nbsp; (140) | (1991) | &nbsp;&nbsp;&nbsp;&nbsp; (25) |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp; 48528 | &nbsp;&nbsp;&nbsp; 1899 | &nbsp;&nbsp;&nbsp; 1175 | &nbsp;&nbsp;&nbsp; 2165 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 68 |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp; 54326 | &nbsp;&nbsp;&nbsp; 3045 | &nbsp;&nbsp;&nbsp; 1808 | &nbsp;&nbsp;&nbsp; 2057 | &nbsp;&nbsp;&nbsp;&nbsp; 750 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp; 13319 | 12997 | &nbsp;&nbsp;&nbsp; 1320 | &nbsp;&nbsp;&nbsp; 7715 | &nbsp;&nbsp;&nbsp; 2726 |
| Net transfers<sup>(1)</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp; 4965 | &nbsp;&nbsp;&nbsp; 4788 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 12 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp; (1480) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 551 | (5606) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Policy charges | &nbsp;&nbsp;&nbsp; (8072) | (1991) | (1264) | (2824) | &nbsp;&nbsp;&nbsp;&nbsp; (529) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | &nbsp;&nbsp;&nbsp; (3692) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (30) |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | &nbsp;&nbsp;&nbsp;&nbsp; 5040 | 15794 | &nbsp;&nbsp;&nbsp;&nbsp; 607 | &nbsp;&nbsp;&nbsp;&nbsp; (703) | &nbsp;&nbsp;&nbsp; 2167 |
| Increase (decrease) in net assets | &nbsp;&nbsp;&nbsp; 59366 | 18839 | &nbsp;&nbsp;&nbsp; 2415 | &nbsp;&nbsp;&nbsp; 1354 | &nbsp;&nbsp;&nbsp; 2917 |
| Net assets at beginning of year | 363733 | 29756 | 24391 | 47976 | 18696 |
| Net assets at end of year | $423099 | $48595 | $26806 | $49330 | $21613 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | 415316 | 27933 | 20694 | 46547 | 15984 |
| Units purchased | &nbsp;&nbsp;&nbsp; 38593 | 16311 | &nbsp;&nbsp;&nbsp; 1547 | &nbsp;&nbsp;&nbsp; 7354 | &nbsp;&nbsp;&nbsp; 2280 |
| Units redeemed | (31766) | (1800) | (1034) | (7981) | &nbsp;&nbsp;&nbsp;&nbsp; (469) |
| Units outstanding at end of year | 422143 | 42444 | 21207 | 45920 | 17795 |

---

See accompanying notes to financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**70 ■ RiverSource of New York Account 8**

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **CTIVP BR Gl** <br> **Infl Prot Sec,** <br>**Cl 3**<br>| **CTIVP** <br> **CenterSquare** <br> **Real Est,** <br>**Cl 1**<br>| **CTIVP** <br> **CenterSquare** <br> **Real Est,** <br>**Cl 2**<br>| **CTIVP Prin Lg** <br> **Cap Gro,** <br>**Cl 1**<br>| **CTIVP Prin Lg** <br> **Cap Gro,** <br>**Cl 2**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $15116 | $2445 | $5365 | $— | $— |
| Net realized gain (loss) on sales of investments | (30924) | &nbsp;&nbsp;&nbsp;&nbsp; (261) | &nbsp;&nbsp;&nbsp; (4028) | &nbsp;&nbsp;&nbsp;&nbsp; 1545 | &nbsp;&nbsp;&nbsp;&nbsp; 5083 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; 4446 | &nbsp;&nbsp;&nbsp; 10651 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp; 32565 | (4734) | &nbsp;&nbsp;&nbsp; (7746) | &nbsp;&nbsp;&nbsp; 24164 | &nbsp;&nbsp;&nbsp;&nbsp; 8434 |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp; 16757 | &nbsp;&nbsp;&nbsp; 1896 | &nbsp;&nbsp;&nbsp;&nbsp; 4242 | &nbsp;&nbsp;&nbsp; 25709 | &nbsp;&nbsp;&nbsp; 13517 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp; 24886 | 12745 | &nbsp;&nbsp;&nbsp; 11379 | &nbsp;&nbsp;&nbsp; 31705 | &nbsp;&nbsp;&nbsp;&nbsp; 6350 |
| Net transfers<sup>(1)</sup> <br>| (11119) | &nbsp;&nbsp;&nbsp;&nbsp; (828) | &nbsp;&nbsp;&nbsp; (4581) | &nbsp;&nbsp;&nbsp; 14161 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp;&nbsp; 1580 | (1633) | &nbsp;&nbsp;&nbsp; (9036) | &nbsp;&nbsp;&nbsp;&nbsp; (448) | &nbsp;&nbsp;&nbsp; (8577) |
| Policy charges | (32361) | (3072) | &nbsp;&nbsp;&nbsp; (6516) | (11799) | &nbsp;&nbsp;&nbsp; (4036) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | (29251) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; (2952) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; (3309) |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | (46265) | &nbsp;&nbsp;&nbsp; 7212 | (11706) | &nbsp;&nbsp;&nbsp; 33619 | &nbsp;&nbsp;&nbsp; (9572) |
| Increase (decrease) in net assets | (29508) | &nbsp;&nbsp;&nbsp; 9108 | &nbsp;&nbsp;&nbsp; (7464) | &nbsp;&nbsp;&nbsp; 59328 | &nbsp;&nbsp;&nbsp;&nbsp; 3945 |
| Net assets at beginning of year | 517698 | 80823 | 207575 | 165077 | 116623 |
| Net assets at end of year | $488190 | $89931 | $200111 | $224405 | $120568 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | 385099 | 56675 | 101951 | &nbsp;&nbsp;&nbsp; 73703 | &nbsp;&nbsp;&nbsp; 22022 |
| Units purchased | &nbsp;&nbsp;&nbsp; 50344 | &nbsp;&nbsp;&nbsp; 8857 | &nbsp;&nbsp;&nbsp;&nbsp; 5538 | &nbsp;&nbsp;&nbsp; 19458 | &nbsp;&nbsp;&nbsp;&nbsp; 1111 |
| Units redeemed | (76519) | (3823) | (11233) | &nbsp;&nbsp;&nbsp; (5100) | &nbsp;&nbsp;&nbsp; (3072) |
| Units outstanding at end of year | 358924 | 61709 | &nbsp;&nbsp;&nbsp; 96256 | &nbsp;&nbsp;&nbsp; 88061 | &nbsp;&nbsp;&nbsp; 20061 |

---

See accompanying notes to financial statements.

**RiverSource of New York Account 8** ■ 71

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **CTIVP T Rowe** <br> **Price LgCap** <br> **Val,** <br>**Cl 1**<br>| **CTIVP T Rowe** <br> **Price LgCap** <br> **Val,** <br>**Cl 2**<br>| **CTIVP TCW** <br> **Core Plus** <br> **Bond,** <br>**Cl 1**<br>| **CTIVP TCW** <br> **Core Plus** <br> **Bond,** <br>**Cl 2**<br>| **CTIVP Vty** <br> **Sycamore Estb** <br> **Val,** <br>**Cl 1**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $— | $— | $4102 | $1975 | $— |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp; 5054 | &nbsp;&nbsp;&nbsp;&nbsp; 1349 | &nbsp;&nbsp;&nbsp;&nbsp; (311) | &nbsp;&nbsp;&nbsp;&nbsp; (65) | &nbsp;&nbsp;&nbsp;&nbsp; 9271 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp; 31402 | &nbsp;&nbsp;&nbsp; 17676 | &nbsp;&nbsp;&nbsp; 2478 | &nbsp;&nbsp;&nbsp; 1111 | &nbsp;&nbsp;&nbsp; 11051 |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp; 36456 | &nbsp;&nbsp;&nbsp; 19025 | &nbsp;&nbsp;&nbsp; 6269 | &nbsp;&nbsp;&nbsp; 3021 | &nbsp;&nbsp;&nbsp; 20322 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp; 78188 | &nbsp;&nbsp;&nbsp;&nbsp; 6465 | &nbsp;&nbsp;&nbsp; 8588 | &nbsp;&nbsp;&nbsp;&nbsp; 647 | 171759 |
| Net transfers<sup>(1)</sup> <br>| &nbsp;&nbsp;&nbsp; 37174 | &nbsp;&nbsp;&nbsp;&nbsp; 5355 | &nbsp;&nbsp;&nbsp;&nbsp; (289) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; 11277 |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 651 | &nbsp;&nbsp;&nbsp;&nbsp; (165) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | (16859) |
| Policy charges | (23587) | &nbsp;&nbsp;&nbsp; (1723) | (5623) | (1315) | (36026) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | &nbsp;&nbsp;&nbsp;&nbsp; (534) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (221) |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | &nbsp;&nbsp;&nbsp; 91892 | &nbsp;&nbsp;&nbsp;&nbsp; 9932 | &nbsp;&nbsp;&nbsp; 2676 | &nbsp;&nbsp;&nbsp;&nbsp; (668) | 129930 |
| Increase (decrease) in net assets | 128348 | &nbsp;&nbsp;&nbsp; 28957 | &nbsp;&nbsp;&nbsp; 8945 | &nbsp;&nbsp;&nbsp; 2353 | 150252 |
| Net assets at beginning of year | 229224 | 150027 | 83356 | 42424 | 757846 |
| Net assets at end of year | $357572 | $178984 | $92301 | $44777 | $908098 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | 133695 | &nbsp;&nbsp;&nbsp; 53322 | 78699 | 37292 | 400633 |
| Units purchased | &nbsp;&nbsp;&nbsp; 65369 | &nbsp;&nbsp;&nbsp;&nbsp; 4053 | &nbsp;&nbsp;&nbsp; 7703 | &nbsp;&nbsp;&nbsp;&nbsp; 546 | &nbsp;&nbsp;&nbsp; 96621 |
| Units redeemed | (13514) | &nbsp;&nbsp;&nbsp;&nbsp; (638) | (5371) | (1118) | (27823) |
| Units outstanding at end of year | 185550 | &nbsp;&nbsp;&nbsp; 56737 | 81031 | 36720 | 469431 |

---

See accompanying notes to financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**72 ■ RiverSource of New York Account 8**

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **CTIVP Vty** <br> **Sycamore Estb** <br> **Val,** <br>**Cl 2**<br>| **CTIVP Vty** <br> **Sycamore Estb** <br> **Val,** <br>**Cl 3**<br>| **CTIVP** <br> **Wellington Lg** <br> **Cap Val,** <br>**Cl 1**<br>| **CTIVP** <br> **Wellington Lg** <br> **Cap Val,** <br>**Cl 2**<br>| **CTIVP** <br> **Westfield Mid** <br> **Cap Gro,** <br>**Cl 1**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $— | $(6453) | $— | $— | $— |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp; 53675 | &nbsp;&nbsp;&nbsp;&nbsp; 76809 | &nbsp;&nbsp;&nbsp;&nbsp; 4888 | &nbsp;&nbsp;&nbsp; 11463 | &nbsp;&nbsp;&nbsp;&nbsp; 7007 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | (44498) | &nbsp;&nbsp;&nbsp;&nbsp; (41005) | 120892 | &nbsp;&nbsp;&nbsp; 47818 | &nbsp;&nbsp;&nbsp;&nbsp; 9279 |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp;&nbsp; 9177 | &nbsp;&nbsp;&nbsp;&nbsp; 29351 | 125780 | &nbsp;&nbsp;&nbsp; 59281 | &nbsp;&nbsp;&nbsp; 16286 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp; 34448 | &nbsp;&nbsp;&nbsp;&nbsp; 15986 | 131384 | &nbsp;&nbsp;&nbsp; 13620 | &nbsp;&nbsp;&nbsp; 45580 |
| Net transfers<sup>(1)</sup> <br>| (98402) | &nbsp;&nbsp;&nbsp;&nbsp; 301581 | 131902 | &nbsp;&nbsp;&nbsp;&nbsp; 6491 | (15768) |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1 | &nbsp;&nbsp;&nbsp;&nbsp; 37127 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (140) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 806 |
| Policy charges | (12147) | &nbsp;&nbsp;&nbsp;&nbsp; (13902) | (48902) | &nbsp;&nbsp;&nbsp; (5929) | &nbsp;&nbsp;&nbsp; (7866) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | &nbsp;&nbsp;&nbsp;&nbsp; (334) | &nbsp;&nbsp; (109868) | &nbsp;&nbsp;&nbsp;&nbsp; (966) | &nbsp;&nbsp;&nbsp;&nbsp; (725) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | (76434) | &nbsp;&nbsp;&nbsp;&nbsp; 230924 | 213418 | &nbsp;&nbsp;&nbsp; 13317 | &nbsp;&nbsp;&nbsp; 22752 |
| Increase (decrease) in net assets | (67257) | &nbsp;&nbsp;&nbsp;&nbsp; 260275 | 339198 | &nbsp;&nbsp;&nbsp; 72598 | &nbsp;&nbsp;&nbsp; 39038 |
| Net assets at beginning of year | 548799 | 1112696 | 533567 | 285727 | 120981 |
| Net assets at end of year | $481542 | $1372971 | $872765 | $358325 | $160019 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | 135268 | &nbsp;&nbsp;&nbsp;&nbsp; 221544 | 312584 | &nbsp;&nbsp;&nbsp; 86525 | &nbsp;&nbsp;&nbsp; 61424 |
| Units purchased | &nbsp;&nbsp;&nbsp;&nbsp; 8485 | &nbsp;&nbsp;&nbsp;&nbsp; 118766 | 140783 | &nbsp;&nbsp;&nbsp;&nbsp; 6119 | &nbsp;&nbsp;&nbsp; 22743 |
| Units redeemed | (27391) | &nbsp;&nbsp;&nbsp;&nbsp; (33169) | (26987) | &nbsp;&nbsp;&nbsp; (1924) | (10572) |
| Units outstanding at end of year | 116362 | &nbsp;&nbsp;&nbsp;&nbsp; 307141 | 426380 | &nbsp;&nbsp;&nbsp; 90720 | &nbsp;&nbsp;&nbsp; 73595 |

---

See accompanying notes to financial statements.

**RiverSource of New York Account 8** ■ 73

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **CTIVP** <br> **Westfield Mid** <br> **Cap Gro,** <br>**Cl 2**<br>| **CTIVP** <br> **Westfield Sel** <br> **Lg Cp Gr,** <br>**Cl 1**<br>| **CTIVP** <br> **Westfield Sel** <br> **Lg Cp Gr,** <br>**Cl 2**<br>| **CVT EAFE Intl** <br> **Index,** <br>**Cl F**<br>| **CVT EAFE Intl** <br> **Index,** <br>**Cl I**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $— | $— | $— | $440 | $7400 |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp; 8277 | &nbsp;&nbsp;&nbsp;&nbsp; 1696 | &nbsp;&nbsp;&nbsp;&nbsp; 853 | &nbsp;&nbsp;&nbsp;&nbsp; 394 | &nbsp;&nbsp;&nbsp;&nbsp; 5944 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp; (3787) | &nbsp;&nbsp;&nbsp; 38118 | 10991 | &nbsp;&nbsp;&nbsp; 3906 | &nbsp;&nbsp;&nbsp; 56684 |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp;&nbsp; 4490 | &nbsp;&nbsp;&nbsp; 39814 | 11844 | &nbsp;&nbsp;&nbsp; 4740 | &nbsp;&nbsp;&nbsp; 70028 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp; 3121 | &nbsp;&nbsp;&nbsp; 20095 | &nbsp;&nbsp;&nbsp; 4738 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | 133983 |
| Net transfers<sup>(1)</sup> <br>| (29430) | &nbsp;&nbsp;&nbsp;&nbsp; 3124 | &nbsp;&nbsp;&nbsp;&nbsp; (888) | (2465) | 131339 |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 6 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | (1389) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Policy charges | &nbsp;&nbsp;&nbsp;&nbsp; (501) | &nbsp;&nbsp;&nbsp; (8715) | (2597) | (1937) | (20150) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | &nbsp;&nbsp;&nbsp; (1213) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (216) |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | (28017) | &nbsp;&nbsp;&nbsp; 14504 | &nbsp;&nbsp;&nbsp;&nbsp; (136) | (4402) | 244956 |
| Increase (decrease) in net assets | (23527) | &nbsp;&nbsp;&nbsp; 54318 | 11708 | &nbsp;&nbsp;&nbsp;&nbsp; 338 | 314984 |
| Net assets at beginning of year | &nbsp;&nbsp;&nbsp; 90162 | 215499 | 67471 | 18261 | 169263 |
| Net assets at end of year | $66635 | $269817 | $79179 | $18599 | $484247 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | &nbsp;&nbsp;&nbsp; 23850 | 116506 | 15818 | 15401 | 142007 |
| Units purchased | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 804 | &nbsp;&nbsp;&nbsp; 12350 | &nbsp;&nbsp;&nbsp; 1175 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | 182629 |
| Units redeemed | &nbsp;&nbsp;&nbsp; (8648) | &nbsp;&nbsp;&nbsp; (4466) | (1125) | (3394) | (14274) |
| Units outstanding at end of year | &nbsp;&nbsp;&nbsp; 16006 | 124390 | 15868 | 12007 | 310362 |

---

See accompanying notes to financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**74 ■ RiverSource of New York Account 8**

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **CVT Nasdaq** <br> **100 Index,** <br>**Cl F**<br>| **CVT Nasdaq** <br> **100 Index,** <br>**Cl I**<br>| **CVT Russ 2000** <br> **Sm Cap Ind,** <br>**Cl F**<br>| **CVT Russ 2000** <br> **Sm Cap Ind,** <br>**Cl I**<br>| **DWS Alt Asset** <br> **Alloc VIP,** <br>**Cl A**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $263 | $1556 | $291 | $1978 | $6833 |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp; 2178 | &nbsp;&nbsp;&nbsp;&nbsp; 3106 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 77 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 680 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 308 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp; 1542 | &nbsp;&nbsp;&nbsp;&nbsp; 9131 | &nbsp;&nbsp;&nbsp;&nbsp; 947 | &nbsp;&nbsp;&nbsp;&nbsp; 6435 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | 12249 | &nbsp;&nbsp;&nbsp; 87968 | &nbsp;&nbsp;&nbsp;&nbsp; 844 | &nbsp;&nbsp;&nbsp;&nbsp; 7090 | &nbsp;&nbsp;&nbsp; 10582 |
| Net increase (decrease) in net assets resulting from operations | 16232 | 101761 | &nbsp;&nbsp;&nbsp; 2159 | &nbsp;&nbsp;&nbsp; 16183 | &nbsp;&nbsp;&nbsp; 17723 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | 14425 | 234792 | &nbsp;&nbsp;&nbsp; 3146 | 109605 | &nbsp;&nbsp;&nbsp; 48189 |
| Net transfers<sup>(1)</sup> <br>| &nbsp;&nbsp;&nbsp; 5586 | &nbsp;&nbsp;&nbsp; 52005 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; 68005 | &nbsp;&nbsp;&nbsp; 67159 |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 20 | &nbsp;&nbsp;&nbsp; (1229) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (858) |
| Policy charges | (2712) | (52974) | (1817) | (16597) | (10380) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (114) |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | 17319 | 232594 | &nbsp;&nbsp;&nbsp; 1329 | 161013 | 103996 |
| Increase (decrease) in net assets | 33551 | 334355 | &nbsp;&nbsp;&nbsp; 3488 | 177196 | 121719 |
| Net assets at beginning of year | 65957 | 360945 | 16721 | &nbsp;&nbsp;&nbsp; 86606 | 135029 |
| Net assets at end of year | $99508 | $695300 | $20209 | $263802 | $256748 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | 40194 | 218493 | 13588 | &nbsp;&nbsp;&nbsp; 70000 | 101885 |
| Units purchased | 11847 | 161822 | &nbsp;&nbsp;&nbsp; 2511 | 132808 | &nbsp;&nbsp;&nbsp; 81540 |
| Units redeemed | (1550) | (30720) | (1466) | (13201) | &nbsp;&nbsp;&nbsp; (8101) |
| Units outstanding at end of year | 50491 | 349595 | 14633 | 189607 | 175324 |

---

See accompanying notes to financial statements.

**RiverSource of New York Account 8** ■ 75

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **DWS Alt Asset** <br> **Alloc VIP,** <br>**Cl B**<br>| **EV VT** <br> **Floating-Rate** <br> **Inc, Init Cl**<br>| **EV VT** <br> **Floating-Rate** <br> **Inc, Inst Cl**<sup>(2)</sup> <br>| **Fid VIP** <br> **Contrafund,** <br> **Init Cl**<br>| **Fid VIP** <br> **Contrafund,** <br>**Serv Cl 2**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $11945 | $84489 | $461 | $4099 | $(40688) |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 818 | &nbsp;&nbsp;&nbsp;&nbsp; (20442) | &nbsp;&nbsp;&nbsp;&nbsp; (3) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 9543 | &nbsp;&nbsp;&nbsp;&nbsp; 215284 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 448457 | 1515934 |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp; 21580 | &nbsp;&nbsp;&nbsp;&nbsp; (18428) | &nbsp;&nbsp; (207) | &nbsp;&nbsp;&nbsp;&nbsp; 56370 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 6134 |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp; 34343 | &nbsp;&nbsp;&nbsp;&nbsp; 45619 | &nbsp;&nbsp;&nbsp;&nbsp; 251 | &nbsp;&nbsp;&nbsp;&nbsp; 518469 | 1696664 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp; 13426 | &nbsp;&nbsp;&nbsp;&nbsp; 16788 | &nbsp;&nbsp;&nbsp;&nbsp; 546 | &nbsp;&nbsp;&nbsp;&nbsp; 603665 | &nbsp;&nbsp;&nbsp;&nbsp; 256998 |
| Net transfers<sup>(1)</sup> <br>| &nbsp;&nbsp;&nbsp; 77838 | &nbsp;&nbsp; (125599) | &nbsp;&nbsp;&nbsp;&nbsp; 40 | &nbsp;&nbsp;&nbsp;&nbsp; 206480 | &nbsp;&nbsp;&nbsp;&nbsp; 262772 |
| Transfers for policy loans | (16345) | &nbsp;&nbsp;&nbsp;&nbsp; (45926) | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (18327) | &nbsp;&nbsp;&nbsp;&nbsp; 153743 |
| Policy charges | &nbsp;&nbsp;&nbsp; (9751) | &nbsp;&nbsp;&nbsp;&nbsp; (27715) | &nbsp;&nbsp; (314) | &nbsp;&nbsp; (131854) | &nbsp;&nbsp; (204856) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | (10085) | &nbsp;&nbsp;&nbsp;&nbsp; (36596) | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (15495) | &nbsp;&nbsp; (171548) |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | &nbsp;&nbsp;&nbsp; 55083 | &nbsp;&nbsp; (219048) | &nbsp;&nbsp;&nbsp;&nbsp; 272 | &nbsp;&nbsp;&nbsp;&nbsp; 644469 | &nbsp;&nbsp;&nbsp;&nbsp; 297109 |
| Increase (decrease) in net assets | &nbsp;&nbsp;&nbsp; 89426 | &nbsp;&nbsp; (173429) | &nbsp;&nbsp;&nbsp;&nbsp; 523 | 1162938 | 1993773 |
| Net assets at beginning of year | 308271 | 1455720 | 6126 | 2012247 | 7879819 |
| Net assets at end of year | $397697 | $1282291 | $6649 | $3175185 | $9873592 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | 228440 | &nbsp;&nbsp;&nbsp;&nbsp; 888922 | 3673 | &nbsp;&nbsp;&nbsp;&nbsp; 785153 | 1384664 |
| Units purchased | &nbsp;&nbsp;&nbsp; 70790 | &nbsp;&nbsp;&nbsp;&nbsp; 74759 | &nbsp;&nbsp;&nbsp;&nbsp; 507 | &nbsp;&nbsp;&nbsp;&nbsp; 294371 | &nbsp;&nbsp;&nbsp;&nbsp; 357287 |
| Units redeemed | (25457) | &nbsp;&nbsp; (181643) | &nbsp;&nbsp; (285) | &nbsp;&nbsp;&nbsp;&nbsp; (59676) | &nbsp;&nbsp; (133853) |
| Units outstanding at end of year | 273773 | &nbsp;&nbsp;&nbsp;&nbsp; 782038 | 3895 | 1019848 | 1608098 |

---

See accompanying notes to financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**76 ■ RiverSource of New York Account 8**

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **Fid VIP Emer** <br> **Mkts, Init Cl**<br>| **Fid VIP** <br> **Energy, Init Cl**<br>| **Fid VIP Gro &** <br> **Inc,** <br>**Serv Cl**<br>| **Fid VIP Gro &** <br> **Inc,** <br>**Serv Cl 2**<br>| **Fid VIP Gro** <br> **Opp, Init Cl**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $953 | $53 | $46080 | $28709 | $— |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp; 1176 | &nbsp;&nbsp;&nbsp;&nbsp; (30) | &nbsp;&nbsp;&nbsp;&nbsp; 202600 | &nbsp;&nbsp;&nbsp;&nbsp; 198305 | &nbsp;&nbsp;&nbsp;&nbsp; (221) |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp; 367 | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 527382 | &nbsp;&nbsp;&nbsp;&nbsp; 271539 | &nbsp;&nbsp;&nbsp;&nbsp; 1340 |
| Net change in unrealized appreciation (depreciation) of investments | 13212 | &nbsp;&nbsp;&nbsp;&nbsp; 169 | &nbsp;&nbsp;&nbsp;&nbsp; 260018 | &nbsp;&nbsp;&nbsp;&nbsp; 23816 | &nbsp;&nbsp;&nbsp; 14725 |
| Net increase (decrease) in net assets resulting from operations | 15708 | &nbsp;&nbsp;&nbsp;&nbsp; 192 | 1036080 | &nbsp;&nbsp;&nbsp;&nbsp; 522369 | &nbsp;&nbsp;&nbsp; 15844 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | 36813 | 1496 | &nbsp;&nbsp;&nbsp;&nbsp; 100954 | &nbsp;&nbsp;&nbsp;&nbsp; 49296 | &nbsp;&nbsp;&nbsp;&nbsp; 9860 |
| Net transfers<sup>(1)</sup> <br>| &nbsp;&nbsp;&nbsp; 3581 | &nbsp;&nbsp;&nbsp;&nbsp; 36 | &nbsp;&nbsp;&nbsp;&nbsp; (16043) | &nbsp;&nbsp;&nbsp;&nbsp; 171189 | (28195) |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 91723 | &nbsp;&nbsp;&nbsp;&nbsp; (62537) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Policy charges | (1337) | &nbsp;&nbsp;&nbsp;&nbsp; (95) | &nbsp;&nbsp; (178509) | &nbsp;&nbsp;&nbsp;&nbsp; (54894) | &nbsp;&nbsp;&nbsp;&nbsp; (797) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | &nbsp;&nbsp;&nbsp;&nbsp; (96) | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp; (305745) | &nbsp;&nbsp;&nbsp;&nbsp; (51970) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | 38961 | 1437 | &nbsp;&nbsp; (307620) | &nbsp;&nbsp;&nbsp;&nbsp; 51084 | (19132) |
| Increase (decrease) in net assets | 54669 | 1629 | &nbsp;&nbsp;&nbsp;&nbsp; 728460 | &nbsp;&nbsp;&nbsp;&nbsp; 573453 | &nbsp;&nbsp;&nbsp; (3288) |
| Net assets at beginning of year | &nbsp;&nbsp;&nbsp; 3298 | 1231 | 5240442 | 2453023 | &nbsp;&nbsp;&nbsp; 98715 |
| Net assets at end of year | $57967 | $2860 | $5968902 | $3026476 | $95427 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | &nbsp;&nbsp;&nbsp; 2833 | 1061 | &nbsp;&nbsp;&nbsp;&nbsp; 855419 | &nbsp;&nbsp;&nbsp;&nbsp; 852975 | &nbsp;&nbsp;&nbsp; 71300 |
| Units purchased | 34367 | 1366 | &nbsp;&nbsp;&nbsp;&nbsp; 43578 | &nbsp;&nbsp;&nbsp;&nbsp; 234758 | &nbsp;&nbsp;&nbsp;&nbsp; 6588 |
| Units redeemed | &nbsp;&nbsp;&nbsp;&nbsp; (987) | &nbsp;&nbsp;&nbsp;&nbsp; (86) | &nbsp;&nbsp;&nbsp;&nbsp; (86184) | &nbsp;&nbsp; (174360) | (21369) |
| Units outstanding at end of year | 36213 | 2341 | &nbsp;&nbsp;&nbsp;&nbsp; 812813 | &nbsp;&nbsp;&nbsp;&nbsp; 913373 | &nbsp;&nbsp;&nbsp; 56519 |

---

See accompanying notes to financial statements.

**RiverSource of New York Account 8** ■ 77

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **Fid VIP Invest** <br> **Gr, Init Cl**<br>| **Fid VIP Mid** <br> **Cap, Init Cl**<br>| **Fid VIP Mid** <br> **Cap,** <br>**Serv Cl**<br>| **Fid VIP Mid** <br> **Cap,** <br>**Serv Cl 2**<br>| **Fid VIP** <br> **Overseas,** <br>**Serv Cl**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $1593 | $5421 | $(19347) | $(4594) | $15435 |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 15 | &nbsp;&nbsp;&nbsp;&nbsp; (18375) | &nbsp;&nbsp;&nbsp;&nbsp; 44042 | &nbsp;&nbsp;&nbsp;&nbsp; (22292) | &nbsp;&nbsp;&nbsp;&nbsp; 29057 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 123826 | &nbsp;&nbsp;&nbsp;&nbsp; 707850 | &nbsp;&nbsp;&nbsp;&nbsp; 703456 | &nbsp;&nbsp;&nbsp;&nbsp; 161537 |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp; 1325 | &nbsp;&nbsp;&nbsp;&nbsp; 37342 | &nbsp;&nbsp;&nbsp;&nbsp; (67996) | &nbsp;&nbsp;&nbsp;&nbsp; (30392) | &nbsp;&nbsp;&nbsp;&nbsp; 98772 |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp; 2933 | &nbsp;&nbsp;&nbsp;&nbsp; 148214 | &nbsp;&nbsp;&nbsp;&nbsp; 664549 | &nbsp;&nbsp;&nbsp;&nbsp; 646178 | &nbsp;&nbsp;&nbsp;&nbsp; 304801 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | 16417 | &nbsp;&nbsp;&nbsp;&nbsp; 340009 | &nbsp;&nbsp;&nbsp;&nbsp; 100739 | &nbsp;&nbsp;&nbsp;&nbsp; 125249 | &nbsp;&nbsp;&nbsp;&nbsp; 39313 |
| Net transfers<sup>(1)</sup> <br>| &nbsp;&nbsp;&nbsp; 3803 | &nbsp;&nbsp;&nbsp;&nbsp; 155184 | &nbsp;&nbsp;&nbsp;&nbsp; (42504) | &nbsp;&nbsp;&nbsp;&nbsp; 56972 | &nbsp;&nbsp;&nbsp;&nbsp; (7065) |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (7038) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1534 | &nbsp;&nbsp;&nbsp;&nbsp; (56317) | &nbsp;&nbsp;&nbsp;&nbsp; 21872 |
| Policy charges | (5305) | &nbsp;&nbsp;&nbsp;&nbsp; (65605) | &nbsp;&nbsp; (196339) | &nbsp;&nbsp; (103220) | &nbsp;&nbsp;&nbsp;&nbsp; (43037) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (5633) | &nbsp;&nbsp; (256360) | &nbsp;&nbsp;&nbsp;&nbsp; (95016) | &nbsp;&nbsp;&nbsp;&nbsp; (49764) |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (18343) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | 14915 | &nbsp;&nbsp;&nbsp;&nbsp; 416917 | &nbsp;&nbsp; (392930) | &nbsp;&nbsp;&nbsp;&nbsp; (90675) | &nbsp;&nbsp;&nbsp;&nbsp; (38681) |
| Increase (decrease) in net assets | 17848 | &nbsp;&nbsp;&nbsp;&nbsp; 565131 | &nbsp;&nbsp;&nbsp;&nbsp; 271619 | &nbsp;&nbsp;&nbsp;&nbsp; 555503 | &nbsp;&nbsp;&nbsp;&nbsp; 266120 |
| Net assets at beginning of year | 36743 | &nbsp;&nbsp;&nbsp;&nbsp; 869539 | 6222657 | 5802465 | 1589418 |
| Net assets at end of year | $54591 | $1434670 | $6494276 | $6357968 | $1855538 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | 36034 | &nbsp;&nbsp;&nbsp;&nbsp; 476008 | &nbsp;&nbsp;&nbsp;&nbsp; 915663 | 2223076 | &nbsp;&nbsp;&nbsp;&nbsp; 595510 |
| Units purchased | 18867 | &nbsp;&nbsp;&nbsp;&nbsp; 268636 | &nbsp;&nbsp;&nbsp;&nbsp; 21585 | &nbsp;&nbsp;&nbsp;&nbsp; 498124 | &nbsp;&nbsp;&nbsp;&nbsp; 18585 |
| Units redeemed | (4971) | &nbsp;&nbsp;&nbsp;&nbsp; (41869) | &nbsp;&nbsp;&nbsp;&nbsp; (75417) | &nbsp;&nbsp; (429290) | &nbsp;&nbsp;&nbsp;&nbsp; (33621) |
| Units outstanding at end of year | 49930 | &nbsp;&nbsp;&nbsp;&nbsp; 702775 | &nbsp;&nbsp;&nbsp;&nbsp; 861831 | 2291910 | &nbsp;&nbsp;&nbsp;&nbsp; 580474 |

---

See accompanying notes to financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**78 ■ RiverSource of New York Account 8**

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **Fid VIP** <br> **Overseas,** <br>**Serv Cl 2**<br>| **Fid VIP** <br> **Strategic Inc,** <br> **Init Cl**<br>| **Fid VIP** <br> **Strategic Inc,** <br>**Serv Cl 2**<br>| **Frank Global** <br> **Real Est,** <br>**Cl 2**<br>| **Frank Inc,** <br>**Cl 1**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $14034 | $25599 | $2077 | $16885 | $3603 |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp; 63177 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3421 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 74 | &nbsp;&nbsp;&nbsp;&nbsp; (40672) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 115 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp; 121771 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 721 |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp;&nbsp; 36156 | &nbsp;&nbsp;&nbsp;&nbsp; 23516 | &nbsp;&nbsp;&nbsp; 1828 | &nbsp;&nbsp;&nbsp;&nbsp; 155428 | &nbsp;&nbsp;&nbsp;&nbsp; 4783 |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp;&nbsp; 235138 | &nbsp;&nbsp;&nbsp;&nbsp; 52536 | &nbsp;&nbsp;&nbsp; 3979 | &nbsp;&nbsp;&nbsp;&nbsp; 131641 | &nbsp;&nbsp;&nbsp;&nbsp; 9222 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp; 29670 | &nbsp;&nbsp;&nbsp; 185821 | 21142 | &nbsp;&nbsp;&nbsp;&nbsp; 67536 | &nbsp;&nbsp;&nbsp; 56560 |
| Net transfers<sup>(1)</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp; (63757) | (216800) | 21991 | &nbsp;&nbsp;&nbsp;&nbsp; (50105) | &nbsp;&nbsp;&nbsp;&nbsp; 5251 |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (779) | &nbsp;&nbsp;&nbsp; (11856) | &nbsp;&nbsp;&nbsp;&nbsp; (232) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 9558 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Policy charges | &nbsp;&nbsp;&nbsp;&nbsp; (21265) | &nbsp;&nbsp;&nbsp; (42357) | (2245) | &nbsp;&nbsp;&nbsp;&nbsp; (62796) | &nbsp;&nbsp;&nbsp; (8884) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | &nbsp;&nbsp;&nbsp;&nbsp; (26815) | &nbsp;&nbsp;&nbsp;&nbsp; (2988) | &nbsp;&nbsp;&nbsp;&nbsp; (771) | &nbsp;&nbsp;&nbsp;&nbsp; (52984) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | &nbsp;&nbsp;&nbsp;&nbsp; (82946) | &nbsp;&nbsp;&nbsp; (88180) | 39885 | &nbsp;&nbsp;&nbsp;&nbsp; (88791) | &nbsp;&nbsp;&nbsp; 52927 |
| Increase (decrease) in net assets | &nbsp;&nbsp;&nbsp;&nbsp; 152192 | &nbsp;&nbsp;&nbsp; (35644) | 43864 | &nbsp;&nbsp;&nbsp;&nbsp; 42850 | &nbsp;&nbsp;&nbsp; 62149 |
| Net assets at beginning of year | 1237285 | &nbsp;&nbsp;&nbsp; 601820 | 23289 | 1802383 | &nbsp;&nbsp;&nbsp; 61370 |
| Net assets at end of year | $1389477 | $566176 | $67153 | $1845233 | $123519 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | &nbsp;&nbsp;&nbsp;&nbsp; 693170 | &nbsp;&nbsp;&nbsp; 492241 | 16021 | &nbsp;&nbsp;&nbsp;&nbsp; 835984 | &nbsp;&nbsp;&nbsp; 43489 |
| Units purchased | &nbsp;&nbsp;&nbsp;&nbsp; 91795 | &nbsp;&nbsp;&nbsp; 146811 | 28644 | &nbsp;&nbsp;&nbsp;&nbsp; 134387 | &nbsp;&nbsp;&nbsp; 39965 |
| Units redeemed | &nbsp;&nbsp; (126529) | (213607) | (2120) | &nbsp;&nbsp; (117436) | &nbsp;&nbsp;&nbsp; (5907) |
| Units outstanding at end of year | &nbsp;&nbsp;&nbsp;&nbsp; 658436 | &nbsp;&nbsp;&nbsp; 425445 | 42545 | &nbsp;&nbsp;&nbsp;&nbsp; 852935 | &nbsp;&nbsp;&nbsp; 77547 |

---

See accompanying notes to financial statements.

**RiverSource of New York Account 8** ■ 79

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **Frank Inc,** <br>**Cl 2**<br>| **Frank Mutual** <br> **Shares,** <br>**Cl 1**<br>| **Frank Mutual** <br> **Shares,** <br>**Cl 2**<br>| **Frank Sm Cap** <br> **Val,** <br>**Cl 1**<br>| **Frank Sm Cap** <br> **Val,** <br>**Cl 2**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $21686 | $815 | $30110 | $3492 | $18294 |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp; (815) | &nbsp;&nbsp;&nbsp;&nbsp; 119 | &nbsp;&nbsp;&nbsp;&nbsp; (34453) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 299 | &nbsp;&nbsp;&nbsp;&nbsp; (58041) |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp; 5098 | &nbsp;&nbsp;&nbsp; 3536 | &nbsp;&nbsp;&nbsp;&nbsp; 185784 | &nbsp;&nbsp;&nbsp; 21971 | &nbsp;&nbsp;&nbsp;&nbsp; 246722 |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp; 28193 | &nbsp;&nbsp;&nbsp;&nbsp; (714) | &nbsp;&nbsp;&nbsp;&nbsp; 12079 | &nbsp;&nbsp;&nbsp; (1051) | &nbsp;&nbsp;&nbsp;&nbsp; (1084) |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp; 54162 | &nbsp;&nbsp;&nbsp; 3756 | &nbsp;&nbsp;&nbsp;&nbsp; 193520 | &nbsp;&nbsp;&nbsp; 24711 | &nbsp;&nbsp;&nbsp;&nbsp; 205891 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp; 9348 | &nbsp;&nbsp;&nbsp; 6526 | &nbsp;&nbsp;&nbsp;&nbsp; 56894 | 111569 | &nbsp;&nbsp;&nbsp;&nbsp; 53331 |
| Net transfers<sup>(1)</sup> <br>| &nbsp;&nbsp;&nbsp; 28815 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 14328 | &nbsp;&nbsp;&nbsp;&nbsp; 7849 | &nbsp;&nbsp;&nbsp;&nbsp; (40773) |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp;&nbsp; 3997 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (12051) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (20050) |
| Policy charges | (16940) | (2704) | &nbsp;&nbsp;&nbsp;&nbsp; (37630) | (17181) | &nbsp;&nbsp;&nbsp;&nbsp; (58683) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | (48117) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (9548) | &nbsp;&nbsp;&nbsp; (1339) | &nbsp;&nbsp;&nbsp;&nbsp; (49492) |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | (22897) | &nbsp;&nbsp;&nbsp; 3822 | &nbsp;&nbsp;&nbsp;&nbsp; 11993 | 100898 | &nbsp;&nbsp; (115667) |
| Increase (decrease) in net assets | &nbsp;&nbsp;&nbsp; 31265 | &nbsp;&nbsp;&nbsp; 7578 | &nbsp;&nbsp;&nbsp;&nbsp; 205513 | 125609 | &nbsp;&nbsp;&nbsp;&nbsp; 90224 |
| Net assets at beginning of year | 478492 | 30565 | 1752176 | 247381 | 2972298 |
| Net assets at end of year | $509757 | $38143 | $1957689 | $372990 | $3062522 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | 313296 | 20534 | &nbsp;&nbsp;&nbsp;&nbsp; 576964 | 148955 | &nbsp;&nbsp;&nbsp;&nbsp; 707609 |
| Units purchased | &nbsp;&nbsp;&nbsp; 29066 | &nbsp;&nbsp;&nbsp; 4124 | &nbsp;&nbsp;&nbsp;&nbsp; 236240 | &nbsp;&nbsp;&nbsp; 70298 | &nbsp;&nbsp;&nbsp;&nbsp; 188524 |
| Units redeemed | (46940) | (1741) | &nbsp;&nbsp; (125769) | (11082) | &nbsp;&nbsp;&nbsp;&nbsp; (99821) |
| Units outstanding at end of year | 295422 | 22917 | &nbsp;&nbsp;&nbsp;&nbsp; 687435 | 208171 | &nbsp;&nbsp;&nbsp;&nbsp; 796312 |

---

See accompanying notes to financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**80 ■ RiverSource of New York Account 8**

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **GS VIT Mid** <br> **Cap Val, Inst**<br>| **GS VIT Sm Cap** <br> **Eq Insights,** <br> **Inst**<br>| **GS VIT U.S. Eq** <br> **Insights, Inst**<br>| **Invesco VI Am** <br> **Fran, Ser I**<br>| **Invesco VI Am** <br> **Fran, Ser II**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $44442 | $630 | $6908 | $(5190) | $(4648) |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp; 45650 | &nbsp;&nbsp;&nbsp;&nbsp; 3999 | &nbsp;&nbsp;&nbsp;&nbsp; 151517 | &nbsp;&nbsp;&nbsp; 33931 | &nbsp;&nbsp;&nbsp;&nbsp; 32587 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp; 681715 | &nbsp;&nbsp;&nbsp; 33849 | &nbsp;&nbsp;&nbsp;&nbsp; 411506 | &nbsp;&nbsp;&nbsp; 73992 | &nbsp;&nbsp;&nbsp;&nbsp; 126809 |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp; (239111) | &nbsp;&nbsp;&nbsp; 17456 | &nbsp;&nbsp; (120072) | (23239) | &nbsp;&nbsp;&nbsp;&nbsp; (31960) |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp;&nbsp; 532696 | &nbsp;&nbsp;&nbsp; 55934 | &nbsp;&nbsp;&nbsp;&nbsp; 449859 | &nbsp;&nbsp;&nbsp; 79494 | &nbsp;&nbsp;&nbsp;&nbsp; 122788 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp; 126800 | &nbsp;&nbsp;&nbsp;&nbsp; 8955 | &nbsp;&nbsp;&nbsp;&nbsp; 62511 | &nbsp;&nbsp;&nbsp; 10026 | &nbsp;&nbsp;&nbsp;&nbsp; 12068 |
| Net transfers<sup>(1)</sup> <br>| &nbsp;&nbsp; (137276) | &nbsp;&nbsp;&nbsp; (1627) | &nbsp;&nbsp; (156860) | &nbsp;&nbsp;&nbsp; (5156) | &nbsp;&nbsp;&nbsp;&nbsp; (18393) |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (187) | &nbsp;&nbsp;&nbsp;&nbsp; 2889 | &nbsp;&nbsp;&nbsp;&nbsp; (38583) | &nbsp;&nbsp;&nbsp; 11251 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2915 |
| Policy charges | &nbsp;&nbsp; (141745) | (12546) | &nbsp;&nbsp;&nbsp;&nbsp; (61594) | (23491) | &nbsp;&nbsp;&nbsp;&nbsp; (14096) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | &nbsp;&nbsp; (187601) | (62957) | &nbsp;&nbsp;&nbsp;&nbsp; (97358) | (59715) | &nbsp;&nbsp;&nbsp;&nbsp; (15836) |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | &nbsp;&nbsp; (340009) | (65286) | &nbsp;&nbsp; (291884) | (67085) | &nbsp;&nbsp;&nbsp;&nbsp; (33342) |
| Increase (decrease) in net assets | &nbsp;&nbsp;&nbsp;&nbsp; 192687 | &nbsp;&nbsp;&nbsp; (9352) | &nbsp;&nbsp;&nbsp;&nbsp; 157975 | &nbsp;&nbsp;&nbsp; 12409 | &nbsp;&nbsp;&nbsp;&nbsp; 89446 |
| Net assets at beginning of year | 6330532 | 446097 | 3151214 | 773227 | 1174764 |
| Net assets at end of year | $6523219 | $436745 | $3309189 | $785636 | $1264210 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | 1354490 | &nbsp;&nbsp;&nbsp; 73025 | &nbsp;&nbsp;&nbsp;&nbsp; 537375 | 150898 | &nbsp;&nbsp;&nbsp;&nbsp; 285793 |
| Units purchased | &nbsp;&nbsp;&nbsp;&nbsp; 335356 | &nbsp;&nbsp;&nbsp;&nbsp; 2039 | &nbsp;&nbsp;&nbsp;&nbsp; 159126 | &nbsp;&nbsp;&nbsp;&nbsp; 4379 | &nbsp;&nbsp;&nbsp;&nbsp; 40082 |
| Units redeemed | &nbsp;&nbsp; (210714) | (14664) | &nbsp;&nbsp; (112571) | (16710) | &nbsp;&nbsp;&nbsp;&nbsp; (37707) |
| Units outstanding at end of year | 1479132 | &nbsp;&nbsp;&nbsp; 60400 | &nbsp;&nbsp;&nbsp;&nbsp; 583930 | 138567 | &nbsp;&nbsp;&nbsp;&nbsp; 288168 |

---

See accompanying notes to financial statements.

**RiverSource of New York Account 8** ■ 81

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **Invesco VI Bal** <br> **Risk Alloc, Ser** <br> **I**<br>| **Invesco VI Bal** <br> **Risk Alloc, Ser** <br> **II**<br>| **Invesco VI** <br> **Comstock, Ser** <br> **II**<br>| **Invesco VI** <br> **Core Eq, Ser I**<br>| **Invesco VI Dis** <br> **Mid Cap** <br> **Gro, Ser I**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $2985 | $19802 | $5050 | $(25199) | $(5166) |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp; (462) | &nbsp;&nbsp;&nbsp; (1247) | &nbsp;&nbsp;&nbsp;&nbsp; 5825 | &nbsp;&nbsp;&nbsp;&nbsp; 257385 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 9849 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; 62727 | &nbsp;&nbsp;&nbsp;&nbsp; 914520 | &nbsp;&nbsp;&nbsp;&nbsp; 82408 |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp;&nbsp; 872 | &nbsp;&nbsp;&nbsp;&nbsp; 5319 | &nbsp;&nbsp;&nbsp; 14869 | &nbsp;&nbsp;&nbsp;&nbsp; 591269 | &nbsp;&nbsp;&nbsp;&nbsp; (45023) |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp; 3395 | &nbsp;&nbsp;&nbsp; 23874 | &nbsp;&nbsp;&nbsp; 88471 | &nbsp;&nbsp;&nbsp; 1737975 | &nbsp;&nbsp;&nbsp;&nbsp; 42068 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | 12576 | &nbsp;&nbsp;&nbsp;&nbsp; 8880 | &nbsp;&nbsp;&nbsp;&nbsp; 5943 | &nbsp;&nbsp;&nbsp;&nbsp; 268723 | &nbsp;&nbsp;&nbsp;&nbsp; 31938 |
| Net transfers<sup>(1)</sup> <br>| (3021) | &nbsp;&nbsp;&nbsp;&nbsp; 8726 | &nbsp;&nbsp;&nbsp; 11958 | &nbsp;&nbsp;&nbsp;&nbsp; (243252) | &nbsp;&nbsp;&nbsp;&nbsp; 10370 |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 454 | &nbsp;&nbsp;&nbsp;&nbsp; 1245 | &nbsp;&nbsp;&nbsp;&nbsp; (13091) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (788) |
| Policy charges | (2859) | &nbsp;&nbsp;&nbsp; (2532) | (10388) | &nbsp;&nbsp;&nbsp;&nbsp; (397552) | &nbsp;&nbsp;&nbsp;&nbsp; (19783) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (177) | &nbsp;&nbsp;&nbsp; (7968) | &nbsp;&nbsp;&nbsp;&nbsp; (850712) | &nbsp;&nbsp;&nbsp;&nbsp; (30514) |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | &nbsp;&nbsp;&nbsp; 6696 | &nbsp;&nbsp;&nbsp; 15351 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 790 | (1235884) | &nbsp;&nbsp;&nbsp;&nbsp; (8777) |
| Increase (decrease) in net assets | 10091 | &nbsp;&nbsp;&nbsp; 39225 | &nbsp;&nbsp;&nbsp; 89261 | &nbsp;&nbsp;&nbsp;&nbsp; 502091 | &nbsp;&nbsp;&nbsp;&nbsp; 33291 |
| Net assets at beginning of year | 35948 | 279578 | 533190 | 11977612 | &nbsp;&nbsp;&nbsp;&nbsp; 976451 |
| Net assets at end of year | $46039 | $318803 | $622451 | $12479703 | $1009742 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | 29080 | 201489 | 136271 | &nbsp;&nbsp;&nbsp; 1889391 | &nbsp;&nbsp;&nbsp;&nbsp; 571573 |
| Units purchased | &nbsp;&nbsp;&nbsp; 9778 | &nbsp;&nbsp;&nbsp; 14711 | &nbsp;&nbsp;&nbsp; 28292 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 41253 | &nbsp;&nbsp;&nbsp;&nbsp; 68148 |
| Units redeemed | (4694) | &nbsp;&nbsp;&nbsp; (3797) | (12398) | &nbsp;&nbsp;&nbsp;&nbsp; (224237) | &nbsp;&nbsp;&nbsp;&nbsp; (65286) |
| Units outstanding at end of year | 34164 | 212403 | 152165 | &nbsp;&nbsp;&nbsp; 1706407 | &nbsp;&nbsp;&nbsp;&nbsp; 574435 |

---

See accompanying notes to financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**82 ■ RiverSource of New York Account 8**

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **Invesco VI Div** <br> **Divd, Ser I**<br>| **Invesco VI** <br> **EQV Intl** <br> **Eq, Ser II**<br>| **Invesco VI Gbl** <br> **Strat Inc, Ser I**<br>| **Invesco VI Gbl** <br> **Strat Inc, Ser** <br> **II**<br>| **Invesco VI** <br> **Global, Ser I**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $11408 | $6050 | $3210 | $78214 | $— |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp; 17359 | &nbsp;&nbsp;&nbsp;&nbsp; 18129 | &nbsp;&nbsp;&nbsp;&nbsp; 814 | &nbsp;&nbsp;&nbsp;&nbsp; (15634) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 985 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp; 79032 | &nbsp;&nbsp;&nbsp;&nbsp; 62473 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | 135195 |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp;&nbsp; 37647 | &nbsp;&nbsp;&nbsp;&nbsp; 68014 | &nbsp;&nbsp;&nbsp; 2219 | &nbsp;&nbsp;&nbsp;&nbsp; 117179 | (38338) |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp;&nbsp; 145446 | &nbsp;&nbsp;&nbsp;&nbsp; 154666 | &nbsp;&nbsp;&nbsp; 6243 | &nbsp;&nbsp;&nbsp;&nbsp; 179759 | &nbsp;&nbsp;&nbsp; 97842 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp; 13317 | &nbsp;&nbsp;&nbsp;&nbsp; 25512 | 16884 | &nbsp;&nbsp;&nbsp;&nbsp; 44873 | 137268 |
| Net transfers<sup>(1)</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp; (3598) | &nbsp;&nbsp;&nbsp;&nbsp; (46071) | (4847) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5375 | &nbsp;&nbsp;&nbsp;&nbsp; 3828 |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 9237 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1434 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 106780 | &nbsp;&nbsp;&nbsp;&nbsp; 3360 |
| Policy charges | &nbsp;&nbsp;&nbsp;&nbsp; (19390) | &nbsp;&nbsp;&nbsp;&nbsp; (19652) | (4297) | &nbsp;&nbsp;&nbsp;&nbsp; (48464) | (35198) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | &nbsp;&nbsp; (175167) | &nbsp;&nbsp; (173610) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (60792) | &nbsp;&nbsp;&nbsp;&nbsp; (377) |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | &nbsp;&nbsp; (175601) | &nbsp;&nbsp; (212387) | &nbsp;&nbsp;&nbsp; 7740 | &nbsp;&nbsp;&nbsp;&nbsp; 47772 | 108881 |
| Increase (decrease) in net assets | &nbsp;&nbsp;&nbsp;&nbsp; (30155) | &nbsp;&nbsp;&nbsp;&nbsp; (57721) | 13983 | &nbsp;&nbsp;&nbsp;&nbsp; 227531 | 206723 |
| Net assets at beginning of year | 1107258 | 1066345 | 44542 | 1440992 | 573558 |
| Net assets at end of year | $1077103 | $1008624 | $58525 | $1668523 | $780281 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | &nbsp;&nbsp;&nbsp;&nbsp; 376100 | &nbsp;&nbsp;&nbsp;&nbsp; 463932 | 42297 | &nbsp;&nbsp;&nbsp;&nbsp; 948955 | 315937 |
| Units purchased | &nbsp;&nbsp;&nbsp;&nbsp; 18035 | &nbsp;&nbsp;&nbsp;&nbsp; 43350 | 15053 | &nbsp;&nbsp;&nbsp;&nbsp; 185226 | &nbsp;&nbsp;&nbsp; 75394 |
| Units redeemed | &nbsp;&nbsp;&nbsp;&nbsp; (82783) | &nbsp;&nbsp; (110697) | (8162) | &nbsp;&nbsp; (110951) | (18629) |
| Units outstanding at end of year | &nbsp;&nbsp;&nbsp;&nbsp; 311352 | &nbsp;&nbsp;&nbsp;&nbsp; 396585 | 49188 | 1023230 | 372702 |

---

See accompanying notes to financial statements.

**RiverSource of New York Account 8** ■ 83

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **Invesco VI** <br> **Global, Ser II**<br>| **Invesco VI** <br> **Mn St Sm** <br> **Cap, Ser I**<br>| **Invesco VI** <br> **Mn St Sm** <br> **Cap, Ser II**<br>| **Invesco VI** <br> **Tech, Ser I**<br>| **Invesco VI** <br> **Tech, Ser II**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $(6596) | $2698 | $(1732) | $(7900) | $— |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp; 13162 | &nbsp;&nbsp;&nbsp; (1014) | &nbsp;&nbsp;&nbsp;&nbsp; 27962 | &nbsp;&nbsp;&nbsp;&nbsp; 45498 | &nbsp;&nbsp;&nbsp;&nbsp; 86 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp; 345924 | &nbsp;&nbsp;&nbsp; 60557 | &nbsp;&nbsp;&nbsp;&nbsp; 212569 | &nbsp;&nbsp;&nbsp;&nbsp; 223546 | 1234 |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp; (105227) | &nbsp;&nbsp;&nbsp; (7979) | &nbsp;&nbsp;&nbsp;&nbsp; (73334) | &nbsp;&nbsp;&nbsp;&nbsp; 109869 | &nbsp;&nbsp;&nbsp;&nbsp; 360 |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp;&nbsp; 247263 | &nbsp;&nbsp;&nbsp; 54262 | &nbsp;&nbsp;&nbsp;&nbsp; 165465 | &nbsp;&nbsp;&nbsp;&nbsp; 371013 | 1680 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp; 70062 | 129572 | &nbsp;&nbsp;&nbsp;&nbsp; 50751 | &nbsp;&nbsp;&nbsp;&nbsp; 76771 | &nbsp;&nbsp;&nbsp;&nbsp; — |
| Net transfers<sup>(1)</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp; (62458) | &nbsp;&nbsp;&nbsp; 47764 | &nbsp;&nbsp;&nbsp;&nbsp; 89302 | &nbsp;&nbsp;&nbsp;&nbsp; (1818) | &nbsp;&nbsp;&nbsp;&nbsp; — |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5320 | &nbsp;&nbsp;&nbsp; (1205) | &nbsp;&nbsp;&nbsp;&nbsp; (50148) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 8654 | &nbsp;&nbsp;&nbsp;&nbsp; — |
| Policy charges | &nbsp;&nbsp;&nbsp;&nbsp; (32744) | (29859) | &nbsp;&nbsp;&nbsp;&nbsp; (30415) | &nbsp;&nbsp;&nbsp;&nbsp; (41847) | &nbsp;&nbsp; (301) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | &nbsp;&nbsp;&nbsp;&nbsp; (48614) | &nbsp;&nbsp;&nbsp; (2098) | &nbsp;&nbsp;&nbsp;&nbsp; (79914) | &nbsp;&nbsp;&nbsp;&nbsp; (75651) | &nbsp;&nbsp;&nbsp;&nbsp; — |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | &nbsp;&nbsp;&nbsp;&nbsp; (68434) | 144174 | &nbsp;&nbsp;&nbsp;&nbsp; (20424) | &nbsp;&nbsp;&nbsp;&nbsp; (33891) | &nbsp;&nbsp; (301) |
| Increase (decrease) in net assets | &nbsp;&nbsp;&nbsp;&nbsp; 178829 | 198436 | &nbsp;&nbsp;&nbsp;&nbsp; 145041 | &nbsp;&nbsp;&nbsp;&nbsp; 337122 | 1379 |
| Net assets at beginning of year | 1722539 | 454948 | 1998634 | 1746829 | 8599 |
| Net assets at end of year | $1901368 | $653384 | $2143675 | $2083951 | $9978 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | &nbsp;&nbsp;&nbsp;&nbsp; 409134 | 256773 | &nbsp;&nbsp;&nbsp;&nbsp; 508352 | &nbsp;&nbsp;&nbsp;&nbsp; 379599 | 5424 |
| Units purchased | &nbsp;&nbsp;&nbsp;&nbsp; 70061 | 100902 | &nbsp;&nbsp;&nbsp;&nbsp; 55995 | &nbsp;&nbsp;&nbsp;&nbsp; 98499 | &nbsp;&nbsp;&nbsp;&nbsp; — |
| Units redeemed | &nbsp;&nbsp;&nbsp;&nbsp; (58066) | (18419) | &nbsp;&nbsp;&nbsp;&nbsp; (54780) | &nbsp;&nbsp;&nbsp;&nbsp; (31773) | &nbsp;&nbsp; (187) |
| Units outstanding at end of year | &nbsp;&nbsp;&nbsp;&nbsp; 421129 | 339256 | &nbsp;&nbsp;&nbsp;&nbsp; 509567 | &nbsp;&nbsp;&nbsp;&nbsp; 446325 | 5237 |

---

See accompanying notes to financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**84 ■ RiverSource of New York Account 8**

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **Janus Hend** <br> **VIT Gbl Tech** <br> **Innov, Srv**<br>| **Janus** <br> **Henderson VIT** <br> **Bal, Inst**<br>| **Janus** <br> **Henderson VIT** <br> **Bal, Serv**<br>| **Janus** <br> **Henderson VIT** <br> **Enter, Serv**<br>| **Janus** <br> **Henderson VIT** <br> **Flex Bd, Inst**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $(15125) | $22720 | $947 | $(4414) | $27380 |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp; 129195 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3630 | &nbsp;&nbsp;&nbsp;&nbsp; 152 | &nbsp;&nbsp;&nbsp;&nbsp; 5566 | &nbsp;&nbsp;&nbsp;&nbsp; (520) |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp; 265641 | &nbsp;&nbsp;&nbsp;&nbsp; 35265 | &nbsp;&nbsp;&nbsp; 1672 | &nbsp;&nbsp;&nbsp; 78476 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp;&nbsp; 250275 | &nbsp;&nbsp;&nbsp;&nbsp; 95148 | &nbsp;&nbsp;&nbsp; 4839 | (18166) | &nbsp;&nbsp;&nbsp;&nbsp; 7669 |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp;&nbsp; 629986 | &nbsp;&nbsp;&nbsp;&nbsp; 156763 | &nbsp;&nbsp;&nbsp; 7610 | &nbsp;&nbsp;&nbsp; 61462 | &nbsp;&nbsp;&nbsp; 34529 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp; 38361 | &nbsp;&nbsp;&nbsp;&nbsp; 131609 | &nbsp;&nbsp;&nbsp; 1843 | &nbsp;&nbsp;&nbsp; 11440 | 112418 |
| Net transfers<sup>(1)</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp; (17114) | &nbsp;&nbsp;&nbsp;&nbsp; 143211 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 1306 | &nbsp;&nbsp;&nbsp; 68532 |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp;&nbsp; 18070 | &nbsp;&nbsp;&nbsp;&nbsp; (4074) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; (1532) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Policy charges | &nbsp;&nbsp;&nbsp;&nbsp; (50945) | &nbsp;&nbsp;&nbsp;&nbsp; (45216) | &nbsp;&nbsp;&nbsp;&nbsp; (653) | (13089) | (35115) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | &nbsp;&nbsp;&nbsp;&nbsp; (66814) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (87) | (17814) | &nbsp;&nbsp;&nbsp;&nbsp; (658) |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | &nbsp;&nbsp;&nbsp;&nbsp; (78442) | &nbsp;&nbsp;&nbsp;&nbsp; 225530 | &nbsp;&nbsp;&nbsp; 1103 | (19689) | 145177 |
| Increase (decrease) in net assets | &nbsp;&nbsp;&nbsp;&nbsp; 551544 | &nbsp;&nbsp;&nbsp;&nbsp; 382293 | &nbsp;&nbsp;&nbsp; 8713 | &nbsp;&nbsp;&nbsp; 41773 | 179706 |
| Net assets at beginning of year | 2644952 | &nbsp;&nbsp;&nbsp;&nbsp; 971399 | 50813 | 907723 | 388337 |
| Net assets at end of year | $3196496 | $1353692 | $59526 | $949496 | $568043 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | &nbsp;&nbsp;&nbsp;&nbsp; 290659 | &nbsp;&nbsp;&nbsp;&nbsp; 568545 | 28302 | 116033 | 353189 |
| Units purchased | &nbsp;&nbsp;&nbsp;&nbsp; 70786 | &nbsp;&nbsp;&nbsp;&nbsp; 146804 | &nbsp;&nbsp;&nbsp;&nbsp; 962 | &nbsp;&nbsp;&nbsp;&nbsp; 2143 | 159099 |
| Units redeemed | &nbsp;&nbsp;&nbsp;&nbsp; (32852) | &nbsp;&nbsp;&nbsp;&nbsp; (27025) | &nbsp;&nbsp;&nbsp;&nbsp; (389) | &nbsp;&nbsp;&nbsp; (5395) | (31256) |
| Units outstanding at end of year | &nbsp;&nbsp;&nbsp;&nbsp; 328593 | &nbsp;&nbsp;&nbsp;&nbsp; 688324 | 28875 | 112781 | 481032 |

---

See accompanying notes to financial statements.

**RiverSource of New York Account 8** ■ 85

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **Janus** <br> **Henderson VIT** <br> **Flex Bd, Serv**<br>| **Janus** <br> **Henderson VIT** <br> **Overseas,** <br> **Serv**<br>| **Janus** <br> **Henderson VIT** <br> **Res, Inst**<br>| **Janus** <br> **Henderson VIT** <br> **Res, Serv**<br>| **Lazard Ret** <br> **Global Dyn** <br> **MA, Inv**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $2495 | $15431 | $— | $(4383) | $274 |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp; (10) | &nbsp;&nbsp;&nbsp;&nbsp; 50741 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 58 | &nbsp;&nbsp;&nbsp; 33040 | &nbsp;&nbsp;&nbsp;&nbsp; 193 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 6173 | &nbsp;&nbsp;&nbsp; 65748 | &nbsp;&nbsp;&nbsp;&nbsp; 607 |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp; 1189 | &nbsp;&nbsp;&nbsp;&nbsp; 421123 | &nbsp;&nbsp;&nbsp;&nbsp; 8575 | &nbsp;&nbsp;&nbsp; 39956 | &nbsp;&nbsp;&nbsp; 2101 |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp; 3674 | &nbsp;&nbsp;&nbsp;&nbsp; 487295 | &nbsp;&nbsp;&nbsp; 14806 | 134361 | &nbsp;&nbsp;&nbsp; 3175 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp; 6757 | &nbsp;&nbsp;&nbsp;&nbsp; 54505 | &nbsp;&nbsp;&nbsp;&nbsp; 5281 | &nbsp;&nbsp;&nbsp; 15594 | &nbsp;&nbsp;&nbsp; 7882 |
| Net transfers<sup>(1)</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 13949 | &nbsp;&nbsp;&nbsp; 10389 | (29514) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 10950 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; (3527) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Policy charges | &nbsp;&nbsp;&nbsp;&nbsp; (425) | &nbsp;&nbsp;&nbsp;&nbsp; (61068) | &nbsp;&nbsp;&nbsp; (1568) | (15826) | (3218) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (44010) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | (12021) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | &nbsp;&nbsp;&nbsp; 6332 | &nbsp;&nbsp;&nbsp;&nbsp; (25674) | &nbsp;&nbsp;&nbsp; 14102 | (45294) | &nbsp;&nbsp;&nbsp; 4664 |
| Increase (decrease) in net assets | 10006 | &nbsp;&nbsp;&nbsp;&nbsp; 461621 | &nbsp;&nbsp;&nbsp; 28908 | &nbsp;&nbsp;&nbsp; 89067 | &nbsp;&nbsp;&nbsp; 7839 |
| Net assets at beginning of year | 46913 | 1751750 | &nbsp;&nbsp;&nbsp; 73477 | 803181 | 16369 |
| Net assets at end of year | $56919 | $2213371 | $102385 | $892248 | $24208 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | 38882 | &nbsp;&nbsp;&nbsp;&nbsp; 697030 | &nbsp;&nbsp;&nbsp; 28416 | 128108 | 13258 |
| Units purchased | &nbsp;&nbsp;&nbsp; 5454 | &nbsp;&nbsp;&nbsp;&nbsp; 69443 | &nbsp;&nbsp;&nbsp;&nbsp; 5599 | &nbsp;&nbsp;&nbsp; 16678 | &nbsp;&nbsp;&nbsp; 6101 |
| Units redeemed | &nbsp;&nbsp;&nbsp;&nbsp; (340) | &nbsp;&nbsp;&nbsp;&nbsp; (58378) | &nbsp;&nbsp;&nbsp;&nbsp; (569) | (13574) | (2453) |
| Units outstanding at end of year | 43996 | &nbsp;&nbsp;&nbsp;&nbsp; 708095 | &nbsp;&nbsp;&nbsp; 33446 | 131212 | 16906 |

---

See accompanying notes to financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**86 ■ RiverSource of New York Account 8**

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **Lazard Ret** <br> **Global Dyn** <br> **MA, Serv**<br>| **Lord Abt Bond** <br> **Debenture,** <br>**Cl VC**<br>| **LVIP AC Intl,** <br>**Serv Cl**<br>| **LVIP AC Intl,** <br> **Std** <br>**Cl II**<br>| **LVIP AC Mid** <br> **Cap Val, Std** <br>**Cl II**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $90 | $1510 | $5414 | $3711 | $873 |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 72 | &nbsp;&nbsp;&nbsp;&nbsp; (43) | &nbsp;&nbsp;&nbsp;&nbsp; 8194 | &nbsp;&nbsp;&nbsp;&nbsp; 6193 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (9) |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp; 455 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; 3815 |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp; 1712 | &nbsp;&nbsp;&nbsp;&nbsp; 228 | &nbsp;&nbsp;&nbsp; 87740 | &nbsp;&nbsp;&nbsp; 79417 | (1900) |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp; 2329 | &nbsp;&nbsp;&nbsp; 1695 | 101348 | &nbsp;&nbsp;&nbsp; 89321 | &nbsp;&nbsp;&nbsp; 2779 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp; 227 | &nbsp;&nbsp;&nbsp; 5500 | &nbsp;&nbsp;&nbsp; 20204 | &nbsp;&nbsp;&nbsp; 17867 | 14842 |
| Net transfers<sup>(1)</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp; (58) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; (8294) | &nbsp;&nbsp;&nbsp;&nbsp; (978) | 12052 |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp; 3254 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 1178 | &nbsp;&nbsp;&nbsp;&nbsp; 9784 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Policy charges | &nbsp;&nbsp;&nbsp;&nbsp; (571) | (2358) | (10675) | (22180) | (4756) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; (3741) | (17442) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | &nbsp;&nbsp;&nbsp; 2852 | &nbsp;&nbsp;&nbsp; 3142 | &nbsp;&nbsp;&nbsp; (1328) | (12949) | 22138 |
| Increase (decrease) in net assets | &nbsp;&nbsp;&nbsp; 5181 | &nbsp;&nbsp;&nbsp; 4837 | 100020 | &nbsp;&nbsp;&nbsp; 76372 | 24917 |
| Net assets at beginning of year | 15700 | 21150 | 659800 | 587922 | 24162 |
| Net assets at end of year | $20881 | $25987 | $759820 | $664294 | $49079 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | 10634 | 19857 | 423884 | 245736 | 22198 |
| Units purchased | &nbsp;&nbsp;&nbsp; 2701 | &nbsp;&nbsp;&nbsp; 4808 | &nbsp;&nbsp;&nbsp; 64888 | &nbsp;&nbsp;&nbsp;&nbsp; 9990 | 23354 |
| Units redeemed | (1065) | (2142) | (57857) | (15859) | (4184) |
| Units outstanding at end of year | 12270 | 22523 | 430915 | 239867 | 41368 |

---

See accompanying notes to financial statements.

**RiverSource of New York Account 8** ■ 87

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **LVIP AC Val,** <br>**Serv Cl**<br>| **LVIP AC Val,** <br> **Std** <br>**Cl II**<br>| **MFS Gbl Real** <br> **Est, Init Cl**<br>| **MFS Intl Gro,** <br> **Init Cl**<br>| **MFS Mass Inv** <br> **Gro Stock,** <br>**Serv Cl**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $28579 | $37822 | $2 | $1773 | $(15986) |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp; 92296 | &nbsp;&nbsp;&nbsp;&nbsp; 106955 | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 3156 | &nbsp;&nbsp;&nbsp;&nbsp; 102585 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp; 190564 | &nbsp;&nbsp;&nbsp;&nbsp; 309726 | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; 10547 | &nbsp;&nbsp;&nbsp;&nbsp; 452917 |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp;&nbsp; 41933 | &nbsp;&nbsp;&nbsp;&nbsp; 119770 | &nbsp;&nbsp;&nbsp;&nbsp; 2 | &nbsp;&nbsp;&nbsp; 15475 | &nbsp;&nbsp; (279561) |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp;&nbsp; 353372 | &nbsp;&nbsp;&nbsp;&nbsp; 574273 | &nbsp;&nbsp;&nbsp;&nbsp; 4 | &nbsp;&nbsp;&nbsp; 30951 | &nbsp;&nbsp;&nbsp;&nbsp; 259955 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp; 55715 | &nbsp;&nbsp;&nbsp;&nbsp; 120360 | &nbsp;&nbsp;&nbsp; — | 118928 | &nbsp;&nbsp;&nbsp;&nbsp; 42075 |
| Net transfers<sup>(1)</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp; 14844 | &nbsp;&nbsp;&nbsp;&nbsp; (85553) | &nbsp;&nbsp;&nbsp; 73 | &nbsp;&nbsp;&nbsp; 24079 | &nbsp;&nbsp; (266850) |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp;&nbsp; (11068) | &nbsp;&nbsp;&nbsp;&nbsp; (10239) | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (18645) |
| Policy charges | &nbsp;&nbsp;&nbsp;&nbsp; (47920) | &nbsp;&nbsp; (137635) | (26) | (11947) | &nbsp;&nbsp;&nbsp;&nbsp; (66532) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | &nbsp;&nbsp;&nbsp;&nbsp; (28113) | &nbsp;&nbsp; (143434) | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp; (511939) |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp; (40596) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | &nbsp;&nbsp;&nbsp;&nbsp; (57138) | &nbsp;&nbsp; (256501) | &nbsp;&nbsp;&nbsp; 47 | 131060 | &nbsp;&nbsp; (821891) |
| Increase (decrease) in net assets | &nbsp;&nbsp;&nbsp;&nbsp; 296234 | &nbsp;&nbsp;&nbsp;&nbsp; 317772 | &nbsp;&nbsp;&nbsp; 51 | 162011 | &nbsp;&nbsp; (561936) |
| Net assets at beginning of year | 2348755 | 3865924 | &nbsp;&nbsp;&nbsp; 75 | &nbsp;&nbsp;&nbsp; 74424 | 3433692 |
| Net assets at end of year | $2644989 | $4183696 | $126 | $236435 | $2871756 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | &nbsp;&nbsp;&nbsp;&nbsp; 957896 | &nbsp;&nbsp;&nbsp;&nbsp; 789770 | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; 67300 | 1101492 |
| Units purchased | &nbsp;&nbsp;&nbsp;&nbsp; 255541 | &nbsp;&nbsp;&nbsp;&nbsp; 35551 | &nbsp;&nbsp;&nbsp; 73 | 118764 | &nbsp;&nbsp;&nbsp;&nbsp; 85976 |
| Units redeemed | &nbsp;&nbsp; (219244) | &nbsp;&nbsp;&nbsp;&nbsp; (69857) | (25) | &nbsp;&nbsp;&nbsp; (9536) | &nbsp;&nbsp; (340515) |
| Units outstanding at end of year | &nbsp;&nbsp;&nbsp;&nbsp; 994193 | &nbsp;&nbsp;&nbsp;&nbsp; 755464 | &nbsp;&nbsp;&nbsp; 48 | 176528 | &nbsp;&nbsp;&nbsp;&nbsp; 846953 |

---

See accompanying notes to financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**88 ■ RiverSource of New York Account 8**

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **MFS New Dis,** <br>**Serv Cl**<br>| **MFS Utilities,** <br> **Init Cl**<br>| **MFS Utilities,** <br>**Serv Cl**<br>| **MS VIF Dis,** <br>**Cl I**<br>| **MS VIF Dis,** <br>**Cl II**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $(9603) | $3960 | $27351 | $2676 | $(924) |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp; (74450) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 212 | &nbsp;&nbsp;&nbsp;&nbsp; 20414 | &nbsp;&nbsp;&nbsp;&nbsp; 4716 | &nbsp;&nbsp;&nbsp;&nbsp; (18744) |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 1811 | &nbsp;&nbsp;&nbsp;&nbsp; 16065 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp;&nbsp; 313375 | &nbsp;&nbsp;&nbsp; 12234 | &nbsp;&nbsp;&nbsp;&nbsp; 94486 | &nbsp;&nbsp;&nbsp; 55339 | &nbsp;&nbsp;&nbsp;&nbsp; 149991 |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp;&nbsp; 229322 | &nbsp;&nbsp;&nbsp; 18217 | &nbsp;&nbsp;&nbsp;&nbsp; 158316 | &nbsp;&nbsp;&nbsp; 62731 | &nbsp;&nbsp;&nbsp;&nbsp; 130323 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp; 40734 | &nbsp;&nbsp;&nbsp; 18070 | &nbsp;&nbsp;&nbsp;&nbsp; 43434 | &nbsp;&nbsp;&nbsp; 98968 | &nbsp;&nbsp;&nbsp;&nbsp; 32482 |
| Net transfers<sup>(1)</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp; (43377) | &nbsp;&nbsp;&nbsp; 26259 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 6969 | &nbsp;&nbsp;&nbsp; 33173 | &nbsp;&nbsp;&nbsp;&nbsp; 188657 |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp;&nbsp; 25014 | &nbsp;&nbsp;&nbsp;&nbsp; (449) | &nbsp;&nbsp;&nbsp;&nbsp; (12893) | &nbsp;&nbsp;&nbsp;&nbsp; 3757 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 569 |
| Policy charges | &nbsp;&nbsp;&nbsp;&nbsp; (47060) | &nbsp;&nbsp;&nbsp; (6211) | &nbsp;&nbsp;&nbsp;&nbsp; (38287) | (33359) | &nbsp;&nbsp;&nbsp;&nbsp; (31588) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | &nbsp;&nbsp;&nbsp;&nbsp; (67611) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (75005) | &nbsp;&nbsp;&nbsp; (4695) | &nbsp;&nbsp;&nbsp;&nbsp; (32342) |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | &nbsp;&nbsp;&nbsp;&nbsp; (92300) | &nbsp;&nbsp;&nbsp; 37669 | &nbsp;&nbsp;&nbsp;&nbsp; (75782) | &nbsp;&nbsp;&nbsp; 97844 | &nbsp;&nbsp;&nbsp;&nbsp; 157778 |
| Increase (decrease) in net assets | &nbsp;&nbsp;&nbsp;&nbsp; 137022 | &nbsp;&nbsp;&nbsp; 55886 | &nbsp;&nbsp;&nbsp;&nbsp; 82534 | 160575 | &nbsp;&nbsp;&nbsp;&nbsp; 288101 |
| Net assets at beginning of year | 1994114 | &nbsp;&nbsp;&nbsp; 92735 | 1143778 | 527285 | 1149990 |
| Net assets at end of year | $2131136 | $148621 | $1226312 | $687860 | $1438091 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | &nbsp;&nbsp;&nbsp;&nbsp; 474772 | &nbsp;&nbsp;&nbsp; 60709 | &nbsp;&nbsp;&nbsp;&nbsp; 352465 | 272828 | &nbsp;&nbsp;&nbsp;&nbsp; 194506 |
| Units purchased | &nbsp;&nbsp;&nbsp;&nbsp; 42785 | &nbsp;&nbsp;&nbsp; 27951 | &nbsp;&nbsp;&nbsp;&nbsp; 64217 | &nbsp;&nbsp;&nbsp; 61136 | &nbsp;&nbsp;&nbsp;&nbsp; 45882 |
| Units redeemed | &nbsp;&nbsp;&nbsp;&nbsp; (37574) | &nbsp;&nbsp;&nbsp; (4063) | &nbsp;&nbsp;&nbsp;&nbsp; (63078) | (17821) | &nbsp;&nbsp;&nbsp;&nbsp; (10523) |
| Units outstanding at end of year | &nbsp;&nbsp;&nbsp;&nbsp; 479983 | &nbsp;&nbsp;&nbsp; 84597 | &nbsp;&nbsp;&nbsp;&nbsp; 353604 | 316143 | &nbsp;&nbsp;&nbsp;&nbsp; 229865 |

---

See accompanying notes to financial statements.

**RiverSource of New York Account 8** ■ 89

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **NB AMT** <br> **Quality Eq,** <br>**Cl I**<br>| **NB AMT** <br> **Quality Eq,** <br>**Cl S**<br>| **Nom VIP Asset** <br> **Strategy,** <br>**Serv Cl**<br>| **Nom VIP Asset** <br> **Strategy, Std** <br> **Cl**<br>| **Nom VIP Intl** <br> **Core Eq, Std Cl**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $— | $— | $569 | $4 | $1 |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp; 471 | &nbsp;&nbsp;&nbsp;&nbsp; 103 | &nbsp;&nbsp;&nbsp;&nbsp; (215) | &nbsp;&nbsp;&nbsp; — |  |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp; 3393 | &nbsp;&nbsp;&nbsp; 4959 | &nbsp;&nbsp;&nbsp;&nbsp; 3276 | &nbsp;&nbsp;&nbsp; 16 | &nbsp;&nbsp;&nbsp; 4 |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp; 3246 | &nbsp;&nbsp;&nbsp; 5635 | &nbsp;&nbsp;&nbsp;&nbsp; 3541 | &nbsp;&nbsp;&nbsp; 13 | &nbsp;&nbsp; 14 |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp; 7110 | 10697 | &nbsp;&nbsp;&nbsp;&nbsp; 7171 | &nbsp;&nbsp;&nbsp; 33 | &nbsp;&nbsp; 19 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp; 7572 | &nbsp;&nbsp;&nbsp; 2454 | &nbsp;&nbsp;&nbsp;&nbsp; 2846 | 145 |  |
| Net transfers<sup>(1)</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | 15142 | (13103) | &nbsp;&nbsp;&nbsp; — |  |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; — |  |
| Policy charges | (2624) | &nbsp;&nbsp;&nbsp;&nbsp; (668) | &nbsp;&nbsp;&nbsp;&nbsp; (476) | (57) |  |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | &nbsp;&nbsp;&nbsp;&nbsp; (795) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (77) | &nbsp;&nbsp;&nbsp; — |  |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; — |  |
| Increase (decrease) from transactions | &nbsp;&nbsp;&nbsp; 4153 | 16928 | (10810) | &nbsp;&nbsp;&nbsp; 88 |  |
| Increase (decrease) in net assets | 11263 | 27625 | &nbsp;&nbsp;&nbsp; (3639) | 121 | &nbsp;&nbsp; 19 |
| Net assets at beginning of year | 49139 | 60548 | &nbsp;&nbsp;&nbsp; 55397 | 153 | &nbsp;&nbsp; 75 |
| Net assets at end of year | $60402 | $88173 | $51758 | $274 | $94 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | 22675 | 13941 | &nbsp;&nbsp;&nbsp; 33717 | &nbsp;&nbsp;&nbsp; 60 |  |
| Units purchased | &nbsp;&nbsp;&nbsp; 3317 | &nbsp;&nbsp;&nbsp; 4104 | &nbsp;&nbsp;&nbsp;&nbsp; 1538 | 119 |  |
| Units redeemed | (1488) | &nbsp;&nbsp;&nbsp;&nbsp; (148) | &nbsp;&nbsp;&nbsp; (8843) | (47) |  |
| Units outstanding at end of year | 24504 | 17897 | &nbsp;&nbsp;&nbsp; 26412 | 132 |  |

---

See accompanying notes to financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**90 ■ RiverSource of New York Account 8**

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **PIMCO VIT All** <br> **Asset, Advisor** <br> **Cl**<br>| **PIMCO VIT All** <br> **Asset, Inst Cl**<br>| **PIMCO VIT Glb** <br> **Man As Alloc,** <br> **Adv Cl**<br>| **PIMCO VIT Tot** <br> **Return,** <br> **Advisor Cl**<br>| **PIMCO VIT Tot** <br> **Return, Inst Cl**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $23919 | $822 | $266 | $25153 | $10975 |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp; (9531) | &nbsp;&nbsp;&nbsp;&nbsp; (39) | &nbsp;&nbsp;&nbsp;&nbsp; (17) | &nbsp;&nbsp;&nbsp; (2803) | &nbsp;&nbsp;&nbsp;&nbsp; (179) |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp; 62136 | &nbsp;&nbsp;&nbsp; 1497 | &nbsp;&nbsp;&nbsp;&nbsp; 980 | &nbsp;&nbsp;&nbsp; 39336 | &nbsp;&nbsp;&nbsp; 12458 |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp; 76524 | &nbsp;&nbsp;&nbsp; 2280 | 1229 | &nbsp;&nbsp;&nbsp; 61686 | &nbsp;&nbsp;&nbsp; 23254 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp; 17370 | &nbsp;&nbsp;&nbsp; 6506 | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 2996 | &nbsp;&nbsp;&nbsp; 50016 |
| Net transfers<sup>(1)</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 849 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | 323916 | 108174 |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp;&nbsp; 4268 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | (14855) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Policy charges | (19790) | (3916) | &nbsp;&nbsp; (326) | &nbsp;&nbsp;&nbsp; (8404) | (16275) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | (36241) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | (12313) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | (33544) | &nbsp;&nbsp;&nbsp; 2590 | &nbsp;&nbsp; (326) | 291340 | 141915 |
| Increase (decrease) in net assets | &nbsp;&nbsp;&nbsp; 42980 | &nbsp;&nbsp;&nbsp; 4870 | &nbsp;&nbsp;&nbsp;&nbsp; 903 | 353026 | 165169 |
| Net assets at beginning of year | 579002 | 16140 | 5822 | 518842 | 166980 |
| Net assets at end of year | $621982 | $21010 | $6725 | $871868 | $332149 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | 269295 | 12090 | 3434 | 464701 | 155453 |
| Units purchased | &nbsp;&nbsp;&nbsp; 53155 | &nbsp;&nbsp;&nbsp; 4435 | &nbsp;&nbsp;&nbsp;&nbsp; — | 293223 | 142598 |
| Units redeemed | (52646) | (2761) | &nbsp;&nbsp; (177) | (31573) | (14498) |
| Units outstanding at end of year | 269804 | 13764 | 3257 | 726351 | 283553 |

---

See accompanying notes to financial statements.

**RiverSource of New York Account 8** ■ 91

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **Put VT Global** <br> **Hlth Care,** <br>**Cl IA**<br>| **Put VT Global** <br> **Hlth Care,** <br>**Cl IB**<br>| **Put VT Hi** <br> **Yield,** <br>**Cl IB**<br>| **Put VT Intl Eq,** <br>**Cl IB**<br>| **Put VT Intl Val,** <br>**Cl IA**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $— | $(6577) | $14096 | $(823) | $38 |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp; (58) | &nbsp;&nbsp;&nbsp;&nbsp; (22521) | &nbsp;&nbsp;&nbsp; (1437) | &nbsp;&nbsp;&nbsp;&nbsp; 8535 | &nbsp;&nbsp;&nbsp; 2627 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp; 4660 | &nbsp;&nbsp;&nbsp;&nbsp; 97266 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; 11789 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 24 |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp; 6548 | &nbsp;&nbsp;&nbsp;&nbsp; 105498 | &nbsp;&nbsp;&nbsp;&nbsp; 7362 | &nbsp;&nbsp;&nbsp; 41632 | 14585 |
| Net increase (decrease) in net assets resulting from operations | 11150 | &nbsp;&nbsp;&nbsp;&nbsp; 173666 | &nbsp;&nbsp;&nbsp; 20021 | &nbsp;&nbsp;&nbsp; 61133 | 17274 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | 25225 | &nbsp;&nbsp;&nbsp;&nbsp; 20224 | &nbsp;&nbsp;&nbsp;&nbsp; 7568 | &nbsp;&nbsp;&nbsp;&nbsp; 3869 | 70502 |
| Net transfers<sup>(1)</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 36 | &nbsp;&nbsp;&nbsp;&nbsp; (51094) | &nbsp;&nbsp;&nbsp;&nbsp; 8505 | (13389) | &nbsp;&nbsp;&nbsp; 2719 |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2661 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 139 | &nbsp;&nbsp;&nbsp; (1417) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Policy charges | (4607) | &nbsp;&nbsp;&nbsp;&nbsp; (22117) | (11677) | &nbsp;&nbsp;&nbsp; (4415) | (2826) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (62248) | &nbsp;&nbsp;&nbsp; (6594) | &nbsp;&nbsp;&nbsp; (2351) | &nbsp;&nbsp;&nbsp;&nbsp; (96) |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | 20654 | &nbsp;&nbsp; (112574) | &nbsp;&nbsp;&nbsp; (2059) | (17703) | 70299 |
| Increase (decrease) in net assets | 31804 | &nbsp;&nbsp;&nbsp;&nbsp; 61092 | &nbsp;&nbsp;&nbsp; 17962 | &nbsp;&nbsp;&nbsp; 43430 | 87573 |
| Net assets at beginning of year | 62191 | 1377448 | 255662 | 178600 | &nbsp;&nbsp;&nbsp; 2554 |
| Net assets at end of year | $93995 | $1438540 | $273624 | $222030 | $90127 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | 54526 | &nbsp;&nbsp;&nbsp;&nbsp; 338029 | &nbsp;&nbsp;&nbsp; 80922 | &nbsp;&nbsp;&nbsp; 82364 | &nbsp;&nbsp;&nbsp; 2315 |
| Units purchased | 20824 | &nbsp;&nbsp;&nbsp;&nbsp; 45754 | &nbsp;&nbsp;&nbsp;&nbsp; 4847 | &nbsp;&nbsp;&nbsp; 16710 | 62350 |
| Units redeemed | (3897) | &nbsp;&nbsp;&nbsp;&nbsp; (49138) | &nbsp;&nbsp;&nbsp; (5477) | (16333) | (2179) |
| Units outstanding at end of year | 71453 | &nbsp;&nbsp;&nbsp;&nbsp; 334645 | &nbsp;&nbsp;&nbsp; 80292 | &nbsp;&nbsp;&nbsp; 82741 | 62486 |

---

See accompanying notes to financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**92 ■ RiverSource of New York Account 8**

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **Put VT Lg Cap** <br> **Val,** <br>**Cl IA**<br>| **Put VT Sus** <br> **Leaders,** <br>**Cl IA**<br>| **Put VT Sus** <br> **Leaders,** <br>**Cl IB**<br>| **Royce Micro-**<br> **Cap, Invest Cl**<br>| **Temp Global** <br> **Bond,** <br>**Cl 1**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $925 | $2255 | $564 | $(12665) | $— |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp; (3212) | &nbsp;&nbsp;&nbsp;&nbsp; 506461 | &nbsp;&nbsp;&nbsp;&nbsp; 9326 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1179 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (8) |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp; 3865 | &nbsp;&nbsp;&nbsp; 1579985 | &nbsp;&nbsp;&nbsp; 23079 | &nbsp;&nbsp;&nbsp;&nbsp; 308901 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp; 37107 | &nbsp;&nbsp;&nbsp;&nbsp; (747557) | (12746) | &nbsp;&nbsp;&nbsp;&nbsp; (53290) | &nbsp;&nbsp;&nbsp; 4791 |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp; 38685 | &nbsp;&nbsp;&nbsp; 1341144 | &nbsp;&nbsp;&nbsp; 20223 | &nbsp;&nbsp;&nbsp;&nbsp; 244125 | &nbsp;&nbsp;&nbsp; 4783 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | 139432 | &nbsp;&nbsp;&nbsp;&nbsp; 218511 | &nbsp;&nbsp;&nbsp;&nbsp; 1916 | &nbsp;&nbsp;&nbsp;&nbsp; 57360 | &nbsp;&nbsp;&nbsp; 4511 |
| Net transfers<sup>(1)</sup> <br>| &nbsp;&nbsp;&nbsp; 18385 | &nbsp;&nbsp;&nbsp;&nbsp; (226908) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1 | &nbsp;&nbsp;&nbsp;&nbsp; (37946) | &nbsp;&nbsp;&nbsp; 3990 |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (55239) | &nbsp;&nbsp;&nbsp;&nbsp; 1638 | &nbsp;&nbsp;&nbsp;&nbsp; 21782 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Policy charges | (12582) | &nbsp;&nbsp;&nbsp;&nbsp; (354606) | &nbsp;&nbsp;&nbsp; (3784) | &nbsp;&nbsp;&nbsp;&nbsp; (72488) | (1961) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | (1174898) | &nbsp;&nbsp;&nbsp; (1509) | &nbsp;&nbsp;&nbsp;&nbsp; (76098) | &nbsp;&nbsp;&nbsp;&nbsp; (274) |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | 145235 | (1593140) | &nbsp;&nbsp;&nbsp; (1738) | &nbsp;&nbsp; (107390) | &nbsp;&nbsp;&nbsp; 6266 |
| Increase (decrease) in net assets | 183920 | &nbsp;&nbsp;&nbsp;&nbsp; (251996) | &nbsp;&nbsp;&nbsp; 18485 | &nbsp;&nbsp;&nbsp;&nbsp; 136735 | 11049 |
| Net assets at beginning of year | &nbsp;&nbsp;&nbsp; 43474 | 14435490 | 198944 | 1936148 | 27184 |
| Net assets at end of year | $227394 | $14183494 | $217429 | $2072883 | $38233 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | &nbsp;&nbsp;&nbsp; 36380 | &nbsp;&nbsp;&nbsp; 1737413 | &nbsp;&nbsp;&nbsp; 44299 | &nbsp;&nbsp;&nbsp;&nbsp; 379713 | 34703 |
| Units purchased | 131057 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 26292 | &nbsp;&nbsp;&nbsp; 12856 | &nbsp;&nbsp;&nbsp;&nbsp; 16587 | &nbsp;&nbsp;&nbsp; 9916 |
| Units redeemed | &nbsp;&nbsp;&nbsp; (9740) | &nbsp;&nbsp;&nbsp;&nbsp; (208339) | &nbsp;&nbsp;&nbsp; (9974) | &nbsp;&nbsp;&nbsp;&nbsp; (36151) | (2575) |
| Units outstanding at end of year | 157697 | &nbsp;&nbsp;&nbsp; 1555366 | &nbsp;&nbsp;&nbsp; 47181 | &nbsp;&nbsp;&nbsp;&nbsp; 360149 | 42044 |

---

See accompanying notes to financial statements.

**RiverSource of New York Account 8** ■ 93

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **Temp Global** <br> **Bond,** <br>**Cl 2**<br>| **Third Ave VST** <br> **Third Ave** <br> **Value**<br>| **VanEck VIP** <br> **Global Gold,** <br>**Cl S**<br>| **VP Aggr,** <br>**Cl 1**<br>| **VP Aggr,** <br>**Cl 2**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $(459) | $40219 | $3126 | $— | $(64454) |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp; (9607) | &nbsp;&nbsp;&nbsp;&nbsp; 51171 | &nbsp;&nbsp;&nbsp; 33530 | &nbsp;&nbsp;&nbsp;&nbsp; 65274 | &nbsp;&nbsp;&nbsp;&nbsp; 950698 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 181041 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp; 28443 | &nbsp;&nbsp;&nbsp;&nbsp; 448792 | 276549 | &nbsp;&nbsp;&nbsp;&nbsp; 720784 | &nbsp;&nbsp;&nbsp; 3765517 |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp; 18377 | &nbsp;&nbsp;&nbsp;&nbsp; 721223 | 313205 | &nbsp;&nbsp;&nbsp;&nbsp; 786058 | &nbsp;&nbsp;&nbsp; 4651761 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp; 8324 | &nbsp;&nbsp;&nbsp;&nbsp; 59915 | &nbsp;&nbsp;&nbsp;&nbsp; 4259 | &nbsp;&nbsp;&nbsp;&nbsp; 785989 | &nbsp;&nbsp;&nbsp; 1079344 |
| Net transfers<sup>(1)</sup> <br>| &nbsp;&nbsp;&nbsp; 22597 | &nbsp;&nbsp; (110348) | &nbsp;&nbsp;&nbsp;&nbsp; 2808 | &nbsp;&nbsp;&nbsp;&nbsp; (43730) | &nbsp;&nbsp;&nbsp;&nbsp; (956803) |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp;&nbsp; 2637 | &nbsp;&nbsp;&nbsp;&nbsp; 25005 | &nbsp;&nbsp;&nbsp; (2636) | &nbsp;&nbsp;&nbsp;&nbsp; (14968) | &nbsp;&nbsp;&nbsp;&nbsp; (91849) |
| Policy charges | &nbsp;&nbsp;&nbsp; (3706) | &nbsp;&nbsp;&nbsp;&nbsp; (74480) | &nbsp;&nbsp;&nbsp; (6594) | &nbsp;&nbsp; (218179) | &nbsp;&nbsp;&nbsp;&nbsp; (345542) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | (47913) | &nbsp;&nbsp;&nbsp;&nbsp; (49111) | &nbsp;&nbsp;&nbsp; (4889) | &nbsp;&nbsp;&nbsp;&nbsp; (6524) | &nbsp;&nbsp;&nbsp;&nbsp; (939257) |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | (18061) | &nbsp;&nbsp; (149019) | &nbsp;&nbsp;&nbsp; (7052) | &nbsp;&nbsp;&nbsp;&nbsp; 502588 | (1254107) |
| Increase (decrease) in net assets | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 316 | &nbsp;&nbsp;&nbsp;&nbsp; 572204 | 306153 | 1288646 | &nbsp;&nbsp;&nbsp; 3397654 |
| Net assets at beginning of year | 157094 | 2181855 | 192364 | 4038556 | 27790640 |
| Net assets at end of year | $157410 | $2754059 | $498517 | $5327202 | $31188294 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | 199389 | &nbsp;&nbsp;&nbsp;&nbsp; 594679 | 135307 | 2485504 | 10899361 |
| Units purchased | &nbsp;&nbsp;&nbsp; 39398 | &nbsp;&nbsp;&nbsp;&nbsp; 21088 | &nbsp;&nbsp;&nbsp; 33726 | &nbsp;&nbsp;&nbsp;&nbsp; 450321 | &nbsp;&nbsp;&nbsp;&nbsp; 441603 |
| Units redeemed | (66009) | &nbsp;&nbsp;&nbsp;&nbsp; (55447) | (35007) | &nbsp;&nbsp; (155926) | &nbsp;&nbsp;&nbsp;&nbsp; (902882) |
| Units outstanding at end of year | 172778 | &nbsp;&nbsp;&nbsp;&nbsp; 560320 | 134026 | 2779899 | 10438082 |

---

See accompanying notes to financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**94 ■ RiverSource of New York Account 8**

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **VP Aggr,** <br>**Cl 4**<br>| **VP Conserv,** <br>**Cl 1**<br>| **VP Conserv,** <br>**Cl 2**<br>| **VP Conserv,** <br>**Cl 4**<br>| **VP Man Vol** <br> **Conserv Gro,** <br>**Cl 1**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $(123359) | $— | $(2785) | $(2703) | $— |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp; 1887340 |  | &nbsp;&nbsp;&nbsp;&nbsp; 35958 | &nbsp;&nbsp;&nbsp; 15546 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 87 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp; 2440166 | &nbsp;&nbsp;&nbsp; 3 | &nbsp;&nbsp;&nbsp;&nbsp; 54368 | &nbsp;&nbsp;&nbsp; 39997 | &nbsp;&nbsp;&nbsp; 6706 |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp; 4204147 | &nbsp;&nbsp;&nbsp; 3 | &nbsp;&nbsp;&nbsp;&nbsp; 87541 | &nbsp;&nbsp;&nbsp; 52840 | &nbsp;&nbsp;&nbsp; 6793 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp; 442171 |  | &nbsp;&nbsp;&nbsp;&nbsp; 47305 | &nbsp;&nbsp;&nbsp; 19907 | &nbsp;&nbsp;&nbsp; 2400 |
| Net transfers<sup>(1)</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp; (235265) |  | (329853) | (69091) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp;&nbsp; (527153) |  | &nbsp;&nbsp;&nbsp;&nbsp; (3063) | &nbsp;&nbsp;&nbsp; (1468) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Policy charges | &nbsp;&nbsp;&nbsp;&nbsp; (402456) |  | &nbsp;&nbsp;&nbsp; (41645) | (31843) | (1885) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | &nbsp;&nbsp;&nbsp;&nbsp; (777163) |  | &nbsp;&nbsp;&nbsp;&nbsp; (9548) | &nbsp;&nbsp;&nbsp; (1935) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |  | &nbsp;&nbsp;&nbsp; (22398) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | (1499866) |  | (359202) | (84430) | &nbsp;&nbsp;&nbsp;&nbsp; 515 |
| Increase (decrease) in net assets | &nbsp;&nbsp;&nbsp; 2704281 | &nbsp;&nbsp;&nbsp; 3 | (271661) | (31590) | &nbsp;&nbsp;&nbsp; 7308 |
| Net assets at beginning of year | 25535380 | &nbsp;&nbsp; 23 | &nbsp;&nbsp;&nbsp; 900263 | 614964 | 60636 |
| Net assets at end of year | $28239661 | $26 | $628602 | $583374 | $67944 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | 10125909 |  | &nbsp;&nbsp;&nbsp; 643584 | 432851 | 49055 |
| Units purchased | &nbsp;&nbsp;&nbsp; 1224555 |  | &nbsp;&nbsp;&nbsp;&nbsp; 51025 | &nbsp;&nbsp;&nbsp; 12958 | &nbsp;&nbsp;&nbsp; 1806 |
| Units redeemed | (1430431) |  | (286314) | (68905) | (1452) |
| Units outstanding at end of year | &nbsp;&nbsp;&nbsp; 9920033 |  | &nbsp;&nbsp;&nbsp; 408295 | 376904 | 49409 |

---

See accompanying notes to financial statements.

**RiverSource of New York Account 8** ■ 95

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **VP Man Vol** <br> **Conserv Gro,** <br>**Cl 2**<br>| **VP Man Vol** <br> **Conserv,** <br>**Cl 1**<br>| **VP Man Vol** <br> **Conserv,** <br>**Cl 2**<br>| **VP Man Vol** <br> **Gro,** <br>**Cl 1**<br>| **VP Man Vol** <br> **Gro,** <br>**Cl 2**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $(933) | $— | $(1031) | $— | $(7965) |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp; 2179 | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 778 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 9775 | &nbsp;&nbsp;&nbsp;&nbsp; 78769 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp; 35896 | &nbsp;&nbsp;&nbsp;&nbsp; 301 | &nbsp;&nbsp;&nbsp; 12588 | &nbsp;&nbsp;&nbsp;&nbsp; 289340 | &nbsp;&nbsp;&nbsp;&nbsp; 301805 |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp; 37142 | &nbsp;&nbsp;&nbsp;&nbsp; 301 | &nbsp;&nbsp;&nbsp; 12335 | &nbsp;&nbsp;&nbsp;&nbsp; 299115 | &nbsp;&nbsp;&nbsp;&nbsp; 372609 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp; 4498 | 1440 | &nbsp;&nbsp;&nbsp;&nbsp; 3377 | &nbsp;&nbsp;&nbsp;&nbsp; 183174 | &nbsp;&nbsp;&nbsp;&nbsp; 53096 |
| Net transfers<sup>(1)</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | 280115 | &nbsp;&nbsp;&nbsp;&nbsp; 84654 | &nbsp;&nbsp; (280748) |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp;&nbsp; (361) | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 22848 |
| Policy charges | (15442) | &nbsp;&nbsp; (571) | &nbsp;&nbsp;&nbsp; (7149) | &nbsp;&nbsp;&nbsp;&nbsp; (87003) | &nbsp;&nbsp;&nbsp;&nbsp; (23435) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (28) | &nbsp;&nbsp;&nbsp;&nbsp; — | (14540) | &nbsp;&nbsp;&nbsp;&nbsp; (48148) | &nbsp;&nbsp;&nbsp;&nbsp; (32101) |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | (11333) | &nbsp;&nbsp;&nbsp;&nbsp; 869 | 261803 | &nbsp;&nbsp;&nbsp;&nbsp; 132677 | &nbsp;&nbsp; (260340) |
| Increase (decrease) in net assets | &nbsp;&nbsp;&nbsp; 25809 | 1170 | 274138 | &nbsp;&nbsp;&nbsp;&nbsp; 431792 | &nbsp;&nbsp;&nbsp;&nbsp; 112269 |
| Net assets at beginning of year | 352646 | 2799 | 109464 | 1973357 | 2768128 |
| Net assets at end of year | $378455 | $3969 | $383602 | $2405149 | $2880397 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | 259766 | 2409 | &nbsp;&nbsp;&nbsp; 91757 | 1379639 | 1708250 |
| Units purchased | &nbsp;&nbsp;&nbsp; 12095 | 1193 | 217276 | &nbsp;&nbsp;&nbsp;&nbsp; 175384 | &nbsp;&nbsp;&nbsp;&nbsp; 54480 |
| Units redeemed | (20147) | &nbsp;&nbsp; (473) | (16883) | &nbsp;&nbsp;&nbsp;&nbsp; (92410) | &nbsp;&nbsp; (206655) |
| Units outstanding at end of year | 251714 | 3129 | 292150 | 1462613 | 1556075 |

---

See accompanying notes to financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**96 ■ RiverSource of New York Account 8**

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **VP Man Vol** <br> **Mod Gro,** <br>**Cl 1**<br>| **VP Man Vol** <br> **Mod Gro,** <br>**Cl 2**<br>| **VP Mod Aggr,** <br>**Cl 1**<br>| **VP Mod Aggr,** <br>**Cl 2**<br>| **VP Mod Aggr,** <br>**Cl 4**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $— | $(6889) | $— | $(162297) | $(277846) |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3491 | &nbsp;&nbsp;&nbsp;&nbsp; 85762 | &nbsp;&nbsp;&nbsp;&nbsp; 171741 | &nbsp;&nbsp;&nbsp; 1642536 | &nbsp;&nbsp;&nbsp; 3928371 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp;&nbsp; 154362 | &nbsp;&nbsp;&nbsp;&nbsp; 174022 | &nbsp;&nbsp;&nbsp; 2077575 | &nbsp;&nbsp;&nbsp; 5012459 | &nbsp;&nbsp;&nbsp; 4856012 |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp;&nbsp; 157853 | &nbsp;&nbsp;&nbsp;&nbsp; 252895 | &nbsp;&nbsp;&nbsp; 2249316 | &nbsp;&nbsp;&nbsp; 6492698 | &nbsp;&nbsp;&nbsp; 8506537 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp; 133059 | &nbsp;&nbsp;&nbsp;&nbsp; 63867 | &nbsp;&nbsp;&nbsp; 2647312 | &nbsp;&nbsp;&nbsp; 1783589 | &nbsp;&nbsp;&nbsp; 1546587 |
| Net transfers<sup>(1)</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3395 | &nbsp;&nbsp;&nbsp;&nbsp; 212737 | &nbsp;&nbsp;&nbsp;&nbsp; 844765 | &nbsp;&nbsp;&nbsp;&nbsp; (527464) | &nbsp;&nbsp;&nbsp;&nbsp; (286621) |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (8565) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 17056 | &nbsp;&nbsp;&nbsp;&nbsp; (573885) | &nbsp;&nbsp;&nbsp;&nbsp; (360498) |
| Policy charges | &nbsp;&nbsp;&nbsp;&nbsp; (75622) | &nbsp;&nbsp;&nbsp;&nbsp; (74110) | &nbsp;&nbsp;&nbsp;&nbsp; (787638) | &nbsp;&nbsp;&nbsp;&nbsp; (977456) | (1316071) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (57661) | &nbsp;&nbsp;&nbsp;&nbsp; (32745) | (1606437) | (2475459) |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | &nbsp;&nbsp;&nbsp;&nbsp; 60832 | &nbsp;&nbsp;&nbsp;&nbsp; 136268 | &nbsp;&nbsp;&nbsp; 2688750 | (1901653) | (2892062) |
| Increase (decrease) in net assets | &nbsp;&nbsp;&nbsp;&nbsp; 218685 | &nbsp;&nbsp;&nbsp;&nbsp; 389163 | &nbsp;&nbsp;&nbsp; 4938066 | &nbsp;&nbsp;&nbsp; 4591045 | &nbsp;&nbsp;&nbsp; 5614475 |
| Net assets at beginning of year | 1152932 | 2002651 | 12903674 | 43391902 | 57884693 |
| Net assets at end of year | $1371617 | $2391814 | $17841740 | $47982947 | $63499168 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | &nbsp;&nbsp;&nbsp;&nbsp; 863646 | 1345470 | &nbsp;&nbsp;&nbsp; 8600949 | 18893269 | 24907823 |
| Units purchased | &nbsp;&nbsp;&nbsp;&nbsp; 98226 | &nbsp;&nbsp;&nbsp;&nbsp; 220766 | &nbsp;&nbsp;&nbsp; 2163321 | &nbsp;&nbsp;&nbsp; 1466889 | &nbsp;&nbsp;&nbsp; 3336613 |
| Units redeemed | &nbsp;&nbsp;&nbsp;&nbsp; (53628) | &nbsp;&nbsp; (144201) | &nbsp;&nbsp;&nbsp;&nbsp; (509253) | (1961069) | (3616375) |
| Units outstanding at end of year | &nbsp;&nbsp;&nbsp;&nbsp; 908244 | 1422035 | 10255017 | 18399089 | 24628061 |

---

See accompanying notes to financial statements.

**RiverSource of New York Account 8** ■ 97

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **VP Mod** <br> **Conserv,** <br>**Cl 1**<br>| **VP Mod** <br> **Conserv,** <br>**Cl 2**<br>| **VP Mod** <br> **Conserv,** <br>**Cl 4**<br>| **VP Mod,** <br>**Cl 1**<br>| **VP Mod,** <br>**Cl 2**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $— | $(10048) | $(11949) | $— | $(126042) |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp; 55364 | &nbsp;&nbsp;&nbsp;&nbsp; 54516 | &nbsp;&nbsp;&nbsp;&nbsp; 147508 | &nbsp;&nbsp;&nbsp;&nbsp; 97665 | &nbsp;&nbsp;&nbsp;&nbsp; 947700 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp; (45335) | &nbsp;&nbsp;&nbsp;&nbsp; 197889 | &nbsp;&nbsp;&nbsp;&nbsp; 167268 | &nbsp;&nbsp;&nbsp;&nbsp; 699351 | &nbsp;&nbsp;&nbsp; 2672204 |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp;&nbsp; 10029 | &nbsp;&nbsp;&nbsp;&nbsp; 242357 | &nbsp;&nbsp;&nbsp;&nbsp; 302827 | &nbsp;&nbsp;&nbsp;&nbsp; 797016 | &nbsp;&nbsp;&nbsp; 3493862 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 119951 | &nbsp;&nbsp;&nbsp;&nbsp; 124104 | &nbsp;&nbsp;&nbsp;&nbsp; 737204 | &nbsp;&nbsp;&nbsp; 1049241 |
| Net transfers<sup>(1)</sup> <br>| (360591) | &nbsp;&nbsp;&nbsp;&nbsp; 345295 | &nbsp;&nbsp;&nbsp;&nbsp; 84965 | &nbsp;&nbsp;&nbsp;&nbsp; 653811 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 97348 |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (47559) | &nbsp;&nbsp;&nbsp;&nbsp; (9891) | &nbsp;&nbsp;&nbsp;&nbsp; (50171) | &nbsp;&nbsp;&nbsp;&nbsp; (29184) |
| Policy charges | &nbsp;&nbsp;&nbsp;&nbsp; (2375) | &nbsp;&nbsp; (115508) | &nbsp;&nbsp; (145195) | &nbsp;&nbsp; (370247) | (1007788) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp; (111704) | &nbsp;&nbsp;&nbsp;&nbsp; (42924) | &nbsp;&nbsp;&nbsp;&nbsp; (40397) | &nbsp;&nbsp;&nbsp;&nbsp; (916998) |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | (362966) | &nbsp;&nbsp;&nbsp;&nbsp; 190475 | &nbsp;&nbsp;&nbsp;&nbsp; 11059 | &nbsp;&nbsp;&nbsp;&nbsp; 930200 | &nbsp;&nbsp;&nbsp;&nbsp; (807381) |
| Increase (decrease) in net assets | (352937) | &nbsp;&nbsp;&nbsp;&nbsp; 432832 | &nbsp;&nbsp;&nbsp;&nbsp; 313886 | 1727216 | &nbsp;&nbsp;&nbsp; 2686481 |
| Net assets at beginning of year | &nbsp;&nbsp;&nbsp; 353794 | 2172972 | 2637394 | 5272969 | 26765053 |
| Net assets at end of year | $857 | $2605804 | $2951280 | $7000185 | $29451534 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | &nbsp;&nbsp;&nbsp; 278435 | 1227084 | 1565651 | 3783956 | 13596036 |
| Units purchased | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 281760 | &nbsp;&nbsp;&nbsp;&nbsp; 303543 | &nbsp;&nbsp;&nbsp;&nbsp; 932341 | &nbsp;&nbsp;&nbsp; 1105593 |
| Units redeemed | (277835) | &nbsp;&nbsp; (174467) | &nbsp;&nbsp; (228272) | &nbsp;&nbsp; (315206) | (1359144) |
| Units outstanding at end of year | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 600 | 1334377 | 1640922 | 4401091 | 13342485 |

---

See accompanying notes to financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**98 ■ RiverSource of New York Account 8**

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **VP Mod,** <br>**Cl 4**<br>| **VP Ptnrs Core** <br> **Bond,** <br>**Cl 1**<br>| **VP Ptnrs Core** <br> **Bond,** <br>**Cl 2**<br>| **VP Ptnrs Core** <br> **Eq,** <br>**Cl 1**<br>| **VP Ptnrs Core** <br> **Eq,** <br>**Cl 2**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $(165205) | $1570 | $1272 | $— | $— |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp; 2064151 | &nbsp;&nbsp;&nbsp;&nbsp; (26) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 30 | &nbsp;&nbsp;&nbsp;&nbsp; 446 | &nbsp;&nbsp;&nbsp;&nbsp; 375 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp; 2429611 | &nbsp;&nbsp;&nbsp;&nbsp; 653 | &nbsp;&nbsp;&nbsp;&nbsp; 198 | &nbsp;&nbsp;&nbsp;&nbsp; 185 | &nbsp;&nbsp;&nbsp; 4752 |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp; 4328557 | &nbsp;&nbsp;&nbsp; 2197 | &nbsp;&nbsp;&nbsp; 1500 | &nbsp;&nbsp;&nbsp;&nbsp; 631 | &nbsp;&nbsp;&nbsp; 5127 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp; 1122930 | &nbsp;&nbsp;&nbsp; 3971 | &nbsp;&nbsp;&nbsp;&nbsp; 153 | &nbsp;&nbsp;&nbsp; 4803 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 51 |
| Net transfers<sup>(1)</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp; (152533) | &nbsp;&nbsp;&nbsp; 7208 | 12100 | &nbsp;&nbsp;&nbsp;&nbsp; (658) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp;&nbsp; (224156) | &nbsp;&nbsp;&nbsp;&nbsp; (457) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Policy charges | (1382940) | (2486) | &nbsp;&nbsp;&nbsp;&nbsp; (831) | (2119) | (1394) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | (1293569) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp; (328032) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | (2258300) | &nbsp;&nbsp;&nbsp; 8236 | 11422 | &nbsp;&nbsp;&nbsp; 2026 | (1343) |
| Increase (decrease) in net assets | &nbsp;&nbsp;&nbsp; 2070257 | 10433 | 12922 | &nbsp;&nbsp;&nbsp; 2657 | &nbsp;&nbsp;&nbsp; 3784 |
| Net assets at beginning of year | 33773143 | 27685 | 12461 | &nbsp;&nbsp;&nbsp; 5406 | 40096 |
| Net assets at end of year | $35843400 | $38118 | $25383 | $8063 | $43880 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | 17045168 | 25583 | 10621 | &nbsp;&nbsp;&nbsp; 2488 | &nbsp;&nbsp;&nbsp; 9746 |
| Units purchased | &nbsp;&nbsp;&nbsp; 1784275 | &nbsp;&nbsp;&nbsp; 9732 | 10232 | &nbsp;&nbsp;&nbsp; 2015 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 12 |
| Units redeemed | (2344124) | (2585) | &nbsp;&nbsp;&nbsp;&nbsp; (685) | (1232) | &nbsp;&nbsp;&nbsp;&nbsp; (330) |
| Units outstanding at end of year | 16485319 | 32730 | 20168 | &nbsp;&nbsp;&nbsp; 3271 | &nbsp;&nbsp;&nbsp; 9428 |

---

See accompanying notes to financial statements.

**RiverSource of New York Account 8** ■ 99

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **VP Ptnrs Core** <br> **Eq,** <br>**Cl 3**<br>| **VP Ptnrs Intl** <br> **Core Eq,** <br>**Cl 1**<br>| **VP Ptnrs Intl** <br> **Core Eq,** <br>**Cl 2**<br>| **VP Ptnrs Intl** <br> **Gro,** <br>**Cl 1**<br>| **VP Ptnrs Intl** <br> **Gro,** <br>**Cl 2**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $(2532) | $4686 | $853 | $1129 | $1082 |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp; 52596 | &nbsp;&nbsp;&nbsp;&nbsp; 1218 | &nbsp;&nbsp;&nbsp;&nbsp; 233 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 554 | &nbsp;&nbsp;&nbsp;&nbsp; 1125 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; 14839 | &nbsp;&nbsp;&nbsp; 2898 | &nbsp;&nbsp;&nbsp;&nbsp; 1278 | &nbsp;&nbsp;&nbsp;&nbsp; 1822 |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp; 11937 | &nbsp;&nbsp;&nbsp; 52665 | 10544 | &nbsp;&nbsp;&nbsp; 24470 | &nbsp;&nbsp;&nbsp; 30622 |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp; 62001 | &nbsp;&nbsp;&nbsp; 73408 | 14528 | &nbsp;&nbsp;&nbsp; 27431 | &nbsp;&nbsp;&nbsp; 34651 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp; 8428 | &nbsp;&nbsp;&nbsp; 76840 | &nbsp;&nbsp;&nbsp; 1558 | &nbsp;&nbsp;&nbsp; 10984 | &nbsp;&nbsp;&nbsp; 12122 |
| Net transfers<sup>(1)</sup> <br>| (35180) | &nbsp;&nbsp;&nbsp; 50690 | &nbsp;&nbsp;&nbsp;&nbsp; (314) | &nbsp;&nbsp;&nbsp; 89229 | &nbsp;&nbsp;&nbsp; 13620 |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp;&nbsp; (291) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (31) | &nbsp;&nbsp;&nbsp;&nbsp; (400) | &nbsp;&nbsp;&nbsp; (7404) |
| Policy charges | &nbsp;&nbsp;&nbsp; (7601) | (25095) | (2161) | &nbsp;&nbsp;&nbsp; (5759) | &nbsp;&nbsp;&nbsp; (6146) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | &nbsp;&nbsp;&nbsp; (4510) | &nbsp;&nbsp;&nbsp;&nbsp; (174) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; (2682) |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | (39154) | 102261 | &nbsp;&nbsp;&nbsp;&nbsp; (948) | &nbsp;&nbsp;&nbsp; 94054 | &nbsp;&nbsp;&nbsp;&nbsp; 9510 |
| Increase (decrease) in net assets | &nbsp;&nbsp;&nbsp; 22847 | 175669 | 13580 | 121485 | &nbsp;&nbsp;&nbsp; 44161 |
| Net assets at beginning of year | 488169 | 255992 | 59583 | 146012 | 187641 |
| Net assets at end of year | $511016 | $431661 | $73163 | $267497 | $231802 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | &nbsp;&nbsp;&nbsp; 91293 | 186218 | 34866 | 112977 | 114003 |
| Units purchased | &nbsp;&nbsp;&nbsp; 14180 | &nbsp;&nbsp;&nbsp; 81080 | &nbsp;&nbsp;&nbsp;&nbsp; 800 | &nbsp;&nbsp;&nbsp; 67124 | &nbsp;&nbsp;&nbsp; 14618 |
| Units redeemed | (13313) | (15795) | (1292) | &nbsp;&nbsp;&nbsp; (4353) | &nbsp;&nbsp;&nbsp; (8765) |
| Units outstanding at end of year | &nbsp;&nbsp;&nbsp; 92160 | 251503 | 34374 | 175748 | 119856 |

---

See accompanying notes to financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**100 ■ RiverSource of New York Account 8**

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **VP Ptnrs Intl** <br> **Val,** <br>**Cl 1**<br>| **VP Ptnrs Intl** <br> **Val,** <br>**Cl 2**<br>| **VP Ptnrs Sm** <br> **Cap Gro,** <br>**Cl 1**<br>| **VP Ptnrs Sm** <br> **Cap Gro,** <br>**Cl 2**<br>| **VP Ptnrs Sm** <br> **Cap Val,** <br>**Cl 1**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $1651 | $2090 | $— | $— | $— |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp; 435 | &nbsp;&nbsp;&nbsp; 1938 | &nbsp;&nbsp;&nbsp;&nbsp; 650 | &nbsp;&nbsp;&nbsp;&nbsp; 2628 | &nbsp;&nbsp;&nbsp;&nbsp; 302 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp; 154 | &nbsp;&nbsp;&nbsp;&nbsp; 199 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | 16161 | 18725 | &nbsp;&nbsp;&nbsp; 4839 | &nbsp;&nbsp;&nbsp; (2610) | &nbsp;&nbsp;&nbsp;&nbsp; (82) |
| Net increase (decrease) in net assets resulting from operations | 18401 | 22952 | &nbsp;&nbsp;&nbsp; 5489 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 18 | &nbsp;&nbsp;&nbsp;&nbsp; 220 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp; 9759 | &nbsp;&nbsp;&nbsp; 2979 | &nbsp;&nbsp;&nbsp; 9210 | &nbsp;&nbsp;&nbsp;&nbsp; 3562 | &nbsp;&nbsp;&nbsp; 1381 |
| Net transfers<sup>(1)</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp; 564 | (7085) | (2806) | (20727) | (4197) |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 361 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 50 |
| Policy charges | (3288) | (1486) | (2701) | &nbsp;&nbsp;&nbsp;&nbsp; (257) | &nbsp;&nbsp;&nbsp;&nbsp; (306) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | &nbsp;&nbsp;&nbsp;&nbsp; (248) | (1883) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | &nbsp;&nbsp;&nbsp; 6787 | (7114) | &nbsp;&nbsp;&nbsp; 3703 | (17422) | (3072) |
| Increase (decrease) in net assets | 25188 | 15838 | &nbsp;&nbsp;&nbsp; 9192 | (17404) | (2852) |
| Net assets at beginning of year | 50035 | 67354 | 64354 | &nbsp;&nbsp;&nbsp; 42242 | &nbsp;&nbsp;&nbsp; 7240 |
| Net assets at end of year | $75223 | $83192 | $73546 | $24838 | $4388 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | 40904 | 43223 | 46036 | &nbsp;&nbsp;&nbsp; 16798 | &nbsp;&nbsp;&nbsp; 5267 |
| Units purchased | &nbsp;&nbsp;&nbsp; 7035 | &nbsp;&nbsp;&nbsp; 1870 | &nbsp;&nbsp;&nbsp; 6558 | &nbsp;&nbsp;&nbsp;&nbsp; 1416 | &nbsp;&nbsp;&nbsp; 1027 |
| Units redeemed | (2437) | (5501) | (3938) | &nbsp;&nbsp;&nbsp; (9057) | (3321) |
| Units outstanding at end of year | 45502 | 39592 | 48656 | &nbsp;&nbsp;&nbsp;&nbsp; 9157 | &nbsp;&nbsp;&nbsp; 2973 |

---

See accompanying notes to financial statements.

**RiverSource of New York Account 8** ■ 101

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **VP Ptnrs Sm** <br> **Cap Val,** <br>**Cl 2**<br>| **VP Ptnrs Sm** <br> **Cap Val,** <br>**Cl 3**<br>| **VP US Flex** <br> **Conserv Gro,** <br>**Cl 1**<br>| **VP US Flex** <br> **Gro,** <br>**Cl 1**<br>| **VP US Flex** <br> **Mod Gro,** <br>**Cl 1**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $— | $(2697) | $— | $— | $— |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp; 80 | &nbsp;&nbsp;&nbsp; 41799 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 90 | &nbsp;&nbsp;&nbsp;&nbsp; 1554 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 138 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp;&nbsp; 408 | &nbsp;&nbsp;&nbsp;&nbsp; 6115 | &nbsp;&nbsp;&nbsp;&nbsp; 732 | &nbsp;&nbsp;&nbsp; 29399 | &nbsp;&nbsp;&nbsp; 12322 |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp;&nbsp; 488 | &nbsp;&nbsp;&nbsp; 45217 | &nbsp;&nbsp;&nbsp;&nbsp; 822 | &nbsp;&nbsp;&nbsp; 30953 | &nbsp;&nbsp;&nbsp; 12460 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp; 548 | &nbsp;&nbsp;&nbsp; 18474 | &nbsp;&nbsp;&nbsp; 2243 | &nbsp;&nbsp;&nbsp; 64877 | &nbsp;&nbsp;&nbsp;&nbsp; 4737 |
| Net transfers<sup>(1)</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (458) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 4803 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Transfers for policy loans | &nbsp;&nbsp; (124) | &nbsp;&nbsp;&nbsp; (1487) | &nbsp;&nbsp;&nbsp;&nbsp; (429) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Policy charges | &nbsp;&nbsp; (243) | (15746) | &nbsp;&nbsp;&nbsp;&nbsp; (349) | (20265) | &nbsp;&nbsp;&nbsp; (3407) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; (3973) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | &nbsp;&nbsp;&nbsp;&nbsp; 181 | &nbsp;&nbsp;&nbsp; (3190) | &nbsp;&nbsp;&nbsp; 1465 | &nbsp;&nbsp;&nbsp; 49415 | &nbsp;&nbsp;&nbsp;&nbsp; 1330 |
| Increase (decrease) in net assets | &nbsp;&nbsp;&nbsp;&nbsp; 669 | &nbsp;&nbsp;&nbsp; 42027 | &nbsp;&nbsp;&nbsp; 2287 | &nbsp;&nbsp;&nbsp; 80368 | &nbsp;&nbsp;&nbsp; 13790 |
| Net assets at beginning of year | 6531 | 647489 | &nbsp;&nbsp;&nbsp; 8131 | 233344 | 117569 |
| Net assets at end of year | $7200 | $689516 | $10418 | $313712 | $131359 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | 2755 | 232044 | &nbsp;&nbsp;&nbsp; 6328 | 152626 | &nbsp;&nbsp;&nbsp; 83620 |
| Units purchased | &nbsp;&nbsp;&nbsp;&nbsp; 237 | &nbsp;&nbsp;&nbsp; 74028 | &nbsp;&nbsp;&nbsp; 1670 | &nbsp;&nbsp;&nbsp; 44470 | &nbsp;&nbsp;&nbsp;&nbsp; 3364 |
| Units redeemed | &nbsp;&nbsp; (156) | (36151) | &nbsp;&nbsp;&nbsp;&nbsp; (592) | (12861) | &nbsp;&nbsp;&nbsp; (2334) |
| Units outstanding at end of year | 2836 | 269921 | &nbsp;&nbsp;&nbsp; 7406 | 184235 | &nbsp;&nbsp;&nbsp; 84650 |

---

See accompanying notes to financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**102 ■ RiverSource of New York Account 8**

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | |
|:---|:---|:---|
| **Year ended December 31, 2025 (continued)** | **WA Var Global** <br> **Hi Yd Bond,** <br>**Cl I**<br>| **WA Var Global** <br> **Hi Yd Bond,** <br>**Cl II**<br>|
| **Operations** |  |  |
| Investment income (loss) — net | $1892 | $463 |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp; (12) | &nbsp;&nbsp;&nbsp;&nbsp; (160) |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp;&nbsp; 676 | &nbsp;&nbsp;&nbsp;&nbsp; 399 |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp; 2556 | &nbsp;&nbsp;&nbsp;&nbsp; 702 |
| **Contract transactions** |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp; 2369 | &nbsp;&nbsp;&nbsp;&nbsp; 654 |
| Net transfers<sup>(1)</sup> <br>| &nbsp;&nbsp;&nbsp; 2058 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | (1158) |
| Policy charges | (1461) | &nbsp;&nbsp;&nbsp;&nbsp; (586) |
| Contract terminations: |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | &nbsp;&nbsp;&nbsp; 2966 | (1090) |
| Increase (decrease) in net assets | &nbsp;&nbsp;&nbsp; 5522 | &nbsp;&nbsp;&nbsp;&nbsp; (388) |
| Net assets at beginning of year | 24771 | &nbsp;&nbsp;&nbsp; 7929 |
| Net assets at end of year | $30293 | $7541 |
| **Accumulation unit activity** |  |  |
| Units outstanding at beginning of year | 20702 | &nbsp;&nbsp;&nbsp; 5589 |
| Units purchased | &nbsp;&nbsp;&nbsp; 3487 | &nbsp;&nbsp;&nbsp;&nbsp; 445 |
| Units redeemed | (1165) | (1200) |
| Units outstanding at end of year | 23024 | &nbsp;&nbsp;&nbsp; 4834 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

<sup>(1)</sup> Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY's fixed account. <br> <sup>(2)</sup> See Note 9 in the Notes to Financial Statements.

See accompanying notes to financial statements.

**RiverSource of New York Account 8** ■ 103

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2024** | **AB VPS Dyn** <br> **Asset Alloc,** <br>**Cl B**<br>| **AB VPS Intl** <br> **Val,** <br>**Cl B**<br>| **AB VPS Lg** <br> **Cap Gro,** <br>**Cl A**<br>| **AB VPS Lg** <br> **Cap Gro,** <br>**Cl B**<br>| **AB VPS** <br> **Relative Val,** <br>**Cl B**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $5 | $50019 | $320 | $(10918) | $21014 |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 57910 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2038 | &nbsp;&nbsp;&nbsp;&nbsp; 159654 | &nbsp;&nbsp;&nbsp;&nbsp; 53289 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 23703 | &nbsp;&nbsp;&nbsp;&nbsp; 145045 | &nbsp;&nbsp;&nbsp;&nbsp; 92753 |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp; 44 | &nbsp;&nbsp;&nbsp;&nbsp; 16203 | &nbsp;&nbsp;&nbsp;&nbsp; 89092 | &nbsp;&nbsp;&nbsp;&nbsp; 397294 | &nbsp;&nbsp;&nbsp;&nbsp; 135032 |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp; 49 | &nbsp;&nbsp;&nbsp;&nbsp; 124132 | &nbsp;&nbsp;&nbsp;&nbsp; 115153 | &nbsp;&nbsp;&nbsp;&nbsp; 691075 | &nbsp;&nbsp;&nbsp;&nbsp; 302088 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 117505 | &nbsp;&nbsp;&nbsp;&nbsp; 191242 | &nbsp;&nbsp;&nbsp;&nbsp; 130090 | &nbsp;&nbsp;&nbsp;&nbsp; 42160 |
| Net transfers<sup>(1)</sup> <br>| &nbsp;&nbsp;&nbsp; (1) | &nbsp;&nbsp;&nbsp;&nbsp; (3538) | &nbsp;&nbsp;&nbsp;&nbsp; 404952 | &nbsp;&nbsp;&nbsp;&nbsp; 22024 | &nbsp;&nbsp;&nbsp;&nbsp; 11023 |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (41669) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp; (133982) | &nbsp;&nbsp; (100891) |
| Policy charges | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (82311) | &nbsp;&nbsp;&nbsp;&nbsp; (42853) | &nbsp;&nbsp;&nbsp;&nbsp; (58785) | &nbsp;&nbsp;&nbsp;&nbsp; (55266) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp; (259413) | &nbsp;&nbsp;&nbsp;&nbsp; (2906) | &nbsp;&nbsp;&nbsp;&nbsp; (48931) | &nbsp;&nbsp;&nbsp;&nbsp; (98065) |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (2240) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | &nbsp;&nbsp;&nbsp; (1) | &nbsp;&nbsp; (271666) | &nbsp;&nbsp;&nbsp;&nbsp; 550435 | &nbsp;&nbsp;&nbsp;&nbsp; (89584) | &nbsp;&nbsp; (201039) |
| Increase (decrease) in net assets | &nbsp;&nbsp;&nbsp; 48 | &nbsp;&nbsp; (147534) | &nbsp;&nbsp;&nbsp;&nbsp; 665588 | &nbsp;&nbsp;&nbsp;&nbsp; 601491 | &nbsp;&nbsp;&nbsp;&nbsp; 101049 |
| Net assets at beginning of year | 482 | 2702634 | &nbsp;&nbsp;&nbsp;&nbsp; 349453 | 2799308 | 2515292 |
| Net assets at end of year | $530 | $2555100 | $1015041 | $3400799 | $2616341 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | &nbsp;&nbsp;&nbsp; — | 1463164 | &nbsp;&nbsp;&nbsp;&nbsp; 174392 | &nbsp;&nbsp;&nbsp;&nbsp; 454378 | &nbsp;&nbsp;&nbsp;&nbsp; 620773 |
| Units purchased | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 287549 | &nbsp;&nbsp;&nbsp;&nbsp; 249639 | &nbsp;&nbsp;&nbsp;&nbsp; 77965 | &nbsp;&nbsp;&nbsp;&nbsp; 221070 |
| Units redeemed | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp; (358244) | &nbsp;&nbsp;&nbsp;&nbsp; (19618) | &nbsp;&nbsp;&nbsp;&nbsp; (75176) | &nbsp;&nbsp; (156818) |
| Units outstanding at end of year | &nbsp;&nbsp;&nbsp; — | 1392469 | &nbsp;&nbsp;&nbsp;&nbsp; 404413 | &nbsp;&nbsp;&nbsp;&nbsp; 457167 | &nbsp;&nbsp;&nbsp;&nbsp; 685025 |

---

See accompanying notes to financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**104 ■ RiverSource of New York Account 8**

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2024 (continued)** | **Allspg VT** <br> **Index Asset** <br> **Alloc,** <br>**Cl 2**<br>| **Allspg VT Opp,** <br>**Cl 1**<br>| **Allspg VT Opp,** <br>**Cl 2**<br>| **Allspg VT Sm** <br> **Cap Gro,** <br>**Cl 1**<br>| **Allspg VT Sm** <br> **Cap Gro,** <br>**Cl 2**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $5304 | $56 | $(4695) | $— | $(4236) |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp; 3956 | &nbsp;&nbsp;&nbsp;&nbsp; 285 | &nbsp;&nbsp;&nbsp;&nbsp; 24998 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 817 | &nbsp;&nbsp;&nbsp;&nbsp; (47549) |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp; 35444 | &nbsp;&nbsp;&nbsp; 2020 | &nbsp;&nbsp;&nbsp;&nbsp; 143466 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp; 30864 | &nbsp;&nbsp;&nbsp;&nbsp; 505 | &nbsp;&nbsp;&nbsp;&nbsp; 33134 | &nbsp;&nbsp;&nbsp; 56781 | &nbsp;&nbsp;&nbsp;&nbsp; 289176 |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp; 75568 | &nbsp;&nbsp;&nbsp; 2866 | &nbsp;&nbsp;&nbsp;&nbsp; 196903 | &nbsp;&nbsp;&nbsp; 57598 | &nbsp;&nbsp;&nbsp;&nbsp; 237391 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp; 17749 | &nbsp;&nbsp;&nbsp; 6963 | &nbsp;&nbsp;&nbsp;&nbsp; 38868 | &nbsp;&nbsp;&nbsp; 95869 | &nbsp;&nbsp;&nbsp;&nbsp; 68930 |
| Net transfers<sup>(1)</sup> <br>| (24987) | (4811) | &nbsp;&nbsp;&nbsp;&nbsp; (52468) | &nbsp;&nbsp;&nbsp; (5486) | &nbsp;&nbsp;&nbsp;&nbsp; (63678) |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp;&nbsp; 4621 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp; (123180) | &nbsp;&nbsp;&nbsp; (5233) | &nbsp;&nbsp;&nbsp;&nbsp; (39836) |
| Policy charges | (15150) | (1483) | &nbsp;&nbsp;&nbsp;&nbsp; (27609) | (25255) | &nbsp;&nbsp;&nbsp;&nbsp; (32233) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | &nbsp;&nbsp;&nbsp;&nbsp; (131) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (57431) | &nbsp;&nbsp;&nbsp; (4904) | &nbsp;&nbsp;&nbsp;&nbsp; (33839) |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | (17898) | &nbsp;&nbsp;&nbsp;&nbsp; 669 | &nbsp;&nbsp; (221820) | &nbsp;&nbsp;&nbsp; 54991 | &nbsp;&nbsp; (100656) |
| Increase (decrease) in net assets | &nbsp;&nbsp;&nbsp; 57670 | &nbsp;&nbsp;&nbsp; 3535 | &nbsp;&nbsp;&nbsp;&nbsp; (24917) | 112589 | &nbsp;&nbsp;&nbsp;&nbsp; 136735 |
| Net assets at beginning of year | 536098 | 20536 | 1367078 | 279900 | 1311216 |
| Net assets at end of year | $593768 | $24071 | $1342161 | $392489 | $1447951 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | 246263 | 11587 | &nbsp;&nbsp;&nbsp;&nbsp; 266120 | 225126 | &nbsp;&nbsp;&nbsp;&nbsp; 397422 |
| Units purchased | &nbsp;&nbsp;&nbsp; 74337 | &nbsp;&nbsp;&nbsp; 3579 | &nbsp;&nbsp;&nbsp;&nbsp; 53872 | &nbsp;&nbsp;&nbsp; 67895 | &nbsp;&nbsp;&nbsp;&nbsp; 149185 |
| Units redeemed | (77488) | (3392) | &nbsp;&nbsp;&nbsp;&nbsp; (57320) | (27898) | &nbsp;&nbsp;&nbsp;&nbsp; (95051) |
| Units outstanding at end of year | 243112 | 11774 | &nbsp;&nbsp;&nbsp;&nbsp; 262672 | 265123 | &nbsp;&nbsp;&nbsp;&nbsp; 451556 |

---

See accompanying notes to financial statements.

**RiverSource of New York Account 8** ■ 105

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2024 (continued)** | **ALPS Alerian** <br> **Engy Infr,** <br> **Class I**<br>| **ALPS Alerian** <br> **Engy Infr,** <br> **Class III**<br>| **BlackRock** <br> **Global Alloc,** <br>**Cl I**<br>| **BlackRock** <br> **Global Alloc,** <br>**Cl III**<br>| **Calvert VP SRI** <br> **Bal,** <br>**Cl I**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $3396 | $19820 | $2415 | $1904 | $32126 |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp; 585 | &nbsp;&nbsp;&nbsp;&nbsp; 89776 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 92 | &nbsp;&nbsp;&nbsp;&nbsp; (996) | &nbsp;&nbsp;&nbsp;&nbsp; 76638 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp; 2485 | &nbsp;&nbsp;&nbsp;&nbsp; 18444 | &nbsp;&nbsp;&nbsp; 19361 | &nbsp;&nbsp;&nbsp; 48409 | &nbsp;&nbsp;&nbsp;&nbsp; 46619 |
| Net change in unrealized appreciation (depreciation) of investments | 15776 | &nbsp;&nbsp;&nbsp;&nbsp; 72474 | &nbsp;&nbsp;&nbsp; (1839) | &nbsp;&nbsp;&nbsp; (3444) | &nbsp;&nbsp;&nbsp;&nbsp; 322962 |
| Net increase (decrease) in net assets resulting from operations | 22242 | &nbsp;&nbsp;&nbsp; 200514 | &nbsp;&nbsp;&nbsp; 20029 | &nbsp;&nbsp;&nbsp; 45873 | &nbsp;&nbsp;&nbsp;&nbsp; 478345 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | 20980 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 9878 | &nbsp;&nbsp;&nbsp; 83291 | &nbsp;&nbsp;&nbsp; 16104 | &nbsp;&nbsp;&nbsp;&nbsp; 141307 |
| Net transfers<sup>(1)</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp; (737) | &nbsp;&nbsp;&nbsp; (85402) | &nbsp;&nbsp;&nbsp; 16242 | &nbsp;&nbsp;&nbsp;&nbsp; 2740 | &nbsp;&nbsp; (266680) |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; (85450) | &nbsp;&nbsp;&nbsp;&nbsp; 3130 | &nbsp;&nbsp;&nbsp;&nbsp; (466) | &nbsp;&nbsp; (122508) |
| Policy charges | (3299) | &nbsp;&nbsp;&nbsp;&nbsp; (7193) | (20198) | &nbsp;&nbsp;&nbsp; (9568) | &nbsp;&nbsp; (111666) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (3404) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; (3309) | &nbsp;&nbsp; (314051) |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (700) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | 16944 | (172271) | &nbsp;&nbsp;&nbsp; 82465 | &nbsp;&nbsp;&nbsp;&nbsp; 5501 | &nbsp;&nbsp; (673598) |
| Increase (decrease) in net assets | 39186 | &nbsp;&nbsp;&nbsp;&nbsp; 28243 | 102494 | &nbsp;&nbsp;&nbsp; 51374 | &nbsp;&nbsp; (195253) |
| Net assets at beginning of year | 49847 | &nbsp;&nbsp;&nbsp; 514470 | 189307 | 514457 | 2776355 |
| Net assets at end of year | $89033 | $542713 | $291801 | $565831 | $2581102 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | 35085 | &nbsp;&nbsp;&nbsp; 463683 | 139635 | 347023 | &nbsp;&nbsp;&nbsp;&nbsp; 911054 |
| Units purchased | 11872 | &nbsp;&nbsp;&nbsp;&nbsp; 13606 | &nbsp;&nbsp;&nbsp; 71413 | &nbsp;&nbsp;&nbsp; 23736 | &nbsp;&nbsp;&nbsp;&nbsp; 59756 |
| Units redeemed | (2523) | (133077) | (14005) | (20463) | &nbsp;&nbsp; (283459) |
| Units outstanding at end of year | 44434 | &nbsp;&nbsp;&nbsp; 344212 | 197043 | 350296 | &nbsp;&nbsp;&nbsp;&nbsp; 687351 |

---

See accompanying notes to financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**106 ■ RiverSource of New York Account 8**

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2024 (continued)** | **Col VP Acorn** | **Col VP Acorn** <br> **Intl**<br>| **Col VP Bal,** <br>**Cl 1**<br>| **Col VP Bal,** <br>**Cl 3**<br>| **Col VP** <br> **Commodity** <br> **Strategy,** <br>**Cl 1**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $(29906) | $36519 | $— | $(137873) | $2278 |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp; (433510) | &nbsp;&nbsp; (166793) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 8786 | &nbsp;&nbsp;&nbsp; 1009494 | (1902) |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | 1197735 | &nbsp;&nbsp; (229753) | &nbsp;&nbsp;&nbsp;&nbsp; 237277 | &nbsp;&nbsp;&nbsp; 1396991 | &nbsp;&nbsp;&nbsp; 3859 |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp;&nbsp; 734319 | &nbsp;&nbsp; (360027) | &nbsp;&nbsp;&nbsp;&nbsp; 246063 | &nbsp;&nbsp;&nbsp; 2268612 | &nbsp;&nbsp;&nbsp; 4235 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp; 138632 | &nbsp;&nbsp;&nbsp;&nbsp; 154014 | &nbsp;&nbsp;&nbsp;&nbsp; 406079 | &nbsp;&nbsp;&nbsp;&nbsp; 573530 | 17615 |
| Net transfers<sup>(1)</sup> <br>| &nbsp;&nbsp; (127559) | &nbsp;&nbsp;&nbsp;&nbsp; 66285 | &nbsp;&nbsp;&nbsp;&nbsp; 445663 | &nbsp;&nbsp;&nbsp;&nbsp; 353537 | (7800) |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp;&nbsp; (75186) | &nbsp;&nbsp; (138373) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (93314) | &nbsp;&nbsp;&nbsp; 1565 |
| Policy charges | &nbsp;&nbsp; (140764) | &nbsp;&nbsp; (115213) | &nbsp;&nbsp;&nbsp;&nbsp; (93101) | &nbsp;&nbsp;&nbsp;&nbsp; (870762) | (4545) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | &nbsp;&nbsp; (306524) | &nbsp;&nbsp; (160889) | &nbsp;&nbsp;&nbsp;&nbsp; (11037) | &nbsp;&nbsp;&nbsp;&nbsp; (640207) | &nbsp;&nbsp;&nbsp;&nbsp; (954) |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (228) | &nbsp;&nbsp;&nbsp;&nbsp; (1839) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | &nbsp;&nbsp; (511629) | &nbsp;&nbsp; (196015) | &nbsp;&nbsp;&nbsp;&nbsp; 747604 | &nbsp;&nbsp;&nbsp;&nbsp; (677216) | &nbsp;&nbsp;&nbsp; 5881 |
| Increase (decrease) in net assets | &nbsp;&nbsp;&nbsp;&nbsp; 222690 | &nbsp;&nbsp; (556042) | &nbsp;&nbsp;&nbsp;&nbsp; 993667 | &nbsp;&nbsp;&nbsp; 1591396 | 10116 |
| Net assets at beginning of year | 5633902 | 4275604 | 1561171 | 17115084 | 59443 |
| Net assets at end of year | $5856592 | $3719562 | $2554838 | $18706480 | $69559 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | 1270144 | 1573372 | &nbsp;&nbsp;&nbsp;&nbsp; 998820 | &nbsp;&nbsp;&nbsp; 5581173 | 40576 |
| Units purchased | &nbsp;&nbsp;&nbsp;&nbsp; 294830 | &nbsp;&nbsp;&nbsp;&nbsp; 258891 | &nbsp;&nbsp;&nbsp;&nbsp; 488441 | &nbsp;&nbsp;&nbsp;&nbsp; 315386 | 12451 |
| Units redeemed | &nbsp;&nbsp; (257967) | &nbsp;&nbsp; (267859) | &nbsp;&nbsp;&nbsp;&nbsp; (60375) | &nbsp;&nbsp;&nbsp;&nbsp; (519972) | (8751) |
| Units outstanding at end of year | 1307007 | 1564404 | 1426886 | &nbsp;&nbsp;&nbsp; 5376587 | 44276 |

---

See accompanying notes to financial statements.

**RiverSource of New York Account 8** ■ 107

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2024 (continued)** | **Col VP** <br> **Commodity** <br> **Strategy,** <br>**Cl 2**<br>| **Col VP** <br> **Contrarian** <br> **Core,** <br>**Cl 1**<br>| **Col VP** <br> **Contrarian** <br> **Core,** <br>**Cl 2**<br>| **Col VP** <br> **Corporate** <br> **Bond,** <br>**Cl 1**<sup>(2)</sup> <br>| **Col VP** <br> **Corporate** <br> **Bond,** <br>**Cl 2**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $1381 | $— | $— | $53 | $2871 |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp; (260) | &nbsp;&nbsp;&nbsp;&nbsp; 6846 | &nbsp;&nbsp;&nbsp;&nbsp; 2354 | &nbsp;&nbsp;&nbsp;&nbsp; 10 | &nbsp;&nbsp;&nbsp;&nbsp; (248) |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp; 1586 | &nbsp;&nbsp;&nbsp; 71681 | &nbsp;&nbsp;&nbsp; 49101 | &nbsp;&nbsp;&nbsp;&nbsp; 77 | &nbsp;&nbsp;&nbsp;&nbsp; 379 |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp; 2707 | &nbsp;&nbsp;&nbsp; 78527 | &nbsp;&nbsp;&nbsp; 51455 | &nbsp;&nbsp;&nbsp;&nbsp; 140 | &nbsp;&nbsp;&nbsp; 3002 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp; 2826 | &nbsp;&nbsp;&nbsp; 81091 | &nbsp;&nbsp;&nbsp; 12852 | 2191 | &nbsp;&nbsp;&nbsp; 5229 |
| Net transfers<sup>(1)</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; 43649 | &nbsp;&nbsp;&nbsp; 57347 | 5206 | &nbsp;&nbsp;&nbsp;&nbsp; (70) |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp;&nbsp; 881 | &nbsp;&nbsp;&nbsp; (7568) | &nbsp;&nbsp;&nbsp; 16168 | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (55) |
| Policy charges | (1284) | (33777) | &nbsp;&nbsp;&nbsp; (3571) | &nbsp;&nbsp; (853) | (2926) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; (3589) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | &nbsp;&nbsp;&nbsp; 2423 | &nbsp;&nbsp;&nbsp; 79806 | &nbsp;&nbsp;&nbsp; 82796 | 6544 | &nbsp;&nbsp;&nbsp; 2178 |
| Increase (decrease) in net assets | &nbsp;&nbsp;&nbsp; 5130 | 158333 | 134251 | 6684 | &nbsp;&nbsp;&nbsp; 5180 |
| Net assets at beginning of year | 35719 | 298501 | 201452 | &nbsp;&nbsp;&nbsp;&nbsp; — | 88721 |
| Net assets at end of year | $40849 | $456834 | $335703 | $6684 | $93901 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | 39768 | 153411 | &nbsp;&nbsp;&nbsp; 61689 | &nbsp;&nbsp;&nbsp;&nbsp; — | 92992 |
| Units purchased | &nbsp;&nbsp;&nbsp; 4061 | &nbsp;&nbsp;&nbsp; 56675 | &nbsp;&nbsp;&nbsp; 22785 | 7204 | &nbsp;&nbsp;&nbsp; 5433 |
| Units redeemed | (1361) | (19824) | &nbsp;&nbsp;&nbsp;&nbsp; (962) | &nbsp;&nbsp; (829) | (3149) |
| Units outstanding at end of year | 42468 | 190262 | &nbsp;&nbsp;&nbsp; 83512 | 6375 | 95276 |

---

See accompanying notes to financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**108 ■ RiverSource of New York Account 8**

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2024 (continued)** | **Col VP** <br> **Corporate** <br> **Bond,** <br>**Cl 3**<br>| **Col VP** <br> **Disciplined** <br> **Core,** <br>**Cl 1**<br>| **Col VP** <br> **Disciplined** <br> **Core,** <br>**Cl 2**<br>| **Col VP** <br> **Disciplined** <br> **Core,** <br>**Cl 3**<br>| **Col VP Divd** <br> **Opp,** <br>**Cl 1**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $34054 | $— | $— | $(258538) | $— |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp; (53942) | &nbsp;&nbsp;&nbsp;&nbsp; 1592 | &nbsp;&nbsp;&nbsp; 26680 | &nbsp;&nbsp;&nbsp; 2455566 | &nbsp;&nbsp;&nbsp;&nbsp; 1591 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp;&nbsp; 55889 | &nbsp;&nbsp;&nbsp; 41420 | &nbsp;&nbsp;&nbsp; 89146 | &nbsp;&nbsp;&nbsp; 4624992 | &nbsp;&nbsp;&nbsp; 15772 |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp;&nbsp; 36001 | &nbsp;&nbsp;&nbsp; 43012 | 115826 | &nbsp;&nbsp;&nbsp; 6822020 | &nbsp;&nbsp;&nbsp; 17363 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp; 52616 | &nbsp;&nbsp;&nbsp; 98332 | &nbsp;&nbsp;&nbsp; 21770 | &nbsp;&nbsp;&nbsp;&nbsp; 801757 | &nbsp;&nbsp;&nbsp; 78536 |
| Net transfers<sup>(1)</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp; 87743 | &nbsp;&nbsp;&nbsp;&nbsp; 8090 | (41235) | &nbsp;&nbsp;&nbsp;&nbsp; (432034) | 322270 |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp;&nbsp; (48930) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; (1201) | &nbsp;&nbsp;&nbsp;&nbsp; (59527) | &nbsp;&nbsp;&nbsp;&nbsp; 4696 |
| Policy charges | &nbsp;&nbsp;&nbsp;&nbsp; (43331) | (15572) | (17392) | (1320745) | (25541) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | &nbsp;&nbsp; (150608) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (457) | (1625360) | &nbsp;&nbsp;&nbsp;&nbsp; (449) |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (365) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | &nbsp;&nbsp; (102875) | &nbsp;&nbsp;&nbsp; 90850 | (38515) | (2635909) | 379512 |
| Increase (decrease) in net assets | &nbsp;&nbsp;&nbsp;&nbsp; (66874) | 133862 | &nbsp;&nbsp;&nbsp; 77311 | &nbsp;&nbsp;&nbsp; 4186111 | 396875 |
| Net assets at beginning of year | 1264754 | 164764 | 464570 | 28607416 | 131296 |
| Net assets at end of year | $1197880 | $298626 | $541881 | $32793527 | $528171 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | 1016695 | &nbsp;&nbsp;&nbsp; 96368 | 127054 | &nbsp;&nbsp;&nbsp; 8713826 | &nbsp;&nbsp;&nbsp; 88734 |
| Units purchased | &nbsp;&nbsp;&nbsp;&nbsp; 217416 | &nbsp;&nbsp;&nbsp; 50135 | &nbsp;&nbsp;&nbsp;&nbsp; 5241 | &nbsp;&nbsp;&nbsp;&nbsp; 295437 | 236518 |
| Units redeemed | &nbsp;&nbsp; (293159) | &nbsp;&nbsp;&nbsp; (7953) | (14428) | &nbsp;&nbsp;&nbsp;&nbsp; (959806) | (15979) |
| Units outstanding at end of year | &nbsp;&nbsp;&nbsp;&nbsp; 940952 | 138550 | 117867 | &nbsp;&nbsp;&nbsp; 8049457 | 309273 |

---

See accompanying notes to financial statements.

**RiverSource of New York Account 8** ■ 109

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2024 (continued)** | **Col VP Divd** <br> **Opp,** <br>**Cl 2**<br>| **Col VP Divd** <br> **Opp,** <br>**Cl 3**<br>| **Col VP Emer** <br> **Mkts,** <br>**Cl 1**<br>| **Col VP Emer** <br> **Mkts,** <br>**Cl 2**<br>| **Col VP Emer** <br> **Mkts,** <br>**Cl 3**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $— | $(71766) | $2770 | $3663 | $11342 |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp; 5386 | &nbsp;&nbsp;&nbsp; 1203792 | &nbsp;&nbsp;&nbsp;&nbsp; (753) | &nbsp;&nbsp;&nbsp; (6994) | &nbsp;&nbsp; (146100) |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp; 32382 | &nbsp;&nbsp;&nbsp;&nbsp; 602146 | &nbsp;&nbsp;&nbsp; 10653 | &nbsp;&nbsp;&nbsp; 22758 | &nbsp;&nbsp;&nbsp;&nbsp; 222800 |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp; 37768 | &nbsp;&nbsp;&nbsp; 1734172 | &nbsp;&nbsp;&nbsp; 12670 | &nbsp;&nbsp;&nbsp; 19427 | &nbsp;&nbsp;&nbsp;&nbsp; 88042 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp; 6933 | &nbsp;&nbsp;&nbsp;&nbsp; 343037 | &nbsp;&nbsp;&nbsp; 37133 | &nbsp;&nbsp;&nbsp; 31664 | &nbsp;&nbsp;&nbsp;&nbsp; 96864 |
| Net transfers<sup>(1)</sup> <br>| &nbsp;&nbsp;&nbsp; 46321 | &nbsp;&nbsp;&nbsp;&nbsp; (26655) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 96 | &nbsp;&nbsp;&nbsp; (5152) | &nbsp;&nbsp;&nbsp;&nbsp; (86401) |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (10) | &nbsp;&nbsp;&nbsp;&nbsp; (93301) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; (3481) | &nbsp;&nbsp;&nbsp;&nbsp; (43369) |
| Policy charges | &nbsp;&nbsp;&nbsp; (4754) | &nbsp;&nbsp;&nbsp;&nbsp; (386787) | &nbsp;&nbsp;&nbsp; (9335) | (11596) | &nbsp;&nbsp;&nbsp;&nbsp; (52110) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (854163) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; (2601) | &nbsp;&nbsp;&nbsp;&nbsp; (62338) |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (6436) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (2327) |
| Increase (decrease) from transactions | &nbsp;&nbsp;&nbsp; 48490 | (1024305) | &nbsp;&nbsp;&nbsp; 27894 | &nbsp;&nbsp;&nbsp;&nbsp; 8834 | &nbsp;&nbsp; (149681) |
| Increase (decrease) in net assets | &nbsp;&nbsp;&nbsp; 86258 | &nbsp;&nbsp;&nbsp;&nbsp; 709867 | &nbsp;&nbsp;&nbsp; 40564 | &nbsp;&nbsp;&nbsp; 28261 | &nbsp;&nbsp;&nbsp;&nbsp; (61639) |
| Net assets at beginning of year | 236403 | 12144207 | 211450 | 349799 | 1916622 |
| Net assets at end of year | $322661 | $12854074 | $252014 | $378060 | $1854983 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | &nbsp;&nbsp;&nbsp; 89136 | &nbsp;&nbsp;&nbsp; 3105866 | 196965 | 263235 | &nbsp;&nbsp;&nbsp;&nbsp; 768028 |
| Units purchased | &nbsp;&nbsp;&nbsp; 18186 | &nbsp;&nbsp;&nbsp;&nbsp; 631662 | &nbsp;&nbsp;&nbsp; 33533 | &nbsp;&nbsp;&nbsp; 23174 | &nbsp;&nbsp;&nbsp;&nbsp; 84350 |
| Units redeemed | &nbsp;&nbsp;&nbsp; (1640) | &nbsp;&nbsp;&nbsp;&nbsp; (623205) | &nbsp;&nbsp;&nbsp; (8366) | (16620) | &nbsp;&nbsp; (126108) |
| Units outstanding at end of year | 105682 | &nbsp;&nbsp;&nbsp; 3114323 | 222132 | 269789 | &nbsp;&nbsp;&nbsp;&nbsp; 726270 |

---

See accompanying notes to financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**110 ■ RiverSource of New York Account 8**

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2024 (continued)** | **Col VP Emerg** <br> **Mkts Bond,** <br>**Cl 1**<br>| **Col VP Emerg** <br> **Mkts Bond,** <br>**Cl 2**<br>| **Col VP Govt** <br> **Money Mkt,** <br>**Cl 1**<br>| **Col VP Govt** <br> **Money Mkt,** <br>**Cl 2**<br>| **Col VP Govt** <br> **Money Mkt,** <br>**Cl 3**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $1810 | $795 | $23568 | $20830 | $140430 |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 11 | &nbsp;&nbsp;&nbsp;&nbsp; (69) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp;&nbsp; 272 | &nbsp;&nbsp;&nbsp;&nbsp; 212 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (1) |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp; 2093 | &nbsp;&nbsp;&nbsp;&nbsp; 938 | &nbsp;&nbsp;&nbsp;&nbsp; 23568 | &nbsp;&nbsp;&nbsp; 20830 | &nbsp;&nbsp;&nbsp;&nbsp; 140430 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp; 5632 | &nbsp;&nbsp;&nbsp; 1222 | &nbsp;&nbsp;&nbsp; 188306 | 116178 | &nbsp;&nbsp;&nbsp;&nbsp; 244488 |
| Net transfers<sup>(1)</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp; 378 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | (258805) | (16577) | 1070671 |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; (4143) | &nbsp;&nbsp;&nbsp;&nbsp; 88388 |
| Policy charges | (1438) | &nbsp;&nbsp;&nbsp;&nbsp; (565) | &nbsp;&nbsp;&nbsp; (18037) | (18457) | &nbsp;&nbsp; (270930) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; (7426) | &nbsp;&nbsp; (215940) |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | &nbsp;&nbsp;&nbsp; 4572 | &nbsp;&nbsp;&nbsp;&nbsp; 657 | &nbsp;&nbsp;&nbsp; (88536) | &nbsp;&nbsp;&nbsp; 69575 | &nbsp;&nbsp;&nbsp;&nbsp; 916677 |
| Increase (decrease) in net assets | &nbsp;&nbsp;&nbsp; 6665 | &nbsp;&nbsp;&nbsp; 1595 | &nbsp;&nbsp;&nbsp; (64968) | &nbsp;&nbsp;&nbsp; 90405 | 1057107 |
| Net assets at beginning of year | 31360 | 15252 | &nbsp;&nbsp;&nbsp; 561703 | 404225 | 2635490 |
| Net assets at end of year | $38025 | $16847 | $496735 | $494630 | $3692597 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | 30339 | 12215 | &nbsp;&nbsp;&nbsp; 520159 | 370143 | 2521711 |
| Units purchased | &nbsp;&nbsp;&nbsp; 5582 | &nbsp;&nbsp;&nbsp;&nbsp; 936 | &nbsp;&nbsp;&nbsp; 171914 | 104067 | 1303669 |
| Units redeemed | (1343) | &nbsp;&nbsp;&nbsp;&nbsp; (438) | (253981) | (41753) | &nbsp;&nbsp; (448852) |
| Units outstanding at end of year | 34578 | 12713 | &nbsp;&nbsp;&nbsp; 438092 | 432457 | 3376528 |

---

See accompanying notes to financial statements.

**RiverSource of New York Account 8** ■ 111

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2024 (continued)** | **Col VP Hi** <br> **Yield Bond,** <br>**Cl 1**<br>| **Col VP Hi** <br> **Yield Bond,** <br>**Cl 2**<br>| **Col VP Hi** <br> **Yield Bond,** <br>**Cl 3**<br>| **Col VP Inc** <br> **Opp,** <br>**Cl 1**<br>| **Col VP Inc** <br> **Opp,** <br>**Cl 2**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $9544 | $20082 | $135944 | $1359 | $4530 |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 86 | &nbsp;&nbsp;&nbsp;&nbsp; (442) | &nbsp;&nbsp;&nbsp;&nbsp; (40971) | &nbsp;&nbsp;&nbsp;&nbsp; (88) | &nbsp;&nbsp;&nbsp;&nbsp; (185) |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp;&nbsp; 1244 | &nbsp;&nbsp;&nbsp;&nbsp; 3785 | &nbsp;&nbsp;&nbsp;&nbsp; 69808 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 97 | &nbsp;&nbsp;&nbsp;&nbsp; 302 |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp; 10874 | &nbsp;&nbsp;&nbsp; 23425 | &nbsp;&nbsp;&nbsp;&nbsp; 164781 | &nbsp;&nbsp;&nbsp; 1368 | &nbsp;&nbsp;&nbsp; 4647 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp; 63896 | &nbsp;&nbsp;&nbsp; 25314 | &nbsp;&nbsp;&nbsp;&nbsp; 68267 | &nbsp;&nbsp;&nbsp; 3231 | &nbsp;&nbsp;&nbsp; 3462 |
| Net transfers<sup>(1)</sup> <br>| &nbsp;&nbsp;&nbsp; 45778 | &nbsp;&nbsp;&nbsp; 11870 | &nbsp;&nbsp;&nbsp;&nbsp; 140600 | &nbsp;&nbsp;&nbsp; 1980 | &nbsp;&nbsp;&nbsp; 4266 |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 345 | &nbsp;&nbsp;&nbsp;&nbsp; (27604) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (15) |
| Policy charges | (12775) | (10995) | &nbsp;&nbsp;&nbsp;&nbsp; (73744) | (1275) | (2742) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | &nbsp;&nbsp;&nbsp; (4499) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp; (294106) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (32440) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | &nbsp;&nbsp;&nbsp; 92400 | &nbsp;&nbsp;&nbsp; 26534 | &nbsp;&nbsp; (219027) | &nbsp;&nbsp;&nbsp; 3936 | &nbsp;&nbsp;&nbsp; 4971 |
| Increase (decrease) in net assets | 103274 | &nbsp;&nbsp;&nbsp; 49959 | &nbsp;&nbsp;&nbsp;&nbsp; (54246) | &nbsp;&nbsp;&nbsp; 5304 | &nbsp;&nbsp;&nbsp; 9618 |
| Net assets at beginning of year | 122128 | 318522 | 2638118 | 22053 | 79753 |
| Net assets at end of year | $225402 | $368481 | $2583872 | $27357 | $89371 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | &nbsp;&nbsp;&nbsp; 98881 | 194745 | 1050926 | 18104 | 50138 |
| Units purchased | &nbsp;&nbsp;&nbsp; 84991 | &nbsp;&nbsp;&nbsp; 22556 | &nbsp;&nbsp;&nbsp;&nbsp; 229783 | &nbsp;&nbsp;&nbsp; 4114 | &nbsp;&nbsp;&nbsp; 4694 |
| Units redeemed | (13383) | &nbsp;&nbsp;&nbsp; (6511) | &nbsp;&nbsp; (284338) | (1013) | (1683) |
| Units outstanding at end of year | 170489 | 210790 | &nbsp;&nbsp;&nbsp;&nbsp; 996371 | 21205 | 53149 |

---

See accompanying notes to financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**112 ■ RiverSource of New York Account 8**

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2024 (continued)** | **Col VP Inc** <br> **Opp,** <br>**Cl 3**<br>| **Col VP Inter** <br> **Bond,** <br>**Cl 1**<br>| **Col VP Inter** <br> **Bond,** <br>**Cl 2**<br>| **Col VP Inter** <br> **Bond,** <br>**Cl 3**<br>| **Col VP Lg Cap** <br> **Gro,** <br>**Cl 1**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $58202 | $5410 | $3848 | $235528 | $— |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp; (31159) | &nbsp;&nbsp;&nbsp;&nbsp; (739) | (1923) | &nbsp;&nbsp; (160376) | &nbsp;&nbsp;&nbsp;&nbsp; 43931 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp;&nbsp; 31941 | &nbsp;&nbsp;&nbsp; (2240) | &nbsp;&nbsp;&nbsp;&nbsp; 442 | &nbsp;&nbsp;&nbsp;&nbsp; (2565) | &nbsp;&nbsp;&nbsp;&nbsp; 569608 |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp;&nbsp; 58984 | &nbsp;&nbsp;&nbsp;&nbsp; 2431 | &nbsp;&nbsp;&nbsp; 2367 | &nbsp;&nbsp;&nbsp;&nbsp; 72587 | &nbsp;&nbsp;&nbsp;&nbsp; 613539 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp; 25420 | &nbsp;&nbsp;&nbsp; 18044 | 13422 | &nbsp;&nbsp;&nbsp;&nbsp; 214151 | &nbsp;&nbsp;&nbsp;&nbsp; 551032 |
| Net transfers<sup>(1)</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp; 152652 | &nbsp;&nbsp;&nbsp; 18191 | &nbsp;&nbsp;&nbsp;&nbsp; (323) | &nbsp;&nbsp;&nbsp;&nbsp; 419238 | &nbsp;&nbsp;&nbsp;&nbsp; 164526 |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp;&nbsp; (6176) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 7 | &nbsp;&nbsp;&nbsp;&nbsp; (81508) | &nbsp;&nbsp;&nbsp;&nbsp; (7921) |
| Policy charges | &nbsp;&nbsp;&nbsp;&nbsp; (26105) | (10055) | (3945) | &nbsp;&nbsp; (232620) | &nbsp;&nbsp; (118136) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | &nbsp;&nbsp;&nbsp;&nbsp; (31755) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp; (160302) | &nbsp;&nbsp;&nbsp;&nbsp; (44115) |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (290) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | &nbsp;&nbsp;&nbsp;&nbsp; 114036 | &nbsp;&nbsp;&nbsp; 26180 | &nbsp;&nbsp;&nbsp; 9161 | &nbsp;&nbsp;&nbsp;&nbsp; 158669 | &nbsp;&nbsp;&nbsp;&nbsp; 545386 |
| Increase (decrease) in net assets | &nbsp;&nbsp;&nbsp;&nbsp; 173020 | &nbsp;&nbsp;&nbsp; 28611 | 11528 | &nbsp;&nbsp;&nbsp;&nbsp; 231256 | 1158925 |
| Net assets at beginning of year | 1082634 | &nbsp;&nbsp;&nbsp; 87090 | 54558 | 5536137 | 1690340 |
| Net assets at end of year | $1255654 | $115701 | $66086 | $5767393 | $2849265 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | &nbsp;&nbsp;&nbsp;&nbsp; 533773 | &nbsp;&nbsp;&nbsp; 81911 | 45767 | 3460080 | &nbsp;&nbsp;&nbsp;&nbsp; 829300 |
| Units purchased | &nbsp;&nbsp;&nbsp;&nbsp; 207132 | &nbsp;&nbsp;&nbsp; 34121 | 12007 | &nbsp;&nbsp;&nbsp;&nbsp; 511014 | &nbsp;&nbsp;&nbsp;&nbsp; 305651 |
| Units redeemed | &nbsp;&nbsp; (118430) | &nbsp;&nbsp;&nbsp; (9315) | (3279) | &nbsp;&nbsp; (326822) | &nbsp;&nbsp;&nbsp;&nbsp; (70549) |
| Units outstanding at end of year | &nbsp;&nbsp;&nbsp;&nbsp; 622475 | 106717 | 54495 | 3644272 | 1064402 |

---

See accompanying notes to financial statements.

**RiverSource of New York Account 8** ■ 113

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2024 (continued)** | **Col VP Lg Cap** <br> **Gro,** <br>**Cl 2**<br>| **Col VP Lg Cap** <br> **Gro,** <br>**Cl 3**<br>| **Col VP Lg Cap** <br> **Index,** <br>**Cl 1**<br>| **Col VP Lg Cap** <br> **Index,** <br>**Cl 3**<br>| **Col VP Limited** <br> **Duration Cr,** <br>**Cl 1**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $— | $(20530) | $— | $(73939) | $1583 |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp; 7077 | &nbsp;&nbsp;&nbsp;&nbsp; 640570 | &nbsp;&nbsp;&nbsp;&nbsp; 93945 | &nbsp;&nbsp;&nbsp; 1971920 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 42 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | 138922 | &nbsp;&nbsp;&nbsp;&nbsp; 351074 | 1370146 | &nbsp;&nbsp;&nbsp; 1419824 | &nbsp;&nbsp;&nbsp;&nbsp; 116 |
| Net increase (decrease) in net assets resulting from operations | 145999 | &nbsp;&nbsp;&nbsp;&nbsp; 971114 | 1464091 | &nbsp;&nbsp;&nbsp; 3317805 | &nbsp;&nbsp;&nbsp; 1741 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp; 45264 | &nbsp;&nbsp;&nbsp;&nbsp; 68328 | 1569927 | &nbsp;&nbsp;&nbsp;&nbsp; 395952 | &nbsp;&nbsp;&nbsp; 7679 |
| Net transfers<sup>(1)</sup> <br>| (12460) | &nbsp;&nbsp;&nbsp;&nbsp; (71944) | 1191221 | &nbsp;&nbsp;&nbsp;&nbsp; 734205 | 17337 |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 490 | &nbsp;&nbsp; (217753) | &nbsp;&nbsp; (325538) | &nbsp;&nbsp;&nbsp;&nbsp; (194496) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Policy charges | &nbsp;&nbsp;&nbsp; (9530) | &nbsp;&nbsp;&nbsp;&nbsp; (92912) | &nbsp;&nbsp; (507475) | &nbsp;&nbsp;&nbsp;&nbsp; (299626) | (4642) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp; (312863) | &nbsp;&nbsp;&nbsp;&nbsp; (26710) | (1786293) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (18087) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | &nbsp;&nbsp;&nbsp; 23764 | &nbsp;&nbsp; (627144) | 1901425 | (1168345) | 20374 |
| Increase (decrease) in net assets | 169763 | &nbsp;&nbsp;&nbsp;&nbsp; 343970 | 3365516 | &nbsp;&nbsp;&nbsp; 2149460 | 22115 |
| Net assets at beginning of year | 470350 | 3401791 | 5146295 | 14291500 | 22154 |
| Net assets at end of year | $640113 | $3745761 | $8511811 | $16440960 | $44269 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | 104731 | &nbsp;&nbsp;&nbsp;&nbsp; 702754 | 2812179 | &nbsp;&nbsp;&nbsp; 3050599 | 19759 |
| Units purchased | &nbsp;&nbsp;&nbsp;&nbsp; 8615 | &nbsp;&nbsp;&nbsp;&nbsp; 142781 | 1320666 | &nbsp;&nbsp;&nbsp;&nbsp; 682880 | 21942 |
| Units redeemed | &nbsp;&nbsp;&nbsp; (4552) | &nbsp;&nbsp; (152943) | &nbsp;&nbsp; (402783) | &nbsp;&nbsp;&nbsp;&nbsp; (747388) | (4009) |
| Units outstanding at end of year | 108794 | &nbsp;&nbsp;&nbsp;&nbsp; 692592 | 3730062 | &nbsp;&nbsp;&nbsp; 2986091 | 37692 |

---

See accompanying notes to financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**114 ■ RiverSource of New York Account 8**

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2024 (continued)** | **Col VP Limited** <br> **Duration Cr,** <br>**Cl 2**<br>| **Col VP Long** <br> **Govt/Cr Bond,** <br>**Cl 1**<br>| **Col VP Long** <br> **Govt/Cr Bond,** <br>**Cl 2**<br>| **Col VP** <br> **Overseas** <br> **Core,** <br>**Cl 1**<br>| **Col VP** <br> **Overseas** <br> **Core,** <br>**Cl 2**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $27118 | $417 | $315 | $11035 | $8070 |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 59 | &nbsp;&nbsp;&nbsp;&nbsp; (98) | (3082) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 275 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 178 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp;&nbsp; 7582 | &nbsp;&nbsp;&nbsp;&nbsp; (741) | &nbsp;&nbsp;&nbsp; 3058 | (10615) | &nbsp;&nbsp;&nbsp; (1957) |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp; 34759 | &nbsp;&nbsp;&nbsp;&nbsp; (422) | &nbsp;&nbsp;&nbsp;&nbsp; 291 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 695 | &nbsp;&nbsp;&nbsp;&nbsp; 6291 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp; 6787 | &nbsp;&nbsp;&nbsp; 1061 | &nbsp;&nbsp;&nbsp;&nbsp; 259 | &nbsp;&nbsp;&nbsp; 93780 | &nbsp;&nbsp;&nbsp; 11841 |
| Net transfers<sup>(1)</sup> <br>| &nbsp;&nbsp;&nbsp; (8835) | &nbsp;&nbsp;&nbsp;&nbsp; 159 | (8490) | 228553 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 89 |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp;&nbsp; 1994 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 505 |
| Policy charges | (15800) | &nbsp;&nbsp;&nbsp;&nbsp; (677) | &nbsp;&nbsp;&nbsp;&nbsp; (32) | (20761) | &nbsp;&nbsp;&nbsp; (3700) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | (10758) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; (1338) |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | (26612) | &nbsp;&nbsp;&nbsp;&nbsp; 543 | (8263) | 301572 | &nbsp;&nbsp;&nbsp;&nbsp; 7397 |
| Increase (decrease) in net assets | &nbsp;&nbsp;&nbsp;&nbsp; 8147 | &nbsp;&nbsp;&nbsp;&nbsp; 121 | (7972) | 302267 | &nbsp;&nbsp;&nbsp; 13688 |
| Net assets at beginning of year | 874816 | 10295 | &nbsp;&nbsp;&nbsp; 8689 | 225445 | 182815 |
| Net assets at end of year | $882963 | $10416 | $717 | $527712 | $196503 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | 820495 | 10023 | &nbsp;&nbsp;&nbsp; 7386 | 169745 | 103471 |
| Units purchased | &nbsp;&nbsp;&nbsp; 19278 | &nbsp;&nbsp;&nbsp; 1227 | &nbsp;&nbsp;&nbsp;&nbsp; 226 | 229271 | &nbsp;&nbsp;&nbsp;&nbsp; 6982 |
| Units redeemed | (44477) | &nbsp;&nbsp;&nbsp;&nbsp; (671) | (6974) | (14929) | &nbsp;&nbsp;&nbsp; (2724) |
| Units outstanding at end of year | 795296 | 10579 | &nbsp;&nbsp;&nbsp;&nbsp; 638 | 384087 | 107729 |

---

See accompanying notes to financial statements.

**RiverSource of New York Account 8** ■ 115

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2024 (continued)** | **Col VP** <br> **Overseas** <br> **Core,** <br>**Cl 3**<br>| **Col VP Sel Gbl** <br> **Tech,** <br>**Cl 1**<br>| **Col VP Sel Gbl** <br> **Tech,** <br>**Cl 2**<br>| **Col VP Select** <br> **Lg Cap Val,** <br>**Cl 1**<br>| **Col VP Select** <br> **Lg Cap Val,** <br>**Cl 2**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $161947 | $— | $— | $— | $— |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp; 53583 | &nbsp;&nbsp;&nbsp;&nbsp; 3273 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2 | &nbsp;&nbsp;&nbsp; 19769 | &nbsp;&nbsp;&nbsp;&nbsp; 3394 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; 18473 | &nbsp;&nbsp;&nbsp;&nbsp; 4944 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp; (101780) | &nbsp;&nbsp;&nbsp; 42680 | &nbsp;&nbsp;&nbsp; 12446 | &nbsp;&nbsp;&nbsp; 71356 | &nbsp;&nbsp;&nbsp; 17095 |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp;&nbsp; 113750 | &nbsp;&nbsp;&nbsp; 64426 | &nbsp;&nbsp;&nbsp; 17392 | &nbsp;&nbsp;&nbsp; 91125 | &nbsp;&nbsp;&nbsp; 20489 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp; 203299 | &nbsp;&nbsp;&nbsp; 99691 | &nbsp;&nbsp;&nbsp;&nbsp; 2282 | 198520 | &nbsp;&nbsp;&nbsp; 11524 |
| Net transfers<sup>(1)</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp; 22325 | &nbsp;&nbsp;&nbsp; 46512 | &nbsp;&nbsp;&nbsp; 42242 | &nbsp;&nbsp;&nbsp; 41253 | &nbsp;&nbsp;&nbsp; 35259 |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp;&nbsp; (24403) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 20 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; (3148) |
| Policy charges | &nbsp;&nbsp; (221302) | (27045) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (42) | (75068) | &nbsp;&nbsp;&nbsp; (5462) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | &nbsp;&nbsp; (157597) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | (15754) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (271) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | &nbsp;&nbsp; (177949) | 119158 | &nbsp;&nbsp;&nbsp; 44502 | 148951 | &nbsp;&nbsp;&nbsp; 38173 |
| Increase (decrease) in net assets | &nbsp;&nbsp;&nbsp;&nbsp; (64199) | 183584 | &nbsp;&nbsp;&nbsp; 61894 | 240076 | &nbsp;&nbsp;&nbsp; 58662 |
| Net assets at beginning of year | 4687997 | 184277 | &nbsp;&nbsp;&nbsp; 40654 | 659264 | 145583 |
| Net assets at end of year | $4623798 | $367861 | $102548 | $899340 | $204245 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | 3265282 | 147096 | &nbsp;&nbsp;&nbsp; 32586 | 419471 | &nbsp;&nbsp;&nbsp; 44483 |
| Units purchased | &nbsp;&nbsp;&nbsp;&nbsp; 187475 | 103542 | &nbsp;&nbsp;&nbsp; 32379 | 139645 | &nbsp;&nbsp;&nbsp; 13398 |
| Units redeemed | &nbsp;&nbsp; (308975) | (19265) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (29) | (52117) | &nbsp;&nbsp;&nbsp; (2447) |
| Units outstanding at end of year | 3143782 | 231373 | &nbsp;&nbsp;&nbsp; 64936 | 506999 | &nbsp;&nbsp;&nbsp; 55434 |

---

See accompanying notes to financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**116 ■ RiverSource of New York Account 8**

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2024 (continued)** | **Col VP Select** <br> **Lg Cap Val,** <br>**Cl 3**<br>| **Col VP Select** <br> **Mid Cap Gro,** <br>**Cl 1**<br>| **Col VP Select** <br> **Mid Cap Gro,** <br>**Cl 2**<br>| **Col VP Select** <br> **Mid Cap Gro,** <br>**Cl 3**<br>| **Col VP Select** <br> **Mid Cap Val,** <br>**Cl 1**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $(4354) | $— | $— | $(5307) | $— |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp; 90091 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 757 | &nbsp;&nbsp;&nbsp;&nbsp; 2014 | &nbsp;&nbsp;&nbsp;&nbsp; 119635 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 913 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp;&nbsp; 12708 | &nbsp;&nbsp;&nbsp; 91823 | &nbsp;&nbsp;&nbsp; 20567 | &nbsp;&nbsp;&nbsp;&nbsp; 105117 | &nbsp;&nbsp;&nbsp; 43209 |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp;&nbsp; 98445 | &nbsp;&nbsp;&nbsp; 92580 | &nbsp;&nbsp;&nbsp; 22581 | &nbsp;&nbsp;&nbsp;&nbsp; 219445 | &nbsp;&nbsp;&nbsp; 44122 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp; 10985 | &nbsp;&nbsp;&nbsp; 79750 | &nbsp;&nbsp;&nbsp;&nbsp; 9069 | &nbsp;&nbsp;&nbsp;&nbsp; 23345 | &nbsp;&nbsp;&nbsp; 90305 |
| Net transfers<sup>(1)</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp; 15132 | &nbsp;&nbsp;&nbsp; 51322 | &nbsp;&nbsp;&nbsp; (2870) | &nbsp;&nbsp;&nbsp;&nbsp; (28741) | &nbsp;&nbsp;&nbsp; 65911 |
| Transfers for policy loans | (234935) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 578 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Policy charges | &nbsp;&nbsp;&nbsp; (20639) | (12277) | &nbsp;&nbsp;&nbsp; (1887) | &nbsp;&nbsp;&nbsp;&nbsp; (22046) | (25303) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | &nbsp;&nbsp;&nbsp;&nbsp; (6078) | &nbsp;&nbsp;&nbsp;&nbsp; (898) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (22782) | &nbsp;&nbsp;&nbsp;&nbsp; (154) |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | (235535) | 117897 | &nbsp;&nbsp;&nbsp;&nbsp; 4312 | &nbsp;&nbsp;&nbsp;&nbsp; (49646) | 130759 |
| Increase (decrease) in net assets | (137090) | 210477 | &nbsp;&nbsp;&nbsp; 26893 | &nbsp;&nbsp;&nbsp;&nbsp; 169799 | 174881 |
| Net assets at beginning of year | &nbsp;&nbsp;&nbsp; 911236 | 313355 | &nbsp;&nbsp;&nbsp; 95372 | 1030424 | 290223 |
| Net assets at end of year | $774146 | $523832 | $122265 | $1200223 | $465104 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | &nbsp;&nbsp;&nbsp; 263954 | 196990 | &nbsp;&nbsp;&nbsp; 29996 | &nbsp;&nbsp;&nbsp;&nbsp; 255977 | 181820 |
| Units purchased | &nbsp;&nbsp;&nbsp;&nbsp; 11125 | &nbsp;&nbsp;&nbsp; 76803 | &nbsp;&nbsp;&nbsp;&nbsp; 2680 | &nbsp;&nbsp;&nbsp;&nbsp; 70838 | &nbsp;&nbsp;&nbsp; 91714 |
| Units redeemed | &nbsp;&nbsp;&nbsp; (88709) | &nbsp;&nbsp;&nbsp; (7534) | &nbsp;&nbsp;&nbsp; (1506) | &nbsp;&nbsp;&nbsp;&nbsp; (31074) | (14623) |
| Units outstanding at end of year | &nbsp;&nbsp;&nbsp; 186370 | 266259 | &nbsp;&nbsp;&nbsp; 31170 | &nbsp;&nbsp;&nbsp;&nbsp; 295741 | 258911 |

---

See accompanying notes to financial statements.

**RiverSource of New York Account 8** ■ 117

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2024 (continued)** | **Col VP Select** <br> **Mid Cap Val,** <br>**Cl 2**<br>| **Col VP Select** <br> **Mid Cap Val,** <br>**Cl 3**<br>| **Col VP Select** <br> **Sm Cap Val,** <br>**Cl 1**<br>| **Col VP Select** <br> **Sm Cap Val,** <br>**Cl 2**<br>| **Col VP Select** <br> **Sm Cap Val,** <br>**Cl 3**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $— | $(4098) | $— | $— | $(6275) |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp; 3197 | &nbsp;&nbsp;&nbsp; 71233 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 952 | &nbsp;&nbsp;&nbsp;&nbsp; 3179 | &nbsp;&nbsp;&nbsp;&nbsp; 57800 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp; 16567 | &nbsp;&nbsp;&nbsp; 41113 | &nbsp;&nbsp;&nbsp; 16386 | &nbsp;&nbsp;&nbsp; 18025 | &nbsp;&nbsp;&nbsp;&nbsp; 91973 |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp; 19764 | 108248 | &nbsp;&nbsp;&nbsp; 17338 | &nbsp;&nbsp;&nbsp; 21204 | &nbsp;&nbsp;&nbsp;&nbsp; 143498 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp; 8861 | &nbsp;&nbsp;&nbsp; 28021 | &nbsp;&nbsp;&nbsp; 45823 | &nbsp;&nbsp;&nbsp;&nbsp; 8982 | &nbsp;&nbsp;&nbsp;&nbsp; 33861 |
| Net transfers<sup>(1)</sup> <br>| &nbsp;&nbsp;&nbsp; (4147) | &nbsp;&nbsp;&nbsp;&nbsp; (748) | &nbsp;&nbsp;&nbsp; 14938 | &nbsp;&nbsp;&nbsp; (5693) | &nbsp;&nbsp;&nbsp;&nbsp; (7498) |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 505 | (11693) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (4479) |
| Policy charges | &nbsp;&nbsp;&nbsp; (4327) | (22502) | (11014) | &nbsp;&nbsp;&nbsp; (5157) | &nbsp;&nbsp;&nbsp;&nbsp; (36225) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | (18300) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (30085) |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 892 | (25222) | &nbsp;&nbsp;&nbsp; 49747 | &nbsp;&nbsp;&nbsp; (1868) | &nbsp;&nbsp;&nbsp;&nbsp; (44426) |
| Increase (decrease) in net assets | &nbsp;&nbsp;&nbsp; 20656 | &nbsp;&nbsp;&nbsp; 83026 | &nbsp;&nbsp;&nbsp; 67085 | &nbsp;&nbsp;&nbsp; 19336 | &nbsp;&nbsp;&nbsp;&nbsp; 99072 |
| Net assets at beginning of year | 157860 | 905717 | &nbsp;&nbsp;&nbsp; 99284 | 150492 | 1118237 |
| Net assets at end of year | $178516 | $988743 | $166369 | $169828 | $1217309 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | &nbsp;&nbsp;&nbsp; 50894 | 249515 | &nbsp;&nbsp;&nbsp; 71214 | &nbsp;&nbsp;&nbsp; 53970 | &nbsp;&nbsp;&nbsp;&nbsp; 269612 |
| Units purchased | &nbsp;&nbsp;&nbsp;&nbsp; 2836 | &nbsp;&nbsp;&nbsp; 63466 | &nbsp;&nbsp;&nbsp; 40898 | &nbsp;&nbsp;&nbsp;&nbsp; 3112 | &nbsp;&nbsp;&nbsp;&nbsp; 37058 |
| Units redeemed | &nbsp;&nbsp;&nbsp; (2466) | (27236) | &nbsp;&nbsp;&nbsp; (7375) | &nbsp;&nbsp;&nbsp; (3498) | &nbsp;&nbsp;&nbsp;&nbsp; (31220) |
| Units outstanding at end of year | &nbsp;&nbsp;&nbsp; 51264 | 285745 | 104737 | &nbsp;&nbsp;&nbsp; 53584 | &nbsp;&nbsp;&nbsp;&nbsp; 275450 |

---

See accompanying notes to financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**118 ■ RiverSource of New York Account 8**

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2024 (continued)** | **Col VP** <br> **Strategic Inc,** <br>**Cl 1**<br>| **Col VP** <br> **Strategic Inc,** <br>**Cl 2**<br>| **Col VP US** <br> **Govt Mtge,** <br>**Cl 1**<br>| **Col VP US** <br> **Govt Mtge,** <br>**Cl 2**<br>| **Col VP US** <br> **Govt Mtge,** <br>**Cl 3**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $7685 | $10001 | $739 | $589 | $31833 |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp; (196) | &nbsp;&nbsp;&nbsp; (3084) | &nbsp;&nbsp;&nbsp;&nbsp; (88) | &nbsp;&nbsp;&nbsp;&nbsp; (61) | &nbsp;&nbsp;&nbsp;&nbsp; (25403) |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 215 | &nbsp;&nbsp;&nbsp;&nbsp; 2555 | &nbsp;&nbsp;&nbsp;&nbsp; (169) | &nbsp;&nbsp;&nbsp;&nbsp; (268) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 4028 |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp;&nbsp; 7704 | &nbsp;&nbsp;&nbsp;&nbsp; 9472 | &nbsp;&nbsp;&nbsp;&nbsp; 482 | &nbsp;&nbsp;&nbsp;&nbsp; 260 | &nbsp;&nbsp;&nbsp;&nbsp; 10458 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp; 48234 | &nbsp;&nbsp;&nbsp; 46461 | &nbsp;&nbsp;&nbsp; 5189 | &nbsp;&nbsp;&nbsp;&nbsp; 316 | &nbsp;&nbsp;&nbsp;&nbsp; 62551 |
| Net transfers<sup>(1)</sup> <br>| &nbsp;&nbsp;&nbsp; 17068 | 124234 | &nbsp;&nbsp;&nbsp;&nbsp; 861 | &nbsp;&nbsp;&nbsp;&nbsp; 587 | &nbsp;&nbsp;&nbsp;&nbsp; 37098 |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 1011 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (13) | &nbsp;&nbsp;&nbsp;&nbsp; (9800) |
| Policy charges | (14039) | (76730) | (1955) | &nbsp;&nbsp;&nbsp;&nbsp; (982) | &nbsp;&nbsp;&nbsp;&nbsp; (61789) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | &nbsp;&nbsp;&nbsp;&nbsp; (210) | &nbsp;&nbsp;&nbsp;&nbsp; (191) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (40495) |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | &nbsp;&nbsp;&nbsp; 51053 | &nbsp;&nbsp;&nbsp; 94785 | &nbsp;&nbsp;&nbsp; 4095 | &nbsp;&nbsp;&nbsp;&nbsp; (92) | &nbsp;&nbsp;&nbsp;&nbsp; (12435) |
| Increase (decrease) in net assets | &nbsp;&nbsp;&nbsp; 58757 | 104257 | &nbsp;&nbsp;&nbsp; 4577 | &nbsp;&nbsp;&nbsp;&nbsp; 168 | &nbsp;&nbsp;&nbsp;&nbsp; (1977) |
| Net assets at beginning of year | 145094 | 179736 | 17377 | 18754 | 1185996 |
| Net assets at end of year | $203851 | $283993 | $21954 | $18922 | $1184019 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | 128023 | 131824 | 17401 | 16737 | &nbsp;&nbsp;&nbsp;&nbsp; 982038 |
| Units purchased | &nbsp;&nbsp;&nbsp; 56054 | 122536 | &nbsp;&nbsp;&nbsp; 6189 | &nbsp;&nbsp;&nbsp;&nbsp; 813 | &nbsp;&nbsp;&nbsp;&nbsp; 96420 |
| Units redeemed | (12283) | (55053) | (1945) | &nbsp;&nbsp;&nbsp;&nbsp; (885) | &nbsp;&nbsp; (103588) |
| Units outstanding at end of year | 171794 | 199307 | 21645 | 16665 | &nbsp;&nbsp;&nbsp;&nbsp; 974870 |

---

See accompanying notes to financial statements.

**RiverSource of New York Account 8** ■ 119

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2024 (continued)** | **CS Commodity** <br> **Return,** <br>**Cl 1**<br>| **CTIVP AC Div** <br> **Bond,** <br>**Cl 1**<br>| **CTIVP AC Div** <br> **Bond,** <br>**Cl 2**<br>| **CTIVP BR Gl** <br> **Infl Prot Sec,** <br>**Cl 1**<br>| **CTIVP BR Gl** <br> **Infl Prot Sec,** <br>**Cl 2**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $10293 | $1190 | $798 | $780 | $335 |
| Net realized gain (loss) on sales of investments | (27031) | &nbsp;&nbsp;&nbsp;&nbsp; (435) | &nbsp;&nbsp;&nbsp;&nbsp; (188) | &nbsp;&nbsp;&nbsp;&nbsp; (918) | &nbsp;&nbsp;&nbsp;&nbsp; (239) |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp; 33451 | &nbsp;&nbsp;&nbsp;&nbsp; (340) | &nbsp;&nbsp;&nbsp;&nbsp; (431) | &nbsp;&nbsp;&nbsp;&nbsp; (420) | &nbsp;&nbsp;&nbsp;&nbsp; (292) |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp; 16713 | &nbsp;&nbsp;&nbsp;&nbsp; 415 | &nbsp;&nbsp;&nbsp;&nbsp; 179 | &nbsp;&nbsp;&nbsp;&nbsp; (558) | &nbsp;&nbsp;&nbsp;&nbsp; (196) |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp; 14684 | &nbsp;&nbsp;&nbsp; 2654 | &nbsp;&nbsp;&nbsp; 2470 | 12777 | &nbsp;&nbsp;&nbsp; 3568 |
| Net transfers<sup>(1)</sup> <br>| (36986) | (2631) | &nbsp;&nbsp;&nbsp; 4199 | (2464) | &nbsp;&nbsp;&nbsp;&nbsp; (630) |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp; (8114) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (363) | &nbsp;&nbsp;&nbsp; 3130 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (1) |
| Policy charges | &nbsp;&nbsp;&nbsp; (7563) | (1806) | &nbsp;&nbsp;&nbsp;&nbsp; (567) | (2687) | &nbsp;&nbsp;&nbsp;&nbsp; (962) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | (20786) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (140) |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp; (575) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | (59340) | (1783) | &nbsp;&nbsp;&nbsp; 5739 | 10756 | &nbsp;&nbsp;&nbsp; 1835 |
| Increase (decrease) in net assets | (42627) | (1368) | &nbsp;&nbsp;&nbsp; 5918 | 10198 | &nbsp;&nbsp;&nbsp; 1639 |
| Net assets at beginning of year | 406360 | 31124 | 18473 | 37778 | 17057 |
| Net assets at end of year | $363733 | $29756 | $24391 | $47976 | $18696 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | 485059 | 29736 | 15912 | 36316 | 14408 |
| Units purchased | &nbsp;&nbsp;&nbsp; 28124 | &nbsp;&nbsp;&nbsp; 2462 | &nbsp;&nbsp;&nbsp; 5537 | 15203 | &nbsp;&nbsp;&nbsp; 3043 |
| Units redeemed | (97867) | (4265) | &nbsp;&nbsp;&nbsp;&nbsp; (755) | (4972) | (1467) |
| Units outstanding at end of year | 415316 | 27933 | 20694 | 46547 | 15984 |

---

See accompanying notes to financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**120 ■ RiverSource of New York Account 8**

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2024 (continued)** | **CTIVP BR Gl** <br> **Infl Prot Sec,** <br>**Cl 3**<br>| **CTIVP** <br> **CenterSquare** <br> **Real Est,** <br>**Cl 1**<br>| **CTIVP** <br> **CenterSquare** <br> **Real Est,** <br>**Cl 2**<br>| **CTIVP Prin Lg** <br> **Cap Gro,** <br>**Cl 1**<br>| **CTIVP Prin Lg** <br> **Cap Gro,** <br>**Cl 2**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $7221 | $1850 | $5403 | $— | $— |
| Net realized gain (loss) on sales of investments | (30834) | &nbsp;&nbsp;&nbsp;&nbsp; (115) | &nbsp;&nbsp;&nbsp; (4008) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 375 | &nbsp;&nbsp;&nbsp;&nbsp; 4528 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp; 15102 | &nbsp;&nbsp;&nbsp; 5289 | &nbsp;&nbsp;&nbsp; 22785 | &nbsp;&nbsp;&nbsp; 26411 | &nbsp;&nbsp;&nbsp; 13300 |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp; (8511) | &nbsp;&nbsp;&nbsp; 7024 | &nbsp;&nbsp;&nbsp; 24180 | &nbsp;&nbsp;&nbsp; 26786 | &nbsp;&nbsp;&nbsp; 17828 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp; 27414 | 12311 | &nbsp;&nbsp;&nbsp; 14602 | &nbsp;&nbsp;&nbsp; 26018 | &nbsp;&nbsp;&nbsp;&nbsp; 7303 |
| Net transfers<sup>(1)</sup> <br>| (23848) | &nbsp;&nbsp;&nbsp;&nbsp; 133 | (37467) | &nbsp;&nbsp;&nbsp;&nbsp; 1623 | &nbsp;&nbsp;&nbsp; 25316 |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp; (3690) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (354) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Policy charges | (27635) | (2583) | &nbsp;&nbsp;&nbsp; (5674) | &nbsp;&nbsp;&nbsp; (8249) | &nbsp;&nbsp;&nbsp; (4260) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | &nbsp;&nbsp;&nbsp;&nbsp; (757) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; (1016) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; (7459) |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp; (146) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | (28662) | &nbsp;&nbsp;&nbsp; 9861 | (29909) | &nbsp;&nbsp;&nbsp; 19392 | &nbsp;&nbsp;&nbsp; 20900 |
| Increase (decrease) in net assets | (37173) | 16885 | &nbsp;&nbsp;&nbsp; (5729) | &nbsp;&nbsp;&nbsp; 46178 | &nbsp;&nbsp;&nbsp; 38728 |
| Net assets at beginning of year | 554871 | 63938 | 213304 | 118899 | &nbsp;&nbsp;&nbsp; 77895 |
| Net assets at end of year | $517698 | $80823 | $207575 | $165077 | $116623 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | 400168 | 49470 | 115096 | &nbsp;&nbsp;&nbsp; 64457 | &nbsp;&nbsp;&nbsp; 17815 |
| Units purchased | &nbsp;&nbsp;&nbsp; 41326 | &nbsp;&nbsp;&nbsp; 9108 | &nbsp;&nbsp;&nbsp;&nbsp; 7713 | &nbsp;&nbsp;&nbsp; 13209 | &nbsp;&nbsp;&nbsp;&nbsp; 6568 |
| Units redeemed | (56395) | (1903) | (20858) | &nbsp;&nbsp;&nbsp; (3963) | &nbsp;&nbsp;&nbsp; (2361) |
| Units outstanding at end of year | 385099 | 56675 | 101951 | &nbsp;&nbsp;&nbsp; 73703 | &nbsp;&nbsp;&nbsp; 22022 |

---

See accompanying notes to financial statements.

**RiverSource of New York Account 8** ■ 121

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2024 (continued)** | **CTIVP T Rowe** <br> **Price LgCap** <br> **Val,** <br>**Cl 1**<br>| **CTIVP T Rowe** <br> **Price LgCap** <br> **Val,** <br>**Cl 2**<br>| **CTIVP TCW** <br> **Core Plus** <br> **Bond,** <br>**Cl 1**<br>| **CTIVP TCW** <br> **Core Plus** <br> **Bond,** <br>**Cl 2**<br>| **CTIVP Vty** <br> **Sycamore Estb** <br> **Val,** <br>**Cl 1**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $— | $— | $3325 | $1654 | $— |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp; 4550 | &nbsp;&nbsp;&nbsp;&nbsp; 1472 | &nbsp;&nbsp;&nbsp; (1090) | &nbsp;&nbsp;&nbsp;&nbsp; (32) | &nbsp;&nbsp;&nbsp; 11346 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp; 18933 | &nbsp;&nbsp;&nbsp; 14077 | &nbsp;&nbsp;&nbsp; (1915) | (1400) | &nbsp;&nbsp;&nbsp; 50998 |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp; 23483 | &nbsp;&nbsp;&nbsp; 15549 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 320 | &nbsp;&nbsp;&nbsp;&nbsp; 222 | &nbsp;&nbsp;&nbsp; 62344 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp; 45997 | &nbsp;&nbsp;&nbsp;&nbsp; 7446 | &nbsp;&nbsp;&nbsp;&nbsp; 7526 | &nbsp;&nbsp;&nbsp;&nbsp; 941 | 154735 |
| Net transfers<sup>(1)</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp; 7965 | &nbsp;&nbsp;&nbsp; (2635) | &nbsp;&nbsp;&nbsp; (6234) | &nbsp;&nbsp;&nbsp;&nbsp; 749 | &nbsp;&nbsp;&nbsp; 25064 |
| Transfers for policy loans | (17013) | &nbsp;&nbsp;&nbsp;&nbsp; (451) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 3756 |
| Policy charges | (18532) | &nbsp;&nbsp;&nbsp; (1262) | &nbsp;&nbsp;&nbsp; (5343) | &nbsp;&nbsp;&nbsp;&nbsp; (653) | (31517) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | (10588) |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | &nbsp;&nbsp;&nbsp; 18417 | &nbsp;&nbsp;&nbsp;&nbsp; 3098 | &nbsp;&nbsp;&nbsp; (4051) | &nbsp;&nbsp;&nbsp; 1037 | 141450 |
| Increase (decrease) in net assets | &nbsp;&nbsp;&nbsp; 41900 | &nbsp;&nbsp;&nbsp; 18647 | &nbsp;&nbsp;&nbsp; (3731) | &nbsp;&nbsp;&nbsp; 1259 | 203794 |
| Net assets at beginning of year | 187324 | 131380 | &nbsp;&nbsp;&nbsp; 87087 | 41165 | 554052 |
| Net assets at end of year | $229224 | $150027 | $83356 | $42424 | $757846 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | 122303 | &nbsp;&nbsp;&nbsp; 52147 | &nbsp;&nbsp;&nbsp; 82841 | 36369 | 321941 |
| Units purchased | &nbsp;&nbsp;&nbsp; 32222 | &nbsp;&nbsp;&nbsp;&nbsp; 2698 | &nbsp;&nbsp;&nbsp;&nbsp; 7077 | &nbsp;&nbsp;&nbsp; 1500 | 101233 |
| Units redeemed | (20830) | &nbsp;&nbsp;&nbsp; (1523) | (11219) | &nbsp;&nbsp;&nbsp;&nbsp; (577) | (22541) |
| Units outstanding at end of year | 133695 | &nbsp;&nbsp;&nbsp; 53322 | &nbsp;&nbsp;&nbsp; 78699 | 37292 | 400633 |

---

See accompanying notes to financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**122 ■ RiverSource of New York Account 8**

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2024 (continued)** | **CTIVP Vty** <br> **Sycamore Estb** <br> **Val,** <br>**Cl 2**<br>| **CTIVP Vty** <br> **Sycamore Estb** <br> **Val,** <br>**Cl 3**<br>| **CTIVP** <br> **Wellington Lg** <br> **Cap Val,** <br>**Cl 1**<br>| **CTIVP** <br> **Wellington Lg** <br> **Cap Val,** <br>**Cl 2**<br>| **CTIVP** <br> **Westfield Mid** <br> **Cap Gro,** <br>**Cl 1**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $— | $(6112) | $— | $— | $— |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp; 39131 | &nbsp;&nbsp;&nbsp;&nbsp; 115313 | &nbsp;&nbsp;&nbsp;&nbsp; 5213 | &nbsp;&nbsp;&nbsp;&nbsp; 3256 | &nbsp;&nbsp;&nbsp;&nbsp; 1295 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp; 15979 | &nbsp;&nbsp;&nbsp;&nbsp; (2508) | &nbsp;&nbsp;&nbsp; 15151 | &nbsp;&nbsp;&nbsp; 26351 | &nbsp;&nbsp;&nbsp; 14743 |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp; 55110 | &nbsp;&nbsp;&nbsp;&nbsp; 106693 | &nbsp;&nbsp;&nbsp; 20364 | &nbsp;&nbsp;&nbsp; 29607 | &nbsp;&nbsp;&nbsp; 16038 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp; 41085 | &nbsp;&nbsp;&nbsp;&nbsp; 18373 | 129138 | &nbsp;&nbsp;&nbsp; 13520 | &nbsp;&nbsp;&nbsp; 29423 |
| Net transfers<sup>(1)</sup> <br>| (63884) | &nbsp;&nbsp;&nbsp;&nbsp; (53727) | 203563 | &nbsp;&nbsp;&nbsp;&nbsp; 1425 | &nbsp;&nbsp;&nbsp;&nbsp; 4664 |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp; (6531) | &nbsp;&nbsp; (129138) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; (6464) | &nbsp;&nbsp;&nbsp; (6025) |
| Policy charges | (11310) | &nbsp;&nbsp;&nbsp;&nbsp; (16533) | (27292) | &nbsp;&nbsp;&nbsp; (4779) | &nbsp;&nbsp;&nbsp; (5284) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | &nbsp;&nbsp;&nbsp;&nbsp; (254) | &nbsp;&nbsp;&nbsp;&nbsp; (60544) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | (40894) | &nbsp;&nbsp; (241569) | 305409 | &nbsp;&nbsp;&nbsp;&nbsp; 3702 | &nbsp;&nbsp;&nbsp; 22778 |
| Increase (decrease) in net assets | &nbsp;&nbsp;&nbsp; 14216 | &nbsp;&nbsp; (134876) | 325773 | &nbsp;&nbsp;&nbsp; 33309 | &nbsp;&nbsp;&nbsp; 38816 |
| Net assets at beginning of year | 534583 | 1247572 | 207794 | 252418 | &nbsp;&nbsp;&nbsp; 82165 |
| Net assets at end of year | $548799 | $1112696 | $533567 | $285727 | $120981 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | 144447 | &nbsp;&nbsp;&nbsp;&nbsp; 270524 | 135989 | &nbsp;&nbsp;&nbsp; 85181 | &nbsp;&nbsp;&nbsp; 49013 |
| Units purchased | &nbsp;&nbsp;&nbsp; 10339 | &nbsp;&nbsp;&nbsp;&nbsp; 18820 | 192831 | &nbsp;&nbsp;&nbsp;&nbsp; 4731 | &nbsp;&nbsp;&nbsp; 18773 |
| Units redeemed | (19518) | &nbsp;&nbsp;&nbsp;&nbsp; (67800) | (16236) | &nbsp;&nbsp;&nbsp; (3387) | &nbsp;&nbsp;&nbsp; (6362) |
| Units outstanding at end of year | 135268 | &nbsp;&nbsp;&nbsp;&nbsp; 221544 | 312584 | &nbsp;&nbsp;&nbsp; 86525 | &nbsp;&nbsp;&nbsp; 61424 |

---

See accompanying notes to financial statements.

**RiverSource of New York Account 8** ■ 123

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2024 (continued)** | **CTIVP** <br> **Westfield Mid** <br> **Cap Gro,** <br>**Cl 2**<br>| **CTIVP** <br> **Westfield Sel** <br> **Lg Cp Gr,** <br>**Cl 1**<br>| **CTIVP** <br> **Westfield Sel** <br> **Lg Cp Gr,** <br>**Cl 2**<br>| **CVT EAFE Intl** <br> **Index,** <br>**Cl F**<br>| **CVT EAFE Intl** <br> **Index,** <br>**Cl I**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $— | $— | $— | $520 | $4621 |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp; 436 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 972 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 319 | &nbsp;&nbsp;&nbsp;&nbsp; 104 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 355 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | 12620 | &nbsp;&nbsp;&nbsp; 44557 | &nbsp;&nbsp;&nbsp; 15219 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (8) | &nbsp;&nbsp;&nbsp; (4248) |
| Net increase (decrease) in net assets resulting from operations | 13056 | &nbsp;&nbsp;&nbsp; 45529 | &nbsp;&nbsp;&nbsp; 15538 | &nbsp;&nbsp;&nbsp;&nbsp; 616 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 728 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp; 3294 | &nbsp;&nbsp;&nbsp; 26691 | &nbsp;&nbsp;&nbsp;&nbsp; 5060 | &nbsp;&nbsp;&nbsp;&nbsp; 480 | &nbsp;&nbsp;&nbsp; 37375 |
| Net transfers<sup>(1)</sup> <br>| &nbsp;&nbsp;&nbsp; 5000 | &nbsp;&nbsp;&nbsp; (2688) | (21189) | 17278 | &nbsp;&nbsp;&nbsp; 37264 |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp;&nbsp; 505 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 525 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Policy charges | &nbsp;&nbsp;&nbsp;&nbsp; (477) | &nbsp;&nbsp;&nbsp; (5063) | &nbsp;&nbsp;&nbsp; (3008) | (1666) | &nbsp;&nbsp;&nbsp; (8260) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | (1175) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (413) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | &nbsp;&nbsp;&nbsp; 7147 | &nbsp;&nbsp;&nbsp; 18940 | (18612) | 15679 | &nbsp;&nbsp;&nbsp; 66379 |
| Increase (decrease) in net assets | 20203 | &nbsp;&nbsp;&nbsp; 64469 | &nbsp;&nbsp;&nbsp; (3074) | 16295 | &nbsp;&nbsp;&nbsp; 67107 |
| Net assets at beginning of year | 69959 | 151030 | &nbsp;&nbsp;&nbsp; 70545 | &nbsp;&nbsp;&nbsp; 1966 | 102156 |
| Net assets at end of year | $90162 | $215499 | $67471 | $18261 | $169263 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | 21688 | 104109 | &nbsp;&nbsp;&nbsp; 21029 | &nbsp;&nbsp;&nbsp; 1364 | &nbsp;&nbsp;&nbsp; 88401 |
| Units purchased | &nbsp;&nbsp;&nbsp; 2592 | &nbsp;&nbsp;&nbsp; 17299 | &nbsp;&nbsp;&nbsp;&nbsp; 1594 | 15405 | &nbsp;&nbsp;&nbsp; 60341 |
| Units redeemed | &nbsp;&nbsp;&nbsp;&nbsp; (430) | &nbsp;&nbsp;&nbsp; (4902) | &nbsp;&nbsp;&nbsp; (6805) | (1368) | &nbsp;&nbsp;&nbsp; (6735) |
| Units outstanding at end of year | 23850 | 116506 | &nbsp;&nbsp;&nbsp; 15818 | 15401 | 142007 |

---

See accompanying notes to financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**124 ■ RiverSource of New York Account 8**

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2024 (continued)** | **CVT Nasdaq** <br> **100 Index,** <br>**Cl F**<br>| **CVT Nasdaq** <br> **100 Index,** <br>**Cl I**<br>| **CVT Russ 2000** <br> **Sm Cap Ind,** <br>**Cl F**<br>| **CVT Russ 2000** <br> **Sm Cap Ind,** <br>**Cl I**<br>| **DWS Alt Asset** <br> **Alloc VIP,** <br>**Cl A**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $211 | $1064 | $206 | $1037 | $1604 |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp; 144 | &nbsp;&nbsp;&nbsp;&nbsp; 1879 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 98 | &nbsp;&nbsp;&nbsp;&nbsp; 518 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 10 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp; 4147 | &nbsp;&nbsp;&nbsp; 20909 | &nbsp;&nbsp;&nbsp;&nbsp; 333 | &nbsp;&nbsp;&nbsp; 1677 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 25 |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp; 6548 | &nbsp;&nbsp;&nbsp; 29033 | &nbsp;&nbsp;&nbsp; 1259 | &nbsp;&nbsp;&nbsp; 4287 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 508 |
| Net increase (decrease) in net assets resulting from operations | 11050 | &nbsp;&nbsp;&nbsp; 52885 | &nbsp;&nbsp;&nbsp; 1896 | &nbsp;&nbsp;&nbsp; 7519 | &nbsp;&nbsp;&nbsp;&nbsp; 2147 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp; 1742 | 101559 | &nbsp;&nbsp;&nbsp;&nbsp; 557 | 16420 | &nbsp;&nbsp;&nbsp; 41252 |
| Net transfers<sup>(1)</sup> <br>| 35617 | 134140 | 15667 | 50013 | &nbsp;&nbsp;&nbsp; 68447 |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 20 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Policy charges | (1583) | (36803) | (1391) | (9157) | &nbsp;&nbsp;&nbsp; (3860) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (379) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | 35796 | 198896 | 14454 | 57276 | 105839 |
| Increase (decrease) in net assets | 46846 | 251781 | 16350 | 64795 | 107986 |
| Net assets at beginning of year | 19111 | 109164 | &nbsp;&nbsp;&nbsp;&nbsp; 371 | 21811 | &nbsp;&nbsp;&nbsp; 27043 |
| Net assets at end of year | $65957 | $360945 | $16721 | $86606 | $135029 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | 14544 | &nbsp;&nbsp;&nbsp; 82737 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | 19609 | &nbsp;&nbsp;&nbsp; 21555 |
| Units purchased | 26723 | 160057 | 14771 | 58102 | &nbsp;&nbsp;&nbsp; 83262 |
| Units redeemed | (1073) | (24301) | (1183) | (7711) | &nbsp;&nbsp;&nbsp; (2932) |
| Units outstanding at end of year | 40194 | 218493 | 13588 | 70000 | 101885 |

---

See accompanying notes to financial statements.

**RiverSource of New York Account 8** ■ 125

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2024 (continued)** | **DWS Alt Asset** <br> **Alloc VIP,** <br>**Cl B**<br>| **EV VT** <br> **Floating-Rate** <br> **Inc, Init Cl**<br>| **EV VT** <br> **Floating-Rate** <br> **Inc, Inst Cl**<sup>(2)</sup><sup>,</sup><sup>(3)</sup> <br>| **Fid VIP** <br> **Contrafund,** <br> **Init Cl**<br>| **Fid VIP** <br> **Contrafund,** <br>**Serv Cl 2**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $8662 | $104330 | $339 | $3218 | $(32242) |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp; (214) | &nbsp;&nbsp;&nbsp;&nbsp; (15756) | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 6988 | &nbsp;&nbsp;&nbsp;&nbsp; 489100 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 157 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 219457 | &nbsp;&nbsp;&nbsp;&nbsp; 944950 |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp;&nbsp; 4703 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 9105 | &nbsp;&nbsp;&nbsp;&nbsp; (6) | &nbsp;&nbsp;&nbsp;&nbsp; 101784 | &nbsp;&nbsp;&nbsp;&nbsp; 546087 |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp; 13308 | &nbsp;&nbsp;&nbsp;&nbsp; 97679 | &nbsp;&nbsp;&nbsp;&nbsp; 333 | &nbsp;&nbsp;&nbsp;&nbsp; 331447 | 1947895 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp; 21230 | &nbsp;&nbsp;&nbsp;&nbsp; 20984 | 2263 | &nbsp;&nbsp;&nbsp;&nbsp; 312426 | &nbsp;&nbsp;&nbsp;&nbsp; 184532 |
| Net transfers<sup>(1)</sup> <br>| &nbsp;&nbsp;&nbsp; 21294 | &nbsp;&nbsp;&nbsp;&nbsp; (23275) | 3719 | &nbsp;&nbsp;&nbsp;&nbsp; 772742 | &nbsp;&nbsp;&nbsp;&nbsp; 780897 |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 503 | &nbsp;&nbsp;&nbsp;&nbsp; (9573) | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (14058) | &nbsp;&nbsp; (294877) |
| Policy charges | &nbsp;&nbsp;&nbsp; (8610) | &nbsp;&nbsp;&nbsp;&nbsp; (32797) | &nbsp;&nbsp; (189) | &nbsp;&nbsp;&nbsp;&nbsp; (91008) | &nbsp;&nbsp; (141801) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (8) | &nbsp;&nbsp;&nbsp;&nbsp; (22452) | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (1829) | &nbsp;&nbsp; (492548) |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (1048) | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (1256) |
| Increase (decrease) from transactions | &nbsp;&nbsp;&nbsp; 34409 | &nbsp;&nbsp;&nbsp;&nbsp; (68161) | 5793 | &nbsp;&nbsp;&nbsp;&nbsp; 978273 | &nbsp;&nbsp;&nbsp;&nbsp; 34947 |
| Increase (decrease) in net assets | &nbsp;&nbsp;&nbsp; 47717 | &nbsp;&nbsp;&nbsp;&nbsp; 29518 | 6126 | 1309720 | 1982842 |
| Net assets at beginning of year | 260554 | 1426202 | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 702527 | 5896977 |
| Net assets at end of year | $308271 | $1455720 | $6126 | $2012247 | $7879819 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | 202119 | &nbsp;&nbsp;&nbsp;&nbsp; 883468 | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 366743 | 1339507 |
| Units purchased | &nbsp;&nbsp;&nbsp; 32851 | &nbsp;&nbsp;&nbsp;&nbsp; 200883 | 3854 | &nbsp;&nbsp;&nbsp;&nbsp; 463354 | &nbsp;&nbsp;&nbsp;&nbsp; 254108 |
| Units redeemed | &nbsp;&nbsp;&nbsp; (6530) | &nbsp;&nbsp; (195429) | &nbsp;&nbsp; (181) | &nbsp;&nbsp;&nbsp;&nbsp; (44944) | &nbsp;&nbsp; (208951) |
| Units outstanding at end of year | 228440 | &nbsp;&nbsp;&nbsp;&nbsp; 888922 | 3673 | &nbsp;&nbsp;&nbsp;&nbsp; 785153 | 1384664 |

---

See accompanying notes to financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**126 ■ RiverSource of New York Account 8**

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2024 (continued)** | **Fid VIP Emer** <br> **Mkts, Init Cl**<sup>(2)</sup> <br>| **Fid VIP** <br> **Energy, Init** <br> **Cl**<sup>(2)</sup> <br>| **Fid VIP Gro &** <br> **Inc,** <br>**Serv Cl**<br>| **Fid VIP Gro &** <br> **Inc,** <br>**Serv Cl 2**<br>| **Fid VIP Gro** <br> **Opp, Init Cl**<sup>(2)</sup> <br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $42 | $23 | $37350 | $20774 | $— |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2 | &nbsp;&nbsp;&nbsp;&nbsp; (1) | &nbsp;&nbsp;&nbsp;&nbsp; 167846 | &nbsp;&nbsp;&nbsp;&nbsp; 252128 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3799 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 337343 | &nbsp;&nbsp;&nbsp;&nbsp; 162243 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp;&nbsp; (4) | &nbsp;&nbsp;&nbsp;&nbsp; (86) | &nbsp;&nbsp;&nbsp;&nbsp; 409102 | &nbsp;&nbsp;&nbsp;&nbsp; 27412 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1676 |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp;&nbsp; 40 | &nbsp;&nbsp;&nbsp;&nbsp; (64) | &nbsp;&nbsp;&nbsp;&nbsp; 951641 | &nbsp;&nbsp;&nbsp;&nbsp; 462557 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5475 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp; 258 | &nbsp;&nbsp;&nbsp;&nbsp; 319 | &nbsp;&nbsp;&nbsp;&nbsp; 122213 | &nbsp;&nbsp;&nbsp;&nbsp; 48276 | &nbsp;&nbsp;&nbsp; 261215 |
| Net transfers<sup>(1)</sup> <br>| 3084 | 1014 | &nbsp;&nbsp;&nbsp;&nbsp; (37536) | &nbsp;&nbsp;&nbsp;&nbsp; (13320) | (167486) |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 8906 | &nbsp;&nbsp; (120127) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Policy charges | &nbsp;&nbsp;&nbsp;&nbsp; (84) | &nbsp;&nbsp;&nbsp;&nbsp; (38) | &nbsp;&nbsp; (185753) | &nbsp;&nbsp;&nbsp;&nbsp; (54998) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (219) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp; (198224) | &nbsp;&nbsp; (135566) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (270) |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | 3258 | 1295 | &nbsp;&nbsp; (290394) | &nbsp;&nbsp; (275735) | &nbsp;&nbsp;&nbsp;&nbsp; 93240 |
| Increase (decrease) in net assets | 3298 | 1231 | &nbsp;&nbsp;&nbsp;&nbsp; 661247 | &nbsp;&nbsp;&nbsp;&nbsp; 186822 | &nbsp;&nbsp;&nbsp;&nbsp; 98715 |
| Net assets at beginning of year | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | 4579195 | 2266201 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net assets at end of year | $3298 | $1231 | $5240442 | $2453023 | $98715 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 906130 | &nbsp;&nbsp;&nbsp;&nbsp; 865574 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Units purchased | 2905 | 1096 | &nbsp;&nbsp;&nbsp;&nbsp; 29372 | &nbsp;&nbsp;&nbsp;&nbsp; 276643 | &nbsp;&nbsp;&nbsp; 191231 |
| Units redeemed | &nbsp;&nbsp;&nbsp;&nbsp; (72) | &nbsp;&nbsp;&nbsp;&nbsp; (35) | &nbsp;&nbsp;&nbsp;&nbsp; (80083) | &nbsp;&nbsp; (289242) | (119931) |
| Units outstanding at end of year | 2833 | 1061 | &nbsp;&nbsp;&nbsp;&nbsp; 855419 | &nbsp;&nbsp;&nbsp;&nbsp; 852975 | &nbsp;&nbsp;&nbsp;&nbsp; 71300 |

---

See accompanying notes to financial statements.

**RiverSource of New York Account 8** ■ 127

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2024 (continued)** | **Fid VIP Invest** <br> **Gr, Init Cl**<sup>(2)</sup> <br>| **Fid VIP Mid** <br> **Cap, Init Cl**<br>| **Fid VIP Mid** <br> **Cap,** <br>**Serv Cl**<br>| **Fid VIP Mid** <br> **Cap,** <br>**Serv Cl 2**<br>| **Fid VIP** <br> **Overseas,** <br>**Serv Cl**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $872 | $4385 | $(13362) | $(1501) | $14774 |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 19 | &nbsp;&nbsp;&nbsp;&nbsp; 2100 | &nbsp;&nbsp;&nbsp;&nbsp; 86638 | &nbsp;&nbsp;&nbsp;&nbsp; 165999 | &nbsp;&nbsp;&nbsp;&nbsp; 38372 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; 96920 | &nbsp;&nbsp;&nbsp;&nbsp; 791081 | &nbsp;&nbsp;&nbsp;&nbsp; 769222 | &nbsp;&nbsp;&nbsp;&nbsp; 74911 |
| Net change in unrealized appreciation (depreciation) of investments | (1429) | (21331) | &nbsp;&nbsp;&nbsp;&nbsp; 52815 | &nbsp;&nbsp;&nbsp;&nbsp; (37276) | &nbsp;&nbsp;&nbsp;&nbsp; (67200) |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp;&nbsp; (538) | &nbsp;&nbsp;&nbsp; 82074 | &nbsp;&nbsp;&nbsp;&nbsp; 917172 | &nbsp;&nbsp;&nbsp;&nbsp; 896444 | &nbsp;&nbsp;&nbsp;&nbsp; 60857 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp; 7926 | 164275 | &nbsp;&nbsp;&nbsp;&nbsp; 107555 | &nbsp;&nbsp;&nbsp;&nbsp; 133871 | &nbsp;&nbsp;&nbsp;&nbsp; 43319 |
| Net transfers<sup>(1)</sup> <br>| 30538 | 241253 | &nbsp;&nbsp;&nbsp;&nbsp; (22706) | &nbsp;&nbsp; (105695) | &nbsp;&nbsp;&nbsp;&nbsp; 125134 |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | (13360) | &nbsp;&nbsp;&nbsp;&nbsp; (32651) | &nbsp;&nbsp; (181138) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3406 |
| Policy charges | (1105) | (37696) | &nbsp;&nbsp; (198315) | &nbsp;&nbsp; (113384) | &nbsp;&nbsp;&nbsp;&nbsp; (41662) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | &nbsp;&nbsp;&nbsp;&nbsp; (78) | &nbsp;&nbsp;&nbsp;&nbsp; (667) | &nbsp;&nbsp; (236687) | &nbsp;&nbsp; (399158) | &nbsp;&nbsp;&nbsp;&nbsp; (72590) |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (4297) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (382) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | 37281 | 353805 | &nbsp;&nbsp; (387101) | &nbsp;&nbsp; (665886) | &nbsp;&nbsp;&nbsp;&nbsp; 57607 |
| Increase (decrease) in net assets | 36743 | 435879 | &nbsp;&nbsp;&nbsp;&nbsp; 530071 | &nbsp;&nbsp;&nbsp;&nbsp; 230558 | &nbsp;&nbsp;&nbsp;&nbsp; 118464 |
| Net assets at beginning of year | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | 433660 | 5692586 | 5571907 | 1470954 |
| Net assets at end of year | $36743 | $869539 | $6222657 | $5802465 | $1589418 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | 278924 | &nbsp;&nbsp;&nbsp;&nbsp; 974274 | 2433962 | &nbsp;&nbsp;&nbsp;&nbsp; 570392 |
| Units purchased | 37100 | 226332 | &nbsp;&nbsp;&nbsp;&nbsp; 19921 | &nbsp;&nbsp;&nbsp;&nbsp; 486546 | &nbsp;&nbsp;&nbsp;&nbsp; 70226 |
| Units redeemed | (1066) | (29248) | &nbsp;&nbsp;&nbsp;&nbsp; (78532) | &nbsp;&nbsp; (697432) | &nbsp;&nbsp;&nbsp;&nbsp; (45108) |
| Units outstanding at end of year | 36034 | 476008 | &nbsp;&nbsp;&nbsp;&nbsp; 915663 | 2223076 | &nbsp;&nbsp;&nbsp;&nbsp; 595510 |

---

See accompanying notes to financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**128 ■ RiverSource of New York Account 8**

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2024 (continued)** | **Fid VIP** <br> **Overseas,** <br>**Serv Cl 2**<br>| **Fid VIP** <br> **Strategic Inc,** <br> **Init Cl**<br>| **Fid VIP** <br> **Strategic Inc,** <br>**Serv Cl 2**<br>| **Frank Global** <br> **Real Est,** <br>**Cl 2**<br>| **Frank Inc,** <br>**Cl 1**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $13159 | $21543 | $820 | $26201 | $2834 |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp; 67897 | &nbsp;&nbsp;&nbsp;&nbsp; 1810 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (3) | &nbsp;&nbsp;&nbsp;&nbsp; (64081) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 45 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp; 59398 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 221 |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp;&nbsp; (83149) | &nbsp;&nbsp;&nbsp;&nbsp; 3977 | &nbsp;&nbsp;&nbsp;&nbsp; 653 | &nbsp;&nbsp;&nbsp;&nbsp; 30390 | &nbsp;&nbsp;&nbsp;&nbsp; 790 |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp;&nbsp; 57305 | &nbsp;&nbsp;&nbsp; 27330 | &nbsp;&nbsp;&nbsp; 1470 | &nbsp;&nbsp;&nbsp;&nbsp; (7490) | &nbsp;&nbsp;&nbsp; 3890 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp; 37831 | 188407 | &nbsp;&nbsp;&nbsp; 2514 | &nbsp;&nbsp;&nbsp;&nbsp; 76267 | 17495 |
| Net transfers<sup>(1)</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp; 20719 | &nbsp;&nbsp;&nbsp; 66504 | (4234) | &nbsp;&nbsp; (101046) | &nbsp;&nbsp;&nbsp;&nbsp; (700) |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp;&nbsp; (36555) | &nbsp;&nbsp;&nbsp;&nbsp; 5635 | &nbsp;&nbsp;&nbsp;&nbsp; 901 | &nbsp;&nbsp;&nbsp;&nbsp; (67079) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Policy charges | &nbsp;&nbsp;&nbsp;&nbsp; (20059) | (35682) | &nbsp;&nbsp;&nbsp;&nbsp; (786) | &nbsp;&nbsp;&nbsp;&nbsp; (62458) | (5945) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | &nbsp;&nbsp;&nbsp;&nbsp; (46135) | &nbsp;&nbsp;&nbsp; (9611) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (74891) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (119) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | &nbsp;&nbsp;&nbsp;&nbsp; (44199) | 215253 | (1605) | &nbsp;&nbsp; (229326) | 10850 |
| Increase (decrease) in net assets | &nbsp;&nbsp;&nbsp;&nbsp; 13106 | 242583 | &nbsp;&nbsp;&nbsp;&nbsp; (135) | &nbsp;&nbsp; (236816) | 14740 |
| Net assets at beginning of year | 1224179 | 359237 | 23424 | 2039199 | 46630 |
| Net assets at end of year | $1237285 | $601820 | $23289 | $1802383 | $61370 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | &nbsp;&nbsp;&nbsp;&nbsp; 708317 | 311685 | 17046 | &nbsp;&nbsp;&nbsp;&nbsp; 890097 | 35508 |
| Units purchased | &nbsp;&nbsp;&nbsp;&nbsp; 143610 | 218311 | &nbsp;&nbsp;&nbsp; 2411 | &nbsp;&nbsp;&nbsp;&nbsp; 121044 | 12633 |
| Units redeemed | &nbsp;&nbsp; (158757) | (37755) | (3436) | &nbsp;&nbsp; (175157) | (4652) |
| Units outstanding at end of year | &nbsp;&nbsp;&nbsp;&nbsp; 693170 | 492241 | 16021 | &nbsp;&nbsp;&nbsp;&nbsp; 835984 | 43489 |

---

See accompanying notes to financial statements.

**RiverSource of New York Account 8** ■ 129

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2024 (continued)** | **Frank Inc,** <br>**Cl 2**<br>| **Frank Mutual** <br> **Shares,** <br>**Cl 1**<br>| **Frank Mutual** <br> **Shares,** <br>**Cl 2**<br>| **Frank Sm Cap** <br> **Val,** <br>**Cl 1**<br>| **Frank Sm Cap** <br> **Val,** <br>**Cl 2**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $22852 | $652 | $27307 | $2580 | $13078 |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp; (1505) | &nbsp;&nbsp;&nbsp;&nbsp; 136 | &nbsp;&nbsp;&nbsp;&nbsp; (11995) | &nbsp;&nbsp;&nbsp;&nbsp; 2129 | &nbsp;&nbsp;&nbsp;&nbsp; (47162) |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp; 2086 | &nbsp;&nbsp;&nbsp;&nbsp; 602 | &nbsp;&nbsp;&nbsp;&nbsp; 36884 | &nbsp;&nbsp;&nbsp;&nbsp; 5088 | &nbsp;&nbsp;&nbsp;&nbsp; 67059 |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp;&nbsp; 8883 | &nbsp;&nbsp;&nbsp; 1418 | &nbsp;&nbsp;&nbsp;&nbsp; 132091 | &nbsp;&nbsp;&nbsp; 17475 | &nbsp;&nbsp;&nbsp;&nbsp; 273830 |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp; 32316 | &nbsp;&nbsp;&nbsp; 2808 | &nbsp;&nbsp;&nbsp;&nbsp; 184287 | &nbsp;&nbsp;&nbsp; 27272 | &nbsp;&nbsp;&nbsp;&nbsp; 306805 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp; 11441 | &nbsp;&nbsp;&nbsp; 5012 | &nbsp;&nbsp;&nbsp;&nbsp; 62967 | &nbsp;&nbsp;&nbsp; 60567 | &nbsp;&nbsp;&nbsp;&nbsp; 59145 |
| Net transfers<sup>(1)</sup> <br>| &nbsp;&nbsp;&nbsp; 34511 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (7053) | (29652) | &nbsp;&nbsp;&nbsp;&nbsp; (45380) |
| Transfers for policy loans | (21883) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (19436) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (51029) |
| Policy charges | (13734) | (2646) | &nbsp;&nbsp;&nbsp;&nbsp; (36752) | (17978) | &nbsp;&nbsp;&nbsp;&nbsp; (62210) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | (10211) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp; (124556) | &nbsp;&nbsp;&nbsp; (5127) | &nbsp;&nbsp;&nbsp;&nbsp; (90294) |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (341) |
| Increase (decrease) from transactions | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 124 | &nbsp;&nbsp;&nbsp; 2366 | &nbsp;&nbsp; (124830) | &nbsp;&nbsp;&nbsp;&nbsp; 7810 | &nbsp;&nbsp; (190109) |
| Increase (decrease) in net assets | &nbsp;&nbsp;&nbsp; 32440 | &nbsp;&nbsp;&nbsp; 5174 | &nbsp;&nbsp;&nbsp;&nbsp; 59457 | &nbsp;&nbsp;&nbsp; 35082 | &nbsp;&nbsp;&nbsp;&nbsp; 116696 |
| Net assets at beginning of year | 446052 | 25391 | 1692719 | 212299 | 2855602 |
| Net assets at end of year | $478492 | $30565 | $1752176 | $247381 | $2972298 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | 310215 | 19019 | &nbsp;&nbsp;&nbsp;&nbsp; 592966 | 143186 | &nbsp;&nbsp;&nbsp;&nbsp; 678772 |
| Units purchased | &nbsp;&nbsp;&nbsp; 52149 | &nbsp;&nbsp;&nbsp; 3356 | &nbsp;&nbsp;&nbsp;&nbsp; 68977 | &nbsp;&nbsp;&nbsp; 38565 | &nbsp;&nbsp;&nbsp;&nbsp; 127469 |
| Units redeemed | (49068) | (1841) | &nbsp;&nbsp;&nbsp;&nbsp; (84979) | (32796) | &nbsp;&nbsp;&nbsp;&nbsp; (98632) |
| Units outstanding at end of year | 313296 | 20534 | &nbsp;&nbsp;&nbsp;&nbsp; 576964 | 148955 | &nbsp;&nbsp;&nbsp;&nbsp; 707609 |

---

See accompanying notes to financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**130 ■ RiverSource of New York Account 8**

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2024 (continued)** | **GS VIT Mid** <br> **Cap Val, Inst**<br>| **GS VIT Sm Cap** <br> **Eq Insights,** <br> **Inst**<br>| **GS VIT U.S. Eq** <br> **Insights, Inst**<br>| **Invesco VI Am** <br> **Fran, Ser I**<br>| **Invesco VI Am** <br> **Fran, Ser II**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $30199 | $343 | $3632 | $(4744) | $(4721) |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp; 66331 | &nbsp;&nbsp;&nbsp;&nbsp; 39135 | &nbsp;&nbsp;&nbsp;&nbsp; 151196 | &nbsp;&nbsp;&nbsp; 16536 | &nbsp;&nbsp;&nbsp;&nbsp; 40403 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp; 361558 | &nbsp;&nbsp;&nbsp;&nbsp; 34251 | &nbsp;&nbsp;&nbsp;&nbsp; 415257 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp;&nbsp; 243637 | &nbsp;&nbsp;&nbsp;&nbsp; 33190 | &nbsp;&nbsp;&nbsp;&nbsp; 180637 | 193929 | &nbsp;&nbsp;&nbsp;&nbsp; 290774 |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp;&nbsp; 701725 | &nbsp;&nbsp;&nbsp; 106919 | &nbsp;&nbsp;&nbsp;&nbsp; 750722 | 205721 | &nbsp;&nbsp;&nbsp;&nbsp; 326456 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp; 144034 | &nbsp;&nbsp;&nbsp;&nbsp; 11270 | &nbsp;&nbsp;&nbsp;&nbsp; 60049 | &nbsp;&nbsp;&nbsp; 10866 | &nbsp;&nbsp;&nbsp;&nbsp; 13206 |
| Net transfers<sup>(1)</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp; (66096) | &nbsp;&nbsp;&nbsp;&nbsp; (2738) | &nbsp;&nbsp; (120983) | &nbsp;&nbsp;&nbsp; (3733) | &nbsp;&nbsp;&nbsp;&nbsp; 22465 |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp;&nbsp; (26649) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 252 | &nbsp;&nbsp;&nbsp;&nbsp; (90983) | (34916) | &nbsp;&nbsp;&nbsp;&nbsp; (55771) |
| Policy charges | &nbsp;&nbsp; (145232) | &nbsp;&nbsp;&nbsp; (15092) | &nbsp;&nbsp;&nbsp;&nbsp; (60682) | (23918) | &nbsp;&nbsp;&nbsp;&nbsp; (16244) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | &nbsp;&nbsp; (370031) | (206332) | &nbsp;&nbsp; (310584) | &nbsp;&nbsp;&nbsp; (9539) | &nbsp;&nbsp; (110237) |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | &nbsp;&nbsp; (463974) | (212640) | &nbsp;&nbsp; (523183) | (61240) | &nbsp;&nbsp; (146581) |
| Increase (decrease) in net assets | &nbsp;&nbsp;&nbsp;&nbsp; 237751 | (105721) | &nbsp;&nbsp;&nbsp;&nbsp; 227539 | 144481 | &nbsp;&nbsp;&nbsp;&nbsp; 179875 |
| Net assets at beginning of year | 6092781 | &nbsp;&nbsp;&nbsp; 551818 | 2923675 | 628746 | &nbsp;&nbsp;&nbsp;&nbsp; 994889 |
| Net assets at end of year | $6330532 | $446097 | $3151214 | $773227 | $1174764 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | 1274946 | &nbsp;&nbsp;&nbsp; 110189 | &nbsp;&nbsp;&nbsp;&nbsp; 629528 | 164227 | &nbsp;&nbsp;&nbsp;&nbsp; 319425 |
| Units purchased | &nbsp;&nbsp;&nbsp;&nbsp; 298099 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2460 | &nbsp;&nbsp;&nbsp;&nbsp; 24474 | &nbsp;&nbsp;&nbsp;&nbsp; 2535 | &nbsp;&nbsp;&nbsp;&nbsp; 57571 |
| Units redeemed | &nbsp;&nbsp; (218555) | &nbsp;&nbsp;&nbsp; (39624) | &nbsp;&nbsp; (116627) | (15864) | &nbsp;&nbsp;&nbsp;&nbsp; (91203) |
| Units outstanding at end of year | 1354490 | &nbsp;&nbsp;&nbsp;&nbsp; 73025 | &nbsp;&nbsp;&nbsp;&nbsp; 537375 | 150898 | &nbsp;&nbsp;&nbsp;&nbsp; 285793 |

---

See accompanying notes to financial statements.

**RiverSource of New York Account 8** ■ 131

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2024 (continued)** | **Invesco VI Bal** <br> **Risk Alloc, Ser** <br> **I**<br>| **Invesco VI Bal** <br> **Risk Alloc, Ser** <br> **II**<br>| **Invesco VI** <br> **Comstock, Ser** <br> **II**<br>| **Invesco VI** <br> **Core Eq, Ser I**<br>| **Invesco VI Dis** <br> **Mid Cap** <br> **Gro, Ser I**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $2153 | $15601 | $5053 | $(18194) | $(5176) |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp; (73) | &nbsp;&nbsp;&nbsp; (1531) | &nbsp;&nbsp;&nbsp; 18895 | &nbsp;&nbsp;&nbsp;&nbsp; 167301 | &nbsp;&nbsp;&nbsp;&nbsp; (6143) |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; 37704 | &nbsp;&nbsp;&nbsp;&nbsp; 955708 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp;&nbsp; (969) | &nbsp;&nbsp;&nbsp; (6352) | &nbsp;&nbsp;&nbsp; (2815) | &nbsp;&nbsp;&nbsp; 1360024 | &nbsp;&nbsp;&nbsp; 206987 |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp; 1111 | &nbsp;&nbsp;&nbsp;&nbsp; 7718 | &nbsp;&nbsp;&nbsp; 58837 | &nbsp;&nbsp;&nbsp; 2464839 | &nbsp;&nbsp;&nbsp; 195668 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp; 8455 | &nbsp;&nbsp;&nbsp;&nbsp; 9544 | &nbsp;&nbsp;&nbsp;&nbsp; 9858 | &nbsp;&nbsp;&nbsp;&nbsp; 278512 | &nbsp;&nbsp;&nbsp;&nbsp; 34780 |
| Net transfers<sup>(1)</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp; 753 | &nbsp;&nbsp;&nbsp; 10516 | 141689 | &nbsp;&nbsp;&nbsp;&nbsp; (186801) | &nbsp;&nbsp;&nbsp; (55386) |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 840 | &nbsp;&nbsp;&nbsp; (4515) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2344 | &nbsp;&nbsp;&nbsp;&nbsp; (3244) |
| Policy charges | (3607) | &nbsp;&nbsp;&nbsp; (2146) | &nbsp;&nbsp;&nbsp; (6620) | &nbsp;&nbsp;&nbsp;&nbsp; (408900) | &nbsp;&nbsp;&nbsp; (20326) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | (56855) | &nbsp;&nbsp;&nbsp;&nbsp; (513397) | &nbsp;&nbsp;&nbsp; (56535) |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (4993) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | &nbsp;&nbsp;&nbsp; 5601 | &nbsp;&nbsp;&nbsp; 18754 | &nbsp;&nbsp;&nbsp; 83557 | &nbsp;&nbsp;&nbsp;&nbsp; (833235) | (100711) |
| Increase (decrease) in net assets | &nbsp;&nbsp;&nbsp; 6712 | &nbsp;&nbsp;&nbsp; 26472 | 142394 | &nbsp;&nbsp;&nbsp; 1631604 | &nbsp;&nbsp;&nbsp;&nbsp; 94957 |
| Net assets at beginning of year | 29236 | 253106 | 390796 | 10346008 | &nbsp;&nbsp;&nbsp; 881494 |
| Net assets at end of year | $35948 | $279578 | $533190 | $11977612 | $976451 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | 24567 | 188524 | 112553 | &nbsp;&nbsp;&nbsp; 2031002 | &nbsp;&nbsp;&nbsp; 637417 |
| Units purchased | &nbsp;&nbsp;&nbsp; 7403 | &nbsp;&nbsp;&nbsp; 17465 | &nbsp;&nbsp;&nbsp; 43186 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 48540 | &nbsp;&nbsp;&nbsp;&nbsp; 34773 |
| Units redeemed | (2890) | &nbsp;&nbsp;&nbsp; (4500) | (19468) | &nbsp;&nbsp;&nbsp;&nbsp; (190151) | (100617) |
| Units outstanding at end of year | 29080 | 201489 | 136271 | &nbsp;&nbsp;&nbsp; 1889391 | &nbsp;&nbsp;&nbsp; 571573 |

---

See accompanying notes to financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**132 ■ RiverSource of New York Account 8**

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2024 (continued)** | **Invesco VI Div** <br> **Divd, Ser I**<br>| **Invesco VI** <br> **EQV Intl** <br> **Eq, Ser II**<br>| **Invesco VI Gbl** <br> **Strat Inc, Ser I**<br>| **Invesco VI Gbl** <br> **Strat Inc, Ser** <br> **II**<br>| **Invesco VI** <br> **Global, Ser I**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $15044 | $11280 | $1369 | $33641 | $— |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp; 17825 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 7703 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 80 | &nbsp;&nbsp;&nbsp;&nbsp; (40002) | &nbsp;&nbsp;&nbsp; 12167 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp; 44278 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5993 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; 32025 |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp;&nbsp; 64472 | &nbsp;&nbsp;&nbsp;&nbsp; (24320) | &nbsp;&nbsp;&nbsp;&nbsp; (133) | &nbsp;&nbsp;&nbsp;&nbsp; 39191 | &nbsp;&nbsp;&nbsp; 37285 |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp;&nbsp; 141619 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 656 | &nbsp;&nbsp;&nbsp; 1316 | &nbsp;&nbsp;&nbsp;&nbsp; 32830 | &nbsp;&nbsp;&nbsp; 81477 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp; 24636 | &nbsp;&nbsp;&nbsp;&nbsp; 26756 | 16283 | &nbsp;&nbsp;&nbsp;&nbsp; 52842 | 133415 |
| Net transfers<sup>(1)</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp; (91558) | &nbsp;&nbsp;&nbsp;&nbsp; 15395 | &nbsp;&nbsp;&nbsp;&nbsp; 576 | &nbsp;&nbsp;&nbsp;&nbsp; 34009 | (84356) |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp;&nbsp; (74698) | &nbsp;&nbsp;&nbsp;&nbsp; (3463) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp; (215077) | &nbsp;&nbsp;&nbsp; (3422) |
| Policy charges | &nbsp;&nbsp;&nbsp;&nbsp; (20976) | &nbsp;&nbsp;&nbsp;&nbsp; (20308) | (4447) | &nbsp;&nbsp;&nbsp;&nbsp; (46305) | (36515) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | &nbsp;&nbsp;&nbsp;&nbsp; (39163) | &nbsp;&nbsp;&nbsp;&nbsp; (60723) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (41914) | (16213) |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (2069) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (200) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | &nbsp;&nbsp; (201759) | &nbsp;&nbsp;&nbsp;&nbsp; (44412) | 12412 | &nbsp;&nbsp; (216645) | &nbsp;&nbsp;&nbsp; (7091) |
| Increase (decrease) in net assets | &nbsp;&nbsp;&nbsp;&nbsp; (60140) | &nbsp;&nbsp;&nbsp;&nbsp; (43756) | 13728 | &nbsp;&nbsp; (183815) | &nbsp;&nbsp;&nbsp; 74386 |
| Net assets at beginning of year | 1167398 | 1110101 | 30814 | 1624807 | 499172 |
| Net assets at end of year | $1107258 | $1066345 | $44542 | $1440992 | $573558 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | &nbsp;&nbsp;&nbsp;&nbsp; 449499 | &nbsp;&nbsp;&nbsp;&nbsp; 477206 | 30185 | 1128210 | 319139 |
| Units purchased | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 8436 | &nbsp;&nbsp;&nbsp;&nbsp; 42516 | 16418 | &nbsp;&nbsp;&nbsp;&nbsp; 99489 | &nbsp;&nbsp;&nbsp; 75818 |
| Units redeemed | &nbsp;&nbsp;&nbsp;&nbsp; (81835) | &nbsp;&nbsp;&nbsp;&nbsp; (55790) | (4306) | &nbsp;&nbsp; (278744) | (79020) |
| Units outstanding at end of year | &nbsp;&nbsp;&nbsp;&nbsp; 376100 | &nbsp;&nbsp;&nbsp;&nbsp; 463932 | 42297 | &nbsp;&nbsp;&nbsp;&nbsp; 948955 | 315937 |

---

See accompanying notes to financial statements.

**RiverSource of New York Account 8** ■ 133

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2024 (continued)** | **Invesco VI** <br> **Global, Ser II**<br>| **Invesco VI** <br> **Mn St Sm** <br> **Cap, Ser I**<br>| **Invesco VI** <br> **Mn St Sm** <br> **Cap, Ser II**<br>| **Invesco VI** <br> **Tech, Ser I**<br>| **Invesco VI** <br> **Tech, Ser II**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $(6966) | $— | $(6267) | $(6899) | $— |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp; 17309 | &nbsp;&nbsp;&nbsp;&nbsp; 1061 | &nbsp;&nbsp;&nbsp;&nbsp; 27657 | &nbsp;&nbsp;&nbsp;&nbsp; 19474 | &nbsp;&nbsp;&nbsp;&nbsp; 37 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp; 108318 | &nbsp;&nbsp;&nbsp; 14625 | &nbsp;&nbsp;&nbsp;&nbsp; 71274 | &nbsp;&nbsp;&nbsp;&nbsp; 67844 | &nbsp;&nbsp;&nbsp;&nbsp; 393 |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp;&nbsp; 151838 | &nbsp;&nbsp;&nbsp; 21110 | &nbsp;&nbsp;&nbsp;&nbsp; 118934 | &nbsp;&nbsp;&nbsp;&nbsp; 358957 | 1778 |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp;&nbsp; 270499 | &nbsp;&nbsp;&nbsp; 36796 | &nbsp;&nbsp;&nbsp;&nbsp; 211598 | &nbsp;&nbsp;&nbsp;&nbsp; 439376 | 2208 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp; 80780 | &nbsp;&nbsp;&nbsp; 82029 | &nbsp;&nbsp;&nbsp;&nbsp; 60125 | &nbsp;&nbsp;&nbsp;&nbsp; 57312 | &nbsp;&nbsp;&nbsp;&nbsp; — |
| Net transfers<sup>(1)</sup> <br>| &nbsp;&nbsp; (294891) | 110799 | &nbsp;&nbsp;&nbsp;&nbsp; 54294 | &nbsp;&nbsp;&nbsp;&nbsp; 87379 | &nbsp;&nbsp;&nbsp;&nbsp; 226 |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp;&nbsp; (41348) | &nbsp;&nbsp;&nbsp; (7837) | &nbsp;&nbsp;&nbsp;&nbsp; (89183) | &nbsp;&nbsp;&nbsp;&nbsp; (17277) | &nbsp;&nbsp;&nbsp;&nbsp; — |
| Policy charges | &nbsp;&nbsp;&nbsp;&nbsp; (35287) | (17790) | &nbsp;&nbsp;&nbsp;&nbsp; (29711) | &nbsp;&nbsp;&nbsp;&nbsp; (41392) | &nbsp;&nbsp;&nbsp;&nbsp; (31) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | &nbsp;&nbsp;&nbsp;&nbsp; (80528) | &nbsp;&nbsp;&nbsp; (1924) | &nbsp;&nbsp;&nbsp;&nbsp; (11083) | &nbsp;&nbsp;&nbsp;&nbsp; (30838) | &nbsp;&nbsp; (159) |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | &nbsp;&nbsp; (371274) | 165277 | &nbsp;&nbsp;&nbsp;&nbsp; (15558) | &nbsp;&nbsp;&nbsp;&nbsp; 55184 | &nbsp;&nbsp;&nbsp;&nbsp; 36 |
| Increase (decrease) in net assets | &nbsp;&nbsp; (100775) | 202073 | &nbsp;&nbsp;&nbsp;&nbsp; 196040 | &nbsp;&nbsp;&nbsp;&nbsp; 494560 | 2244 |
| Net assets at beginning of year | 1823314 | 252875 | 1802594 | 1252269 | 6355 |
| Net assets at end of year | $1722539 | $454948 | $1998634 | $1746829 | $8599 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | &nbsp;&nbsp;&nbsp;&nbsp; 512963 | 160827 | &nbsp;&nbsp;&nbsp;&nbsp; 497496 | &nbsp;&nbsp;&nbsp;&nbsp; 303612 | 5245 |
| Units purchased | &nbsp;&nbsp;&nbsp;&nbsp; 23998 | 112115 | &nbsp;&nbsp;&nbsp;&nbsp; 56366 | &nbsp;&nbsp;&nbsp;&nbsp; 119088 | &nbsp;&nbsp;&nbsp;&nbsp; 200 |
| Units redeemed | &nbsp;&nbsp; (127827) | (16169) | &nbsp;&nbsp;&nbsp;&nbsp; (45510) | &nbsp;&nbsp;&nbsp;&nbsp; (43101) | &nbsp;&nbsp;&nbsp;&nbsp; (21) |
| Units outstanding at end of year | &nbsp;&nbsp;&nbsp;&nbsp; 409134 | 256773 | &nbsp;&nbsp;&nbsp;&nbsp; 508352 | &nbsp;&nbsp;&nbsp;&nbsp; 379599 | 5424 |

---

See accompanying notes to financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**134 ■ RiverSource of New York Account 8**

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2024 (continued)** | **Janus Hend** <br> **VIT Gbl Tech** <br> **Innov, Srv**<br>| **Janus** <br> **Henderson VIT** <br> **Bal, Inst**<br>| **Janus** <br> **Henderson VIT** <br> **Bal, Serv**<br>| **Janus** <br> **Henderson VIT** <br> **Enter, Serv**<br>| **Janus** <br> **Henderson VIT** <br> **Flex Bd, Inst**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $(13938) | $18639 | $1034 | $840 | $12343 |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp; 203872 | &nbsp;&nbsp;&nbsp;&nbsp; 2463 | &nbsp;&nbsp;&nbsp;&nbsp; 5641 | &nbsp;&nbsp;&nbsp;&nbsp; 4022 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (31) |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; 38221 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp;&nbsp; 501839 | &nbsp;&nbsp;&nbsp; 98222 | &nbsp;&nbsp;&nbsp;&nbsp; 3004 | &nbsp;&nbsp;&nbsp; 73704 | (11477) |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp;&nbsp; 691773 | 119324 | &nbsp;&nbsp;&nbsp;&nbsp; 9679 | 116787 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 835 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp; 41609 | 135096 | &nbsp;&nbsp;&nbsp;&nbsp; 1336 | &nbsp;&nbsp;&nbsp; 11441 | 102904 |
| Net transfers<sup>(1)</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 7824 | &nbsp;&nbsp;&nbsp; 19003 | (23618) | &nbsp;&nbsp;&nbsp; (3014) | 219812 |
| Transfers for policy loans | &nbsp;&nbsp; (111225) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (3) | &nbsp;&nbsp;&nbsp;&nbsp; (860) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Policy charges | &nbsp;&nbsp;&nbsp;&nbsp; (49046) | (39181) | &nbsp;&nbsp;&nbsp;&nbsp; (307) | (13184) | (16449) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | &nbsp;&nbsp; (228273) | &nbsp;&nbsp;&nbsp;&nbsp; (215) | &nbsp;&nbsp;&nbsp;&nbsp; (342) | &nbsp;&nbsp;&nbsp; (3688) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp; (5001) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | &nbsp;&nbsp; (344112) | 114703 | (22934) | &nbsp;&nbsp;&nbsp; (9305) | 306267 |
| Increase (decrease) in net assets | &nbsp;&nbsp;&nbsp;&nbsp; 347661 | 234027 | (13255) | 107482 | 307102 |
| Net assets at beginning of year | 2297291 | 737372 | &nbsp;&nbsp;&nbsp; 64068 | 800241 | &nbsp;&nbsp;&nbsp; 81235 |
| Net assets at end of year | $2644952 | $971399 | $50813 | $907723 | $388337 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | &nbsp;&nbsp;&nbsp;&nbsp; 311522 | 498152 | &nbsp;&nbsp;&nbsp; 41082 | 117904 | &nbsp;&nbsp;&nbsp; 75329 |
| Units purchased | &nbsp;&nbsp;&nbsp;&nbsp; 81835 | &nbsp;&nbsp;&nbsp; 94741 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 794 | &nbsp;&nbsp;&nbsp;&nbsp; 1684 | 292912 |
| Units redeemed | &nbsp;&nbsp; (102698) | (24348) | (13574) | &nbsp;&nbsp;&nbsp; (3555) | (15052) |
| Units outstanding at end of year | &nbsp;&nbsp;&nbsp;&nbsp; 290659 | 568545 | &nbsp;&nbsp;&nbsp; 28302 | 116033 | 353189 |

---

See accompanying notes to financial statements.

**RiverSource of New York Account 8** ■ 135

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2024 (continued)** | **Janus** <br> **Henderson VIT** <br> **Flex Bd, Serv**<br>| **Janus** <br> **Henderson VIT** <br> **Overseas,** <br> **Serv**<br>| **Janus** <br> **Henderson VIT** <br> **Res, Inst**<br>| **Janus** <br> **Henderson VIT** <br> **Res, Serv**<br>| **Lazard Ret** <br> **Global Dyn** <br> **MA, Inv**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $1705 | $13544 | $19 | $(4110) | $— |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp; (12) | &nbsp;&nbsp;&nbsp;&nbsp; 62753 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 86 | &nbsp;&nbsp;&nbsp; 58441 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 95 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; 1815 | &nbsp;&nbsp;&nbsp; 22712 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | (1423) | &nbsp;&nbsp;&nbsp;&nbsp; 14218 | 16689 | 137822 | &nbsp;&nbsp;&nbsp; 1065 |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp;&nbsp; 270 | &nbsp;&nbsp;&nbsp;&nbsp; 90515 | 18609 | 214865 | &nbsp;&nbsp;&nbsp; 1160 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp; 6765 | &nbsp;&nbsp;&nbsp;&nbsp; 62299 | &nbsp;&nbsp;&nbsp; 4170 | &nbsp;&nbsp;&nbsp; 17441 | &nbsp;&nbsp;&nbsp; 5435 |
| Net transfers<sup>(1)</sup> <br>| 14180 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1133 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; 66166 | &nbsp;&nbsp;&nbsp; 1105 |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (64426) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | (40141) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Policy charges | &nbsp;&nbsp;&nbsp;&nbsp; (426) | &nbsp;&nbsp;&nbsp;&nbsp; (60035) | &nbsp;&nbsp;&nbsp;&nbsp; (559) | (17372) | (2936) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (99997) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | (56181) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (217) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | 20519 | &nbsp;&nbsp; (161243) | &nbsp;&nbsp;&nbsp; 3611 | (30087) | &nbsp;&nbsp;&nbsp; 3604 |
| Increase (decrease) in net assets | 20789 | &nbsp;&nbsp;&nbsp;&nbsp; (70728) | 22220 | 184778 | &nbsp;&nbsp;&nbsp; 4764 |
| Net assets at beginning of year | 26124 | 1822478 | 51257 | 618403 | 11605 |
| Net assets at end of year | $46913 | $1751750 | $73477 | $803181 | $16369 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | 22004 | &nbsp;&nbsp;&nbsp;&nbsp; 746386 | 26822 | 125568 | 10212 |
| Units purchased | 17235 | &nbsp;&nbsp;&nbsp;&nbsp; 64024 | &nbsp;&nbsp;&nbsp; 1835 | &nbsp;&nbsp;&nbsp; 25338 | &nbsp;&nbsp;&nbsp; 5481 |
| Units redeemed | &nbsp;&nbsp;&nbsp;&nbsp; (357) | &nbsp;&nbsp; (113380) | &nbsp;&nbsp;&nbsp;&nbsp; (241) | (22798) | (2435) |
| Units outstanding at end of year | 38882 | &nbsp;&nbsp;&nbsp;&nbsp; 697030 | 28416 | 128108 | 13258 |

---

See accompanying notes to financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**136 ■ RiverSource of New York Account 8**

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2024 (continued)** | **Lazard Ret** <br> **Global Dyn** <br> **MA, Serv**<br>| **Lord Abt Bond** <br> **Debenture,** <br>**Cl VC**<sup>(2)</sup> <br>| **LVIP AC Intl,** <br>**Serv Cl**<br>| **LVIP AC Intl,** <br> **Std** <br>**Cl II**<br>| **LVIP AC Mid** <br> **Cap Val, Std** <br>**Cl II**<sup>(2)</sup> <br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $(88) | $1176 | $7252 | $6106 | $504 |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp; (184) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 21 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5526 | &nbsp;&nbsp;&nbsp;&nbsp; 21213 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 78 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 443 |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp; 1548 | (1114) | &nbsp;&nbsp;&nbsp;&nbsp; 10907 | &nbsp;&nbsp;&nbsp; (11369) | &nbsp;&nbsp;&nbsp;&nbsp; (416) |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp; 1276 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 83 | &nbsp;&nbsp;&nbsp;&nbsp; 23685 | &nbsp;&nbsp;&nbsp;&nbsp; 15950 | &nbsp;&nbsp;&nbsp;&nbsp; 609 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp; 241 | &nbsp;&nbsp;&nbsp; 5146 | &nbsp;&nbsp;&nbsp;&nbsp; 18837 | &nbsp;&nbsp;&nbsp;&nbsp; 22702 | &nbsp;&nbsp;&nbsp; 6293 |
| Net transfers<sup>(1)</sup> <br>| (2682) | 16818 | (115636) | &nbsp;&nbsp;&nbsp; (14629) | 19640 |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp;&nbsp; 373 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1672 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3485 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Policy charges | &nbsp;&nbsp;&nbsp;&nbsp; (577) | &nbsp;&nbsp;&nbsp;&nbsp; (817) | &nbsp;&nbsp;&nbsp; (11927) | &nbsp;&nbsp;&nbsp; (23444) | (2274) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (80) | &nbsp;&nbsp;&nbsp; (43021) | (117583) | &nbsp;&nbsp;&nbsp;&nbsp; (106) |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | (2645) | 21067 | (150075) | (129469) | 23553 |
| Increase (decrease) in net assets | (1369) | 21150 | (126390) | (113519) | 24162 |
| Net assets at beginning of year | 17069 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; 786190 | &nbsp;&nbsp;&nbsp; 701441 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net assets at end of year | $15700 | $21150 | $659800 | $587922 | $24162 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | 12357 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; 510154 | &nbsp;&nbsp;&nbsp; 315441 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Units purchased | &nbsp;&nbsp;&nbsp; 2148 | 20624 | &nbsp;&nbsp;&nbsp;&nbsp; 61530 | &nbsp;&nbsp;&nbsp;&nbsp; 10849 | 24308 |
| Units redeemed | (3871) | &nbsp;&nbsp;&nbsp;&nbsp; (767) | (147800) | &nbsp;&nbsp;&nbsp; (80554) | (2110) |
| Units outstanding at end of year | 10634 | 19857 | &nbsp;&nbsp;&nbsp; 423884 | &nbsp;&nbsp;&nbsp; 245736 | 22198 |

---

See accompanying notes to financial statements.

**RiverSource of New York Account 8** ■ 137

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2024 (continued)** | **LVIP AC Val,** <br>**Serv Cl**<br>| **LVIP AC Val,** <br> **Std** <br>**Cl II**<br>| **MFS Gbl Real** <br> **Est, Init Cl**<sup>(2)</sup> <br>| **MFS Intl Gro,** <br> **Init Cl**<sup>(2)</sup> <br>| **MFS Mass Inv** <br> **Gro Stock,** <br>**Serv Cl**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $56762 | $87139 | $2 | $444 | $(14181) |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp; 79173 | &nbsp;&nbsp;&nbsp;&nbsp; 173899 |  | &nbsp;&nbsp;&nbsp;&nbsp; 122 | &nbsp;&nbsp;&nbsp;&nbsp; 61526 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp; 137832 | &nbsp;&nbsp;&nbsp;&nbsp; 231072 |  | &nbsp;&nbsp;&nbsp;&nbsp; 144 | &nbsp;&nbsp;&nbsp;&nbsp; 311360 |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp;&nbsp; (69836) | &nbsp;&nbsp; (142558) | &nbsp;&nbsp; (2) | &nbsp;&nbsp;&nbsp;&nbsp; (490) | &nbsp;&nbsp;&nbsp;&nbsp; 125357 |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp;&nbsp; 203931 | &nbsp;&nbsp;&nbsp;&nbsp; 349552 |  | &nbsp;&nbsp;&nbsp;&nbsp; 220 | &nbsp;&nbsp;&nbsp;&nbsp; 484062 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp; 60540 | &nbsp;&nbsp;&nbsp;&nbsp; 135953 | &nbsp;&nbsp; 75 | 16477 | &nbsp;&nbsp;&nbsp;&nbsp; 52133 |
| Net transfers<sup>(1)</sup> <br>| &nbsp;&nbsp; (100431) | &nbsp;&nbsp; (127065) |  | 62012 | &nbsp;&nbsp;&nbsp;&nbsp; 90252 |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp;&nbsp; (26884) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 6006 |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (29450) |
| Policy charges | &nbsp;&nbsp;&nbsp;&nbsp; (48495) | &nbsp;&nbsp; (146803) |  | (4202) | &nbsp;&nbsp;&nbsp;&nbsp; (69835) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | &nbsp;&nbsp;&nbsp;&nbsp; (92525) | &nbsp;&nbsp; (394236) |  | &nbsp;&nbsp;&nbsp;&nbsp; (83) | &nbsp;&nbsp; (199648) |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | &nbsp;&nbsp; (207795) | &nbsp;&nbsp; (526145) | &nbsp;&nbsp; 75 | 74204 | &nbsp;&nbsp; (156548) |
| Increase (decrease) in net assets | &nbsp;&nbsp;&nbsp;&nbsp; (3864) | &nbsp;&nbsp; (176593) | &nbsp;&nbsp; 75 | 74424 | &nbsp;&nbsp;&nbsp;&nbsp; 327514 |
| Net assets at beginning of year | 2352619 | 4042517 |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | 3106178 |
| Net assets at end of year | $2348755 | $3865924 | $75 | $74424 | $3433692 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | 1020712 | &nbsp;&nbsp;&nbsp;&nbsp; 875017 |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | 1137870 |
| Units purchased | &nbsp;&nbsp;&nbsp;&nbsp; 146231 | &nbsp;&nbsp;&nbsp;&nbsp; 45963 |  | 71046 | &nbsp;&nbsp;&nbsp;&nbsp; 86854 |
| Units redeemed | &nbsp;&nbsp; (209047) | &nbsp;&nbsp; (131210) |  | (3746) | &nbsp;&nbsp; (123232) |
| Units outstanding at end of year | &nbsp;&nbsp;&nbsp;&nbsp; 957896 | &nbsp;&nbsp;&nbsp;&nbsp; 789770 |  | 67300 | 1101492 |

---

See accompanying notes to financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**138 ■ RiverSource of New York Account 8**

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2024 (continued)** | **MFS New Dis,** <br>**Serv Cl**<br>| **MFS Utilities,** <br> **Init Cl**<br>| **MFS Utilities,** <br>**Serv Cl**<br>| **MS VIF Dis,** <br>**Cl I**<br>| **MS VIF Dis,** <br>**Cl II**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $(9986) | $1951 | $18400 | $— | $(4139) |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp; (157174) | &nbsp;&nbsp;&nbsp;&nbsp; (109) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 8367 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (22) | &nbsp;&nbsp; (166749) |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; 2407 | &nbsp;&nbsp;&nbsp;&nbsp; 32375 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp;&nbsp; 280363 | &nbsp;&nbsp;&nbsp; 4809 | &nbsp;&nbsp;&nbsp;&nbsp; 53270 | 159278 | &nbsp;&nbsp;&nbsp;&nbsp; 489456 |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp;&nbsp; 113203 | &nbsp;&nbsp;&nbsp; 9058 | &nbsp;&nbsp;&nbsp;&nbsp; 112412 | 159256 | &nbsp;&nbsp;&nbsp;&nbsp; 318568 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp; 44390 | 17522 | &nbsp;&nbsp;&nbsp;&nbsp; 47584 | &nbsp;&nbsp;&nbsp; 95785 | &nbsp;&nbsp;&nbsp;&nbsp; 34052 |
| Net transfers<sup>(1)</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp; 27586 | (2226) | &nbsp;&nbsp;&nbsp;&nbsp; (17455) | (49682) | &nbsp;&nbsp;&nbsp;&nbsp; 65283 |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp;&nbsp; (96712) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (4801) | &nbsp;&nbsp;&nbsp; (4091) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1374 |
| Policy charges | &nbsp;&nbsp;&nbsp;&nbsp; (46834) | (5480) | &nbsp;&nbsp;&nbsp;&nbsp; (38337) | (27225) | &nbsp;&nbsp;&nbsp;&nbsp; (25357) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | &nbsp;&nbsp;&nbsp;&nbsp; (58416) | (1228) | &nbsp;&nbsp;&nbsp;&nbsp; (17090) | &nbsp;&nbsp;&nbsp; (9200) | &nbsp;&nbsp;&nbsp;&nbsp; (35516) |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (3) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | &nbsp;&nbsp; (129986) | &nbsp;&nbsp;&nbsp; 8588 | &nbsp;&nbsp;&nbsp;&nbsp; (30102) | &nbsp;&nbsp;&nbsp;&nbsp; 5587 | &nbsp;&nbsp;&nbsp;&nbsp; 39836 |
| Increase (decrease) in net assets | &nbsp;&nbsp;&nbsp;&nbsp; (16783) | 17646 | &nbsp;&nbsp;&nbsp;&nbsp; 82310 | 164843 | &nbsp;&nbsp;&nbsp;&nbsp; 358404 |
| Net assets at beginning of year | 2010897 | 75089 | 1061468 | 362442 | &nbsp;&nbsp;&nbsp;&nbsp; 791586 |
| Net assets at end of year | $1994114 | $92735 | $1143778 | $527285 | $1149990 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | &nbsp;&nbsp;&nbsp;&nbsp; 461521 | 54889 | &nbsp;&nbsp;&nbsp;&nbsp; 325018 | 265981 | &nbsp;&nbsp;&nbsp;&nbsp; 176174 |
| Units purchased | &nbsp;&nbsp;&nbsp;&nbsp; 125306 | 11843 | &nbsp;&nbsp;&nbsp;&nbsp; 75423 | &nbsp;&nbsp;&nbsp; 65912 | &nbsp;&nbsp;&nbsp;&nbsp; 38336 |
| Units redeemed | &nbsp;&nbsp; (112055) | (6023) | &nbsp;&nbsp;&nbsp;&nbsp; (47976) | (59065) | &nbsp;&nbsp;&nbsp;&nbsp; (20004) |
| Units outstanding at end of year | &nbsp;&nbsp;&nbsp;&nbsp; 474772 | 60709 | &nbsp;&nbsp;&nbsp;&nbsp; 352465 | 272828 | &nbsp;&nbsp;&nbsp;&nbsp; 194506 |

---

See accompanying notes to financial statements.

**RiverSource of New York Account 8** ■ 139

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2024 (continued)** | **NB AMT** <br> **Quality Eq,** <br>**Cl I**<br>| **NB AMT** <br> **Quality Eq,** <br>**Cl S**<br>| **Nom VIP Asset** <br> **Strategy,** <br>**Serv Cl**<br>| **Nom VIP Asset** <br> **Strategy, Std** <br> **Cl**<sup>(2)</sup> <br>| **Nom VIP Intl** <br> **Core Eq, Std** <br> **Cl**<sup>(4)</sup> <br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $103 | $— | $889 | $3 | $1 |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp; 201 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 85 | &nbsp;&nbsp;&nbsp;&nbsp; 321 | &nbsp;&nbsp;&nbsp; — |  |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp; 2215 | &nbsp;&nbsp;&nbsp; 2730 | &nbsp;&nbsp;&nbsp; 1977 | &nbsp;&nbsp;&nbsp;&nbsp; 6 |  |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp; 6739 | &nbsp;&nbsp;&nbsp; 9298 | &nbsp;&nbsp;&nbsp; 3102 | &nbsp;&nbsp;&nbsp;&nbsp; 3 | &nbsp;&nbsp; (1) |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp; 9258 | 12113 | &nbsp;&nbsp;&nbsp; 6289 | &nbsp;&nbsp;&nbsp; 12 |  |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp; 9506 | &nbsp;&nbsp;&nbsp; 2831 | &nbsp;&nbsp;&nbsp; 6807 | 171 | &nbsp;&nbsp; 75 |
| Net transfers<sup>(1)</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | (7953) | &nbsp;&nbsp;&nbsp; 12 |  |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; — |  |
| Policy charges | (2243) | &nbsp;&nbsp;&nbsp;&nbsp; (671) | (1436) | (42) |  |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | (3203) | &nbsp;&nbsp;&nbsp; — |  |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; — |  |
| Increase (decrease) from transactions | &nbsp;&nbsp;&nbsp; 7263 | &nbsp;&nbsp;&nbsp; 2160 | (5785) | 141 | &nbsp;&nbsp; 75 |
| Increase (decrease) in net assets | 16521 | 14273 | &nbsp;&nbsp;&nbsp;&nbsp; 504 | 153 | &nbsp;&nbsp; 75 |
| Net assets at beginning of year | 32618 | 46275 | 54893 | &nbsp;&nbsp;&nbsp; — |  |
| Net assets at end of year | $49139 | $60548 | $55397 | $153 | $75 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | 18941 | 13374 | 37412 | &nbsp;&nbsp;&nbsp; — |  |
| Units purchased | &nbsp;&nbsp;&nbsp; 4850 | &nbsp;&nbsp;&nbsp;&nbsp; 737 | &nbsp;&nbsp;&nbsp; 4302 | &nbsp;&nbsp;&nbsp; 98 |  |
| Units redeemed | (1116) | &nbsp;&nbsp;&nbsp;&nbsp; (170) | (7997) | (38) |  |
| Units outstanding at end of year | 22675 | 13941 | 33717 | &nbsp;&nbsp;&nbsp; 60 |  |

---

See accompanying notes to financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**140 ■ RiverSource of New York Account 8**

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2024 (continued)** | **PIMCO VIT All** <br> **Asset, Advisor** <br> **Cl**<br>| **PIMCO VIT All** <br> **Asset, Inst Cl**<br>| **PIMCO VIT Glb** <br> **Man As Alloc,** <br> **Adv Cl**<br>| **PIMCO VIT Tot** <br> **Return,** <br> **Advisor Cl**<br>| **PIMCO VIT Tot** <br> **Return, Inst Cl**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $34947 | $943 | $198 | $16288 | $5604 |
| Net realized gain (loss) on sales of investments | (12108) | &nbsp;&nbsp;&nbsp;&nbsp; (130) | &nbsp;&nbsp;&nbsp;&nbsp; (43) | (13071) | &nbsp;&nbsp;&nbsp;&nbsp; (415) |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp; (4189) | &nbsp;&nbsp;&nbsp;&nbsp; (334) | &nbsp;&nbsp;&nbsp;&nbsp; 429 | &nbsp;&nbsp;&nbsp;&nbsp; 5237 | &nbsp;&nbsp;&nbsp; (2355) |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp; 18650 | &nbsp;&nbsp;&nbsp;&nbsp; 479 | &nbsp;&nbsp;&nbsp;&nbsp; 584 | &nbsp;&nbsp;&nbsp;&nbsp; 8454 | &nbsp;&nbsp;&nbsp;&nbsp; 2834 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp; 21991 | &nbsp;&nbsp;&nbsp; 6507 | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 5143 | &nbsp;&nbsp;&nbsp; 41679 |
| Net transfers<sup>(1)</sup> <br>| (32713) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; 86980 | &nbsp;&nbsp;&nbsp; 19308 |
| Transfers for policy loans | (15465) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (392) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Policy charges | (19827) | (3612) | &nbsp;&nbsp; (302) | &nbsp;&nbsp;&nbsp; (8178) | (12274) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | &nbsp;&nbsp;&nbsp; (9887) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; (8524) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | (55901) | &nbsp;&nbsp;&nbsp; 2895 | &nbsp;&nbsp; (302) | &nbsp;&nbsp;&nbsp; 75029 | &nbsp;&nbsp;&nbsp; 48713 |
| Increase (decrease) in net assets | (37251) | &nbsp;&nbsp;&nbsp; 3374 | &nbsp;&nbsp;&nbsp;&nbsp; 282 | &nbsp;&nbsp;&nbsp; 83483 | &nbsp;&nbsp;&nbsp; 51547 |
| Net assets at beginning of year | 616253 | 12766 | 5540 | 435359 | 115433 |
| Net assets at end of year | $579002 | $16140 | $5822 | $518842 | $166980 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | 297716 | &nbsp;&nbsp;&nbsp; 9940 | 3619 | 397569 | 110352 |
| Units purchased | &nbsp;&nbsp;&nbsp; 18110 | &nbsp;&nbsp;&nbsp; 4888 | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; 83075 | &nbsp;&nbsp;&nbsp; 56652 |
| Units redeemed | (46531) | (2738) | &nbsp;&nbsp; (185) | (15943) | (11551) |
| Units outstanding at end of year | 269295 | 12090 | 3434 | 464701 | 155453 |

---

See accompanying notes to financial statements.

**RiverSource of New York Account 8** ■ 141

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2024 (continued)** | **Put VT Global** <br> **Hlth Care,** <br>**Cl IA**<br>| **Put VT Global** <br> **Hlth Care,** <br>**Cl IB**<br>| **Put VT Hi** <br> **Yield,** <br>**Cl IB**<br>| **Put VT Intl Eq,** <br>**Cl IB**<br>| **Put VT Intl Val,** <br>**Cl IA**<sup>(2)</sup> <br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $317 | $(548) | $12940 | $2756 | $2 |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp; 848 | &nbsp;&nbsp;&nbsp;&nbsp; 16197 | &nbsp;&nbsp;&nbsp; (2491) | &nbsp;&nbsp;&nbsp;&nbsp; 3575 | &nbsp;&nbsp;&nbsp;&nbsp; 15 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp; 1954 | &nbsp;&nbsp;&nbsp;&nbsp; 64486 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | (4191) | &nbsp;&nbsp;&nbsp;&nbsp; (64941) | &nbsp;&nbsp;&nbsp;&nbsp; 7301 | &nbsp;&nbsp;&nbsp; (2765) | &nbsp;&nbsp;&nbsp;&nbsp; (3) |
| Net increase (decrease) in net assets resulting from operations | (1072) | &nbsp;&nbsp;&nbsp;&nbsp; 15194 | &nbsp;&nbsp;&nbsp; 17750 | &nbsp;&nbsp;&nbsp;&nbsp; 3566 | &nbsp;&nbsp;&nbsp;&nbsp; 14 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | 22844 | &nbsp;&nbsp;&nbsp;&nbsp; 24033 | &nbsp;&nbsp;&nbsp;&nbsp; 8958 | &nbsp;&nbsp;&nbsp;&nbsp; 3584 | &nbsp;&nbsp;&nbsp;&nbsp; 171 |
| Net transfers<sup>(1)</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 56 | &nbsp;&nbsp;&nbsp;&nbsp; (9581) | &nbsp;&nbsp;&nbsp;&nbsp; 1425 | &nbsp;&nbsp;&nbsp; 16904 | 2908 |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (13483) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 86 | &nbsp;&nbsp;&nbsp;&nbsp; (619) | &nbsp;&nbsp;&nbsp;&nbsp; — |
| Policy charges | (3888) | &nbsp;&nbsp;&nbsp;&nbsp; (24248) | (10692) | &nbsp;&nbsp;&nbsp; (3496) | &nbsp;&nbsp; (539) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (18827) | (13511) | &nbsp;&nbsp;&nbsp; (3829) | &nbsp;&nbsp;&nbsp;&nbsp; — |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | 19012 | &nbsp;&nbsp;&nbsp;&nbsp; (42106) | (13734) | &nbsp;&nbsp;&nbsp; 12544 | 2540 |
| Increase (decrease) in net assets | 17940 | &nbsp;&nbsp;&nbsp;&nbsp; (26912) | &nbsp;&nbsp;&nbsp;&nbsp; 4016 | &nbsp;&nbsp;&nbsp; 16110 | 2554 |
| Net assets at beginning of year | 44251 | 1404360 | 251646 | 162490 | &nbsp;&nbsp;&nbsp;&nbsp; — |
| Net assets at end of year | $62191 | $1377448 | $255662 | $178600 | $2554 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | 39456 | &nbsp;&nbsp;&nbsp;&nbsp; 324414 | &nbsp;&nbsp;&nbsp; 85154 | &nbsp;&nbsp;&nbsp; 73494 | &nbsp;&nbsp;&nbsp;&nbsp; — |
| Units purchased | 18388 | &nbsp;&nbsp;&nbsp;&nbsp; 42041 | &nbsp;&nbsp;&nbsp;&nbsp; 3531 | &nbsp;&nbsp;&nbsp; 28473 | 2806 |
| Units redeemed | (3318) | &nbsp;&nbsp;&nbsp;&nbsp; (28426) | &nbsp;&nbsp;&nbsp; (7763) | (19603) | &nbsp;&nbsp; (491) |
| Units outstanding at end of year | 54526 | &nbsp;&nbsp;&nbsp;&nbsp; 338029 | &nbsp;&nbsp;&nbsp; 80922 | &nbsp;&nbsp;&nbsp; 82364 | 2315 |

---

See accompanying notes to financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**142 ■ RiverSource of New York Account 8**

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2024 (continued)** | **Put VT Lg Cap** <br> **Val,** <br>**Cl IA**<sup>(2)</sup> <br>| **Put VT Sus** <br> **Leaders,** <br>**Cl IA**<br>| **Put VT Sus** <br> **Leaders,** <br>**Cl IB**<br>| **Royce Micro-**<br> **Cap, Invest Cl**<br>| **Temp Global** <br> **Bond,** <br>**Cl 1**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $44 | $(68241) | $(404) | $(13057) | $— |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp; 142 | &nbsp;&nbsp;&nbsp;&nbsp; 370548 | &nbsp;&nbsp;&nbsp;&nbsp; 7929 | &nbsp;&nbsp;&nbsp;&nbsp; (9324) | &nbsp;&nbsp;&nbsp;&nbsp; (17) |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp; 150 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 88696 | &nbsp;&nbsp;&nbsp;&nbsp; 1212 | &nbsp;&nbsp;&nbsp;&nbsp; 130508 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp;&nbsp; 896 | &nbsp;&nbsp;&nbsp; 2365851 | &nbsp;&nbsp;&nbsp; 27614 | &nbsp;&nbsp;&nbsp;&nbsp; 117452 | (3236) |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp; 1232 | &nbsp;&nbsp;&nbsp; 2756854 | &nbsp;&nbsp;&nbsp; 36351 | &nbsp;&nbsp;&nbsp;&nbsp; 225579 | (3253) |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp; 5563 | &nbsp;&nbsp;&nbsp;&nbsp; 222888 | &nbsp;&nbsp;&nbsp;&nbsp; 1630 | &nbsp;&nbsp;&nbsp;&nbsp; 61129 | &nbsp;&nbsp;&nbsp; 5076 |
| Net transfers<sup>(1)</sup> <br>| 39222 | &nbsp;&nbsp;&nbsp;&nbsp; (272202) | &nbsp;&nbsp;&nbsp; 16252 | &nbsp;&nbsp;&nbsp;&nbsp; (71466) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (43758) | &nbsp;&nbsp;&nbsp; (1541) | &nbsp;&nbsp;&nbsp;&nbsp; (11217) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Policy charges | (2398) | &nbsp;&nbsp;&nbsp;&nbsp; (368676) | &nbsp;&nbsp;&nbsp; (3541) | &nbsp;&nbsp;&nbsp;&nbsp; (76038) | (1741) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | &nbsp;&nbsp;&nbsp;&nbsp; (145) | &nbsp;&nbsp;&nbsp;&nbsp; (409837) | &nbsp;&nbsp;&nbsp;&nbsp; (545) | &nbsp;&nbsp; (167577) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (1269) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | 42242 | &nbsp;&nbsp;&nbsp;&nbsp; (871585) | &nbsp;&nbsp;&nbsp; 12255 | &nbsp;&nbsp; (266438) | &nbsp;&nbsp;&nbsp; 3335 |
| Increase (decrease) in net assets | 43474 | &nbsp;&nbsp;&nbsp; 1885269 | &nbsp;&nbsp;&nbsp; 48606 | &nbsp;&nbsp;&nbsp;&nbsp; (40859) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 82 |
| Net assets at beginning of year | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | 12550221 | 150338 | 1977007 | 27102 |
| Net assets at end of year | $43474 | $14435490 | $198944 | $1936148 | $27184 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; 1848151 | &nbsp;&nbsp;&nbsp; 30724 | &nbsp;&nbsp;&nbsp;&nbsp; 435903 | 30749 |
| Units purchased | 38371 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 28573 | &nbsp;&nbsp;&nbsp; 16228 | &nbsp;&nbsp;&nbsp;&nbsp; 13548 | &nbsp;&nbsp;&nbsp; 6026 |
| Units redeemed | (1991) | &nbsp;&nbsp;&nbsp;&nbsp; (139311) | &nbsp;&nbsp;&nbsp; (2653) | &nbsp;&nbsp;&nbsp;&nbsp; (69738) | (2072) |
| Units outstanding at end of year | 36380 | &nbsp;&nbsp;&nbsp; 1737413 | &nbsp;&nbsp;&nbsp; 44299 | &nbsp;&nbsp;&nbsp;&nbsp; 379713 | 34703 |

---

See accompanying notes to financial statements.

**RiverSource of New York Account 8** ■ 143

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2024 (continued)** | **Temp Global** <br> **Bond,** <br>**Cl 2**<br>| **Third Ave VST** <br> **Third Ave** <br> **Value**<br>| **VanEck VIP** <br> **Global Gold,** <br>**Cl S**<br>| **VP Aggr,** <br>**Cl 1**<br>| **VP Aggr,** <br>**Cl 2**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $(630) | $46868 | $3787 | $— | $(66765) |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp; (8009) | &nbsp;&nbsp;&nbsp;&nbsp; 91334 | &nbsp;&nbsp;&nbsp;&nbsp; 1639 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 7243 | &nbsp;&nbsp;&nbsp; 1119008 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 191412 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | (13708) | &nbsp;&nbsp; (386092) | &nbsp;&nbsp;&nbsp; 12112 | &nbsp;&nbsp;&nbsp;&nbsp; 211844 | &nbsp;&nbsp;&nbsp; 2344469 |
| Net increase (decrease) in net assets resulting from operations | (22347) | &nbsp;&nbsp;&nbsp;&nbsp; (56478) | &nbsp;&nbsp;&nbsp; 17538 | &nbsp;&nbsp;&nbsp;&nbsp; 219087 | &nbsp;&nbsp;&nbsp; 3396712 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp; 10357 | &nbsp;&nbsp;&nbsp;&nbsp; 67915 | &nbsp;&nbsp;&nbsp;&nbsp; 5764 | &nbsp;&nbsp;&nbsp;&nbsp; 931284 | &nbsp;&nbsp;&nbsp; 1084223 |
| Net transfers<sup>(1)</sup> <br>| (27544) | &nbsp;&nbsp; (127704) | &nbsp;&nbsp;&nbsp; 28110 | 1369074 | &nbsp;&nbsp;&nbsp;&nbsp; 621104 |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 515 | &nbsp;&nbsp;&nbsp;&nbsp; (21158) | &nbsp;&nbsp;&nbsp;&nbsp; (203) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (289940) |
| Policy charges | &nbsp;&nbsp;&nbsp; (4288) | &nbsp;&nbsp;&nbsp;&nbsp; (73813) | &nbsp;&nbsp;&nbsp; (1987) | &nbsp;&nbsp; (147455) | &nbsp;&nbsp;&nbsp;&nbsp; (386406) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | &nbsp;&nbsp;&nbsp; (2922) | &nbsp;&nbsp;&nbsp;&nbsp; (71525) | &nbsp;&nbsp;&nbsp; (1984) | &nbsp;&nbsp;&nbsp;&nbsp; (2780) | (2755308) |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (1261) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | (23882) | &nbsp;&nbsp; (227546) | &nbsp;&nbsp;&nbsp; 29700 | 2150123 | (1726327) |
| Increase (decrease) in net assets | (46229) | &nbsp;&nbsp; (284024) | &nbsp;&nbsp;&nbsp; 47238 | 2369210 | &nbsp;&nbsp;&nbsp; 1670385 |
| Net assets at beginning of year | 203323 | 2465879 | 145126 | 1669346 | 26120255 |
| Net assets at end of year | $157094 | $2181855 | $192364 | $4038556 | $27790640 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | 229541 | &nbsp;&nbsp;&nbsp;&nbsp; 653424 | 115974 | 1165998 | 11567491 |
| Units purchased | &nbsp;&nbsp;&nbsp; 15026 | &nbsp;&nbsp;&nbsp;&nbsp; 18537 | &nbsp;&nbsp;&nbsp; 22202 | 1415672 | &nbsp;&nbsp;&nbsp;&nbsp; 885563 |
| Units redeemed | (45178) | &nbsp;&nbsp;&nbsp;&nbsp; (77282) | &nbsp;&nbsp;&nbsp; (2869) | &nbsp;&nbsp;&nbsp;&nbsp; (96166) | (1553693) |
| Units outstanding at end of year | 199389 | &nbsp;&nbsp;&nbsp;&nbsp; 594679 | 135307 | 2485504 | 10899361 |

---

See accompanying notes to financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**144 ■ RiverSource of New York Account 8**

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2024 (continued)** | **VP Aggr,** <br>**Cl 4**<br>| **VP Conserv,** <br>**Cl 1**<br>| **VP Conserv,** <br>**Cl 2**<br>| **VP Conserv,** <br>**Cl 4**<br>| **VP Man Vol** <br> **Conserv Gro,** <br>**Cl 1**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $(122982) | $— | $(2794) | $(2502) | $— |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp; 2083812 |  | &nbsp;&nbsp;&nbsp;&nbsp; 3973 | &nbsp;&nbsp;&nbsp;&nbsp; 6040 | &nbsp;&nbsp;&nbsp;&nbsp; (47) |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp; 1021051 | &nbsp;&nbsp;&nbsp; 1 | &nbsp;&nbsp;&nbsp; 20371 | &nbsp;&nbsp;&nbsp; 10512 | &nbsp;&nbsp;&nbsp; 4053 |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp; 2981881 | &nbsp;&nbsp;&nbsp; 1 | &nbsp;&nbsp;&nbsp; 21550 | &nbsp;&nbsp;&nbsp; 14050 | &nbsp;&nbsp;&nbsp; 4006 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp; 473524 |  | &nbsp;&nbsp;&nbsp; 48686 | &nbsp;&nbsp;&nbsp; 24235 | &nbsp;&nbsp;&nbsp; 2401 |
| Net transfers<sup>(1)</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp; 142624 |  | 306337 | 195203 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp;&nbsp; (28571) |  | &nbsp;&nbsp;&nbsp; (2123) | &nbsp;&nbsp;&nbsp; (5062) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Policy charges | &nbsp;&nbsp;&nbsp;&nbsp; (421502) |  | (40932) | (41342) | (1835) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | (1263354) |  | (16579) | &nbsp;&nbsp;&nbsp; (3936) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | (1097279) |  | 295389 | 169098 | &nbsp;&nbsp;&nbsp;&nbsp; 566 |
| Increase (decrease) in net assets | &nbsp;&nbsp;&nbsp; 1884602 | &nbsp;&nbsp;&nbsp; 1 | 316939 | 183148 | &nbsp;&nbsp;&nbsp; 4572 |
| Net assets at beginning of year | 23650778 | &nbsp;&nbsp; 22 | 583324 | 431816 | 56064 |
| Net assets at end of year | $25535380 | $23 | $900263 | $614964 | $60636 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | &nbsp;&nbsp;&nbsp; 9987451 |  | 429668 | 304660 | 48598 |
| Units purchased | &nbsp;&nbsp;&nbsp; 1537684 |  | 268844 | 162956 | &nbsp;&nbsp;&nbsp; 1977 |
| Units redeemed | (1399226) |  | (54928) | (34765) | (1520) |
| Units outstanding at end of year | 10125909 |  | 643584 | 432851 | 49055 |

---

See accompanying notes to financial statements.

**RiverSource of New York Account 8** ■ 145

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2024 (continued)** | **VP Man Vol** <br> **Conserv Gro,** <br>**Cl 2**<br>| **VP Man Vol** <br> **Conserv,** <br>**Cl 1**<br>| **VP Man Vol** <br> **Conserv,** <br>**Cl 2**<br>| **VP Man Vol** <br> **Gro,** <br>**Cl 1**<br>| **VP Man Vol** <br> **Gro,** <br>**Cl 2**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $(872) | $— | $(671) | $— | $(7361) |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp; 1709 | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 303 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3709 | &nbsp;&nbsp;&nbsp;&nbsp; 21176 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp;&nbsp; 4689 | &nbsp;&nbsp;&nbsp;&nbsp; 102 | &nbsp;&nbsp;&nbsp;&nbsp; 4334 | &nbsp;&nbsp;&nbsp;&nbsp; 133556 | &nbsp;&nbsp;&nbsp;&nbsp; 251390 |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp;&nbsp; 5526 | &nbsp;&nbsp;&nbsp;&nbsp; 102 | &nbsp;&nbsp;&nbsp;&nbsp; 3966 | &nbsp;&nbsp;&nbsp;&nbsp; 137265 | &nbsp;&nbsp;&nbsp;&nbsp; 265205 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp; 2815 | 3064 | &nbsp;&nbsp;&nbsp;&nbsp; 1696 | &nbsp;&nbsp;&nbsp;&nbsp; 219660 | &nbsp;&nbsp;&nbsp;&nbsp; 48449 |
| Net transfers<sup>(1)</sup> <br>| 230971 | &nbsp;&nbsp;&nbsp;&nbsp; 120 | &nbsp;&nbsp;&nbsp; 13109 | &nbsp;&nbsp;&nbsp;&nbsp; 747794 | &nbsp;&nbsp;&nbsp;&nbsp; 228800 |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp;&nbsp; (490) | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 15810 |
| Policy charges | (10367) | &nbsp;&nbsp; (509) | &nbsp;&nbsp;&nbsp; (3300) | &nbsp;&nbsp;&nbsp;&nbsp; (75793) | &nbsp;&nbsp;&nbsp;&nbsp; (28757) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | (12075) | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | 210854 | 2675 | &nbsp;&nbsp;&nbsp; 11505 | &nbsp;&nbsp;&nbsp;&nbsp; 891661 | &nbsp;&nbsp;&nbsp;&nbsp; 264302 |
| Increase (decrease) in net assets | 216380 | 2777 | &nbsp;&nbsp;&nbsp; 15471 | 1028926 | &nbsp;&nbsp;&nbsp;&nbsp; 529507 |
| Net assets at beginning of year | 136266 | &nbsp;&nbsp;&nbsp;&nbsp; 22 | &nbsp;&nbsp;&nbsp; 93993 | &nbsp;&nbsp;&nbsp;&nbsp; 944431 | 2238621 |
| Net assets at end of year | $352646 | $2799 | $109464 | $1973357 | $2768128 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | 110210 | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; 81871 | &nbsp;&nbsp;&nbsp;&nbsp; 741206 | 1544321 |
| Units purchased | 166828 | 2858 | &nbsp;&nbsp;&nbsp; 12634 | &nbsp;&nbsp;&nbsp;&nbsp; 693288 | &nbsp;&nbsp;&nbsp;&nbsp; 182215 |
| Units redeemed | (17272) | &nbsp;&nbsp; (449) | &nbsp;&nbsp;&nbsp; (2748) | &nbsp;&nbsp;&nbsp;&nbsp; (54855) | &nbsp;&nbsp;&nbsp;&nbsp; (18286) |
| Units outstanding at end of year | 259766 | 2409 | &nbsp;&nbsp;&nbsp; 91757 | 1379639 | 1708250 |

---

See accompanying notes to financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**146 ■ RiverSource of New York Account 8**

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2024 (continued)** | **VP Man Vol** <br> **Mod Gro,** <br>**Cl 1**<br>| **VP Man Vol** <br> **Mod Gro,** <br>**Cl 2**<br>| **VP Mod Aggr,** <br>**Cl 1**<br>| **VP Mod Aggr,** <br>**Cl 2**<br>| **VP Mod Aggr,** <br>**Cl 4**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $— | $(6646) | $— | $(156713) | $(277118) |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 4991 | &nbsp;&nbsp;&nbsp;&nbsp; 40890 | &nbsp;&nbsp;&nbsp;&nbsp; 101793 | &nbsp;&nbsp;&nbsp; 1342126 | &nbsp;&nbsp;&nbsp; 3267068 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp;&nbsp; 37995 | &nbsp;&nbsp;&nbsp;&nbsp; 137028 | &nbsp;&nbsp;&nbsp;&nbsp; 987256 | &nbsp;&nbsp;&nbsp; 3094212 | &nbsp;&nbsp;&nbsp; 2749076 |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp;&nbsp; 42986 | &nbsp;&nbsp;&nbsp;&nbsp; 171272 | &nbsp;&nbsp;&nbsp; 1089049 | &nbsp;&nbsp;&nbsp; 4279625 | &nbsp;&nbsp;&nbsp; 5739026 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp; 167427 | &nbsp;&nbsp;&nbsp;&nbsp; 60704 | &nbsp;&nbsp;&nbsp; 3344102 | &nbsp;&nbsp;&nbsp; 2051390 | &nbsp;&nbsp;&nbsp; 1789217 |
| Net transfers<sup>(1)</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp; 708764 | &nbsp;&nbsp;&nbsp;&nbsp; 13312 | &nbsp;&nbsp;&nbsp;&nbsp; 845516 | &nbsp;&nbsp;&nbsp;&nbsp; (712609) | (1108784) |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (11087) | &nbsp;&nbsp;&nbsp;&nbsp; (57376) | &nbsp;&nbsp;&nbsp;&nbsp; (175947) | &nbsp;&nbsp;&nbsp;&nbsp; (234641) |
| Policy charges | &nbsp;&nbsp;&nbsp;&nbsp; (61789) | &nbsp;&nbsp;&nbsp;&nbsp; (76460) | &nbsp;&nbsp;&nbsp;&nbsp; (666797) | &nbsp;&nbsp;&nbsp;&nbsp; (984188) | (1334761) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (16327) | &nbsp;&nbsp;&nbsp;&nbsp; (27717) | (1494476) | (2522626) |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (5000) | &nbsp;&nbsp;&nbsp;&nbsp; (279732) |
| Increase (decrease) from transactions | &nbsp;&nbsp;&nbsp;&nbsp; 814402 | &nbsp;&nbsp;&nbsp;&nbsp; (29858) | &nbsp;&nbsp;&nbsp; 3437728 | (1320830) | (3691327) |
| Increase (decrease) in net assets | &nbsp;&nbsp;&nbsp;&nbsp; 857388 | &nbsp;&nbsp;&nbsp;&nbsp; 141414 | &nbsp;&nbsp;&nbsp; 4526777 | &nbsp;&nbsp;&nbsp; 2958795 | &nbsp;&nbsp;&nbsp; 2047699 |
| Net assets at beginning of year | &nbsp;&nbsp;&nbsp;&nbsp; 295544 | 1861237 | &nbsp;&nbsp;&nbsp; 8376897 | 40433107 | 55836994 |
| Net assets at end of year | $1152932 | $2002651 | $12903674 | $43391902 | $57884693 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | &nbsp;&nbsp;&nbsp;&nbsp; 242899 | 1364215 | &nbsp;&nbsp;&nbsp; 6213525 | 19352394 | 26105690 |
| Units purchased | &nbsp;&nbsp;&nbsp;&nbsp; 668270 | &nbsp;&nbsp;&nbsp;&nbsp; 106179 | &nbsp;&nbsp;&nbsp; 2905175 | &nbsp;&nbsp;&nbsp; 1289899 | &nbsp;&nbsp;&nbsp; 2251974 |
| Units redeemed | &nbsp;&nbsp;&nbsp;&nbsp; (47523) | &nbsp;&nbsp; (124924) | &nbsp;&nbsp;&nbsp;&nbsp; (517751) | (1749024) | (3449841) |
| Units outstanding at end of year | &nbsp;&nbsp;&nbsp;&nbsp; 863646 | 1345470 | &nbsp;&nbsp;&nbsp; 8600949 | 18893269 | 24907823 |

---

See accompanying notes to financial statements.

**RiverSource of New York Account 8** ■ 147

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2024 (continued)** | **VP Mod** <br> **Conserv,** <br>**Cl 1**<br>| **VP Mod** <br> **Conserv,** <br>**Cl 2**<br>| **VP Mod** <br> **Conserv,** <br>**Cl 4**<br>| **VP Mod,** <br>**Cl 1**<br>| **VP Mod,** <br>**Cl 2**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $— | $(10535) | $(13326) | $— | $(127094) |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp; 1003 | &nbsp;&nbsp;&nbsp;&nbsp; 43144 | &nbsp;&nbsp;&nbsp;&nbsp; 117332 | &nbsp;&nbsp;&nbsp;&nbsp; 27939 | &nbsp;&nbsp;&nbsp; 1332680 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp; 21582 | &nbsp;&nbsp;&nbsp;&nbsp; 96100 | &nbsp;&nbsp;&nbsp;&nbsp; 61729 | &nbsp;&nbsp;&nbsp;&nbsp; 331833 | &nbsp;&nbsp;&nbsp;&nbsp; 897910 |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp; 22585 | &nbsp;&nbsp;&nbsp;&nbsp; 128709 | &nbsp;&nbsp;&nbsp;&nbsp; 165735 | &nbsp;&nbsp;&nbsp;&nbsp; 359772 | &nbsp;&nbsp;&nbsp; 2103496 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 136768 | &nbsp;&nbsp;&nbsp;&nbsp; 143394 | &nbsp;&nbsp;&nbsp;&nbsp; 893822 | &nbsp;&nbsp;&nbsp; 1116788 |
| Net transfers<sup>(1)</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp; 1886 | &nbsp;&nbsp; (110929) | &nbsp;&nbsp; (259856) | &nbsp;&nbsp;&nbsp;&nbsp; 533357 | &nbsp;&nbsp;&nbsp;&nbsp; (526995) |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (8818) | &nbsp;&nbsp;&nbsp;&nbsp; (1815) | &nbsp;&nbsp;&nbsp;&nbsp; (44117) | &nbsp;&nbsp;&nbsp;&nbsp; (82103) |
| Policy charges | &nbsp;&nbsp;&nbsp; (9309) | &nbsp;&nbsp; (118297) | &nbsp;&nbsp; (146349) | &nbsp;&nbsp; (238379) | (1000140) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (47534) | &nbsp;&nbsp; (105306) | &nbsp;&nbsp;&nbsp;&nbsp; (17633) | &nbsp;&nbsp;&nbsp;&nbsp; (934424) |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (9163) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (35617) |
| Increase (decrease) from transactions | &nbsp;&nbsp;&nbsp; (7423) | &nbsp;&nbsp; (148810) | &nbsp;&nbsp; (379095) | 1127050 | (1462491) |
| Increase (decrease) in net assets | &nbsp;&nbsp;&nbsp; 15162 | &nbsp;&nbsp;&nbsp;&nbsp; (20101) | &nbsp;&nbsp; (213360) | 1486822 | &nbsp;&nbsp;&nbsp;&nbsp; 641005 |
| Net assets at beginning of year | 338632 | 2193073 | 2850754 | 3786147 | 26124048 |
| Net assets at end of year | $353794 | $2172972 | $2637394 | $5272969 | $26765053 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | 284415 | 1309385 | 1779981 | 2961486 | 13942606 |
| Units purchased | &nbsp;&nbsp;&nbsp;&nbsp; 1519 | &nbsp;&nbsp;&nbsp;&nbsp; 95801 | &nbsp;&nbsp;&nbsp;&nbsp; 87511 | 1041999 | &nbsp;&nbsp;&nbsp; 1712704 |
| Units redeemed | &nbsp;&nbsp;&nbsp; (7499) | &nbsp;&nbsp; (178102) | &nbsp;&nbsp; (301841) | &nbsp;&nbsp; (219529) | (2059274) |
| Units outstanding at end of year | 278435 | 1227084 | 1565651 | 3783956 | 13596036 |

---

See accompanying notes to financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**148 ■ RiverSource of New York Account 8**

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2024 (continued)** | **VP Mod,** <br>**Cl 4**<br>| **VP Ptnrs Core** <br> **Bond,** <br>**Cl 1**<br>| **VP Ptnrs Core** <br> **Bond,** <br>**Cl 2**<br>| **VP Ptnrs Core** <br> **Eq,** <br>**Cl 1**<br>| **VP Ptnrs Core** <br> **Eq,** <br>**Cl 2**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $(171723) | $938 | $432 | $— | $— |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp; 2301975 | &nbsp;&nbsp;&nbsp;&nbsp; (31) | &nbsp;&nbsp;&nbsp;&nbsp; (54) | &nbsp;&nbsp;&nbsp;&nbsp; 23 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 38 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp;&nbsp; 569315 | &nbsp;&nbsp;&nbsp;&nbsp; (360) | &nbsp;&nbsp;&nbsp;&nbsp; (114) | &nbsp;&nbsp;&nbsp;&nbsp; 564 | &nbsp;&nbsp;&nbsp; 7523 |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp; 2699567 | &nbsp;&nbsp;&nbsp;&nbsp; 547 | &nbsp;&nbsp;&nbsp;&nbsp; 264 | &nbsp;&nbsp;&nbsp;&nbsp; 587 | &nbsp;&nbsp;&nbsp; 7561 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp; 1200694 | &nbsp;&nbsp;&nbsp; 2602 | &nbsp;&nbsp;&nbsp;&nbsp; 926 | 3902 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 51 |
| Net transfers<sup>(1)</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp; (665125) | &nbsp;&nbsp;&nbsp; 1719 | &nbsp;&nbsp;&nbsp;&nbsp; (924) | &nbsp;&nbsp;&nbsp;&nbsp; 41 | &nbsp;&nbsp;&nbsp; 1125 |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp;&nbsp; (917241) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (14) | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Policy charges | (1410006) | (1526) | (1184) | &nbsp;&nbsp; (658) | &nbsp;&nbsp;&nbsp;&nbsp; (177) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | &nbsp;&nbsp;&nbsp;&nbsp; (867166) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (56) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | (2658844) | &nbsp;&nbsp;&nbsp; 2795 | (1196) | 3229 | &nbsp;&nbsp;&nbsp;&nbsp; 999 |
| Increase (decrease) in net assets | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 40723 | &nbsp;&nbsp;&nbsp; 3342 | &nbsp;&nbsp;&nbsp;&nbsp; (932) | 3816 | &nbsp;&nbsp;&nbsp; 8560 |
| Net assets at beginning of year | 33732420 | 24343 | 13393 | 1590 | 31536 |
| Net assets at end of year | $33773143 | $27685 | $12461 | $5406 | $40096 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | 17953937 | 23002 | 11646 | &nbsp;&nbsp;&nbsp;&nbsp; 878 | &nbsp;&nbsp;&nbsp; 9436 |
| Units purchased | &nbsp;&nbsp;&nbsp; 2380280 | &nbsp;&nbsp;&nbsp; 4009 | &nbsp;&nbsp;&nbsp;&nbsp; 819 | 1932 | &nbsp;&nbsp;&nbsp;&nbsp; 355 |
| Units redeemed | (3289049) | (1428) | (1844) | &nbsp;&nbsp; (322) | &nbsp;&nbsp;&nbsp;&nbsp; (45) |
| Units outstanding at end of year | 17045168 | 25583 | 10621 | 2488 | &nbsp;&nbsp;&nbsp; 9746 |

---

See accompanying notes to financial statements.

**RiverSource of New York Account 8** ■ 149

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2024 (continued)** | **VP Ptnrs Core** <br> **Eq,** <br>**Cl 3**<br>| **VP Ptnrs Intl** <br> **Core Eq,** <br>**Cl 1**<br>| **VP Ptnrs Intl** <br> **Core Eq,** <br>**Cl 2**<br>| **VP Ptnrs Intl** <br> **Gro,** <br>**Cl 1**<br>| **VP Ptnrs Intl** <br> **Gro,** <br>**Cl 2**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $(2469) | $1047 | $637 | $1086 | $953 |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp; 30124 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (20) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 98 | &nbsp;&nbsp;&nbsp;&nbsp; 2260 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 576 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp; 66722 | &nbsp;&nbsp;&nbsp; (1572) | &nbsp;&nbsp;&nbsp; 2478 | &nbsp;&nbsp;&nbsp; (4747) | &nbsp;&nbsp;&nbsp; (3561) |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp; 94377 | &nbsp;&nbsp;&nbsp;&nbsp; (545) | &nbsp;&nbsp;&nbsp; 3213 | &nbsp;&nbsp;&nbsp; (1401) | &nbsp;&nbsp;&nbsp; (2032) |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp; 10709 | &nbsp;&nbsp;&nbsp; 64320 | &nbsp;&nbsp;&nbsp; 2028 | &nbsp;&nbsp;&nbsp; 17332 | &nbsp;&nbsp;&nbsp; 15715 |
| Net transfers<sup>(1)</sup> <br>| (22949) | 138795 | &nbsp;&nbsp;&nbsp;&nbsp; 456 | (13805) | (16589) |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp; (2733) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (27) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 867 |
| Policy charges | &nbsp;&nbsp;&nbsp; (6098) | (10187) | (1768) | &nbsp;&nbsp;&nbsp; (6203) | &nbsp;&nbsp;&nbsp; (6509) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | &nbsp;&nbsp;&nbsp; (8613) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; (1826) |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | (29684) | 192928 | &nbsp;&nbsp;&nbsp;&nbsp; 689 | &nbsp;&nbsp;&nbsp; (2676) | &nbsp;&nbsp;&nbsp; (8342) |
| Increase (decrease) in net assets | &nbsp;&nbsp;&nbsp; 64693 | 192383 | &nbsp;&nbsp;&nbsp; 3902 | &nbsp;&nbsp;&nbsp; (4077) | (10374) |
| Net assets at beginning of year | 423476 | &nbsp;&nbsp;&nbsp; 63609 | 55681 | 150089 | 198015 |
| Net assets at end of year | $488169 | $255992 | $59583 | $146012 | $187641 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | &nbsp;&nbsp;&nbsp; 94932 | &nbsp;&nbsp;&nbsp; 48983 | 34402 | 114769 | 118610 |
| Units purchased | &nbsp;&nbsp;&nbsp;&nbsp; 5412 | 144585 | &nbsp;&nbsp;&nbsp; 1518 | &nbsp;&nbsp;&nbsp; 12721 | &nbsp;&nbsp;&nbsp;&nbsp; 9542 |
| Units redeemed | &nbsp;&nbsp;&nbsp; (9051) | &nbsp;&nbsp;&nbsp; (7350) | (1054) | (14513) | (14149) |
| Units outstanding at end of year | &nbsp;&nbsp;&nbsp; 91293 | 186218 | 34866 | 112977 | 114003 |

---

See accompanying notes to financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**150 ■ RiverSource of New York Account 8**

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2024 (continued)** | **VP Ptnrs Intl** <br> **Val,** <br>**Cl 1**<br>| **VP Ptnrs Intl** <br> **Val,** <br>**Cl 2**<br>| **VP Ptnrs Sm** <br> **Cap Gro,** <br>**Cl 1**<br>| **VP Ptnrs Sm** <br> **Cap Gro,** <br>**Cl 2**<br>| **VP Ptnrs Sm** <br> **Cap Val,** <br>**Cl 1**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $1223 | $1805 | $— | $— | $— |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp; 689 | &nbsp;&nbsp;&nbsp;&nbsp; 457 | &nbsp;&nbsp;&nbsp;&nbsp; 1188 | &nbsp;&nbsp;&nbsp;&nbsp; 106 | &nbsp;&nbsp;&nbsp;&nbsp; 544 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp;&nbsp; (194) | &nbsp;&nbsp;&nbsp;&nbsp; 751 | &nbsp;&nbsp;&nbsp;&nbsp; 9153 | &nbsp;&nbsp;&nbsp; 6460 | &nbsp;&nbsp;&nbsp;&nbsp; 279 |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp; 1718 | &nbsp;&nbsp;&nbsp; 3013 | &nbsp;&nbsp;&nbsp; 10341 | &nbsp;&nbsp;&nbsp; 6566 | &nbsp;&nbsp;&nbsp;&nbsp; 823 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | 16797 | &nbsp;&nbsp;&nbsp; 3187 | &nbsp;&nbsp;&nbsp; 11452 | &nbsp;&nbsp;&nbsp; 2747 | &nbsp;&nbsp;&nbsp; 1526 |
| Net transfers<sup>(1)</sup> <br>| (4204) | (2285) | (12983) | &nbsp;&nbsp;&nbsp; 4740 | &nbsp;&nbsp;&nbsp;&nbsp; 116 |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; (437) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | (5739) |
| Policy charges | (3228) | (1713) | &nbsp;&nbsp;&nbsp; (1840) | &nbsp;&nbsp;&nbsp;&nbsp; (455) | &nbsp;&nbsp;&nbsp;&nbsp; (353) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | (1541) | &nbsp;&nbsp;&nbsp;&nbsp; (198) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | &nbsp;&nbsp;&nbsp; 9365 | (2789) | &nbsp;&nbsp;&nbsp; (3569) | &nbsp;&nbsp;&nbsp; 7032 | (4450) |
| Increase (decrease) in net assets | 11083 | &nbsp;&nbsp;&nbsp;&nbsp; 224 | &nbsp;&nbsp;&nbsp;&nbsp; 6772 | 13598 | (3627) |
| Net assets at beginning of year | 38952 | 67130 | &nbsp;&nbsp;&nbsp; 57582 | 28644 | 10867 |
| Net assets at end of year | $50035 | $67354 | $64354 | $42242 | $7240 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | 33316 | 44933 | &nbsp;&nbsp;&nbsp; 49036 | 13521 | &nbsp;&nbsp;&nbsp; 8536 |
| Units purchased | 13553 | &nbsp;&nbsp;&nbsp; 2020 | &nbsp;&nbsp;&nbsp;&nbsp; 8846 | &nbsp;&nbsp;&nbsp; 3474 | &nbsp;&nbsp;&nbsp; 1212 |
| Units redeemed | (5965) | (3730) | (11846) | &nbsp;&nbsp;&nbsp;&nbsp; (197) | (4481) |
| Units outstanding at end of year | 40904 | 43223 | &nbsp;&nbsp;&nbsp; 46036 | 16798 | &nbsp;&nbsp;&nbsp; 5267 |

---

See accompanying notes to financial statements.

**RiverSource of New York Account 8** ■ 151

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year ended December 31, 2024 (continued)** | **VP Ptnrs Sm** <br> **Cap Val,** <br>**Cl 2**<br>| **VP Ptnrs Sm** <br> **Cap Val,** <br>**Cl 3**<br>| **VP US Flex** <br> **Conserv Gro,** <br>**Cl 1**<br>| **VP US Flex** <br> **Gro,** <br>**Cl 1**<br>| **VP US Flex** <br> **Mod Gro,** <br>**Cl 1**<br>|
| **Operations** |  |  |  |  |  |
| Investment income (loss) — net | $— | $(3064) | $— | $— | $— |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp; 119 | &nbsp;&nbsp;&nbsp; 69568 | &nbsp;&nbsp;&nbsp;&nbsp; 17 | &nbsp;&nbsp;&nbsp;&nbsp; 1006 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 121 |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp;&nbsp; 341 | (19103) | &nbsp;&nbsp;&nbsp;&nbsp; 585 | &nbsp;&nbsp;&nbsp; 26855 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (47) |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp;&nbsp; 460 | &nbsp;&nbsp;&nbsp; 47401 | &nbsp;&nbsp;&nbsp;&nbsp; 602 | &nbsp;&nbsp;&nbsp; 27861 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 74 |
| **Contract transactions** |  |  |  |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp;&nbsp; 616 | &nbsp;&nbsp;&nbsp; 21243 | 1933 | &nbsp;&nbsp;&nbsp; 80104 | &nbsp;&nbsp;&nbsp;&nbsp; 4464 |
| Net transfers<sup>(1)</sup> <br>| &nbsp;&nbsp; (463) | &nbsp;&nbsp;&nbsp; (4596) | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 3458 | 104342 |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp;&nbsp; — | (27086) | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Policy charges | &nbsp;&nbsp; (254) | (16038) | &nbsp;&nbsp; (226) | (17894) | &nbsp;&nbsp;&nbsp; (1441) |
| Contract terminations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | &nbsp;&nbsp;&nbsp;&nbsp; — | (32861) | &nbsp;&nbsp;&nbsp;&nbsp; (24) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | &nbsp;&nbsp; (101) | (59338) | 1683 | &nbsp;&nbsp;&nbsp; 65668 | 107365 |
| Increase (decrease) in net assets | &nbsp;&nbsp;&nbsp;&nbsp; 359 | (11937) | 2285 | &nbsp;&nbsp;&nbsp; 93529 | 107439 |
| Net assets at beginning of year | 6172 | 659426 | 5846 | 139815 | &nbsp;&nbsp;&nbsp; 10130 |
| Net assets at end of year | $6531 | $647489 | $8131 | $233344 | $117569 |
| **Accumulation unit activity** |  |  |  |  |  |
| Units outstanding at beginning of year | 2803 | 192138 | 4970 | 107386 | &nbsp;&nbsp;&nbsp;&nbsp; 8173 |
| Units purchased | &nbsp;&nbsp;&nbsp;&nbsp; 271 | 102134 | 1539 | &nbsp;&nbsp;&nbsp; 57647 | &nbsp;&nbsp;&nbsp; 76518 |
| Units redeemed | &nbsp;&nbsp; (319) | (62228) | &nbsp;&nbsp; (181) | (12407) | &nbsp;&nbsp;&nbsp; (1071) |
| Units outstanding at end of year | 2755 | 232044 | 6328 | 152626 | &nbsp;&nbsp;&nbsp; 83620 |

---

See accompanying notes to financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**152 ■ RiverSource of New York Account 8**

------

**Statement of Changes in Net Assets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | |
|:---|:---|:---|
| **Year ended December 31, 2024 (continued)** | **WA Var Global** <br> **Hi Yd Bond,** <br>**Cl I**<br>| **WA Var Global** <br> **Hi Yd Bond,** <br>**Cl II**<br>|
| **Operations** |  |  |
| Investment income (loss) — net | $1510 | $468 |
| Net realized gain (loss) on sales of investments | &nbsp;&nbsp;&nbsp;&nbsp; (57) | &nbsp;&nbsp;&nbsp;&nbsp; (334) |
| Distributions from capital gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net change in unrealized appreciation (depreciation) of investments | &nbsp;&nbsp;&nbsp;&nbsp; (117) | &nbsp;&nbsp;&nbsp;&nbsp; 386 |
| Net increase (decrease) in net assets resulting from operations | &nbsp;&nbsp;&nbsp; 1336 | &nbsp;&nbsp;&nbsp;&nbsp; 520 |
| **Contract transactions** |  |  |
| Contract purchase payments | &nbsp;&nbsp;&nbsp; 6645 | &nbsp;&nbsp;&nbsp;&nbsp; 813 |
| Net transfers<sup>(1)</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp; 786 | (1966) |
| Transfers for policy loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Policy charges | (1526) | &nbsp;&nbsp;&nbsp;&nbsp; (746) |
| Contract terminations: |  |  |
| &nbsp;&nbsp;&nbsp; Surrender benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| &nbsp;&nbsp;&nbsp; Death benefits | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Increase (decrease) from transactions | &nbsp;&nbsp;&nbsp; 5905 | (1899) |
| Increase (decrease) in net assets | &nbsp;&nbsp;&nbsp; 7241 | (1379) |
| Net assets at beginning of year | 17530 | &nbsp;&nbsp;&nbsp; 9308 |
| Net assets at end of year | $24771 | $7929 |
| **Accumulation unit activity** |  |  |
| Units outstanding at beginning of year | 15685 | &nbsp;&nbsp;&nbsp; 7000 |
| Units purchased | &nbsp;&nbsp;&nbsp; 6346 | &nbsp;&nbsp;&nbsp;&nbsp; 595 |
| Units redeemed | (1329) | (2006) |
| Units outstanding at end of year | 20702 | &nbsp;&nbsp;&nbsp; 5589 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

<sup>(1)</sup> Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY's fixed account.

<sup>(2)</sup> For the period January 16, 2024 (commencement of operations) to December 31, 2024.

<sup>(3)</sup> See Note 9 in the Notes to Financial Statements.

<sup>(4)</sup> For the period April 26, 2024 (commencement of operations) to December 31, 2024.

See accompanying notes to financial statements.

**RiverSource of New York Account 8** ■ 153

------

**Notes to Financial Statements**

**1.** **ORGANIZATION**

RiverSource of New York Account 8 (the Account) was established under New York law as a segregated asset account of RiverSource Life Insurance Co. of New York (RiverSource Life of NY). The Account is registered as a unit investment trust under the Investment Company Act of 1940, as amended (the 1940 Act) and exists in accordance with the rules and regulations of the New York State Department of Financial Services.

The Account is used as a funding vehicle for individual variable life insurance policies issued by RiverSource Life of NY. The following is a list of each variable life insurance product funded through the Account.

---

| |
|:---|
| RiverSource Succession Select<sup>®</sup> Variable Life Insurance (Succession Select)\* <br>|
| RiverSource<sup>®</sup> Variable Second-To-Die Life Insurance (V2D)\* <br>|
| RiverSource<sup>®</sup> Variable Universal Life Insurance (VUL)\* <br>|
| RiverSource<sup>®</sup> Variable Universal Life Insurance III (VUL III)\* <br>|
| RiverSource<sup>®</sup> Variable Universal Life IV (VUL IV)\* <br>|
| RiverSource<sup>®</sup> Variable Universal Life IV – Estate Series (VUL IV – ES)\* <br>|
| RiverSource<sup>®</sup> Variable Universal Life 5 (VUL 5)\* |
| RiverSource<sup>®</sup> Variable Universal Life 5 – Estate Series (VUL 5 – ES)\* <br>|
| RiverSource<sup>®</sup> Variable Universal Life 6 Insurance (VUL 6) |
| RiverSource<sup>®</sup> Survivorship Variable Universal Life Insurance (SVUL) |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

&nbsp;&nbsp; \* New contracts are no longer being issued for this product. As a result, an annual contract prospectus and statement of additional information are no longer <br> distributed. An annual report for this product is distributed to all current contract holders.<br>

The Account is comprised of various divisions. Each division invests exclusively in shares of the following funds or portfolios (collectively, the Funds), which are registered under the 1940 Act as open-end management investment companies. The name of each Fund and the corresponding division name are provided below. Each division is comprised of subaccounts. Individual variable life insurance policies invest in subaccounts. For each division, the financial statements are comprised of a statement of assets and liabilities as of December 31, 2025, a related statement of operations for the year then ended and statements of changes in net assets for each of the two years in the period then ended, all presented to reflect a full twelve month period except as noted below.

---

| | |
|:---|:---|
| **Division** | **Fund** |
| AB VPS Dyn Asset Alloc, Cl B | AB VPS Dynamic Asset Allocation Portfolio (Class B) |
| AB VPS Intl Val, Cl B | AB VPS International Value Portfolio (Class B) |
| AB VPS Lg Cap Gro, Cl A | AB VPS Large Cap Growth Portfolio (Class A) |
| AB VPS Lg Cap Gro, Cl B | AB VPS Large Cap Growth Portfolio (Class B) |
| AB VPS Relative Val, Cl B | AB VPS Relative Value Portfolio (Class B) |
| Allspg VT Index Asset Alloc, Cl 2 | Allspring VT Index Asset Allocation Fund – Class 2 |
| Allspg VT Opp, Cl 1 | Allspring VT Opportunity Fund – Class 1 |
| Allspg VT Opp, Cl 2 | Allspring VT Opportunity Fund – Class 2 |
| Allspg VT Sm Cap Gro, Cl 1 | Allspring VT Small Cap Growth Fund – Class 1 |
| Allspg VT Sm Cap Gro, Cl 2 | Allspring VT Small Cap Growth Fund – Class 2 |
| ALPS Alerian Engy Infr, Class I | ALPS/Alerian Energy Infrastructure Portfolio: Class I |
| ALPS Alerian Engy Infr, Class III | ALPS/Alerian Energy Infrastructure Portfolio: Class III |
| BlackRock Global Alloc, Cl I | BlackRock Global Allocation V.I. Fund (Class I) |
| BlackRock Global Alloc, Cl III | BlackRock Global Allocation V.I. Fund (Class III) |
| Calvert VP SRI Bal, Cl I | Calvert VP SRI Balanced Portfolio – Class I |
| Col VP Acorn | &nbsp;&nbsp;&nbsp;&nbsp; Columbia Variable Portfolio – Acorn Fund <br>(previously Wanger Acorn)<br>|
| Col VP Acorn Intl | &nbsp;&nbsp;&nbsp;&nbsp; Columbia Variable Portfolio – Acorn International Fund <br>(previously Wanger International)<br>|
| Col VP Bal, Cl 1 | Columbia Variable Portfolio – Balanced Fund (Class 1) |
| Col VP Bal, Cl 3 | Columbia Variable Portfolio – Balanced Fund (Class 3) |
| Col VP Commodity Strategy, Cl 1 | Columbia Variable Portfolio – Commodity Strategy Fund (Class 1) |
| Col VP Commodity Strategy, Cl 2 | Columbia Variable Portfolio – Commodity Strategy Fund (Class 2) |
| Col VP Contrarian Core, Cl 1 | Columbia Variable Portfolio – Contrarian Core Fund (Class 1) |
| Col VP Contrarian Core, Cl 2 | Columbia Variable Portfolio – Contrarian Core Fund (Class 2) |
| Col VP Corporate Bond, Cl 1 | &nbsp;&nbsp;&nbsp;&nbsp; Columbia Variable Portfolio – Corporate Bond Fund (Class 1)<sup>(1)</sup> <br>(previously Columbia Variable Portfolio – Global Strategic Income Fund (Class 1), renamed to Columbia Variable Portfolio – <br> Select Corporate Income Fund (Class 1) sometime during the second quarter of 2026)<br>|

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**154 ■ RiverSource of New York Account 8**

------

---

| | |
|:---|:---|
| **Division** | **Fund** |
| Col VP Corporate Bond, Cl 2 | &nbsp;&nbsp;&nbsp;&nbsp; Columbia Variable Portfolio – Corporate Bond Fund (Class 2) <br>(previously Columbia Variable Portfolio – Global Strategic Income Fund (Class 2), renamed to Columbia Variable Portfolio – <br> Select Corporate Income Fund (Class 2) sometime during the second quarter of 2026)<br>|
| Col VP Corporate Bond, Cl 3 | &nbsp;&nbsp;&nbsp;&nbsp; Columbia Variable Portfolio – Corporate Bond Fund (Class 3) <br>(previously Columbia Variable Portfolio – Global Strategic Income Fund (Class 3), renamed to Columbia Variable Portfolio – <br> Select Corporate Income Fund (Class 3) sometime during the second quarter of 2026)<br>|
| Col VP Disciplined Core, Cl 1 | Columbia Variable Portfolio – Disciplined Core Fund (Class 1) |
| Col VP Disciplined Core, Cl 2 | Columbia Variable Portfolio – Disciplined Core Fund (Class 2) |
| Col VP Disciplined Core, Cl 3 | Columbia Variable Portfolio – Disciplined Core Fund (Class 3) |
| Col VP Divd Opp, Cl 1 | Columbia Variable Portfolio – Dividend Opportunity Fund (Class 1) |
| Col VP Divd Opp, Cl 2 | Columbia Variable Portfolio – Dividend Opportunity Fund (Class 2) |
| Col VP Divd Opp, Cl 3 | Columbia Variable Portfolio – Dividend Opportunity Fund (Class 3) |
| Col VP Emer Mkts, Cl 1 | Columbia Variable Portfolio – Emerging Markets Fund (Class 1) |
| Col VP Emer Mkts, Cl 2 | Columbia Variable Portfolio – Emerging Markets Fund (Class 2) |
| Col VP Emer Mkts, Cl 3 | Columbia Variable Portfolio – Emerging Markets Fund (Class 3) |
| Col VP Emerg Mkts Bond, Cl 1 | Columbia Variable Portfolio – Emerging Markets Bond Fund (Class 1) |
| Col VP Emerg Mkts Bond, Cl 2 | Columbia Variable Portfolio – Emerging Markets Bond Fund (Class 2) |
| Col VP Govt Money Mkt, Cl 1 | Columbia Variable Portfolio – Government Money Market Fund (Class 1) |
| Col VP Govt Money Mkt, Cl 2 | Columbia Variable Portfolio – Government Money Market Fund (Class 2) |
| Col VP Govt Money Mkt, Cl 3 | Columbia Variable Portfolio – Government Money Market Fund (Class 3) |
| Col VP Hi Yield Bond, Cl 1 | Columbia Variable Portfolio – High Yield Bond Fund (Class 1) |
| Col VP Hi Yield Bond, Cl 2 | Columbia Variable Portfolio – High Yield Bond Fund (Class 2) |
| Col VP Hi Yield Bond, Cl 3 | Columbia Variable Portfolio – High Yield Bond Fund (Class 3) |
| Col VP Inc Opp, Cl 1 | Columbia Variable Portfolio – Income Opportunities Fund (Class 1) |
| Col VP Inc Opp, Cl 2 | Columbia Variable Portfolio – Income Opportunities Fund (Class 2) |
| Col VP Inc Opp, Cl 3 | Columbia Variable Portfolio – Income Opportunities Fund (Class 3) |
| Col VP Inter Bond, Cl 1 | Columbia Variable Portfolio – Intermediate Bond Fund (Class 1) |
| Col VP Inter Bond, Cl 2 | Columbia Variable Portfolio – Intermediate Bond Fund (Class 2) |
| Col VP Inter Bond, Cl 3 | Columbia Variable Portfolio – Intermediate Bond Fund (Class 3) |
| Col VP Lg Cap Gro, Cl 1 | &nbsp;&nbsp;&nbsp;&nbsp; Columbia Variable Portfolio – Large Cap Growth Fund (Class 1) <br>(renamed to Columbia Variable Portfolio – Cornerstone Growth Fund (Class 1) sometime during the second quarter of 2026)<br>|
| Col VP Lg Cap Gro, Cl 2 | &nbsp;&nbsp;&nbsp;&nbsp; Columbia Variable Portfolio – Large Cap Growth Fund (Class 2) <br>(renamed to Columbia Variable Portfolio – Cornerstone Growth Fund (Class 2) sometime during the second quarter of 2026)<br>|
| Col VP Lg Cap Gro, Cl 3 | &nbsp;&nbsp;&nbsp;&nbsp; Columbia Variable Portfolio – Large Cap Growth Fund (Class 3) <br>(renamed to Columbia Variable Portfolio – Cornerstone Growth Fund (Class 3) sometime during the second quarter of 2026)<br>|
| Col VP Lg Cap Index, Cl 1 | Columbia Variable Portfolio – Large Cap Index Fund (Class 1) |
| Col VP Lg Cap Index, Cl 3 | Columbia Variable Portfolio – Large Cap Index Fund (Class 3) |
| Col VP Limited Duration Cr, Cl 1 | &nbsp;&nbsp;&nbsp;&nbsp; Columbia Variable Portfolio – Limited Duration Credit Fund (Class 1) <br>(renamed to Columbia Variable Portfolio – Select Short Corporate Income (Class 1) sometime during the second quarter of 2026)<br>|
| Col VP Limited Duration Cr, Cl 2 | &nbsp;&nbsp;&nbsp;&nbsp; Columbia Variable Portfolio – Limited Duration Credit Fund (Class 2) <br>(renamed to Columbia Variable Portfolio – Select Short Corporate Income (Class 2) sometime during the second quarter of 2026)<br>|
| Col VP Long Govt/Cr Bond, Cl 1 | Columbia Variable Portfolio – Long Government/Credit Bond Fund (Class 1) |
| Col VP Long Govt/Cr Bond, Cl 2 | Columbia Variable Portfolio – Long Government/Credit Bond Fund (Class 2) |
| Col VP Overseas Core, Cl 1 | Columbia Variable Portfolio – Overseas Core Fund (Class 1) |
| Col VP Overseas Core, Cl 2 | Columbia Variable Portfolio – Overseas Core Fund (Class 2) |
| Col VP Overseas Core, Cl 3 | Columbia Variable Portfolio – Overseas Core Fund (Class 3) |
| Col VP Sel Gbl Tech, Cl 1 | Columbia Variable Portfolio – Seligman Global Technology Fund (Class 1) |
| Col VP Sel Gbl Tech, Cl 2 | Columbia Variable Portfolio – Seligman Global Technology Fund (Class 2) |
| Col VP Select Lg Cap Val, Cl 1 | Columbia Variable Portfolio – Select Large Cap Value Fund (Class 1) |
| Col VP Select Lg Cap Val, Cl 2 | Columbia Variable Portfolio – Select Large Cap Value Fund (Class 2) |
| Col VP Select Lg Cap Val, Cl 3 | Columbia Variable Portfolio – Select Large Cap Value Fund (Class 3) |
| Col VP Select Mid Cap Gro, Cl 1 | Columbia Variable Portfolio – Select Mid Cap Growth Fund (Class 1) |
| Col VP Select Mid Cap Gro, Cl 2 | Columbia Variable Portfolio – Select Mid Cap Growth Fund (Class 2) |
| Col VP Select Mid Cap Gro, Cl 3 | Columbia Variable Portfolio – Select Mid Cap Growth Fund (Class 3) |
| Col VP Select Mid Cap Val, Cl 1 | Columbia Variable Portfolio – Select Mid Cap Value Fund (Class 1) |
| Col VP Select Mid Cap Val, Cl 2 | Columbia Variable Portfolio – Select Mid Cap Value Fund (Class 2) |
| Col VP Select Mid Cap Val, Cl 3 | Columbia Variable Portfolio – Select Mid Cap Value Fund (Class 3) |
| Col VP Select Sm Cap Val, Cl 1 | Columbia Variable Portfolio – Select Small Cap Value Fund (Class 1) |
| Col VP Select Sm Cap Val, Cl 2 | Columbia Variable Portfolio – Select Small Cap Value Fund (Class 2) |
| Col VP Select Sm Cap Val, Cl 3 | Columbia Variable Portfolio – Select Small Cap Value Fund (Class 3) |
| Col VP Strategic Inc, Cl 1 | Columbia Variable Portfolio – Strategic Income Fund (Class 1) |
| Col VP Strategic Inc, Cl 2 | Columbia Variable Portfolio – Strategic Income Fund (Class 2) |

---

**RiverSource of New York Account 8** ■ 155

------

---

| | |
|:---|:---|
| **Division** | **Fund** |
| Col VP US Govt Mtge, Cl 1 | Columbia Variable Portfolio – U.S. Government Mortgage Fund (Class 1) |
| Col VP US Govt Mtge, Cl 2 | Columbia Variable Portfolio – U.S. Government Mortgage Fund (Class 2) |
| Col VP US Govt Mtge, Cl 3 | Columbia Variable Portfolio – U.S. Government Mortgage Fund (Class 3) |
| CS Commodity Return, Cl 1 | &nbsp;&nbsp;&nbsp;&nbsp; Credit Suisse Trust – Commodity Return Strategy Portfolio, Class 1 <br>(renamed Cantor Fitzgerald Commodity Return Strategy Portfolio, Class 1 sometime during the second quarter of 2026)<br>|
| CTIVP AC Div Bond, Cl 1 | &nbsp;&nbsp;&nbsp;&nbsp; CTIVP<sup>®</sup> – American Century Diversified Bond Fund (Class 1) <br>(renamed CTIVP<sup>®</sup> – Fidelity Institutional AM<sup>®</sup> Total Bond Fund (Class 1) sometime during the second quarter of 2026)<br>|
| CTIVP AC Div Bond, Cl 2 | &nbsp;&nbsp;&nbsp;&nbsp; CTIVP<sup>®</sup> – American Century Diversified Bond Fund (Class 2) <br>(renamed CTIVP<sup>®</sup> – Fidelity Institutional AM<sup>®</sup> Total Bond Fund (Class 2) sometime during the second quarter of 2026)<br>|
| CTIVP BR Gl Infl Prot Sec, Cl 1 | &nbsp;&nbsp;&nbsp;&nbsp; CTIVP<sup>®</sup> – BlackRock Global Inflation-Protected Securities Fund (Class 1) <br>(renamed CTIVP<sup>®</sup> – BlackRock Global Inflation-Linked Securities Fund (Class 1) sometime during the second quarter of 2026)<br>|
| CTIVP BR Gl Infl Prot Sec, Cl 2 | &nbsp;&nbsp;&nbsp;&nbsp; CTIVP<sup>®</sup> – BlackRock Global Inflation-Protected Securities Fund (Class 2) <br>(renamed CTIVP<sup>®</sup> – BlackRock Global Inflation-Linked Securities Fund (Class 2) sometime during the second quarter of 2026)<br>|
| CTIVP BR Gl Infl Prot Sec, Cl 3 | &nbsp;&nbsp;&nbsp;&nbsp; CTIVP<sup>®</sup> – BlackRock Global Inflation-Protected Securities Fund (Class 3) <br>(renamed CTIVP<sup>®</sup> – BlackRock Global Inflation-Linked Securities Fund (Class 3) sometime during the second quarter of 2026)<br>|
| CTIVP CenterSquare Real Est, Cl 1 | CTIVP<sup>®</sup> – CenterSquare Real Estate Fund (Class 1) |
| CTIVP CenterSquare Real Est, Cl 2 | CTIVP<sup>®</sup> – CenterSquare Real Estate Fund (Class 2) |
| CTIVP Prin Lg Cap Gro, Cl 1 | &nbsp;&nbsp;&nbsp;&nbsp; CTIVP<sup>®</sup> – Principal Large Cap Growth Fund (Class 1 <br>(previously CTIVP<sup>®</sup> – Principal Blue Chip Growth Fund (Class 1))<br>|
| CTIVP Prin Lg Cap Gro, Cl 2 | &nbsp;&nbsp;&nbsp;&nbsp; CTIVP<sup>®</sup> – Principal Large Cap Growth Fund (Class 2) <br>(previously CTIVP<sup>®</sup> – Principal Blue Chip Growth Fund (Class 2))<br>|
| CTIVP T Rowe Price LgCap Val, Cl 1 | CTIVP<sup>®</sup> – T. Rowe Price Large Cap Value Fund (Class 1) |
| CTIVP T Rowe Price LgCap Val, Cl 2 | CTIVP<sup>®</sup> – T. Rowe Price Large Cap Value Fund (Class 2) |
| CTIVP TCW Core Plus Bond, Cl 1 | &nbsp;&nbsp;&nbsp;&nbsp; CTIVP<sup>®</sup> – TCW Core Plus Bond Fund (Class 1) <br>(renamed CTIVP<sup>®</sup> – TCW Total Return Bond Fund (Class 1) sometime during the second quarter of 2026)<br>|
| CTIVP TCW Core Plus Bond, Cl 2 | &nbsp;&nbsp;&nbsp;&nbsp; CTIVP<sup>®</sup> – TCW Core Plus Bond Fund (Class 2) <br>(renamed CTIVP<sup>®</sup> – TCW Total Return Bond Fund (Class 2) sometime during the second quarter of 2026)<br>|
| CTIVP Vty Sycamore Estb Val, Cl 1 | CTIVP<sup>®</sup> – Victory Sycamore Established Value Fund (Class 1) |
| CTIVP Vty Sycamore Estb Val, Cl 2 | CTIVP<sup>®</sup> – Victory Sycamore Established Value Fund (Class 2) |
| CTIVP Vty Sycamore Estb Val, Cl 3 | CTIVP<sup>®</sup> – Victory Sycamore Established Value Fund (Class 3) |
| CTIVP Wellington Lg Cap Val, Cl 1 | &nbsp;&nbsp;&nbsp;&nbsp; CTIVP<sup>®</sup> – Wellington Large Cap Value Fund (Class 1) <br>(previously CTIVP<sup>®</sup> – MFS<sup>®</sup> Value Fund (Class 1))<br>|
| CTIVP Wellington Lg Cap Val, Cl 2 | &nbsp;&nbsp;&nbsp;&nbsp; CTIVP<sup>®</sup> – Wellington Large Cap Value Fund (Class 2) <br>(previously CTIVP<sup>®</sup> – MFS<sup>®</sup> Value Fund (Class 2))<br>|
| CTIVP Westfield Mid Cap Gro, Cl 1 | CTIVP<sup>®</sup> – Westfield Mid Cap Growth Fund (Class 1) |
| CTIVP Westfield Mid Cap Gro, Cl 2 | CTIVP<sup>®</sup> – Westfield Mid Cap Growth Fund (Class 2) |
| CTIVP Westfield Sel Lg Cp Gr, Cl 1 | CTIVP<sup>®</sup> – Westfield Select Large Cap Growth Fund (Class 1) |
| CTIVP Westfield Sel Lg Cp Gr, Cl 2 | CTIVP<sup>®</sup> – Westfield Select Large Cap Growth Fund (Class 2) |
| CVT EAFE Intl Index, Cl F | CVT EAFE International Index Portfolio – Class F |
| CVT EAFE Intl Index, Cl I | CVT EAFE International Index Portfolio – Class I |
| CVT Nasdaq 100 Index, Cl F | CVT Nasdaq 100 Index Portfolio – Class F |
| CVT Nasdaq 100 Index, Cl I | CVT Nasdaq 100 Index Portfolio – Class I |
| CVT Russ 2000 Sm Cap Ind, Cl F | CVT Russell 2000<sup>®</sup> Small Cap Index Portfolio – Class F |
| CVT Russ 2000 Sm Cap Ind, Cl I | CVT Russell 2000<sup>®</sup> Small Cap Index Portfolio – Class I |
| DWS Alt Asset Alloc VIP, Cl A | DWS Alternative Asset Allocation VIP, Class A |
| DWS Alt Asset Alloc VIP, Cl B | DWS Alternative Asset Allocation VIP, Class B |
| EV VT Floating-Rate Inc, Init Cl | Eaton Vance VT Floating-Rate Income Fund – Initial Class |
| EV VT Floating-Rate Inc, Inst Cl | Eaton Vance VT Floating-Rate Income Fund – Institutional Class<sup>(1)</sup><sup>(2)</sup> <br>|
| Fid VIP Contrafund, Init Cl | Fidelity<sup>®</sup> VIP Contrafund<sup>SM</sup> Portfolio Initial Class |
| Fid VIP Contrafund, Serv Cl 2 | Fidelity<sup>®</sup> VIP Contrafund<sup>SM</sup> Portfolio Service Class 2 |
| Fid VIP Emer Mkts, Init Cl | Fidelity<sup>®</sup> VIP Emerging Markets Portfolio Initial Class<sup>(1)</sup> <br>|
| Fid VIP Energy, Init Cl | Fidelity<sup>®</sup> VIP Energy Portfolio Initial Class<sup>(1)</sup> <br>|
| Fid VIP Gro & Inc, Serv Cl | Fidelity<sup>®</sup> VIP Growth & Income Portfolio Service Class |
| Fid VIP Gro & Inc, Serv Cl 2 | Fidelity<sup>®</sup> VIP Growth & Income Portfolio Service Class 2 |
| Fid VIP Gro Opp, Init Cl | Fidelity<sup>®</sup> VIP Growth Opportunities Portfolio Initial Class<sup>(1)</sup> <br>|
| Fid VIP Invest Gr, Init Cl | Fidelity<sup>®</sup> VIP Investment Grade Bond Portfolio Initial Class<sup>(1)</sup> <br>|
| Fid VIP Mid Cap, Init Cl | Fidelity<sup>®</sup> VIP Mid Cap Portfolio Initial Class |
| Fid VIP Mid Cap, Serv Cl | Fidelity<sup>®</sup> VIP Mid Cap Portfolio Service Class |
| Fid VIP Mid Cap, Serv Cl 2 | Fidelity<sup>®</sup> VIP Mid Cap Portfolio Service Class 2 |
| Fid VIP Overseas, Serv Cl | Fidelity<sup>®</sup> VIP Overseas Portfolio Service Class |
| Fid VIP Overseas, Serv Cl 2 | Fidelity<sup>®</sup> VIP Overseas Portfolio Service Class 2 |
| Fid VIP Strategic Inc, Init Cl | Fidelity<sup>®</sup> VIP Strategic Income Portfolio Initial Class |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**156 ■ RiverSource of New York Account 8**

------

---

| | |
|:---|:---|
| **Division** | **Fund** |
| Fid VIP Strategic Inc, Serv Cl 2 | Fidelity<sup>®</sup> VIP Strategic Income Portfolio Service Class 2 |
| Frank Global Real Est, Cl 2 | Franklin Global Real Estate VIP Fund – Class 2 |
| Frank Inc, Cl 1 | Franklin Income VIP Fund – Class 1 |
| Frank Inc, Cl 2 | Franklin Income VIP Fund – Class 2 |
| Frank Mutual Shares, Cl 1 | Franklin Mutual Shares VIP Fund – Class 1 |
| Frank Mutual Shares, Cl 2 | Franklin Mutual Shares VIP Fund – Class 2 |
| Frank Sm Cap Val, Cl 1 | Franklin Small Cap Value VIP Fund – Class 1 |
| Frank Sm Cap Val, Cl 2 | Franklin Small Cap Value VIP Fund – Class 2 |
| GS VIT Mid Cap Val, Inst | Goldman Sachs VIT Mid Cap Value Fund – Institutional Shares |
| GS VIT Sm Cap Eq Insights, Inst | Goldman Sachs VIT Small Cap Equity Insights Fund – Institutional Shares |
| GS VIT U.S. Eq Insights, Inst | Goldman Sachs VIT U.S. Equity Insights Fund – Institutional Shares |
| Invesco VI Am Fran, Ser I | Invesco V.I. American Franchise Fund, Series I Shares |
| Invesco VI Am Fran, Ser II | Invesco V.I. American Franchise Fund, Series II Shares |
| Invesco VI Bal Risk Alloc, Ser I | Invesco V.I. Balanced-Risk Allocation Fund, Series I Shares |
| Invesco VI Bal Risk Alloc, Ser II | Invesco V.I. Balanced-Risk Allocation Fund, Series II Shares |
| Invesco VI Comstock, Ser II | Invesco V.I. Comstock Fund, Series II Shares |
| Invesco VI Core Eq, Ser I | Invesco V.I. Core Equity Fund, Series I Shares |
| Invesco VI Dis Mid Cap Gro, Ser I | Invesco V.I. Discovery Mid Cap Growth Fund, Series I Shares |
| Invesco VI Div Divd, Ser I | Invesco V.I. Diversified Dividend Fund, Series I Shares |
| Invesco VI EQV Intl Eq, Ser II | Invesco V.I. EQV International Equity Fund, Series II Shares |
| Invesco VI Gbl Strat Inc, Ser I | Invesco V.I. Global Strategic Income Fund, Series I Shares |
| Invesco VI Gbl Strat Inc, Ser II | Invesco V.I. Global Strategic Income Fund, Series II Shares |
| Invesco VI Global, Ser I | Invesco V.I. Global Fund, Series I Shares |
| Invesco VI Global, Ser II | Invesco V.I. Global Fund, Series II Shares |
| Invesco VI Mn St Sm Cap, Ser I | Invesco V.I. Main Street Small Cap Fund<sup>®</sup>, Series I Shares |
| Invesco VI Mn St Sm Cap, Ser II | Invesco V.I. Main Street Small Cap Fund<sup>®</sup>, Series II Shares |
| Invesco VI Tech, Ser I | Invesco V.I. Technology Fund, Series I Shares |
| Invesco VI Tech, Ser II | Invesco V.I. Technology Fund, Series II Shares |
| Janus Hend VIT Gbl Tech Innov, Srv | Janus Henderson VIT Global Technology and Innovation Portfolio: Service Shares |
| Janus Henderson VIT Bal, Inst | Janus Henderson VIT Balanced Portfolio: Institutional Shares |
| Janus Henderson VIT Bal, Serv | Janus Henderson VIT Balanced Portfolio: Service Shares |
| Janus Henderson VIT Enter, Serv | Janus Henderson VIT Enterprise Portfolio: Service Shares |
| Janus Henderson VIT Flex Bd, Inst | Janus Henderson VIT Flexible Bond Portfolio: Institutional Shares |
| Janus Henderson VIT Flex Bd, Serv | Janus Henderson VIT Flexible Bond Portfolio: Service Shares |
| Janus Henderson VIT Overseas, Serv | Janus Henderson VIT Overseas Portfolio: Service Shares |
| Janus Henderson VIT Res, Inst | Janus Henderson VIT Research Portfolio: Institutional Shares |
| Janus Henderson VIT Res, Serv | Janus Henderson VIT Research Portfolio: Service Shares |
| Lazard Ret Global Dyn MA, Inv | Lazard Retirement Global Dynamic Multi-Asset Portfolio – Investor Shares |
| Lazard Ret Global Dyn MA, Serv | Lazard Retirement Global Dynamic Multi-Asset Portfolio – Service Shares |
| Lord Abt Bond Debenture, Cl VC | Lord Abbett Series Fund Bond Debenture Portfolio – Class VC<sup>(1)</sup> <br>|
| LVIP AC Intl, Serv Cl | LVIP American Century International Fund, Service Class<sup>(3)</sup> <br>|
| LVIP AC Intl, Std Cl II | LVIP American Century International Fund, Standard Class II<sup>(4)</sup> <br>|
| LVIP AC Mid Cap Val, Std Cl II | LVIP American Century Mid Cap Value Fund, Standard Class II<sup>(1)</sup><sup>(5)</sup> <br>|
| LVIP AC Val, Serv Cl | LVIP American Century Value Fund, Service Class<sup>(6)</sup> <br>|
| LVIP AC Val, Std Cl II | LVIP American Century Value Fund, Standard Class II<sup>(7)</sup> <br>|
| MFS Gbl Real Est, Init Cl | MFS<sup>®</sup> Global Real Estate Portfolio – Initial Class<sup>(1)</sup> <br>|
| MFS Intl Gro, Init Cl | MFS<sup>®</sup> International Growth Portfolio – Initial Class<sup>(1)</sup> <br>|
| MFS Mass Inv Gro Stock, Serv Cl | MFS<sup>®</sup> Massachusetts Investors Growth Stock Portfolio – Service Class |
| MFS New Dis, Serv Cl | MFS<sup>®</sup> New Discovery Series – Service Class |
| MFS Utilities, Init Cl | MFS<sup>®</sup> Utilities Series – Initial Class |
| MFS Utilities, Serv Cl | MFS<sup>®</sup> Utilities Series – Service Class |
| MS VIF Dis, Cl I | Morgan Stanley VIF Discovery Portfolio, Class I Shares |
| MS VIF Dis, Cl II | Morgan Stanley VIF Discovery Portfolio, Class II Shares |
| NB AMT Quality Eq, Cl I | &nbsp;&nbsp;&nbsp;&nbsp; Neuberger Berman AMT Quality Equity Portfolio (Class I) <br>(previously Neuberger Berman AMT Sustainable Equity Portfolio (Class I)<br>|
| NB AMT Quality Eq, Cl S | &nbsp;&nbsp;&nbsp;&nbsp; Neuberger Berman AMT Quality Equity Portfolio (Class S) <br>(previously Neuberger Berman AMT Sustainable Equity Portfolio (Class S)<br>|
| Nom VIP Asset Strategy, Serv Cl | &nbsp;&nbsp;&nbsp;&nbsp; Nomura VIP Asset Strategy Series – Service Class <br>(previously Macquarie VIP Asset Strategy Series – Service Class)<br>|
| Nom VIP Asset Strategy, Std Cl | &nbsp;&nbsp;&nbsp;&nbsp; Nomura VIP Asset Strategy Series – Standard Class <sup>(1)</sup> <br>(previously Macquarie VIP Asset Strategy Series – Standard Class)<br>|

---

**RiverSource of New York Account 8** ■ 157

------

---

| | |
|:---|:---|
| **Division** | **Fund** |
| Nom VIP Intl Core Eq, Std Cl | &nbsp;&nbsp;&nbsp;&nbsp; Nomura VIP International Core Equity Series – Standard Class<sup>(8)</sup><sup>(9)</sup> <br>(previously Macquarie VIP International Core Equity Series – Standard Class)<br>|
| PIMCO VIT All Asset, Advisor Cl | PIMCO VIT All Asset Portfolio, Advisor Class |
| PIMCO VIT All Asset, Inst Cl | PIMCO VIT All Asset Portfolio, Institutional Class |
| PIMCO VIT Glb Man As Alloc, Adv Cl | PIMCO VIT Global Managed Asset Allocation Portfolio, Advisor Class |
| PIMCO VIT Tot Return, Advisor Cl | PIMCO VIT Total Return Portfolio, Advisor Class |
| PIMCO VIT Tot Return, Inst Cl | PIMCO VIT Total Return Portfolio, Institutional Class |
| Put VT Global Hlth Care, Cl IA | Putnam VT Global Health Care Fund – Class IA Shares |
| Put VT Global Hlth Care, Cl IB | Putnam VT Global Health Care Fund – Class IB Shares |
| Put VT Hi Yield, Cl IB | Putnam VT High Yield Fund – Class IB Shares |
| Put VT Intl Eq, Cl IB | Putnam VT International Equity Fund – Class IB Shares |
| Put VT Intl Val, Cl IA | Putnam VT International Value Fund – Class IA Shares<sup>(1)</sup> <br>|
| Put VT Lg Cap Val, Cl IA | Putnam VT Large Cap Value Fund – Class IA Shares<sup>(1)</sup> <br>|
| Put VT Sus Leaders, Cl IA | Putnam VT Sustainable Leaders Fund – Class IA Shares |
| Put VT Sus Leaders, Cl IB | Putnam VT Sustainable Leaders Fund – Class IB Shares |
| Royce Micro-Cap, Invest Cl | Royce Capital Fund – Micro-Cap Portfolio, Investment Class |
| Temp Global Bond, Cl 1 | Templeton Global Bond VIP Fund – Class 1 |
| Temp Global Bond, Cl 2 | Templeton Global Bond VIP Fund – Class 2 |
| Third Ave VST Third Ave Value | Third Avenue VST Third Avenue Value Portfolio |
| VanEck VIP Global Gold, Cl S | VanEck VIP Global Gold Fund (Class S Shares) |
| VP Aggr, Cl 1 | Variable Portfolio – Aggressive Portfolio (Class 1) |
| VP Aggr, Cl 2 | Variable Portfolio – Aggressive Portfolio (Class 2) |
| VP Aggr, Cl 4 | Variable Portfolio – Aggressive Portfolio (Class 4) |
| VP Conserv, Cl 1 | Variable Portfolio – Conservative Portfolio (Class 1) |
| VP Conserv, Cl 2 | Variable Portfolio – Conservative Portfolio (Class 2) |
| VP Conserv, Cl 4 | Variable Portfolio – Conservative Portfolio (Class 4) |
| VP Man Vol Conserv Gro, Cl 1 | Variable Portfolio – Managed Volatility Conservative Growth Fund (Class 1) |
| VP Man Vol Conserv Gro, Cl 2 | Variable Portfolio – Managed Volatility Conservative Growth Fund (Class 2) |
| VP Man Vol Conserv, Cl 1 | Variable Portfolio – Managed Volatility Conservative Fund (Class 1) |
| VP Man Vol Conserv, Cl 2 | Variable Portfolio – Managed Volatility Conservative Fund (Class 2) |
| VP Man Vol Gro, Cl 1 | Variable Portfolio – Managed Volatility Growth Fund (Class 1) |
| VP Man Vol Gro, Cl 2 | Variable Portfolio – Managed Volatility Growth Fund (Class 2) |
| VP Man Vol Mod Gro, Cl 1 | Variable Portfolio – Managed Volatility Moderate Growth Fund (Class 1) |
| VP Man Vol Mod Gro, Cl 2 | Variable Portfolio – Managed Volatility Moderate Growth Fund (Class 2) |
| VP Mod Aggr, Cl 1 | Variable Portfolio – Moderately Aggressive Portfolio (Class 1) |
| VP Mod Aggr, Cl 2 | Variable Portfolio – Moderately Aggressive Portfolio (Class 2) |
| VP Mod Aggr, Cl 4 | Variable Portfolio – Moderately Aggressive Portfolio (Class 4) |
| VP Mod Conserv, Cl 1 | Variable Portfolio – Moderately Conservative Portfolio (Class 1) |
| VP Mod Conserv, Cl 2 | Variable Portfolio – Moderately Conservative Portfolio (Class 2) |
| VP Mod Conserv, Cl 4 | Variable Portfolio – Moderately Conservative Portfolio (Class 4) |
| VP Mod, Cl 1 | Variable Portfolio – Moderate Portfolio (Class 1) |
| VP Mod, Cl 2 | Variable Portfolio – Moderate Portfolio (Class 2) |
| VP Mod, Cl 4 | Variable Portfolio – Moderate Portfolio (Class 4) |
| VP Ptnrs Core Bond, Cl 1 | Variable Portfolio – Partners Core Bond Fund (Class 1) |
| VP Ptnrs Core Bond, Cl 2 | Variable Portfolio – Partners Core Bond Fund (Class 2) |
| VP Ptnrs Core Eq, Cl 1 | Variable Portfolio – Partners Core Equity Fund (Class 1) |
| VP Ptnrs Core Eq, Cl 2 | Variable Portfolio – Partners Core Equity Fund (Class 2) |
| VP Ptnrs Core Eq, Cl 3 | Variable Portfolio – Partners Core Equity Fund (Class 3) |
| VP Ptnrs Intl Core Eq, Cl 1 | Variable Portfolio – Partners International Core Equity Fund (Class 1) |
| VP Ptnrs Intl Core Eq, Cl 2 | Variable Portfolio – Partners International Core Equity Fund (Class 2) |
| VP Ptnrs Intl Gro, Cl 1 | Variable Portfolio – Partners International Growth Fund (Class 1) |
| VP Ptnrs Intl Gro, Cl 2 | Variable Portfolio – Partners International Growth Fund (Class 2) |
| VP Ptnrs Intl Val, Cl 1 | Variable Portfolio – Partners International Value Fund (Class 1) |
| VP Ptnrs Intl Val, Cl 2 | Variable Portfolio – Partners International Value Fund (Class 2) |
| VP Ptnrs Sm Cap Gro, Cl 1 | Variable Portfolio – Partners Small Cap Growth Fund (Class 1) |
| VP Ptnrs Sm Cap Gro, Cl 2 | Variable Portfolio – Partners Small Cap Growth Fund (Class 2) |
| VP Ptnrs Sm Cap Val, Cl 1 | Variable Portfolio – Partners Small Cap Value Fund (Class 1) |
| VP Ptnrs Sm Cap Val, Cl 2 | Variable Portfolio – Partners Small Cap Value Fund (Class 2) |
| VP Ptnrs Sm Cap Val, Cl 3 | Variable Portfolio – Partners Small Cap Value Fund (Class 3) |
| VP US Flex Conserv Gro, Cl 1 | Variable Portfolio – U.S. Flexible Conservative Growth Fund (Class 1) |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**158 ■ RiverSource of New York Account 8**

------

---

| | |
|:---|:---|
| **Division** | **Fund** |
| VP US Flex Gro, Cl 1 | Variable Portfolio – U.S. Flexible Growth Fund (Class 1) |
| VP US Flex Mod Gro, Cl 1 | Variable Portfolio – U.S. Flexible Moderate Growth Fund (Class 1) |
| WA Var Global Hi Yd Bond, Cl I | Western Asset Variable Global High Yield Bond Portfolio – Class I |
| WA Var Global Hi Yd Bond, Cl II | Western Asset Variable Global High Yield Bond Portfolio – Class II |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

<sup>(1)</sup> For the period January 16, 2024 (commencement of operations) to December 31, 2024.

<sup>(2)</sup> See Note 9 in the Notes to Financial Statements.

<sup>(3)</sup> American Century VP International, Class II reorganized into LVIP American Century International Fund, Service Class on April 26, 2024.

<sup>(4)</sup> American Century VP International, Class I reorganized into LVIP American Century International Fund, Standard Class II on April 26, 2024.

<sup>(5)</sup> American Century VP Mid Cap Value, Class I reorganized into LVIP American Century Mid Cap Value Fund, Standard Class II on April 26, 2024.

<sup>(6)</sup> American Century VP Value, Class II reorganized into LVIP American Century Value Fund, Service Class on April 26, 2024.

<sup>(7)</sup> American Century VP Value, Class I reorganized into LVIP American Century Value Fund, Standard Class II on April 26, 2024.

<sup>(8)</sup> For the period April 26, 2024 (commencement of operations) to December 31, 2024.

<sup>(9)</sup> Delaware VIP<sup>®</sup> International Series – Standard Class merged into Delaware Ivy VIP International Core Equity – Class I on April 26, 2024. Subsequent to the merger, the fund was renamed to Macquerie VIP International Core Equity Series – Standard Class. 

The assets of each division of the Account are not chargeable with liabilities arising out of the business conducted by any other segregated asset account or by RiverSource Life of NY.

RiverSource Life of NY serves as issuer of the variable life insurance policies.

**2.** **SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES**

**Investments in the Funds**

Investment transactions are accounted for on the trade date the shares are purchased and sold. Realized gains and losses on the sales of investments are computed using the average cost method. Income from dividends and gains from realized capital gain distributions are reinvested in additional shares of the Funds and are recorded as income by the divisions on the ex-dividend date.

Unrealized appreciation or depreciation of investments in the accompanying financial statements represents the division's share of the Funds' undistributed net investment income, undistributed realized gain or loss and the unrealized appreciation or depreciation on their investment securities.

The Account categorizes its fair value measurements according to a three-level hierarchy. An investment's level within the fair value hierarchy is based on the lowest level of any input that is deemed significant to the fair value measurement. The three levels of the fair value hierarchy are defined as follows:

Level 1 – Unadjusted quoted prices for identical assets or liabilities in active markets that are accessible at the measurement date.

Level 2 – Prices or valuations based on observable inputs other than quoted prices in active markets for identical assets and liabilities.

Level 3 – Prices or valuations that require inputs that are both significant to the fair value measurement and unobservable.

The Funds in the Account have been measured at fair value using the net asset value per share (or its equivalent) as a practical expedient and are therefore not categorized in the fair value hierarchy. There were no transfers between levels in the period ended December 31, 2025.

**Federal Income Taxes**

RiverSource Life of NY is taxed as a life insurance company. The Account is treated as part of RiverSource Life of NY for federal income tax purposes. Under existing federal income tax law, no income taxes are payable with respect to any investment income of the Account to the extent the earnings are credited under the policies. Based on this, no charge is being made currently to the Account for federal income taxes. RiverSource Life of NY will review periodically the status of this policy. In the event of changes in the tax law, a charge may be made in future years for any federal income taxes that would be attributable to the policies.

**Subsequent Events**

Management has evaluated Account related events and transactions that occurred through the date the financial statements were issued. Management noted there were no items requiring adjustments or additional disclosures in the Account's financial statements.

**RiverSource of New York Account 8** ■ 159

------

**Use of Estimates**

The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements. Actual results could differ from those estimates.

**Segment Reporting**

Accounting Standards Update 2023-07, Segment Reporting (Topic 280) - *Improvements to Reportable Segment Disclosures* enables investors to better understand an entity's overall performance and to assess its potential future cash flows through improved segment disclosures. The Chairman and President and Chief Executive Officer of RiverSource Life Insurance Co. of New York acts as the Account's chief operating decision maker ("CODM") in assessing performance and making decisions about resource allocation. The CODM has determined that the Account has a single operating segment because the CODM monitors net income, investment performance and overall operating results of the Account as a whole in making decisions about resource allocation. The financial information provided to and reviewed by the CODM is consistent with that presented within the Account's financial statements.

**3.** **VARIABLE ACCOUNT EXPENSES**

RiverSource Life of NY deducts a daily mortality and expense risk fee equal, on an annual basis, to the following percent of the average daily net assets of each subaccount.

---

| | |
|:---|:---|
| **Product** | **Mortality and expense risk fee** |
| Succession Select | &nbsp;&nbsp;&nbsp;&nbsp; 0.45% or 0.90% <br>(depending on the policy selected)<br>|
| V2D | 0.90% |
| VUL | 0.90% |
| VUL III | &nbsp;&nbsp;&nbsp;&nbsp; 0.45% or 0.90% <br>(depending on the policy selected)<br>|
| VUL IV | &nbsp;&nbsp;&nbsp;&nbsp; 0.30%, 0.45% or 0.90% <br>(depending on the policy selected)<br>|
| VUL IV – ES | &nbsp;&nbsp;&nbsp;&nbsp; 0.20%, 0.30% or 0.90% <br>(depending on the policy selected)<br>|
| VUL 5 | 0.00% |
| VUL 5 – ES | 0.00% |
| VUL 6 | 0.00% |
| SVUL | 0.00% |

---

**4.** **POLICY CHARGES**

A monthly deduction is made for the cost of insurance and the policy fee. The cost of insurance for the policy month is determined on the monthly date by determining the net amount at risk, as of that day, and by then applying the cost of insurance rates to the net amount at risk which RiverSource Life of NY is assuming for the succeeding month. The monthly deduction will be taken from the subaccounts as specified by the policyholder.

A policy fee may be deducted each month to reimburse RiverSource Life of NY for expenses incurred in administering the policy, such as processing claims, maintaining records, making policy changes and communicating with owners of policies.

RiverSource Life of NY deducts a premium expense charge from each premium payment. It partially compensates RiverSource Life of NY for expenses associated with administering and distributing the policy, including the agents' compensation, advertising and printing the prospectus and sales literature. It also compensates RiverSource Life of NY for paying premium taxes imposed by the state of New York.

Each month RiverSource Life of NY deducts charges for any optional insurance benefits added to the policy by rider.

Some products may also charge a death benefit guarantee charge or a no lapse guarantee charge.

**5.** **SURRENDER CHARGES**

RiverSource Life of NY may assess a surrender charge to help it recover certain expenses related to the issuance of the policy. Such charges are not treated as a separate expense of the divisions as they are ultimately deducted from surrender benefits paid by RiverSource Life of NY. Charges by RiverSource Life of NY for surrenders are not identified on an individual division basis.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**160 ■ RiverSource of New York Account 8**

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

**6.** **RELATED PARTY TRANSACTIONS**

RiverSource Life of NY is a wholly-owned subsidiary of RiverSource Life Insurance Company, which is a wholly-owned subsidiary of Ameriprise Financial, Inc. (Ameriprise Financial).

The following table reflects fees paid by certain affiliated funds to Ameriprise Financial and its affiliates.

---

| | |
|:---|:---|
| **Fee Agreement:** | **Fees Paid To:** |
| Management Agreement | Columbia Management Investment Advisers, LLC |
| Shareholder Services Agreement | Columbia Management Investment Services Corp. |
| Plan and Agreement of Distribution | Columbia Management Investment Distributors, Inc. |
| Investment Advisory Agreement\* | Columbia Wanger Asset Management, LLC |
| Administrative Services Agreement\* | Columbia Wanger Asset Management, LLC |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

\* Prior to April 1, 2025, Columbia Wanger Asset Management, LLC (CWAM) furnished investment advisory services to funds in the Columbia Acorn Trust (CAT) and the Columbia Funds Variable Series Trust (CFVST) (formerly known as Wanger Advisors Trust) under an investment advisory agreement (the Advisory Agreement) and provided administrative services to such funds under a separate administrative services agreement (the Administration Services Agreement). Effective April 1, 2025, CAT and CFVST, on behalf of these funds, entered into a new management services agreement (the Management Agreement) that combined the management services fee that was previously paid under the Advisory Agreement with the administrative services fee that was previously paid under the Administration Services Agreement. Pursuant to a Novation of Management Agreement effective July 7, 2025, Columbia Management Investment Advisors, LLC (CMIA) replaced CWAM, a wholly owned subsidiary of CMIA as a party to the Management Agreement. 

**7.** **INVESTMENT TRANSACTIONS**

The divisions' purchases of Funds' shares, including reinvestment of dividend distributions, for the year ended December 31, 2025 were as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | |
|:---|:---|
| **Division** | **Purchases** |
| AB VPS Dyn Asset Alloc, Cl B | $10 |
| AB VPS Intl Val, Cl B | 943492 |
| AB VPS Lg Cap Gro, Cl A | 400421 |
| AB VPS Lg Cap Gro, Cl B | 984360 |
| AB VPS Relative Val, Cl B | 571003 |
| Allspg VT Index Asset Alloc, Cl 2 | 95269 |
| Allspg VT Opp, Cl 1 | 7344 |
| Allspg VT Opp, Cl 2 | 319113 |
| Allspg VT Sm Cap Gro, Cl 1 | 137136 |
| Allspg VT Sm Cap Gro, Cl 2 | 361025 |
| ALPS Alerian Engy Infr, Class I | 64530 |
| ALPS Alerian Engy Infr, Class III | 129306 |
| BlackRock Global Alloc, Cl I | 119677 |
| BlackRock Global Alloc, Cl III | 123062 |
| Calvert VP SRI Bal, Cl I | 456713 |
| Col VP Acorn | 829342 |
| Col VP Acorn Intl | 670679 |
| Col VP Bal, Cl 1 | 1106228 |
| Col VP Bal, Cl 3 | 399287 |
| Col VP Commodity Strategy, Cl 1 | 34208 |
| Col VP Commodity Strategy, Cl 2 | 6773 |
| Col VP Contrarian Core, Cl 1 | 122680 |
| Col VP Contrarian Core, Cl 2 | 70569 |
| Col VP Corporate Bond, Cl 1 | 9102 |
| Col VP Corporate Bond, Cl 2 | 14334 |
| Col VP Corporate Bond, Cl 3 | 378720 |
| Col VP Disciplined Core, Cl 1 | 80790 |
| Col VP Disciplined Core, Cl 2 | 14500 |
| Col VP Disciplined Core, Cl 3 | 592534 |
| Col VP Divd Opp, Cl 1 | 195925 |
| Col VP Divd Opp, Cl 2 | 36350 |
| Col VP Divd Opp, Cl 3 | 1906602 |
| Col VP Emer Mkts, Cl 1 | 66999 |
| Col VP Emer Mkts, Cl 2 | 23398 |
| Col VP Emer Mkts, Cl 3 | 261272 |
| Col VP Emerg Mkts Bond, Cl 1 | 17187 |
| Col VP Emerg Mkts Bond, Cl 2 | 1539 |
| Col VP Govt Money Mkt, Cl 1 | 343767 |

---

---

| | |
|:---|:---|
| **Division** | **Purchases** |
| Col VP Govt Money Mkt, Cl 2 | $97637 |
| Col VP Govt Money Mkt, Cl 3 | 849023 |
| Col VP Hi Yield Bond, Cl 1 | 226394 |
| Col VP Hi Yield Bond, Cl 2 | 51731 |
| Col VP Hi Yield Bond, Cl 3 | 665552 |
| Col VP Inc Opp, Cl 1 | 5620 |
| Col VP Inc Opp, Cl 2 | 9981 |
| Col VP Inc Opp, Cl 3 | 110435 |
| Col VP Inter Bond, Cl 1 | 227733 |
| Col VP Inter Bond, Cl 2 | 58589 |
| Col VP Inter Bond, Cl 3 | 1107255 |
| Col VP Lg Cap Gro, Cl 1 | 1032101 |
| Col VP Lg Cap Gro, Cl 2 | 35164 |
| Col VP Lg Cap Gro, Cl 3 | 359061 |
| Col VP Lg Cap Index, Cl 1 | 2630475 |
| Col VP Lg Cap Index, Cl 3 | 2211479 |
| Col VP Limited Duration Cr, Cl 1 | 67540 |
| Col VP Limited Duration Cr, Cl 2 | 175503 |
| Col VP Long Govt/Cr Bond, Cl 1 | 39944 |
| Col VP Long Govt/Cr Bond, Cl 2 | 291 |
| Col VP Overseas Core, Cl 1 | 267188 |
| Col VP Overseas Core, Cl 2 | 24299 |
| Col VP Overseas Core, Cl 3 | 651765 |
| Col VP Sel Gbl Tech, Cl 1 | 173171 |
| Col VP Sel Gbl Tech, Cl 2 | 69060 |
| Col VP Select Lg Cap Val, Cl 1 | 329012 |
| Col VP Select Lg Cap Val, Cl 2 | 13367 |
| Col VP Select Lg Cap Val, Cl 3 | 245416 |
| Col VP Select Mid Cap Gro, Cl 1 | 95376 |
| Col VP Select Mid Cap Gro, Cl 2 | 25762 |
| Col VP Select Mid Cap Gro, Cl 3 | 292566 |
| Col VP Select Mid Cap Val, Cl 1 | 96603 |
| Col VP Select Mid Cap Val, Cl 2 | 10748 |
| Col VP Select Mid Cap Val, Cl 3 | 203774 |
| Col VP Select Sm Cap Val, Cl 1 | 75424 |
| Col VP Select Sm Cap Val, Cl 2 | 17565 |
| Col VP Select Sm Cap Val, Cl 3 | 166070 |
| Col VP Strategic Inc, Cl 1 | 81335 |

---

**RiverSource of New York Account 8** ■ 161

------

---

| | |
|:---|:---|
| **Division** | **Purchases** |
| Col VP Strategic Inc, Cl 2 | $130917 |
| Col VP US Govt Mtge, Cl 1 | 5279 |
| Col VP US Govt Mtge, Cl 2 | 1201 |
| Col VP US Govt Mtge, Cl 3 | 291215 |
| CS Commodity Return, Cl 1 | 72449 |
| CTIVP AC Div Bond, Cl 1 | 22675 |
| CTIVP AC Div Bond, Cl 2 | 2501 |
| CTIVP BR Gl Infl Prot Sec, Cl 1 | 13460 |
| CTIVP BR Gl Infl Prot Sec, Cl 2 | 3003 |
| CTIVP BR Gl Infl Prot Sec, Cl 3 | 82287 |
| CTIVP CenterSquare Real Est, Cl 1 | 17854 |
| CTIVP CenterSquare Real Est, Cl 2 | 25959 |
| CTIVP Prin Lg Cap Gro, Cl 1 | 40228 |
| CTIVP Prin Lg Cap Gro, Cl 2 | 3905 |
| CTIVP T Rowe Price LgCap Val, Cl 1 | 123065 |
| CTIVP T Rowe Price LgCap Val, Cl 2 | 14101 |
| CTIVP TCW Core Plus Bond, Cl 1 | 10566 |
| CTIVP TCW Core Plus Bond, Cl 2 | 2302 |
| CTIVP Vty Sycamore Estb Val, Cl 1 | 193056 |
| CTIVP Vty Sycamore Estb Val, Cl 2 | 81236 |
| CTIVP Vty Sycamore Estb Val, Cl 3 | 464442 |
| CTIVP Wellington Lg Cap Val, Cl 1 | 251355 |
| CTIVP Wellington Lg Cap Val, Cl 2 | 46451 |
| CTIVP Westfield Mid Cap Gro, Cl 1 | 51167 |
| CTIVP Westfield Mid Cap Gro, Cl 2 | 2712 |
| CTIVP Westfield Sel Lg Cp Gr, Cl 1 | 20344 |
| CTIVP Westfield Sel Lg Cp Gr, Cl 2 | 4495 |
| CVT EAFE Intl Index, Cl F | 440 |
| CVT EAFE Intl Index, Cl I | 302611 |
| CVT Nasdaq 100 Index, Cl F | 33994 |
| CVT Nasdaq 100 Index, Cl I | 266096 |
| CVT Russ 2000 Sm Cap Ind, Cl F | 3825 |
| CVT Russ 2000 Sm Cap Ind, Cl I | 181798 |
| DWS Alt Asset Alloc VIP, Cl A | 123558 |
| DWS Alt Asset Alloc VIP, Cl B | 104709 |
| EV VT Floating-Rate Inc, Init Cl | 222494 |
| EV VT Floating-Rate Inc, Inst Cl | 887 |
| Fid VIP Contrafund, Init Cl | 1176227 |
| Fid VIP Contrafund, Serv Cl 2 | 2853220 |
| Fid VIP Emer Mkts, Init Cl | 74880 |
| Fid VIP Energy, Init Cl | 2488 |
| Fid VIP Gro & Inc, Serv Cl | 809516 |
| Fid VIP Gro & Inc, Serv Cl 2 | 1135517 |
| Fid VIP Gro Opp, Init Cl | 11158 |
| Fid VIP Invest Gr, Init Cl | 21135 |
| Fid VIP Mid Cap, Init Cl | 695852 |
| Fid VIP Mid Cap, Serv Cl | 901008 |
| Fid VIP Mid Cap, Serv Cl 2 | 1938754 |
| Fid VIP Overseas, Serv Cl | 262220 |
| Fid VIP Overseas, Serv Cl 2 | 402153 |
| Fid VIP Strategic Inc, Init Cl | 198465 |
| Fid VIP Strategic Inc, Serv Cl 2 | 49803 |
| Frank Global Real Est, Cl 2 | 330942 |
| Frank Inc, Cl 1 | 64582 |
| Frank Inc, Cl 2 | 97348 |
| Frank Mutual Shares, Cl 1 | 9884 |
| Frank Mutual Shares, Cl 2 | 722342 |
| Frank Sm Cap Val, Cl 1 | 134920 |
| Frank Sm Cap Val, Cl 2 | 761238 |
| GS VIT Mid Cap Val, Inst | 1653626 |

---

---

| | |
|:---|:---|
| **Division** | **Purchases** |
| GS VIT Sm Cap Eq Insights, Inst | $65881 |
| GS VIT U.S. Eq Insights, Inst | 1061102 |
| Invesco VI Am Fran, Ser I | 122319 |
| Invesco VI Am Fran, Ser II | 299386 |
| Invesco VI Bal Risk Alloc, Ser I | 14008 |
| Invesco VI Bal Risk Alloc, Ser II | 44118 |
| Invesco VI Comstock, Ser II | 157485 |
| Invesco VI Core Eq, Ser I | 1106542 |
| Invesco VI Dis Mid Cap Gro, Ser I | 261142 |
| Invesco VI Div Divd, Ser I | 147096 |
| Invesco VI EQV Intl Eq, Ser II | 146623 |
| Invesco VI Gbl Strat Inc, Ser I | 23333 |
| Invesco VI Gbl Strat Inc, Ser II | 355996 |
| Invesco VI Global, Ser I | 258919 |
| Invesco VI Global, Ser II | 615235 |
| Invesco VI Mn St Sm Cap, Ser I | 262649 |
| Invesco VI Mn St Sm Cap, Ser II | 411460 |
| Invesco VI Tech, Ser I | 521895 |
| Invesco VI Tech, Ser II | 1234 |
| Janus Hend VIT Gbl Tech Innov, Srv | 552527 |
| Janus Henderson VIT Bal, Inst | 304936 |
| Janus Henderson VIT Bal, Serv | 4397 |
| Janus Henderson VIT Enter, Serv | 89262 |
| Janus Henderson VIT Flex Bd, Inst | 220160 |
| Janus Henderson VIT Flex Bd, Serv | 9228 |
| Janus Henderson VIT Overseas, Serv | 196679 |
| Janus Henderson VIT Res, Inst | 20443 |
| Janus Henderson VIT Res, Serv | 132123 |
| Lazard Ret Global Dyn MA, Inv | 7791 |
| Lazard Ret Global Dyn MA, Serv | 5066 |
| Lord Abt Bond Debenture, Cl VC | 7010 |
| LVIP AC Intl, Serv Cl | 167957 |
| LVIP AC Intl, Std Cl II | 27940 |
| LVIP AC Mid Cap Val, Std Cl II | 31341 |
| LVIP AC Val, Serv Cl | 901753 |
| LVIP AC Val, Std Cl II | 496668 |
| MFS Gbl Real Est, Init Cl | 72 |
| MFS Intl Gro, Init Cl | 227143 |
| MFS Mass Inv Gro Stock, Serv Cl | 714807 |
| MFS New Dis, Serv Cl | 161147 |
| MFS Utilities, Init Cl | 48153 |
| MFS Utilities, Serv Cl | 190387 |
| MS VIF Dis, Cl I | 119593 |
| MS VIF Dis, Cl II | 302023 |
| NB AMT Quality Eq, Cl I | 9684 |
| NB AMT Quality Eq, Cl S | 22419 |
| Nom VIP Asset Strategy, Serv Cl | 6677 |
| Nom VIP Asset Strategy, Std Cl | 108 |
| Nom VIP Intl Core Eq, Std Cl | 5 |
| PIMCO VIT All Asset, Advisor Cl | 129971 |
| PIMCO VIT All Asset, Inst Cl | 7274 |
| PIMCO VIT Glb Man As Alloc, Adv Cl | 266 |
| PIMCO VIT Tot Return, Advisor Cl | 362720 |
| PIMCO VIT Tot Return, Inst Cl | 163403 |
| Put VT Global Hlth Care, Cl IA | 26948 |
| Put VT Global Hlth Care, Cl IB | 300937 |
| Put VT Hi Yield, Cl IB | 28931 |
| Put VT Intl Eq, Cl IB | 54998 |
| Put VT Intl Val, Cl IA | 137797 |
| Put VT Lg Cap Val, Cl IA | 259341 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**162 ■ RiverSource of New York Account 8**

------

---

| | |
|:---|:---|
| **Division** | **Purchases** |
| Put VT Sus Leaders, Cl IA | $1772052 |
| Put VT Sus Leaders, Cl IB | 82225 |
| Royce Micro-Cap, Invest Cl | 396737 |
| Temp Global Bond, Cl 1 | 6930 |
| Temp Global Bond, Cl 2 | 37909 |
| Third Ave VST Third Ave Value | 317684 |
| VanEck VIP Global Gold, Cl S | 104687 |
| VP Aggr, Cl 1 | 864484 |
| VP Aggr, Cl 2 | 1396705 |
| VP Aggr, Cl 4 | 2938039 |
| VP Conserv, Cl 1 |  |
| VP Conserv, Cl 2 | 46759 |
| VP Conserv, Cl 4 | 14320 |
| VP Man Vol Conserv Gro, Cl 1 | 2400 |
| VP Man Vol Conserv Gro, Cl 2 | 15976 |
| VP Man Vol Conserv, Cl 1 | 869 |
| VP Man Vol Conserv, Cl 2 | 283385 |
| VP Man Vol Gro, Cl 1 | 233745 |
| VP Man Vol Gro, Cl 2 | 99713 |
| VP Man Vol Mod Gro, Cl 1 | 99852 |
| VP Man Vol Mod Gro, Cl 2 | 515095 |
| VP Mod Aggr, Cl 1 | 3601953 |
| VP Mod Aggr, Cl 2 | 3117305 |
| VP Mod Aggr, Cl 4 | 6450336 |
| VP Mod Conserv, Cl 1 |  |
| VP Mod Conserv, Cl 2 | 496152 |

---

---

| | |
|:---|:---|
| **Division** | **Purchases** |
| VP Mod Conserv, Cl 4 | $716853 |
| VP Mod, Cl 1 | 1769130 |
| VP Mod, Cl 2 | 2300673 |
| VP Mod, Cl 4 | 4032801 |
| VP Ptnrs Core Bond, Cl 1 | 12489 |
| VP Ptnrs Core Bond, Cl 2 | 18019 |
| VP Ptnrs Core Eq, Cl 1 | 4953 |
| VP Ptnrs Core Eq, Cl 2 | 51 |
| VP Ptnrs Core Eq, Cl 3 | 59346 |
| VP Ptnrs Intl Core Eq, Cl 1 | 142449 |
| VP Ptnrs Intl Core Eq, Cl 2 | 4740 |
| VP Ptnrs Intl Gro, Cl 1 | 101905 |
| VP Ptnrs Intl Gro, Cl 2 | 30592 |
| VP Ptnrs Intl Val, Cl 1 | 11122 |
| VP Ptnrs Intl Val, Cl 2 | 5100 |
| VP Ptnrs Sm Cap Gro, Cl 1 | 8082 |
| VP Ptnrs Sm Cap Gro, Cl 2 | 3559 |
| VP Ptnrs Sm Cap Val, Cl 1 | 1544 |
| VP Ptnrs Sm Cap Val, Cl 2 | 495 |
| VP Ptnrs Sm Cap Val, Cl 3 | 139287 |
| VP US Flex Conserv Gro, Cl 1 | 2189 |
| VP US Flex Gro, Cl 1 | 58580 |
| VP US Flex Mod Gro, Cl 1 | 4318 |
| WA Var Global Hi Yd Bond, Cl I | 6069 |
| WA Var Global Hi Yd Bond, Cl II | 1025 |

---

**RiverSource of New York Account 8** ■ 163

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

**8.** **FINANCIAL HIGHLIGHTS**

The table below shows certain financial information regarding the division(s).

---

| | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **At December 31** | **At December 31** | **At December 31** | **At December 31** | **At December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** |
|  | **Units (000s)** | **Accumulation unit value** <br>**lowest to highest**<sup>(1)</sup>  | **Accumulation unit value** <br>**lowest to highest**<sup>(1)</sup>  | **Accumulation unit value** <br>**lowest to highest**<sup>(1)</sup>  | **Net assets** <br> **(000s)**<br>| **Investment** <br> **income ratio**<sup>(2)</sup> <br>| **Expense ratio** <br>**lowest to highest**<sup>(3)</sup>  | **Expense ratio** <br>**lowest to highest**<sup>(3)</sup>  | **Expense ratio** <br>**lowest to highest**<sup>(3)</sup>  | &nbsp;&nbsp; **Total return** <br>**lowest to highest**<sup>(1)</sup><sup>,</sup><sup>(4)</sup>  | &nbsp;&nbsp; **Total return** <br>**lowest to highest**<sup>(1)</sup><sup>,</sup><sup>(4)</sup>  | &nbsp;&nbsp; **Total return** <br>**lowest to highest**<sup>(1)</sup><sup>,</sup><sup>(4)</sup>  |
| **AB VPS Dyn Asset Alloc, Cl B** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 |  | $1.77 | to | $1.49 | $1 | 1.61<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 13.22<br> %<br>| to | 12.20<br> %<br>|
| 2024 |  | $1.57 | to | $1.33 | $1 | 1.09<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 10.43<br> %<br>| to | 9.42<br> %<br>|
| 2023 |  | $1.42 | to | $1.22 | $0 | 0.61<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 13.48<br> %<br>| to | 12.46<br> %<br>|
| 2022 |  | $1.25 | to | $1.08 | $0 | 2.56<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp; (18.68)%<br>| to | (19.40)%<br>|
| 2021 |  | $1.54 | to | $1.34 | $1 | 1.56<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 9.28<br> %<br>| to | 8.30<br> %<br>|
| **AB VPS Intl Val, Cl B** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 1519 | $2.00 | to | $2.61 | $3582 | 2.37<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 40.99<br> %<br>| to | 40.01<br> %<br>|
| 2024 | 1392 | $1.42 | to | $1.86 | $2555 | 2.27<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 4.60<br> %<br>| to | 3.86<br> %<br>|
| 2023 | 1463 | $1.36 | to | $1.79 | $2703 | 0.70<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 14.60<br> %<br>| to | 13.80<br> %<br>|
| 2022 | 1516 | $1.18 | to | $1.58 | $2447 | 4.22<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 18.83 %<sup>(5)</sup><br>| to | (14.57)%<br>|
| 2021 | 1523 | $1.32 | to | $1.84 | $2868 | 1.72<br> %<br>| 0.30<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 10.52<br> %<br>| to | 9.86<br> %<br>|
| **AB VPS Lg Cap Gro, Cl A** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 490 | $2.84 | to | $2.84 | $1391 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 13.14<br> %<br>| to | 13.14<br> %<br>|
| 2024 | 404 | $2.51 | to | $2.51 | $1015 | 0.05<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 25.25<br> %<br>| to | 25.25<br> %<br>|
| 2023 | 174 | $2.00 | to | $2.00 | $349 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 35.13<br> %<br>| to | 35.13<br> %<br>|
| 2022 | 117 | $1.48 | to | $1.48 | $173 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (28.51)%<br>| to | (28.51)%<br>|
| 2021 | 59 | $2.07 | to | $2.07 | $122 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 28.97<br> %<br>| to | 28.97<br> %<br>|
| **AB VPS Lg Cap Gro, Cl B** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 494 | $7.42 | to | $6.95 | $3777 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 12.85<br> %<br>| to | 11.84<br> %<br>|
| 2024 | 457 | $6.57 | to | $6.22 | $3401 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 24.95<br> %<br>| to | 23.83<br> %<br>|
| 2023 | 454 | $5.26 | to | $5.02 | $2799 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 34.79<br> %<br>| to | 33.59<br> %<br>|
| 2022 | 392 | $3.90 | to | $3.76 | $1723 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp; (28.69)%<br>| to | (29.33)%<br>|
| 2021 | 350 | $5.47 | to | $5.32 | $2208 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 28.65<br> %<br>| to | 27.50<br> %<br>|
| **AB VPS Relative Val, Cl B** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 719 | $1.52 | to | $5.21 | $2746 | 0.89<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 9.98<br> %<br>| to | 9.21<br> %<br>|
| 2024 | 685 | $1.38 | to | $4.77 | $2616 | 1.24<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 12.54<br> %<br>| to | 11.75<br> %<br>|
| 2023 | 621 | $1.23 | to | $4.27 | $2515 | 1.33<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 11.50<br> %<br>| to | 10.72<br> %<br>|
| 2022 | 698 | $1.10 | to | $3.86 | $2531 | 1.10<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 10.30 %<sup>(5)</sup><br>| to | (5.27)%<br>|
| 2021 | 721 | $2.35 | to | $4.07 | $2756 | 0.64<br> %<br>| 0.30<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 27.45<br> %<br>| to | 26.69<br> %<br>|
| **Allspg VT Index Asset Alloc, Cl 2** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 241 | $1.54 | to | $4.74 | $652 | 1.25<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 11.26<br> %<br>| to | 10.49<br> %<br>|
| 2024 | 243 | $1.38 | to | $4.29 | $594 | 1.31<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 14.64<br> %<br>| to | 13.83<br> %<br>|
| 2023 | 246 | $1.21 | to | $3.77 | $536 | 0.96<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 16.47<br> %<br>| to | 15.66<br> %<br>|
| 2022 | 260 | $1.04 | to | $3.26 | $495 | 0.63<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 4.13 %<sup>(5)</sup><br>| to | (17.76)%<br>|
| 2021 | 268 | $2.32 | to | $3.96 | $620 | 0.56<br> %<br>| 0.30<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 15.65<br> %<br>| to | 14.96<br> %<br>|
| **Allspg VT Opp, Cl 1** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 13 | $2.19 | to | $2.19 | $28 | 0.31<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 7.00<br> %<br>| to | 7.00<br> %<br>|
| 2024 | 12 | $2.04 | to | $2.04 | $24 | 0.26<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 15.35<br> %<br>| to | 15.35<br> %<br>|
| 2023 | 12 | $1.77 | to | $1.77 | $21 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 26.83<br> %<br>| to | 26.83<br> %<br>|
| 2022 | 8 | $1.40 | to | $1.40 | $12 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (20.61)%<br>| to | (20.61)%<br>|
| 2021 | 2 | $1.76 | to | $1.76 | $3 | 0.23<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 25.06<br> %<br>| to | 25.06<br> %<br>|
| **Allspg VT Opp, Cl 2** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 274 | $4.39 | to | $7.24 | $1340 | 0.05<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 6.71<br> %<br>| to | 5.76<br> %<br>|
| 2024 | 263 | $4.12 | to | $6.85 | $1342 | 0.05<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 15.05<br> %<br>| to | 14.01<br> %<br>|
| 2023 | 266 | $3.58 | to | $6.01 | $1367 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 26.50<br> %<br>| to | 25.37<br> %<br>|
| 2022 | 287 | $2.83 | to | $4.79 | $1192 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp; (20.81)%<br>| to | (21.52)%<br>|
| 2021 | 298 | $3.57 | to | $6.11 | $1579 | 0.04<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 24.78<br> %<br>| to | 23.66<br> %<br>|
| **Allspg VT Sm Cap Gro, Cl 1** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 329 | $1.62 | to | $1.62 | $534 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 9.55<br> %<br>| to | 9.55<br> %<br>|
| 2024 | 265 | $1.48 | to | $1.48 | $392 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 19.07<br> %<br>| to | 19.07<br> %<br>|
| 2023 | 225 | $1.24 | to | $1.24 | $280 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 4.35<br> %<br>| to | 4.35<br> %<br>|
| 2022 | 132 | $1.19 | to | $1.19 | $157 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (34.30)%<br>| to | (34.30)%<br>|

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**164 ■ RiverSource of New York Account 8**

------

---

| | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **At December 31** | **At December 31** | **At December 31** | **At December 31** | **At December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** |
|  | **Units (000s)** | **Accumulation unit** <br> **value**<br> **lowest to highest**<sup>(1)</sup> | **Accumulation unit** <br> **value**<br> **lowest to highest**<sup>(1)</sup> | **Accumulation unit** <br> **value**<br> **lowest to highest**<sup>(1)</sup> | **Net assets** <br> **(000s)**<br>| **Investment** <br> **income ratio**<sup>(2)</sup><br>| **Expense ratio**<br> **lowest to** <br> **highest**<sup>(3)</sup> | **Expense ratio**<br> **lowest to** <br> **highest**<sup>(3)</sup> | **Expense ratio**<br> **lowest to** <br> **highest**<sup>(3)</sup> | &nbsp;&nbsp; **Total return**<br> **lowest to highest**<sup>(1)</sup><sup>,</sup><sup>(4)</sup> | &nbsp;&nbsp; **Total return**<br> **lowest to highest**<sup>(1)</sup><sup>,</sup><sup>(4)</sup> | &nbsp;&nbsp; **Total return**<br> **lowest to highest**<sup>(1)</sup><sup>,</sup><sup>(4)</sup> |
| 2021 | 46 | $1.81 | to | $1.81 | $83 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 7.93<br> %<br>| to | 7.93<br> %<br>|
| **Allspg VT Sm Cap Gro, Cl 2** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 479 | $3.55 | to | $7.01 | $1544 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 9.26<br> %<br>| to | 8.28<br> %<br>|
| 2024 | 452 | $3.25 | to | $6.48 | $1448 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 18.70<br> %<br>| to | 17.63<br> %<br>|
| 2023 | 397 | $2.74 | to | $5.51 | $1311 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 4.11<br> %<br>| to | 3.18<br> %<br>|
| 2022 | 367 | $2.63 | to | $5.34 | $1211 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp; (34.42)%<br>| to | (35.01)%<br>|
| 2021 | 371 | $4.01 | to | $8.21 | $1937 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 7.64<br> %<br>| to | 6.68<br> %<br>|
| **ALPS Alerian Engy Infr, Class I** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 49 | $2.11 | to | $2.11 | $103 | 4.40<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 5.09<br> %<br>| to | 5.09<br> %<br>|
| 2024 | 44 | $2.00 | to | $2.00 | $89 | 5.13<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 41.03<br> %<br>| to | 41.03<br> %<br>|
| 2023 | 35 | $1.42 | to | $1.42 | $50 | 5.14<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 14.25<br> %<br>| to | 14.25<br> %<br>|
| 2022 | 18 | $1.24 | to | $1.24 | $23 | 10.76<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 17.84<br> %<br>| to | 17.84<br> %<br>|
| 2021 | 2 | $1.06 | to | $1.06 | $2 | 5.09<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 38.25<br> %<br>| to | 38.25<br> %<br>|
| **ALPS Alerian Engy Infr, Class III** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 314 | $2.07 | to | $1.52 | $518 | 4.41<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 4.66<br> %<br>| to | 3.72<br> %<br>|
| 2024 | 344 | $1.98 | to | $1.46 | $543 | 4.00<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 40.60<br> %<br>| to | 39.33<br> %<br>|
| 2023 | 464 | $1.41 | to | $1.05 | $514 | 2.87<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 13.91<br> %<br>| to | 12.89<br> %<br>|
| 2022 | 517 | $1.24 | to | $0.93 | $504 | 4.42<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 17.32<br> %<br>| to | 16.27<br> %<br>|
| 2021 | 464 | $1.05 | to | $0.80 | $390 | 1.76<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 37.78<br> %<br>| to | 36.54<br> %<br>|
| **BlackRock Global Alloc, Cl I** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 213 | $1.77 | to | $1.77 | $378 | 3.66<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 19.80<br> %<br>| to | 19.80<br> %<br>|
| 2024 | 197 | $1.48 | to | $1.48 | $292 | 0.98<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 9.23<br> %<br>| to | 9.23<br> %<br>|
| 2023 | 140 | $1.36 | to | $1.36 | $189 | 2.45<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 12.83<br> %<br>| to | 12.83<br> %<br>|
| 2022 | 99 | $1.20 | to | $1.20 | $119 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (15.86)%<br>| to | (15.86)%<br>|
| 2021 | 67 | $1.43 | to | $1.43 | $95 | 1.20<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 6.67<br> %<br>| to | 6.67<br> %<br>|
| **BlackRock Global Alloc, Cl III** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 321 | $2.36 | to | $1.80 | $618 | 4.25<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 19.51<br> %<br>| to | 18.44<br> %<br>|
| 2024 | 350 | $1.97 | to | $1.52 | $566 | 0.81<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 8.93<br> %<br>| to | 7.94<br> %<br>|
| 2023 | 347 | $1.81 | to | $1.40 | $514 | 2.63<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 12.49<br> %<br>| to | 11.48<br> %<br>|
| 2022 | 318 | $1.61 | to | $1.26 | $423 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp; (16.07)%<br>| to | (16.82)%<br>|
| 2021 | 336 | $1.92 | to | $1.51 | $536 | 0.84<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 6.42<br> %<br>| to | 5.46<br> %<br>|
| **Calvert VP SRI Bal, Cl I** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 729 | $1.32 | to | $3.34 | $3010 | 1.71<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 11.48<br> %<br>| to | 10.48<br> %<br>|
| 2024 | 687 | $1.19 | to | $3.02 | $2581 | 1.65<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 19.12 %<sup>(6)</sup><br>| to | 18.53<br> %<br>|
| 2023 | 911 | $1.21 | to | $2.55 | $2776 | 1.59<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 16.60<br> %<br>| to | 15.77<br> %<br>|
| 2022 | 917 | $1.04 | to | $2.20 | $2393 | 1.21<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 4.47 %<sup>(5)</sup><br>| to | (16.17)%<br>|
| 2021 | 947 | $2.15 | to | $2.63 | $2937 | 1.24<br> %<br>| 0.30<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 14.77<br> %<br>| to | 14.08<br> %<br>|
| **Col VP Acorn** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 1450 | $1.45 | to | $6.50 | $5847 | —<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 4.26<br> %<br>| to | 3.53<br> %<br>|
| 2024 | 1307 | $1.39 | to | $6.27 | $5857 | —<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 13.95<br> %<br>| to | 13.15<br> %<br>|
| 2023 | 1270 | $1.22 | to | $5.54 | $5634 | —<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 21.49<br> %<br>| to | 20.65<br> %<br>|
| 2022 | 1295 | $1.01 | to | $4.60 | $4899 | —<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 2.29 %<sup>(5)</sup><br>| to | (34.06)%<br>|
| 2021 | 1293 | $2.64 | to | $6.97 | $7460 | 0.76<br> %<br>| 0.30<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 8.57<br> %<br>| to | 7.92<br> %<br>|
| **Col VP Acorn Intl** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 1663 | $1.38 | to | $3.45 | $4081 | 1.27<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 12.53<br> %<br>| to | 11.75<br> %<br>|
| 2024 | 1564 | $1.23 | to | $3.08 | $3720 | 1.39<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp; (8.43)%<br>| to | (9.08)%<br>|
| 2023 | 1573 | $1.34 | to | $3.39 | $4276 | 0.32<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 16.72<br> %<br>| to | 15.91<br> %<br>|
| 2022 | 1707 | $1.15 | to | $2.93 | $3948 | 0.92<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 15.79 %<sup>(5)</sup><br>| to | (34.44)%<br>|
| 2021 | 1667 | $1.98 | to | $4.46 | $5916 | 0.55<br> %<br>| 0.30<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 18.45<br> %<br>| to | 17.74<br> %<br>|
| **Col VP Bal, Cl 1** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 1788 | $2.04 | to | $2.04 | $3651 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 14.05<br> %<br>| to | 14.05<br> %<br>|
| 2024 | 1427 | $1.79 | to | $1.79 | $2555 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 14.55<br> %<br>| to | 14.55<br> %<br>|
| 2023 | 999 | $1.56 | to | $1.56 | $1561 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 21.40<br> %<br>| to | 21.40<br> %<br>|
| 2022 | 820 | $1.29 | to | $1.29 | $1056 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (16.65)%<br>| to | (16.65)%<br>|

---

**RiverSource of New York Account 8** ■ 165

------

---

| | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **At December 31** | **At December 31** | **At December 31** | **At December 31** | **At December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** |
|  | **Units (000s)** | **Accumulation unit** <br> **value**<br> **lowest to highest**<sup>(1)</sup> | **Accumulation unit** <br> **value**<br> **lowest to highest**<sup>(1)</sup> | **Accumulation unit** <br> **value**<br> **lowest to highest**<sup>(1)</sup> | **Net assets** <br> **(000s)**<br>| **Investment** <br> **income ratio**<sup>(2)</sup><br>| **Expense ratio**<br> **lowest to** <br> **highest**<sup>(3)</sup> | **Expense ratio**<br> **lowest to** <br> **highest**<sup>(3)</sup> | **Expense ratio**<br> **lowest to** <br> **highest**<sup>(3)</sup> | &nbsp;&nbsp; **Total return**<br> **lowest to highest**<sup>(1)</sup><sup>,</sup><sup>(4)</sup> | &nbsp;&nbsp; **Total return**<br> **lowest to highest**<sup>(1)</sup><sup>,</sup><sup>(4)</sup> | &nbsp;&nbsp; **Total return**<br> **lowest to highest**<sup>(1)</sup><sup>,</sup><sup>(4)</sup> |
| 2021 | 704 | $1.54 | to | $1.54 | $1087 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 14.87<br> %<br>| to | 14.87<br> %<br>|
| **Col VP Bal, Cl 3** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 5105 | $3.38 | to | $3.59 | $20073 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 13.92<br> %<br>| to | 12.90<br> %<br>|
| 2024 | 5377 | $2.97 | to | $3.18 | $18706 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 14.43<br> %<br>| to | 13.40<br> %<br>|
| 2023 | 5581 | $2.59 | to | $2.80 | $17115 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 21.23<br> %<br>| to | 20.15<br> %<br>|
| 2022 | 5946 | $2.14 | to | $2.33 | $15098 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp; (16.74)%<br>| to | (17.49)%<br>|
| 2021 | 6268 | $2.57 | to | $2.83 | $19187 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 14.74<br> %<br>| to | 13.71<br> %<br>|
| **Col VP Commodity Strategy, Cl 1** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 57 | $1.81 | to | $1.81 | $104 | 8.36<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 15.48<br> %<br>| to | 15.48<br> %<br>|
| 2024 | 44 | $1.57 | to | $1.57 | $70 | 3.60<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 7.24<br> %<br>| to | 7.24<br> %<br>|
| 2023 | 41 | $1.46 | to | $1.46 | $59 | 22.73<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (6.82)%<br>| to | (6.82)%<br>|
| 2022 | 38 | $1.57 | to | $1.57 | $60 | 25.52<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 19.09<br> %<br>| to | 19.09<br> %<br>|
| 2021 | 30 | $1.32 | to | $1.32 | $39 | 0.21<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 32.63<br> %<br>| to | 32.63<br> %<br>|
| **Col VP Commodity Strategy, Cl 2** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 40 | $1.11 | to | $1.11 | $44 | 7.98<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 15.31<br> %<br>| to | 15.31<br> %<br>|
| 2024 | 42 | $0.96 | to | $0.96 | $41 | 3.46<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 7.09<br> %<br>| to | 7.09<br> %<br>|
| 2023 | 40 | $0.90 | to | $0.90 | $36 | 21.97<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (7.13)%<br>| to | (7.13)%<br>|
| 2022 | 38 | $0.97 | to | $0.97 | $36 | 24.92<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 18.70<br> %<br>| to | 18.70<br> %<br>|
| 2021 | 38 | $0.81 | to | $0.81 | $31 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 32.01<br> %<br>| to | 32.01<br> %<br>|
| **Col VP Contrarian Core, Cl 1** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 223 | $2.82 | to | $2.82 | $631 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 17.65<br> %<br>| to | 17.65<br> %<br>|
| 2024 | 190 | $2.40 | to | $2.40 | $457 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 23.40<br> %<br>| to | 23.40<br> %<br>|
| 2023 | 153 | $1.95 | to | $1.95 | $299 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 32.21<br> %<br>| to | 32.21<br> %<br>|
| 2022 | 105 | $1.47 | to | $1.47 | $155 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (18.65)%<br>| to | (18.65)%<br>|
| 2021 | 60 | $1.81 | to | $1.81 | $108 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 24.28<br> %<br>| to | 24.28<br> %<br>|
| **Col VP Contrarian Core, Cl 2** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 100 | $4.72 | to | $4.72 | $470 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 17.35<br> %<br>| to | 17.35<br> %<br>|
| 2024 | 84 | $4.02 | to | $4.02 | $336 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 23.09<br> %<br>| to | 23.09<br> %<br>|
| 2023 | 62 | $3.27 | to | $3.27 | $201 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 31.89<br> %<br>| to | 31.89<br> %<br>|
| 2022 | 51 | $2.48 | to | $2.48 | $127 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (18.85)%<br>| to | (18.85)%<br>|
| 2021 | 52 | $3.05 | to | $3.05 | $158 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 23.96<br> %<br>| to | 23.96<br> %<br>|
| **Col VP Corporate Bond, Cl 1** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 13 | $1.12 | to | $1.12 | $14 | 4.93<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 7.93<br> %<br>| to | 7.93<br> %<br>|
| 2024 | 6 | $1.04 | to | $1.04 | $7 | 1.72<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 4.15 %<sup>(6)</sup><br>| to | 4.15 %<sup>(6)</sup><br>|
| **Col VP Corporate Bond, Cl 2** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 96 | $1.06 | to | $1.06 | $102 | 6.57<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 7.55<br> %<br>| to | 7.55<br> %<br>|
| 2024 | 95 | $0.99 | to | $0.99 | $94 | 3.11<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 3.30<br> %<br>| to | 3.30<br> %<br>|
| 2023 | 93 | $0.95 | to | $0.95 | $89 | 3.09<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 9.47<br> %<br>| to | 9.47<br> %<br>|
| 2022 | 93 | $0.87 | to | $0.87 | $81 | 3.07<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (13.63)%<br>| to | (13.63)%<br>|
| 2021 | 92 | $1.01 | to | $1.01 | $93 | 3.85<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 1.03<br> %<br>| to | 1.03<br> %<br>|
| **Col VP Corporate Bond, Cl 3** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 890 | $1.24 | to | $1.88 | $1202 | 6.61<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 7.53<br> %<br>| to | 6.77<br> %<br>|
| 2024 | 941 | $1.16 | to | $1.76 | $1198 | 3.22<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 3.05<br> %<br>| to | 2.32<br> %<br>|
| 2023 | 1017 | $1.12 | to | $1.72 | $1265 | 3.20<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 9.59<br> %<br>| to | 8.82<br> %<br>|
| 2022 | 1038 | $1.02 | to | $1.58 | $1185 | 3.32<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 2.78 %<sup>(5)</sup><br>| to | (14.38)%<br>|
| 2021 | 1050 | $1.06 | to | $1.84 | $1395 | 3.84<br> %<br>| 0.30<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 0.84<br> %<br>| to | 0.23<br> %<br>|
| **Col VP Disciplined Core, Cl 1** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 168 | $2.47 | to | $2.47 | $416 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 14.64<br> %<br>| to | 14.64<br> %<br>|
| 2024 | 139 | $2.16 | to | $2.16 | $299 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 26.06<br> %<br>| to | 26.06<br> %<br>|
| 2023 | 96 | $1.71 | to | $1.71 | $165 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 24.36<br> %<br>| to | 24.36<br> %<br>|
| 2022 | 74 | $1.37 | to | $1.37 | $101 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (18.72)%<br>| to | (18.72)%<br>|
| 2021 | 25 | $1.69 | to | $1.69 | $43 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 32.74<br> %<br>| to | 32.74<br> %<br>|
| **Col VP Disciplined Core, Cl 2** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 104 | $5.26 | to | $5.26 | $548 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 14.35<br> %<br>| to | 14.35<br> %<br>|

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**166 ■ RiverSource of New York Account 8**

------

---

| | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **At December 31** | **At December 31** | **At December 31** | **At December 31** | **At December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** |
|  | **Units (000s)** | **Accumulation unit** <br> **value**<br> **lowest to highest**<sup>(1)</sup> | **Accumulation unit** <br> **value**<br> **lowest to highest**<sup>(1)</sup> | **Accumulation unit** <br> **value**<br> **lowest to highest**<sup>(1)</sup> | **Net assets** <br> **(000s)**<br>| **Investment** <br> **income ratio**<sup>(2)</sup><br>| **Expense ratio**<br> **lowest to** <br> **highest**<sup>(3)</sup> | **Expense ratio**<br> **lowest to** <br> **highest**<sup>(3)</sup> | **Expense ratio**<br> **lowest to** <br> **highest**<sup>(3)</sup> | &nbsp;&nbsp; **Total return**<br> **lowest to highest**<sup>(1)</sup><sup>,</sup><sup>(4)</sup> | &nbsp;&nbsp; **Total return**<br> **lowest to highest**<sup>(1)</sup><sup>,</sup><sup>(4)</sup> | &nbsp;&nbsp; **Total return**<br> **lowest to highest**<sup>(1)</sup><sup>,</sup><sup>(4)</sup> |
| 2024 | 118 | $4.60 | to | $4.60 | $542 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 25.73<br> %<br>| to | 25.73<br> %<br>|
| 2023 | 127 | $3.66 | to | $3.66 | $465 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 24.08<br> %<br>| to | 24.08<br> %<br>|
| 2022 | 123 | $2.95 | to | $2.95 | $362 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (18.94)%<br>| to | (18.94)%<br>|
| 2021 | 124 | $3.64 | to | $3.64 | $449 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 32.43<br> %<br>| to | 32.43<br> %<br>|
| **Col VP Disciplined Core, Cl 3** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 7411 | $1.86 | to | $4.20 | $34146 | —<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 14.26<br> %<br>| to | 13.46<br> %<br>|
| 2024 | 8049 | $1.63 | to | $3.70 | $32794 | —<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 25.65<br> %<br>| to | 24.76<br> %<br>|
| 2023 | 8714 | $1.30 | to | $2.97 | $28607 | —<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 23.98<br> %<br>| to | 23.12<br> %<br>|
| 2022 | 9379 | $1.05 | to | $2.41 | $25011 | —<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 5.12 %<sup>(5)</sup><br>| to | (19.56)%<br>|
| 2021 | 9994 | $3.02 | to | $3.00 | $32947 | —<br> %<br>| 0.30<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 32.17<br> %<br>| to | 31.38<br> %<br>|
| **Col VP Divd Opp, Cl 1** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 405 | $1.98 | to | $1.98 | $802 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 15.83<br> %<br>| to | 15.83<br> %<br>|
| 2024 | 309 | $1.71 | to | $1.71 | $528 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 15.42<br> %<br>| to | 15.42<br> %<br>|
| 2023 | 89 | $1.48 | to | $1.48 | $131 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 5.09<br> %<br>| to | 5.09<br> %<br>|
| 2022 | 79 | $1.41 | to | $1.41 | $111 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (1.11)%<br>| to | (1.11)%<br>|
| 2021 | 57 | $1.42 | to | $1.42 | $81 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 26.16<br> %<br>| to | 26.16<br> %<br>|
| **Col VP Divd Opp, Cl 2** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 114 | $3.53 | to | $3.53 | $403 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 15.56<br> %<br>| to | 15.56<br> %<br>|
| 2024 | 106 | $3.05 | to | $3.05 | $323 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 15.12<br> %<br>| to | 15.12<br> %<br>|
| 2023 | 89 | $2.65 | to | $2.65 | $236 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 4.84<br> %<br>| to | 4.84<br> %<br>|
| 2022 | 60 | $2.53 | to | $2.53 | $152 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (1.39)%<br>| to | (1.39)%<br>|
| 2021 | 44 | $2.57 | to | $2.57 | $113 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 25.89<br> %<br>| to | 25.89<br> %<br>|
| **Col VP Divd Opp, Cl 3** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 3316 | $1.55 | to | $5.69 | $13971 | —<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 15.45<br> %<br>| to | 14.64<br> %<br>|
| 2024 | 3114 | $1.35 | to | $4.96 | $12854 | —<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 15.04<br> %<br>| to | 14.24<br> %<br>|
| 2023 | 3106 | $1.17 | to | $4.34 | $12144 | —<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 4.74<br> %<br>| to | 4.02<br> %<br>|
| 2022 | 3286 | $1.12 | to | $4.18 | $12375 | —<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 12.24 %<sup>(5)</sup><br>| to | (2.12)%<br>|
| 2021 | 3425 | $2.13 | to | $4.27 | $13121 | —<br> %<br>| 0.30<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 25.64<br> %<br>| to | 24.89<br> %<br>|
| **Col VP Emer Mkts, Cl 1** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 265 | $1.49 | to | $1.49 | $394 | 0.26<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 31.18<br> %<br>| to | 31.18<br> %<br>|
| 2024 | 222 | $1.13 | to | $1.13 | $252 | 1.17<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 5.68<br> %<br>| to | 5.68<br> %<br>|
| 2023 | 197 | $1.07 | to | $1.07 | $211 | 0.11<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 9.46<br> %<br>| to | 9.46<br> %<br>|
| 2022 | 171 | $0.98 | to | $0.98 | $168 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (32.90)%<br>| to | (32.90)%<br>|
| 2021 | 77 | $1.46 | to | $1.46 | $112 | 0.92<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (7.20)%<br>| to | (7.20)%<br>|
| **Col VP Emer Mkts, Cl 2** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 263 | $1.83 | to | $1.83 | $482 | 0.06<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 30.87<br> %<br>| to | 30.87<br> %<br>|
| 2024 | 270 | $1.40 | to | $1.40 | $378 | 0.99<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 5.45<br> %<br>| to | 5.45<br> %<br>|
| 2023 | 263 | $1.33 | to | $1.33 | $350 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 9.19<br> %<br>| to | 9.19<br> %<br>|
| 2022 | 253 | $1.22 | to | $1.22 | $308 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (33.07)%<br>| to | (33.07)%<br>|
| 2021 | 250 | $1.82 | to | $1.82 | $455 | 0.85<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (7.47)%<br>| to | (7.47)%<br>|
| **Col VP Emer Mkts, Cl 3** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 759 | $1.58 | to | $4.77 | $2359 | 0.17<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 30.76<br> %<br>| to | 29.85<br> %<br>|
| 2024 | 726 | $1.21 | to | $3.67 | $1855 | 1.14<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 5.29<br> %<br>| to | 4.55<br> %<br>|
| 2023 | 768 | $1.15 | to | $3.51 | $1917 | —<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 9.09<br> %<br>| to | 8.33<br> %<br>|
| 2022 | 829 | $1.05 | to | $3.24 | $1880 | —<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 6.78 %<sup>(5)</sup><br>| to | (33.58)%<br>|
| 2021 | 848 | $1.80 | to | $4.88 | $2927 | 0.99<br> %<br>| 0.30<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp; (7.61)%<br>| to | (8.16)%<br>|
| **Col VP Emerg Mkts Bond, Cl 1** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 44 | $1.24 | to | $1.24 | $54 | 5.51<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 12.79<br> %<br>| to | 12.79<br> %<br>|
| 2024 | 35 | $1.10 | to | $1.10 | $38 | 5.29<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 6.39<br> %<br>| to | 6.39<br> %<br>|
| 2023 | 30 | $1.03 | to | $1.03 | $31 | 5.72<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 10.43<br> %<br>| to | 10.43<br> %<br>|
| 2022 | 23 | $0.94 | to | $0.94 | $21 | 5.56<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (16.03)%<br>| to | (16.03)%<br>|
| 2021 | 2 | $1.11 | to | $1.11 | $2 | 4.23<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (2.20)%<br>| to | (2.20)%<br>|
| **Col VP Emerg Mkts Bond, Cl 2** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 13 | $1.49 | to | $1.49 | $19 | 5.16<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 12.65<br> %<br>| to | 12.65<br> %<br>|

---

**RiverSource of New York Account 8** ■ 167

------

---

| | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **At December 31** | **At December 31** | **At December 31** | **At December 31** | **At December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** |
|  | **Units (000s)** | **Accumulation unit** <br> **value**<br> **lowest to highest**<sup>(1)</sup> | **Accumulation unit** <br> **value**<br> **lowest to highest**<sup>(1)</sup> | **Accumulation unit** <br> **value**<br> **lowest to highest**<sup>(1)</sup> | **Net assets** <br> **(000s)**<br>| **Investment** <br> **income ratio**<sup>(2)</sup><br>| **Expense ratio**<br> **lowest to** <br> **highest**<sup>(3)</sup> | **Expense ratio**<br> **lowest to** <br> **highest**<sup>(3)</sup> | **Expense ratio**<br> **lowest to** <br> **highest**<sup>(3)</sup> | &nbsp;&nbsp; **Total return**<br> **lowest to highest**<sup>(1)</sup><sup>,</sup><sup>(4)</sup> | &nbsp;&nbsp; **Total return**<br> **lowest to highest**<sup>(1)</sup><sup>,</sup><sup>(4)</sup> | &nbsp;&nbsp; **Total return**<br> **lowest to highest**<sup>(1)</sup><sup>,</sup><sup>(4)</sup> |
| 2024 | 13 | $1.33 | to | $1.33 | $17 | 4.96<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 6.13<br> %<br>| to | 6.13<br> %<br>|
| 2023 | 12 | $1.25 | to | $1.25 | $15 | 4.98<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 10.02<br> %<br>| to | 10.02<br> %<br>|
| 2022 | 18 | $1.13 | to | $1.13 | $20 | 4.21<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (16.16)%<br>| to | (16.16)%<br>|
| 2021 | 16 | $1.35 | to | $1.35 | $22 | 3.66<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (2.45)%<br>| to | (2.45)%<br>|
| **Col VP Govt Money Mkt, Cl 1** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 592 | $1.18 | to | $1.18 | $698 | 3.88<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 3.98<br> %<br>| to | 3.98<br> %<br>|
| 2024 | 438 | $1.13 | to | $1.13 | $497 | 4.85<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 5.00<br> %<br>| to | 5.00<br> %<br>|
| 2023 | 520 | $1.08 | to | $1.08 | $562 | 4.69<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 4.73<br> %<br>| to | 4.73<br> %<br>|
| 2022 | 162 | $1.03 | to | $1.03 | $167 | 1.82<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 1.20<br> %<br>| to | 1.20<br> %<br>|
| 2021 | 44 | $1.02 | to | $1.02 | $45 | 0.01<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 0.01<br> %<br>| to | 0.01<br> %<br>|
| **Col VP Govt Money Mkt, Cl 2** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 445 | $1.19 | to | $1.19 | $528 | 3.64<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 3.71<br> %<br>| to | 3.71<br> %<br>|
| 2024 | 432 | $1.14 | to | $1.14 | $495 | 4.58<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 4.74<br> %<br>| to | 4.74<br> %<br>|
| 2023 | 370 | $1.09 | to | $1.09 | $404 | 4.37<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 4.46<br> %<br>| to | 4.46<br> %<br>|
| 2022 | 488 | $1.05 | to | $1.05 | $510 | 1.03<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 1.10<br> %<br>| to | 1.10<br> %<br>|
| 2021 | 476 | $1.03 | to | $1.03 | $492 | 0.01<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 0.02<br> %<br>| to | 0.02<br> %<br>|
| **Col VP Govt Money Mkt, Cl 3** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 3236 | $1.18 | to | $1.16 | $3668 | 3.77<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 3.63<br> %<br>| to | 2.91<br> %<br>|
| 2024 | 3377 | $1.13 | to | $1.13 | $3693 | 4.71<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 4.66<br> %<br>| to | 3.92<br> %<br>|
| 2023 | 2522 | $1.08 | to | $1.09 | $2635 | 4.51<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 4.39<br> %<br>| to | 3.66<br> %<br>|
| 2022 | 2647 | $1.04 | to | $1.05 | $2660 | 1.16<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 0.96<br> %<br>| to | 0.26<br> %<br>|
| 2021 | 2737 | $1.03 | to | $1.05 | $2734 | 0.01<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp; (0.17)%<br>| to | (0.86)%<br>|
| **Col VP Hi Yield Bond, Cl 1** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 287 | $1.44 | to | $1.44 | $412 | 6.14<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 8.81<br> %<br>| to | 8.81<br> %<br>|
| 2024 | 170 | $1.32 | to | $1.32 | $225 | 5.85<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 7.04<br> %<br>| to | 7.04<br> %<br>|
| 2023 | 99 | $1.24 | to | $1.24 | $122 | 5.24<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 12.19<br> %<br>| to | 12.19<br> %<br>|
| 2022 | 62 | $1.10 | to | $1.10 | $68 | 5.76<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (10.54)%<br>| to | (10.54)%<br>|
| 2021 | 22 | $1.23 | to | $1.23 | $27 | 4.97<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 4.98<br> %<br>| to | 4.98<br> %<br>|
| **Col VP Hi Yield Bond, Cl 2** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 212 | $1.90 | to | $1.90 | $402 | 5.94<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 8.50<br> %<br>| to | 8.50<br> %<br>|
| 2024 | 211 | $1.75 | to | $1.75 | $368 | 5.71<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 6.88<br> %<br>| to | 6.88<br> %<br>|
| 2023 | 195 | $1.64 | to | $1.64 | $319 | 5.30<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 11.87<br> %<br>| to | 11.87<br> %<br>|
| 2022 | 193 | $1.46 | to | $1.46 | $283 | 5.05<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (10.78)%<br>| to | (10.78)%<br>|
| 2021 | 189 | $1.64 | to | $1.64 | $310 | 4.84<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 4.79<br> %<br>| to | 4.79<br> %<br>|
| **Col VP Hi Yield Bond, Cl 3** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 1097 | $1.32 | to | $3.69 | $2784 | 6.06<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 8.33<br> %<br>| to | 7.57<br> %<br>|
| 2024 | 996 | $1.22 | to | $3.43 | $2584 | 5.66<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 6.74<br> %<br>| to | 5.98<br> %<br>|
| 2023 | 1051 | $1.14 | to | $3.24 | $2638 | 5.42<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 11.86<br> %<br>| to | 11.08<br> %<br>|
| 2022 | 1041 | $1.02 | to | $2.92 | $2419 | 5.10<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 2.27 %<sup>(5)</sup><br>| to | (11.50)%<br>|
| 2021 | 1113 | $1.53 | to | $3.30 | $2890 | 4.98<br> %<br>| 0.30<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 4.55<br> %<br>| to | 3.92<br> %<br>|
| **Col VP Inc Opp, Cl 1** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 22 | $1.40 | to | $1.40 | $30 | 1.86<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 8.78<br> %<br>| to | 8.78<br> %<br>|
| 2024 | 21 | $1.29 | to | $1.29 | $27 | 5.46<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 5.90<br> %<br>| to | 5.90<br> %<br>|
| 2023 | 18 | $1.22 | to | $1.22 | $22 | 5.21<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 11.56<br> %<br>| to | 11.56<br> %<br>|
| 2022 | 17 | $1.09 | to | $1.09 | $18 | 5.62<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (10.01)%<br>| to | (10.01)%<br>|
| 2021 | 15 | $1.21 | to | $1.21 | $18 | 9.06<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 4.50<br> %<br>| to | 4.50<br> %<br>|
| **Col VP Inc Opp, Cl 2** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 49 | $1.82 | to | $1.82 | $89 | 1.80<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 8.43<br> %<br>| to | 8.43<br> %<br>|
| 2024 | 53 | $1.68 | to | $1.68 | $89 | 5.28<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 5.71<br> %<br>| to | 5.71<br> %<br>|
| 2023 | 50 | $1.59 | to | $1.59 | $80 | 5.57<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 11.36<br> %<br>| to | 11.36<br> %<br>|
| 2022 | 31 | $1.43 | to | $1.43 | $44 | 4.99<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (10.22)%<br>| to | (10.22)%<br>|
| 2021 | 20 | $1.59 | to | $1.59 | $31 | 7.51<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 4.14<br> %<br>| to | 4.14<br> %<br>|
| **Col VP Inc Opp, Cl 3** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 584 | $1.30 | to | $2.62 | $1253 | 1.88<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 8.37<br> %<br>| to | 7.60<br> %<br>|

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**168 ■ RiverSource of New York Account 8**

------

---

| | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **At December 31** | **At December 31** | **At December 31** | **At December 31** | **At December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** |
|  | **Units (000s)** | **Accumulation unit** <br> **value**<br> **lowest to highest**<sup>(1)</sup> | **Accumulation unit** <br> **value**<br> **lowest to highest**<sup>(1)</sup> | **Accumulation unit** <br> **value**<br> **lowest to highest**<sup>(1)</sup> | **Net assets** <br> **(000s)**<br>| **Investment** <br> **income ratio**<sup>(2)</sup><br>| **Expense ratio**<br> **lowest to** <br> **highest**<sup>(3)</sup> | **Expense ratio**<br> **lowest to** <br> **highest**<sup>(3)</sup> | **Expense ratio**<br> **lowest to** <br> **highest**<sup>(3)</sup> | &nbsp;&nbsp; **Total return**<br> **lowest to highest**<sup>(1)</sup><sup>,</sup><sup>(4)</sup> | &nbsp;&nbsp; **Total return**<br> **lowest to highest**<sup>(1)</sup><sup>,</sup><sup>(4)</sup> | &nbsp;&nbsp; **Total return**<br> **lowest to highest**<sup>(1)</sup><sup>,</sup><sup>(4)</sup> |
| 2024 | 622 | $1.20 | to | $2.43 | $1256 | 5.52<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 5.69<br> %<br>| to | 4.94<br> %<br>|
| 2023 | 534 | $1.14 | to | $2.32 | $1083 | 5.04<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 11.29<br> %<br>| to | 10.51<br> %<br>|
| 2022 | 536 | $1.02 | to | $2.10 | $1015 | 5.25<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 2.16 %<sup>(5)</sup><br>| to | (11.02)%<br>|
| 2021 | 554 | $1.50 | to | $2.36 | $1182 | 8.90<br> %<br>| 0.30<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 4.16<br> %<br>| to | 3.54<br> %<br>|
| **Col VP Inter Bond, Cl 1** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 229 | $1.18 | to | $1.18 | $271 | 5.61<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 9.06<br> %<br>| to | 9.06<br> %<br>|
| 2024 | 107 | $1.08 | to | $1.08 | $116 | 5.17<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 1.97<br> %<br>| to | 1.97<br> %<br>|
| 2023 | 82 | $1.06 | to | $1.06 | $87 | 2.48<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 6.34<br> %<br>| to | 6.34<br> %<br>|
| 2022 | 56 | $1.00 | to | $1.00 | $56 | 3.29<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (17.06)%<br>| to | (17.06)%<br>|
| 2021 | 40 | $1.21 | to | $1.21 | $48 | 3.30<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (0.24)%<br>| to | (0.24)%<br>|
| **Col VP Inter Bond, Cl 2** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 79 | $1.32 | to | $1.32 | $104 | 5.67<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 8.84<br> %<br>| to | 8.84<br> %<br>|
| 2024 | 54 | $1.21 | to | $1.21 | $66 | 4.92<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 1.73<br> %<br>| to | 1.73<br> %<br>|
| 2023 | 46 | $1.19 | to | $1.19 | $55 | 2.13<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 6.08<br> %<br>| to | 6.08<br> %<br>|
| 2022 | 37 | $1.12 | to | $1.12 | $42 | 2.44<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (17.22)%<br>| to | (17.22)%<br>|
| 2021 | 49 | $1.36 | to | $1.36 | $66 | 3.01<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (0.58)%<br>| to | (0.58)%<br>|
| **Col VP Inter Bond, Cl 3** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 3526 | $1.19 | to | $2.00 | $5886 | 5.32<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 8.82<br> %<br>| to | 8.06<br> %<br>|
| 2024 | 3644 | $1.09 | to | $1.85 | $5767 | 4.73<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 1.64<br> %<br>| to | 0.93<br> %<br>|
| 2023 | 3460 | $1.08 | to | $1.83 | $5536 | 2.20<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 5.98<br> %<br>| to | 5.24<br> %<br>|
| 2022 | 3592 | $1.02 | to | $1.74 | $5476 | 3.08<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 1.80 %<sup>(5)</sup><br>| to | (17.91)%<br>|
| 2021 | 3718 | $1.37 | to | $2.12 | $6924 | 3.19<br> %<br>| 0.30<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp; (0.65)%<br>| to | (1.25)%<br>|
| **Col VP Lg Cap Gro, Cl 1** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 1387 | $3.11 | to | $3.11 | $4313 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 16.14<br> %<br>| to | 16.14<br> %<br>|
| 2024 | 1064 | $2.68 | to | $2.68 | $2849 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 31.33<br> %<br>| to | 31.33<br> %<br>|
| 2023 | 829 | $2.04 | to | $2.04 | $1690 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 43.16<br> %<br>| to | 43.16<br> %<br>|
| 2022 | 514 | $1.42 | to | $1.42 | $731 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (31.38)%<br>| to | (31.38)%<br>|
| 2021 | 167 | $2.07 | to | $2.07 | $346 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 28.73<br> %<br>| to | 28.73<br> %<br>|
| **Col VP Lg Cap Gro, Cl 2** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 107 | $6.82 | to | $6.82 | $729 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 15.85<br> %<br>| to | 15.85<br> %<br>|
| 2024 | 109 | $5.88 | to | $5.88 | $640 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 31.01<br> %<br>| to | 31.01<br> %<br>|
| 2023 | 105 | $4.49 | to | $4.49 | $470 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 42.77<br> %<br>| to | 42.77<br> %<br>|
| 2022 | 95 | $3.15 | to | $3.15 | $298 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (31.53)%<br>| to | (31.53)%<br>|
| 2021 | 85 | $4.59 | to | $4.59 | $392 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 28.35<br> %<br>| to | 28.35<br> %<br>|
| **Col VP Lg Cap Gro, Cl 3** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 711 | $2.19 | to | $4.36 | $4159 | —<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 15.75<br> %<br>| to | 14.94<br> %<br>|
| 2024 | 693 | $1.89 | to | $3.79 | $3746 | —<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 30.93<br> %<br>| to | 30.01<br> %<br>|
| 2023 | 703 | $1.45 | to | $2.91 | $3402 | —<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 42.66<br> %<br>| to | 41.67<br> %<br>|
| 2022 | 761 | $1.01 | to | $2.06 | $2585 | —<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 2.68 %<sup>(5)</sup><br>| to | (32.06)%<br>|
| 2021 | 809 | $3.90 | to | $3.03 | $3968 | —<br> %<br>| 0.30<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 28.15<br> %<br>| to | 27.39<br> %<br>|
| **Col VP Lg Cap Index, Cl 1** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 4716 | $2.68 | to | $2.68 | $12654 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 17.58<br> %<br>| to | 17.58<br> %<br>|
| 2024 | 3730 | $2.28 | to | $2.28 | $8512 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 24.70<br> %<br>| to | 24.70<br> %<br>|
| 2023 | 2812 | $1.83 | to | $1.83 | $5146 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 25.96<br> %<br>| to | 25.96<br> %<br>|
| 2022 | 1730 | $1.45 | to | $1.45 | $2514 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (18.34)%<br>| to | (18.34)%<br>|
| 2021 | 791 | $1.78 | to | $1.78 | $1407 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 28.39<br> %<br>| to | 28.39<br> %<br>|
| **Col VP Lg Cap Index, Cl 3** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 3187 | $5.67 | to | $5.71 | $18706 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 17.42<br> %<br>| to | 16.37<br> %<br>|
| 2024 | 2986 | $4.83 | to | $4.91 | $16441 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 24.54<br> %<br>| to | 23.42<br> %<br>|
| 2023 | 3051 | $3.88 | to | $3.98 | $14291 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 25.81<br> %<br>| to | 24.69<br> %<br>|
| 2022 | 3028 | $3.08 | to | $3.19 | $11465 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp; (18.45)%<br>| to | (19.18)%<br>|
| 2021 | 3012 | $3.78 | to | $3.95 | $14197 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 28.22<br> %<br>| to | 27.07<br> %<br>|
| **Col VP Limited Duration Cr, Cl 1** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 84 | $1.25 | to | $1.25 | $105 | 8.32<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 6.35<br> %<br>| to | 6.35<br> %<br>|

---

**RiverSource of New York Account 8** ■ 169

------

---

| | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **At December 31** | **At December 31** | **At December 31** | **At December 31** | **At December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** |
|  | **Units (000s)** | **Accumulation unit** <br> **value**<br> **lowest to highest**<sup>(1)</sup> | **Accumulation unit** <br> **value**<br> **lowest to highest**<sup>(1)</sup> | **Accumulation unit** <br> **value**<br> **lowest to highest**<sup>(1)</sup> | **Net assets** <br> **(000s)**<br>| **Investment** <br> **income ratio**<sup>(2)</sup><br>| **Expense ratio**<br> **lowest to** <br> **highest**<sup>(3)</sup> | **Expense ratio**<br> **lowest to** <br> **highest**<sup>(3)</sup> | **Expense ratio**<br> **lowest to** <br> **highest**<sup>(3)</sup> | &nbsp;&nbsp; **Total return**<br> **lowest to highest**<sup>(1)</sup><sup>,</sup><sup>(4)</sup> | &nbsp;&nbsp; **Total return**<br> **lowest to highest**<sup>(1)</sup><sup>,</sup><sup>(4)</sup> | &nbsp;&nbsp; **Total return**<br> **lowest to highest**<sup>(1)</sup><sup>,</sup><sup>(4)</sup> |
| 2024 | 38 | $1.17 | to | $1.17 | $44 | 4.54<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 4.75<br> %<br>| to | 4.75<br> %<br>|
| 2023 | 20 | $1.12 | to | $1.12 | $22 | 3.31<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 6.89<br> %<br>| to | 6.89<br> %<br>|
| 2022 | 17 | $1.05 | to | $1.05 | $18 | 0.75<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (6.08)%<br>| to | (6.08)%<br>|
| 2021 | 9 | $1.12 | to | $1.12 | $11 | 0.21<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (0.60)%<br>| to | (0.60)%<br>|
| **Col VP Limited Duration Cr, Cl 2** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 784 | $1.33 | to | $1.12 | $925 | 6.12<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 6.01<br> %<br>| to | 5.05<br> %<br>|
| 2024 | 795 | $1.25 | to | $1.06 | $883 | 3.62<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 4.63<br> %<br>| to | 3.69<br> %<br>|
| 2023 | 820 | $1.20 | to | $1.03 | $875 | 2.34<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 6.66<br> %<br>| to | 5.70<br> %<br>|
| 2022 | 1388 | $1.12 | to | $0.97 | $1459 | 0.39<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp; (6.36)%<br>| to | (7.20)%<br>|
| 2021 | 636 | $1.20 | to | $1.05 | $681 | 1.39<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp; (0.84)%<br>| to | (1.74)%<br>|
| **Col VP Long Govt/Cr Bond, Cl 1** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 35 | $1.05 | to | $1.05 | $36 | 11.56<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 6.24<br> %<br>| to | 6.24<br> %<br>|
| 2024 | 11 | $0.98 | to | $0.98 | $10 | 3.92<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (4.14)%<br>| to | (4.14)%<br>|
| 2023 | 10 | $1.03 | to | $1.03 | $10 | 3.45<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 6.97<br> %<br>| to | 6.97<br> %<br>|
| 2022 | 11 | $0.96 | to | $0.96 | $11 | 3.53<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (27.55)%<br>| to | (27.55)%<br>|
| 2021 | 3 | $1.33 | to | $1.33 | $3 | 2.54<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (3.21)%<br>| to | (3.21)%<br>|
| **Col VP Long Govt/Cr Bond, Cl 2** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 0 | $1.19 | to | $1.19 | $1 | 8.62<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 5.98<br> %<br>| to | 5.98<br> %<br>|
| 2024 | 1 | $1.12 | to | $1.12 | $1 | 4.91<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (4.39)%<br>| to | (4.39)%<br>|
| 2023 | 7 | $1.18 | to | $1.18 | $9 | 3.12<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 6.68<br> %<br>| to | 6.68<br> %<br>|
| 2022 | 7 | $1.10 | to | $1.10 | $8 | 2.49<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (27.70)%<br>| to | (27.70)%<br>|
| 2021 | 6 | $1.53 | to | $1.53 | $10 | 1.75<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (3.47)%<br>| to | (3.47)%<br>|
| **Col VP Overseas Core, Cl 1** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 520 | $1.90 | to | $1.90 | $987 | 1.66<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 38.26<br> %<br>| to | 38.26<br> %<br>|
| 2024 | 384 | $1.37 | to | $1.37 | $528 | 3.29<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 3.45<br> %<br>| to | 3.45<br> %<br>|
| 2023 | 170 | $1.33 | to | $1.33 | $225 | 1.79<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 15.64<br> %<br>| to | 15.64<br> %<br>|
| 2022 | 140 | $1.15 | to | $1.15 | $161 | 0.61<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (14.68)%<br>| to | (14.68)%<br>|
| 2021 | 58 | $1.35 | to | $1.35 | $78 | 1.39<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 9.96<br> %<br>| to | 9.96<br> %<br>|
| **Col VP Overseas Core, Cl 2** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 99 | $2.51 | to | $2.51 | $250 | 1.69<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 37.86<br> %<br>| to | 37.86<br> %<br>|
| 2024 | 108 | $1.82 | to | $1.82 | $197 | 4.10<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 3.24<br> %<br>| to | 3.24<br> %<br>|
| 2023 | 103 | $1.77 | to | $1.77 | $183 | 1.71<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 15.32<br> %<br>| to | 15.32<br> %<br>|
| 2022 | 101 | $1.53 | to | $1.53 | $154 | 0.73<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (14.90)%<br>| to | (14.90)%<br>|
| 2021 | 94 | $1.80 | to | $1.80 | $170 | 1.10<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 9.74<br> %<br>| to | 9.74<br> %<br>|
| **Col VP Overseas Core, Cl 3** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 3074 | $1.88 | to | $1.87 | $6205 | 1.76<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 37.82<br> %<br>| to | 36.87<br> %<br>|
| 2024 | 3144 | $1.36 | to | $1.36 | $4624 | 4.25<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 3.14<br> %<br>| to | 2.41<br> %<br>|
| 2023 | 3265 | $1.32 | to | $1.33 | $4688 | 1.82<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 15.24<br> %<br>| to | 14.44<br> %<br>|
| 2022 | 3464 | $1.14 | to | $1.16 | $4341 | 0.79<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 15.40 %<sup>(5)</sup><br>| to | (15.56)%<br>|
| 2021 | 3611 | $1.55 | to | $1.38 | $5339 | 1.18<br> %<br>| 0.30<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 9.55<br> %<br>| to | 8.90<br> %<br>|
| **Col VP Sel Gbl Tech, Cl 1** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 270 | $2.14 | to | $2.14 | $578 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 34.73<br> %<br>| to | 34.73<br> %<br>|
| 2024 | 231 | $1.59 | to | $1.59 | $368 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 26.91<br> %<br>| to | 26.91<br> %<br>|
| 2023 | 147 | $1.25 | to | $1.25 | $184 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 45.28<br> %<br>| to | 45.28<br> %<br>|
| 2022 | 71 | $0.86 | to | $0.86 | $61 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (15.48 )%<sup>(7)</sup><br>| to | (15.48 )%<sup>(7)</sup><br>|
| **Col VP Sel Gbl Tech, Cl 2** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 98 | $2.12 | to | $2.12 | $207 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 34.37<br> %<br>| to | 34.37<br> %<br>|
| 2024 | 65 | $1.58 | to | $1.58 | $103 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 26.58<br> %<br>| to | 26.58<br> %<br>|
| 2023 | 33 | $1.25 | to | $1.25 | $41 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 44.87<br> %<br>| to | 44.87<br> %<br>|
| 2022 | 2 | $0.86 | to | $0.86 | $2 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (15.57 )%<sup>(7)</sup><br>| to | (15.57 )%<sup>(7)</sup><br>|
| **Col VP Select Lg Cap Val, Cl 1** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 607 | $2.28 | to | $2.28 | $1381 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 28.27<br> %<br>| to | 28.27<br> %<br>|
| 2024 | 507 | $1.77 | to | $1.77 | $899 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 12.87<br> %<br>| to | 12.87<br> %<br>|
| 2023 | 419 | $1.57 | to | $1.57 | $659 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 5.39<br> %<br>| to | 5.39<br> %<br>|

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**170 ■ RiverSource of New York Account 8**

------

---

| | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **At December 31** | **At December 31** | **At December 31** | **At December 31** | **At December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** |
|  | **Units (000s)** | **Accumulation unit** <br> **value**<br> **lowest to highest**<sup>(1)</sup> | **Accumulation unit** <br> **value**<br> **lowest to highest**<sup>(1)</sup> | **Accumulation unit** <br> **value**<br> **lowest to highest**<sup>(1)</sup> | **Net assets** <br> **(000s)**<br>| **Investment** <br> **income ratio**<sup>(2)</sup><br>| **Expense ratio**<br> **lowest to** <br> **highest**<sup>(3)</sup> | **Expense ratio**<br> **lowest to** <br> **highest**<sup>(3)</sup> | **Expense ratio**<br> **lowest to** <br> **highest**<sup>(3)</sup> | &nbsp;&nbsp; **Total return**<br> **lowest to highest**<sup>(1)</sup><sup>,</sup><sup>(4)</sup> | &nbsp;&nbsp; **Total return**<br> **lowest to highest**<sup>(1)</sup><sup>,</sup><sup>(4)</sup> | &nbsp;&nbsp; **Total return**<br> **lowest to highest**<sup>(1)</sup><sup>,</sup><sup>(4)</sup> |
| 2022 | 238 | $1.49 | to | $1.49 | $355 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (1.84)%<br>| to | (1.84)%<br>|
| 2021 | 70 | $1.52 | to | $1.52 | $106 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 26.29<br> %<br>| to | 26.29<br> %<br>|
| **Col VP Select Lg Cap Val, Cl 2** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 55 | $4.72 | to | $4.72 | $259 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 27.97<br> %<br>| to | 27.97<br> %<br>|
| 2024 | 55 | $3.68 | to | $3.68 | $204 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 12.58<br> %<br>| to | 12.58<br> %<br>|
| 2023 | 44 | $3.27 | to | $3.27 | $146 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 5.11<br> %<br>| to | 5.11<br> %<br>|
| 2022 | 39 | $3.11 | to | $3.11 | $121 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (2.06)%<br>| to | (2.06)%<br>|
| 2021 | 34 | $3.18 | to | $3.18 | $107 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 25.98<br> %<br>| to | 25.98<br> %<br>|
| **Col VP Select Lg Cap Val, Cl 3** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 236 | $1.68 | to | $4.66 | $945 | —<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 27.85<br> %<br>| to | 26.95<br> %<br>|
| 2024 | 186 | $1.32 | to | $3.67 | $774 | —<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 12.53<br> %<br>| to | 11.74<br> %<br>|
| 2023 | 264 | $1.17 | to | $3.29 | $911 | —<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 5.02<br> %<br>| to | 4.29<br> %<br>|
| 2022 | 283 | $1.11 | to | $3.15 | $940 | —<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 12.68 %<sup>(5)</sup><br>| to | (2.83)%<br>|
| 2021 | 276 | $2.41 | to | $3.24 | $928 | —<br> %<br>| 0.30<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 25.77<br> %<br>| to | 25.02<br> %<br>|
| **Col VP Select Mid Cap Gro, Cl 1** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 308 | $2.27 | to | $2.27 | $698 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 15.14<br> %<br>| to | 15.14<br> %<br>|
| 2024 | 266 | $1.97 | to | $1.97 | $524 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 23.68<br> %<br>| to | 23.68<br> %<br>|
| 2023 | 197 | $1.59 | to | $1.59 | $313 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 25.24<br> %<br>| to | 25.24<br> %<br>|
| 2022 | 160 | $1.27 | to | $1.27 | $203 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (30.83)%<br>| to | (30.83)%<br>|
| 2021 | 78 | $1.84 | to | $1.84 | $143 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 16.57<br> %<br>| to | 16.57<br> %<br>|
| **Col VP Select Mid Cap Gro, Cl 2** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 32 | $4.51 | to | $4.51 | $144 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 14.86<br> %<br>| to | 14.86<br> %<br>|
| 2024 | 31 | $3.92 | to | $3.92 | $122 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 23.37<br> %<br>| to | 23.37<br> %<br>|
| 2023 | 30 | $3.18 | to | $3.18 | $95 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 24.92<br> %<br>| to | 24.92<br> %<br>|
| 2022 | 27 | $2.55 | to | $2.55 | $70 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (31.01)%<br>| to | (31.01)%<br>|
| 2021 | 30 | $3.69 | to | $3.69 | $109 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 16.27<br> %<br>| to | 16.27<br> %<br>|
| **Col VP Select Mid Cap Gro, Cl 3** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 311 | $1.78 | to | $6.16 | $1348 | —<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 14.77<br> %<br>| to | 13.97<br> %<br>|
| 2024 | 296 | $1.55 | to | $5.40 | $1200 | —<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 23.28<br> %<br>| to | 22.41<br> %<br>|
| 2023 | 256 | $1.26 | to | $4.41 | $1030 | —<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 24.84<br> %<br>| to | 23.97<br> %<br>|
| 2022 | 220 | $1.01 | to | $3.56 | $804 | —<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 2.87 %<sup>(5)</sup><br>| to | (31.54)%<br>|
| 2021 | 245 | $3.04 | to | $5.20 | $1252 | —<br> %<br>| 0.30<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 16.06<br> %<br>| to | 15.36<br> %<br>|
| **Col VP Select Mid Cap Val, Cl 1** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 306 | $2.05 | to | $2.05 | $627 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 14.18<br> %<br>| to | 14.18<br> %<br>|
| 2024 | 259 | $1.80 | to | $1.80 | $465 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 12.54<br> %<br>| to | 12.54<br> %<br>|
| 2023 | 182 | $1.60 | to | $1.60 | $290 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 10.30<br> %<br>| to | 10.30<br> %<br>|
| 2022 | 139 | $1.45 | to | $1.45 | $201 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (9.44)%<br>| to | (9.44)%<br>|
| 2021 | 41 | $1.60 | to | $1.60 | $66 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 32.33<br> %<br>| to | 32.33<br> %<br>|
| **Col VP Select Mid Cap Val, Cl 2** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 52 | $3.97 | to | $3.97 | $204 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 13.87<br> %<br>| to | 13.87<br> %<br>|
| 2024 | 51 | $3.48 | to | $3.48 | $179 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 12.27<br> %<br>| to | 12.27<br> %<br>|
| 2023 | 51 | $3.10 | to | $3.10 | $158 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 10.05<br> %<br>| to | 10.05<br> %<br>|
| 2022 | 47 | $2.82 | to | $2.82 | $133 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (9.66)%<br>| to | (9.66)%<br>|
| 2021 | 39 | $3.12 | to | $3.12 | $123 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 31.97<br> %<br>| to | 31.97<br> %<br>|
| **Col VP Select Mid Cap Val, Cl 3** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 334 | $1.52 | to | $3.86 | $1071 | —<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 13.78<br> %<br>| to | 12.99<br> %<br>|
| 2024 | 286 | $1.34 | to | $3.41 | $989 | —<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 12.18<br> %<br>| to | 11.40<br> %<br>|
| 2023 | 250 | $1.19 | to | $3.06 | $906 | —<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 9.96<br> %<br>| to | 9.20<br> %<br>|
| 2022 | 216 | $1.08 | to | $2.80 | $800 | —<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 9.03 %<sup>(5)</sup><br>| to | (10.37)%<br>|
| 2021 | 224 | $2.35 | to | $3.13 | $938 | —<br> %<br>| 0.30<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 31.74<br> %<br>| to | 30.95<br> %<br>|
| **Col VP Select Sm Cap Val, Cl 1** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 146 | $1.69 | to | $1.69 | $247 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 6.59<br> %<br>| to | 6.59<br> %<br>|
| 2024 | 105 | $1.59 | to | $1.59 | $166 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 13.93<br> %<br>| to | 13.93<br> %<br>|
| 2023 | 71 | $1.39 | to | $1.39 | $99 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 13.14<br> %<br>| to | 13.14<br> %<br>|

---

**RiverSource of New York Account 8** ■ 171

------

---

| | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **At December 31** | **At December 31** | **At December 31** | **At December 31** | **At December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** |
|  | **Units (000s)** | **Accumulation unit** <br> **value**<br> **lowest to highest**<sup>(1)</sup> | **Accumulation unit** <br> **value**<br> **lowest to highest**<sup>(1)</sup> | **Accumulation unit** <br> **value**<br> **lowest to highest**<sup>(1)</sup> | **Net assets** <br> **(000s)**<br>| **Investment** <br> **income ratio**<sup>(2)</sup><br>| **Expense ratio**<br> **lowest to** <br> **highest**<sup>(3)</sup> | **Expense ratio**<br> **lowest to** <br> **highest**<sup>(3)</sup> | **Expense ratio**<br> **lowest to** <br> **highest**<sup>(3)</sup> | &nbsp;&nbsp; **Total return**<br> **lowest to highest**<sup>(1)</sup><sup>,</sup><sup>(4)</sup> | &nbsp;&nbsp; **Total return**<br> **lowest to highest**<sup>(1)</sup><sup>,</sup><sup>(4)</sup> | &nbsp;&nbsp; **Total return**<br> **lowest to highest**<sup>(1)</sup><sup>,</sup><sup>(4)</sup> |
| 2022 | 47 | $1.23 | to | $1.23 | $57 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (14.70)%<br>| to | (14.70)%<br>|
| 2021 | 19 | $1.44 | to | $1.44 | $27 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 30.93<br> %<br>| to | 30.93<br> %<br>|
| **Col VP Select Sm Cap Val, Cl 2** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 58 | $3.37 | to | $3.37 | $196 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 6.30<br> %<br>| to | 6.30<br> %<br>|
| 2024 | 54 | $3.17 | to | $3.17 | $170 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 13.66<br> %<br>| to | 13.66<br> %<br>|
| 2023 | 54 | $2.79 | to | $2.79 | $150 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 12.85<br> %<br>| to | 12.85<br> %<br>|
| 2022 | 50 | $2.47 | to | $2.47 | $123 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (14.93)%<br>| to | (14.93)%<br>|
| 2021 | 41 | $2.90 | to | $2.90 | $119 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 30.62<br> %<br>| to | 30.62<br> %<br>|
| **Col VP Select Sm Cap Val, Cl 3** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 284 | $1.43 | to | $4.63 | $1107 | —<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 6.23<br> %<br>| to | 5.49<br> %<br>|
| 2024 | 275 | $1.35 | to | $4.39 | $1217 | —<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 13.58<br> %<br>| to | 12.78<br> %<br>|
| 2023 | 270 | $1.19 | to | $3.89 | $1118 | —<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 12.75<br> %<br>| to | 11.97<br> %<br>|
| 2022 | 254 | $1.05 | to | $3.48 | $1013 | —<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 5.87 %<sup>(5)</sup><br>| to | (15.58)%<br>|
| 2021 | 267 | $2.09 | to | $4.12 | $1261 | —<br> %<br>| 0.30<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 30.41<br> %<br>| to | 29.63<br> %<br>|
| **Col VP Strategic Inc, Cl 1** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 210 | $1.27 | to | $1.27 | $267 | 4.77<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 7.32<br> %<br>| to | 7.32<br> %<br>|
| 2024 | 172 | $1.19 | to | $1.19 | $204 | 4.44<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 4.70<br> %<br>| to | 4.70<br> %<br>|
| 2023 | 128 | $1.13 | to | $1.13 | $145 | 3.67<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 9.67<br> %<br>| to | 9.67<br> %<br>|
| 2022 | 92 | $1.03 | to | $1.03 | $95 | 2.87<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (11.37)%<br>| to | (11.37)%<br>|
| 2021 | 73 | $1.17 | to | $1.17 | $85 | 5.75<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 2.09<br> %<br>| to | 2.09<br> %<br>|
| **Col VP Strategic Inc, Cl 2** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 178 | $1.53 | to | $1.53 | $272 | 4.46<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 7.16<br> %<br>| to | 7.16<br> %<br>|
| 2024 | 199 | $1.42 | to | $1.42 | $284 | 4.73<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 4.51<br> %<br>| to | 4.51<br> %<br>|
| 2023 | 132 | $1.36 | to | $1.36 | $180 | 3.31<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 9.20<br> %<br>| to | 9.20<br> %<br>|
| 2022 | 103 | $1.25 | to | $1.25 | $128 | 2.45<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (11.52)%<br>| to | (11.52)%<br>|
| 2021 | 110 | $1.41 | to | $1.41 | $155 | 5.10<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 1.63<br> %<br>| to | 1.63<br> %<br>|
| **Col VP US Govt Mtge, Cl 1** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 24 | $1.11 | to | $1.11 | $27 | 2.42<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 9.19<br> %<br>| to | 9.19<br> %<br>|
| 2024 | 22 | $1.01 | to | $1.01 | $22 | 3.67<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 1.57<br> %<br>| to | 1.57<br> %<br>|
| 2023 | 17 | $1.00 | to | $1.00 | $17 | 3.16<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 5.70<br> %<br>| to | 5.70<br> %<br>|
| 2022 | 13 | $0.94 | to | $0.94 | $12 | 2.52<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (14.14)%<br>| to | (14.14)%<br>|
| 2021 | 6 | $1.10 | to | $1.10 | $6 | 1.78<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (0.95)%<br>| to | (0.95)%<br>|
| **Col VP US Govt Mtge, Cl 2** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 13 | $1.24 | to | $1.24 | $16 | 1.75<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 8.83<br> %<br>| to | 8.83<br> %<br>|
| 2024 | 17 | $1.14 | to | $1.14 | $19 | 3.11<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 1.33<br> %<br>| to | 1.33<br> %<br>|
| 2023 | 17 | $1.12 | to | $1.12 | $19 | 2.64<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 5.43<br> %<br>| to | 5.43<br> %<br>|
| 2022 | 9 | $1.06 | to | $1.06 | $10 | 2.03<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (14.32)%<br>| to | (14.32)%<br>|
| 2021 | 5 | $1.24 | to | $1.24 | $7 | 1.85<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (1.20)%<br>| to | (1.20)%<br>|
| **Col VP US Govt Mtge, Cl 3** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 947 | $1.18 | to | $1.41 | $1237 | 2.13<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 8.84<br> %<br>| to | 8.08<br> %<br>|
| 2024 | 975 | $1.09 | to | $1.30 | $1184 | 3.24<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 1.24<br> %<br>| to | 0.53<br> %<br>|
| 2023 | 982 | $1.07 | to | $1.29 | $1186 | 2.66<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 5.35<br> %<br>| to | 4.61<br> %<br>|
| 2022 | 993 | $1.02 | to | $1.24 | $1145 | 2.02<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 2.31 %<sup>(5)</sup><br>| to | (15.03)%<br>|
| 2021 | 1027 | $1.26 | to | $1.46 | $1391 | 1.95<br> %<br>| 0.30<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp; (1.36)%<br>| to | (1.96)%<br>|
| **CS Commodity Return, Cl 1** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 422 | $1.06 | to | $0.72 | $423 | 4.06<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 15.13<br> %<br>| to | 14.32<br> %<br>|
| 2024 | 415 | $0.92 | to | $0.63 | $364 | 3.07<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 4.62<br> %<br>| to | 3.88<br> %<br>|
| 2023 | 485 | $0.88 | to | $0.61 | $406 | 20.79<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp; (9.30)%<br>| to | (9.93)%<br>|
| 2022 | 538 | $0.97 | to | $0.68 | $501 | 15.76<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp; (2.05 )%<sup>(5)</sup><br>| to | 14.99<br> %<br>|
| 2021 | 491 | $0.82 | to | $0.59 | $391 | 4.98<br> %<br>| 0.30<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 27.52<br> %<br>| to | 26.75<br> %<br>|
| **CTIVP AC Div Bond, Cl 1** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 42 | $1.14 | to | $1.14 | $49 | 3.45<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 7.48<br> %<br>| to | 7.48<br> %<br>|
| 2024 | 28 | $1.07 | to | $1.07 | $30 | 4.02<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 1.78<br> %<br>| to | 1.78<br> %<br>|
| 2023 | 30 | $1.05 | to | $1.05 | $31 | 3.37<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 5.59<br> %<br>| to | 5.59<br> %<br>|

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**172 ■ RiverSource of New York Account 8**

------

---

| | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **At December 31** | **At December 31** | **At December 31** | **At December 31** | **At December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** |
|  | **Units (000s)** | **Accumulation unit** <br> **value**<br> **lowest to highest**<sup>(1)</sup> | **Accumulation unit** <br> **value**<br> **lowest to highest**<sup>(1)</sup> | **Accumulation unit** <br> **value**<br> **lowest to highest**<sup>(1)</sup> | **Net assets** <br> **(000s)**<br>| **Investment** <br> **income ratio**<sup>(2)</sup><br>| **Expense ratio**<br> **lowest to** <br> **highest**<sup>(3)</sup> | **Expense ratio**<br> **lowest to** <br> **highest**<sup>(3)</sup> | **Expense ratio**<br> **lowest to** <br> **highest**<sup>(3)</sup> | &nbsp;&nbsp; **Total return**<br> **lowest to highest**<sup>(1)</sup><sup>,</sup><sup>(4)</sup> | &nbsp;&nbsp; **Total return**<br> **lowest to highest**<sup>(1)</sup><sup>,</sup><sup>(4)</sup> | &nbsp;&nbsp; **Total return**<br> **lowest to highest**<sup>(1)</sup><sup>,</sup><sup>(4)</sup> |
| 2022 | 31 | $0.99 | to | $0.99 | $30 | 3.72<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (15.29)%<br>| to | (15.29)%<br>|
| 2021 | 8 | $1.17 | to | $1.17 | $9 | 1.74<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 0.45<br> %<br>| to | 0.45<br> %<br>|
| **CTIVP AC Div Bond, Cl 2** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 21 | $1.26 | to | $1.26 | $27 | 3.00<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 7.24<br> %<br>| to | 7.24<br> %<br>|
| 2024 | 21 | $1.18 | to | $1.18 | $24 | 3.80<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 1.53<br> %<br>| to | 1.53<br> %<br>|
| 2023 | 16 | $1.16 | to | $1.16 | $18 | 3.10<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 5.33<br> %<br>| to | 5.33<br> %<br>|
| 2022 | 16 | $1.10 | to | $1.10 | $17 | 2.92<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (15.51)%<br>| to | (15.51)%<br>|
| 2021 | 14 | $1.30 | to | $1.30 | $18 | 2.31<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 0.29<br> %<br>| to | 0.29<br> %<br>|
| **CTIVP BR Gl Infl Prot Sec, Cl 1** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 46 | $1.07 | to | $1.07 | $49 | 3.75<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 4.23<br> %<br>| to | 4.23<br> %<br>|
| 2024 | 47 | $1.03 | to | $1.03 | $48 | 1.91<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (0.92)%<br>| to | (0.92)%<br>|
| 2023 | 36 | $1.04 | to | $1.04 | $38 | 9.56<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 4.10<br> %<br>| to | 4.10<br> %<br>|
| 2022 | 58 | $1.00 | to | $1.00 | $58 | 2.80<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (17.51)%<br>| to | (17.51)%<br>|
| 2021 | 45 | $1.21 | to | $1.21 | $54 | 0.66<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 4.56<br> %<br>| to | 4.56<br> %<br>|
| **CTIVP BR Gl Infl Prot Sec, Cl 2** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 18 | $1.21 | to | $1.21 | $22 | 3.51<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 3.84<br> %<br>| to | 3.84<br> %<br>|
| 2024 | 16 | $1.17 | to | $1.17 | $19 | 1.83<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (1.20)%<br>| to | (1.20)%<br>|
| 2023 | 14 | $1.18 | to | $1.18 | $17 | 8.11<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 3.89<br> %<br>| to | 3.89<br> %<br>|
| 2022 | 17 | $1.14 | to | $1.14 | $19 | 4.47<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (17.69)%<br>| to | (17.69)%<br>|
| 2021 | 15 | $1.38 | to | $1.38 | $21 | 0.55<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 4.43<br> %<br>| to | 4.43<br> %<br>|
| **CTIVP BR Gl Infl Prot Sec, Cl 3** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 359 | $1.10 | to | $1.47 | $488 | 3.51<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 3.68<br> %<br>| to | 2.95<br> %<br>|
| 2024 | 385 | $1.06 | to | $1.43 | $518 | 1.85<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp; (1.25)%<br>| to | (1.95)%<br>|
| 2023 | 400 | $1.07 | to | $1.46 | $555 | 8.72<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 3.75<br> %<br>| to | 3.02<br> %<br>|
| 2022 | 421 | $1.03 | to | $1.41 | $568 | 4.44<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 5.32 %<sup>(5)</sup><br>| to | (18.32)%<br>|
| 2021 | 437 | $1.40 | to | $1.73 | $720 | 0.68<br> %<br>| 0.30<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 4.17<br> %<br>| to | 3.54<br> %<br>|
| **CTIVP CenterSquare Real Est, Cl 1** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 62 | $1.46 | to | $1.46 | $90 | 2.89<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 2.19<br> %<br>| to | 2.19<br> %<br>|
| 2024 | 57 | $1.43 | to | $1.43 | $81 | 2.59<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 10.34<br> %<br>| to | 10.34<br> %<br>|
| 2023 | 49 | $1.29 | to | $1.29 | $64 | 2.17<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 13.76<br> %<br>| to | 13.76<br> %<br>|
| 2022 | 38 | $1.14 | to | $1.14 | $43 | 1.71<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (24.12)%<br>| to | (24.12)%<br>|
| 2021 | 22 | $1.50 | to | $1.50 | $33 | 1.38<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 41.44<br> %<br>| to | 41.44<br> %<br>|
| **CTIVP CenterSquare Real Est, Cl 2** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 96 | $2.08 | to | $2.08 | $200 | 2.63<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 2.11<br> %<br>| to | 2.11<br> %<br>|
| 2024 | 102 | $2.04 | to | $2.04 | $208 | 2.48<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 9.86<br> %<br>| to | 9.86<br> %<br>|
| 2023 | 115 | $1.85 | to | $1.85 | $213 | 1.81<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 13.56<br> %<br>| to | 13.56<br> %<br>|
| 2022 | 121 | $1.63 | to | $1.63 | $197 | 1.33<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (24.33)%<br>| to | (24.33)%<br>|
| 2021 | 116 | $2.16 | to | $2.16 | $251 | 1.13<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 41.20<br> %<br>| to | 41.20<br> %<br>|
| **CTIVP Prin Lg Cap Gro, Cl 1** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 88 | $2.55 | to | $2.55 | $224 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 13.78<br> %<br>| to | 13.78<br> %<br>|
| 2024 | 74 | $2.24 | to | $2.24 | $165 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 21.42<br> %<br>| to | 21.42<br> %<br>|
| 2023 | 64 | $1.84 | to | $1.84 | $119 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 39.54<br> %<br>| to | 39.54<br> %<br>|
| 2022 | 55 | $1.32 | to | $1.32 | $73 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (28.00)%<br>| to | (28.00)%<br>|
| 2021 | 38 | $1.84 | to | $1.84 | $70 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 18.57<br> %<br>| to | 18.57<br> %<br>|
| **CTIVP Prin Lg Cap Gro, Cl 2** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 20 | $6.01 | to | $6.01 | $121 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 13.49<br> %<br>| to | 13.49<br> %<br>|
| 2024 | 22 | $5.30 | to | $5.30 | $117 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 21.12<br> %<br>| to | 21.12<br> %<br>|
| 2023 | 18 | $4.37 | to | $4.37 | $78 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 39.21<br> %<br>| to | 39.21<br> %<br>|
| 2022 | 17 | $3.14 | to | $3.14 | $54 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (28.19)%<br>| to | (28.19)%<br>|
| 2021 | 18 | $4.37 | to | $4.37 | $79 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 18.28<br> %<br>| to | 18.28<br> %<br>|
| **CTIVP T Rowe Price LgCap Val, Cl 1** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 186 | $1.93 | to | $1.93 | $358 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 12.40<br> %<br>| to | 12.40<br> %<br>|
| 2024 | 134 | $1.71 | to | $1.71 | $229 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 11.94<br> %<br>| to | 11.94<br> %<br>|
| 2023 | 122 | $1.53 | to | $1.53 | $187 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 9.59<br> %<br>| to | 9.59<br> %<br>|

---

**RiverSource of New York Account 8** ■ 173

------

---

| | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **At December 31** | **At December 31** | **At December 31** | **At December 31** | **At December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** |
|  | **Units (000s)** | **Accumulation unit** <br> **value**<br> **lowest to highest**<sup>(1)</sup> | **Accumulation unit** <br> **value**<br> **lowest to highest**<sup>(1)</sup> | **Accumulation unit** <br> **value**<br> **lowest to highest**<sup>(1)</sup> | **Net assets** <br> **(000s)**<br>| **Investment** <br> **income ratio**<sup>(2)</sup><br>| **Expense ratio**<br> **lowest to** <br> **highest**<sup>(3)</sup> | **Expense ratio**<br> **lowest to** <br> **highest**<sup>(3)</sup> | **Expense ratio**<br> **lowest to** <br> **highest**<sup>(3)</sup> | &nbsp;&nbsp; **Total return**<br> **lowest to highest**<sup>(1)</sup><sup>,</sup><sup>(4)</sup> | &nbsp;&nbsp; **Total return**<br> **lowest to highest**<sup>(1)</sup><sup>,</sup><sup>(4)</sup> | &nbsp;&nbsp; **Total return**<br> **lowest to highest**<sup>(1)</sup><sup>,</sup><sup>(4)</sup> |
| 2022 | 82 | $1.40 | to | $1.40 | $115 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (4.96)%<br>| to | (4.96)%<br>|
| 2021 | 70 | $1.47 | to | $1.47 | $103 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 25.29<br> %<br>| to | 25.29<br> %<br>|
| **CTIVP T Rowe Price LgCap Val, Cl 2** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 57 | $3.15 | to | $3.15 | $179 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 12.12<br> %<br>| to | 12.12<br> %<br>|
| 2024 | 53 | $2.81 | to | $2.81 | $150 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 11.68<br> %<br>| to | 11.68<br> %<br>|
| 2023 | 52 | $2.52 | to | $2.52 | $131 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 9.28<br> %<br>| to | 9.28<br> %<br>|
| 2022 | 50 | $2.31 | to | $2.31 | $114 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (5.17)%<br>| to | (5.17)%<br>|
| 2021 | 40 | $2.43 | to | $2.43 | $98 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 24.98<br> %<br>| to | 24.98<br> %<br>|
| **CTIVP TCW Core Plus Bond, Cl 1** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 81 | $1.14 | to | $1.14 | $92 | 4.71<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 7.55<br> %<br>| to | 7.55<br> %<br>|
| 2024 | 79 | $1.06 | to | $1.06 | $83 | 3.96<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 0.75<br> %<br>| to | 0.75<br> %<br>|
| 2023 | 83 | $1.05 | to | $1.05 | $87 | 2.36<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 5.92<br> %<br>| to | 5.92<br> %<br>|
| 2022 | 59 | $0.99 | to | $0.99 | $58 | 1.16<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (14.19)%<br>| to | (14.19)%<br>|
| 2021 | 46 | $1.16 | to | $1.16 | $53 | 1.38<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (1.14)%<br>| to | (1.14)%<br>|
| **CTIVP TCW Core Plus Bond, Cl 2** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 37 | $1.22 | to | $1.22 | $45 | 4.53<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 7.19<br> %<br>| to | 7.19<br> %<br>|
| 2024 | 37 | $1.14 | to | $1.14 | $42 | 3.90<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 0.51<br> %<br>| to | 0.51<br> %<br>|
| 2023 | 36 | $1.13 | to | $1.13 | $41 | 1.96<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 5.54<br> %<br>| to | 5.54<br> %<br>|
| 2022 | 20 | $1.07 | to | $1.07 | $21 | 0.87<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (14.31)%<br>| to | (14.31)%<br>|
| 2021 | 21 | $1.25 | to | $1.25 | $26 | 1.16<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (1.41)%<br>| to | (1.41)%<br>|
| **CTIVP Vty Sycamore Estb Val, Cl 1** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 469 | $1.93 | to | $1.93 | $908 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 2.27<br> %<br>| to | 2.27<br> %<br>|
| 2024 | 401 | $1.89 | to | $1.89 | $758 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 9.92<br> %<br>| to | 9.92<br> %<br>|
| 2023 | 322 | $1.72 | to | $1.72 | $554 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 9.92<br> %<br>| to | 9.92<br> %<br>|
| 2022 | 233 | $1.57 | to | $1.57 | $365 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (2.75)%<br>| to | (2.75)%<br>|
| 2021 | 91 | $1.61 | to | $1.61 | $146 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 31.90<br> %<br>| to | 31.90<br> %<br>|
| **CTIVP Vty Sycamore Estb Val, Cl 2** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 116 | $4.14 | to | $4.14 | $482 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 2.00<br> %<br>| to | 2.00<br> %<br>|
| 2024 | 135 | $4.06 | to | $4.06 | $549 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 9.63<br> %<br>| to | 9.63<br> %<br>|
| 2023 | 144 | $3.70 | to | $3.70 | $535 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 9.67<br> %<br>| to | 9.67<br> %<br>|
| 2022 | 133 | $3.37 | to | $3.37 | $447 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (3.00)%<br>| to | (3.00)%<br>|
| 2021 | 128 | $3.48 | to | $3.48 | $446 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 31.55<br> %<br>| to | 31.55<br> %<br>|
| **CTIVP Vty Sycamore Estb Val, Cl 3** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 307 | $1.35 | to | $4.52 | $1373 | —<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 1.92<br> %<br>| to | 1.21<br> %<br>|
| 2024 | 222 | $1.32 | to | $4.47 | $1113 | —<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 9.55<br> %<br>| to | 8.78<br> %<br>|
| 2023 | 271 | $1.21 | to | $4.11 | $1248 | —<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 9.59<br> %<br>| to | 8.83<br> %<br>|
| 2022 | 256 | $1.10 | to | $3.78 | $1135 | —<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 10.35 %<sup>(5)</sup><br>| to | (3.75)%<br>|
| 2021 | 273 | $2.76 | to | $3.92 | $1267 | —<br> %<br>| 0.30<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 31.35<br> %<br>| to | 30.57<br> %<br>|
| **CTIVP Wellington Lg Cap Val, Cl 1** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 426 | $2.05 | to | $2.05 | $873 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 19.92<br> %<br>| to | 19.92<br> %<br>|
| 2024 | 313 | $1.71 | to | $1.71 | $534 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 11.71<br> %<br>| to | 11.71<br> %<br>|
| 2023 | 136 | $1.53 | to | $1.53 | $208 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 8.04<br> %<br>| to | 8.04<br> %<br>|
| 2022 | 90 | $1.41 | to | $1.41 | $127 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (6.10)%<br>| to | (6.10)%<br>|
| 2021 | 43 | $1.51 | to | $1.51 | $64 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 25.43<br> %<br>| to | 25.43<br> %<br>|
| **CTIVP Wellington Lg Cap Val, Cl 2** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 91 | $3.95 | to | $3.95 | $358 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 19.61<br> %<br>| to | 19.61<br> %<br>|
| 2024 | 87 | $3.30 | to | $3.30 | $286 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 11.44<br> %<br>| to | 11.44<br> %<br>|
| 2023 | 85 | $2.96 | to | $2.96 | $252 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 7.77<br> %<br>| to | 7.77<br> %<br>|
| 2022 | 69 | $2.75 | to | $2.75 | $191 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (6.36)%<br>| to | (6.36)%<br>|
| 2021 | 67 | $2.94 | to | $2.94 | $196 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 25.11<br> %<br>| to | 25.11<br> %<br>|
| **CTIVP Westfield Mid Cap Gro, Cl 1** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 74 | $2.17 | to | $2.17 | $160 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 10.39<br> %<br>| to | 10.39<br> %<br>|
| 2024 | 61 | $1.97 | to | $1.97 | $121 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 17.49<br> %<br>| to | 17.49<br> %<br>|
| 2023 | 49 | $1.68 | to | $1.68 | $82 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 25.48<br> %<br>| to | 25.48<br> %<br>|

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**174 ■ RiverSource of New York Account 8**

------

---

| | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **At December 31** | **At December 31** | **At December 31** | **At December 31** | **At December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** |
|  | **Units (000s)** | **Accumulation unit** <br> **value**<br> **lowest to highest**<sup>(1)</sup> | **Accumulation unit** <br> **value**<br> **lowest to highest**<sup>(1)</sup> | **Accumulation unit** <br> **value**<br> **lowest to highest**<sup>(1)</sup> | **Net assets** <br> **(000s)**<br>| **Investment** <br> **income ratio**<sup>(2)</sup><br>| **Expense ratio**<br> **lowest to** <br> **highest**<sup>(3)</sup> | **Expense ratio**<br> **lowest to** <br> **highest**<sup>(3)</sup> | **Expense ratio**<br> **lowest to** <br> **highest**<sup>(3)</sup> | &nbsp;&nbsp; **Total return**<br> **lowest to highest**<sup>(1)</sup><sup>,</sup><sup>(4)</sup> | &nbsp;&nbsp; **Total return**<br> **lowest to highest**<sup>(1)</sup><sup>,</sup><sup>(4)</sup> | &nbsp;&nbsp; **Total return**<br> **lowest to highest**<sup>(1)</sup><sup>,</sup><sup>(4)</sup> |
| 2022 | 38 | $1.34 | to | $1.34 | $50 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (25.60)%<br>| to | (25.60)%<br>|
| 2021 | 8 | $1.80 | to | $1.80 | $14 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 16.72<br> %<br>| to | 16.72<br> %<br>|
| **CTIVP Westfield Mid Cap Gro, Cl 2** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 16 | $4.16 | to | $4.16 | $67 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 10.12<br> %<br>| to | 10.12<br> %<br>|
| 2024 | 24 | $3.78 | to | $3.78 | $90 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 17.19<br> %<br>| to | 17.19<br> %<br>|
| 2023 | 22 | $3.23 | to | $3.23 | $70 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 25.17<br> %<br>| to | 25.17<br> %<br>|
| 2022 | 21 | $2.58 | to | $2.58 | $55 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (25.79)%<br>| to | (25.79)%<br>|
| 2021 | 23 | $3.47 | to | $3.47 | $81 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 16.41<br> %<br>| to | 16.41<br> %<br>|
| **CTIVP Westfield Sel Lg Cp Gr, Cl 1** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 124 | $2.17 | to | $2.17 | $270 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 17.27<br> %<br>| to | 17.27<br> %<br>|
| 2024 | 117 | $1.85 | to | $1.85 | $215 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 27.50<br> %<br>| to | 27.50<br> %<br>|
| 2023 | 104 | $1.45 | to | $1.45 | $151 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 31.00<br> %<br>| to | 31.00<br> %<br>|
| 2022 | 85 | $1.11 | to | $1.11 | $94 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (41.07)%<br>| to | (41.07)%<br>|
| 2021 | 16 | $1.88 | to | $1.88 | $31 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (4.11)%<br>| to | (4.11)%<br>|
| **CTIVP Westfield Sel Lg Cp Gr, Cl 2** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 16 | $4.99 | to | $4.99 | $79 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 16.98<br> %<br>| to | 16.98<br> %<br>|
| 2024 | 16 | $4.27 | to | $4.27 | $67 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 27.15<br> %<br>| to | 27.15<br> %<br>|
| 2023 | 21 | $3.35 | to | $3.35 | $71 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 30.62<br> %<br>| to | 30.62<br> %<br>|
| 2022 | 20 | $2.57 | to | $2.57 | $51 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (41.21)%<br>| to | (41.21)%<br>|
| 2021 | 21 | $4.37 | to | $4.37 | $90 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (4.35)%<br>| to | (4.35)%<br>|
| **CVT EAFE Intl Index, Cl F** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 12 | $1.55 | to | $1.55 | $19 | 2.48<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 30.64<br> %<br>| to | 30.64<br> %<br>|
| 2024 | 15 | $1.19 | to | $1.19 | $18 | 2.91<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 2.95<br> %<br>| to | 2.95<br> %<br>|
| 2023 | 1 | $1.15 | to | $1.15 | $2 | 3.12<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 17.53<br> %<br>| to | 17.53<br> %<br>|
| 2022 |  | $0.98 | to | $0.98 | $0 | 5.68<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (1.64 )%<sup>(7)</sup><br>| to | (1.64 )%<sup>(7)</sup><br>|
| **CVT EAFE Intl Index, Cl I** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 310 | $1.56 | to | $1.56 | $484 | 2.66<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 30.90<br> %<br>| to | 30.90<br> %<br>|
| 2024 | 142 | $1.19 | to | $1.19 | $169 | 3.17<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 3.14<br> %<br>| to | 3.14<br> %<br>|
| 2023 | 88 | $1.16 | to | $1.16 | $102 | 3.20<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 17.77<br> %<br>| to | 17.77<br> %<br>|
| 2022 | 38 | $0.98 | to | $0.98 | $38 | 5.16<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (1.51 )%<sup>(7)</sup><br>| to | (1.51 )%<sup>(7)</sup><br>|
| **CVT Nasdaq 100 Index, Cl F** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 50 | $1.97 | to | $1.97 | $100 | 0.30<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 20.10<br> %<br>| to | 20.10<br> %<br>|
| 2024 | 40 | $1.64 | to | $1.64 | $66 | 0.39<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 24.89<br> %<br>| to | 24.89<br> %<br>|
| 2023 | 15 | $1.31 | to | $1.31 | $19 | 0.57<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 54.02<br> %<br>| to | 54.02<br> %<br>|
| 2022 |  | $0.85 | to | $0.85 | $0 | 0.31<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (16.12 )%<sup>(7)</sup><br>| to | (16.12 )%<sup>(7)</sup><br>|
| **CVT Nasdaq 100 Index, Cl I** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 350 | $1.99 | to | $1.99 | $695 | 0.30<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 20.39<br> %<br>| to | 20.39<br> %<br>|
| 2024 | 218 | $1.65 | to | $1.65 | $361 | 0.42<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 25.21<br> %<br>| to | 25.21<br> %<br>|
| 2023 | 83 | $1.32 | to | $1.32 | $109 | 0.46<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 54.40<br> %<br>| to | 54.40<br> %<br>|
| 2022 | 6 | $0.85 | to | $0.85 | $5 | 0.42<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (15.98 )%<sup>(7)</sup><br>| to | (15.98 )%<sup>(7)</sup><br>|
| **CVT Russ 2000 Sm Cap Ind, Cl F** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 15 | $1.38 | to | $1.38 | $20 | 1.67<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 12.23<br> %<br>| to | 12.23<br> %<br>|
| 2024 | 14 | $1.23 | to | $1.23 | $17 | 1.48<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 11.00<br> %<br>| to | 11.00<br> %<br>|
| 2023 |  | $1.11 | to | $1.11 | $0 | 0.90<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 16.36<br> %<br>| to | 16.36<br> %<br>|
| 2022 |  | $0.95 | to | $0.95 | $0 | 1.32<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (5.66 )%<sup>(7)</sup><br>| to | (5.66 )%<sup>(7)</sup><br>|
| **CVT Russ 2000 Sm Cap Ind, Cl I** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 190 | $1.39 | to | $1.39 | $264 | 1.54<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 12.45<br> %<br>| to | 12.45<br> %<br>|
| 2024 | 70 | $1.24 | to | $1.24 | $87 | 1.57<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 11.23<br> %<br>| to | 11.23<br> %<br>|
| 2023 | 20 | $1.11 | to | $1.11 | $22 | 1.44<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 16.60<br> %<br>| to | 16.60<br> %<br>|
| 2022 |  | $0.95 | to | $0.95 | $0 | 1.31<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (5.55 )%<sup>(7)</sup><br>| to | (5.55 )%<sup>(7)</sup><br>|
| **DWS Alt Asset Alloc VIP, Cl A** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 175 | $1.46 | to | $1.46 | $257 | 3.76<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 10.50<br> %<br>| to | 10.50<br> %<br>|
| 2024 | 102 | $1.33 | to | $1.33 | $135 | 2.36<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 5.64<br> %<br>| to | 5.64<br> %<br>|
| 2023 | 22 | $1.25 | to | $1.25 | $27 | 5.79<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 6.19<br> %<br>| to | 6.19<br> %<br>|

---

**RiverSource of New York Account 8** ■ 175

------

---

| | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **At December 31** | **At December 31** | **At December 31** | **At December 31** | **At December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** |
|  | **Units (000s)** | **Accumulation unit** <br> **value**<br> **lowest to highest**<sup>(1)</sup> | **Accumulation unit** <br> **value**<br> **lowest to highest**<sup>(1)</sup> | **Accumulation unit** <br> **value**<br> **lowest to highest**<sup>(1)</sup> | **Net assets** <br> **(000s)**<br>| **Investment** <br> **income ratio**<sup>(2)</sup><br>| **Expense ratio**<br> **lowest to** <br> **highest**<sup>(3)</sup> | **Expense ratio**<br> **lowest to** <br> **highest**<sup>(3)</sup> | **Expense ratio**<br> **lowest to** <br> **highest**<sup>(3)</sup> | &nbsp;&nbsp; **Total return**<br> **lowest to highest**<sup>(1)</sup><sup>,</sup><sup>(4)</sup> | &nbsp;&nbsp; **Total return**<br> **lowest to highest**<sup>(1)</sup><sup>,</sup><sup>(4)</sup> | &nbsp;&nbsp; **Total return**<br> **lowest to highest**<sup>(1)</sup><sup>,</sup><sup>(4)</sup> |
| 2022 | 10 | $1.18 | to | $1.18 | $12 | 3.95<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (7.42)%<br>| to | (7.42)%<br>|
| 2021 | 1 | $1.28 | to | $1.28 | $2 | 1.99<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 12.74<br> %<br>| to | 12.74<br> %<br>|
| **DWS Alt Asset Alloc VIP, Cl B** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 274 | $1.52 | to | $1.29 | $398 | 3.46<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 10.03<br> %<br>| to | 9.05<br> %<br>|
| 2024 | 228 | $1.38 | to | $1.18 | $308 | 3.18<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 5.30<br> %<br>| to | 4.35<br> %<br>|
| 2023 | 202 | $1.31 | to | $1.13 | $261 | 6.38<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 5.67<br> %<br>| to | 4.73<br> %<br>|
| 2022 | 207 | $1.24 | to | $1.08 | $252 | 6.92<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp; (7.74)%<br>| to | (8.57)%<br>|
| 2021 | 202 | $1.35 | to | $1.18 | $265 | 1.64<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 12.35<br> %<br>| to | 11.34<br> %<br>|
| **EV VT Floating-Rate Inc, Init Cl** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 782 | $1.26 | to | $1.68 | $1282 | 6.74<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 3.76<br> %<br>| to | 3.04<br> %<br>|
| 2024 | 889 | $1.21 | to | $1.63 | $1456 | 7.78<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 7.42<br> %<br>| to | 6.67<br> %<br>|
| 2023 | 883 | $1.13 | to | $1.53 | $1426 | 8.20<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 10.99<br> %<br>| to | 10.22<br> %<br>|
| 2022 | 889 | $1.02 | to | $1.39 | $1301 | 4.64<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 1.54 %<sup>(5)</sup><br>| to | (3.61)%<br>|
| 2021 | 827 | $1.25 | to | $1.44 | $1253 | 2.90<br> %<br>| 0.30<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 3.32<br> %<br>| to | 2.70<br> %<br>|
| **EV VT Floating-Rate Inc, Inst Cl** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025<sup>(8)</sup> <br>| 4 | $1.13 | to | $1.13 | $7 | 7.24<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 4.52<br> %<br>| to | 4.52<br> %<br>|
| 2024<sup>(8)</sup> <br>| 4 | $1.08 | to | $1.08 | $6 | 8.21<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 7.99 %<sup>(6)</sup><br>| to | 7.99 %<sup>(6)</sup><br>|
| **Fid VIP Contrafund, Init Cl** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 1020 | $3.11 | to | $3.11 | $3175 | 0.16<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 21.48<br> %<br>| to | 21.48<br> %<br>|
| 2024 | 785 | $2.56 | to | $2.56 | $2012 | 0.23<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 33.79<br> %<br>| to | 33.79<br> %<br>|
| 2023 | 367 | $1.92 | to | $1.92 | $703 | 0.53<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 33.45<br> %<br>| to | 33.45<br> %<br>|
| 2022 | 285 | $1.44 | to | $1.44 | $409 | 0.74<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (26.31)%<br>| to | (26.31)%<br>|
| 2021 | 151 | $1.95 | to | $1.95 | $295 | 0.04<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 27.83<br> %<br>| to | 27.83<br> %<br>|
| **Fid VIP Contrafund, Serv Cl 2** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 1608 | $6.13 | to | $5.84 | $9874 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 21.19<br> %<br>| to | 20.11<br> %<br>|
| 2024 | 1385 | $5.06 | to | $4.86 | $7880 | 0.03<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 33.45<br> %<br>| to | 32.25<br> %<br>|
| 2023 | 1340 | $3.79 | to | $3.68 | $5897 | 0.26<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 33.12<br> %<br>| to | 31.93<br> %<br>|
| 2022 | 1450 | $2.85 | to | $2.79 | $4762 | 0.26<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp; (26.49)%<br>| to | (27.14)%<br>|
| 2021 | 1514 | $3.87 | to | $3.83 | $6736 | 0.03<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 27.51<br> %<br>| to | 26.37<br> %<br>|
| **Fid VIP Emer Mkts, Init Cl** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 36 | $1.60 | to | $1.60 | $58 | 2.61<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 41.21<br> %<br>| to | 41.21<br> %<br>|
| 2024 | 3 | $1.13 | to | $1.13 | $3 | 2.69<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 16.19 %<sup>(6)</sup><br>| to | 16.19 %<sup>(6)</sup><br>|
| **Fid VIP Energy, Init Cl** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 2 | $1.17 | to | $1.17 | $3 | 2.75<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 10.59<br> %<br>| to | 10.59<br> %<br>|
| 2024 | 1 | $1.06 | to | $1.06 | $1 | 4.44<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 8.33 %<sup>(6)</sup><br>| to | 8.33 %<sup>(6)</sup><br>|
| **Fid VIP Gro & Inc, Serv Cl** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 813 | $9.28 | to | $5.66 | $5969 | 1.47<br> %<br>| 0.45<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 20.84<br> %<br>| to | 20.30<br> %<br>|
| 2024 | 855 | $7.68 | to | $4.71 | $5240 | 1.37<br> %<br>| 0.45<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 21.58<br> %<br>| to | 21.04<br> %<br>|
| 2023 | 906 | $6.32 | to | $3.89 | $4579 | 1.56<br> %<br>| 0.45<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 18.05<br> %<br>| to | 17.52<br> %<br>|
| 2022 | 1035 | $5.35 | to | $3.31 | $4385 | 1.57<br> %<br>| 0.45<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp; (5.45)%<br>| to | (5.87)%<br>|
| 2021 | 1114 | $5.66 | to | $3.52 | $4961 | 2.34<br> %<br>| 0.45<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 25.20<br> %<br>| to | 24.64<br> %<br>|
| **Fid VIP Gro & Inc, Serv Cl 2** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 913 | $1.90 | to | $6.50 | $3026 | 1.40<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 20.97<br> %<br>| to | 20.12<br> %<br>|
| 2024 | 853 | $1.57 | to | $5.41 | $2453 | 1.23<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 21.71<br> %<br>| to | 20.85<br> %<br>|
| 2023 | 866 | $1.29 | to | $4.48 | $2266 | 1.51<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 18.13<br> %<br>| to | 17.32<br> %<br>|
| 2022 | 875 | $1.09 | to | $3.82 | $1993 | 1.52<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 10.16 %<sup>(5)</sup><br>| to | (6.02)%<br>|
| 2021 | 876 | $2.43 | to | $4.06 | $2112 | 2.23<br> %<br>| 0.30<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 25.26<br> %<br>| to | 24.51<br> %<br>|
| **Fid VIP Gro Opp, Init Cl** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 57 | $1.69 | to | $1.69 | $95 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 21.95<br> %<br>| to | 21.95<br> %<br>|
| 2024 | 71 | $1.38 | to | $1.38 | $99 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 38.63 %<sup>(6)</sup><br>| to | 38.63 %<sup>(6)</sup><br>|
| **Fid VIP Invest Gr, Init Cl** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 50 | $1.09 | to | $1.09 | $55 | 3.73<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 7.22<br> %<br>| to | 7.22<br> %<br>|
| 2024 | 36 | $1.02 | to | $1.02 | $37 | 7.08<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 2.61 %<sup>(6)</sup><br>| to | 2.61 %<sup>(6)</sup><br>|

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**176 ■ RiverSource of New York Account 8**

------

---

| | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **At December 31** | **At December 31** | **At December 31** | **At December 31** | **At December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** |
|  | **Units (000s)** | **Accumulation unit** <br> **value**<br> **lowest to highest**<sup>(1)</sup> | **Accumulation unit** <br> **value**<br> **lowest to highest**<sup>(1)</sup> | **Accumulation unit** <br> **value**<br> **lowest to highest**<sup>(1)</sup> | **Net assets** <br> **(000s)**<br>| **Investment** <br> **income ratio**<sup>(2)</sup><br>| **Expense ratio**<br> **lowest to** <br> **highest**<sup>(3)</sup> | **Expense ratio**<br> **lowest to** <br> **highest**<sup>(3)</sup> | **Expense ratio**<br> **lowest to** <br> **highest**<sup>(3)</sup> | &nbsp;&nbsp; **Total return**<br> **lowest to highest**<sup>(1)</sup><sup>,</sup><sup>(4)</sup> | &nbsp;&nbsp; **Total return**<br> **lowest to highest**<sup>(1)</sup><sup>,</sup><sup>(4)</sup> | &nbsp;&nbsp; **Total return**<br> **lowest to highest**<sup>(1)</sup><sup>,</sup><sup>(4)</sup> |
| **Fid VIP Mid Cap, Init Cl** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 703 | $2.04 | to | $2.04 | $1435 | 0.50<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 11.75<br> %<br>| to | 11.75<br> %<br>|
| 2024 | 476 | $1.83 | to | $1.83 | $870 | 0.70<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 17.49<br> %<br>| to | 17.49<br> %<br>|
| 2023 | 279 | $1.55 | to | $1.55 | $434 | 0.64<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 15.08<br> %<br>| to | 15.08<br> %<br>|
| 2022 | 242 | $1.35 | to | $1.35 | $327 | 0.71<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (14.74)%<br>| to | (14.74)%<br>|
| 2021 | 119 | $1.58 | to | $1.58 | $189 | 0.79<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 25.60<br> %<br>| to | 25.60<br> %<br>|
| **Fid VIP Mid Cap, Serv Cl** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 862 | $6.97 | to | $8.23 | $6494 | 0.37<br> %<br>| 0.45<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 11.16<br> %<br>| to | 10.66<br> %<br>|
| 2024 | 916 | $6.27 | to | $7.44 | $6223 | 0.47<br> %<br>| 0.45<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 16.82<br> %<br>| to | 16.30<br> %<br>|
| 2023 | 974 | $5.37 | to | $6.40 | $5693 | 0.51<br> %<br>| 0.45<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 14.49<br> %<br>| to | 13.98<br> %<br>|
| 2022 | 1062 | $4.69 | to | $5.61 | $5429 | 0.40<br> %<br>| 0.45<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp; (15.24)%<br>| to | (15.62)%<br>|
| 2021 | 1134 | $5.53 | to | $6.65 | $6880 | 0.51<br> %<br>| 0.45<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 24.94<br> %<br>| to | 24.38<br> %<br>|
| **Fid VIP Mid Cap, Serv Cl 2** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 2292 | $3.82 | to | $7.76 | $6358 | 0.25<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 11.49<br> %<br>| to | 10.49<br> %<br>|
| 2024 | 2223 | $3.43 | to | $7.02 | $5802 | 0.34<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 17.18<br> %<br>| to | 16.12<br> %<br>|
| 2023 | 2434 | $2.92 | to | $6.05 | $5572 | 0.38<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 14.80<br> %<br>| to | 13.78<br> %<br>|
| 2022 | 2546 | $2.55 | to | $5.31 | $5126 | 0.27<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp; (14.97)%<br>| to | (15.73)%<br>|
| 2021 | 2636 | $3.00 | to | $6.30 | $6271 | 0.37<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 25.31<br> %<br>| to | 24.18<br> %<br>|
| **Fid VIP Overseas, Serv Cl** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 580 | $3.97 | to | $2.72 | $1856 | 1.56<br> %<br>| 0.45<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 19.74<br> %<br>| to | 19.20<br> %<br>|
| 2024 | 596 | $3.31 | to | $2.28 | $1589 | 1.60<br> %<br>| 0.45<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 4.48<br> %<br>| to | 4.01<br> %<br>|
| 2023 | 570 | $3.17 | to | $2.19 | $1471 | 0.94<br> %<br>| 0.45<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 19.87<br> %<br>| to | 19.33<br> %<br>|
| 2022 | 605 | $2.65 | to | $1.84 | $1301 | 0.95<br> %<br>| 0.45<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp; (24.92)%<br>| to | (25.26)%<br>|
| 2021 | 644 | $3.52 | to | $2.46 | $1833 | 0.44<br> %<br>| 0.45<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 19.04<br> %<br>| to | 18.50<br> %<br>|
| **Fid VIP Overseas, Serv Cl 2** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 658 | $1.72 | to | $3.77 | $1389 | 1.40<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 19.81<br> %<br>| to | 18.97<br> %<br>|
| 2024 | 693 | $1.43 | to | $3.17 | $1237 | 1.37<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 4.60<br> %<br>| to | 3.86<br> %<br>|
| 2023 | 708 | $1.37 | to | $3.05 | $1224 | 0.83<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 19.98<br> %<br>| to | 19.15<br> %<br>|
| 2022 | 682 | $1.14 | to | $2.56 | $984 | 0.86<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 15.16 %<sup>(5)</sup><br>| to | (25.36)%<br>|
| 2021 | 682 | $1.94 | to | $3.43 | $1312 | 0.34<br> %<br>| 0.30<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 19.03<br> %<br>| to | 18.32<br> %<br>|
| **Fid VIP Strategic Inc, Init Cl** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 425 | $1.33 | to | $1.33 | $566 | 4.02<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 8.85<br> %<br>| to | 8.85<br> %<br>|
| 2024 | 492 | $1.22 | to | $1.22 | $602 | 4.52<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 6.08<br> %<br>| to | 6.08<br> %<br>|
| 2023 | 312 | $1.15 | to | $1.15 | $359 | 5.34<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 9.41<br> %<br>| to | 9.41<br> %<br>|
| 2022 | 178 | $1.05 | to | $1.05 | $188 | 4.92<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (11.26)%<br>| to | (11.26)%<br>|
| 2021 | 97 | $1.19 | to | $1.19 | $115 | 5.17<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 3.74<br> %<br>| to | 3.74<br> %<br>|
| **Fid VIP Strategic Inc, Serv Cl 2** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 43 | $1.58 | to | $1.58 | $67 | 4.28<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 8.58<br> %<br>| to | 8.58<br> %<br>|
| 2024 | 16 | $1.45 | to | $1.45 | $23 | 3.33<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 5.78<br> %<br>| to | 5.78<br> %<br>|
| 2023 | 17 | $1.37 | to | $1.37 | $23 | 4.57<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 9.18<br> %<br>| to | 9.18<br> %<br>|
| 2022 | 15 | $1.26 | to | $1.26 | $19 | 1.96<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (11.52)%<br>| to | (11.52)%<br>|
| 2021 | 27 | $1.42 | to | $1.42 | $38 | 2.59<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 3.53<br> %<br>| to | 3.53<br> %<br>|
| **Frank Global Real Est, Cl 2** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 853 | $1.30 | to | $2.93 | $1845 | 1.40<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 7.71<br> %<br>| to | 6.96<br> %<br>|
| 2024 | 836 | $1.21 | to | $2.74 | $1802 | 1.85<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp; (0.52)%<br>| to | (1.22)%<br>|
| 2023 | 890 | $1.21 | to | $2.77 | $2039 | 2.92<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 11.21<br> %<br>| to | 10.44<br> %<br>|
| 2022 | 920 | $1.09 | to | $2.51 | $1957 | 2.39<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 10.23 %<sup>(5)</sup><br>| to | (26.72)%<br>|
| 2021 | 940 | $1.72 | to | $3.43 | $2744 | 0.89<br> %<br>| 0.30<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 26.41<br> %<br>| to | 25.66<br> %<br>|
| **Frank Inc, Cl 1** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 78 | $1.59 | to | $1.59 | $124 | 4.76<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 12.88<br> %<br>| to | 12.88<br> %<br>|
| 2024 | 43 | $1.41 | to | $1.41 | $61 | 5.08<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 7.46<br> %<br>| to | 7.46<br> %<br>|
| 2023 | 36 | $1.31 | to | $1.31 | $47 | 5.34<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 8.87<br> %<br>| to | 8.87<br> %<br>|
| 2022 | 8 | $1.21 | to | $1.21 | $9 | 3.30<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (5.24)%<br>| to | (5.24)%<br>|
| 2021 | 2 | $1.27 | to | $1.27 | $3 | 0.60<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 17.01<br> %<br>| to | 17.01<br> %<br>|

---

**RiverSource of New York Account 8** ■ 177

------

---

| | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **At December 31** | **At December 31** | **At December 31** | **At December 31** | **At December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** |
|  | **Units (000s)** | **Accumulation unit** <br> **value**<br> **lowest to highest**<sup>(1)</sup> | **Accumulation unit** <br> **value**<br> **lowest to highest**<sup>(1)</sup> | **Accumulation unit** <br> **value**<br> **lowest to highest**<sup>(1)</sup> | **Net assets** <br> **(000s)**<br>| **Investment** <br> **income ratio**<sup>(2)</sup><br>| **Expense ratio**<br> **lowest to** <br> **highest**<sup>(3)</sup> | **Expense ratio**<br> **lowest to** <br> **highest**<sup>(3)</sup> | **Expense ratio**<br> **lowest to** <br> **highest**<sup>(3)</sup> | &nbsp;&nbsp; **Total return**<br> **lowest to highest**<sup>(1)</sup><sup>,</sup><sup>(4)</sup> | &nbsp;&nbsp; **Total return**<br> **lowest to highest**<sup>(1)</sup><sup>,</sup><sup>(4)</sup> | &nbsp;&nbsp; **Total return**<br> **lowest to highest**<sup>(1)</sup><sup>,</sup><sup>(4)</sup> |
| **Frank Inc, Cl 2** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 295 | $2.07 | to | $1.63 | $510 | 5.10<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 12.56<br> %<br>| to | 11.55<br> %<br>|
| 2024 | 313 | $1.84 | to | $1.46 | $478 | 5.29<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 7.20<br> %<br>| to | 6.24<br> %<br>|
| 2023 | 310 | $1.71 | to | $1.38 | $446 | 5.15<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 8.62<br> %<br>| to | 7.65<br> %<br>|
| 2022 | 284 | $1.58 | to | $1.28 | $375 | 4.85<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp; (5.47)%<br>| to | (6.32)%<br>|
| 2021 | 254 | $1.67 | to | $1.37 | $361 | 4.67<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 16.75<br> %<br>| to | 15.71<br> %<br>|
| **Frank Mutual Shares, Cl 1** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 23 | $1.66 | to | $1.66 | $38 | 2.41<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 11.81<br> %<br>| to | 11.81<br> %<br>|
| 2024 | 21 | $1.49 | to | $1.49 | $31 | 2.34<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 11.50<br> %<br>| to | 11.50<br> %<br>|
| 2023 | 19 | $1.34 | to | $1.34 | $25 | 2.04<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 13.73<br> %<br>| to | 13.73<br> %<br>|
| 2022 | 15 | $1.17 | to | $1.17 | $18 | 2.59<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (7.15)%<br>| to | (7.15)%<br>|
| 2021 | 12 | $1.26 | to | $1.26 | $15 | 3.03<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 19.52<br> %<br>| to | 19.52<br> %<br>|
| **Frank Mutual Shares, Cl 2** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 687 | $2.69 | to | $3.76 | $1958 | 2.07<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 11.52<br> %<br>| to | 10.52<br> %<br>|
| 2024 | 577 | $2.41 | to | $3.40 | $1752 | 1.98<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 11.27<br> %<br>| to | 10.27<br> %<br>|
| 2023 | 593 | $2.17 | to | $3.08 | $1693 | 1.84<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 13.46<br> %<br>| to | 12.45<br> %<br>|
| 2022 | 679 | $1.91 | to | $2.74 | $1662 | 1.86<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp; (7.43)%<br>| to | (8.26)%<br>|
| 2021 | 690 | $2.06 | to | $2.99 | $1850 | 2.89<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 19.17<br> %<br>| to | 18.10<br> %<br>|
| **Frank Sm Cap Val, Cl 1** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 208 | $1.79 | to | $1.79 | $373 | 1.21<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 7.90<br> %<br>| to | 7.90<br> %<br>|
| 2024 | 149 | $1.66 | to | $1.66 | $247 | 1.10<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 12.01<br> %<br>| to | 12.01<br> %<br>|
| 2023 | 143 | $1.48 | to | $1.48 | $212 | 0.72<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 13.02<br> %<br>| to | 13.02<br> %<br>|
| 2022 | 82 | $1.31 | to | $1.31 | $108 | 1.20<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (9.82)%<br>| to | (9.82)%<br>|
| 2021 | 33 | $1.45 | to | $1.45 | $47 | 1.10<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 25.67<br> %<br>| to | 25.67<br> %<br>|
| **Frank Sm Cap Val, Cl 2** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 796 | $3.44 | to | $7.40 | $3063 | 1.08<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 7.65<br> %<br>| to | 6.69<br> %<br>|
| 2024 | 708 | $3.19 | to | $6.93 | $2972 | 0.93<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 11.71<br> %<br>| to | 10.70<br> %<br>|
| 2023 | 679 | $2.86 | to | $6.26 | $2856 | 0.52<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 12.75<br> %<br>| to | 11.74<br> %<br>|
| 2022 | 661 | $2.54 | to | $5.60 | $2614 | 0.98<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp; (10.06)%<br>| to | (10.87)%<br>|
| 2021 | 692 | $2.82 | to | $6.29 | $3092 | 1.00<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 25.37<br> %<br>| to | 24.24<br> %<br>|
| **GS VIT Mid Cap Val, Inst** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 1479 | $1.47 | to | $8.30 | $6523 | 1.19<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 9.18<br> %<br>| to | 8.41<br> %<br>|
| 2024 | 1354 | $1.34 | to | $7.66 | $6331 | 1.00<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 12.17<br> %<br>| to | 11.39<br> %<br>|
| 2023 | 1275 | $1.20 | to | $6.87 | $6093 | 1.01<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 11.20<br> %<br>| to | 10.42<br> %<br>|
| 2022 | 1381 | $1.08 | to | $6.23 | $5910 | 0.68<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 8.14 %<sup>(5)</sup><br>| to | (10.79)%<br>|
| 2021 | 1440 | $2.27 | to | $6.98 | $6993 | 0.48<br> %<br>| 0.30<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 30.56<br> %<br>| to | 29.78<br> %<br>|
| **GS VIT Sm Cap Eq Insights, Inst** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 60 | $7.88 | to | $5.88 | $437 | 0.74<br> %<br>| 0.45<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 15.62<br> %<br>| to | 15.10<br> %<br>|
| 2024 | 73 | $6.82 | to | $5.11 | $446 | 0.72<br> %<br>| 0.45<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 18.51<br> %<br>| to | 17.98<br> %<br>|
| 2023 | 110 | $5.75 | to | $4.33 | $552 | 1.04<br> %<br>| 0.45<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 18.74<br> %<br>| to | 18.21<br> %<br>|
| 2022 | 111 | $4.85 | to | $3.67 | $467 | 0.32<br> %<br>| 0.45<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp; (19.74)%<br>| to | (20.10)%<br>|
| 2021 | 114 | $6.04 | to | $4.59 | $602 | 0.46<br> %<br>| 0.45<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 23.23<br> %<br>| to | 22.68<br> %<br>|
| **GS VIT U.S. Eq Insights, Inst** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 584 | $1.91 | to | $5.46 | $3309 | 0.70<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 15.52<br> %<br>| to | 14.71<br> %<br>|
| 2024 | 537 | $1.66 | to | $4.76 | $3151 | 0.62<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 28.07<br> %<br>| to | 27.17<br> %<br>|
| 2023 | 630 | $1.29 | to | $3.75 | $2924 | 0.70<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 23.57<br> %<br>| to | 22.70<br> %<br>|
| 2022 | 594 | $1.05 | to | $3.05 | $2456 | 0.82<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 5.39 %<sup>(5)</sup><br>| to | (20.46)%<br>|
| 2021 | 632 | $3.08 | to | $3.84 | $3232 | 0.81<br> %<br>| 0.30<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 29.02<br> %<br>| to | 28.25<br> %<br>|
| **Invesco VI Am Fran, Ser I** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 139 | $5.85 | to | $5.50 | $786 | —<br> %<br>| 0.45<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 11.16<br> %<br>| to | 10.66<br> %<br>|
| 2024 | 151 | $5.26 | to | $4.97 | $773 | —<br> %<br>| 0.45<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 34.28<br> %<br>| to | 33.67<br> %<br>|
| 2023 | 164 | $3.92 | to | $3.72 | $629 | —<br> %<br>| 0.45<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 40.30<br> %<br>| to | 39.67<br> %<br>|
| 2022 | 183 | $2.79 | to | $2.66 | $502 | —<br> %<br>| 0.45<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp; (31.42)%<br>| to | (31.73)%<br>|
| 2021 | 194 | $4.07 | to | $3.90 | $777 | —<br> %<br>| 0.45<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 11.42<br> %<br>| to | 10.92<br> %<br>|

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**178 ■ RiverSource of New York Account 8**

------

---

| | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **At December 31** | **At December 31** | **At December 31** | **At December 31** | **At December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** |
|  | **Units (000s)** | **Accumulation unit** <br> **value**<br> **lowest to highest**<sup>(1)</sup> | **Accumulation unit** <br> **value**<br> **lowest to highest**<sup>(1)</sup> | **Accumulation unit** <br> **value**<br> **lowest to highest**<sup>(1)</sup> | **Net assets** <br> **(000s)**<br>| **Investment** <br> **income ratio**<sup>(2)</sup><br>| **Expense ratio**<br> **lowest to** <br> **highest**<sup>(3)</sup> | **Expense ratio**<br> **lowest to** <br> **highest**<sup>(3)</sup> | **Expense ratio**<br> **lowest to** <br> **highest**<sup>(3)</sup> | &nbsp;&nbsp; **Total return**<br> **lowest to highest**<sup>(1)</sup><sup>,</sup><sup>(4)</sup> | &nbsp;&nbsp; **Total return**<br> **lowest to highest**<sup>(1)</sup><sup>,</sup><sup>(4)</sup> | &nbsp;&nbsp; **Total return**<br> **lowest to highest**<sup>(1)</sup><sup>,</sup><sup>(4)</sup> |
| **Invesco VI Am Fran, Ser II** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 288 | $2.11 | to | $5.32 | $1264 | —<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 11.16<br> %<br>| to | 10.39<br> %<br>|
| 2024 | 286 | $1.89 | to | $4.82 | $1175 | —<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 34.29<br> %<br>| to | 33.35<br> %<br>|
| 2023 | 319 | $1.41 | to | $3.61 | $995 | —<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 40.32<br> %<br>| to | 39.34<br> %<br>|
| 2022 | 309 | $1.01 | to | $2.59 | $729 | —<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 1.87 %<sup>(5)</sup><br>| to | (31.91)%<br>|
| 2021 | 306 | $3.48 | to | $3.81 | $1053 | —<br> %<br>| 0.30<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 11.31<br> %<br>| to | 10.65<br> %<br>|
| **Invesco VI Bal Risk Alloc, Ser I** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 34 | $1.35 | to | $1.35 | $46 | 7.51<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 9.01<br> %<br>| to | 9.01<br> %<br>|
| 2024 | 29 | $1.24 | to | $1.24 | $36 | 6.37<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 3.88<br> %<br>| to | 3.88<br> %<br>|
| 2023 | 25 | $1.19 | to | $1.19 | $29 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 6.63<br> %<br>| to | 6.63<br> %<br>|
| 2022 | 18 | $1.12 | to | $1.12 | $20 | 8.24<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (14.35)%<br>| to | (14.35)%<br>|
| 2021 | 14 | $1.30 | to | $1.30 | $19 | 3.60<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 9.55<br> %<br>| to | 9.55<br> %<br>|
| **Invesco VI Bal Risk Alloc, Ser II** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 212 | $1.64 | to | $1.40 | $319 | 7.00<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 8.69<br> %<br>| to | 7.72<br> %<br>|
| 2024 | 201 | $1.51 | to | $1.30 | $280 | 6.08<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 3.56<br> %<br>| to | 2.63<br> %<br>|
| 2023 | 189 | $1.45 | to | $1.27 | $253 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 6.40<br> %<br>| to | 5.45<br> %<br>|
| 2022 | 202 | $1.37 | to | $1.20 | $253 | 7.29<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp; (14.52)%<br>| to | (15.28)%<br>|
| 2021 | 219 | $1.60 | to | $1.42 | $322 | 3.01<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 9.26<br> %<br>| to | 8.28<br> %<br>|
| **Invesco VI Comstock, Ser II** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 152 | $1.66 | to | $3.61 | $622 | 1.47<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 16.91<br> %<br>| to | 16.09<br> %<br>|
| 2024 | 136 | $1.42 | to | $3.11 | $533 | 1.70<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 14.64<br> %<br>| to | 13.83<br> %<br>|
| 2023 | 113 | $1.24 | to | $2.73 | $391 | 1.59<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 11.87<br> %<br>| to | 11.09<br> %<br>|
| 2022 | 124 | $1.11 | to | $2.46 | $400 | 1.28<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 11.38 %<sup>(5)</sup><br>| to | (0.06)%<br>|
| 2021 | 135 | $2.14 | to | $2.46 | $441 | 1.75<br> %<br>| 0.30<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 32.65<br> %<br>| to | 31.85<br> %<br>|
| **Invesco VI Core Eq, Ser I** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 1706 | $6.40 | to | $7.44 | $12480 | 0.65<br> %<br>| 0.45<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 15.65<br> %<br>| to | 15.13<br> %<br>|
| 2024 | 1889 | $5.54 | to | $6.47 | $11978 | 0.69<br> %<br>| 0.45<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 25.04<br> %<br>| to | 24.48<br> %<br>|
| 2023 | 2031 | $4.43 | to | $5.19 | $10346 | 0.74<br> %<br>| 0.45<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 22.81<br> %<br>| to | 22.26<br> %<br>|
| 2022 | 2133 | $3.60 | to | $4.25 | $8886 | 0.91<br> %<br>| 0.45<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp; (20.90)%<br>| to | (21.26)%<br>|
| 2021 | 2248 | $4.56 | to | $5.40 | $11888 | 0.66<br> %<br>| 0.45<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 27.17<br> %<br>| to | 26.59<br> %<br>|
| **Invesco VI Dis Mid Cap Gro, Ser I** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 574 | $1.46 | to | $1.74 | $1010 | —<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 4.58<br> %<br>| to | 3.85<br> %<br>|
| 2024 | 572 | $1.40 | to | $1.68 | $976 | —<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 23.98<br> %<br>| to | 23.11<br> %<br>|
| 2023 | 637 | $1.13 | to | $1.36 | $881 | —<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 12.93<br> %<br>| to | 12.14<br> %<br>|
| 2022 | 568 | $1.00 | to | $1.22 | $698 | —<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 1.14 %<sup>(5)</sup><br>| to | (31.60)%<br>|
| 2021 | 647 | $1.80 | to | $1.78 | $1157 | —<br> %<br>| 0.30<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 18.74<br> %<br>| to | 18.03<br> %<br>|
| **Invesco VI Div Divd, Ser I** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 311 | $1.55 | to | $3.49 | $1077 | 1.64<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 15.51<br> %<br>| to | 14.70<br> %<br>|
| 2024 | 376 | $1.35 | to | $3.05 | $1107 | 1.76<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 12.99<br> %<br>| to | 12.20<br> %<br>|
| 2023 | 449 | $1.19 | to | $2.71 | $1167 | 2.07<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 8.82<br> %<br>| to | 8.07<br> %<br>|
| 2022 | 444 | $1.09 | to | $2.51 | $1101 | 1.94<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 10.06 %<sup>(5)</sup><br>| to | (2.56)%<br>|
| 2021 | 473 | $2.05 | to | $2.58 | $1171 | 2.15<br> %<br>| 0.30<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 18.54<br> %<br>| to | 17.83<br> %<br>|
| **Invesco VI EQV Intl Eq, Ser II** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 397 | $1.52 | to | $1.76 | $1009 | 1.09<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 16.00<br> %<br>| to | 15.19<br> %<br>|
| 2024 | 464 | $1.31 | to | $1.53 | $1066 | 1.52<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 0.14<br> %<br>| to | (0.56)%<br>|
| 2023 | 477 | $1.31 | to | $1.54 | $1110 | —<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 17.63<br> %<br>| to | 16.81<br> %<br>|
| 2022 | 501 | $1.11 | to | $1.32 | $989 | 1.44<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 12.44 %<sup>(5)</sup><br>| to | (19.23)%<br>|
| 2021 | 521 | $1.68 | to | $1.63 | $1253 | 1.05<br> %<br>| 0.30<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 5.29<br> %<br>| to | 4.66<br> %<br>|
| **Invesco VI Gbl Strat Inc, Ser I** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 49 | $1.19 | to | $1.19 | $59 | 6.30<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 12.98<br> %<br>| to | 12.98<br> %<br>|
| 2024 | 42 | $1.05 | to | $1.05 | $45 | 3.56<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 3.16<br> %<br>| to | 3.16<br> %<br>|
| 2023 | 30 | $1.02 | to | $1.02 | $31 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 8.88<br> %<br>| to | 8.88<br> %<br>|
| 2022 | 18 | $0.94 | to | $0.94 | $17 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (11.46)%<br>| to | (11.46)%<br>|
| 2021 | 5 | $1.06 | to | $1.06 | $5 | 6.56<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (3.41)%<br>| to | (3.41)%<br>|

---

**RiverSource of New York Account 8** ■ 179

------

---

| | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **At December 31** | **At December 31** | **At December 31** | **At December 31** | **At December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** |
|  | **Units (000s)** | **Accumulation unit** <br> **value**<br> **lowest to highest**<sup>(1)</sup> | **Accumulation unit** <br> **value**<br> **lowest to highest**<sup>(1)</sup> | **Accumulation unit** <br> **value**<br> **lowest to highest**<sup>(1)</sup> | **Net assets** <br> **(000s)**<br>| **Investment** <br> **income ratio**<sup>(2)</sup><br>| **Expense ratio**<br> **lowest to** <br> **highest**<sup>(3)</sup> | **Expense ratio**<br> **lowest to** <br> **highest**<sup>(3)</sup> | **Expense ratio**<br> **lowest to** <br> **highest**<sup>(3)</sup> | &nbsp;&nbsp; **Total return**<br> **lowest to highest**<sup>(1)</sup><sup>,</sup><sup>(4)</sup> | &nbsp;&nbsp; **Total return**<br> **lowest to highest**<sup>(1)</sup><sup>,</sup><sup>(4)</sup> | &nbsp;&nbsp; **Total return**<br> **lowest to highest**<sup>(1)</sup><sup>,</sup><sup>(4)</sup> |
| **Invesco VI Gbl Strat Inc, Ser II** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 1023 | $1.33 | to | $1.67 | $1669 | 5.47<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 12.75<br> %<br>| to | 11.74<br> %<br>|
| 2024 | 949 | $1.18 | to | $1.49 | $1441 | 2.64<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 2.79<br> %<br>| to | 1.86<br> %<br>|
| 2023 | 1128 | $1.14 | to | $1.46 | $1625 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 8.60<br> %<br>| to | 7.63<br> %<br>|
| 2022 | 1140 | $1.05 | to | $1.36 | $1533 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp; (11.71)%<br>| to | (12.51)%<br>|
| 2021 | 1155 | $1.19 | to | $1.55 | $1772 | 4.30<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp; (3.56)%<br>| to | (4.43)%<br>|
| **Invesco VI Global, Ser I** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 373 | $2.09 | to | $2.09 | $780 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 15.32<br> %<br>| to | 15.32<br> %<br>|
| 2024 | 316 | $1.82 | to | $1.82 | $574 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 16.07<br> %<br>| to | 16.07<br> %<br>|
| 2023 | 319 | $1.56 | to | $1.56 | $499 | 0.28<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 34.74<br> %<br>| to | 34.74<br> %<br>|
| 2022 | 160 | $1.16 | to | $1.16 | $185 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (31.76)%<br>| to | (31.76)%<br>|
| 2021 | 47 | $1.70 | to | $1.70 | $80 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 15.49<br> %<br>| to | 15.49<br> %<br>|
| **Invesco VI Global, Ser II** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 421 | $3.89 | to | $3.77 | $1901 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 15.01<br> %<br>| to | 13.98<br> %<br>|
| 2024 | 409 | $3.39 | to | $3.31 | $1723 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 15.78<br> %<br>| to | 14.74<br> %<br>|
| 2023 | 513 | $2.92 | to | $2.89 | $1823 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 34.45<br> %<br>| to | 33.25<br> %<br>|
| 2022 | 520 | $2.17 | to | $2.17 | $1384 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp; (31.94)%<br>| to | (32.55)%<br>|
| 2021 | 550 | $3.20 | to | $3.21 | $2195 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 15.17<br> %<br>| to | 14.14<br> %<br>|
| **Invesco VI Mn St Sm Cap, Ser I** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 339 | $1.93 | to | $1.93 | $653 | 0.49<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 8.70<br> %<br>| to | 8.70<br> %<br>|
| 2024 | 257 | $1.77 | to | $1.77 | $455 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 12.68<br> %<br>| to | 12.68<br> %<br>|
| 2023 | 161 | $1.57 | to | $1.57 | $253 | 1.24<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 18.13<br> %<br>| to | 18.13<br> %<br>|
| 2022 | 133 | $1.33 | to | $1.33 | $177 | 0.60<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (15.83)%<br>| to | (15.83)%<br>|
| 2021 | 82 | $1.58 | to | $1.58 | $130 | 0.47<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 22.55<br> %<br>| to | 22.55<br> %<br>|
| **Invesco VI Mn St Sm Cap, Ser II** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 510 | $4.06 | to | $3.92 | $2144 | 0.24<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 8.44<br> %<br>| to | 7.47<br> %<br>|
| 2024 | 508 | $3.75 | to | $3.65 | $1999 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 12.41<br> %<br>| to | 11.39<br> %<br>|
| 2023 | 497 | $3.33 | to | $3.28 | $1803 | 0.95<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 17.82<br> %<br>| to | 16.77<br> %<br>|
| 2022 | 490 | $2.83 | to | $2.81 | $1561 | 0.26<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp; (16.04)%<br>| to | (16.79)%<br>|
| 2021 | 508 | $3.37 | to | $3.37 | $1906 | 0.19<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 22.26<br> %<br>| to | 21.17<br> %<br>|
| **Invesco VI Tech, Ser I** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 446 | $1.92 | to | $8.83 | $2084 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 20.47<br> %<br>| to | 19.39<br> %<br>|
| 2024 | 380 | $1.60 | to | $7.39 | $1747 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 34.27<br> %<br>| to | 33.06<br> %<br>|
| 2023 | 304 | $1.19 | to | $5.56 | $1252 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 46.94<br> %<br>| to | 45.63<br> %<br>|
| 2022 | 207 | $0.81 | to | $3.82 | $782 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp; (20.38 )%<sup>(7)</sup><br>| to | (40.49)%<br>|
| 2021 | 185 | $3.87 | to | $6.41 | $1343 | —<br> %<br>| 0.30<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 14.07<br> %<br>| to | 13.39<br> %<br>|
| **Invesco VI Tech, Ser II** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 5 | $1.91 | to | $1.91 | $10 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 20.16<br> %<br>| to | 20.16<br> %<br>|
| 2024 | 5 | $1.59 | to | $1.59 | $9 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 33.85<br> %<br>| to | 33.85<br> %<br>|
| 2023 | 5 | $1.18 | to | $1.18 | $6 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 46.72<br> %<br>| to | 46.72<br> %<br>|
| 2022 |  | $0.81 | to | $0.81 | $0 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (20.54 )%<sup>(7)</sup><br>| to | (20.54 )%<sup>(7)</sup><br>|
| **Janus Hend VIT Gbl Tech Innov, Srv** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 329 | $2.56 | to | $6.79 | $3196 | —<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 24.59<br> %<br>| to | 23.72<br> %<br>|
| 2024 | 291 | $2.05 | to | $5.49 | $2645 | —<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 31.49<br> %<br>| to | 30.57<br> %<br>|
| 2023 | 312 | $1.56 | to | $4.21 | $2297 | —<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 53.97<br> %<br>| to | 52.90<br> %<br>|
| 2022 | 326 | $1.01 | to | $2.75 | $1612 | —<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 3.74 %<sup>(5)</sup><br>| to | (37.69)%<br>|
| 2021 | 359 | $5.42 | to | $4.41 | $2811 | 0.11<br> %<br>| 0.30<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 17.39<br> %<br>| to | 16.69<br> %<br>|
| **Janus Henderson VIT Bal, Inst** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 688 | $1.97 | to | $1.97 | $1354 | 2.08<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 15.10<br> %<br>| to | 15.10<br> %<br>|
| 2024 | 569 | $1.71 | to | $1.71 | $971 | 2.14<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 15.43<br> %<br>| to | 15.43<br> %<br>|
| 2023 | 498 | $1.48 | to | $1.48 | $737 | 2.24<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 15.41<br> %<br>| to | 15.41<br> %<br>|
| 2022 | 421 | $1.28 | to | $1.28 | $540 | 1.32<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (16.40)%<br>| to | (16.40)%<br>|
| 2021 | 355 | $1.53 | to | $1.53 | $544 | 0.92<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 17.20<br> %<br>| to | 17.20<br> %<br>|
| **Janus Henderson VIT Bal, Serv** |  |  |  |  |  |  |  |  |  |  |  |  |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**180 ■ RiverSource of New York Account 8**

------

---

| | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **At December 31** | **At December 31** | **At December 31** | **At December 31** | **At December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** |
|  | **Units (000s)** | **Accumulation unit** <br> **value**<br> **lowest to highest**<sup>(1)</sup> | **Accumulation unit** <br> **value**<br> **lowest to highest**<sup>(1)</sup> | **Accumulation unit** <br> **value**<br> **lowest to highest**<sup>(1)</sup> | **Net assets** <br> **(000s)**<br>| **Investment** <br> **income ratio**<sup>(2)</sup><br>| **Expense ratio**<br> **lowest to** <br> **highest**<sup>(3)</sup> | **Expense ratio**<br> **lowest to** <br> **highest**<sup>(3)</sup> | **Expense ratio**<br> **lowest to** <br> **highest**<sup>(3)</sup> | &nbsp;&nbsp; **Total return**<br> **lowest to highest**<sup>(1)</sup><sup>,</sup><sup>(4)</sup> | &nbsp;&nbsp; **Total return**<br> **lowest to highest**<sup>(1)</sup><sup>,</sup><sup>(4)</sup> | &nbsp;&nbsp; **Total return**<br> **lowest to highest**<sup>(1)</sup><sup>,</sup><sup>(4)</sup> |
| 2025 | 29 | $2.06 | to | $2.06 | $60 | 1.73<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 14.82<br> %<br>| to | 14.82<br> %<br>|
| 2024 | 28 | $1.80 | to | $1.80 | $51 | 1.61<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 15.15<br> %<br>| to | 15.15<br> %<br>|
| 2023 | 41 | $1.56 | to | $1.56 | $64 | 1.58<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 15.13<br> %<br>| to | 15.13<br> %<br>|
| 2022 | 55 | $1.36 | to | $1.36 | $75 | 1.17<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (16.62)%<br>| to | (16.62)%<br>|
| 2021 | 38 | $1.63 | to | $1.63 | $61 | 0.70<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 16.91<br> %<br>| to | 16.91<br> %<br>|
| **Janus Henderson VIT Enter, Serv** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 113 | $10.30 | to | $4.34 | $949 | 0.05<br> %<br>| 0.45<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 6.93<br> %<br>| to | 6.45<br> %<br>|
| 2024 | 116 | $9.63 | to | $4.08 | $908 | 0.63<br> %<br>| 0.45<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 14.80<br> %<br>| to | 14.28<br> %<br>|
| 2023 | 118 | $8.39 | to | $3.57 | $800 | 0.09<br> %<br>| 0.45<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 17.25<br> %<br>| to | 16.72<br> %<br>|
| 2022 | 123 | $7.15 | to | $3.06 | $710 | 0.08<br> %<br>| 0.45<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp; (16.53)%<br>| to | (16.90)%<br>|
| 2021 | 129 | $8.57 | to | $3.68 | $890 | 0.24<br> %<br>| 0.45<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 16.02<br> %<br>| to | 15.50<br> %<br>|
| **Janus Henderson VIT Flex Bd, Inst** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 481 | $1.18 | to | $1.18 | $568 | 5.63<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 7.40<br> %<br>| to | 7.40<br> %<br>|
| 2024 | 353 | $1.10 | to | $1.10 | $388 | 6.36<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 1.96<br> %<br>| to | 1.96<br> %<br>|
| 2023 | 75 | $1.08 | to | $1.08 | $81 | 5.78<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 5.50<br> %<br>| to | 5.50<br> %<br>|
| 2022 | 35 | $1.02 | to | $1.02 | $36 | 4.36<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (13.66)%<br>| to | (13.66)%<br>|
| 2021 | 3 | $1.18 | to | $1.18 | $4 | 2.32<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (0.90)%<br>| to | (0.90)%<br>|
| **Janus Henderson VIT Flex Bd, Serv** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 44 | $1.29 | to | $1.29 | $57 | 4.70<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 7.23<br> %<br>| to | 7.23<br> %<br>|
| 2024 | 39 | $1.21 | to | $1.21 | $47 | 4.87<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 1.63<br> %<br>| to | 1.63<br> %<br>|
| 2023 | 22 | $1.19 | to | $1.19 | $26 | 3.92<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 5.29<br> %<br>| to | 5.29<br> %<br>|
| 2022 | 7 | $1.13 | to | $1.13 | $8 | 2.08<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (13.90)%<br>| to | (13.90)%<br>|
| 2021 | 6 | $1.31 | to | $1.31 | $8 | 1.72<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (1.11)%<br>| to | (1.11)%<br>|
| **Janus Henderson VIT Overseas,** <br> **Serv**<br>|  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 708 | $1.73 | to | $2.98 | $2213 | 1.34<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 28.32<br> %<br>| to | 27.43<br> %<br>|
| 2024 | 697 | $1.35 | to | $2.34 | $1752 | 1.29<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 5.37<br> %<br>| to | 4.63<br> %<br>|
| 2023 | 746 | $1.28 | to | $2.24 | $1822 | 1.43<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 10.36<br> %<br>| to | 9.60<br> %<br>|
| 2022 | 774 | $1.16 | to | $2.04 | $1736 | 1.69<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 17.25 %<sup>(5)</sup><br>| to | (9.65)%<br>|
| 2021 | 814 | $1.50 | to | $2.26 | $2015 | 1.03<br> %<br>| 0.30<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 12.95<br> %<br>| to | 12.27<br> %<br>|
| **Janus Henderson VIT Res, Inst** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 33 | $3.06 | to | $3.06 | $102 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 18.39<br> %<br>| to | 18.39<br> %<br>|
| 2024 | 28 | $2.59 | to | $2.59 | $73 | 0.03<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 35.31<br> %<br>| to | 35.31<br> %<br>|
| 2023 | 27 | $1.91 | to | $1.91 | $51 | 0.14<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 43.17<br> %<br>| to | 43.17<br> %<br>|
| 2022 | 23 | $1.33 | to | $1.33 | $31 | 0.67<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (29.89)%<br>| to | (29.89)%<br>|
| 2021 | 2 | $1.90 | to | $1.90 | $4 | 0.11<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 20.33<br> %<br>| to | 20.33<br> %<br>|
| **Janus Henderson VIT Res, Serv** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 131 | $6.56 | to | $6.05 | $892 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 18.10<br> %<br>| to | 17.04<br> %<br>|
| 2024 | 128 | $5.56 | to | $5.17 | $803 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 34.96<br> %<br>| to | 33.74<br> %<br>|
| 2023 | 126 | $4.12 | to | $3.86 | $618 | 0.06<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 42.81<br> %<br>| to | 41.54<br> %<br>|
| 2022 | 130 | $2.88 | to | $2.73 | $454 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp; (30.06)%<br>| to | (30.69)%<br>|
| 2021 | 143 | $4.12 | to | $3.94 | $697 | 0.02<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 20.05<br> %<br>| to | 18.97<br> %<br>|
| **Lazard Ret Global Dyn MA, Inv** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 17 | $1.43 | to | $1.43 | $24 | 1.32<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 15.98<br> %<br>| to | 15.98<br> %<br>|
| 2024 | 13 | $1.23 | to | $1.23 | $16 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 8.64<br> %<br>| to | 8.64<br> %<br>|
| 2023 | 10 | $1.14 | to | $1.14 | $12 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 11.06<br> %<br>| to | 11.06<br> %<br>|
| 2022 | 2 | $1.02 | to | $1.02 | $2 | 0.28<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (17.28)%<br>| to | (17.28)%<br>|
| 2021 | 1 | $1.24 | to | $1.24 | $2 | 3.53<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 12.16<br> %<br>| to | 12.16<br> %<br>|
| **Lazard Ret Global Dyn MA, Serv** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 12 | $1.94 | to | $1.59 | $21 | 1.08<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 15.73<br> %<br>| to | 14.69<br> %<br>|
| 2024 | 11 | $1.68 | to | $1.39 | $16 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 8.60<br> %<br>| to | 7.62<br> %<br>|
| 2023 | 12 | $1.55 | to | $1.29 | $17 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 10.81<br> %<br>| to | 9.82<br> %<br>|
| 2022 | 13 | $1.40 | to | $1.17 | $16 | 0.08<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp; (17.37)%<br>| to | (18.11)%<br>|
| 2021 | 20 | $1.69 | to | $1.43 | $30 | 2.76<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 11.94<br> %<br>| to | 10.93<br> %<br>|

---

**RiverSource of New York Account 8** ■ 181

------

---

| | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **At December 31** | **At December 31** | **At December 31** | **At December 31** | **At December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** |
|  | **Units (000s)** | **Accumulation unit** <br> **value**<br> **lowest to highest**<sup>(1)</sup> | **Accumulation unit** <br> **value**<br> **lowest to highest**<sup>(1)</sup> | **Accumulation unit** <br> **value**<br> **lowest to highest**<sup>(1)</sup> | **Net assets** <br> **(000s)**<br>| **Investment** <br> **income ratio**<sup>(2)</sup><br>| **Expense ratio**<br> **lowest to** <br> **highest**<sup>(3)</sup> | **Expense ratio**<br> **lowest to** <br> **highest**<sup>(3)</sup> | **Expense ratio**<br> **lowest to** <br> **highest**<sup>(3)</sup> | &nbsp;&nbsp; **Total return**<br> **lowest to highest**<sup>(1)</sup><sup>,</sup><sup>(4)</sup> | &nbsp;&nbsp; **Total return**<br> **lowest to highest**<sup>(1)</sup><sup>,</sup><sup>(4)</sup> | &nbsp;&nbsp; **Total return**<br> **lowest to highest**<sup>(1)</sup><sup>,</sup><sup>(4)</sup> |
| **Lord Abt Bond Debenture, Cl VC** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 23 | $1.15 | to | $1.15 | $26 | 7.19<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 8.33<br> %<br>| to | 8.33<br> %<br>|
| 2024 | 20 | $1.07 | to | $1.07 | $21 | 19.21<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 6.93 %<sup>(6)</sup><br>| to | 6.93 %<sup>(6)</sup><br>|
| **LVIP AC Intl, Serv Cl** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 431 | $1.52 | to | $3.36 | $760 | 1.11<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 15.58<br> %<br>| to | 14.78<br> %<br>|
| 2024 | 424 | $1.31 | to | $2.93 | $660 | 1.30<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 2.25<br> %<br>| to | 1.54<br> %<br>|
| 2023 | 510 | $1.29 | to | $2.88 | $786 | 1.22<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 12.20<br> %<br>| to | 11.43<br> %<br>|
| 2022 | 505 | $1.15 | to | $2.59 | $701 | 1.29<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 15.50 %<sup>(5)</sup><br>| to | (25.54)%<br>|
| 2021 | 499 | $1.87 | to | $3.47 | $926 | 0.02<br> %<br>| 0.30<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 8.28<br> %<br>| to | 7.63<br> %<br>|
| **LVIP AC Intl, Std Cl II** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 240 | $3.59 | to | $2.09 | $664 | 1.22<br> %<br>| 0.45<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 15.46<br> %<br>| to | 14.95<br> %<br>|
| 2024 | 246 | $3.11 | to | $1.82 | $588 | 1.53<br> %<br>| 0.45<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 2.14<br> %<br>| to | 1.68<br> %<br>|
| 2023 | 315 | $3.05 | to | $1.79 | $701 | 1.40<br> %<br>| 0.45<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 12.07<br> %<br>| to | 11.57<br> %<br>|
| 2022 | 335 | $2.72 | to | $1.60 | $665 | 1.48<br> %<br>| 0.45<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp; (25.09)%<br>| to | (25.43)%<br>|
| 2021 | 355 | $3.63 | to | $2.15 | $928 | 0.16<br> %<br>| 0.45<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 8.26<br> %<br>| to | 7.78<br> %<br>|
| **LVIP AC Mid Cap Val, Std Cl II** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 41 | $1.19 | to | $1.19 | $49 | 2.48<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 9.00<br> %<br>| to | 9.00<br> %<br>|
| 2024 | 22 | $1.09 | to | $1.09 | $24 | 4.52<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 9.75 %<sup>(6)</sup><br>| to | 9.75 %<sup>(6)</sup><br>|
| **LVIP AC Val, Serv Cl** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 994 | $3.71 | to | $5.34 | $2645 | 1.52<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 15.85<br> %<br>| to | 14.82<br> %<br>|
| 2024 | 958 | $3.20 | to | $4.65 | $2349 | 2.74<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 9.29<br> %<br>| to | 8.30<br> %<br>|
| 2023 | 1021 | $2.93 | to | $4.29 | $2353 | 2.21<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 9.02<br> %<br>| to | 8.05<br> %<br>|
| 2022 | 1156 | $2.69 | to | $3.97 | $2448 | 1.95<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 0.31<br> %<br>| to | (0.59)%<br>|
| 2021 | 1182 | $2.68 | to | $4.00 | $2521 | 1.60<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 24.28<br> %<br>| to | 23.17<br> %<br>|
| **LVIP AC Val, Std Cl II** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 755 | $1.99 | to | $6.44 | $4184 | 1.63<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 16.02<br> %<br>| to | 14.98<br> %<br>|
| 2024 | 790 | $1.72 | to | $5.60 | $3866 | 2.81<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 9.48<br> %<br>| to | 8.49<br> %<br>|
| 2023 | 875 | $1.57 | to | $5.16 | $4043 | 2.39<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 9.10<br> %<br>| to | 8.12<br> %<br>|
| 2022 | 912 | $1.44 | to | $4.77 | $3973 | 2.10<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 0.54<br> %<br>| to | (0.36)%<br>|
| 2021 | 918 | $1.43 | to | $4.79 | $4099 | 1.75<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 24.51<br> %<br>| to | 23.39<br> %<br>|
| **MFS Gbl Real Est, Init Cl** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 0 | $1.02 | to | $1.02 | $0 | 1.76<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 3.53<br> %<br>| to | 3.53<br> %<br>|
| 2024 |  | $0.99 | to | $0.99 | $0 | 2.19<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (0.16 )%<sup>(6)</sup><br>| to | (0.16 )%<sup>(6)</sup><br>|
| **MFS Intl Gro, Init Cl** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 177 | $1.34 | to | $1.34 | $236 | 1.05<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 21.12<br> %<br>| to | 21.12<br> %<br>|
| 2024 | 67 | $1.11 | to | $1.11 | $74 | 1.32<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 11.67 %<sup>(6)</sup><br>| to | 11.67 %<sup>(6)</sup><br>|
| **MFS Mass Inv Gro Stock, Serv Cl** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 847 | $1.67 | to | $3.31 | $2872 | 0.02<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 9.39<br> %<br>| to | 8.62<br> %<br>|
| 2024 | 1101 | $1.53 | to | $3.04 | $3434 | 0.13<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 15.75<br> %<br>| to | 14.94<br> %<br>|
| 2023 | 1138 | $1.32 | to | $2.65 | $3106 | 0.05<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 23.45<br> %<br>| to | 22.60<br> %<br>|
| 2022 | 1184 | $1.07 | to | $2.16 | $2623 | —<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 8.09 %<sup>(5)</sup><br>| to | (20.17)%<br>|
| 2021 | 1293 | $2.82 | to | $2.71 | $3574 | 0.03<br> %<br>| 0.30<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 25.28<br> %<br>| to | 24.53<br> %<br>|
| **MFS New Dis, Serv Cl** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 480 | $1.41 | to | $4.34 | $2131 | —<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 12.33<br> %<br>| to | 11.55<br> %<br>|
| 2024 | 475 | $1.26 | to | $3.89 | $1994 | —<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 6.22<br> %<br>| to | 5.48<br> %<br>|
| 2023 | 462 | $1.18 | to | $3.69 | $2011 | —<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 14.03<br> %<br>| to | 13.23<br> %<br>|
| 2022 | 448 | $1.04 | to | $3.26 | $1822 | —<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 5.44 %<sup>(5)</sup><br>| to | (30.62)%<br>|
| 2021 | 473 | $2.81 | to | $4.70 | $2729 | —<br> %<br>| 0.30<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 1.27<br> %<br>| to | 0.66<br> %<br>|
| **MFS Utilities, Init Cl** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 85 | $1.76 | to | $1.76 | $149 | 3.09<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 15.01<br> %<br>| to | 15.01<br> %<br>|
| 2024 | 61 | $1.53 | to | $1.53 | $93 | 2.30<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 11.66<br> %<br>| to | 11.66<br> %<br>|
| 2023 | 55 | $1.37 | to | $1.37 | $75 | 3.73<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (2.11)%<br>| to | (2.11)%<br>|
| 2022 | 37 | $1.40 | to | $1.40 | $51 | 2.48<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 0.76<br> %<br>| to | 0.76<br> %<br>|
| 2021 | 23 | $1.39 | to | $1.39 | $32 | 1.80<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 14.09<br> %<br>| to | 14.09<br> %<br>|

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**182 ■ RiverSource of New York Account 8**

------

---

| | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **At December 31** | **At December 31** | **At December 31** | **At December 31** | **At December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** |
|  | **Units (000s)** | **Accumulation unit** <br> **value**<br> **lowest to highest**<sup>(1)</sup> | **Accumulation unit** <br> **value**<br> **lowest to highest**<sup>(1)</sup> | **Accumulation unit** <br> **value**<br> **lowest to highest**<sup>(1)</sup> | **Net assets** <br> **(000s)**<br>| **Investment** <br> **income ratio**<sup>(2)</sup><br>| **Expense ratio**<br> **lowest to** <br> **highest**<sup>(3)</sup> | **Expense ratio**<br> **lowest to** <br> **highest**<sup>(3)</sup> | **Expense ratio**<br> **lowest to** <br> **highest**<sup>(3)</sup> | &nbsp;&nbsp; **Total return**<br> **lowest to highest**<sup>(1)</sup><sup>,</sup><sup>(4)</sup> | &nbsp;&nbsp; **Total return**<br> **lowest to highest**<sup>(1)</sup><sup>,</sup><sup>(4)</sup> | &nbsp;&nbsp; **Total return**<br> **lowest to highest**<sup>(1)</sup><sup>,</sup><sup>(4)</sup> |
| **MFS Utilities, Serv Cl** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 354 | $2.76 | to | $7.46 | $1226 | 2.73<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 14.76<br> %<br>| to | 13.73<br> %<br>|
| 2024 | 352 | $2.41 | to | $6.56 | $1144 | 2.09<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 11.34<br> %<br>| to | 10.34<br> %<br>|
| 2023 | 325 | $2.16 | to | $5.95 | $1061 | 3.38<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp; (2.33)%<br>| to | (3.20)%<br>|
| 2022 | 324 | $2.22 | to | $6.14 | $1130 | 2.23<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 0.48<br> %<br>| to | (0.42)%<br>|
| 2021 | 328 | $2.20 | to | $6.17 | $1163 | 1.54<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 13.82<br> %<br>| to | 12.80<br> %<br>|
| **MS VIF Dis, Cl I** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 316 | $2.18 | to | $2.18 | $688 | 0.42<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 12.58<br> %<br>| to | 12.58<br> %<br>|
| 2024 | 273 | $1.93 | to | $1.93 | $527 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 41.83<br> %<br>| to | 41.83<br> %<br>|
| 2023 | 266 | $1.36 | to | $1.36 | $362 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 44.34<br> %<br>| to | 44.34<br> %<br>|
| 2022 | 135 | $0.94 | to | $0.94 | $127 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (62.96)%<br>| to | (62.96)%<br>|
| 2021 | 31 | $2.55 | to | $2.55 | $79 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (11.06)%<br>| to | (11.06)%<br>|
| **MS VIF Dis, Cl II** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 230 | $5.00 | to | $5.04 | $1438 | 0.39<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 12.44<br> %<br>| to | 11.43<br> %<br>|
| 2024 | 195 | $4.44 | to | $4.53 | $1150 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 41.73<br> %<br>| to | 40.45<br> %<br>|
| 2023 | 176 | $3.14 | to | $3.22 | $792 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 44.13<br> %<br>| to | 42.84<br> %<br>|
| 2022 | 163 | $2.18 | to | $2.26 | $529 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp; (62.97)%<br>| to | (63.30)%<br>|
| 2021 | 183 | $5.87 | to | $6.15 | $1519 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp; (11.19)%<br>| to | (11.99)%<br>|
| **NB AMT Quality Eq, Cl I** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 25 | $2.46 | to | $2.46 | $60 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 13.74<br> %<br>| to | 13.74<br> %<br>|
| 2024 | 23 | $2.17 | to | $2.17 | $49 | 0.24<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 25.84<br> %<br>| to | 25.84<br> %<br>|
| 2023 | 19 | $1.72 | to | $1.72 | $33 | 0.40<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 26.90<br> %<br>| to | 26.90<br> %<br>|
| 2022 | 10 | $1.36 | to | $1.36 | $14 | 0.61<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (18.45)%<br>| to | (18.45)%<br>|
| 2021 | 3 | $1.66 | to | $1.66 | $5 | 0.56<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 23.48<br> %<br>| to | 23.48<br> %<br>|
| **NB AMT Quality Eq, Cl S** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 18 | $4.93 | to | $4.93 | $88 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 13.43<br> %<br>| to | 13.43<br> %<br>|
| 2024 | 14 | $4.34 | to | $4.34 | $61 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 25.52<br> %<br>| to | 25.52<br> %<br>|
| 2023 | 13 | $3.46 | to | $3.46 | $46 | 0.08<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 26.57<br> %<br>| to | 26.57<br> %<br>|
| 2022 | 13 | $2.73 | to | $2.73 | $35 | 0.14<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (18.65)%<br>| to | (18.65)%<br>|
| 2021 | 7 | $3.36 | to | $3.36 | $24 | 0.19<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 23.16<br> %<br>| to | 23.16<br> %<br>|
| **Nom VIP Asset Strategy, Serv Cl** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 26 | $2.01 | to | $1.70 | $52 | 1.32<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 16.66<br> %<br>| to | 15.62<br> %<br>|
| 2024 | 34 | $1.72 | to | $1.47 | $55 | 1.82<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 12.44<br> %<br>| to | 11.42<br> %<br>|
| 2023 | 37 | $1.53 | to | $1.32 | $55 | 1.78<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 13.94<br> %<br>| to | 12.92<br> %<br>|
| 2022 | 50 | $1.35 | to | $1.17 | $63 | 1.60<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp; (14.74)%<br>| to | (15.50)%<br>|
| 2021 | 51 | $1.58 | to | $1.38 | $74 | 1.32<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 10.44<br> %<br>| to | 9.45<br> %<br>|
| **Nom VIP Asset Strategy, Std Cl** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 0 | $1.31 | to | $1.31 | $0 | 1.93<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 16.88<br> %<br>| to | 16.88<br> %<br>|
| 2024 | 0 | $1.12 | to | $1.12 | $0 | 2.57<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 13.40 %<sup>(6)</sup><br>| to | 13.40 %<sup>(6)</sup><br>|
| **Nom VIP Intl Core Eq, Std Cl** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 |  | $1.24 | to | $1.24 | $0 | 1.31<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 24.55<br> %<br>| to | 24.55<br> %<br>|
| 2024 |  | $1.00 | to | $1.00 | $0 | 1.84<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (0.41 )%<sup>(9)</sup><br>| to | (0.41 )%<sup>(9)</sup><br>|
| **PIMCO VIT All Asset, Advisor Cl** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 270 | $1.77 | to | $2.10 | $622 | 4.52<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 14.19<br> %<br>| to | 13.17<br> %<br>|
| 2024 | 269 | $1.55 | to | $1.86 | $579 | 6.27<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 3.57<br> %<br>| to | 2.64<br> %<br>|
| 2023 | 298 | $1.50 | to | $1.81 | $616 | 2.84<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 8.02<br> %<br>| to | 7.05<br> %<br>|
| 2022 | 325 | $1.39 | to | $1.69 | $611 | 7.44<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp; (11.87)%<br>| to | (12.66)%<br>|
| 2021 | 384 | $1.58 | to | $1.94 | $820 | 11.21<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 16.04<br> %<br>| to | 15.00<br> %<br>|
| **PIMCO VIT All Asset, Inst Cl** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 14 | $1.53 | to | $1.53 | $21 | 4.76<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 14.34<br> %<br>| to | 14.34<br> %<br>|
| 2024 | 12 | $1.33 | to | $1.33 | $16 | 6.56<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 3.95<br> %<br>| to | 3.95<br> %<br>|
| 2023 | 10 | $1.28 | to | $1.28 | $13 | 3.17<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 8.28<br> %<br>| to | 8.28<br> %<br>|
| 2022 | 7 | $1.19 | to | $1.19 | $9 | 8.47<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (11.66)%<br>| to | (11.66)%<br>|
| 2021 | 4 | $1.34 | to | $1.34 | $6 | 12.05<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 16.41<br> %<br>| to | 16.41<br> %<br>|

---

**RiverSource of New York Account 8** ■ 183

------

---

| | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **At December 31** | **At December 31** | **At December 31** | **At December 31** | **At December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** |
|  | **Units (000s)** | **Accumulation unit** <br> **value**<br> **lowest to highest**<sup>(1)</sup> | **Accumulation unit** <br> **value**<br> **lowest to highest**<sup>(1)</sup> | **Accumulation unit** <br> **value**<br> **lowest to highest**<sup>(1)</sup> | **Net assets** <br> **(000s)**<br>| **Investment** <br> **income ratio**<sup>(2)</sup><br>| **Expense ratio**<br> **lowest to** <br> **highest**<sup>(3)</sup> | **Expense ratio**<br> **lowest to** <br> **highest**<sup>(3)</sup> | **Expense ratio**<br> **lowest to** <br> **highest**<sup>(3)</sup> | &nbsp;&nbsp; **Total return**<br> **lowest to highest**<sup>(1)</sup><sup>,</sup><sup>(4)</sup> | &nbsp;&nbsp; **Total return**<br> **lowest to highest**<sup>(1)</sup><sup>,</sup><sup>(4)</sup> | &nbsp;&nbsp; **Total return**<br> **lowest to highest**<sup>(1)</sup><sup>,</sup><sup>(4)</sup> |
| **PIMCO VIT Glb Man As Alloc, Adv** <br> **Cl**<br>|  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 3 | $2.06 | to | $2.06 | $7 | 4.31<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 21.77<br> %<br>| to | 21.77<br> %<br>|
| 2024 | 3 | $1.70 | to | $1.70 | $6 | 3.42<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 10.76<br> %<br>| to | 10.76<br> %<br>|
| 2023 | 4 | $1.53 | to | $1.53 | $6 | 2.18<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 12.85<br> %<br>| to | 12.85<br> %<br>|
| 2022 | 4 | $1.36 | to | $1.36 | $5 | 1.92<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (18.40)%<br>| to | (18.40)%<br>|
| 2021 | 4 | $1.66 | to | $1.66 | $7 | 2.31<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 12.60<br> %<br>| to | 12.60<br> %<br>|
| **PIMCO VIT Tot Return, Advisor Cl** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 726 | $1.30 | to | $1.15 | $872 | 4.00<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 8.78<br> %<br>| to | 7.81<br> %<br>|
| 2024 | 465 | $1.20 | to | $1.07 | $519 | 3.92<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 2.43<br> %<br>| to | 1.51<br> %<br>|
| 2023 | 398 | $1.17 | to | $1.05 | $435 | 3.48<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 5.83<br> %<br>| to | 4.88<br> %<br>|
| 2022 | 367 | $1.11 | to | $1.00 | $382 | 2.53<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp; (14.39)%<br>| to | (15.15)%<br>|
| 2021 | 349 | $1.29 | to | $1.18 | $426 | 1.73<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp; (1.37)%<br>| to | (2.25)%<br>|
| **PIMCO VIT Tot Return, Inst Cl** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 284 | $1.17 | to | $1.17 | $332 | 4.25<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 9.05<br> %<br>| to | 9.05<br> %<br>|
| 2024 | 155 | $1.07 | to | $1.07 | $167 | 4.17<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 2.69<br> %<br>| to | 2.69<br> %<br>|
| 2023 | 110 | $1.05 | to | $1.05 | $115 | 3.73<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 6.09<br> %<br>| to | 6.09<br> %<br>|
| 2022 | 68 | $0.99 | to | $0.99 | $67 | 2.87<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (14.17)%<br>| to | (14.17)%<br>|
| 2021 | 35 | $1.15 | to | $1.15 | $41 | 1.98<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (1.12)%<br>| to | (1.12)%<br>|
| **Put VT Global Hlth Care, Cl IA** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 71 | $1.32 | to | $1.32 | $94 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 15.34<br> %<br>| to | 15.34<br> %<br>|
| 2024 | 55 | $1.14 | to | $1.14 | $62 | 0.62<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 1.70<br> %<br>| to | 1.70<br> %<br>|
| 2023 | 39 | $1.12 | to | $1.12 | $44 | 0.39<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 9.39<br> %<br>| to | 9.39<br> %<br>|
| 2022 | 13 | $1.03 | to | $1.03 | $13 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 3.27 %<sup>(7)</sup><br>| to | 3.27 %<sup>(7)</sup><br>|
| **Put VT Global Hlth Care, Cl IB** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 335 | $1.30 | to | $6.19 | $1439 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 15.05<br> %<br>| to | 14.02<br> %<br>|
| 2024 | 338 | $1.13 | to | $5.43 | $1377 | 0.46<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 1.43<br> %<br>| to | 0.51<br> %<br>|
| 2023 | 324 | $1.12 | to | $5.40 | $1404 | 0.30<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 9.14<br> %<br>| to | 8.16<br> %<br>|
| 2022 | 323 | $1.02 | to | $4.99 | $1349 | 0.40<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 3.12 %<sup>(7)</sup><br>| to | (5.53)%<br>|
| 2021 | 298 | $2.72 | to | $5.29 | $1439 | 1.10<br> %<br>| 0.30<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 19.04<br> %<br>| to | 18.33<br> %<br>|
| **Put VT Hi Yield, Cl IB** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 80 | $3.25 | to | $3.56 | $274 | 6.09<br> %<br>| 0.45<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 8.19<br> %<br>| to | 7.70<br> %<br>|
| 2024 | 81 | $3.00 | to | $3.30 | $256 | 5.71<br> %<br>| 0.45<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 7.38<br> %<br>| to | 6.89<br> %<br>|
| 2023 | 85 | $2.79 | to | $3.09 | $252 | 5.32<br> %<br>| 0.45<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 11.64<br> %<br>| to | 11.13<br> %<br>|
| 2022 | 88 | $2.50 | to | $2.78 | $234 | 5.48<br> %<br>| 0.45<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp; (12.00)%<br>| to | (12.39)%<br>|
| 2021 | 108 | $2.84 | to | $3.17 | $328 | 5.61<br> %<br>| 0.45<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 4.51<br> %<br>| to | 4.03<br> %<br>|
| **Put VT Intl Eq, Cl IB** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 83 | $1.93 | to | $3.49 | $222 | 0.01<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 37.41<br> %<br>| to | 36.45<br> %<br>|
| 2024 | 82 | $1.40 | to | $2.56 | $179 | 2.03<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 2.77<br> %<br>| to | 2.04<br> %<br>|
| 2023 | 73 | $1.37 | to | $2.51 | $162 | 0.04<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 18.26<br> %<br>| to | 17.45<br> %<br>|
| 2022 | 73 | $1.15 | to | $2.14 | $140 | 1.54<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 16.28 %<sup>(5)</sup><br>| to | (15.53)%<br>|
| 2021 | 73 | $1.58 | to | $2.53 | $167 | 1.20<br> %<br>| 0.30<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 8.50<br> %<br>| to | 7.85<br> %<br>|
| **Put VT Intl Val, Cl IA** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 62 | $1.44 | to | $1.44 | $90 | 0.06<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 35.07<br> %<br>| to | 35.07<br> %<br>|
| 2024 | 2 | $1.07 | to | $1.07 | $3 | 0.13<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 8.35 %<sup>(6)</sup><br>| to | 8.35 %<sup>(6)</sup><br>|
| **Put VT Lg Cap Val, Cl IA** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 158 | $1.44 | to | $1.44 | $227 | 0.59<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 20.66<br> %<br>| to | 20.66<br> %<br>|
| 2024 | 36 | $1.20 | to | $1.20 | $43 | 0.23<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 20.16 %<sup>(6)</sup><br>| to | 20.16 %<sup>(6)</sup><br>|
| **Put VT Sus Leaders, Cl IA** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 1555 | $10.77 | to | $8.98 | $14183 | 0.88<br> %<br>| 0.45<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 10.49<br> %<br>| to | 10.00<br> %<br>|
| 2024 | 1737 | $9.75 | to | $8.16 | $14435 | 0.38<br> %<br>| 0.45<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 22.78<br> %<br>| to | 22.22<br> %<br>|
| 2023 | 1848 | $7.94 | to | $6.68 | $12550 | 0.75<br> %<br>| 0.45<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 25.85<br> %<br>| to | 25.29<br> %<br>|
| 2022 | 1950 | $6.31 | to | $5.33 | $10570 | 0.83<br> %<br>| 0.45<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp; (23.07)%<br>| to | (23.41)%<br>|
| 2021 | 2067 | $8.20 | to | $6.96 | $14623 | 0.34<br> %<br>| 0.45<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 23.28<br> %<br>| to | 22.73<br> %<br>|

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**184 ■ RiverSource of New York Account 8**

------

---

| | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **At December 31** | **At December 31** | **At December 31** | **At December 31** | **At December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** |
|  | **Units (000s)** | **Accumulation unit** <br> **value**<br> **lowest to highest**<sup>(1)</sup> | **Accumulation unit** <br> **value**<br> **lowest to highest**<sup>(1)</sup> | **Accumulation unit** <br> **value**<br> **lowest to highest**<sup>(1)</sup> | **Net assets** <br> **(000s)**<br>| **Investment** <br> **income ratio**<sup>(2)</sup><br>| **Expense ratio**<br> **lowest to** <br> **highest**<sup>(3)</sup> | **Expense ratio**<br> **lowest to** <br> **highest**<sup>(3)</sup> | **Expense ratio**<br> **lowest to** <br> **highest**<sup>(3)</sup> | &nbsp;&nbsp; **Total return**<br> **lowest to highest**<sup>(1)</sup><sup>,</sup><sup>(4)</sup> | &nbsp;&nbsp; **Total return**<br> **lowest to highest**<sup>(1)</sup><sup>,</sup><sup>(4)</sup> | &nbsp;&nbsp; **Total return**<br> **lowest to highest**<sup>(1)</sup><sup>,</sup><sup>(4)</sup> |
| **Put VT Sus Leaders, Cl IB** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 47 | $1.78 | to | $6.66 | $217 | 0.65<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 10.47<br> %<br>| to | 9.70<br> %<br>|
| 2024 | 44 | $1.61 | to | $6.07 | $199 | 0.20<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 22.78<br> %<br>| to | 21.91<br> %<br>|
| 2023 | 31 | $1.31 | to | $4.98 | $150 | 0.46<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 25.86<br> %<br>| to | 24.98<br> %<br>|
| 2022 | 23 | $1.04 | to | $3.99 | $98 | 0.54<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 5.04 %<sup>(5)</sup><br>| to | (23.60)%<br>|
| 2021 | 24 | $3.73 | to | $5.22 | $131 | 0.15<br> %<br>| 0.30<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 23.16<br> %<br>| to | 22.43<br> %<br>|
| **Royce Micro-Cap, Invest Cl** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 360 | $5.21 | to | $6.46 | $2073 | —<br> %<br>| 0.45<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 13.38<br> %<br>| to | 12.87<br> %<br>|
| 2024 | 380 | $4.60 | to | $5.72 | $1936 | —<br> %<br>| 0.45<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 13.16<br> %<br>| to | 12.65<br> %<br>|
| 2023 | 436 | $4.06 | to | $5.08 | $1977 | —<br> %<br>| 0.45<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 18.25<br> %<br>| to | 17.72<br> %<br>|
| 2022 | 447 | $3.43 | to | $4.32 | $1720 | —<br> %<br>| 0.45<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp; (22.78)%<br>| to | (23.13)%<br>|
| 2021 | 480 | $4.45 | to | $5.61 | $2399 | —<br> %<br>| 0.45<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 29.40<br> %<br>| to | 28.82<br> %<br>|
| **Temp Global Bond, Cl 1** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 42 | $0.91 | to | $0.91 | $38 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 16.09<br> %<br>| to | 16.09<br> %<br>|
| 2024 | 35 | $0.78 | to | $0.78 | $27 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (11.13)%<br>| to | (11.13)%<br>|
| 2023 | 31 | $0.88 | to | $0.88 | $27 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 3.19<br> %<br>| to | 3.19<br> %<br>|
| 2022 | 26 | $0.85 | to | $0.85 | $22 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (4.85)%<br>| to | (4.85)%<br>|
| 2021 | 23 | $0.90 | to | $0.90 | $20 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (4.62)%<br>| to | (4.62)%<br>|
| **Temp Global Bond, Cl 2** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 173 | $0.98 | to | $0.84 | $157 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 15.73<br> %<br>| to | 14.69<br> %<br>|
| 2024 | 199 | $0.85 | to | $0.73 | $157 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp; (11.37)%<br>| to | (12.17)%<br>|
| 2023 | 230 | $0.95 | to | $0.84 | $203 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 2.88<br> %<br>| to | 1.97<br> %<br>|
| 2022 | 205 | $0.93 | to | $0.82 | $176 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp; (4.95)%<br>| to | (5.80)%<br>|
| 2021 | 206 | $0.98 | to | $0.87 | $187 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp; (4.99)%<br>| to | (5.84)%<br>|
| **Third Ave VST Third Ave Value** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 560 | $4.78 | to | $5.11 | $2754 | 2.31<br> %<br>| 0.45<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 34.24<br> %<br>| to | 33.64<br> %<br>|
| 2024 | 595 | $3.56 | to | $3.82 | $2182 | 2.54<br> %<br>| 0.45<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp; (2.71)%<br>| to | (3.15)%<br>|
| 2023 | 653 | $3.66 | to | $3.95 | $2466 | 2.36<br> %<br>| 0.45<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 20.27<br> %<br>| to | 19.73<br> %<br>|
| 2022 | 701 | $3.04 | to | $3.30 | $2208 | 1.51<br> %<br>| 0.45<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 15.59<br> %<br>| to | 15.07<br> %<br>|
| 2021 | 721 | $2.63 | to | $2.87 | $1981 | 0.69<br> %<br>| 0.45<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 21.51<br> %<br>| to | 20.97<br> %<br>|
| **VanEck VIP Global Gold, Cl S** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 134 | $4.10 | to | $3.48 | $499 | 1.40<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 164.43<br> %<br>| to | 162.07<br> %<br>|
| 2024 | 135 | $1.55 | to | $1.33 | $192 | 2.63<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 14.41<br> %<br>| to | 13.38<br> %<br>|
| 2023 | 116 | $1.35 | to | $1.17 | $145 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 10.41<br> %<br>| to | 9.42<br> %<br>|
| 2022 | 112 | $1.23 | to | $1.07 | $127 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp; (13.36)%<br>| to | (14.13)%<br>|
| 2021 | 110 | $1.42 | to | $1.25 | $145 | 11.22<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp; (14.01)%<br>| to | (14.78)%<br>|
| **VP Aggr, Cl 1** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 2780 | $1.92 | to | $1.92 | $5327 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 17.94<br> %<br>| to | 17.94<br> %<br>|
| 2024 | 2486 | $1.62 | to | $1.62 | $4039 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 13.49<br> %<br>| to | 13.49<br> %<br>|
| 2023 | 1166 | $1.43 | to | $1.43 | $1669 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 17.51<br> %<br>| to | 17.51<br> %<br>|
| 2022 | 559 | $1.22 | to | $1.22 | $681 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (17.99)%<br>| to | (17.99)%<br>|
| 2021 | 269 | $1.49 | to | $1.49 | $400 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 16.03<br> %<br>| to | 16.03<br> %<br>|
| **VP Aggr, Cl 2** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 10438 | $3.03 | to | $3.25 | $31188 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 17.63<br> %<br>| to | 16.58<br> %<br>|
| 2024 | 10899 | $2.58 | to | $2.79 | $27791 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 13.20<br> %<br>| to | 12.18<br> %<br>|
| 2023 | 11567 | $2.28 | to | $2.48 | $26120 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 17.22<br> %<br>| to | 16.18<br> %<br>|
| 2022 | 10747 | $1.94 | to | $2.14 | $20899 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp; (18.19)%<br>| to | (18.92)%<br>|
| 2021 | 10581 | $2.38 | to | $2.64 | $25283 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 15.76<br> %<br>| to | 14.72<br> %<br>|
| **VP Aggr, Cl 4** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 9920 | $1.66 | to | $3.25 | $28240 | —<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 17.40<br> %<br>| to | 16.58<br> %<br>|
| 2024 | 10126 | $1.42 | to | $2.79 | $25535 | —<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 12.99<br> %<br>| to | 12.19<br> %<br>|
| 2023 | 9987 | $1.25 | to | $2.49 | $23651 | —<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 16.96<br> %<br>| to | 16.15<br> %<br>|
| 2022 | 10359 | $1.07 | to | $2.14 | $21227 | —<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 7.96 %<sup>(5)</sup><br>| to | (18.92)%<br>|
| 2021 | 10513 | $2.04 | to | $2.64 | $26365 | —<br> %<br>| 0.30<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 15.43<br> %<br>| to | 14.74<br> %<br>|

---

**RiverSource of New York Account 8** ■ 185

------

---

| | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **At December 31** | **At December 31** | **At December 31** | **At December 31** | **At December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** |
|  | **Units (000s)** | **Accumulation unit** <br> **value**<br> **lowest to highest**<sup>(1)</sup> | **Accumulation unit** <br> **value**<br> **lowest to highest**<sup>(1)</sup> | **Accumulation unit** <br> **value**<br> **lowest to highest**<sup>(1)</sup> | **Net assets** <br> **(000s)**<br>| **Investment** <br> **income ratio**<sup>(2)</sup><br>| **Expense ratio**<br> **lowest to** <br> **highest**<sup>(3)</sup> | **Expense ratio**<br> **lowest to** <br> **highest**<sup>(3)</sup> | **Expense ratio**<br> **lowest to** <br> **highest**<sup>(3)</sup> | &nbsp;&nbsp; **Total return**<br> **lowest to highest**<sup>(1)</sup><sup>,</sup><sup>(4)</sup> | &nbsp;&nbsp; **Total return**<br> **lowest to highest**<sup>(1)</sup><sup>,</sup><sup>(4)</sup> | &nbsp;&nbsp; **Total return**<br> **lowest to highest**<sup>(1)</sup><sup>,</sup><sup>(4)</sup> |
| **VP Conserv, Cl 1** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 |  | $1.29 | to | $1.29 | $0 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 10.55<br> %<br>| to | 10.55<br> %<br>|
| 2024 |  | $1.17 | to | $1.17 | $0 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 4.69<br> %<br>| to | 4.69<br> %<br>|
| 2023 |  | $1.12 | to | $1.12 | $0 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 8.65<br> %<br>| to | 8.65<br> %<br>|
| 2022 |  | $1.03 | to | $1.03 | $0 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (15.26)%<br>| to | (15.26)%<br>|
| 2021 |  | $1.21 | to | $1.21 | $0 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 3.05<br> %<br>| to | 3.05<br> %<br>|
| **VP Conserv, Cl 2** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 408 | $1.53 | to | $1.54 | $629 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 10.21<br> %<br>| to | 9.22<br> %<br>|
| 2024 | 644 | $1.38 | to | $1.41 | $900 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 4.42<br> %<br>| to | 3.48<br> %<br>|
| 2023 | 430 | $1.33 | to | $1.36 | $583 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 8.46<br> %<br>| to | 7.49<br> %<br>|
| 2022 | 436 | $1.22 | to | $1.26 | $550 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp; (15.54)%<br>| to | (16.30)%<br>|
| 2021 | 417 | $1.45 | to | $1.51 | $633 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 2.82<br> %<br>| to | 1.89<br> %<br>|
| **VP Conserv, Cl 4** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 377 | $1.28 | to | $1.54 | $583 | —<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 9.99<br> %<br>| to | 9.22<br> %<br>|
| 2024 | 433 | $1.16 | to | $1.41 | $615 | —<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 4.28<br> %<br>| to | 3.55<br> %<br>|
| 2023 | 305 | $1.11 | to | $1.36 | $432 | —<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 8.18<br> %<br>| to | 7.42<br> %<br>|
| 2022 | 344 | $1.03 | to | $1.26 | $453 | —<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 3.31 %<sup>(5)</sup><br>| to | (16.25)%<br>|
| 2021 | 384 | $1.39 | to | $1.51 | $596 | —<br> %<br>| 0.30<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 2.51<br> %<br>| to | 1.90<br> %<br>|
| **VP Man Vol Conserv Gro, Cl 1** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 49 | $1.38 | to | $1.38 | $68 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 11.25<br> %<br>| to | 11.25<br> %<br>|
| 2024 | 49 | $1.24 | to | $1.24 | $61 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 7.15<br> %<br>| to | 7.15<br> %<br>|
| 2023 | 49 | $1.15 | to | $1.15 | $56 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 10.19<br> %<br>| to | 10.19<br> %<br>|
| 2022 | 49 | $1.05 | to | $1.05 | $50 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (16.88)%<br>| to | (16.88)%<br>|
| 2021 | 48 | $1.26 | to | $1.26 | $60 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 5.77<br> %<br>| to | 5.77<br> %<br>|
| **VP Man Vol Conserv Gro, Cl 2** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 252 | $1.55 | to | $1.40 | $378 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 11.02<br> %<br>| to | 10.02<br> %<br>|
| 2024 | 260 | $1.40 | to | $1.27 | $353 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 6.80<br> %<br>| to | 5.84<br> %<br>|
| 2023 | 110 | $1.31 | to | $1.20 | $136 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 9.98<br> %<br>| to | 8.99<br> %<br>|
| 2022 | 118 | $1.19 | to | $1.10 | $134 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp; (17.06)%<br>| to | (17.81)%<br>|
| 2021 | 127 | $1.43 | to | $1.34 | $175 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 5.45<br> %<br>| to | 4.51<br> %<br>|
| **VP Man Vol Conserv, Cl 1** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 3 | $1.26 | to | $1.26 | $4 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 9.41<br> %<br>| to | 9.41<br> %<br>|
| 2024 | 2 | $1.15 | to | $1.15 | $3 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 4.65<br> %<br>| to | 4.65<br> %<br>|
| 2023 |  | $1.10 | to | $1.10 | $0 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 8.05<br> %<br>| to | 8.05<br> %<br>|
| 2022 |  | $1.02 | to | $1.02 | $0 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (15.75)%<br>| to | (15.75)%<br>|
| 2021 |  | $1.21 | to | $1.21 | $0 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 2.91<br> %<br>| to | 2.91<br> %<br>|
| **VP Man Vol Conserv, Cl 2** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 292 | $1.39 | to | $1.25 | $384 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 9.17<br> %<br>| to | 8.19<br> %<br>|
| 2024 | 92 | $1.27 | to | $1.16 | $109 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 4.31<br> %<br>| to | 3.37<br> %<br>|
| 2023 | 82 | $1.22 | to | $1.12 | $94 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 7.87<br> %<br>| to | 6.90<br> %<br>|
| 2022 | 84 | $1.13 | to | $1.05 | $90 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp; (15.99)%<br>| to | (16.74)%<br>|
| 2021 | 111 | $1.35 | to | $1.26 | $143 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 2.63<br> %<br>| to | 1.71<br> %<br>|
| **VP Man Vol Gro, Cl 1** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 1463 | $1.64 | to | $1.64 | $2405 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 14.97<br> %<br>| to | 14.97<br> %<br>|
| 2024 | 1380 | $1.43 | to | $1.43 | $1973 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 12.26<br> %<br>| to | 12.26<br> %<br>|
| 2023 | 741 | $1.27 | to | $1.27 | $944 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 14.87<br> %<br>| to | 14.87<br> %<br>|
| 2022 | 422 | $1.11 | to | $1.11 | $468 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (19.22)%<br>| to | (19.22)%<br>|
| 2021 | 312 | $1.37 | to | $1.37 | $428 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 12.22<br> %<br>| to | 12.22<br> %<br>|
| **VP Man Vol Gro, Cl 2** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 1556 | $1.92 | to | $1.73 | $2880 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 14.75<br> %<br>| to | 13.72<br> %<br>|
| 2024 | 1708 | $1.67 | to | $1.52 | $2768 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 11.98<br> %<br>| to | 10.97<br> %<br>|
| 2023 | 1544 | $1.49 | to | $1.37 | $2239 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 14.59<br> %<br>| to | 13.57<br> %<br>|
| 2022 | 1558 | $1.30 | to | $1.20 | $1976 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp; (19.43)%<br>| to | (20.15)%<br>|
| 2021 | 1487 | $1.61 | to | $1.51 | $2346 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 11.89<br> %<br>| to | 10.89<br> %<br>|

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**186 ■ RiverSource of New York Account 8**

------

---

| | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **At December 31** | **At December 31** | **At December 31** | **At December 31** | **At December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** |
|  | **Units (000s)** | **Accumulation unit** <br> **value**<br> **lowest to highest**<sup>(1)</sup> | **Accumulation unit** <br> **value**<br> **lowest to highest**<sup>(1)</sup> | **Accumulation unit** <br> **value**<br> **lowest to highest**<sup>(1)</sup> | **Net assets** <br> **(000s)**<br>| **Investment** <br> **income ratio**<sup>(2)</sup><br>| **Expense ratio**<br> **lowest to** <br> **highest**<sup>(3)</sup> | **Expense ratio**<br> **lowest to** <br> **highest**<sup>(3)</sup> | **Expense ratio**<br> **lowest to** <br> **highest**<sup>(3)</sup> | &nbsp;&nbsp; **Total return**<br> **lowest to highest**<sup>(1)</sup><sup>,</sup><sup>(4)</sup> | &nbsp;&nbsp; **Total return**<br> **lowest to highest**<sup>(1)</sup><sup>,</sup><sup>(4)</sup> | &nbsp;&nbsp; **Total return**<br> **lowest to highest**<sup>(1)</sup><sup>,</sup><sup>(4)</sup> |
| **VP Man Vol Mod Gro, Cl 1** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 908 | $1.51 | to | $1.51 | $1372 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 13.13<br> %<br>| to | 13.13<br> %<br>|
| 2024 | 864 | $1.33 | to | $1.33 | $1153 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 9.72<br> %<br>| to | 9.72<br> %<br>|
| 2023 | 243 | $1.22 | to | $1.22 | $296 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 12.49<br> %<br>| to | 12.49<br> %<br>|
| 2022 | 112 | $1.08 | to | $1.08 | $121 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (17.94)%<br>| to | (17.94)%<br>|
| 2021 | 51 | $1.32 | to | $1.32 | $67 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 9.02<br> %<br>| to | 9.02<br> %<br>|
| **VP Man Vol Mod Gro, Cl 2** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 1422 | $1.74 | to | $1.57 | $2392 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 12.87<br> %<br>| to | 11.86<br> %<br>|
| 2024 | 1345 | $1.54 | to | $1.40 | $2003 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 9.41<br> %<br>| to | 8.42<br> %<br>|
| 2023 | 1364 | $1.41 | to | $1.29 | $1861 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 12.27<br> %<br>| to | 11.27<br> %<br>|
| 2022 | 1315 | $1.26 | to | $1.16 | $1604 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp; (18.15)%<br>| to | (18.89)%<br>|
| 2021 | 1436 | $1.53 | to | $1.43 | $2147 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 8.70<br> %<br>| to | 7.72<br> %<br>|
| **VP Mod Aggr, Cl 1** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 10255 | $1.74 | to | $1.74 | $17842 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 15.97<br> %<br>| to | 15.97<br> %<br>|
| 2024 | 8601 | $1.50 | to | $1.50 | $12904 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 11.28<br> %<br>| to | 11.28<br> %<br>|
| 2023 | 6214 | $1.35 | to | $1.35 | $8377 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 15.23<br> %<br>| to | 15.23<br> %<br>|
| 2022 | 4464 | $1.17 | to | $1.17 | $5223 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (17.38)%<br>| to | (17.38)%<br>|
| 2021 | 2573 | $1.42 | to | $1.42 | $3644 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 12.61<br> %<br>| to | 12.61<br> %<br>|
| **VP Mod Aggr, Cl 2** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 18399 | $2.57 | to | $2.74 | $47983 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 15.71<br> %<br>| to | 14.67<br> %<br>|
| 2024 | 18893 | $2.22 | to | $2.39 | $43392 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 11.00<br> %<br>| to | 10.00<br> %<br>|
| 2023 | 19352 | $2.00 | to | $2.17 | $40433 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 14.93<br> %<br>| to | 13.91<br> %<br>|
| 2022 | 20860 | $1.74 | to | $1.90 | $37869 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp; (17.59)%<br>| to | (18.33)%<br>|
| 2021 | 20138 | $2.11 | to | $2.33 | $44693 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 12.31<br> %<br>| to | 11.30<br> %<br>|
| **VP Mod Aggr, Cl 4** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 24628 | $1.56 | to | $2.74 | $63499 | —<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 15.45<br> %<br>| to | 14.65<br> %<br>|
| 2024 | 24908 | $1.35 | to | $2.39 | $57885 | —<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 10.76<br> %<br>| to | 9.98<br> %<br>|
| 2023 | 26106 | $1.22 | to | $2.17 | $55837 | —<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 14.68<br> %<br>| to | 13.88<br> %<br>|
| 2022 | 28412 | $1.06 | to | $1.91 | $53424 | —<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 6.74 %<sup>(5)</sup><br>| to | (18.30)%<br>|
| 2021 | 29528 | $1.86 | to | $2.34 | $67643 | —<br> %<br>| 0.30<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 12.00<br> %<br>| to | 11.33<br> %<br>|
| **VP Mod Conserv, Cl 1** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 1 | $1.43 | to | $1.43 | $1 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 12.39<br> %<br>| to | 12.39<br> %<br>|
| 2024 | 278 | $1.27 | to | $1.27 | $354 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 6.72<br> %<br>| to | 6.72<br> %<br>|
| 2023 | 284 | $1.19 | to | $1.19 | $339 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 10.78<br> %<br>| to | 10.78<br> %<br>|
| 2022 | 292 | $1.07 | to | $1.07 | $314 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (15.93)%<br>| to | (15.93)%<br>|
| 2021 | 299 | $1.28 | to | $1.28 | $383 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 5.99<br> %<br>| to | 5.99<br> %<br>|
| **VP Mod Conserv, Cl 2** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 1334 | $1.82 | to | $1.87 | $2606 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 12.10<br> %<br>| to | 11.09<br> %<br>|
| 2024 | 1227 | $1.62 | to | $1.69 | $2173 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 6.41<br> %<br>| to | 5.45<br> %<br>|
| 2023 | 1309 | $1.52 | to | $1.60 | $2193 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 10.50<br> %<br>| to | 9.51<br> %<br>|
| 2022 | 1324 | $1.38 | to | $1.46 | $2002 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp; (16.09)%<br>| to | (16.84)%<br>|
| 2021 | 1425 | $1.64 | to | $1.76 | $2570 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 5.74<br> %<br>| to | 4.79<br> %<br>|
| **VP Mod Conserv, Cl 4** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 1641 | $1.36 | to | $1.88 | $2951 | —<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 11.91<br> %<br>| to | 11.13<br> %<br>|
| 2024 | 1566 | $1.22 | to | $1.69 | $2637 | —<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 6.19<br> %<br>| to | 5.44<br> %<br>|
| 2023 | 1780 | $1.15 | to | $1.60 | $2851 | —<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 10.26<br> %<br>| to | 9.49<br> %<br>|
| 2022 | 1854 | $1.04 | to | $1.46 | $2712 | —<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 4.54 %<sup>(5)</sup><br>| to | (16.85)%<br>|
| 2021 | 1832 | $1.54 | to | $1.76 | $3213 | —<br> %<br>| 0.30<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 5.47<br> %<br>| to | 4.84<br> %<br>|
| **VP Mod, Cl 1** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 4401 | $1.59 | to | $1.59 | $7000 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 14.14<br> %<br>| to | 14.14<br> %<br>|
| 2024 | 3784 | $1.39 | to | $1.39 | $5273 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 9.00<br> %<br>| to | 9.00<br> %<br>|
| 2023 | 2961 | $1.28 | to | $1.28 | $3786 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 13.22<br> %<br>| to | 13.22<br> %<br>|
| 2022 | 1790 | $1.13 | to | $1.13 | $2021 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (16.42)%<br>| to | (16.42)%<br>|
| 2021 | 1185 | $1.35 | to | $1.35 | $1602 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 9.31<br> %<br>| to | 9.31<br> %<br>|

---

**RiverSource of New York Account 8** ■ 187

------

---

| | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **At December 31** | **At December 31** | **At December 31** | **At December 31** | **At December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** |
|  | **Units (000s)** | **Accumulation unit** <br> **value**<br> **lowest to highest**<sup>(1)</sup> | **Accumulation unit** <br> **value**<br> **lowest to highest**<sup>(1)</sup> | **Accumulation unit** <br> **value**<br> **lowest to highest**<sup>(1)</sup> | **Net assets** <br> **(000s)**<br>| **Investment** <br> **income ratio**<sup>(2)</sup><br>| **Expense ratio**<br> **lowest to** <br> **highest**<sup>(3)</sup> | **Expense ratio**<br> **lowest to** <br> **highest**<sup>(3)</sup> | **Expense ratio**<br> **lowest to** <br> **highest**<sup>(3)</sup> | &nbsp;&nbsp; **Total return**<br> **lowest to highest**<sup>(1)</sup><sup>,</sup><sup>(4)</sup> | &nbsp;&nbsp; **Total return**<br> **lowest to highest**<sup>(1)</sup><sup>,</sup><sup>(4)</sup> | &nbsp;&nbsp; **Total return**<br> **lowest to highest**<sup>(1)</sup><sup>,</sup><sup>(4)</sup> |
| **VP Mod, Cl 2** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 13342 | $2.18 | to | $2.30 | $29452 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 13.86<br> %<br>| to | 12.84<br> %<br>|
| 2024 | 13596 | $1.92 | to | $2.04 | $26765 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 8.72<br> %<br>| to | 7.74<br> %<br>|
| 2023 | 13943 | $1.76 | to | $1.89 | $26124 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 12.96<br> %<br>| to | 11.95<br> %<br>|
| 2022 | 14671 | $1.56 | to | $1.69 | $24482 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp; (16.61)%<br>| to | (17.35)%<br>|
| 2021 | 15164 | $1.87 | to | $2.05 | $30374 | —<br> %<br>| 0.00<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 9.00<br> %<br>| to | 8.03<br> %<br>|
| **VP Mod, Cl 4** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 16485 | $1.46 | to | $2.31 | $35843 | —<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 13.61<br> %<br>| to | 12.82<br> %<br>|
| 2024 | 17045 | $1.28 | to | $2.04 | $33773 | —<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 8.49<br> %<br>| to | 7.73<br> %<br>|
| 2023 | 17954 | $1.18 | to | $1.90 | $33732 | —<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 12.72<br> %<br>| to | 11.93<br> %<br>|
| 2022 | 18733 | $1.05 | to | $1.70 | $31437 | —<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 5.51 %<sup>(5)</sup><br>| to | (17.33)%<br>|
| 2021 | 19360 | $1.70 | to | $2.05 | $39217 | —<br> %<br>| 0.30<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 8.72<br> %<br>| to | 8.07<br> %<br>|
| **VP Ptnrs Core Bond, Cl 1** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 33 | $1.16 | to | $1.16 | $38 | 5.09<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 7.62<br> %<br>| to | 7.62<br> %<br>|
| 2024 | 26 | $1.08 | to | $1.08 | $28 | 3.58<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 2.25<br> %<br>| to | 2.25<br> %<br>|
| 2023 | 23 | $1.06 | to | $1.06 | $24 | 2.75<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 6.30<br> %<br>| to | 6.30<br> %<br>|
| 2022 | 11 | $1.00 | to | $1.00 | $11 | 1.67<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (13.29)%<br>| to | (13.29)%<br>|
| 2021 | 5 | $1.15 | to | $1.15 | $5 | 1.21<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (1.24)%<br>| to | (1.24)%<br>|
| **VP Ptnrs Core Bond, Cl 2** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 20 | $1.26 | to | $1.26 | $25 | 5.45<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 7.28<br> %<br>| to | 7.28<br> %<br>|
| 2024 | 11 | $1.17 | to | $1.17 | $12 | 3.37<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 2.01<br> %<br>| to | 2.01<br> %<br>|
| 2023 | 12 | $1.15 | to | $1.15 | $13 | 2.62<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 6.06<br> %<br>| to | 6.06<br> %<br>|
| 2022 | 3 | $1.08 | to | $1.08 | $4 | 1.38<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (13.60)%<br>| to | (13.60)%<br>|
| 2021 | 3 | $1.25 | to | $1.25 | $4 | 1.19<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (1.41)%<br>| to | (1.41)%<br>|
| **VP Ptnrs Core Eq, Cl 1** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 3 | $2.46 | to | $2.46 | $8 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 13.42<br> %<br>| to | 13.42<br> %<br>|
| 2024 | 2 | $2.17 | to | $2.17 | $5 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 23.44<br> %<br>| to | 23.44<br> %<br>|
| 2023 | 1 | $1.76 | to | $1.76 | $2 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 24.71<br> %<br>| to | 24.71<br> %<br>|
| 2022 | 1 | $1.41 | to | $1.41 | $1 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (17.33)%<br>| to | (17.33)%<br>|
| 2021 | 1 | $1.71 | to | $1.71 | $1 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 29.45<br> %<br>| to | 29.45<br> %<br>|
| **VP Ptnrs Core Eq, Cl 2** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 9 | $4.65 | to | $4.65 | $44 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 13.13<br> %<br>| to | 13.13<br> %<br>|
| 2024 | 10 | $4.11 | to | $4.11 | $40 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 23.10<br> %<br>| to | 23.10<br> %<br>|
| 2023 | 9 | $3.34 | to | $3.34 | $32 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 24.43<br> %<br>| to | 24.43<br> %<br>|
| 2022 |  | $2.69 | to | $2.69 | $1 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (17.55)%<br>| to | (17.55)%<br>|
| 2021 |  | $3.26 | to | $3.26 | $1 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 29.18<br> %<br>| to | 29.18<br> %<br>|
| **VP Ptnrs Core Eq, Cl 3** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 92 | $1.83 | to | $3.80 | $511 | —<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 13.04<br> %<br>| to | 12.25<br> %<br>|
| 2024 | 91 | $1.62 | to | $3.38 | $488 | —<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 23.01<br> %<br>| to | 22.15<br> %<br>|
| 2023 | 95 | $1.31 | to | $2.77 | $423 | —<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 24.30<br> %<br>| to | 23.44<br> %<br>|
| 2022 | 102 | $1.06 | to | $2.24 | $370 | —<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 6.59 %<sup>(5)</sup><br>| to | (18.17)%<br>|
| 2021 | 130 | $2.73 | to | $2.74 | $528 | —<br> %<br>| 0.30<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 28.95<br> %<br>| to | 28.18<br> %<br>|
| **VP Ptnrs Intl Core Eq, Cl 1** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 252 | $1.72 | to | $1.72 | $432 | 1.32<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 24.85<br> %<br>| to | 24.85<br> %<br>|
| 2024 | 186 | $1.37 | to | $1.37 | $256 | 0.76<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 5.86<br> %<br>| to | 5.86<br> %<br>|
| 2023 | 49 | $1.30 | to | $1.30 | $64 | 1.35<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 17.70<br> %<br>| to | 17.70<br> %<br>|
| 2022 | 49 | $1.10 | to | $1.10 | $54 | 1.50<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (19.51)%<br>| to | (19.51)%<br>|
| 2021 | 14 | $1.37 | to | $1.37 | $19 | 1.19<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 13.55<br> %<br>| to | 13.55<br> %<br>|
| **VP Ptnrs Intl Core Eq, Cl 2** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 34 | $2.13 | to | $2.13 | $73 | 1.25<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 24.55<br> %<br>| to | 24.55<br> %<br>|
| 2024 | 35 | $1.71 | to | $1.71 | $60 | 1.06<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 5.58<br> %<br>| to | 5.58<br> %<br>|
| 2023 | 34 | $1.62 | to | $1.62 | $56 | 1.02<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 17.34<br> %<br>| to | 17.34<br> %<br>|
| 2022 | 20 | $1.38 | to | $1.38 | $27 | 1.75<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (19.64)%<br>| to | (19.64)%<br>|
| 2021 | 23 | $1.72 | to | $1.72 | $40 | 1.81<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 13.18<br> %<br>| to | 13.18<br> %<br>|

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**188 ■ RiverSource of New York Account 8**

------

---

| | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **At December 31** | **At December 31** | **At December 31** | **At December 31** | **At December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** |
|  | **Units (000s)** | **Accumulation unit** <br> **value**<br> **lowest to highest**<sup>(1)</sup> | **Accumulation unit** <br> **value**<br> **lowest to highest**<sup>(1)</sup> | **Accumulation unit** <br> **value**<br> **lowest to highest**<sup>(1)</sup> | **Net assets** <br> **(000s)**<br>| **Investment** <br> **income ratio**<sup>(2)</sup><br>| **Expense ratio**<br> **lowest to** <br> **highest**<sup>(3)</sup> | **Expense ratio**<br> **lowest to** <br> **highest**<sup>(3)</sup> | **Expense ratio**<br> **lowest to** <br> **highest**<sup>(3)</sup> | &nbsp;&nbsp; **Total return**<br> **lowest to highest**<sup>(1)</sup><sup>,</sup><sup>(4)</sup> | &nbsp;&nbsp; **Total return**<br> **lowest to highest**<sup>(1)</sup><sup>,</sup><sup>(4)</sup> | &nbsp;&nbsp; **Total return**<br> **lowest to highest**<sup>(1)</sup><sup>,</sup><sup>(4)</sup> |
| **VP Ptnrs Intl Gro, Cl 1** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 176 | $1.52 | to | $1.52 | $267 | 0.69<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 17.77<br> %<br>| to | 17.77<br> %<br>|
| 2024 | 113 | $1.29 | to | $1.29 | $146 | 0.70<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (1.17)%<br>| to | (1.17)%<br>|
| 2023 | 115 | $1.31 | to | $1.31 | $150 | 0.48<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 14.77<br> %<br>| to | 14.77<br> %<br>|
| 2022 | 107 | $1.14 | to | $1.14 | $121 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (26.69)%<br>| to | (26.69)%<br>|
| 2021 | 79 | $1.55 | to | $1.55 | $122 | 0.06<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 10.63<br> %<br>| to | 10.63<br> %<br>|
| **VP Ptnrs Intl Gro, Cl 2** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 120 | $1.93 | to | $1.93 | $232 | 0.50<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 17.50<br> %<br>| to | 17.50<br> %<br>|
| 2024 | 114 | $1.65 | to | $1.65 | $188 | 0.46<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (1.41)%<br>| to | (1.41)%<br>|
| 2023 | 119 | $1.67 | to | $1.67 | $198 | 0.24<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 14.45<br> %<br>| to | 14.45<br> %<br>|
| 2022 | 124 | $1.46 | to | $1.46 | $181 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (26.87)%<br>| to | (26.87)%<br>|
| 2021 | 134 | $1.99 | to | $1.99 | $268 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 10.33<br> %<br>| to | 10.33<br> %<br>|
| **VP Ptnrs Intl Val, Cl 1** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 46 | $1.65 | to | $1.65 | $75 | 2.63<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 35.15<br> %<br>| to | 35.15<br> %<br>|
| 2024 | 41 | $1.22 | to | $1.22 | $50 | 2.68<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 4.62<br> %<br>| to | 4.62<br> %<br>|
| 2023 | 33 | $1.17 | to | $1.17 | $39 | 1.82<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 17.14<br> %<br>| to | 17.14<br> %<br>|
| 2022 | 21 | $1.00 | to | $1.00 | $21 | 1.96<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (11.46)%<br>| to | (11.46)%<br>|
| 2021 | 9 | $1.13 | to | $1.13 | $10 | 1.97<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 11.80<br> %<br>| to | 11.80<br> %<br>|
| **VP Ptnrs Intl Val, Cl 2** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 40 | $2.10 | to | $2.10 | $83 | 2.68<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 34.84<br> %<br>| to | 34.84<br> %<br>|
| 2024 | 43 | $1.56 | to | $1.56 | $67 | 2.59<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 4.30<br> %<br>| to | 4.30<br> %<br>|
| 2023 | 45 | $1.49 | to | $1.49 | $67 | 1.93<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 16.96<br> %<br>| to | 16.96<br> %<br>|
| 2022 | 44 | $1.28 | to | $1.28 | $56 | 2.19<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (11.75)%<br>| to | (11.75)%<br>|
| 2021 | 62 | $1.45 | to | $1.45 | $90 | 1.99<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 11.64<br> %<br>| to | 11.64<br> %<br>|
| **VP Ptnrs Sm Cap Gro, Cl 1** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 49 | $1.51 | to | $1.51 | $74 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 8.13<br> %<br>| to | 8.13<br> %<br>|
| 2024 | 46 | $1.40 | to | $1.40 | $64 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 19.04<br> %<br>| to | 19.04<br> %<br>|
| 2023 | 49 | $1.17 | to | $1.17 | $58 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 7.20<br> %<br>| to | 7.20<br> %<br>|
| 2022 | 39 | $1.10 | to | $1.10 | $43 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (28.97)%<br>| to | (28.97)%<br>|
| 2021 | 4 | $1.54 | to | $1.54 | $7 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 8.29<br> %<br>| to | 8.29<br> %<br>|
| **VP Ptnrs Sm Cap Gro, Cl 2** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 9 | $2.71 | to | $2.71 | $25 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 7.86<br> %<br>| to | 7.86<br> %<br>|
| 2024 | 17 | $2.51 | to | $2.51 | $42 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 18.70<br> %<br>| to | 18.70<br> %<br>|
| 2023 | 14 | $2.12 | to | $2.12 | $29 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 6.93<br> %<br>| to | 6.93<br> %<br>|
| 2022 | 12 | $1.98 | to | $1.98 | $24 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (29.13)%<br>| to | (29.13)%<br>|
| 2021 | 12 | $2.80 | to | $2.80 | $34 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 8.02<br> %<br>| to | 8.02<br> %<br>|
| **VP Ptnrs Sm Cap Val, Cl 1** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 3 | $1.48 | to | $1.48 | $4 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 7.35<br> %<br>| to | 7.35<br> %<br>|
| 2024 | 5 | $1.37 | to | $1.37 | $7 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 7.97<br> %<br>| to | 7.97<br> %<br>|
| 2023 | 9 | $1.27 | to | $1.27 | $11 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 11.38<br> %<br>| to | 11.38<br> %<br>|
| 2022 | 7 | $1.14 | to | $1.14 | $8 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (12.94)%<br>| to | (12.94)%<br>|
| 2021 | 1 | $1.31 | to | $1.31 | $1 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 24.01<br> %<br>| to | 24.01<br> %<br>|
| **VP Ptnrs Sm Cap Val, Cl 2** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 3 | $2.54 | to | $2.54 | $7 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 7.07<br> %<br>| to | 7.07<br> %<br>|
| 2024 | 3 | $2.37 | to | $2.37 | $7 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 7.70<br> %<br>| to | 7.70<br> %<br>|
| 2023 | 3 | $2.20 | to | $2.20 | $6 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 11.08<br> %<br>| to | 11.08<br> %<br>|
| 2022 | 3 | $1.98 | to | $1.98 | $6 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (13.16)%<br>| to | (13.16)%<br>|
| 2021 | 3 | $2.28 | to | $2.28 | $6 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 23.75<br> %<br>| to | 23.75<br> %<br>|
| **VP Ptnrs Sm Cap Val, Cl 3** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 270 | $1.38 | to | $4.41 | $690 | —<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 6.99<br> %<br>| to | 6.25<br> %<br>|
| 2024 | 232 | $1.29 | to | $4.15 | $647 | —<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 7.61<br> %<br>| to | 6.86<br> %<br>|
| 2023 | 192 | $1.20 | to | $3.89 | $659 | —<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 11.04<br> %<br>| to | 10.27<br> %<br>|
| 2022 | 187 | $1.08 | to | $3.52 | $605 | —<br> %<br>| 0.20<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 8.27 %<sup>(5)</sup><br>| to | (13.84)%<br>|
| 2021 | 210 | $1.76 | to | $4.09 | $785 | —<br> %<br>| 0.30<br> %<br>| to | 0.90<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 23.52<br> %<br>| to | 22.78<br> %<br>|

---

**RiverSource of New York Account 8** ■ 189

------

---

| | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **At December 31** | **At December 31** | **At December 31** | **At December 31** | **At December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** |
|  | **Units (000s)** | **Accumulation unit** <br> **value**<br> **lowest to highest**<sup>(1)</sup> | **Accumulation unit** <br> **value**<br> **lowest to highest**<sup>(1)</sup> | **Accumulation unit** <br> **value**<br> **lowest to highest**<sup>(1)</sup> | **Net assets** <br> **(000s)**<br>| **Investment** <br> **income ratio**<sup>(2)</sup><br>| **Expense ratio**<br> **lowest to** <br> **highest**<sup>(3)</sup> | **Expense ratio**<br> **lowest to** <br> **highest**<sup>(3)</sup> | **Expense ratio**<br> **lowest to** <br> **highest**<sup>(3)</sup> | &nbsp;&nbsp; **Total return**<br> **lowest to highest**<sup>(1)</sup><sup>,</sup><sup>(4)</sup> | &nbsp;&nbsp; **Total return**<br> **lowest to highest**<sup>(1)</sup><sup>,</sup><sup>(4)</sup> | &nbsp;&nbsp; **Total return**<br> **lowest to highest**<sup>(1)</sup><sup>,</sup><sup>(4)</sup> |
| **VP US Flex Conserv Gro, Cl 1** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 7 | $1.41 | to | $1.41 | $10 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 9.49<br> %<br>| to | 9.49<br> %<br>|
| 2024 | 6 | $1.28 | to | $1.28 | $8 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 9.67<br> %<br>| to | 9.67<br> %<br>|
| 2023 | 5 | $1.17 | to | $1.17 | $6 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 11.53<br> %<br>| to | 11.53<br> %<br>|
| 2022 | 3 | $1.05 | to | $1.05 | $4 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (16.54)%<br>| to | (16.54)%<br>|
| 2021 | 1 | $1.26 | to | $1.26 | $1 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 7.76<br> %<br>| to | 7.76<br> %<br>|
| **VP US Flex Gro, Cl 1** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 184 | $1.70 | to | $1.70 | $314 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 11.38<br> %<br>| to | 11.38<br> %<br>|
| 2024 | 153 | $1.53 | to | $1.53 | $233 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 17.43<br> %<br>| to | 17.43<br> %<br>|
| 2023 | 107 | $1.30 | to | $1.30 | $140 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 17.14<br> %<br>| to | 17.14<br> %<br>|
| 2022 | 79 | $1.11 | to | $1.11 | $88 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (18.54)%<br>| to | (18.54)%<br>|
| 2021 | 15 | $1.36 | to | $1.36 | $20 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 15.76<br> %<br>| to | 15.76<br> %<br>|
| **VP US Flex Mod Gro, Cl 1** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 85 | $1.55 | to | $1.55 | $131 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 10.37<br> %<br>| to | 10.37<br> %<br>|
| 2024 | 84 | $1.41 | to | $1.41 | $118 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 13.44<br> %<br>| to | 13.44<br> %<br>|
| 2023 | 8 | $1.24 | to | $1.24 | $10 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 14.29<br> %<br>| to | 14.29<br> %<br>|
| 2022 | 5 | $1.08 | to | $1.08 | $6 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (17.36)%<br>| to | (17.36)%<br>|
| 2021 | 5 | $1.31 | to | $1.31 | $7 | —<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 11.71<br> %<br>| to | 11.71<br> %<br>|
| **WA Var Global Hi Yd Bond, Cl I** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 23 | $1.32 | to | $1.32 | $30 | 7.03<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 9.96<br> %<br>| to | 9.96<br> %<br>|
| 2024 | 21 | $1.20 | to | $1.20 | $25 | 7.68<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 7.06<br> %<br>| to | 7.06<br> %<br>|
| 2023 | 16 | $1.12 | to | $1.12 | $18 | 5.63<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 10.26<br> %<br>| to | 10.26<br> %<br>|
| 2022 | 16 | $1.01 | to | $1.01 | $17 | 9.59<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (13.72)%<br>| to | (13.72)%<br>|
| 2021 | 6 | $1.17 | to | $1.17 | $8 | 8.92<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 1.33<br> %<br>| to | 1.33<br> %<br>|
| **WA Var Global Hi Yd Bond, Cl II** |  |  |  |  |  |  |  |  |  |  |  |  |
| 2025 | 5 | $1.56 | to | $1.56 | $8 | 6.23<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 9.95<br> %<br>| to | 9.95<br> %<br>|
| 2024 | 6 | $1.42 | to | $1.42 | $8 | 5.79<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 6.70<br> %<br>| to | 6.70<br> %<br>|
| 2023 | 7 | $1.33 | to | $1.33 | $9 | 5.39<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 9.96<br> %<br>| to | 9.96<br> %<br>|
| 2022 | 7 | $1.21 | to | $1.21 | $8 | 5.98<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp; (13.87)%<br>| to | (13.87)%<br>|
| 2021 | 7 | $1.40 | to | $1.40 | $10 | 5.04<br> %<br>| 0.00<br> %<br>| to | 0.00<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 1.04<br> %<br>| to | 1.04<br> %<br>|

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

<sup>(1)</sup> The accumulation unit values and total returns are presented as a range of values based on the life insurance policies with the lowest and highest expense ratios.

<sup>(2)</sup> These amounts represent the dividends, excluding distributions of capital gains, received by the division from the underlying fund, net of management fees assessed by the fund manager, divided by the average net assets. These ratios exclude variable account expenses that result in direct reductions in the unit values. The recognition of investment income by the division is affected by the timing of the declaration of dividends by the underlying fund in which the division invests. These ratios are annualized for periods less than one year. 

<sup>(3)</sup> These ratios represent the annualized policy expenses of the separate account, consisting primarily of mortality and expense charges, for each period indicated. The ratios include only those expenses that result in a direct reduction to unit values. Charges made directly to policy owner accounts through the redemption of units and expenses of the underlying fund are excluded. 

<sup>(4)</sup> These amounts represent the total return for the periods indicated, including changes in the value of the underlying fund, and reflect deductions for all items included in the expense ratio. The total return does not include any expenses assessed through the redemption of units; inclusion of these expenses in the calculation would result in a reduction in the total return presented. The total return is calculated for the period indicated or from the notated effective date through the end of the reporting period. Although the total return is presented as a range of values based on the subaccounts representing the lowest and highest expense ratios, some individual subaccount total returns are not within the ranges presented due to the introduction of new subaccounts during the year and other market factors. 

<sup>(5)</sup> New subaccount operations commenced on October 10, 2022.

<sup>(6)</sup> New subaccount operations commenced on January 16, 2024.

<sup>(7)</sup> New subaccount operations commenced on May 2, 2022.

<sup>(8)</sup> The investment income ratio and total return reflect the effect of a reimbursement of income from a trade error. See Note 9 in the Notes to Financial Statements.

<sup>(9)</sup> New subaccount operations commenced on April 26, 2024.

**9.** **REIMBURSEMENT OF INCOME FROM TRADE ERROR**

Due to an error in trading instructions during the period, the investment owned by the EV VT Floating-Rate Inc, Inst Cl division of the Account as of December 31, 2024, is comprised of shares of the Initial Class of Eaton Vance VT Floating-Rate Fund. The EV VT Floating-Rate Inc, Inst Cl division intended to invest in Institutional Class shares of the Eaton Vance VT Floating-Rate Fund. On April 8, 2025, the EV VT Floating-Rate Inc, Inst Cl's Initial Class shares were exchanged to Institutional Class shares of the Fund.

The Eaton Vance VT Floating-Rate Fund Institutional Class shares and its Initial Class shares differ in that Institutional Class shares typically incur lower fund expenses. If the EV VT Floating-Rate Inc, Inst Cl division had held Institutional shares, it would

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**190 ■ RiverSource of New York Account 8**

------

have recorded higher dividend income. RiverSource Life of NY and/or its affiliates have agreed to reimburse the EV VT Floating-Rate Inc, Inst Cl division $23 and $12 representing the amount of lower dividend distributions received for periods ending December 31, 2024 and December 31, 2025, respectively.

There were no material impacts to any contract holder transactions or account values at any time as a result of this trade error.

The investment income ratio and total return presented in the financial highlights reflect the effect of the reimbursement.

**RiverSource of New York Account 8** ■ 191

------

**REPORT OF INDEPENDENT AUDITORS** 

TO THE BOARD OF DIRECTORS AND SHAREHOLDER OF RIVERSOURCE LIFE INSURANCE CO. OF NEW YORK

***Opinion***

We have audited the accompanying financial statements of RiverSource Life Insurance Co. of New York (the "Company"), which comprise the balance sheets as of December 31, 2025 and 2024, and the related statements of income, of comprehensive income, of shareholder's equity and of cash flows for each of the three years in the period ended December 31, 2025, including the related notes (collectively referred to as the "financial statements").

In our opinion, the accompanying financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2025 and 2024, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2025 in accordance with accounting principles generally accepted in the United States of America.

***Basis for Opinion***

We conducted our audit in accordance with auditing standards generally accepted in the United States of America (US GAAS). Our responsibilities under those standards are further described in the Auditors' Responsibilities for the Audit of the Financial Statements section of our report. We are required to be independent of the Company and to meet our other ethical responsibilities, in accordance with the relevant ethical requirements relating to our audit. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our audit opinion.

***Responsibilities of Management for the Financial Statements***

Management is responsible for the preparation and fair presentation of the financial statements in accordance with accounting principles generally accepted in the United States of America, and for the design, implementation, and maintenance of internal control relevant to the preparation and fair presentation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, management is required to evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the Company's ability to continue as a going concern for one year after the date the financial statements are available to be issued.

***Auditors' Responsibilities for the Audit of the Financial Statements***

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditors' report that includes our opinion. Reasonable assurance is a high level of assurance but is not absolute assurance and therefore is not a guarantee that an audit conducted in accordance with US GAAS will always detect a material misstatement when it exists. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control. Misstatements are considered material if there is a substantial likelihood that, individually or in the aggregate, they would influence the judgment made by a reasonable user based on the financial statements.

---

| | |
|:---|:---|
| **www.pwc.com/us** | PricewaterhouseCoopers LLP<br> 45 South 7th Street, Suite 3400<br> Minneapolis, Minnesota 55402<br> (612) 596 6000 |

---

**F-1** 

------

In performing an audit in accordance with US GAAS, we:

• Exercise professional judgment and maintain professional skepticism throughout the audit.

• Identify and assess the risks of material misstatement of the financial statements, whether due to fraud or
error, and design and perform audit procedures responsive to those risks. Such procedures include examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements.

• Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are
appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control. Accordingly, no such opinion is expressed.

• Evaluate the appropriateness of accounting policies used and the reasonableness of significant accounting
estimates made by management, as well as evaluate the overall presentation of the financial statements.

• Conclude whether, in our judgment, there are conditions or events, considered in the aggregate, that raise
substantial doubt about the Company's ability to continue as a going concern for a reasonable period of time.

We are required to communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit, significant audit findings, and certain internal control-related matters that we identified during the audit.

/s/ PricewaterhouseCoopers LLP

Minneapolis, Minnesota

April 22, 2026

 **F-2** 

------

*Riversource Life Insurance Co. of New York* 

**BALANCE SHEETS** 

**(in thousands, except share amounts)** 

---

| | | |
|:---|:---|:---|
| **December 31,** | **2025** | **2024** |
| **Assets** |  |  |
|  Investments: |  |  |
|  Available-for-Sale: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Fixed maturities, at fair value (amortized cost: 2025, $1,519,304; 2024, $1,545,537) | $1445880 | $1420630 |
|  Mortgage loans, at amortized cost (allowance for credit losses: 2025, $316; 2024, $424) | 116775 | 130826 |
|  Policy loans | 62715 | 60538 |
|  Other investments | 682 | 638 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total investments | 1626052 | 1612632 |
|  Cash and cash equivalents | 120625 | 145878 |
|  Market risk benefits | 155104 | 147075 |
|  Reinsurance recoverables (allowance for credit losses: 2025, $3,200; 2024, $3,300) | 214436 | 195919 |
|  Receivables | 11096 | 10340 |
|  Accrued investment income | 14188 | 14363 |
|  Deferred acquisition costs | 154783 | 161696 |
|  Other assets | 131784 | 189005 |
|  Separate account assets | 4767199 | 4634856 |
|  Total assets | $7195267 | $7111764 |
| **Liabilities and Shareholder's Equity** |  |  |
|  Liabilities: |  |  |
|  Policyholder account balances, future policy benefits and claims | $1800874 | $1843572 |
|  Market risk benefits | 21487 | 26470 |
|  Other liabilities | 133848 | 175985 |
|  Separate account liabilities | 4767199 | 4634856 |
|  Total liabilities | 6723408 | 6680883 |
|  Shareholder's Equity: |  |  |
|  Common stock, $10 par value; 200,000 shares authorized, issued and outstanding | 2000 | 2000 |
|  Additional paid-in capital | 106926 | 106926 |
|  Retained earnings | 434593 | 428525 |
|  Accumulated other comprehensive income (loss), net of tax | (71660) | (106570) |
|  Total shareholder's equity | 471859 | 430881 |
|  Total liabilities and shareholder's equity | $7195267 | $7111764 |

---

See Notes to Financial Statements.

**F-3** 

------

*Riversource Life Insurance Co. of New York* 

**STATEMENTS OF INCOME** 

**(in thousands)** 

---

| | | | |
|:---|:---|:---|:---|
| **Years Ended December 31,** | **2025** | **2024** | **2023** |
| **Revenues** |  |  |  |
|  Premiums | $18713 | $27135 | $21413 |
|  Net investment income | 79877 | 82817 | 84585 |
|  Policy and contract charges | 132420 | 125670 | 123750 |
|  Other revenues | 24330 | 23564 | 22102 |
|  Net realized investment gains (losses) | (1527) | (419) | 187 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total revenues | 253813 | 258767 | 252037 |
| **Benefits and Expenses** |  |  |  |
|  Benefits, claims, losses and settlement expenses | 45366 | 51316 | 48540 |
|  Interest credited to fixed accounts | 41050 | 49396 | 51609 |
|  Remeasurement (gains) losses of future policy benefit reserves | 1204 | (8588) | 2003 |
|  Change in fair value of market risk benefits | 50518 | 26843 | 45118 |
|  Amortization of deferred acquisition costs | 13820 | 14146 | 14822 |
|  Other insurance and operating expenses | 34685 | 36697 | 35823 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total benefits and expenses | 186643 | 169810 | 197915 |
|  Pretax income (loss) | 67170 | 88957 | 54122 |
|  Income tax provision (benefit) | 11102 | 15563 | 7555 |
|  Net income | $56068 | $73394 | $46567 |

---

See Notes to Financial Statements.

**STATEMENTS OF COMPREHENSIVE INCOME** 

**(in thousands)** 

---

| | | | |
|:---|:---|:---|:---|
| **Years Ended December 31,** | **2025** | **2024** | **2023** |
|  Net income | $56068 | $73394 | $46567 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other comprehensive income (loss), net of tax: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net unrealized gains (losses) on securities | 39880 | (23676) | 41675 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Effect of changes in discount rate assumptions on certain long-duration contracts | (6092) | 9241 | (6125) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Effect of changes in instrument-specific credit risk on market risk benefits | 1122 | (2175) | (2950) |
|  Total other comprehensive income (loss), net of tax | 34910 | (16610) | 32600 |
|  Total comprehensive income (loss) | $90978 | $56784 | $79167 |

---

See Notes to Financial Statements.

 **F-4** 

------

*Riversource Life Insurance Co. of New York* 

**STATEMENTS OF SHAREHOLDER'S EQUITY** 

**(in thousands)** 

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Common**<br> **Stock** | **Additional**<br> **Paid-In**<br> **Capital** | **Retained**<br> **Earnings** | **Accumulated Other**<br> **Comprehensive**<br> **Income (Loss)** | **Total** |
|  **Balances at January 1, 2023** | $2000 | $106926 | $408564 | $(122560) | $394930 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net income |  |  | 46567 |  | 46567 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other comprehensive income, net of tax |  |  |  | 32600 | 32600 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cash dividend to RiverSource Life Insurance Company |  |  | (50000) |  | (50000) |
|  **Balances at December 31, 2023** | 2000 | 106926 | 405131 | (89960) | 424097 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net income |  |  | 73394 |  | 73394 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other comprehensive loss, net of tax |  |  |  | (16610) | (16610) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cash dividend to RiverSource Life Insurance Company |  |  | (50000) |  | (50000) |
|  **Balances at December 31, 2024** | 2000 | 106926 | 428525 | (106570) | 430881 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net income |  |  | 56068 |  | 56068 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other comprehensive income, net of tax |  |  |  | 34910 | 34910 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cash dividend to RiverSource Life Insurance Company |  |  | (50000) |  | (50000) |
|  **Balances at December 31, 2025** | $2000 | $106926 | $434593 | $(71660) | $471859 |

---

See Notes to Financial Statements.

**F-5** 

------

*Riversource Life Insurance Co. of New York* 

**STATEMENTS OF CASH FLOWS** 

**(in thousands)** 

---

| | | | |
|:---|:---|:---|:---|
| **Years Ended December 31,** | **2025** | **2024** | **2023** |
| **Cash Flows from Operating Activities** |  |  |  |
|  Net income | $56068 | $73394 | $46567 |
|  Adjustments to reconcile net income to net cash provided by (used in) operating activities: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Depreciation, amortization and accretion, net | 833 | 1412 | 2049 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Deferred income tax (benefit) expense | 13955 | 14880 | (1519) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Contractholder and policyholder charges, non-cash | (27665) | (27735) | (27744) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(Gain) loss from equity method investments | (65) | (62) | (72) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net realized investment (gains) losses | 1635 | 914 | 431 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Impairments and provision for loan losses | (108) | (495) | (618) |
|  Changes in operating assets and liabilities: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Deferred acquisition costs | 6913 | 5237 | 7105 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Policyholder account balances, future policy benefits and claims, and market risk<br> benefits, net | (698) | (77148) | (42580) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Derivatives, net of collateral | (7711) | 1897 | (36844) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Reinsurance recoverables | (13131) | 349 | (4765) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Receivables | (956) | (2277) | 553 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Accrued investment income | 175 | 1013 | (654) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Current income tax, net | (242) | (1753) | (3253) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other, net | (41) | 9397 | 4121 |
|  Net cash provided by (used in) operating activities | 28962 | (977) | (57223) |
| **Cash Flows from Investing Activities** |  |  |  |
|  Available-for-Sale securities: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Proceeds from sales | 7501 | 4609 | 902 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Maturities, sinking fund payments and calls | 174342 | 127776 | 115763 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Purchases | (157878) | (216) | (120653) |
|  Proceeds from maturities and repayments of mortgage loans | 14159 | 17214 | 15195 |
|  Funding of mortgage loans |  | (3000) | (2626) |
|  Proceeds from sales of other investments | 21 | 21 | 22 |
|  Change in policy loans, net | (2177) | (6923) | (2824) |
|  Net cash provided by (used in) investing activities | 35968 | 139481 | 5779 |
| **Cash Flows from Financing Activities** |  |  |  |
|  Policyholder account balances: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Deposits and other additions | 84763 | 111071 | 105284 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net transfers from (to) separate accounts | (3138) | (11509) | (5907) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Surrenders and other benefits | (121680) | (122035) | (132933) |
|  Proceeds from line of credit with Ameriprise Financial, Inc. |  | 2600 |  |
|  Payments on line of credit with Ameriprise Financial, Inc. |  | (2600) |  |
|  Cash received for purchased options with deferred premiums |  |  | 10823 |
|  Cash paid for purchased options with deferred premiums | (128) | (235) | (501) |
|  Cash dividends to RiverSource Life Insurance Company | (50000) | (50000) | (50000) |
|  Net cash provided by (used in) financing activities | (90183) | (72708) | (73234) |
|  Net increase (decrease) in cash and cash equivalents | (25253) | 65796 | (124678) |
|  Cash and cash equivalents at beginning of period | 145878 | 80082 | 204760 |
|  Cash and cash equivalents at end of period | $120625 | $145878 | $80082 |

---

See Notes to Financial Statements.

 **F-6** 

------

*RiverSource Life Insurance Co. of New York* 

## NOTES TO FINANCIAL STATEMENTS
**1. NATURE OF BUSINESS AND BASIS OF PRESENTATION** 

RiverSource Life Insurance Co. of New York (the "Company") is a stock life insurance company which is domiciled and holds a Certificate of Authority in the State of New York. The Company is a wholly owned subsidiary of RiverSource Life Insurance Company ("RiverSource Life"), which is domiciled in Minnesota. RiverSource Life is a wholly owned subsidiary of Ameriprise Financial, Inc. ("Ameriprise Financial"). The Company issues insurance and annuity products to customers in the State of New York.

The accompanying financial statements are prepared in accordance with U.S. generally accepted accounting principles ("GAAP") which vary in certain respects from reporting practices prescribed or permitted by the New York State Department of Financial Services ("New York Department") (the Company's primary regulator) as described in Note 14. Certain reclassifications of prior period amounts have been made to conform with the current presentation.

The Company evaluated events or transactions that occurred after the balance sheet date for potential recognition or disclosure through April 22, 2026, the date the financial statements were issued. No subsequent events or transactions requiring recognition or disclosure were identified.

The Company's operations constitute a single operating segment, and therefore a single reportable segment, as the chief operating decision maker ("CODM") manages the business activities using information of the Company as a whole. As its CODM, the Company's President and Chief Executive Officer utilizes the Statements of Income and its net income metric to allocate resources and assess performance of the Company. The accounting policies used to measure the profit and loss of the segment are the same as those described in Note 2.

The Company's principal products are variable annuities, universal life ("UL") insurance, including indexed universal life ("IUL") and variable universal life ("VUL") insurance, which are issued primarily to individuals. Waiver of premium and accidental death benefit riders are generally available with UL products, in addition to other benefit riders. Variable annuity contract purchasers can choose to add an optional guaranteed minimum death benefit ("GMDB") rider to their contract.

The Company also offers payout annuities, term life insurance and disability income ("DI") insurance.

The Company's business is sold through the advisor network of Ameriprise Financial Services, LLC ("AFS"), a subsidiary of Ameriprise Financial. RiverSource Distributors, Inc., a subsidiary of Ameriprise Financial, serves as the principal underwriter and distributor of variable annuity and life insurance products issued by the Company.

**2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES** 

**Amounts Based on Estimates and Assumptions** 

Accounting estimates are an integral part of the financial statements. In part, they are based upon assumptions concerning future events. Among the more significant are those that relate to investment securities valuation and the recognition of credit losses or impairments, valuation of derivative instruments, litigation reserves, future policy benefits, market risk benefits, and income taxes and the recognition of deferred tax assets and liabilities. These accounting estimates reflect the best judgment of management and actual results could differ.

**Investments** 

*Available-for-Sale Securities* 

Available-for-Sale securities are carried at fair value with unrealized gains (losses) recorded in accumulated other comprehensive income (loss) ("AOCI"), net of impacts to benefit reserves, reinsurance recoverables and income taxes. Gains and losses are recognized on a trade date basis in the Statements of Income upon disposition of the securities.

Available-for-Sale securities are impaired when the fair value of an investment is less than its amortized cost. When an Available-for-Sale security is impaired, the Company first assesses whether or not: (i) it has the intent to sell the security (i.e., made a decision to sell) or (ii) it is more likely than not that the Company will be required to sell the security before its anticipated recovery. If either of these conditions exist, the Company recognizes an impairment by reducing the book value of the security for the difference between the investment's amortized cost and its fair value with a corresponding charge to earnings. Subsequent increases in the fair value of Available-for-Sale securities that occur in periods after a write-down has occurred are recorded as unrealized gains in other comprehensive income (loss) ("OCI"), while subsequent decreases in fair value would continue to be recorded as reductions of book value with a charge to earnings.

For securities that do not meet the above criteria, the Company determines whether the decrease in fair value is due to a credit loss or due to other factors. The amount of impairment due to credit-related factors, if any, is recognized as an allowance for credit losses with a related charge to Net realized investment gains (losses). The allowance for credit losses is limited to the amount by which the security's amortized cost basis exceeds its fair value. The amount of the impairment related to other factors is recognized in OCI.

**F-7** 

------

*RiverSource Life Insurance Co. of New York* 

Factors the Company considers in determining whether declines in the fair value of fixed maturity securities are due to credit-related factors include: (i) the extent to which the market value is below amortized cost; (ii) fundamental analysis of the liquidity, business prospects and overall financial condition of the issuer; and (iii) market events that could impact credit ratings, economic and business climate, litigation and government actions, and similar external business factors.

If through subsequent evaluation there is a sustained increase in cash flows expected, both the allowance and related charge to earnings may be reversed to reflect the increase in expected principal and interest payments.

In order to determine the amount of the credit loss component for corporate debt securities, a best estimate of the present value of cash flows expected to be collected discounted at the security's effective interest rate is compared to the amortized cost basis of the security. The significant inputs to cash flow projections consider potential debt restructuring terms, projected cash flows available to pay creditors and the Company's position in the debtor's overall capital structure. When assessing potential credit-related impairments for structured investments (e.g., residential mortgage backed securities, commercial mortgage backed securities and asset backed securities), the Company also considers credit-related factors such as overall deal structure and its position within the structure, quality of underlying collateral, delinquencies and defaults, loss severities, recoveries, prepayments and cumulative loss projections.

Management has elected to exclude accrued interest in its measurement of the allowance for credit losses for Available-for-Sale securities. Accrued interest on Available-for-Sale securities is recorded as earned in Accrued investment income. Available-for-Sale securities are generally placed on nonaccrual status when the accrued balance becomes 90 days past due or earlier based on management's evaluation of the facts and circumstances of each security under review. All previously accrued interest is reversed through Net investment income.

The Company invests in structured investments which are considered variable interest entities ("VIEs") for which it is not the sponsor. These structured investments typically invest in fixed income instruments and are managed by third parties and include asset backed securities and commercial and residential mortgage backed securities. The Company classifies these investments as Available-for-Sale securities. The Company has determined that it is not the primary beneficiary of these structures due to the size of the Company's investment in the entities and position in the capital structure of these entities. The Company's maximum exposure to loss as a result of its investment in these structured investments is limited to its amortized cost. The Company has no obligation to provide financial or other support to the structured investments beyond its investment nor has the Company provided any support to the structured investments. See Note 5 for additional information on these structured investments.

**Financing Receivables** 

Financing receivables are comprised of mortgage loans and policy loans.

*Mortgage Loans* 

Mortgage loans are loans on commercial properties that are originated by the Company and are recorded at amortized cost less the allowance for credit losses.

Interest income is accrued as earned on the unpaid principal balances of the loans. Interest income recognized on mortgage loans is recorded in Net investment income.

*Policy Loans* 

Policy loans do not exceed the cash surrender value at origination. As there is minimal risk of loss related to policy loans, there is no allowance for credit losses.

Interest income is accrued as earned on the unpaid principal balances of the loans. Interest income recognized on policy loans is recorded in Net investment income.

See Note 6 for additional information on financing receivables.

*Allowance for Credit Losses* 

The allowance for credit losses is a valuation account that is deducted from the amortized cost basis of the financial assets to present the net amount expected to be collected over the asset's expected life, considering past events, current conditions and reasonable and supportable forecasts of future economic conditions. Estimates of expected credit losses consider both historical charge-off and recovery experience as well as current economic conditions and management's expectation of future charge-off and recovery levels. Expected losses related to risks other than credit risk are excluded from the allowance for credit losses. The allowance for credit losses is measured and recorded upon initial recognition of the loan, regardless of whether it is originated or purchased.

The allowance for credit losses for mortgage loans utilizes a probability of default and loss severity approach to estimate lifetime expected credit losses. Actual historical default and loss severity data is adjusted for current conditions and reasonable and supportable forecasts of future economic conditions to develop the probability of default and loss severity assumptions that are applied to the amortized cost basis of the loans over the expected life of each portfolio. The allowance for credit losses on mortgage loans is recorded through provisions charged to Net realized investment gains (losses) and is reduced/increased by net charge-offs/recoveries.

 **F-8** 

------

*RiverSource Life Insurance Co. of New York* 

Management determines the adequacy of the allowance for credit losses based on the overall loan portfolio composition, recent and historical loss experience, and other pertinent factors, including when applicable, internal risk ratings, loan-to-value ratios, and occupancy rates, along with reasonable and supportable forecasts of economic and market conditions. This evaluation is inherently subjective as it requires estimates, which may be susceptible to significant change. While the Company may attribute portions of the allowance to specific loan pools as part of the allowance estimation process, the entire allowance is available to absorb losses expected over the life of the loan portfolio.

*Nonaccrual Loans* 

Mortgage loans are placed on nonaccrual status when either the collection of interest or principal has become 90 days past due or is otherwise considered doubtful of collection. When a loan is placed on nonaccrual status, unpaid accrued interest is reversed. Interest payments received on loans on nonaccrual status are generally applied to principal unless the remaining principal balance has been determined to be fully collectible. Management has elected to exclude accrued interest in its measurement of the allowance for credit losses for mortgage loans.

*Loan Modifications* 

A loan is modified when the Company makes certain concessionary modifications to contractual terms such as principal forgiveness, interest rate reductions, other-than-insignificant payment delays, and/or term extensions in an attempt to make the loan more affordable to a borrower experiencing financial difficulties. Generally, performance prior to the modification or significant events that coincide with the modification are considered in assessing whether the borrower can meet the new terms which may result in the loan being returned to accrual status at the time of the modification or after a performance period. If the borrower's ability to meet the revised payment schedule is not reasonably assured, the loan remains on nonaccrual status.

*Charge-off and Foreclosure* 

Charge-offs are recorded when the Company concludes that all or a portion of the mortgage loan is uncollectible. Factors used by the Company to determine whether all amounts due on mortgage loans will be collected, include but are not limited to, the financial condition of the borrower, performance of the underlying properties, collateral and/or guarantees on the loan, and the borrower's estimated future ability to pay based on property type and geographic location.

If it is determined that foreclosure on a mortgage loan is probable and the fair value is less than the current loan balance, expected credit losses are measured as the difference between the amortized cost basis of the asset and fair value less estimated costs to sell, if applicable. Upon foreclosure, the mortgage loan and related allowance are reversed, and the foreclosed property is recorded as real estate owned within Other assets.

**Cash and Cash Equivalents** 

Cash equivalents include highly liquid investments with original or remaining maturities at the time of purchase of 90 days or less.

**Reinsurance** 

The Company cedes insurance risk to other insurers under reinsurance agreements.

Reinsurance premiums paid and benefits received are accounted for consistently with the basis used in accounting for the policies from which risk is reinsured and consistently with the terms of the reinsurance contracts. Reinsurance premiums paid for traditional life, long term care ("LTC") and DI insurance and life contingent payout annuities, net of the change in any prepaid reinsurance asset, are reported as a reduction of Premiums. Reinsurance recoveries are reported as components of Benefits, claims, losses and settlement expenses.

UL and VUL reinsurance premiums are reported as a reduction of Policy and contract charges. In addition, for UL and VUL insurance policies, the net cost of reinsurance ceded, which represents the discounted amount of the expected cash flows between the reinsurer and the Company, is classified as an asset and amortized based on estimated gross profits over the period the reinsurance policies are in force. Changes in the net cost of reinsurance are reflected as a component of Policy and contract charges.

Insurance liabilities are reported before the effects of reinsurance. Policyholder account balances, future policy benefits and claims recoverable under reinsurance contracts are recorded within Reinsurance recoverables, net of the allowance for credit losses. The Company evaluates the financial condition of its reinsurers prior to entering into new reinsurance contracts and on a periodic basis during the contract term. The allowance for credit losses related to reinsurance recoverable is based on applying observable industry data including insurer ratings, default and loss severity data to the Company's reinsurance recoverable balances. Management evaluates the results of the calculation and considers differences between the industry data and the Company's data. Such differences include that the Company has no actual history of significant losses and that industry data may contain non-life insurers. This evaluation is inherently subjective as it requires estimates, which may be susceptible to significant change given the long-term nature of these receivables. The allowance for credit losses on reinsurance recoverable is recorded through provisions charged to Benefits, claims, losses and settlement expenses.

**F-9** 

------

*RiverSource Life Insurance Co. of New York* 

The Company also assumes life insurance risk from other insurers in limited circumstances. Reinsurance premiums received and benefits paid are accounted for consistently with the basis used in accounting for the policies from which risk is reinsured and consistently with the terms of the reinsurance contracts. Liabilities for assumed business are recorded within Policyholder account balances, future policy benefits and claims.

See Note 8 for additional information on reinsurance.

**Derivative Instruments and Hedging Activities** 

Freestanding derivative instruments are recorded at fair value and are reflected in Other assets or Other liabilities. The Company's policy is to not offset fair value amounts recognized for derivatives and collateral arrangements executed with the same counterparty under the same master netting arrangement. The accounting for changes in the fair value of a derivative instrument depends on its intended use and the resulting hedge designation, if any. The Company primarily uses derivatives as economic hedges that are not designated as accounting hedges or do not qualify for hedge accounting treatment.

Derivative instruments that are entered into for hedging purposes are designated as such at the time the Company enters into the contract. For all derivative instruments that are designated for hedging activities, the Company documents all of the hedging relationships between the hedge instruments and the hedged items at the inception of the relationships. Management also documents its risk management objectives and strategies for entering into the hedge transactions. The Company assesses, at inception and on a quarterly basis, whether derivatives designated as hedges are highly effective in offsetting the fair value or cash flows of hedged items. If it is determined that a derivative is no longer highly effective as a hedge, the Company will discontinue the application of hedge accounting.

For derivative instruments that do not qualify for hedge accounting or are not designated as accounting hedges, changes in fair value are recognized in current period earnings. Changes in fair value of derivatives are presented in the Statements of Income based on the nature and use of the instrument. Changes in fair value of derivatives used as economic hedges are presented in the Statements of Income with the corresponding change in the hedged asset or liability.

The equity component of IUL obligations is considered an embedded derivative.

See Note 12 for information regarding the Company's fair value measurement of derivative instruments and Note 16 for the impact of derivatives on the Statements of Income.

**Market Risk Benefits** 

Market risk benefits are contracts or contract features that both provide protection to the contractholder from other-than-nominal capital market risk and expose the Company to other-than-nominal capital market risk. Market risk benefits include certain contract features on variable annuity products that provide minimum guarantees to contractholders. Guarantees accounted for as market risk benefits include GMDB, guaranteed minimum income benefit ("GMIB"), guaranteed minimum withdrawal benefits ("GMWB") and guaranteed minimum accumulation benefits ("GMAB"). If a contract contains multiple market risk benefits, those market risk benefits are bundled together as a single compound market risk benefit.

Market risk benefits are measured at fair value, at the individual contract level, using a non-option-based valuation approach or an option-based valuation approach dependent upon the fee structure of the contract. Changes in fair value are recognized in net income each period with the exception of the portion of the change in fair value due to a change in the instrument-specific credit risk, which is recognized in OCI.

**Deferred Acquisition Costs** 

The Company incurs costs in connection with acquiring new and renewal insurance and annuity businesses. The portion of these costs which are incremental and direct to the acquisition of a new or renewal insurance policy or annuity contract are deferred. Significant costs capitalized include sales based compensation related to the acquisition of new and renewal insurance policies and annuity contracts, medical inspection costs for successful sales, and a portion of employee compensation and benefit costs based upon the amount of time spent on successful sales. Sales based compensation paid to Ameriprise Financial's advisors and employees and third-party distributors is capitalized. Employee compensation and benefits costs which are capitalized relate primarily to sales efforts, underwriting and processing. All other costs which are not incremental direct costs of acquiring an insurance policy or annuity contract are expensed as incurred. The deferred acquisition costs ("DAC") associated with insurance policies or annuity contracts that are significantly modified or internally replaced with another contract are accounted for as write-offs. These transactions are anticipated in establishing amortization periods and other valuation assumptions.

The Company monitors other DAC amortization assumptions, such as persistency, mortality, morbidity, and variable annuity benefit utilization each quarter and, when assessed independently, each could impact the Company's DAC balances. Unamortized DAC is reduced for actual experience in excess of expected experience.

The analysis of DAC balances and the corresponding amortization considers all relevant factors and assumptions described previously. Unless the Company's management identifies a significant deviation over the course of the quarterly monitoring, management reviews and updates these DAC amortization assumptions annually in the third quarter of each year.

 **F-10** 

------

*RiverSource Life Insurance Co. of New York* 

DAC is amortized on a constant-level basis for the grouped contracts over the expected contract term to approximate straight-line amortization. Contracts are grouped by contract type and issue year into cohorts consistent with the grouping used in estimating the associated liability for future policy benefits. DAC related to all long-duration product types (except for life contingent payout annuities) is grouped on a calendar-year annual basis for each legal entity. Further disaggregation is reported for any contracts that include an additional liability for death or other insurance benefit. DAC related to life contingent payout annuities is grouped on a calendar-year annual basis for each legal entity for policies issued prior to 2021 and on a quarterly basis for each legal entity thereafter.

DAC related to annuity products (including variable deferred annuities, fixed deferred annuities, and life contingent payout annuities) is amortized based on initial premium. DAC related to life insurance products (including UL insurance, VUL insurance, IUL insurance, term life insurance, and whole life insurance) is amortized based on original specified amount (i.e., face amount). DAC related to DI insurance is amortized based on original monthly benefit.

The accounting contract term for annuity products (except for life contingent payout annuities) is the projected accumulation period. Life contingent payout annuities are amortized over the period which annuity payments are expected to be paid. The accounting contract term for life insurance products is the projected life of the contract. DI insurance is amortized over the projected life of the contract, including the claim paying period.

**Deferred Sales Inducement Costs** 

Deferred sales inducements are contract features that are intended to attract new customers or to persuade existing customers to keep their current policy. Sales inducement costs consist of bonus interest credits and premium credits added to certain annuity contract and insurance policy values. These benefits are capitalized to the extent they are incremental to amounts that would be credited on similar contracts without the applicable feature. The amounts capitalized are amortized on a constant level basis using the same methodology and assumptions used to amortize DAC. Deferred sales inducement costs ("DSIC") is recorded in Other assets and amortization of DSIC is recorded in Benefits, claims, losses and settlement expenses.

**Separate Account Assets and Liabilities** 

Separate account assets represent funds held for the benefit of, and Separate account liabilities represent the obligation to, the variable annuity contractholders and variable life insurance policyholders who have a contractual right to receive the benefits of their contract or policy and bear the related investment risk. Gains and losses on separate account assets accrue directly to the contractholder or policyholder and are not reported in the Company's Statements of Income. Separate account assets are recorded at fair value and Separate account liabilities are equal to the assets recognized.

**Policyholder Account Balances, Future Policy Benefits and Claims** 

The Company establishes reserves to cover the benefits associated with non-traditional and traditional long-duration products. Non-traditional long-duration products include variable annuity contracts, fixed annuity contracts and UL and VUL policies. Traditional long-duration products include term life, whole life, DI and LTC insurance products and life contingent payout annuity products.

*Non-Traditional Long-Duration Products* 

The liabilities for non-traditional long-duration products include fixed account values on variable and fixed annuities and UL and VUL policies, non-life contingent payout annuities, liabilities for guaranteed benefits associated with variable annuities and embedded derivatives for IUL products.

Liabilities for fixed account values on variable annuities, fixed deferred annuities, and UL and VUL policies are equal to accumulation values, which are the cumulative gross deposits and credited interest less withdrawals and various charges. The liability for non-life contingent payout annuities is recognized as the present value of future payments using the effective yield at inception of the contract.

A portion of the Company's UL and VUL policies have product features that result in profits followed by losses from the insurance component of the contract. These profits followed by losses can be generated by the cost structure of the product or secondary guarantees in the contract. The secondary guarantee ensures that, subject to specified conditions, the policy will not terminate and will continue to provide a death benefit even if there is insufficient policy value to cover the monthly deductions and charges. The liability for these future losses is determined at the reporting date by estimating the death benefits in excess of account value and recognizing the excess over the estimated life based on expected assessments (e.g. cost of insurance charges, contractual administrative charges, similar fees and investment margin). See Note 9 for information regarding the liability for contracts with secondary guarantees. Liabilities for IUL products are equal to the accumulation of host contract values, guaranteed benefits, and the fair value of embedded derivatives.

See Note 11 for information regarding variable annuity guarantees.

**F-11** 

------

*RiverSource Life Insurance Co. of New York* 

*Embedded Derivatives* 

The fair value of embedded derivatives related to IUL fluctuate based on equity markets and interest rates and the estimate of the Company's nonperformance risk and is recorded in Policyholder account balances, future policy benefits and claims. See Note 12 for information regarding the fair value measurement of embedded derivatives.

*Traditional Long-Duration Products* 

The liability for future policy benefits for traditional long-duration products include cash flows related to unpaid amounts on reported claims, estimates of benefits payable on claims incurred but not yet reported and estimates of benefits that will become payable on term life, whole life, DI and LTC insurance policies and life contingent payout annuity policies as claims are incurred in the future. A liability for future policy benefits, which is the present value of estimated future policy benefits to be paid to or on behalf of policyholders and certain related expenses less the present value of estimated future net premiums to be collected from policyholders, is accrued as premium revenue is recognized. Expected insurance benefits are accrued over the life of the contract in proportion to premium revenue recognized (referred to as the net premium approach). The net premium ratio reflects cash flows from contract inception to contract termination (i.e., through the claim paying period) and cannot exceed 100%.

Assumptions utilized in the net premium approach, including mortality, morbidity, and terminations, are reviewed as part of experience studies at least annually or more frequently if suggested by evidence. Expense assumptions and actual expenses are updated within the net premium calculation consistent with other policyholder assumptions.

The updated cash flows used in the calculation are discounted using a forward rate curve. The discount rate represents an upper-medium-grade (i.e., low credit risk) fixed-income instrument yield (i.e., an A rating) that reflects the duration characteristics of the liability. Discount rates are locked in annually, at the end of each year for all products, except life contingent payout annuities, and calculated as the monthly average discount rate curves for the year. For life contingent payout annuities, the discount rates are locked in quarterly at the end of each quarter based on the average of the three months for the quarter.

The liability for future policy benefits will be updated for actual experience at least on an annual basis and concurrent with changes to cash flow assumptions. When net premiums are updated for cash flow changes, the estimated cash flows over the entire life of a group of contracts are updated using historical experience and updated future cash flow assumptions.

The revised net premiums are used to calculate an updated liability for future policy benefits as of the beginning of the reporting period, discounted at the original locked in rate (i.e., contract issuance rate). The updated liability for future policy benefits as of the beginning of the reporting period is then compared with the carrying amount of the liability as of that date prior to updating cash flow assumptions to determine the current period remeasurement gain or loss reflected in current period earnings. The revised net premiums are then applied as of the beginning of the quarter to calculate the benefit expense for the current reporting period.

The difference between the updated carrying amount of the liability for future policy benefits measured using the current discount rate assumption and the original discount rate assumption is recognized in OCI. The interest accretion rate remains the original discount rate used at contract issue date.

If the updating of cash flow assumptions results in the present value of future benefits and expenses exceeding the present value of future gross premiums, a charge to net income is recorded for the current reporting period such that net premiums are set equal to gross premiums. In subsequent periods, the liability for future policy benefits is accrued with net premiums set equal to gross premiums.

Contracts (except for life contingent payout annuities sold subsequent to December 31, 2020) are grouped into cohorts by contract type and issue year, as well as by legal entity and reportable segment. Life contingent payout annuities sold in periods beginning in 2021 are grouped into quarterly cohorts.

See Note 9 for information regarding the liabilities for traditional long-duration products.

*Deferred Profit Liability* 

For limited-payment products, gross premiums received in excess of net premiums are deferred at initial recognition as a deferred profit liability ("DPL"). Gross premiums are measured using assumptions consistent with those used in the measurement of the liability for future policy benefits, including discount rate, mortality, lapses and expenses.

The DPL is amortized and recognized as premium revenue in proportion to expected future benefit payments from annuity contracts. Interest is accreted on the balance of the DPL using the discount rate determined at contract issuance. The Company reviews and updates its estimate of cash flows from the DPL at the same time as the estimates of cash flows for the liability for future policy benefits. When cash flows are updated, the updated estimates are used to recalculate the DPL at contract issuance. The recalculated DPL as of the beginning of the current reporting period is compared to the carrying amount of the DPL as of the beginning of the current reporting period, and any difference is recognized as either a charge or credit to premium revenue.

DPL is recorded in Policyholder account balances, future policy benefits and claims and included as a reconciling item within Note 9.

 **F-12** 

------

*RiverSource Life Insurance Co. of New York* 

**Unearned Revenue Liability** 

The Company's UL and VUL policies require payment of fees or other policyholder assessments in advance for services to be provided in future periods. These charges are deferred as unearned revenue and amortized using the same assumptions and factors used to amortize DAC. The unearned revenue liability is recorded in Other liabilities and the amortization is recorded in Policy and contract charges.

**Income Taxes** 

The Company qualifies as a life insurance company for federal income tax purposes. As such, the Company is subject to the Internal Revenue Code provisions applicable to life insurance companies.

The Company's taxable income is included in the consolidated federal income tax return of Ameriprise Financial. The Company provides for income taxes on a separate return basis, except that, under an agreement between Ameriprise Financial and the Company, tax benefits are recognized for losses to the extent they can be used in the consolidated return. It is the policy of Ameriprise Financial that it will reimburse its subsidiaries for any tax benefits recorded. The controlled group for which the Company is a member is an applicable corporation with regard to the corporate alternative minimum tax ("CAMT") and is therefore required to compute the CAMT. In accordance with the tax sharing agreement, Ameriprise Financial will be liable for any CAMT liability and expense.

The Company's provision for income taxes represents the net amount of income taxes that the Company expects to pay or to receive from various taxing jurisdictions in connection with its operations. The Company provides for income taxes based on amounts that the Company believes it will ultimately owe taking into account the recognition and measurement for uncertain tax positions. Inherent in the provision for income taxes are estimates and judgments regarding the tax treatment of certain items.

In connection with the provision for income taxes, the financial statements reflect certain amounts related to deferred tax assets and liabilities, which result from temporary differences between the assets and liabilities measured for financial statement purposes versus the assets and liabilities measured for tax return purposes.

The Company is required to establish a valuation allowance for any portion of its deferred tax assets that management believes will not be realized. Significant judgment is required in determining if a valuation allowance should be established and the amount of such allowance if required. Factors used in making this determination include estimates relating to the performance of the business. Consideration is given to, among other things in making this determination: (i) future taxable income exclusive of reversing temporary differences and carryforwards; (ii) future reversals of existing taxable temporary differences; (iii) taxable income in prior carryback years; and (iv) tax planning strategies. Management may need to identify and implement appropriate planning strategies to ensure its ability to realize deferred tax assets and reduce the likelihood of the establishment of a valuation allowance with respect to such assets. See Note 18 for additional information on the Company's valuation allowance.

Changes in tax rates and tax law are accounted for in the period of enactment. Deferred tax assets and liabilities are adjusted for the effect of a change in tax laws or rates and the effect is included in net income.

**Revenue Recognition** 

Premiums on traditional life, DI and LTC insurance products and life contingent payout annuities are net of reinsurance ceded and are recognized as revenue when due.

Interest income is accrued as earned using the effective interest method, which makes an adjustment of the yield for security premiums and discounts on all performing fixed maturity securities classified as Available-for-Sale so that the related security or loan recognizes a constant rate of return on the outstanding balance throughout its term. When actual prepayments differ significantly from originally anticipated prepayments, the retrospective effective yield is recalculated to reflect actual payments to date and updated future payment assumptions and a catch-up adjustment is recorded in the current period. In addition, the new effective yield, which reflects anticipated future payments, is used prospectively.

Mortality and expense risk fees are generally calculated as a percentage of the fair value of assets held in separate accounts and recognized when assessed. Variable annuity guaranteed benefit rider charges and cost of insurance charges on UL and VUL insurance and contract charges (net of reinsurance premiums and cost of reinsurance for UL insurance products) and surrender charges on annuities and UL and VUL insurance are recognized as revenue when assessed. These fees and charges are recorded in Policy and contract charges.

Realized gains and losses on the sale of securities, other than equity method investments, are recognized using the specific identification method on a trade date basis.

Fees received under marketing support and distribution services arrangements are recognized as revenue when earned.

See Note 4 for further discussion of accounting policies on revenue from contracts with customers.

**F-13** 

------

*RiverSource Life Insurance Co. of New York* 

**3. RECENT ACCOUNTING PRONOUNCEMENTS** 

**Adoption of New Accounting Standards** 

*Income Taxes — Improvements to Income Tax Disclosures* 

In December 2023, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2023-09, *Improvements to Income Tax Disclosures*, updating the accounting standards related to income tax disclosures, primarily focused on the disaggregation of income taxes paid and the rate reconciliation table. The standard is to be applied prospectively with an option for retrospective application and is effective for annual periods beginning after December 15, 2024. The Company elected retrospective application and adopted the standard on January 1, 2025. The adoption of the standard did not have an impact on the Company's financial condition and results of operations as the standard is disclosure-related only.

**Future Adoption of New Accounting Standards** 

*Expenses — Disaggregation of Income Statement Expenses* 

In November 2024, the FASB issued ASU 2024-03, *Disaggregation of Income Statement Expenses*, requiring public business entities to disclose disaggregated information about certain income statement expense line items. The disaggregated disclosures are required to be in the footnotes to the financial statements on an annual and interim basis. The standard is to be applied prospectively and is effective for annual periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027. The Company is assessing changes to disclosures resulting from the standard. The adoption of the standard will not have an impact on the Company's financial condition and results of operations as the standard is disclosure-related only.

*Financial Instruments — Measurement of Credit Losses for Accounts Receivable and Contract Assets* 

In July 2025, the FASB issued ASU 2025-05, *Measurement of Credit Losses for Accounts Receivable and Contract Assets*, which allows all entities to apply a practical expedient when estimating expected credit losses that assumes current conditions as of the balance sheet date will remain unchanged over the asset's remaining life. The standard is effective for annual periods beginning after December 15, 2025, and interim reporting periods within those years. The adoption of the standard will not have an impact on the Company's financial condition and results of operations.

*Intangibles — Internal-Use Software* 

In September 2025, the FASB issued ASU 2025-06, *Targeted Improvements to the Accounting for Internal-Use Software*, to clarify and modernize the accounting treatment for internal-use software costs by eliminating the use of the sequential software development project stages method and provide further guidance on when an entity is required to start capitalizing eligible costs. Under the new guidance, capitalization begins when both of the following occur: (a) management, with the relevant authority, implicitly or explicitly authorizes and commits to funding a computer software project and (b) it is probable that the project will be completed, and the software will be used to perform the function intended. The Company can elect prospective, retrospective, or modified retrospective adoption. The standard is effective for annual periods beginning after December 15, 2027, and interim reporting periods within those years. The Company is evaluating the impact of the standard on its financial condition and results of operations.

*Financial Instruments — Credit Losses: Purchased Loans* 

In November 2025, the FASB issued ASU 2025-08, *Purchased Loans*, which amends the accounting for certain acquired seasoned loans to require recognizing them at their purchase price plus an allowance for expected credit losses (referred to as the gross-up method). The standard is effective for annual periods beginning after December 15, 2026, including interim periods within those years, and must be applied prospectively. The Company is evaluating the impact of this standard on its financial condition and results of operations.

*Derivatives and Hedging — Hedge Accounting Improvements* 

In November 2025, the FASB issued ASU 2025-09, *Hedge Accounting Improvements*, to make targeted changes within the hedge accounting model. The updates primarily relate to cash flow hedges and certain fair value and net investment hedges. The standard is effective for annual periods beginning after December 15, 2026, including interim periods within those years, and must be applied prospectively. The Company is evaluating the impact of this standard on its financial condition and results of operations.

 **F-14** 

------

*RiverSource Life Insurance Co. of New York* 

**4. REVENUE FROM CONTRACTS WITH CUSTOMERS** 

The following table presents disaggregated revenue from contracts with customers and a reconciliation to total revenues reported on the Statements of Income:

---

| | | | |
|:---|:---|:---|:---|
| | **Years Ended December 31,** | **Years Ended December 31,** | **Years Ended December 31,** |
| <br>**(in thousands)** | **2025** | **2024** | **2023** |
|  Policy and contract charges |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Affiliated (from Columbia Management Investment Distributors, Inc.) | $9570 | $9678 | $9193 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Unaffiliated | 1040 | 996 | 850 |
|  Total | 10610 | 10674 | 10043 |
|  Other revenues |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Administrative fees |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Affiliated (from Columbia Management Investment Services, Corp.) | 2460 | 2498 | 2317 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Unaffiliated | 1213 | 1172 | 1029 |
|  | 3673 | 3670 | 3346 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other fees |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Affiliated (from Columbia Management Investment Advisers, LLC ("CMIA")) | 20240 | 19527 | 18482 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Unaffiliated | 285 | 272 | 230 |
|  | 20525 | 19799 | 18712 |
|  Total | 24198 | 23469 | 22058 |
|  Total revenue from contracts with customers | 34808 | 34143 | 32101 |
|  Revenue from other sources<sup>(1)</sup> | 219005 | 224624 | 219936 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total revenues | $253813 | $258767 | $252037 |

---

<sup>(1)</sup> Amounts primarily consist of revenue associated with insurance and annuity products and investment income from financial instruments. 

The following discussion describes the nature, timing, and uncertainty of revenues and cash flows arising from the Company's contracts with customers.

**Policy and Contract Charges** 

The Company earns revenue for providing distribution-related services to affiliated and unaffiliated mutual funds that are available as underlying investments in its variable annuity and variable life insurance products. The performance obligation is satisfied at the time the mutual fund is distributed. Revenue is recognized over the time the mutual fund is held in the variable product and is generally earned based on a fixed rate applied, as a percentage, to the net asset value of the fund. The revenue is not recognized at the time of sale because it is variably constrained due to factors outside the Company's control, including market volatility and how long the fund(s) remain in the insurance policy or annuity contract. The revenue will not be recognized until it is probable that a significant reversal will not occur. These fees are accrued and collected on a monthly basis.

**Other Revenues** 

*Administrative Fees* 

The Company earns revenue for providing customer support, contract servicing and administrative services for affiliated and unaffiliated mutual funds that are available as underlying instruments in its variable annuity and variable life insurance products. The transfer agent and administration revenue is earned daily based on a fixed rate applied, as a percentage, to assets under management. These performance obligations are considered a series of distinct services that are substantially the same and are satisfied each day over the contract term. These fees are accrued and collected on a monthly basis.

*Other Fees* 

The Company earns revenue for providing affiliated and unaffiliated partners an opportunity to educate the financial advisors of its affiliate, AFS, that sell the Company's products as well as product and marketing personnel to support the offer, sale and servicing of funds within the Company's variable annuity and variable life insurance products. These payments allow the parties to train and support the advisors, explain the features of their products, and distribute marketing and educational materials. The affiliated revenue is earned based on a rate, updated at least annually, which is applied, as a percentage, to the market value of assets invested. The unaffiliated revenue is earned based on a fixed rate applied, as a percentage, to the market value of assets invested. These performance obligations are considered a series of distinct services that are substantially the same and are satisfied each day over the contract term. These fees are accrued and collected on a monthly basis.

**Receivables** 

Receivables for revenue from contracts with customers are recognized when the performance obligation is satisfied and the Company has an unconditional right to the revenue. Receivables related to revenues from contracts with customers were $3.4 million and $3.2 million as of December 31, 2025 and 2024, respectively.

**F-15** 

------

*RiverSource Life Insurance Co. of New York* 

**5. INVESTMENTS** 

Available-for-Sale securities distributed by type were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** |
| <br>**Description of Securities (in thousands)** | **Amortized<br>Cost** | **Gross**<br> **Unrealized**<br> **Gains** | **Gross**<br> **Unrealized**<br> **Losses** | **Fair**<br> **Value** |
|  Fixed maturities: |  |  |  |  |
|  Corporate debt securities | $915381 | $21506 | $(55163) | $881724 |
|  Residential mortgage backed securities | 284339 | 806 | (30120) | 255025 |
|  Commercial mortgage backed securities | 232459 | 57 | (14854) | 217662 |
|  State and municipal obligations | 67798 | 4800 | (315) | 72283 |
|  Asset backed securities | 18579 | 466 | (701) | 18344 |
|  Foreign government bonds and obligations | 528 | 91 |  | 619 |
|  U.S. government and agency obligations | 220 | 3 |  | 223 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total | $1519304 | $27729 | $(101153) | $1445880 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** |
| <br>**Description of Securities (in thousands)** | **Amortized<br>Cost** | **Gross**<br> **Unrealized**<br> **Gains** | **Gross**<br> **Unrealized**<br> **Losses** | **Fair**<br> **Value** |
|  Fixed maturities: |  |  |  |  |
|  Corporate debt securities | $902842 | $14151 | $(75598) | $841395 |
|  Residential mortgage backed securities | 264471 | 146 | (40511) | 224106 |
|  Commercial mortgage backed securities | 283246 |  | (25417) | 257829 |
|  State and municipal obligations | 69925 | 3528 | (446) | 73007 |
|  Asset backed securities | 24305 | 544 | (1359) | 23490 |
|  Foreign government bonds and obligations | 531 | 54 |  | 585 |
|  U.S. government and agency obligations | 217 | 1 |  | 218 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total | $1545537 | $18424 | $(143331) | $1420630 |

---

As of December 31, 2025 and 2024, accrued interest of $13.8 million and $13.9 million, respectively, is excluded from the amortized cost basis of Available-for-Sale securities in the tables above and is recorded in Accrued investment income.

As of December 31, 2025 and 2024, fixed maturity securities comprised approximately 89% and 88%, respectively, of the Company's total investments. Rating agency designations are based on the availability of ratings from Nationally Recognized Statistical Rating Organizations ("NRSROs"), including Moody's Investors Service ("Moody's"), Standard & Poor's Ratings Services ("S&P") and Fitch Ratings Ltd. ("Fitch"). The Company uses the median of available ratings from Moody's, S&P and Fitch, or if fewer than three ratings are available, the lower rating is used. When ratings from Moody's, S&P and Fitch are unavailable, the Company may utilize ratings from other NRSROs or rate the securities internally. As of December 31, 2025 and 2024, $4.9 million and $9.4 million, respectively, of securities were internally rated by CMIA, an affiliate of the Company, using criteria similar to those used by NRSROs.

A summary of fixed maturity securities by rating was as follows:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** |
| <br>**Ratings (in thousands, except percentages)** | **Amortized<br>Cost** | **Fair**<br> **Value** | **Percent of<br>Total Fair<br>Value** | **Amortized<br>Cost** | **Fair**<br> **Value** | **Percent of<br>Total Fair<br>Value** |
|  AAA | $261858 | $247062 | 17% | $295791 | $270009 | 19% |
|  AA | 319545 | 296261 | 21 | 321502 | 285980 | 20 |
|  A | 266064 | 261977 | 18 | 187262 | 181984 | 13 |
|  BBB | 641660 | 612782 | 42 | 707754 | 651579 | 46 |
|  Below investment grade | 30177 | 27798 | 2 | 33228 | 31078 | 2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total fixed maturities | $1519304 | $1445880 | 100% | $1545537 | $1420630 | 100% |

---

As of December 31, 2025 and 2024, approximately 76% and 74% of securities rated AA were GNMA, FNMA and FHLMC mortgage backed securities, respectively. No holdings of any issuer were greater than 10% of the Company's total shareholder's equity as of both December 31, 2025 and 2024.

 **F-16** 

------

*RiverSource Life Insurance Co. of New York* 

The following tables summarize the fair value and gross unrealized losses on Available-for-Sale securities, aggregated by major investment type and the length of time that individual securities have been in a continuous unrealized loss position for which no allowance for credit losses has been recorded:

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** |
| | **Less than 12 Months** | **Less than 12 Months** | **Less than 12 Months** | **12 Months or More** | **12 Months or More** | **12 Months or More** | **Total** | **Total** | **Total** |
| <br>**Description of Securities**<br> **(in thousands, except number of securities)** | **Number of<br>Securities** | **Fair**<br> **Value** | **Unrealized<br>Losses** | **Number of<br>Securities** | **Fair**<br> **Value** | **Unrealized<br>Losses** | **Number of<br>Securities** | **Fair**<br> **Value** | **Unrealized<br>Losses** |
|  Corporate debt securities | 17 | $62861 | $(4605) | 133 | $497497 | $(50558) | 150 | $560358 | $(55163) |
|  Residential mortgage backed securities | 1 | 297 | (1) | 56 | 204887 | (30119) | 57 | 205184 | (30120) |
|  Commercial mortgage backed securities |  |  |  | 69 | 209765 | (14854) | 69 | 209765 | (14854) |
|  State and municipal obligations | 2 | 1280 | (34) | 6 | 4319 | (281) | 8 | 5599 | (315) |
|  Asset backed securities |  |  |  | 8 | 16368 | (701) | 8 | 16368 | (701) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total | 20 | $64438 | $(4640) | 272 | $932836 | $(96513) | 292 | $997274 | $(101153) |

---

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** |
| | **Less than 12 Months** | **Less than 12 Months** | **Less than 12 Months** | **12 Months or More** | **12 Months or More** | **12 Months or More** | **Total** | **Total** | **Total** |
| <br>**Description of Securities**<br> **(in thousands, except number of securities)** | **Number of<br>Securities** | **Fair**<br> **Value** | **Unrealized<br>Losses** | **Number of<br>Securities** | **Fair**<br> **Value** | **Unrealized<br>Losses** | **Number of<br>Securities** | **Fair**<br> **Value** | **Unrealized<br>Losses** |
|  Corporate debt securities | 45 | $160846 | $(7630) | 151 | $515598 | $(67968) | 196 | $676444 | $(75598) |
|  Residential mortgage backed securities | 2 | 2242 | (94) | 56 | 215835 | (40417) | 58 | 218077 | (40511) |
|  Commercial mortgage backed securities |  |  |  | 86 | 257829 | (25417) | 86 | 257829 | (25417) |
|  State and municipal obligations | 5 | 3860 | (63) | 9 | 6372 | (383) | 14 | 10232 | (446) |
|  Asset backed securities |  |  |  | 9 | 18493 | (1359) | 9 | 18493 | (1359) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total | 52 | $166948 | $(7787) | 311 | $1014127 | $(135544) | 363 | $1181075 | $(143331) |

---

As part of the Company's ongoing monitoring process, management determined that the decrease in total gross unrealized losses on its Available-for-Sale securities for which an allowance for credit losses has not been recognized during the year ended December 31, 2025 is primarily attributable to interest rate movements and tightening of credit spreads. As of December 31, 2025, the Company did not recognize these unrealized losses in earnings because it was determined that such losses were due to non-credit factors. The Company does not intend to sell these securities and does not believe that it is more likely than not that the Company will be required to sell these securities before the anticipated recovery of the remaining amortized cost basis. As of December 31, 2025 and 2024, approximately 92% and 93%, respectively, of the total of Available-for-Sale securities with gross unrealized losses were considered investment grade.

The following table presents a rollforward of the allowance for credit losses on Available-for-Sale securities:

---

| | |
|:---|:---|
| **(in thousands)** | **Corporate Debt<br>Securities** |
|  Balance at January 1, 2023 | $572 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Additions for which credit losses were not previously recorded | 365 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Reductions for securities sold during the period (realized) | (458) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Additional increases (decreases) on securities that had an allowance recorded in a previous period | (114) |
|  Balance at December 31, 2023 | 365 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Reductions for securities sold during the period (realized) | (389) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Additional increases (decreases) on securities that had an allowance recorded in a previous period | 24 |
|  Balance at December 31, 2024 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Additional increases (decreases) on securities that had an allowance recorded in a previous period |  |
|  Balance at December 31, 2025 | $— |

---

Net realized gains and losses on Available-for-Sale securities, determined using the specific identification method, recognized in Net realized investment gains (losses) were as follows:

---

| | | | |
|:---|:---|:---|:---|
| | **Years Ended December 31,** | **Years Ended December 31,** | **Years Ended December 31,** |
| <br>**(in thousands)** | **2025** | **2024** | **2023** |
|  Gross realized investment gains | $757 | $403 | $93 |
|  Gross realized investment losses | (2392) | (1317) | (524) |
|  Credit reversals (losses) |  | 365 | 207 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total | $(1635) | $(549) | $(224) |

---

**F-17** 

------

*RiverSource Life Insurance Co. of New York* 

For the year ended December 31, 2024, net credit reversals primarily related to the sale of a previously impaired corporate debt security in the communications industry. For the year ended December 31, 2023, net credit reversals primarily related to the reversal of a previously recorded allowance for credit losses due to the sale of a corporate debt security in the communications industry partially offset by recording an allowance for credit losses of another corporate debt security in the communications industry.

See Note 17 for a rollforward of net unrealized investment gains (losses) included in AOCI.

Available-for-Sale securities by contractual maturity as of December 31, 2025 were as follows:

---

| | | |
|:---|:---|:---|
| **(in thousands)** | **Amortized**<br> **Cost** | **Fair**<br> **Value** |
|  Due within one year | $37063 | $36883 |
|  Due after one year through five years | 136629 | 131741 |
|  Due after five years through 10 years | 218565 | 204045 |
|  Due after 10 years | 591670 | 582180 |
|  | 983927 | 954849 |
|  Residential mortgage backed securities | 284339 | 255025 |
|  Commercial mortgage backed securities | 232459 | 217662 |
|  Asset backed securities | 18579 | 18344 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total | $1519304 | $1445880 |

---

Actual maturities may differ from contractual maturities because issuers may have the right to call or prepay obligations. Residential mortgage backed securities, commercial mortgage backed securities and asset backed securities are not due at a single maturity date. As such, these securities were not included in the maturities distribution.

The following is a summary of Net investment income:

---

| | | | |
|:---|:---|:---|:---|
| | **Years Ended December 31,** | **Years Ended December 31,** | **Years Ended December 31,** |
| <br>**(in thousands)** | **2025** | **2024** | **2023** |
|  Available-for-Sale securities | $64083 | $65545 | $66737 |
|  Mortgage loans | 5087 | 5649 | 6080 |
|  Other investments | 12130 | 13094 | 13384 |
|  | 81300 | 84288 | 86201 |
|  Less: investment expenses | 1423 | 1471 | 1616 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total | $79877 | $82817 | $84585 |

---

Net realized investment gains (losses) are summarized as follows:

---

| | | | |
|:---|:---|:---|:---|
| | **Years Ended December 31,** | **Years Ended December 31,** | **Years Ended December 31,** |
| <br>**(in thousands)** | **2025** | **2024** | **2023** |
|  Fixed maturities | $(1635) | $(549) | $(224) |
|  Mortgage loans | 108 | 130 | 411 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total | $(1527) | $(419) | $187 |

---

**6. FINANCING RECEIVABLES** 

Financing receivables are comprised of mortgage loans and policy loans. See Note 2 for information regarding the Company's accounting policies related to financing receivables and the allowance for credit losses.

**Allowance for Credit Losses** 

The following table presents a rollforward of the allowance for credit losses:

---

| | |
|:---|:---|
| **(in thousands)** | **Mortgage<br>Loans** |
|  Balance at January 1, 2023 | $965 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Provisions | (411) |
|  Balance at December 31, 2023 | 554 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Provisions | (130) |
|  Balance at December 31, 2024 | 424 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Provisions | (108) |
|  Balance at December 31, 2025 | $316 |

---

As of December 31, 2025 and 2024, accrued interest on mortgage loans was $387 thousand and $432 thousand, respectively, and is recorded in Accrued investment income and excluded from the amortized cost basis of mortgage loans.

 **F-18** 

------

*RiverSource Life Insurance Co. of New York* 

**Credit Quality Information** 

There were no nonperforming loans as of both December 31, 2025 and 2024.

***Mortgage Loans***

The Company reviews the credit worthiness of the borrower and the performance of the underlying properties in order to determine the risk of loss on mortgage loans. Loan-to-value ratio is the primary credit quality indicator included in this review.

Based on this review, the mortgage loans are assigned an internal risk rating, which management updates when credit risk changes. There were no mortgage loans which management has assigned its highest risk rating as of both December 31, 2025 and 2024. Loans with the highest risk rating represent distressed loans which the Company has identified as impaired or expects to become delinquent or enter into foreclosure within the next six months. There were no mortgage loans past due as of both December 31, 2025 and 2024.

The tables below present the amortized cost basis of mortgage loans by year of origination and loan-to-value ratio:

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** |
| <br>**(in thousands)** | **2025** | **2024** | **2023** | **2022** | **2021** | **Prior** | **Total** |
|  **Loan-to-Value Ratio** |  |  |  |  |  |  |  |
|  >100% | $— | $— | $— | $— | $— | $— | $— |
|  80% – 100% |  |  |  |  |  |  |  |
|  60% – 80% |  | 2932 |  | 5144 |  | 7137 | 15213 |
|  40% – 60% |  |  |  | 2620 | 2333 | 18603 | 23556 |
|  <40% |  |  | 1306 |  | 2777 | 74239 | 78322 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total | $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;— | $2932 | $1306 | $7764 | $5110 | $99979 | $117091 |

---

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** |
| <br>**(in thousands)** | **2024** | **2023** | **2022** | **2021** | **2020** | **Prior** | **Total** |
|  **Loan-to-Value Ratio** |  |  |  |  |  |  |  |
|  >100% | $— | $— | $— | $— | $— | $— | $— |
|  80% – 100% |  |  |  |  |  |  |  |
|  60% – 80% | 2987 |  | 4111 |  | 5418 | 5108 | 17624 |
|  40% – 60% |  |  | 2755 | 2384 | 6366 | 28864 | 40369 |
|  <40% |  | 1414 | 1100 | 2881 | 8324 | 59538 | 73257 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total | $2987 | $1414 | $7966 | $5265 | $20108 | $93510 | $131250 |

---

Loan-to-value ratio is based on income and expense data provided by borrowers at least annually and long-term capitalization rate assumptions based on property type.

In addition, the Company reviews the concentrations of credit risk by region and property type. Concentrations of credit risk of mortgage loans by U.S. region were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Loans** | **Loans** | **Percentage** | **Percentage** |
| | **December 31,** | **December 31,** | **December 31,** | **December 31,** |
| <br>**(in thousands)** | **2025** | **2024** | **2025** | **2024** |
|  East North Central | $9864 | $10463 | 8% | 8% |
|  East South Central | 4121 | 4520 | 4 | 3 |
|  Middle Atlantic | 14388 | 15236 | 12 | 12 |
|  Mountain | 11335 | 15563 | 10 | 12 |
|  New England | 3233 | 3382 | 3 | 3 |
|  Pacific | 36974 | 41816 | 32 | 32 |
|  South Atlantic | 24835 | 26828 | 21 | 20 |
|  West North Central | 7442 | 8202 | 6 | 6 |
|  West South Central | 4899 | 5240 | 4 | 4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total | $117091 | $131250 | 100% | 100% |

---

**F-19** 

------

*RiverSource Life Insurance Co. of New York* 

Concentrations of credit risk of mortgage loans by property type were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Loans** | **Loans** | **Percentage** | **Percentage** |
| | **December 31,** | **December 31,** | **December 31,** | **December 31,** |
| <br>**(in thousands)** | **2025** | **2024** | **2025** | **2024** |
|  Apartments | $38002 | $42598 | 32% | 33% |
|  Industrial | 22212 | 23951 | 19 | 18 |
|  Mixed use | 5260 | 5575 | 4 | 4 |
|  Office | 11255 | 16088 | 10 | 12 |
|  Retail | 32613 | 34710 | 28 | 27 |
|  Other | 7749 | 8328 | 7 | 6 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total | $117091 | $131250 | 100% | 100% |

---

***Policy Loans***

Policy loans do not exceed the cash surrender value at origination. As there is minimal risk of loss related to policy loans, there is no allowance for credit losses.

**7. DEFERRED ACQUISITION COSTS AND DEFERRED SALES INDUCEMENT COSTS** 

The following tables summarize the balances of and changes in DAC:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **(in thousands)** | **Variable<br>Annuities** | **Fixed<br>Annuities** | **Universal<br>Life<br>Insurance** | **Variable<br>Universal<br>Life<br>Insurance** | **Indexed<br>Universal Life<br>Insurance** |
|  Balance at January 1, 2025 | $101018 | $2102 | $5484 | $29889 | $16901 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Capitalization of acquisition costs | 3068 |  | 19 | 3366 | 184 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Amortization | (8574) | (403) | (412) | (2482) | (1253) |
|  Balance at December 31, 2025 | $95512 | $1699 | $5091 | $30773 | $15832 |
| **(in thousands)** | **Other Life<br>Insurance** | **Life<br>Contingent<br>Payout<br>Annuities** | **Term and<br>Whole Life<br>Insurance** | **Disability<br>Income<br>Insurance** | **Total, All<br>Products** |
|  Balance at January 1, 2025 | $71 | $577 | $783 | $4871 | $161696 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Capitalization of acquisition costs |  | 92 | (14) | 192 | 6907 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Amortization | (8) | (40) | (61) | (587) | (13820) |
|  Balance at December 31, 2025 | $63 | $629 | $708 | $4476 | $154783 |
| **(in thousands)** | **Variable<br>Annuities** | **Fixed<br>Annuities** | **Universal<br>Life<br>Insurance** | **Variable<br>Universal<br>Life<br>Insurance** | **Indexed<br>Universal Life<br>Insurance** |
|  Balance at January 1, 2024 | $105559 | $2569 | $5897 | $28611 | $17858 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Capitalization of acquisition costs | 4264 |  | 23 | 3693 | 355 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Amortization | (8805) | (467) | (436) | (2415) | (1312) |
|  Balance at December 31, 2024 | $101018 | $2102 | $5484 | $29889 | $16901 |
| **(in thousands)** | **Other Life<br>Insurance** | **Life<br>Contingent<br>Payout<br>Annuities** | **Term and<br>Whole Life<br>Insurance** | **Disability<br>Income<br>Insurance** | **Total, All<br>Products** |
|  Balance at January 1, 2024 | $79 | $264 | $807 | $5289 | $166933 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Capitalization of acquisition costs |  | 340 | 39 | 195 | 8909 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Amortization | (8) | (27) | (63) | (613) | (14146) |
|  Balance at December 31, 2024 | $71 | $577 | $783 | $4871 | $161696 |

---

 **F-20** 

------

*RiverSource Life Insurance Co. of New York* 

The following tables summarize the balances of and changes in DSIC:

---

| | | | |
|:---|:---|:---|:---|
| **(in thousands)** | **Variable Annuities** | **Fixed Annuities** | **Total, All Products** |
|  Balance at January 1, 2025 | $5366 | $624 | $5990 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Amortization | (540) | (119) | (659) |
|  Balance at December 31, 2025 | $4826 | $505 | $5331 |

---

---

| | | | |
|:---|:---|:---|:---|
| **(in thousands)** | **Variable Annuities** | **Fixed Annuities** | **Total, All Products** |
|  Balance at January 1, 2024 | $5950 | $771 | $6721 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Amortization | (584) | (147) | (731) |
|  Balance at December 31, 2024 | $5366 | $624 | $5990 |

---

**8. REINSURANCE** 

The Company reinsures a portion of its insurance risks through reinsurance agreements with unaffiliated reinsurance companies.

Reinsurance contracts do not relieve the Company from its primary obligation to policyholders.

The Company generally reinsures 90% of the death benefit liability for new term life insurance policies beginning in 2002 and new individual UL and VUL insurance policies beginning in 2003. Policies issued prior to these dates are not subject to these same reinsurance levels.

For IUL policies issued after September 1, 2013 and VUL policies issued after January 1, 2014, the Company generally reinsures 50% of the death benefit liability.

The maximum amount of life insurance risk the Company will retain is $10 million on a single life and $10 million on any flexible premium survivorship life policy; however, reinsurance agreements are in place such that retaining more than $1.5 million of insurance risk on a single life or a flexible premium survivorship life policy is very unusual. Risk on UL and VUL policies is reinsured on a yearly renewable term basis. Risk on most term life policies starting in 2002 is reinsured on a coinsurance basis, a type of reinsurance in which the reinsurer participates proportionally in all material risks and premiums associated with a policy.

The Company also has life insurance risk previously assumed under reinsurance arrangements with an unaffiliated insurance company.

As of December 31, 2002, the Company discontinued underwriting LTC insurance. For existing LTC policies, the Company has continued ceding 50% of the risk on a coinsurance basis to Genworth Life Insurance Company of New York ("Genworth") and retains the remaining risk. This reinsurance arrangement applies for 1996 and later issues only, which are about 91% of the Company's total in force policies. Under these agreements, the Company has the right, but never the obligation, to recapture some, or all, of the risk ceded to Genworth.

Generally, the Company retains at most $5,000 per month of risk per life on DI policies sold on policy forms introduced in 2010 and reinsures the remainder of the risk on a coinsurance basis with unaffiliated reinsurance companies. The Company retains all risk for new claims on DI contracts sold prior to 2010. The Company also retains all risk on accidental death benefit claims and substantially all risk associated with waiver of premium provisions.

As of both December 31, 2025 and 2024, traditional life and UL insurance policies in force were $11.2 billion, of which $7.8 billion and $7.9 billion as of December 31, 2025 and 2024, respectively, were reinsured at the respective year ends.

The effect of reinsurance on premiums for traditional long-duration products was as follows:

---

| | | | |
|:---|:---|:---|:---|
| | **Years Ended December 31,** | **Years Ended December 31,** | **Years Ended December 31,** |
| <br>**(in thousands)** | **2025** | **2024** | **2023** |
|  Direct premiums | $29504 | $37884 | $32254 |
|  Reinsurance ceded | (10791) | (10749) | (10841) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net premiums | $18713 | $27135 | $21413 |

---

Policy and contract charges are presented on the Statements of Income net of $12.4 million, $11.6 million and $11.0 million of reinsurance ceded for non-traditional long-duration products for the years ended December 31, 2025, 2024 and 2023, respectively.

The amount of claims recovered through reinsurance on all contracts was $25.4 million, $20.3 million and $22.6 million for the years ended December 31, 2025, 2024 and 2023, respectively.

Reinsurance recoverables include approximately $152.1 million and $146.7 million related to LTC risk ceded to Genworth as of December 31, 2025 and 2024, respectively.

Policyholder account balances, future policy benefits and claims include $880 thousand and $981 thousand related to previously assumed reinsurance arrangements as of December 31, 2025 and 2024, respectively.

**F-21** 

------

*RiverSource Life Insurance Co. of New York* 

**9. POLICYHOLDER ACCOUNT BALANCES, FUTURE POLICY BENEFITS AND CLAIMS** 

Policyholder account balances, future policy benefits and claims consisted of the following:

---

| | | |
|:---|:---|:---|
| | **December 31,** | **December 31,** |
| <br>**(in thousands)** | **2025** | **2024** |
|  **Policyholder account balances** |  |  |
|  Policyholder account balances | $1201148 | $1266039 |
|  **Future policy benefits** |  |  |
|  Reserve for future policy benefits | 462888 | 452282 |
|  Deferred profit liability | 8603 | 8412 |
|  Additional liabilities for insurance guarantees | 105216 | 93655 |
|  Other insurance and annuity liabilities | 10561 | 14399 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total future policy benefits | 587268 | 568748 |
|  Policy claims and other policyholders' funds | 12458 | 8785 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total policyholder account balances, future policy benefits and claims | $1800874 | $1843572 |

---

*Variable Annuities* 

Purchasers of variable annuities can select from a variety of investment options and can elect to allocate a portion to a fixed account. A vast majority of the premiums received for variable annuity contracts are held in separate accounts where the assets are held for the exclusive benefit of those contractholders.

Most of the variable annuity contracts issued by the Company contain a GMDB. The Company previously offered contracts with GMAB, GMWB and GMIB provisions. See Note 2 and Note 11 for information regarding the Company's variable annuity guarantees. See Note 12 and Note 16 for additional information regarding the Company's derivative instruments used to hedge risks related to these guarantees.

*Fixed Annuities* 

Fixed annuities include both deferred and payout contracts. In 2020, the Company discontinued sales of fixed deferred annuities.

Deferred contracts offer a guaranteed minimum rate of interest and security of the principal invested. Payout contracts guarantee a fixed income payment for life or the term of the contract. Liabilities for fixed annuities in a benefit or payout status are based on future estimated payments using established industry mortality tables and interest rates.

*Insurance Liabilities* 

UL policies accumulate cash value that increases by a fixed interest rate. Purchasers of VUL can select from a variety of investment options and can elect to allocate a portion of their account balance to a fixed account or a separate account. A vast majority of the premiums received for VUL policies are held in separate accounts where the assets are held for the exclusive benefit of those policyholders.

IUL is a UL policy that includes an indexed account. The rate of credited interest for funds allocated by a contractholder to the indexed account is linked to the performance of the specific index for the indexed account (subject to stated account parameters, which include a cap and floor, or a spread). The policyholder may allocate all or a portion of the policy value to a fixed or any available indexed account. The amount allocated by a contractholder to the indexed account creates an embedded derivative which is measured at fair value. The Company hedges the interest credited rate including equity and interest rate risk related to the indexed account with freestanding derivative instruments. See Note 16 for additional information regarding the Company's derivative instruments used to hedge the risk related to IUL.

The Company also offers term life insurance as well as DI products. The Company no longer offers standalone LTC products and whole life insurance but has in force policies from prior years.

Insurance liabilities include accumulation values, incurred but not reported claims, obligations for anticipated future claims, unpaid reported claims and claim adjustment expenses.

 **F-22** 

------

*RiverSource Life Insurance Co. of New York* 

The balances of and changes in policyholder account balances were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **(in thousands, except percentages)** | **Variable Annuities** | **Fixed<br>Annuities** | **Non-Life<br>Contingent<br>Payout<br>Annuities** | **Universal Life<br>Insurance** |
|  Balance at January 1, 2025 | $222195 | $637027 | $25773 | $83432 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Contract deposits | 2224 | 5905 | 3702 | 8127 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Policy charges | (1086) | (3) |  | (11700) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Surrenders and other benefits | (28039) | (75896) | (5648) | (3570) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net transfer from (to) separate account liabilities | (597) |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Interest credited | 6814 | 24301 | 798 | 2738 |
|  Balance at December 31, 2025 | $201511 | $591334 | $24625 | $79027 |
|  Weighted-average crediting rate | 3.3% | 4.1% | N/A | 3.4% |
|  Net amount at risk | N/A | N/A | N/A | $543791 |
|  Cash surrender value<sup>(1)</sup>  | $198910 | $591002 | N/A | $70865 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| **(in thousands, except percentages)** | **Variable Universal<br>Life Insurance** | **Indexed<br>Universal<br>Life<br>Insurance** | **Other Life<br>Insurance** | **Total, All<br>Products** |
|  Balance at January 1, 2025 | $103241 | $170458 | $23913 | $1266039 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Contract deposits | 11133 | 12568 |  | 43659 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Policy charges | (6120) | (8754) | (2) | (27665) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Surrenders and other benefits | (7585) | (4004) | (3090) | (127832) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net transfer from (to) separate account liabilities | (2541) |  |  | (3138) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Interest credited | 4066 | 10559 | 809 | 50085 |
|  Balance at December 31, 2025 | $102194 | $180827 | $21630 | $1201148 |
|  Weighted-average crediting rate | 4.0% | 3.0% | 4.0% |  |
|  Net amount at risk | $3029480 | $881499 | $9168 |  |
|  Cash surrender value<sup>(1)</sup> | $68684 | $160202 | $15769 |  |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| **(in thousands, except percentages)** | **Variable Annuities** | **Fixed<br>Annuities** | **Non-Life<br>Contingent<br>Payout<br>Annuities** | **Universal Life<br>Insurance** |
|  Balance at January 1, 2024 | $251056 | $677635 | $25052 | $87208 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Contract deposits | 5145 | 6120 | 6530 | 8859 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Policy charges | (776) | (26) |  | (12182) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Surrenders and other benefits | (36893) | (72274) | (6642) | (3427) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net transfer from (to) separate account liabilities | (3807) |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Interest credited | 7470 | 25572 | 833 | 2974 |
|  Balance at December 31, 2024 | $222195 | $637027 | $25773 | $83432 |
|  Weighted-average crediting rate | 3.2% | 4.0% | N/A | 3.4% |
|  Net amount at risk | N/A | N/A | N/A | $569918 |
|  Cash surrender value<sup>(1)</sup>  | $219310 | $636172 | N/A | $74110 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| **(in thousands, except percentages)** | **Variable Universal<br>Life Insurance** | **Indexed<br>Universal<br>Life<br>Insurance** | **Other Life<br>Insurance** | **Total, All<br>Products** |
|  Balance at January 1, 2024 | $97977 | $159277 | $24481 | $1322686 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Contract deposits | 19468 | 13651 |  | 59773 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Policy charges | (6339) | (8412) |  | (27735) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Surrenders and other benefits | (4086) | (3355) | (1466) | (128143) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net transfer from (to) separate account liabilities | (7702) |  |  | (11509) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Interest credited | 3923 | 9297 | 898 | 50967 |
|  Balance at December 31, 2024 | $103241 | $170458 | $23913 | $1266039 |
|  Weighted-average crediting rate | 4.0% | 2.3% | 4.0% |  |
|  Net amount at risk | $3021978 | $917731 | $9876 |  |
|  Cash surrender value<sup>(1)</sup>  | $70021 | $147686 | $18280 |  |

---

<sup>(1)</sup> Cash surrender value represents the amount of the contractholder's account balances distributable at the balance sheet date less certain surrender charges. For variable annuities and VUL, the cash surrender value shown is the proportion of the total cash surrender value related to their fixed account liabilities. 

**F-23** 

------

*RiverSource Life Insurance Co. of New York* 

Refer to Note 11 for the net amount at risk for market risk benefits associated with variable annuities. Fixed and non-life contingent payout annuities do not have net amount at risk in excess of account value. Net amount at risk for insurance products is calculated as the death benefit amount in excess of applicable account values, host, embedded derivative and separate account liabilities.

The following tables present the account values of fixed deferred annuities, fixed insurance, and the fixed portion of variable annuities and variable insurance contracts by range of guaranteed minimum interest rates ("GMIRs") and the range of the difference between rates credited to policyholders and contractholders as of December 31, 2025 and 2024 and the respective guaranteed minimums, as well as the percentage of account values subject to rate reset in the time period indicated. Rates are reset at management's discretion, subject to guaranteed minimums.

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** |
| | | **Account Values with Crediting Rates** | **Account Values with Crediting Rates** | **Account Values with Crediting Rates** | **Account Values with Crediting Rates** | **Account Values with Crediting Rates** | **Account Values with Crediting Rates** |
| <br>**(in thousands, except percentages)** |<br>**Range of Guaranteed<br>Minimum Crediting<br>Rates** | **At<br>Guaranteed<br>Minimum** | **1-49 bps above<br>Guaranteed<br>Minimum** | **50-99 bps above<br>Guaranteed<br>Minimum** | **100-150 bps<br>above<br>Guaranteed<br>Minimum** | **Greater than<br>150 bps above<br>Guaranteed<br>Minimum** | **Total** |
|  Fixed accounts of variable annuities | 1% – 1.99% | $257 | $5177 | $10067 | $5011 | $— | $20512 |
|  | 2% – 2.99% | 4337 |  |  |  |  | 4337 |
|  | 3% – 3.99% | 90452 |  |  |  |  | 90452 |
|  | 4% – 5.00% | 81371 |  |  |  |  | 81371 |
|  | Total | $176417 | $5177 | $10067 | $5011 | $— | $196672 |
|  Fixed annuities | 1% – 1.99% | $5 | $9760 | $8292 | $7924 | $3641 | $29622 |
|  | 2% – 2.99% | 300 | 291 | 14 |  |  | 605 |
|  | 3% – 3.99% | 241445 | 27 |  |  |  | 241472 |
|  | 4% – 5.00% | 319451 |  |  |  |  | 319451 |
|  | Total | $561201 | $10078 | $8306 | $7924 | $3641 | $591150 |
|  Universal life insurance | 1% – 1.99% | $— | $— | $— | $— | $— | $— |
|  | 2% – 2.99% | 3309 | 205 | 849 | 153 | 55 | 4571 |
|  | 3% – 3.99% | 43971 | 43 | 279 | 750 |  | 45043 |
|  | 4% – 5.00% | 27068 | 179 | 10 |  |  | 27257 |
|  | Total | $74348 | $427 | $1138 | $903 | $55 | $76871 |
|  Fixed accounts of variable universal life insurance | 1% – 1.99% | $— | $— | $223 | $102 | $1943 | $2268 |
|  | 2% – 2.99% | 58 | 786 | 288 | 31 | 744 | 1907 |
|  | 3% – 3.99% | 5084 | 27 | 155 | 772 |  | 6038 |
|  | 4% – 5.00% | 39149 | 905 |  |  |  | 40054 |
|  | Total | $44291 | $1718 | $666 | $905 | $2687 | $50267 |
|  Non-indexed accounts of indexed universal life insurance | 1% – 1.99% | $— | $— | $— | $— | $202 | $202 |
|  | 2% – 2.99% |  |  |  | 10898 |  | 10898 |
|  | 3% – 3.99% |  |  |  |  |  |  |
|  | 4% – 5.00% |  |  |  |  |  |  |
|  | Total | $— | $— | $— | $10898 | $202 | $11100 |
|  Other life insurance | 1% – 1.99% | $— | $— | $— | $— | $— | $— |
|  | 2% – 2.99% |  |  |  |  |  |  |
|  | 3% – 3.99% |  |  |  |  |  |  |
|  | 4% – 5.00% | 15690 |  |  |  |  | 15690 |
|  | Total | $15690 | $— | $— | $— | $— | $15690 |
|  Total | 1% – 1.99% | $262 | $14937 | $18582 | $13037 | $5786 | $52604 |
|  | 2% – 2.99% | 8004 | 1282 | 1151 | 11082 | 799 | 22318 |
|  | 3% – 3.99% | 380952 | 97 | 434 | 1522 |  | 383005 |
|  | 4% – 5.00% | 482729 | 1084 | 10 |  |  | 483823 |
|  | Total | $871947 | $17400 | $20177 | $25641 | $6585 | $941750 |
|  **Percentage of total account values that reset in:** | **Percentage of total account values that reset in:** | **Percentage of total account values that reset in:** | **Percentage of total account values that reset in:** | **Percentage of total account values that reset in:** | **Percentage of total account values that reset in:** | **Percentage of total account values that reset in:** | **Percentage of total account values that reset in:** |
|  Next 12 months |  | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
|  > 12 months to 24 months |  |  |  |  |  |  |  |
|  > 24 months |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total |  | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |

---

 **F-24** 

------

*RiverSource Life Insurance Co. of New York* 

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** |
| | | **Account Values with Crediting Rates** | **Account Values with Crediting Rates** | **Account Values with Crediting Rates** | **Account Values with Crediting Rates** | **Account Values with Crediting Rates** | **Account Values with Crediting Rates** |
| <br>**(in thousands, except percentages)** |<br>**Range of Guaranteed<br>Minimum Crediting<br>Rates** | **At<br>Guaranteed<br>Minimum** | **1-49 bps above<br>Guaranteed<br>Minimum** | **50-99 bps above<br>Guaranteed<br>Minimum** | **100-150 bps<br>above<br>Guaranteed<br>Minimum** | **Greater than<br>150 bps above<br>Guaranteed<br>Minimum** | **Total** |
|  Fixed accounts of variable annuities | 1% – 1.99% | $2059 | $9655 | $7152 | $5074 | $126 | $24066 |
|  | 2% – 2.99% | 4904 |  |  |  |  | 4904 |
|  | 3% – 3.99% | 102364 | 67 |  |  |  | 102431 |
|  | 4% – 5.00% | 85029 |  |  |  |  | 85029 |
|  | Total | $194356 | $9722 | $7152 | $5074 | $126 | $216430 |
|  Fixed annuities | 1% – 1.99% | $6132 | $12131 | $13918 | $6307 | $3114 | $41602 |
|  | 2% – 2.99% | 572 | 105 | 13 |  |  | 690 |
|  | 3% – 3.99% | 267561 | 148 |  |  |  | 267709 |
|  | 4% – 5.00% | 326709 |  |  |  |  | 326709 |
|  | Total | $600974 | $12384 | $13931 | $6307 | $3114 | $636710 |
|  Universal life insurance | 1% – 1.99% | $— | $— | $— | $— | $— | $— |
|  | 2% – 2.99% | 3389 | 148 | 743 | 7 | 44 | 4331 |
|  | 3% – 3.99% | 45770 | 45 | 254 | 659 |  | 46728 |
|  | 4% – 5.00% | 29958 | 179 | 11 |  |  | 30148 |
|  | Total | $79117 | $372 | $1008 | $666 | $44 | $81207 |
|  Fixed accounts of variable universal life insurance | 1% – 1.99% | $— | $— | $244 | $104 | $1667 | $2015 |
|  | 2% – 2.99% | 376 | 803 |  | 33 | 452 | 1664 |
|  | 3% – 3.99% | 5637 | 32 | 93 | 692 |  | 6454 |
|  | 4% – 5.00% | 42983 | 564 |  |  |  | 43547 |
|  | Total | $48996 | $1399 | $337 | $829 | $2119 | $53680 |
|  Non-indexed accounts of indexed universal life insurance | 1% – 1.99% | $— | $— | $376 | $128 | $— | $504 |
|  | 2% – 2.99% |  | 9783 |  |  |  | 9783 |
|  | 3% – 3.99% |  |  |  |  |  |  |
|  | 4% – 5.00% |  |  |  |  |  |  |
|  | Total | $— | $9783 | $376 | $128 | $— | $10287 |
|  Other life insurance | 1% – 1.99% | $— | $— | $— | $— | $— | $— |
|  | 2% – 2.99% |  |  |  |  |  |  |
|  | 3% – 3.99% |  |  |  |  |  |  |
|  | 4% – 5.00% | 18207 |  |  |  |  | 18207 |
|  | Total | $18207 | $— | $— | $— | $— | $18207 |
|  Total | 1% – 1.99% | $8191 | $21786 | $21690 | $11613 | $4907 | $68187 |
|  | 2% – 2.99% | 9241 | 10839 | 756 | 40 | 496 | 21372 |
|  | 3% – 3.99% | 421332 | 292 | 347 | 1351 |  | 423322 |
|  | 4% – 5.00% | 502886 | 743 | 11 |  |  | 503640 |
|  | Total | $941650 | $33660 | $22804 | $13004 | $5403 | $1016521 |
|  **Percentage of total account values that reset in:** | **Percentage of total account values that reset in:** | **Percentage of total account values that reset in:** | **Percentage of total account values that reset in:** | **Percentage of total account values that reset in:** | **Percentage of total account values that reset in:** | **Percentage of total account values that reset in:** | **Percentage of total account values that reset in:** |
|  Next 12 months |  | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
|  > 12 months to 24 months |  |  |  |  |  |  |  |
|  > 24 months |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total |  | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |

---

**F-25** 

------

*RiverSource Life Insurance Co. of New York* 

The following tables summarize the balances of and changes in the liability for future policy benefits:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **(in thousands, except percentages)** | **Life Contingent<br>Payout<br>Annuities** | **Term and<br>Whole Life<br>Insurance** | **Disability<br>Income<br>Insurance** | **Long Term<br>Care<br>Insurance** | **Total, All<br>Products** |
|  **Present Value of Expected Net Premiums:** |  |  |  |  |  |
|  Balance at January 1, 2025 | $— | $35346 | $4941 | $48273 | $88560 |
|  Beginning balance at original discount rate |  | 38026 | 5185 | 48223 | 91434 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Effect of changes in cash flow assumptions |  | 2380 | (990) | (1877) | (487) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Effect of actual variances from expected experience |  | (2150) | (466) | 2508 | (108) |
|  Adjusted beginning of year balance | $— | $38256 | $3729 | $48854 | $90839 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Issuances | 6925 | 3684 | 625 |  | 11234 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Interest accrual | 23 | 1867 | 224 | 2430 | 4544 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net premiums collected | (6948) | (3566) | (422) | (5331) | (16267) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Derecognition (lapses) |  |  |  |  |  |
|  Ending balance at original discount rate | $— | $40241 | $4156 | $45953 | $90350 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Effect of changes in discount rate assumptions |  | (1734) | (60) | 1283 | (511) |
|  Balance at December 31, 2025 | $— | $38507 | $4096 | $47236 | $89839 |
|  **Present Value of Future Policy Benefits:** |  |  |  |  |  |
|  Balance at January 1, 2025 | $67569 | $73570 | $30612 | $369035 | $540786 |
|  Beginning balance at original discount rate | 71941 | 76041 | 29825 | 373901 | 551708 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Effect of changes in cash flow assumptions | (67) | 1374 | (1550) | (1077) | (1320) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Effect of actual variances from expected experience | (169) | (3773) | (651) | 6205 | 1612 |
|  Adjusted beginning of year balance | $71705 | $73642 | $27624 | $379029 | $552000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Issuances | 6925 | 3655 | 626 |  | 11206 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Interest accrual | 3227 | 4139 | 1745 | 19493 | 28604 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Benefit payments | (9632) | (3971) | (2597) | (26977) | (43177) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Derecognition (lapses) |  |  |  |  |  |
|  Ending balance at original discount rate | $72225 | $77465 | $27398 | $371545 | $548633 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Effect of changes in discount rate assumptions | (2178) | (821) | 1500 | 5473 | 3974 |
|  Balance at December 31, 2025 | $70047 | $76644 | $28898 | $377018 | $552607 |
|  Adjustment due to reserve flooring | $— | $120 | $— | $— | $120 |
|  Net liability for future policy benefits | $70047 | $38257 | $24802 | $329782 | $462888 |
|  Less: reinsurance recoverable |  | 27925 | 656 | 151580 | 180161 |
|  Net liability for future policy benefits, after reinsurance recoverable | $70047 | $10332 | $24146 | $178202 | $282727 |
|  Discounted expected future gross premiums | $— | $100961 | $42652 | $53924 | $197537 |
|  Expected future gross premiums | $— | $163067 | $59642 | $71659 | $294368 |
|  Expected future benefit payments | $102492 | $129035 | $44830 | $609740 | $886097 |
|  Weighted average interest accretion rate | 4.5% | 6.2% | 6.5% | 5.2% |  |
|  Weighted average discount rate | 5.0% | 5.4% | 5.2% | 5.3% |  |
|  Weighted average duration of liability (in years) | 6 | 7 | 6 | 8 |  |

---

 **F-26** 

------

*RiverSource Life Insurance Co. of New York* 

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **(in thousands, except percentages)** | **Life Contingent<br>Payout<br>Annuities** | **Term and<br>Whole Life<br>Insurance** | **Disability<br>Income<br>Insurance** | **Long Term<br>Care<br>Insurance** | **Total, All<br>Products** |
|  **Present Value of Expected Net Premiums:** |  |  |  |  |  |
|  Balance at January 1, 2024 | $— | $34522 | $7836 | $48489 | $90847 |
|  Beginning balance at original discount rate |  | 35649 | 7720 | 47397 | 90766 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Effect of changes in cash flow assumptions |  | 3237 | (1939) | 4830 | 6128 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Effect of actual variances from expected experience |  | (2229) | (837) | (409) | (3475) |
|  Adjusted beginning of year balance | $— | $36657 | $4944 | $51818 | $93419 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Issuances | 13729 | 3071 | 553 |  | 17353 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Interest accrual | 53 | 1788 | 309 | 2512 | 4662 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net premiums collected | (13782) | (3490) | (621) | (6107) | (24000) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Derecognition (lapses) |  |  |  |  |  |
|  Ending balance at original discount rate | $— | $38026 | $5185 | $48223 | $91434 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Effect of changes in discount rate assumptions |  | (2680) | (244) | 50 | (2874) |
|  Balance at December 31, 2024 | $— | $35346 | $4941 | $48273 | $88560 |
|  **Present Value of Future Policy Benefits:** |  |  |  |  |  |
|  Balance at January 1, 2024 | $64261 | $74238 | $37113 | $395386 | $570998 |
|  Beginning balance at original discount rate | 67270 | 73159 | 34643 | 383284 | 558356 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Effect of changes in cash flow assumptions | (1352) | 3921 | (3096) | (1924) | (2451) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Effect of actual variances from expected experience | (1387) | (2563) | (1481) | (2519) | (7950) |
|  Adjusted beginning of year balance | $64531 | $74517 | $30066 | $378841 | $547955 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Issuances | 13729 | 3061 | 552 |  | 17342 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Interest accrual | 3152 | 4132 | 1916 | 19949 | 29149 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Benefit payments | (9471) | (5669) | (2709) | (24889) | (42738) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Derecognition (lapses) |  |  |  |  |  |
|  Ending balance at original discount rate | $71941 | $76041 | $29825 | $373901 | $551708 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Effect of changes in discount rate assumptions | (4372) | (2471) | 787 | (4866) | (10922) |
|  Balance at December 31, 2024 | $67569 | $73570 | $30612 | $369035 | $540786 |
|  Adjustment due to reserve flooring | $— | $56 | $— | $— | $56 |
|  Net liability for future policy benefits | $67569 | $38280 | $25671 | $320762 | $452282 |
|  Less: reinsurance recoverable |  | 27679 | 718 | 146132 | 174529 |
|  Net liability for future policy benefits, after reinsurance recoverable | $67569 | $10601 | $24953 | $174630 | $277753 |
|  Discounted expected future gross premiums | $— | $82293 | $43468 | $57490 | $183251 |
|  Expected future gross premiums | $— | $136563 | $62172 | $79143 | $277878 |
|  Expected future benefit payments | $101241 | $126924 | $49284 | $626799 | $904248 |
|  Weighted average interest accretion rate | 4.5% | 6.2% | 6.5% | 5.4% |  |
|  Weighted average discount rate | 5.4% | 5.7% | 5.6% | 5.6% |  |
|  Weighted average duration of liability (in years) | 6 | 6 | 7 | 8 |  |

---

Impacts of the annual review of policy benefit reserves assumptions are reflected within the effect of changes in cash flow assumptions in the disaggregated rollforwards above. The annual review of policy benefit reserves assumptions in the third quarter of 2025 resulted in a net decrease in future policy benefit reserves, primarily due to decreased disability income insurance claim incidence rates offset by updates to LTC mortality assumptions. The annual review of policy benefit reserves assumptions in the third quarter of 2024 resulted in a net decrease in future policy benefit reserves, primarily due to updates to LTC premium rate increases and decreased disability income insurance claim incidence rates.

**F-27** 

------

*RiverSource Life Insurance Co. of New York* 

The balances of and changes in additional liabilities related to insurance guarantees were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **(in thousands, except percentages)** | **Universal Life<br>Insurance** | **Variable<br>Universal<br>Life<br>Insurance** | **Other Life<br>Insurance** | **Total, All<br>Products** |
|  Balance at January 1, 2025 | $88098 | $5557 | $— | $93655 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Interest accrual | 2807 | 400 | 23 | 3230 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Benefit accrual | 9336 | 560 | 183 | 10079 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Benefit payments | (4657) | (691) | (474) | (5822) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Effect of actual variances from expected experience | 2026 | 105 | 420 | 2551 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Impact of change in net unrealized (gains) losses on securities | 1185 | 47 | 291 | 1523 |
|  Balance at December 31, 2025 | $98795 | $5978 | $443 | $105216 |
|  Weighted average interest accretion rate | 2.9% | 6.8% | 3.7% |  |
|  Weighted average discount rate | 3.1% | 7.1% | 4.0% |  |
|  Weighted average duration of reserves (in years) | 9 | 8 | 7 |  |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| **(in thousands, except percentages)** | **Universal Life<br>Insurance** | **Variable<br>Universal<br>Life<br>Insurance** | **Other Life<br>Insurance** | **Total, All<br>Products** |
|  Balance at January 1, 2024 | $80639 | $5509 | $217 | $86365 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Interest accrual | 2550 | 379 | 22 | 2951 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Benefit accrual | 9648 | 424 | 241 | 10313 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Benefit payments | (3541) | (352) | (231) | (4124) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Effect of actual variances from expected experience | (91) | (352) | (65) | (508) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Impact of change in net unrealized (gains) losses on securities | (1107) | (51) | (184) | (1342) |
|  Balance at December 31, 2024 | $88098 | $5557 | $— | $93655 |
|  Weighted average interest accretion rate | 3.0% | 6.7% | 3.9% |  |
|  Weighted average discount rate | 3.2% | 7.0% | 4.1% |  |
|  Weighted average duration of reserves (in years) | 9 | 7 | 7 |  |

---

The amount of revenue and interest recognized in the Statements of Income was as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Years Ended December 31,** | **Years Ended December 31,** | **Years Ended December 31,** | **Years Ended December 31,** |
| | **2025** | **2025** | **2024** | **2024** |
| <br>**(in thousands)** | **Gross<br>Premiums** | **Interest<br>Expense** | **Gross<br>Premiums** | **Interest<br>Expense** |
|  Life contingent payout annuities | $7284 | $3204 | $15122 | $3099 |
|  Term and whole life insurance | 9569 | 2272 | 9366 | 2344 |
|  Disability income insurance | 6126 | 1521 | 6354 | 1607 |
|  Long term care insurance | 6525 | 17063 | 7042 | 17437 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total | $29504 | $24060 | $37884 | $24487 |

---

The following tables summarize the balances of and changes in unearned revenue:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **(in thousands)** | **Universal Life<br>Insurance** | **Variable<br>Universal<br>Life<br>Insurance** | **Indexed<br>Universal<br>Life<br>Insurance** | **Total, All<br>Products** |
|  Balance at January 1, 2025 | $97 | $11564 | $22279 | $33940 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Deferral of revenue | 11 | 3842 | 3681 | 7534 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Amortization | (13) | (963) | (1830) | (2806) |
|  Balance at December 31, 2025 | $95 | $14443 | $24130 | $38668 |
|  Balance at January 1, 2024 | $98 | $9038 | $20154 | $29290 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Deferral of revenue | 12 | 3285 | 3780 | 7077 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Amortization | (13) | (759) | (1655) | (2427) |
|  Balance at December 31, 2024 | $97 | $11564 | $22279 | $33940 |

---

 **F-28** 

------

*RiverSource Life Insurance Co. of New York* 

**10. SEPARATE ACCOUNT ASSETS AND LIABILITIES** 

The fair value of separate account assets is invested exclusively in mutual funds.

The balances of and changes in separate account liabilities were as follows:

---

| | | | |
|:---|:---|:---|:---|
| **(in thousands)** | **Variable<br>Annuities** | **Variable<br>Universal<br>Life** | **Total** |
|  Balance at January 1, 2025 | $4083723 | $551133 | $4634856 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Premiums and deposits | 86438 | 27776 | 114214 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Policy charges | (77675) | (20341) | (98016) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Surrenders and other benefits | (468025) | (20406) | (488431) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Investment return | 520921 | 82706 | 603627 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net transfer from (to) general account | 545 | 469 | 1014 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other charges | (64) | (1) | (65) |
|  Balance at December 31, 2025 | $4145863 | $621336 | $4767199 |
|  Cash surrender value | $4063004 | $587451 | $4650455 |

---

---

| | | | |
|:---|:---|:---|:---|
| **(in thousands)** | **Variable<br>Annuities** | **Variable<br>Universal<br>Life** | **Total** |
|  Balance at January 1, 2024 | $4018325 | $496999 | $4515324 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Premiums and deposits | 112608 | 28088 | 140696 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Policy charges | (80105) | (19541) | (99646) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Surrenders and other benefits | (424604) | (24446) | (449050) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Investment return | 454577 | 68658 | 523235 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net transfer from (to) general account | 2982 | 1377 | 4359 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other charges | (60) | (2) | (62) |
|  Balance at December 31, 2024 | $4083723 | $551133 | $4634856 |
|  Cash surrender value | $3989419 | $521592 | $4511011 |

---

**11. MARKET RISK BENEFITS** 

Market risk benefits are contracts or contract features that both provide protection to the contractholder from other-than-nominal capital market risk and expose the Company to other-than-nominal capital market risk. Most of the variable annuity contracts issued by the Company contain a GMDB provision. The Company previously offered contracts containing GMWB, GMAB, or GMIB provisions.

The GMDB provisions provide a specified minimum return upon death of the contractholder. The death benefit payable is the greater of (i) the contract value less any purchase payment credits subject to recapture less a pro-rata portion of any rider fees, or (ii) the GMDB provisions specified in the contract.

The Company has the following primary GMDB provisions:

• Return of premium — provides purchase payments minus adjusted partial surrenders.

• Reset — provides that the value resets to the account value at specified contract anniversary intervals
minus adjusted partial surrenders. This provision was often provided in combination with the return of premium provision and is no longer offered.

• Ratchet — provides that the value ratchets up to the maximum account value at specified anniversary
intervals, plus subsequent purchase payments less adjusted partial surrenders.

The variable annuity contracts with GMWB riders typically have account values that are based on an underlying portfolio of mutual funds, the values of which fluctuate based on fund performance. At contract issue, the guaranteed amount is equal to the amount deposited but the guarantee may be increased annually to the account value (a "step-up") in the case of favorable market performance or by a benefit credit if the contract includes this provision.

The Company has GMWB riders in force, which contain one or more of the following provisions:

• Withdrawals at a specified rate per year until the amount withdrawn is equal to the guaranteed amount.

• Withdrawals at a specified rate per year for the life of the contractholder ("GMWB for life").

• Withdrawals at a specified rate per year for joint contractholders while either is alive.

• Withdrawals based on performance of the contract.

• Withdrawals based on the age withdrawals begin.

• Credits are applied annually for a specified number of years to increase the guaranteed amount as long as
withdrawals have not been taken.

**F-29** 

------

*RiverSource Life Insurance Co. of New York* 

Variable annuity contractholders age 79 or younger at contract issue could obtain a principal-back guarantee by purchasing the optional GMAB rider for an additional charge. The GMAB rider guarantees that, regardless of market performance at the end of the 10-year waiting period, the contract value will be no less than the original investment or a specified percentage of the highest anniversary value, adjusted for withdrawals. If the contract value is less than the guarantee at the end of the 10-year period, a lump sum will be added to the contract value to make the contract value equal to the guarantee value.

Individual variable annuity contracts may have both a death benefit and a living benefit. Net amount at risk is quantified for each benefit and a composite net amount at risk is calculated using the greater of the death benefit or living benefit for each individual contract. The net amount at risk for GMDB and GMAB is defined as the current guaranteed benefit amount in excess of the current contract value. The net amount at risk for GMIB is defined as the greater of the present value of the minimum guaranteed annuity payments less the current contract value or zero. The net amount at risk for GMWB is defined as the greater of the present value of the minimum guaranteed withdrawal payments less the current contract value or zero.

The following table summarizes the balances of and changes in market risk benefits:

---

| | | | |
|:---|:---|:---|:---|
| | **Years Ended December 31,** | **Years Ended December 31,** | **Years Ended December 31,** |
| <br>**(in thousands, except age)** | **2025** | **2024** | **2023** |
|  Balance at beginning of period | $(120605) | $(47475) | $4137 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Issuances |  |  | 3 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Interest accrual and time decay | (10735) | (9164) | (8114) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Reserve increase from attributed fees collected | 41880 | 43501 | 43343 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Reserve release for benefit payments and derecognition | (145) | (297) | (1878) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Effect of changes in interest rates and bond markets | (4912) | (53866) | (19266) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Effect of changes in equity markets and subaccount performance | (49488) | (64842) | (69222) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Effect of changes in equity index volatility | 5092 | 3339 | (4254) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Actual policyholder behavior different from expected behavior | 2147 | 1653 | (2579) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Effect of changes in future expected assumptions | 4570 | 3793 | 6621 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Effect of changes in the instrument-specific credit risk on market risk benefits | (1421) | 2753 | 3734 |
|  Balance at end of period | $(133617) | $(120605) | $(47475) |
|  Reconciliation of the gross balances in an asset or liability position: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Asset position | $155104 | $147075 | $94641 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Liability position | (21487) | (26470) | (47166) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net asset (liability) position | $133617 | $120605 | $47475 |
|  Guaranteed benefit amount in excess of current account balances (net amount at risk): |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Death benefits | $5595 | $19210 | $58245 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Living benefits | $23729 | $38955 | $54321 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Composite (greater of) | $29119 | $55956 | $107200 |
|  Weighted average attained age of contractholders | 68 | 68 | 67 |
|  Changes in unrealized (gains) losses in net income relating to liabilities held at end of period | $(59507) | $(118760) | $(96583) |
|  Changes in unrealized (gains) losses in other comprehensive income (loss) relating to liabilities held at end of period | $(1226) | $2866 | $3742 |

---

The following tables provide a summary of the significant inputs and assumptions used in the fair value measurements developed by the Company or reasonably available to the Company of market risk benefits:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** |
|  | **Fair Value** | **Valuation<br>Technique** | **Range** | **Range** | **Weighted<br>Average** |
|  | **(in thousands)** |  | | | |
| Market risk benefits | $(133617) | Discounted cash flow Utilization of guaranteed withdrawals<sup>(1)</sup> | 0.0% | 52.8% | 12.9% |
|  |  | Surrender rate<sup>(2)</sup> | 0.5% | 53.4% | 4.3% |
|  |  | Market volatility<sup>(3)</sup> | 0.0% | 24.9% | 11.2% |
|  |  | Nonperformance risk<sup>(4)</sup> | 65 bps | 65 bps | 65 bps |
|  |  | Mortality rate<sup>(5)</sup> | 0.0% | 39.2% | 2.0% |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** |
|  | **Fair Value** | **Valuation<br>Technique** | **Range** | **Range** | **Weighted<br>Average** |
|  | **(in thousands)** |  | | | |
| Market risk benefits | $(120605) | Discounted cash flow Utilization of guaranteed withdrawals<sup>(1)</sup> | 0.0% | 52.8% | 12.6% |
|  |  | Surrender rate<sup>(2)</sup> | 0.4% | 39.4% | 3.9% |
|  |  | Market volatility<sup>(3)</sup> | 0.0% | 24.6% | 10.3% |
|  |  | Nonperformance risk<sup>(4)</sup> | 65 bps | 65 bps | 65 bps |
|  |  | Mortality rate<sup>(5)</sup> | 0.0% | 37.4% | 1.8% |

---

 **F-30** 

------

*RiverSource Life Insurance Co. of New York* 

<sup>(1)</sup> The utilization of guaranteed withdrawals represents the percentage of contractholders that will begin withdrawing in any given year. The weighted average utilization rate represents the average assumption, weighted based on the benefit base. The calculation excludes policies that have already started taking withdrawals. 

<sup>(2)</sup> The weighted average surrender rate represents the average assumption weighted based on the account value of each contract.

<sup>(3)</sup> Market volatility represents the implied volatility of each contractholder's mix of funds. The weighted average market volatility represents the average volatility across all contracts, weighted by the size of the guaranteed benefit.

<sup>(4)</sup> The nonperformance risk is the spread added to the U.S. Treasury curve.

<sup>(5)</sup> The weighted average mortality rate represents the average assumption weighted based on the account value of each contract.

**Changes to Significant Inputs and Assumptions:** 

During the years ended December 31, 2025 and 2024, the Company updated inputs and assumptions based on management's review of experience studies. These updates resulted in the following notable changes in the fair value estimates of market risk benefits calculations:

Year ended December 31, 2025

• Updates to surrender assumptions resulted in a decrease to pretax income of $3.3 million.

• Updates to utilization of guaranteed withdrawal assumptions resulted in a decrease to pretax income of
$678 thousand.

Year ended December 31, 2024

• Updates to surrender assumptions resulted in a decrease to pretax income of $2.3 million.

• Updates to utilization of guaranteed withdrawal assumptions resulted in a decrease to pretax income of
$994 thousand.

Refer to the rollforward of market risk benefits for the impacts of changes to interest rate, equity market, volatility and nonperformance risk assumptions.

**Uncertainty of Fair Value Measurements** 

Significant increases (decreases) in utilization and volatility used in the fair value measurement of market risk benefits in isolation would have resulted in a significantly higher (lower) liability value.

Significant increases (decreases) in nonperformance risk and surrender assumptions used in the fair value measurement of market risk benefits in isolation would have resulted in a significantly lower (higher) liability value.

Significant increases (decreases) in mortality assumptions used in the fair value measurement of the death benefit portion of market risk benefits in isolation would have resulted in a significantly higher (lower) liability value whereas significant increases (decreases) in mortality rates used in the fair value measurement of the life contingent portion of market risk benefits in isolation would have resulted in a significantly lower (higher) liability value.

Surrender assumptions, utilization assumptions and mortality assumptions vary with the type of base product, type of rider, duration of the policy, age of the contractholder, calendar year of the projection, previous withdrawal history, and the relationship between the value of the guaranteed benefit and the contract accumulation value.

**Determination of Fair Value** 

The Company values market risk benefits using internal valuation models. These models include observable capital market assumptions and significant unobservable inputs related to implied volatility, contractholder behavior assumptions that include margins for risk, and the Company's nonperformance risk. These measurements are classified as Level 3.

**12. FAIR VALUES OF ASSETS AND LIABILITIES** 

GAAP defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date; that is, an exit price. The exit price assumes the asset or liability is not exchanged subject to a forced liquidation or distressed sale.

**Valuation Hierarchy** 

The Company categorizes its fair value measurements according to a three-level hierarchy. The hierarchy prioritizes the inputs used by the Company's valuation techniques. A level is assigned to each fair value measurement based on the lowest level input that is significant to the fair value measurement in its entirety.

The three levels of the fair value hierarchy are defined as follows:

Level 1 Unadjusted quoted prices for identical assets or liabilities in active markets that are accessible at the measurement date.

Level 2 Prices or valuations based on observable inputs other than quoted prices in active markets for identical assets and liabilities.

Level 3 Prices or valuations that require inputs that are both significant to the fair value measurement and unobservable.

**F-31** 

------

*RiverSource Life Insurance Co. of New York* 

The following tables present the balances of assets and liabilities measured at fair value on a recurring basis:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** |
| <br>**(in thousands)** | **Level 1** | **Level 2** | **Level 3** | **Total** |
|  **Assets** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Available-for-Sale securities: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Corporate debt securities | $— | $870864 | $10860 | $881724 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Residential mortgage backed securities |  | 255025 |  | 255025 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Commercial mortgage backed securities |  | 217662 |  | 217662 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; State and municipal obligations |  | 72283 |  | 72283 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Asset backed securities |  | 18344 |  | 18344 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Foreign government bonds and obligations |  | 619 |  | 619 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; U.S. government and agency obligations | 223 |  |  | 223 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total Available-for-Sale securities | 223 | 1434797 | 10860 | 1445880 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cash equivalents |  | 120449 |  | 120449 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Market risk benefits |  |  | 155104 | 155104<sup>(1)</sup> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other assets: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Interest rate derivative contracts | 204 | 1516 |  | 1720 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Equity derivative contracts | 3323 | 81434 |  | 84757 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Foreign exchange derivative contracts | 50 |  |  | 50 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total other assets | 3577 | 82950 |  | 86527 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Separate account assets at net asset value ("NAV") |  |  |  | 4767199<sup>(2)</sup> |
|  Total assets at fair value | $3800 | $1638196 | $165964 | $6575159 |
|  **Liabilities** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Policyholder account balances, future policy benefits and claims: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; IUL embedded derivatives | $— | $— | $61894 | $61894 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total policyholder account balances, future policy benefits and claims |  |  | 61894 | 61894<sup>(3)</sup> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Market risk benefits |  |  | 21487 | 21487<sup>(1)</sup> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other liabilities: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Interest rate derivative contracts |  | 1858 |  | 1858 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Equity derivative contracts | 182 | 52228 |  | 52410 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total other liabilities | 182 | 54086 |  | 54268 |
|  Total liabilities at fair value | $182 | $54086 | $83381 | $137649 |

---

 **F-32** 

------

*RiverSource Life Insurance Co. of New York* 

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** |
| <br>**(in thousands)** | **Level 1** | **Level 2** | **Level 3** | **Total** |
|  **Assets** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Available-for-Sale securities: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Corporate debt securities | $— | $826806 | $14589 | $841395 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Residential mortgage backed securities |  | 224106 |  | 224106 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Commercial mortgage backed securities |  | 257829 |  | 257829 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; State and municipal obligations |  | 73007 |  | 73007 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Asset backed securities |  | 23490 |  | 23490 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Foreign government bonds and obligations |  | 585 |  | 585 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; U.S. government and agency obligations | 218 |  |  | 218 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total Available-for-Sale securities | 218 | 1405823 | 14589 | 1420630 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cash equivalents |  | 145762 |  | 145762 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Market risk benefits |  |  | 147075 | 147075<sup>(1)</sup> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other assets: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Interest rate derivative contracts | 79 | 1712 |  | 1791 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Equity derivative contracts | 2011 | 115824 |  | 117835 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Foreign exchange derivative contracts | 189 | 426 |  | 615 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total other assets | 2279 | 117962 |  | 120241 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Separate account assets at NAV |  |  |  | 4634856<sup>(2)</sup> |
|  Total assets at fair value | $2497 | $1669547 | $161664 | $6468564 |
|  **Liabilities** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Policyholder account balances, future policy benefits and claims: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; IUL embedded derivatives | $— | $— | $59724 | $59724 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total policyholder account balances, future policy benefits and claims |  |  | 59724 | 59724<sup>(3)</sup> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Market risk benefits |  |  | 26470 | 26470<sup>(1)</sup> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other liabilities: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Interest rate derivative contracts |  | 2229 |  | 2229 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Equity derivative contracts | 202 | 45911 |  | 46113 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total other liabilities | 202 | 48140 |  | 48342 |
|  Total liabilities at fair value | $202 | $48140 | $86194 | $134536 |

---

<sup>(1)</sup> See Note 11 for additional information related to market risk benefits, including the balances of and changes in market risk benefits as well as the significant inputs and assumptions used in the fair value measurements of market risk benefits.

<sup>(2)</sup> Amounts are comprised of financial instruments that are measured at fair value using the NAV per share (or its equivalent) as a practical expedient and have not been classified in the fair value hierarchy. 

<sup>(3)</sup> The Company's adjustment for nonperformance risk resulted in a $6.5 million cumulative decrease to the embedded derivatives as of both December 31, 2025 and 2024. 

The following tables provide a summary of changes in Level 3 assets and liabilities measured at fair value on a recurring basis:

---

| | | |
|:---|:---|:---|
| | **Available-for-Sale<br>Securities** | **Policyholder Account<br>Balances, Future Policy<br>Benefits and Claims** |
| <br>**(in thousands)** | **Corporate Debt<br>Securities** | **IUL Embedded<br>Derivatives** |
|  Balance at January 1, 2025 | $14589 | $(59724) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total gains (losses) included in: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net income | (60)<sup>(1)</sup> | (12945)<sup>(2)</sup> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other comprehensive income (loss) | 379 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Issues |  | 1765 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Settlements | (4048) | 9010 |
|  Balance at December 31, 2025 | $10860 | $(61894) |
|  Changes in unrealized gains (losses) in net income relating to assets and liabilities held at December 31, 2025 | $(60)<sup>(1)</sup> | $(12945)<sup>(2)</sup> |
|  Changes in unrealized gains (losses) in other comprehensive income (loss) relating to assets and liabilities held at December 31, 2025 | $346 | $— |

---

**F-33** 

------

*RiverSource Life Insurance Co. of New York* 

---

| | | |
|:---|:---|:---|
| | **Available-for-Sale<br>Securities** | **Policyholder Account<br>Balances, Future Policy<br>Benefits and Claims** |
| <br>**(in thousands)** | **Corporate Debt<br>Securities** | **IUL Embedded<br>Derivatives** |
|  Balance at January 1, 2024 | $23276 | $(50529) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total gains (losses) included in: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net income | (58)<sup>(1)</sup> | (17910)<sup>(2)</sup> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other comprehensive income (loss) | 410 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Issues |  | (257) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Settlements | (9039) | 8972 |
|  Balance at December 31, 2024 | $14589 | $(59724) |
|  Changes in unrealized gains (losses) in net income relating to assets and liabilities held at December 31, 2024 | $(58)<sup>(1)</sup> | $(17910)<sup>(2)</sup> |
|  Changes in unrealized gains (losses) in other comprehensive income (loss) relating to assets and liabilities held at December 31, 2024 | $249 | $— |

---

---

| | | |
|:---|:---|:---|
| | **Available-for-Sale<br>Securities** | **Policyholder Account<br>Balances, Future Policy<br>Benefits and Claims** |
| <br>**(in thousands)** | **Corporate Debt<br>Securities** | **IUL Embedded<br>Derivatives** |
|  Balance at January 1, 2023 | $29372 | $(42382) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total gains (losses) included in: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net income | (68)<sup>(1)</sup> | (13670)<sup>(2)</sup> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other comprehensive income (loss) | 585 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Purchases | 419 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Issues |  | (2453) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Settlements | (7032) | 7976 |
|  Balance at December 31, 2023 | $23276 | $(50529) |
|  Changes in unrealized gains (losses) in net income relating to assets and liabilities held at December 31, 2023 | $(68)<sup>(1)</sup> | $(13670)<sup>(2)</sup> |
|  Changes in unrealized gains (losses) in other comprehensive income (loss) relating to assets and liabilities held at December 31, 2023 | $511 | $— |

---

<sup>(1)</sup> Included in Net investment income.

<sup>(2)</sup> Included in Interest credited to fixed accounts.

The increase (decrease) to pretax income of the Company's adjustment for nonperformance risk on the fair value of its embedded derivatives was $(1.1) million, $(454) thousand and $20 thousand, net of the reinsurance accrual, for the years ended December 31, 2025, 2024 and 2023, respectively.

Securities transferred from Level 3 primarily represent securities with fair values that are now obtained from a third-party pricing service with observable inputs or fair values that were included in an observable transaction with a market participant. Securities transferred to Level 3 represent securities with fair values that are now based on a single non-binding broker quote.

The following tables provide a summary of the significant unobservable inputs used in the fair value measurements developed by the Company or reasonably available to the Company of Level 3 assets and liabilities:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** |
|  | **Fair Value** | **Valuation Technique** | **Unobservable Input** | **Range** | **Range** | **Weighted<br>Average** |
|  | **(in thousands)** |  |  | | | |
| Corporate debt securities (private placements) | $10836 | Discounted cash flow | Yield/spread to U.S. Treasuries<sup>(1)</sup> | 0.9% | 1.4% | 1.1% |
| IUL embedded derivatives | $61894 | Discounted cash flow | Nonperformance risk<sup>(2)</sup> | 65 bps | 65 bps | 65 bps |
|  | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** |
|  | **Fair Value** | **Valuation Technique** | **Unobservable Input** | **Range** | **Range** | **Weighted<br>Average** |
|  | **(in thousands)** |  |  |  |  |  |
| Corporate debt securities (private placements) | $14560 | Discounted cash flow | Yield/spread to U.S. Treasuries<sup>(1)</sup> | 0.8% | 1.6% | 1.3% |
| IUL embedded derivatives | $59724 | Discounted cash flow | Nonperformance risk<sup>(2)</sup> | 65 bps | 65 bps | 65 bps |

---

<sup>(1)</sup> The weighted average for the yield/spread to U.S. Treasuries for corporate debt securities (private placements) is weighted based on the security's market value as a percentage of the aggregate market value of the securities. 

<sup>(2)</sup> The nonperformance risk is the spread added to the U.S. Treasury curve.

 **F-34** 

------

*RiverSource Life Insurance Co. of New York* 

Level 3 measurements not included in the tables above are obtained from non-binding broker quotes where unobservable inputs utilized in the fair value calculation are not reasonably available to the Company.

**Uncertainty of Fair Value Measurements** 

Significant increases (decreases) in the yield/spread to U.S. Treasuries used in the fair value measurement of Level 3 corporate debt securities in isolation would have resulted in a significantly lower (higher) fair value measurement.

Significant increases (decreases) in nonperformance risk used in the fair value measurement of the IUL embedded derivatives in isolation would have resulted in a significantly lower (higher) fair value measurement.

**Determination of Fair Value** 

The Company uses valuation techniques consistent with the market and income approaches to measure the fair value of its assets and liabilities. The Company's market approach uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities. The Company's income approach uses valuation techniques to convert future projected cash flows to a single discounted present value amount. When applying either approach, the Company maximizes the use of observable inputs and minimizes the use of unobservable inputs.

The following is a description of the valuation techniques used to measure fair value and the general classification of these instruments pursuant to the fair value hierarchy.

**Assets** 

*Available-for-Sale Securities* 

When available, the fair value of securities is based on quoted prices in active markets. If quoted prices are not available, fair values are obtained from third-party pricing services, non-binding broker quotes, or other model-based valuation techniques.

Level 1 securities primarily include U.S. Treasuries.

Level 2 securities primarily include corporate bonds, residential mortgage backed securities, commercial mortgage backed securities, state and municipal obligations, asset backed securities and foreign government securities. The fair value of these Level 2 securities is based on a market approach with prices obtained from third-party pricing services. Observable inputs used to value these securities can include, but are not limited to, reported trades, benchmark yields, issuer spreads and non-binding broker quotes. The fair value of securities included in an observable transaction with a market participant are also considered Level 2 when the market is not active.

Level 3 securities primarily include certain corporate bonds. The fair value of corporate bonds classified as Level 3 is typically based on a single non-binding broker quote. The underlying inputs used for some of the non-binding broker quotes are not readily available to the Company. The Company's privately placed corporate bonds are typically based on a single non-binding broker quote.

Management is responsible for the fair values recorded on the financial statements. Prices received from third-party pricing services are subjected to exception reporting that identifies investments with significant daily price movements as well as no movements. The Company reviews the exception reporting and resolves the exceptions through reaffirmation of the price or recording an appropriate fair value estimate. The Company also performs subsequent transaction testing. The Company performs annual due diligence of third-party pricing services. The Company's due diligence procedures include assessing the vendor's valuation qualifications, control environment, analysis of asset-class specific valuation methodologies, and understanding of sources of market observable assumptions and unobservable assumptions, if any, employed in the valuation methodology. The Company also considers the results of its exception reporting controls and any resulting price challenges that arise.

*Cash Equivalents* 

Cash equivalents include time deposits and other highly liquid investments with original or remaining maturities at the time of purchase of 90 days or less. The Company's cash equivalents are classified as Level 2 and measured at amortized cost, which is a reasonable estimate of fair value because of the short time between the purchase of the instrument and its expected realization.

*Other Assets* 

Derivatives that are measured using quoted prices in active markets, such as derivatives that are exchange-traded, are classified as Level 1 measurements. The variation margin on futures contracts is also classified as Level 1. The fair value of derivatives that are traded in less active over-the-counter ("OTC") markets is generally measured using pricing models with market observable inputs such as interest rates and equity index levels. These measurements are classified as Level 2 within the fair value hierarchy and include swaps and the majority of options. The counterparties' nonperformance risk associated with uncollateralized derivative assets was immaterial as of both December 31, 2025 and 2024. See Note 15 and Note 16 for further information on the credit risk of derivative instruments and related collateral.

*Separate Account Assets* 

The fair value of assets held by separate accounts is determined by the NAV of the funds in which those separate accounts are invested. The NAV is used as a practical expedient for fair value and represents the exit price for the separate account. Separate account assets are excluded from classification in the fair value hierarchy.

**F-35** 

------

*RiverSource Life Insurance Co. of New York* 

**Liabilities** 

*Policyholder Account Balances, Future Policy Benefits and Claims* 

There is no active market for the transfer of the Company's embedded derivatives attributable to the provisions of IUL products.

The Company uses discounted cash flow models to determine the fair value of the embedded derivatives associated with the provisions of its IUL products. The fair value of IUL embedded derivatives includes significant observable interest rates, volatilities and equity index levels and the significant unobservable estimate of the Company's nonperformance risk. Given the significance of the nonperformance risk assumption, IUL embedded derivatives are classified as Level 3.

The embedded derivatives attributable to these provisions are recorded in Policyholder account balances, future policy benefits and claims.

*Other Liabilities* 

Derivatives that are measured using quoted prices in active markets, such as derivatives that are exchange-traded, are classified as Level 1 measurements. The variation margin on futures contracts is also classified as Level 1. The fair value of derivatives that are traded in less active OTC markets is generally measured using pricing models with market observable inputs such as interest rates and equity index levels. These measurements are classified as Level 2 within the fair value hierarchy and include swaps and the majority of options. The Company's nonperformance risk associated with uncollateralized derivative liabilities was immaterial as of both December 31, 2025 and 2024. See Note 15 and Note 16 for further information on the credit risk of derivative instruments and related collateral.

**Fair Value on a Nonrecurring Basis** 

During the years ended December 31, 2025 and 2024, there were no material assets or liabilities measured at fair value on a nonrecurring basis.

**Assets and Liabilities Not Reported at Fair Value** 

The following tables provide the carrying value and the estimated fair value of financial instruments that are not reported at fair value:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** |
| | **Carrying<br>Value** | **Fair Value** | **Fair Value** | **Fair Value** | **Fair Value** |
| <br>**(in thousands)** | **Carrying<br>Value** | **Level 1** | **Level 2** | **Level 3** | **Total** |
|  **Financial Assets** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mortgage loans, net | $116775 | $— | $— | $111667 | $111667 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Policy loans | 62715 |  | 62715 |  | 62715 |
|  **Financial Liabilities** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Policyholder account balances, future policy benefits and claims | $618385 | $— | $— | $572904 | $572904 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Separate account liabilities — investment contracts | 3163 |  | 3163 |  | 3163 |
|  | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** |
|  | **Carrying<br>Value** | **Fair Value** | **Fair Value** | **Fair Value** | **Fair Value** |
| **(in thousands)** | **Carrying<br>Value** | **Level 1** | **Level 2** | **Level 3** | **Total** |
|  **Financial Assets** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mortgage loans, net | $130826 | $— | $— | $120595 | $120595 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Policy loans | 60538 |  | 60538 |  | 60538 |
|  **Financial Liabilities** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Policyholder account balances, future policy benefits and claims | $665141 | $— | $— | $636395 | $636395 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Separate account liabilities — investment contracts | 3358 |  | 3358 |  | 3358 |

---

See Note 6 for additional information on mortgage loans and policy loans.

Policyholder account balances, future policy benefits and claims include fixed annuities in deferral status, non-life contingent fixed annuities in payout status and the fixed portion of a small number of variable annuity contracts classified as investment contracts. See Note 9 for additional information on these liabilities. Separate account liabilities are related to certain annuity products that are classified as investment contracts.

**13. RELATED PARTY TRANSACTIONS** 

***Revenues***

See Note 4 for information about revenues from contracts with customers earned by the Company from related party transactions with affiliates.

 **F-36** 

------

*RiverSource Life Insurance Co. of New York* 

***Expenses***

Charges by Ameriprise Financial and affiliated companies to the Company for use of joint facilities, technology support, marketing services and other services aggregated $21.9 million, $22.6 million and $23.0 million for the years ended December 31, 2025, 2024 and 2023, respectively. Certain of these costs are included in DAC. Expenses allocated to the Company may not be reflective of expenses that would have been incurred by the Company on a stand-alone basis.

***Income Taxes***

The Company's taxable income is included in the consolidated federal and various state income tax returns of Ameriprise Financial. The net amount due from Ameriprise Financial for income taxes was $1.6 million and $1.3 million as of December 31, 2025 and 2024, respectively, which is reflected in Other assets.

***Lines of Credit***

The Company, as the borrower, has a revolving credit agreement with Ameriprise Financial as the lender. The aggregate amount outstanding under this line of credit may not exceed the lesser of $25 million or 3% of the Company's statutory admitted assets (excluding separate accounts) as of the prior year end. The interest rate under the agreement is a Daily Simple Secured Overnight Financing Rate plus 0.1% and an applicable margin subject to adjustment based on debt ratings of the senior unsecured debt of Ameriprise Financial. Amounts borrowed may be repaid at any time with no prepayment penalty. The credit agreement is amended to extend the maturity on an annual basis with Ameriprise Financial, subject to the New York Department's non-disapproval. There were no amounts outstanding on this line of credit as of both December 31, 2025 and 2024.

***Dividends or Distributions***

During each of the years ended December 31, 2025, 2024 and 2023, the Company paid cash dividends or distributions of $50 million to RiverSource Life. For dividends or other distributions from the Company, advance notification was provided to the New York Department prior to payments. See Note 14 for additional information.

**14. STATUTORY ACCOUNTING PRINCIPLES AND REQUIREMENTS** 

The National Association of Insurance Commissioners ("NAIC") defines Risk-Based Capital ("RBC") requirements for insurance companies. The RBC requirements are used by the NAIC and state insurance regulators to identify companies that merit regulatory actions designed to protect policyholders. These requirements apply to the Company. The Company has met its minimum RBC requirements.

Insurance companies are required to prepare statutory financial statements in accordance with the accounting practices prescribed or permitted by the insurance departments of their respective states of domicile, which vary materially from GAAP. Prescribed statutory accounting practices include publications of the NAIC, as well as state laws, regulations and general administrative rules. The State of New York has adopted the NAIC Accounting Practices and Procedures Manual as its prescribed basis of statutory accounting principles. In addition, New York has prescribed certain reserve requirements that differ from those required under NAIC statutory accounting principles. As of December 31, 2025 and 2024, application of these New York prescribed practices which deviate from the NAIC requirements resulted in an increase of $11.7 million and a decrease of $469 thousand to the Company's net income, respectively, and a decrease to the Company's statutory surplus of $64.8 million and $76.5 million, respectively. The Company's RBC would not have triggered a regulatory event without the application of these prescribed practices.

The more significant differences between NAIC statutory accounting principles and GAAP include charging policy acquisition costs to expense as incurred, establishing annuity and insurance reserves using different actuarial methods and assumptions, valuing investments on a different basis and excluding certain assets from the balance sheet by charging them directly to surplus, such as a portion of the net deferred income tax assets.

State insurance statutes generally require insurance companies to provide notice to state regulators prior to payment of dividends or distributions and those dividends or distributions exceeding prescribed limitations are subject to potential disapproval. For the Company, dividends or distributions in a calendar year which exceed the greater of: (i) 10% of statutory surplus as of the immediately preceding year end, or (ii) statutory net gain from operations for the immediately preceding calendar year, not to exceed 30% of statutory surplus as of the immediately preceding year end would require pre-notification to the New York Department and are subject to potential disapproval. Statutory net gain from operations was $83.4 million, $83.8 million and $66.6 million for the years ended December 31, 2025, 2024 and 2023, respectively.

**F-37** 

------

*RiverSource Life Insurance Co. of New York* 

Comparisons of net income and shareholder's equity, as shown in the accompanying GAAP financial statements, to that determined using statutory accounting principles prescribed by the State of New York ("SAP") were as follows:

---

| | | | |
|:---|:---|:---|:---|
| | **Years Ended December 31,** | **Years Ended December 31,** | **Years Ended December 31,** |
| <br>**(in thousands)** | **2025** | **2024** | **2023** |
|  **Net Income** |  |  |  |
|  Net income, per accompanying GAAP financial statements | $56068 | $73394 | $46567 |
|  Net income (loss), SAP basis<sup>(1)</sup> | 86956 | (17477) | 60310 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Difference | $(30888) | $90871 | $(13743) |

---

---

| | | |
|:---|:---|:---|
| | **December 31,** | **December 31,** |
| <br>**(in thousands)** | **2025** | **2024** |
|  **Shareholder's Equity** |  |  |
|  Shareholder's equity, per accompanying GAAP financial statements | $471859 | $430881 |
|  Capital and surplus, SAP basis<sup>(2)</sup>  | 215821 | 218309 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Difference | $256038 | $212572 |

---

<sup>(1)</sup> Results may be significantly impacted by changes in reserves for variable annuity guaranteed benefits, however, these impacts may be substantially offset by unrealized gains (losses) on derivatives which are not included in statutory income but are recorded directly to surplus.

<sup>(2)</sup> Includes unassigned surplus of $106.9 million and $109.4 million as of December 31, 2025 and 2024, respectively. 

As of December 31, 2025 and 2024, bonds carried at $221 thousand and $217 thousand, respectively, were on deposit with the State of New York as required by law.

**15. OFFSETTING ASSETS AND LIABILITIES** 

Certain financial instruments and derivative instruments are eligible for offset in the Balance Sheets. The Company's derivative instruments are subject to master netting and collateral arrangements and qualify for offset. A master netting arrangement with a counterparty creates a right of offset for amounts due to and from that same counterparty that is enforceable in the event of a default or bankruptcy. The Company's policy is to recognize amounts subject to master netting arrangements on a gross basis in the Balance Sheets.

The following tables present the gross and net information about the Company's assets subject to master netting arrangements:

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** |
| | **Gross<br>Amounts of<br>Recognized<br>Assets** | **Gross Amounts<br>Offset in the<br>Balance Sheets** | **Amounts of Assets<br>Presented in the<br>Balance Sheets** | **Gross Amounts Not Offset**<br>**in the Balance Sheets** | **Gross Amounts Not Offset**<br>**in the Balance Sheets** | **Gross Amounts Not Offset**<br>**in the Balance Sheets** | **Net<br>Amount** |
| <br>**(in thousands)** | **Gross<br>Amounts of<br>Recognized<br>Assets** | **Gross Amounts<br>Offset in the<br>Balance Sheets** | **Amounts of Assets<br>Presented in the<br>Balance Sheets** | **Financial<br>Instruments<sup>(1)</sup>** | **Cash<br>Collateral** | **Securities<br>Collateral** | **Net<br>Amount** |
|  Derivatives: |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; OTC | $82244 | $— | $82244 | $(44305) | $(25954) | $(11812) | $173 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; OTC cleared | 706 |  | 706 | (706) |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Exchange-traded | 3577 |  | 3577 | (182) |  |  | 3395 |
|  Total | $86527 | $— | $86527 | $(45193) | $(25954) | $(11812) | $3568 |

---

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** |
| | **Gross<br>Amounts of<br>Recognized<br>Assets** | **Gross Amounts<br>Offset in the<br>Balance Sheets** | **Amounts of Assets<br>Presented in the<br>Balance Sheets** | **Gross Amounts Not Offset**<br>**in the Balance Sheets** | **Gross Amounts Not Offset**<br>**in the Balance Sheets** | **Gross Amounts Not Offset**<br>**in the Balance Sheets** | **Net<br>Amount** |
| <br>**(in thousands)** | **Gross<br>Amounts of<br>Recognized<br>Assets** | **Gross Amounts<br>Offset in the<br>Balance Sheets** | **Amounts of Assets<br>Presented in the<br>Balance Sheets** | **Financial<br>Instruments<sup>(1)</sup>** | **Cash<br>Collateral** | **Securities<br>Collateral** | **Net<br>Amount** |
|  Derivatives: |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; OTC | $117297 | $— | $117297 | $(37596) | $(73188) | $(6475) | $38 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; OTC cleared | 665 |  | 665 | (665) |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Exchange-traded | 2279 |  | 2279 | (202) |  |  | 2077 |
|  Total | $120241 | $— | $120241 | $(38463) | $(73188) | $(6475) | $2115 |

---

<sup>(1)</sup> Represents the amount of assets that could be offset by liabilities with the same counterparty under master netting or similar arrangements that management elects not to offset on the Balance Sheets. 

 **F-38** 

------

*RiverSource Life Insurance Co. of New York* 

The following tables present the gross and net information about the Company's liabilities subject to master netting arrangements:

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** |
| | **Gross<br>Amounts of<br>Recognized<br>Liabilities** | **Gross Amounts<br>Offset in the<br>Balance Sheets** | **Amounts of Liabilities<br>Presented in the<br>Balance Sheets** | **Gross Amounts Not Offset**<br>**in the Balance Sheets** | **Gross Amounts Not Offset**<br>**in the Balance Sheets** | **Gross Amounts Not Offset**<br>**in the Balance Sheets** | **Net<br>Amount** |
| <br>**(in thousands)** | **Gross<br>Amounts of<br>Recognized<br>Liabilities** | **Gross Amounts<br>Offset in the<br>Balance Sheets** | **Amounts of Liabilities<br>Presented in the<br>Balance Sheets** | **Financial<br>Instruments<sup>(1)</sup>** | **Cash<br>Collateral** | **Securities<br>Collateral** | **Net<br>Amount** |
|  Derivatives: |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; OTC | $52656 | $— | $52656 | $(44305) | $— | $(8349) | $2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; OTC cleared | 1430 |  | 1430 | (706) |  |  | 724 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Exchange-traded | 182 |  | 182 | (182) |  |  |  |
|  Total | $54268 | $— | $54268 | $(45193) | $— | $(8349) | $726 |

---

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** |
| | **Gross<br>Amounts of<br>Recognized<br>Liabilities** | **Gross Amounts<br>Offset in the<br>Balance Sheets** | **Amounts of Liabilities<br>Presented in the<br>Balance Sheets** | **Gross Amounts Not Offset**<br>**in the Balance Sheets** | **Gross Amounts Not Offset**<br>**in the Balance Sheets** | **Gross Amounts Not Offset**<br>**in the Balance Sheets** | **Net<br>Amount** |
| <br>**(in thousands)** | **Gross<br>Amounts of<br>Recognized<br>Liabilities** | **Gross Amounts<br>Offset in the<br>Balance Sheets** | **Amounts of Liabilities<br>Presented in the<br>Balance Sheets** | **Financial<br>Instruments<sup>(1)</sup>** | **Cash<br>Collateral** | **Securities<br>Collateral** | **Net<br>Amount** |
|  Derivatives: |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; OTC | $46836 | $— | $46836 | $(37596) | $— | $(9240) | $— |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; OTC cleared | 1304 |  | 1304 | (665) |  |  | 639 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Exchange-traded | 202 |  | 202 | (202) |  |  |  |
|  Total | $48342 | $— | $48342 | $(38463) | $— | $(9240) | $639 |

---

<sup>(1)</sup> Represents the amount of liabilities that could be offset by assets with the same counterparty under master netting or similar arrangements that management elects not to offset on the Balance Sheets. 

In the tables above, the amount of assets or liabilities presented are offset first by financial instruments that have the right of offset under master netting or similar arrangements, then any remaining amount is reduced by the amount of cash and securities collateral. The actual collateral may be greater than amounts presented in the tables.

When the fair value of collateral accepted by the Company is less than the amount due to the Company, there is a risk of loss if the counterparty fails to perform or provide additional collateral. To mitigate this risk, the Company monitors collateral values regularly and requires additional collateral when necessary. When the value of collateral pledged by the Company declines, it may be required to post additional collateral.

Freestanding derivative instruments are reflected in Other assets and Other liabilities. Cash collateral pledged by the Company is reflected in Other assets and cash collateral accepted by the Company is reflected in Other liabilities. See Note 16 for additional disclosures related to the Company's derivative instruments.

**16. DERIVATIVES AND HEDGING ACTIVITIES** 

Derivative instruments enable the Company to manage its exposure to various market risks. The value of such instruments is derived from an underlying variable or multiple variables, including equity and interest rate indices or prices. The Company primarily enters into derivative agreements for risk management purposes related to the Company's products and operations.

Certain of the Company's freestanding derivative instruments are subject to master netting arrangements. The Company's policy on the recognition of derivatives on the Balance Sheets is to not offset fair value amounts recognized for derivatives and collateral arrangements executed with the same counterparty under the same master netting arrangement. See Note 15 for additional information regarding the estimated fair value of the Company's freestanding derivatives after considering the effect of master netting arrangements and collateral.

**F-39** 

------

*RiverSource Life Insurance Co. of New York* 

Generally, the Company uses derivatives as economic hedges and accounting hedges. The following table presents the notional value and gross fair value of derivative instruments, including embedded derivatives:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** |
| | **Notional** | **Gross Fair Value** | **Gross Fair Value** | **Notional** | **Gross Fair Value** | **Gross Fair Value** |
| <br>**(in thousands)** | **Notional** | **Assets<sup>(1)</sup>** | **Liabilities<sup>(2)</sup>** | **Notional** | **Assets<sup>(1)</sup>** | **Liabilities<sup>(2)</sup>** |
|  **Derivatives not designated as hedging instruments** |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Interest rate contracts | $2299300 | $1720 | $1858 | $1822300 | $1791 | $2229 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Equity contracts | 1372051 | 84757 | 52410 | 1551292 | 117835 | 46113 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Foreign exchange contracts | 60361 | 50 |  | 88905 | 615 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total non-designated hedges | 3731712 | 86527 | 54268 | 3462497 | 120241 | 48342 |
|  **Embedded derivatives** |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; IUL | N/A |  | 61894 | N/A |  | 59724 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total embedded derivatives | N/A |  | 61894 | N/A |  | 59724 |
|  Total derivatives | $3731712 | $86527 | $116162 | $3462497 | $120241 | $108066 |

---

N/A Not applicable

<sup>(1)</sup> The fair value of freestanding derivative assets is included in Other assets.

<sup>(2)</sup> The fair value of freestanding derivative liabilities is included in Other liabilities. The fair value of IUL embedded derivatives is included in Policyholder account balances, future policy benefits and claims.

See Note 12 for additional information regarding the Company's fair value measurement of derivative instruments.

As of December 31, 2025 and 2024, investment securities with a fair value of $98.4 million and $88.8 million, respectively, were pledged to meet contractual obligations under derivative contracts, of which $9.0 million and $10.6 million, respectively, may be sold, pledged or rehypothecated by the counterparty. As of December 31, 2025 and 2024, investment securities with a fair value of $12.9 million and $7.0 million, respectively, were received as collateral to meet contractual obligations under derivative contracts, of which $12.9 million and $7.0 million, respectively, may be sold, pledged or rehypothecated by the Company. As of both December 31, 2025 and 2024, the Company had sold, pledged or rehypothecated none of these securities. In addition, as of both December 31, 2025 and 2024, non-cash collateral accepted was held in separate custodial accounts and was not included in the Company's Balance Sheets.

The following table presents a summary of the impact of derivatives not designated as hedging instruments, including embedded derivatives, on the Statements of Income:

---

| | | |
|:---|:---|:---|
| **(in thousands)** | **Interest<br>Credited to<br>Fixed Accounts** | **Change in Fair<br>Value of<br>Market Risk<br>Benefits** |
|  **Year Ended December 31, 2025** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Interest rate contracts | $— | $(11823) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Equity contracts | 5526 | (46663) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Foreign exchange contracts |  | (3623) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; IUL embedded derivatives | (3935) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total gain (loss) | $1591 | $(62109) |
|  **Year Ended December 31, 2024** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Interest rate contracts | $— | $(56025) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Equity contracts | 3916 | (56970) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Foreign exchange contracts |  | 6163 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Credit contracts |  | 4105 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; IUL embedded derivatives | (8938) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total gain (loss) | $(5022) | $(102727) |
|  **Year Ended December 31, 2023** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Interest rate contracts | $— | $(23725) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Equity contracts | 4569 | (77123) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Foreign exchange contracts |  | 402 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Credit contracts |  | (19) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; IUL embedded derivatives | (5694) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total gain (loss) | $(1125) | $(100465) |

---

 **F-40** 

------

*RiverSource Life Insurance Co. of New York* 

The Company holds derivative instruments that either do not qualify or are not designated for hedge accounting treatment. These derivative instruments are used as economic hedges of equity, interest rate, credit and foreign currency exchange rate risk related to various products and transactions of the Company.

The deferred premium associated with certain of the above options is paid semi-annually over the life of the contract or at maturity. The following is a summary of the payments the Company is scheduled to make for these options as of December 31, 2025:

---

| | |
|:---|:---|
| **(in thousands)** | **Premiums<br>Payable** |
| 2026 | $23700 |
| 2027 |  |
| 2028 |  |
| 2029 | 13830 |
| 2030 | 21870 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total | $59400 |

---

Actual timing and payment amounts may differ due to future settlements, modifications or exercises of the contracts prior to the full premium being paid or received.

IUL products have returns tied to the performance of equity markets. As a result of fluctuations in equity markets, the obligation incurred by the Company related to IUL products will positively or negatively impact earnings over the life of these products. The equity component of IUL product obligations is considered an embedded derivative, which is bifurcated from the host contract for valuation purposes and reported on the Balance Sheets at fair value with changes in fair value reported in earnings. As a means of economically hedging its obligations under the provisions of this product, the Company enters into interest rate swaps, index options and futures contracts.

As discussed in Note 11, the Company issues variable annuity contracts that provide protection to contractholders from other-than-nominal capital market risk and expose the Company to other-than-nominal capital market risk. The Company economically hedges its obligations under these market risk benefits using options, swaptions, swaps and futures.

**Credit Risk** 

Credit risk associated with the Company's derivatives is the risk that a derivative counterparty will not perform in accordance with the terms of the applicable derivative contract. To mitigate such risk, the Company has established guidelines and oversight of credit risk through a comprehensive enterprise risk management program that includes members of senior management. Key components of this program are to require preapproval of counterparties and the use of master netting and collateral arrangements whenever practical. See Note 15 for additional information on the Company's credit exposure related to derivative assets.

Certain of the Company's derivative contracts contain provisions that adjust the level of collateral the Company is required to post based on the Company's financial strength rating (or based on the debt rating of RiverSource Life's parent, Ameriprise Financial). Additionally, certain of the Company's derivative contracts contain provisions that allow the counterparty to terminate the contract if the Company does not maintain a specific financial strength rating or Ameriprise Financial's debt does not maintain a specific credit rating (generally an investment grade rating). If these termination provisions were to be triggered, the Company's counterparty could require immediate settlement of any net liability position. As of December 31, 2025 and 2024, the aggregate fair value of derivative contracts in a net liability position containing such credit contingent provisions was $8.3 million and $9.1 million, respectively. The aggregate fair value of assets posted as collateral for such instruments as of December 31, 2025 and 2024 was $8.3 million and $9.1 million, respectively. If the credit contingent provisions of derivative contracts in a net liability position as of December 31, 2025 and 2024 were triggered, the aggregate fair value of additional assets that would be required to be posted as collateral or needed to settle the instruments immediately would have been nil as of both December 31, 2025 and 2024, respectively.

**F-41** 

------

*RiverSource Life Insurance Co. of New York* 

**17. SHAREHOLDER'S EQUITY** 

The following tables present the amounts related to each component of OCI:

---

| | | | |
|:---|:---|:---|:---|
| | **Year Ended December 31, 2025** | **Year Ended December 31, 2025** | **Year Ended December 31, 2025** |
| <br>**(in thousands)** | **Pretax** | **Income Tax<br>Benefit<br>(Expense)** | **Net of Tax** |
|  Net unrealized gains (losses) on securities: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net unrealized gains (losses) on securities arising during the period<sup>(1)</sup>  | $49848 | $(10468) | $39380 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Reclassification of net (gains) losses on securities included in net income<sup>(2)</sup>  | 1635 | (343) | 1292 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Impact of benefit reserves and reinsurance recoverables | (1003) | 211 | (792) |
|  Net unrealized gains (losses) on securities | 50480 | (10600) | 39880 |
|  Effect of changes in discount rate assumptions on certain long-duration contracts | (7711) | 1619 | (6092) |
|  Effect of changes in instrument-specific credit risk on market risk benefits ("MRBs") | 1421 | (299) | 1122 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total other comprehensive income (loss) | $44190 | $(9280) | $34910 |
|  | **Year Ended December 31, 2024** | **Year Ended December 31, 2024** | **Year Ended December 31, 2024** |
| **(in thousands)** | **Pretax** | **Income Tax<br>Benefit<br>(Expense)** | **Net of Tax** |
|  Net unrealized gains (losses) on securities: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net unrealized gains (losses) on securities arising during the period<sup>(1)</sup>  | $(31130) | $6537 | $(24593) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Reclassification of net (gains) losses on securities included in net income<sup>(2)</sup>  | 549 | (115) | 434 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Impact of benefit reserves and reinsurance recoverables | 612 | (129) | 483 |
|  Net unrealized gains (losses) on securities | (29969) | 6293 | (23676) |
|  Effect of changes in discount rate assumptions on certain long-duration contracts | 11697 | (2456) | 9241 |
|  Effect of changes in instrument-specific credit risk on MRBs | (2753) | 578 | (2175) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total other comprehensive income (loss) | $(21025) | $4415 | $(16610) |

---

---

| | | | |
|:---|:---|:---|:---|
| | **Year Ended December 31, 2023** | **Year Ended December 31, 2023** | **Year Ended December 31, 2023** |
| <br>**(in thousands)** | **Pretax** | **Income Tax<br>Benefit<br>(Expense)** | **Net of Tax** |
|  Net unrealized gains (losses) on securities: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net unrealized gains (losses) on securities arising during the period<sup>(1)</sup>  | $54710 | $(11489) | $43221 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Reclassification of net (gains) losses on securities included in net income<sup>(2)</sup>  | 224 | (47) | 177 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Impact of benefit reserves and reinsurance recoverables | (2181) | 458 | (1723) |
|  Net unrealized gains (losses) on securities | 52753 | (11078) | 41675 |
|  Effect of changes in discount rate assumptions on certain long-duration contracts | (7753) | 1628 | (6125) |
|  Effect of changes in instrument-specific credit risk on MRBs | (3734) | 784 | (2950) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total other comprehensive income (loss) | $41266 | $(8666) | $32600 |

---

<sup>(1)</sup> Includes impairments on Available-for-Sale securities related to factors other than credit that were recognized in OCI during the period.

<sup>(2)</sup> Reclassification amounts are recorded in Net realized investment gains (losses). 

Other comprehensive income (loss) related to net unrealized gains (losses) on securities includes three components: (i) unrealized gains (losses) that arose from changes in the market value of securities that were held during the period; (ii) (gains) losses that were previously unrealized, but have been recognized in current period net income due to sales of Available-for-Sale securities and due to the reclassification of noncredit losses to credit losses; and (iii) other adjustments primarily consisting of changes in insurance and annuity asset and liability balances, such as benefit reserves and reinsurance recoverables, to reflect the expected impact on their carrying values had the unrealized gains (losses) been realized as of the respective balance sheet dates.

 **F-42** 

------

*RiverSource Life Insurance Co. of New York* 

The following table presents the changes in the balances of each component of AOCI, net of tax:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **(in thousands)** | **Net Unrealized<br>Gains (Losses)<br>on Securities** | **Effect of<br>Changes in<br>Discount<br>Rate<br>Assumptions** | **Effect of<br>Changes in<br>Instrument-<br>Specific<br>Credit Risk<br>on MRBs** | **Total** |
|  **Balance at January 1, 2023** | $(123429) | $144 | $725 | $(122560) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; OCI before reclassifications | 41498 | (6125) | (2950) | 32423 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Amounts reclassified from AOCI | 177 |  |  | 177 |
|  Total OCI | 41675 | (6125) | (2950) | 32600 |
|  **Balance at December 31, 2023** | (81754) | (5981) | (2225) | (89960) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; OCI before reclassifications | (24110) | 9241 | (2175) | (17044) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Amounts reclassified from AOCI | 434 |  |  | 434 |
|  Total OCI | (23676) | 9241 | (2175) | (16610) |
|  **Balance at December 31, 2024** | (105430) | 3260 | (4400) | (106570) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; OCI before reclassifications | 38588 | (6092) | 1122 | 33618 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Amounts reclassified from AOCI | 1292 |  |  | 1292 |
|  Total OCI | 39880 | (6092) | 1122 | 34910 |
|  **Balance at December 31, 2025** | $(65550) | $(2832) | $(3278) | $(71660) |

---

**18. INCOME TAXES** 

The components of income tax provision were as follows:

---

| | | | |
|:---|:---|:---|:---|
| | **Years Ended December 31,** | **Years Ended December 31,** | **Years Ended December 31,** |
| <br>**(in thousands)** | **2025** | **2024** | **2023** |
|  **Current income tax** |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Federal | $(2889) | $566 | $9247 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; State and local | 36 | 117 | (173) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total current income tax | (2853) | 683 | 9074 |
|  **Deferred federal income tax** | 13955 | 14880 | (1519) |
|  Total income tax provision | $11102 | $15563 | $7555 |

---

The principal reasons that the aggregate income tax provision is different from that computed by using the U.S. statutory rate of 21% were as follows:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Years Ended December 31,** | **Years Ended December 31,** | **Years Ended December 31,** | **Years Ended December 31,** | **Years Ended December 31,** | **Years Ended December 31,** |
| | **2025** | **2025** | **2024** | **2024** | **2023** | **2023** |
| <br>**(in thousands, except percentages)** | **Amount** | **Percentage** | **Amount** | **Percentage** | **Amount** | **Percentage** |
|  U.S. federal statutory tax rate | $14106 | 21.0% | $18681 | 21.0% | $11366 | 21.0% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; State and local income taxes, net of federal income tax effect<sup>(1)</sup>  | 28 |  | 93 | 0.1 | (137) | (0.3) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tax credits: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Foreign tax credits, net of addback | (1429) | (2.1) | (1219) | (1.4) | (1576) | (2.9) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Nontaxable or nondeductible items: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dividends received deduction | (1773) | (2.6) | (1857) | (2.1) | (1848) | (3.4) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other | 75 | 0.1 | (6) |  | 109 | 0.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Changes in unrecognized tax benefits |  |  |  |  | (309) | (0.6) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other adjustments | 95 | 0.1 | (129) | (0.1) | (50) |  |
|  Effective tax rate | $11102 | 16.5% | $15563 | 17.5% | $7555 | 14.0% |

---

<sup>(1)</sup> State taxes in Illinois made up the majority (greater than 50 percent) of the tax effect in this category for 2025, 2024 and 2023. 

**F-43** 

------

*RiverSource Life Insurance Co. of New York* 

Deferred income tax assets and liabilities result from temporary differences between the assets and liabilities measured for GAAP reporting versus income tax return purposes. Deferred income tax assets and liabilities are measured at the statutory rate of 21% as of both December 31, 2025 and 2024. The significant components of the Company's deferred income tax assets and liabilities, which are included net within Other assets or Other liabilities, were as follows:

---

| | | |
|:---|:---|:---|
| | **December 31,** | **December 31,** |
| <br>**(in thousands)** | **2025** | **2024** |
|  **Deferred income tax assets** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Insurance and annuity benefits including corresponding hedges | $34864 | $50126 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Investments including net unrealized on Available-for-Sale securities | 15911 | 25863 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other | 358 | 262 |
|  Gross deferred income tax assets | 51133 | 76251 |
|  **Deferred income tax liabilities** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Deferred acquisition costs | 20036 | 21873 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other | 1226 | 1272 |
|  Gross deferred income tax liabilities | 21262 | 23145 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net deferred income tax assets | $29871 | $53106 |

---

Based on analysis of the Company's tax position, management believes it is more likely than not that the Company's results of future operations and implementation of tax planning strategies will generate sufficient taxable income to enable the Company to utilize all of the deferred tax assets. Accordingly, no valuation allowance for deferred tax assets has been established as of both December 31, 2025 and 2024.

A reconciliation of the beginning and ending amount of gross unrecognized tax benefits was as follows:

---

| | | | |
|:---|:---|:---|:---|
| **(in thousands)** | **2025** | **2024** | **2023** |
|  Balance at January 1 | $— | $— | $320 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Additions for tax positions related to the current year |  |  | 6 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Reductions for tax positions related to the current year |  |  | (6) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Additions for tax positions of prior years |  |  | 324 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Reductions for tax positions of prior years |  |  | (644) |
|  Balance at December 31 | $— | $— | $— |

---

For all open tax years and all major taxing jurisdictions, management has concluded that there are no significant uncertain tax positions that would require recognition in the financial statements.

The Company recognizes interest and penalties related to unrecognized tax benefits as a component of the income tax provision. The Company did not recognize interest and penalties for the years ended December 31, 2025 and 2024, and recognized a net decrease of $90 thousand in interest and penalties for the year ended December 31, 2023. As of both December 31, 2025 and 2024, the Company did not have a payable related to accrued interest and penalties.

The Company files its federal income tax return as part of the consolidated income tax return of Ameriprise Financial in the U.S. federal jurisdiction. The Company files as a separate entity and as part of unitary or combined returns with Ameriprise Financial and other affiliates in various state jurisdictions. The federal statutes of limitations are closed on years through 2018, except for two issues for 2016 which were claimed on an amended return. During the second quarter of 2025, the Internal Revenue Service ("IRS") finalized the audit of Ameriprise Financial's U.S. income tax returns for tax years 2019 and 2020, except for one issue for 2020, which remains open. The IRS is currently auditing Ameriprise Financial's U.S. income tax returns for 2021 through 2023. The state income tax returns of Ameriprise Financial or its subsidiaries, including the Company, are currently under examination by various jurisdictions for years ranging from 2018 through 2023.

The legislation commonly referred to as the One Big Beautiful Bill Act ("OBBBA") was enacted on July 4, 2025. The corporate tax law changes resulting from the OBBBA did not have an impact to the Company's financial statements for the year ended December 31, 2025 and, based on current guidance, the Company does not expect to record any material impacts in the future.

Income taxes paid (received) were as follows:

---

| | | | |
|:---|:---|:---|:---|
| **(in thousands)** | **2025** | **2024** | **2023** |
|  Income taxes paid (received), net | $(2612) | $2435 | $12777 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Federal | (2729) | 2608 | 12854 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; State and local | 117 | (173) | (77) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Illinois | \* | (132) | \* |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other state and local | \* | (41) | \* |

---

\* The amount of income taxes paid during the year is below the required 5% disaggregation threshold. 

 **F-44** 

------

*RiverSource Life Insurance Co. of New York* 

**19. COMMITMENTS AND CONTINGENCIES** 

***Commitments***

As of both December 31, 2025 and 2024, the Company had no funding commitments related to mortgage loans.

***Contingencies***

The Company and its affiliates are involved, in the normal course of business, in legal proceedings, which include regulatory inquiries, arbitration and litigation (including class actions), concerning matters arising in connection with the conduct of its activities. These include proceedings specific to the Company as well as proceedings generally applicable to business practices in the industries in which it operates. The Company can also be subject to legal proceedings arising out of its general business activities, such as its investments, contracts and employment relationships. Uncertain economic conditions, heightened and sustained volatility in the financial markets and significant financial reform legislation may increase the likelihood that clients and other persons or regulators may present or threaten legal claims or that regulators increase the scope or frequency of examinations of the Company or the insurance industry generally.

As with other insurance companies, the level of regulatory activity concerning the Company's businesses remains elevated. From time to time, the Company and its affiliates, including AFS and RiverSource Distributors, Inc. receive requests for information from, and/or has been subject to examination or claims by various state, federal and other domestic authorities. The Company and its affiliates are cooperating with the applicable regulators. The Company and its affiliates typically have numerous pending matters that include information requests, exams, inquiries or disputes regarding their business activities and practices and other subjects, including from time to time: sales and distribution of, and disclosure practices related to, various products, including the Company's insurance and annuity products; supervision of associated persons, including AFS financial advisors and RiverSource Distributors, Inc.'s wholesalers; administration of insurance and annuity claims; security of client information; recordkeeping requirements; and transaction monitoring systems and controls.

These pending matters are subject to uncertainties and, as such, it is inherently difficult to determine whether any loss is probable or even reasonably possible, or to reasonably estimate the amount of any loss that may result from such matters. The Company cannot predict with certainty if, how, or when any such proceedings will be initiated or resolved. Matters frequently need to be more developed before a potential loss or range of loss can be reasonably estimated for any matter. An adverse outcome in any matter could result in an adverse judgment, a settlement, fine, penalty, or other sanction, and may lead to further claims, examinations, adverse publicity or reputational damage, each of which could have a material adverse effect on the Company's financial condition, results of operations, or liquidity.

In accordance with applicable accounting standards, the Company establishes an accrued liability for contingent litigation and regulatory matters when those matters present loss contingencies that are both probable and can be reasonably estimated. The Company discloses the nature of the contingency when management believes there is at least a reasonable possibility that the outcome may be material to the Company's financial statements and, where feasible, an estimate of the possible loss. In such cases, there still may be an exposure to loss in excess of any amounts reasonably estimated and accrued. When a loss contingency is not both probable and reasonably estimable, the Company does not establish an accrued liability, but continues to monitor, in conjunction with any outside counsel handling a matter, further developments that would make such loss contingency both probable and reasonably estimable. Once the Company establishes an accrued liability with respect to a loss contingency, the Company continues to monitor the matter for further developments that could affect the amount of the accrued liability that has been previously established, and any appropriate adjustments are made each quarter.

***Guaranty Fund Assessments***

The Company is required by law to be a member of the guaranty fund association in the State of New York. In the event of insolvency of one or more unaffiliated insurance companies, the Company could be adversely affected by the requirement to pay assessments to the guaranty fund association. The Company projects its cost of future guaranty fund assessments based on estimates of insurance company insolvencies provided by the National Organization of Life and Health Insurance Guaranty Associations and the amount of its premiums written relative to the industry-wide premium in the State of New York. The Company accrues the estimated cost of future guaranty fund assessments when it is considered probable that an assessment will be imposed, the event obligating the Company to pay the assessment has occurred and the amount of the assessment can be reasonably estimated.

As of both December 31, 2025 and 2024, the Company had no accrual established for estimated future guaranty fund assessments.

**F-45** 

------

![](g104622img750d1f0a1.gif)

RiverSource Life Insurance Co. of New York

20 Madison Avenue Extension

Albany, NY 12203

1-800-541-2251

ANN9126_12_E01_(05/26)

RiverSource Distributors, Inc. (Distributor), Member FINRA.

Issued by RiverSource Life Insurance Co. of New York, Albany, New York.

Affiliated with Ameriprise Financial Services, LLC.© 2008-2026 RiverSource Life Insurance Company. All rights reserved.

------